0.21784335.16027115.html.plaintext.txt	0	high secretase activity elicits neurodegeneration transgenic mice despite reductions amyloid levels implications treatment alzheimer disease edward rockenstein michael mante michael alford anthony adame leslie crews makoto hashimoto luke esposito lennart mucke eliezer masliahnum
0.21784335.16027115.html.plaintext.txt	1	neurosciences pathology university california san diego school medicine la jolla california num num gladstone institute neurological disease department neurology university california san francisco california num
0.21784335.16027115.html.plaintext.txt	2	received publication june num num revised form july num num
0.21784335.16027115.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references amyloid peptides widely presumed play causal role alzheimer disease release amyloid precursor protein app requires proteolysis site app cleaving enzyme symb although increased symb activity alzheimer disease brains human h symb transgenic tg mice results altered app cleavage contribution molecular alterations neurodegeneration unclear therefore used murine symb promoter express high levels symb without happ neurons tg mice compared happ mice symbhapp doubly tg mice increased levels app c terminal fragments symb symb decreased levels full length app contrast non tg controls happ mice symb mice symbhapp mice showed degeneration neurons neocortex hippocampus degradation myelin neurological deficits also severe symb symbhapp mice happ mice results demonstrate high levels symb activity sufficient elicit neurodegeneration neurological decline vivo pathogenic pathway involves accumulation app c terminal fragments depend increased production human thus inhibiting symb may block dependent also independent pathogenic mechanisms
0.21784335.16027115.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references amyloid peptides widely presumed play causal role alzheimer disease release amyloid precursor protein app requires proteolysis site app cleaving enzyme symb although increased symb activity alzheimer disease brains human h symb transgenic tg mice results altered app cleavage contribution molecular alterations neurodegeneration unclear therefore used murine symb promoter express high levels symb without happ neurons tg mice compared happ mice symbhapp doubly tg mice increased levels app c terminal fragments symb symb decreased levels full length app contrast non tg controls happ mice symb mice symbhapp mice showed degeneration neurons neocortex hippocampus degradation myelin neurological deficits also severe symb symbhapp mice happ mice results demonstrate high levels symb activity sufficient elicit neurodegeneration neurological decline vivo pathogenic pathway involves accumulation app c terminal fragments depend increased production human thus inhibiting symb may block dependent also independent pathogenic mechanisms
0.21784335.16027115.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references precise mechanisms leading neurodegeneration alzheimer disease adnum completely understood however diverse lines evidence suggest alterations processing amyloid precursor protein app leading accumulation amyloid peptides play key role pathogenesis ad num num various products derived app alternative proteolytic cleavage enormous progress recently made identifying enzymes involved num num
0.21784335.16027115.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references precise mechanisms leading neurodegeneration alzheimer disease adnum completely understood however diverse lines evidence suggest alterations processing amyloid precursor protein app leading accumulation amyloid peptides play key role pathogenesis ad num num various products derived app alternative proteolytic cleavage enormous progress recently made identifying enzymes involved num num
0.21784335.16027115.html.plaintext.txt	7	cleavage app secretase results secretion large n terminal ectodomain alternative pathway secretase generates shorter secreted n terminal fragment app c terminal fragments ctfs symb symb remain membrane bound latter fragments cleaved secretase resulting production peptides site app cleaving enzyme symb accounts secretase activity brain num num num num symb typical aspartic protease cleavage prodomain generate mature enzyme occurs c terminal site resulting generation mature protein starting glu num num
0.21784335.16027115.html.plaintext.txt	8	cleavage app secretase results secretion large n terminal ectodomain alternative pathway secretase generates shorter secreted n terminal fragment app c terminal fragments ctfs symb symb remain membrane bound latter fragments cleaved secretase resulting production peptides site app cleaving enzyme symb accounts secretase activity brain num num num num symb typical aspartic protease cleavage prodomain generate mature enzyme occurs c terminal site resulting generation mature protein starting glu num num
0.21784335.16027115.html.plaintext.txt	9	recent evidence suggests pathogenesis ad involves alterations activity symb polymorphism symb gene reported influence ad risk num compared nondemented controls symb immunoreactivity increased around amyloid plaques ad brains levels symb elevated ad brain homogenates num num correlated levels app ctfs symb x symb num num potential pathogenic role increased bace activity investigated vivo analyzing metabolism app human h bace transgenic tg mice num num studies shown expression symb moderate levels happ tg models results increased generation happ ctfs cases associated enhanced amyloid deposition studies confirmed importance symb app processing vivo however relationship high levels symb activity app processing neurodegeneration remains established address issue used strong symb promoter express symb neurons tg mice either alone combination happ high levels symb activity significantly increased cerebral accumulation happ ctfs caused prominent age related neurodegeneration neurological decline
0.21784335.16027115.html.plaintext.txt	10	recent evidence suggests pathogenesis ad involves alterations activity symb polymorphism symb gene reported influence ad risk num compared nondemented controls symb immunoreactivity increased around amyloid plaques ad brains levels symb elevated ad brain homogenates num num correlated levels app ctfs symb x symb num num potential pathogenic role increased bace activity investigated vivo analyzing metabolism app human h bace transgenic tg mice num num studies shown expression symb moderate levels happ tg models results increased generation happ ctfs cases associated enhanced amyloid deposition studies confirmed importance symb app processing vivo however relationship high levels symb activity app processing neurodegeneration remains established address issue used strong symb promoter express symb neurons tg mice either alone combination happ high levels symb activity significantly increased cerebral accumulation happ ctfs caused prominent age related neurodegeneration neurological decline
0.21784335.16027115.html.plaintext.txt	11	experimental procedures top abstract introduction experimental procedures results discussion references generation symb symbhapp tg mice tissue processing cdna encoding wild type symb produced reverse transcription pcr human brain mrna described previously num cdna includes kozak consensus sequence gcc acc atg num end enhance expression symb cdna inserted exons num num symb expression cassette kindly provided dr h van der putten ciba geigy basel switzerland purified microinjected one cell embryos symbnum x dbanum symb transgenic founder mice identified pcr analysis genomic dna extracted tail biopsies doubly tg mice generated crossing heterozygous symb mice lines num num happ tg line num described previously num happ line num expresses mutant symb direction symb promoter produces high levels symb num resulting plaque formation num months age tg lines maintained crossing heterozygous tg mice non tg symbnum x dbanum symb breeders tg mice analyzed study heterozygous respect individual transgenes non tg littermates used controls
0.21784335.16027115.html.plaintext.txt	12	experimental procedures top abstract introduction experimental procedures results discussion references generation symb symbhapp tg mice tissue processing cdna encoding wild type symb produced reverse transcription pcr human brain mrna described previously num cdna includes kozak consensus sequence gcc acc atg num end enhance expression symb cdna inserted exons num num symb expression cassette kindly provided dr h van der putten ciba geigy basel switzerland purified microinjected one cell embryos symbnum x dbanum symb transgenic founder mice identified pcr analysis genomic dna extracted tail biopsies doubly tg mice generated crossing heterozygous symb mice lines num num happ tg line num described previously num happ line num expresses mutant symb direction symb promoter produces high levels symb num resulting plaque formation num months age tg lines maintained crossing heterozygous tg mice non tg symbnum x dbanum symb breeders tg mice analyzed study heterozygous respect individual transgenes non tg littermates used controls
0.21784335.16027115.html.plaintext.txt	13	different ages mice anesthetized chloral hydrate flush perfused transcardially numnum saline brains peripheral tissues removed brains divided sagittally one hemibrain postfixed phosphate buffered num paraformaldehyde ph numnum num degrees c num h neuropathological analysis snap frozen stored num degrees c rna protein analyses
0.21784335.16027115.html.plaintext.txt	14	rna analysis total rna extracted tri reagent molecular research center cincinnati oh snap frozen hemibrains dissected brain regions neocortex hippocampus stored formazol buffer molecular research num degrees c rna analyzed solution hybridization ribonuclease protection assay rpa essentially described previously num samples separated num acrylamide num m urea tris borate edta gels dried gels exposed kodak xar film eastman kodak mrna levels quantitated phosphorimager readings probe specific signals corrected rna contentloading errors normalization actin signals num following nump labeled antisense riboprobes used identify specific mrnas protected nucleotides genbank accession numbers symb nucleotides num num accession number symb genbank mouse m symb num num accession number symb genbank symb num num accession number xmnum mapp exon num num m actin num num accession number symb genbank
0.21784335.16027115.html.plaintext.txt	15	rna analysis total rna extracted tri reagent molecular research center cincinnati oh snap frozen hemibrains dissected brain regions neocortex hippocampus stored formazol buffer molecular research num degrees c rna analyzed solution hybridization ribonuclease protection assay rpa essentially described previously num samples separated num acrylamide num m urea tris borate edta gels dried gels exposed kodak xar film eastman kodak mrna levels quantitated phosphorimager readings probe specific signals corrected rna contentloading errors normalization actin signals num following nump labeled antisense riboprobes used identify specific mrnas protected nucleotides genbank accession numbers symb nucleotides num num accession number symb genbank mouse m symb num num accession number symb genbank symb num num accession number xmnum mapp exon num num m actin num num accession number symb genbank
0.21784335.16027115.html.plaintext.txt	16	western blot analysis symb happ app ctfs determination protein content lowry method frontal cortex homogenates loaded num microg proteinlane separated num sds polyacrylamide gels blotted onto nitrocellulose blots labeled rabbit polyclonal antibody symb prosci inc poway ca numnumnum mouse monoclonal antibody n terminus app numsymb chemicon international temecula ca numnumnum mouse monoclonal antibody happ numsymb elan numnumnum rabbit polyclonal antibody symb symb app symb courtesy dr edward koo numnumnum mouse monoclonal antibody numsymb senetek plc napa ca numnumnum followed anti mouse anti rabbit secondary antibodies blots incubated numi protein icn pharmaceuticals costa mesa ca exposed phosphorimager molecular dynamics piscataway nj screens incubated super signal west pico chemiluminescent substrate pierce exposed film details regarding antibodies utilized described table one control variations loading blots stripped incubated mouse monoclonal antibody actin chemicon numnum signal intensities quantitated imagequant software molecular dynamics
0.21784335.16027115.html.plaintext.txt	17	western blot analysis symb happ app ctfs determination protein content lowry method frontal cortex homogenates loaded num microg proteinlane separated num sds polyacrylamide gels blotted onto nitrocellulose blots labeled rabbit polyclonal antibody symb prosci inc poway ca numnumnum mouse monoclonal antibody n terminus app numsymb chemicon international temecula ca numnumnum mouse monoclonal antibody happ numsymb elan numnumnum rabbit polyclonal antibody symb symb app symb courtesy dr edward koo numnumnum mouse monoclonal antibody numsymb senetek plc napa ca numnumnum followed anti mouse anti rabbit secondary antibodies blots incubated numi protein icn pharmaceuticals costa mesa ca exposed phosphorimager molecular dynamics piscataway nj screens incubated super signal west pico chemiluminescent substrate pierce exposed film details regarding antibodies utilized described table one control variations loading blots stripped incubated mouse monoclonal antibody actin chemicon numnum signal intensities quantitated imagequant software molecular dynamics
0.21784335.16027115.html.plaintext.txt	18	view table table one antibodies bace app app metabolites used study
0.21784335.16027115.html.plaintext.txt	19	additional western blot analysis performed highly denaturing conditions described previously num modifications neocortical tissues homogenized num formic acid num final concentration icn dounce homogenizer centrifuged num min numnum x g num degrees c supernatants collected used highly denaturing acetic acidurea page western blot analysis briefly numnum mg mice without plaques num microg mice plaques total protein determined micro lowry assay loaded per lane numnumnum step gradient polyacrylamide gel containing num m urea num acetic acid electrophoresed anode cathode numnum acetic acid running buffer overnight num degrees c gel neutralized five num min incubations trisglycine transfer buffer num methanol ph numnum transferred nitrocellulose membrane numnum microm pore size membrane boiled phosphate buffered saline num min blocked num milk tris buffered saline numnum tween num tbst num h incubated overnight num degrees c anti antibody num numnum microgml num membranes washed three times num min num bovine serum albumin tbst incubated anti mouse igghorseradish peroxidase secondary antibody num h room temperature membranes washed three times num min tbst detection carried super signal west pico chemiluminescent substrate pierce synthetic symb num symb num peptides num pg biopeptide san diego ca run standards
0.21784335.16027115.html.plaintext.txt	20	additional western blot analysis performed highly denaturing conditions described previously num modifications neocortical tissues homogenized num formic acid num final concentration icn dounce homogenizer centrifuged num min numnum x g num degrees c supernatants collected used highly denaturing acetic acidurea page western blot analysis briefly numnum mg mice without plaques num microg mice plaques total protein determined micro lowry assay loaded per lane numnumnum step gradient polyacrylamide gel containing num m urea num acetic acid electrophoresed anode cathode numnum acetic acid running buffer overnight num degrees c gel neutralized five num min incubations trisglycine transfer buffer num methanol ph numnum transferred nitrocellulose membrane numnum microm pore size membrane boiled phosphate buffered saline num min blocked num milk tris buffered saline numnum tween num tbst num h incubated overnight num degrees c anti antibody num numnum microgml num membranes washed three times num min num bovine serum albumin tbst incubated anti mouse igghorseradish peroxidase secondary antibody num h room temperature membranes washed three times num min tbst detection carried super signal west pico chemiluminescent substrate pierce synthetic symb num symb num peptides num pg biopeptide san diego ca run standards
0.21784335.16027115.html.plaintext.txt	21	view larger version numk figure num symb expression brains symb tg mice non tg controls brain tissues obtained num month old tg mice lines num num num age matched non tg controls num year old nondemented human c human h mouse m symb mrnas frontal cortex quantitated rpa representative autoradiograph lane contains sample different mouse human b c relative mrna levels expressed symbactin b symbactin c ratios correct loading errors rpa signals quantitated described previously num d relative levels symb protein frontal cortex determined western blot analysis representative western blot demonstrates association symb particulate fraction lane contains sample different mouse e western blot bands quantitated imagequant software f symb activity determined red fret peptide substrate based swapp mutant assay differentiate activities human murine symb levels non tg controls defined num g j photomicrographs depicting immunoperoxidase staining symb frontal cortex non tg mouse g symb tg mice lines num hnumi num j bar num microm p numnum versus lines num num tukey kramer test p numnum versus non tg controls dunnetts test
0.21784335.16027115.html.plaintext.txt	22	view larger version numk figure num symb expression brains symb tg mice non tg controls brain tissues obtained num month old tg mice lines num num num age matched non tg controls num year old nondemented human c human h mouse m symb mrnas frontal cortex quantitated rpa representative autoradiograph lane contains sample different mouse human b c relative mrna levels expressed symbactin b symbactin c ratios correct loading errors rpa signals quantitated described previously num d relative levels symb protein frontal cortex determined western blot analysis representative western blot demonstrates association symb particulate fraction lane contains sample different mouse e western blot bands quantitated imagequant software f symb activity determined red fret peptide substrate based swapp mutant assay differentiate activities human murine symb levels non tg controls defined num g j photomicrographs depicting immunoperoxidase staining symb frontal cortex non tg mouse g symb tg mice lines num hnumi num j bar num microm p numnum versus lines num num tukey kramer test p numnum versus non tg controls dunnetts test
0.21784335.16027115.html.plaintext.txt	23	analysis app metabolism related pathways human peptides quantitated enzyme linked immunosorbent assays elisas described previously num symb num elisa detects symb num whereas symb x elisa detects symb num symb num well forms containing amino acids num num analysis app ctfs cortex homogenates analyzed lowry method determine protein concentration loaded num microg proteinlane num num microglane symb symb mice respectively onto num tricinesds polyacrylamide gels blotted onto nitrocellulose probed antibodies app ctfs symb numnumnum phospho p app cell signaling beverly ma numnumnum tubulin loading control numnumnum
0.21784335.16027115.html.plaintext.txt	24	analysis app metabolism related pathways human peptides quantitated enzyme linked immunosorbent assays elisas described previously num symb num elisa detects symb num whereas symb x elisa detects symb num symb num well forms containing amino acids num num analysis app ctfs cortex homogenates analyzed lowry method determine protein concentration loaded num microg proteinlane num num microglane symb symb mice respectively onto num tricinesds polyacrylamide gels blotted onto nitrocellulose probed antibodies app ctfs symb numnumnum phospho p app cell signaling beverly ma numnumnum tubulin loading control numnumnum
0.21784335.16027115.html.plaintext.txt	25	evaluate effects symb expression related pathways western blots probed antibodies neprilysin symb mouse monoclonal abcam cambridge ma numnum insulin degrading enzyme ide rabbit polyclonal calbiochem san diego ca numnumnum symb rabbit polyclonal santa cruz biotechnology santa cruz ca numnumnum
0.21784335.16027115.html.plaintext.txt	26	analysis symb enzymatic activity symb activity determined adapting symb fluorescence resonance energy transfer fret assay kit panvera madison wi uses red fret peptide derived swedish sw mutant app substrate sequence described previously num briefly brain homogenates tg mice incubated symb substrate final concentration num x reagents stop buffer containing numnum m sodium acetate added signal determined num nm spectrofluorometer control experiments performed standard curves generated using baculovirus expressed symb symb product standard rh evnl symb inhibitor provided kit
0.21784335.16027115.html.plaintext.txt	27	analysis symb enzymatic activity symb activity determined adapting symb fluorescence resonance energy transfer fret assay kit panvera madison wi uses red fret peptide derived swedish sw mutant app substrate sequence described previously num briefly brain homogenates tg mice incubated symb substrate final concentration num x reagents stop buffer containing numnum m sodium acetate added signal determined num nm spectrofluorometer control experiments performed standard curves generated using baculovirus expressed symb symb product standard rh evnl symb inhibitor provided kit
0.21784335.16027115.html.plaintext.txt	28	confirm symb activity levels independent method extracted supernatants homogenized samples neutralized tris assayed symb activity utilizing substrate bacterial maltose binding protein mbp fused c terminal num amino acids app mbp symb described previously num briefly assays carried num mm sodium acetate ph numnum numnum triton x num num microgml mbp symb reaction mixtures diluted numnum incubated num degrees c num h quenched reaction mixtures loaded onto num well plates coated polyclonal antibody raised mbp cleaved products detected using biotinylated symb specific reporter antibodies purified symb used standard activity assays
0.21784335.16027115.html.plaintext.txt	29	confirm symb activity levels independent method extracted supernatants homogenized samples neutralized tris assayed symb activity utilizing substrate bacterial maltose binding protein mbp fused c terminal num amino acids app mbp symb described previously num briefly assays carried num mm sodium acetate ph numnum numnum triton x num num microgml mbp symb reaction mixtures diluted numnum incubated num degrees c num h quenched reaction mixtures loaded onto num well plates coated polyclonal antibody raised mbp cleaved products detected using biotinylated symb specific reporter antibodies purified symb used standard activity assays
0.21784335.16027115.html.plaintext.txt	30	view larger version numk figure num decreases fl app increases app ctfs symb tg mice homogenates frontal cortex num month old symb tg mice non tg littermates separated cytosolic particulate fractions analyzed western blotting antibodies fl app numsymb mouse monoclonal app ctfs symb rabbit polyclonal actin mouse monoclonal expression levels quantitated representative western blot samples different symb tg lines lane contains sample different mouse b c quantitation western blot bands n num micegenotype d double immunolabeling confocal microscopic analysis symb red app ctfs green frontal cortex num month old non tg d f symb tg g mice bar num microm p numnum versus non tg controls dunnetts test
0.21784335.16027115.html.plaintext.txt	31	view larger version numk figure num decreases fl app increases app ctfs symb tg mice homogenates frontal cortex num month old symb tg mice non tg littermates separated cytosolic particulate fractions analyzed western blotting antibodies fl app numsymb mouse monoclonal app ctfs symb rabbit polyclonal actin mouse monoclonal expression levels quantitated representative western blot samples different symb tg lines lane contains sample different mouse b c quantitation western blot bands n num micegenotype d double immunolabeling confocal microscopic analysis symb red app ctfs green frontal cortex num month old non tg d f symb tg g mice bar num microm p numnum versus non tg controls dunnetts test
0.21784335.16027115.html.plaintext.txt	32	behavioral analysis mice free access food water experiments carried light cycle experimental control groups contained similar proportions males females water maze test carried described previously num briefly pool diameter num cm filled opaque water num degrees c mice first trained locate visible platform days num num submerged hidden platform days num num three daily trials num num min apart mice failed find hidden platform within num placed num platform location used sessions mice starting point mouse placed water changed randomly two alternative entry points located similar distance platform day num another visible platform trial performed exclude differences motivation fatigue time reach platform latency path length swim speed recorded noldus instruments ethovision video tracking system san diego instruments san diego set analyze two sampless
0.21784335.16027115.html.plaintext.txt	33	behavioral analysis mice free access food water experiments carried light cycle experimental control groups contained similar proportions males females water maze test carried described previously num briefly pool diameter num cm filled opaque water num degrees c mice first trained locate visible platform days num num submerged hidden platform days num num three daily trials num num min apart mice failed find hidden platform within num placed num platform location used sessions mice starting point mouse placed water changed randomly two alternative entry points located similar distance platform day num another visible platform trial performed exclude differences motivation fatigue time reach platform latency path length swim speed recorded noldus instruments ethovision video tracking system san diego instruments san diego set analyze two sampless
0.21784335.16027115.html.plaintext.txt	34	immunohistochemistry vibratome sections num microm brain tissues incubated overnight num degrees c primary antibodies symb prosci inc numnum happ numsymb elan numnumnum table one binding primary antibody detected vector abc elite kit vector laboratories burlingame ca diaminobenzidine tetrahydrochloride numnum symbnum double labeling studies performed essentially described previously num briefly vibratome sections incubated overnight num degrees c anti symb numnum developed tyramide signal amplification direct red system perkinelmer life sciences numnum sections incubated overnight antibody app ctfs symb numnum followed incubation fitc tagged secondary goat anti rabbit vector numnum imaging laser scanning confocal microscopy lscm mrc num bio rad
0.21784335.16027115.html.plaintext.txt	35	immunohistochemistry vibratome sections num microm brain tissues incubated overnight num degrees c primary antibodies symb prosci inc numnum happ numsymb elan numnumnum table one binding primary antibody detected vector abc elite kit vector laboratories burlingame ca diaminobenzidine tetrahydrochloride numnum symbnum double labeling studies performed essentially described previously num briefly vibratome sections incubated overnight num degrees c anti symb numnum developed tyramide signal amplification direct red system perkinelmer life sciences numnum sections incubated overnight antibody app ctfs symb numnum followed incubation fitc tagged secondary goat anti rabbit vector numnum imaging laser scanning confocal microscopy lscm mrc num bio rad
0.21784335.16027115.html.plaintext.txt	36	neuropathological analysis vibratome sections incubated overnight num degrees c mouse monoclonal antibodies neuronal dendritic marker microtubule associated protein num symb chemicon numnum axonal neurofilament marker symb sternberger immuocytochemicals baltimore md numnum astroglial marker glial fibrillary acidic protein gfap chemicon numnum described previously num binding primary antibodies detected vector elite kit diaminobenzidine tetrahydrochloridesymbnum fitc conjugated igg secondary antibodies vector numnum immunoperoxidase labeled sections examined olympus vanox light microscope fitc labeled sections analyzed confocal microscopy num num
0.21784335.16027115.html.plaintext.txt	37	neuropathological analysis vibratome sections incubated overnight num degrees c mouse monoclonal antibodies neuronal dendritic marker microtubule associated protein num symb chemicon numnum axonal neurofilament marker symb sternberger immuocytochemicals baltimore md numnum astroglial marker glial fibrillary acidic protein gfap chemicon numnum described previously num binding primary antibodies detected vector elite kit diaminobenzidine tetrahydrochloridesymbnum fitc conjugated igg secondary antibodies vector numnum immunoperoxidase labeled sections examined olympus vanox light microscope fitc labeled sections analyzed confocal microscopy num num
0.21784335.16027115.html.plaintext.txt	38	ultrastructural analysis blocks neocortex hippocampus postfixed num glutaraldehyde numnum osmium tetroxide numnum m sodium cacodylate buffer embedded epoxy blocks sectioned ultracut e ultramicrotome leica nussloch germany analyzed zeiss symb electron microscope carl zeiss oberkochen germany num
0.21784335.16027115.html.plaintext.txt	39	statistical analysis analyses carried statview numnum program sas institute inc cary nc differences among means assessed students test one way anova followed dunnetts tukey kramer post hoc tests indicated learning curves analyzed repeated measures anova null hypothesis rejected numnum level
0.21784335.16027115.html.plaintext.txt	40	view larger version numk figure num decreases fl app increases app ctfs symbhapp tg mice homogenates frontal cortex num month old symb tg happ tg symbhapp doubly tg mice non tg littermates separated cytosolic particulate fractions analyzed western blotting antibodies fl app numsymb mouse monoclonal app ctfs symb rabbit polyclonal actin mouse monoclonal expression levels quantitated representative western blot samples symbhapp doubly tg mice singly tg symb happ controls b c quantitation western blot bands n num micegroup d double immunolabeling confocal microscopic analysis symb red happ green frontal cortex num month old happ tg d f symbhapp tg g mice bar num microm p numnum versus non tg controls dunnetts test p numnum versus symbhapp doubly tg mice tukey kramer test
0.21784335.16027115.html.plaintext.txt	41	view larger version numk figure num decreases fl app increases app ctfs symbhapp tg mice homogenates frontal cortex num month old symb tg happ tg symbhapp doubly tg mice non tg littermates separated cytosolic particulate fractions analyzed western blotting antibodies fl app numsymb mouse monoclonal app ctfs symb rabbit polyclonal actin mouse monoclonal expression levels quantitated representative western blot samples symbhapp doubly tg mice singly tg symb happ controls b c quantitation western blot bands n num micegroup d double immunolabeling confocal microscopic analysis symb red happ green frontal cortex num month old happ tg d f symbhapp tg g mice bar num microm p numnum versus non tg controls dunnetts test p numnum versus symbhapp doubly tg mice tukey kramer test
0.21784335.16027115.html.plaintext.txt	42	results top abstract introduction experimental procedures results discussion references expression symb brains symb symb tg mice micro injection symb symb construct yielded four tg lines three selected analysis based levels symb mrna determined rpa symb mrna levels whole hemibrains tg lines num num fold higher frontal cortex humans without ad highest levels detected line num fig num b three lines levels endogenous symb decreased num num compared non tg controls fig numc consistent mrna analysis symb protein levels fig num d e hbace activity fig numf neuronal symb immunoreactivity fig num g j higher line num lines num num three lines high levels symb immunoreactivity observed pyramidal neurons layers num num neocortex fig num h j hippocampal formation symb immunoreactivity detected pyramidal cells symb region granule cells dentate gyrus line num pyramidal neurons symb num granule cells lines num num shown moderate symb immunoreactivity also detected subcortical nuclei cerebellum three lines shown brains non tg controls immunoreactivity background levels detected symb specific antibody fig num d e g
0.21784335.16027115.html.plaintext.txt	43	results top abstract introduction experimental procedures results discussion references expression symb brains symb symb tg mice micro injection symb symb construct yielded four tg lines three selected analysis based levels symb mrna determined rpa symb mrna levels whole hemibrains tg lines num num fold higher frontal cortex humans without ad highest levels detected line num fig num b three lines levels endogenous symb decreased num num compared non tg controls fig numc consistent mrna analysis symb protein levels fig num d e hbace activity fig numf neuronal symb immunoreactivity fig num g j higher line num lines num num three lines high levels symb immunoreactivity observed pyramidal neurons layers num num neocortex fig num h j hippocampal formation symb immunoreactivity detected pyramidal cells symb region granule cells dentate gyrus line num pyramidal neurons symb num granule cells lines num num shown moderate symb immunoreactivity also detected subcortical nuclei cerebellum three lines shown brains non tg controls immunoreactivity background levels detected symb specific antibody fig num d e g
0.21784335.16027115.html.plaintext.txt	44	high levels symb expression increase app ctfs decrease levels full length app full length fl app detected western blots brain homogenates triple band fig numa compared non tg controls high expresser symb tg mice decreased levels fl app fig numa b decrease marked two upper bands contrast levels app ctfs num num fold higher symb mice non tg controls determined western blot analysis symb antibody recognizes symb generated symb symb fragments app fig num c well secretase generated symb fragment num double labeling analysis confirmed intraneuronal accumulation app ctfs higher symb mice non tg controls fig num d moreover neurons displaying highest levels symb expression also showed highest levels app ctf immunoreactivity fig num g characterize effects high levels symb expression happ processing homogenates happ singly tg mice expressing familial ad mutant happ line num num symbline numhappline num doubly tg mice analyzed western blot singly tg happ mice showed increase overall levels cerebral app expression compared non tg controls fig num c compared mice symbhapp mice lower levels fl app higher levels app ctfs fig num c immunoreactivities symb app ctfs symbhapp mice colocalized neurons fig num g consistent notion increase app ctfs resulted increased cleavage happ symb
0.21784335.16027115.html.plaintext.txt	45	investigate app metabolism greater detail mice app ctfs detected immunoblot analysis separation tricinesds polyacrylamide gels analysis revealed increase app ctfs symbhapp mice represents primarily accumulation symb results app cleavage site fig numa whereas secretase cleavage symb would result production symb x secretase cleavage symb would result production symb x surprisingly symbhapp mice decreased levels symb x truncated species hippocampal levels symb x fig numb symb num fig numc much lower symbhapp mice happ singly tg mice elisas used obtain measurements specifically detect peptides containing first five amino acids also analyzed levels antibody num raised middle portion peptide amino acids num num table one num extraction hippocampal proteins formic acid followed high resolution acid urea page western blot analysis num antibody confirmed reductions detectable species symbhapp mice compared happ singly tg mice fig numd consistent biochemical data amyloid plaques detected num num months age frontal cortex hippocampus happ mice symbhapp mice fig num e f data shown
0.21784335.16027115.html.plaintext.txt	46	investigate app metabolism greater detail mice app ctfs detected immunoblot analysis separation tricinesds polyacrylamide gels analysis revealed increase app ctfs symbhapp mice represents primarily accumulation symb results app cleavage site fig numa whereas secretase cleavage symb would result production symb x secretase cleavage symb would result production symb x surprisingly symbhapp mice decreased levels symb x truncated species hippocampal levels symb x fig numb symb num fig numc much lower symbhapp mice happ singly tg mice elisas used obtain measurements specifically detect peptides containing first five amino acids also analyzed levels antibody num raised middle portion peptide amino acids num num table one num extraction hippocampal proteins formic acid followed high resolution acid urea page western blot analysis num antibody confirmed reductions detectable species symbhapp mice compared happ singly tg mice fig numd consistent biochemical data amyloid plaques detected num num months age frontal cortex hippocampus happ mice symbhapp mice fig num e f data shown
0.21784335.16027115.html.plaintext.txt	47	view larger version numk figure num accumulation app ctfs decreases levels deposition symbhapp doubly tg mice homogenates frontal cortex num num month old singly tg mice happ line num symb line num doubly tg symbhapp mice non tg controls separated differential centrifugation particulate fractions separated num tricine gels analyzed western blotting antibody app ctfs symb rabbit polyclonal representative western blot samples happ symbhapp doubly tg mice confirm approach detect differences relative abundance different app ctfs included samples hippocampus two previously characterized pdgf happ tg lines expressing comparable levels familial ad mutant symb wild type symb happ num consistent known effects swedish mutation app cleavage symb symb mouse symb symb fragments whereas symb mouse mostly symb b c hippocampal levels symb x b symb num c num month old mice n num num miceline determined elisa d symb num symb num symb num species detected high resolution acid urea page western blot analysis num antibody described previously num lane contained proteins extracted neocortex num mglane different mouse e f deposits detected hippocampal vibratome sections immunostaining numsymb antibody num months age happ tg mice line num amyloid deposits e whereas symbhapp tg mice f g comparison levels neprilysin ide notch non tg controls happ symb symbhapp tg mice western blot analysis levels actin immunoreactivity used loading control homogenates frontal cortex num month old mice h quantitative analysis levels neprilysin ide notch expression analysis phosphorylated fl app app p phosphorylated app ctfs symb p symb p symb p happ symbhapp tg mice homogenates frontal cortex num month old mice separated polyacrylamide tricine gels transferred nitrocellulose probed app p thr num antibody j quantitative analysis showing levels app p symb p symb p reduced bigenic mice p numnum versus happ tg mice unpaired two tailed students test
0.21784335.16027115.html.plaintext.txt	48	view larger version numk figure num accumulation app ctfs decreases levels deposition symbhapp doubly tg mice homogenates frontal cortex num num month old singly tg mice happ line num symb line num doubly tg symbhapp mice non tg controls separated differential centrifugation particulate fractions separated num tricine gels analyzed western blotting antibody app ctfs symb rabbit polyclonal representative western blot samples happ symbhapp doubly tg mice confirm approach detect differences relative abundance different app ctfs included samples hippocampus two previously characterized pdgf happ tg lines expressing comparable levels familial ad mutant symb wild type symb happ num consistent known effects swedish mutation app cleavage symb symb mouse symb symb fragments whereas symb mouse mostly symb b c hippocampal levels symb x b symb num c num month old mice n num num miceline determined elisa d symb num symb num symb num species detected high resolution acid urea page western blot analysis num antibody described previously num lane contained proteins extracted neocortex num mglane different mouse e f deposits detected hippocampal vibratome sections immunostaining numsymb antibody num months age happ tg mice line num amyloid deposits e whereas symbhapp tg mice f g comparison levels neprilysin ide notch non tg controls happ symb symbhapp tg mice western blot analysis levels actin immunoreactivity used loading control homogenates frontal cortex num month old mice h quantitative analysis levels neprilysin ide notch expression analysis phosphorylated fl app app p phosphorylated app ctfs symb p symb p symb p happ symbhapp tg mice homogenates frontal cortex num month old mice separated polyacrylamide tricine gels transferred nitrocellulose probed app p thr num antibody j quantitative analysis showing levels app p symb p symb p reduced bigenic mice p numnum versus happ tg mice unpaired two tailed students test
0.21784335.16027115.html.plaintext.txt	49	view larger version numk figure num learning deficits symb symbhapp tg mice num months age symb line num happ mice line num symbhapp mice non tg littermates n num micegroup mice trained morris water maze locate visible platform days num num submerged platform days num num visible platform day num day num cued component test platform visible four groups achieved comparable escape latency platform hidden three groups tg mice showed significant learning deficits compared non tg controls p numnum days num num p numnum days num num tg groups repeated measures anova trend toward severe deficits observed symbhapp mice repeated measures anova curves hidden platform different among three groups tg mice however last day hidden platform testing day num symbhapp mice performed poorly symb mice happ tg mice p numnum one way anova
0.21784335.16027115.html.plaintext.txt	50	view larger version numk figure num learning deficits symb symbhapp tg mice num months age symb line num happ mice line num symbhapp mice non tg littermates n num micegroup mice trained morris water maze locate visible platform days num num submerged platform days num num visible platform day num day num cued component test platform visible four groups achieved comparable escape latency platform hidden three groups tg mice showed significant learning deficits compared non tg controls p numnum days num num p numnum days num num tg groups repeated measures anova trend toward severe deficits observed symbhapp mice repeated measures anova curves hidden platform different among three groups tg mice however last day hidden platform testing day num symbhapp mice performed poorly symb mice happ tg mice p numnum one way anova
0.21784335.16027115.html.plaintext.txt	51	findings raise possibilities decreased levels symb x symb num result alterations activity secretase availability substrate rate turnover enzymes neprilysin insulin degrading enzyme ide immunoblot analysis antibodies neprilysin ide showed roughly comparable levels enzymes symb mice happ mice symbhapp mice non tg controls fig num g h addition levels notch another secretase substrate comparable among four groups mice fig num g h results suggest decrease levels mice high levels symb activity result increased degradation decreased secretase activity
0.21784335.16027115.html.plaintext.txt	52	findings raise possibilities decreased levels symb x symb num result alterations activity secretase availability substrate rate turnover enzymes neprilysin insulin degrading enzyme ide immunoblot analysis antibodies neprilysin ide showed roughly comparable levels enzymes symb mice happ mice symbhapp mice non tg controls fig num g h addition levels notch another secretase substrate comparable among four groups mice fig num g h results suggest decrease levels mice high levels symb activity result increased degradation decreased secretase activity
0.21784335.16027115.html.plaintext.txt	53	similar decreases independent line symb tg mice recently related decreased availability mature phosphorylated app app p num consistent possibility western blot analysis antibody app p threonine num revealed cerebral levels fl app p symb p lower symbhapp mice happ mice fig num j results support notion high levels symb activity increase happ cleavage early secretory pathway depleting mature happ p transported axon terminals large proportion generation secretase complex takes place num
0.21784335.16027115.html.plaintext.txt	54	similar decreases independent line symb tg mice recently related decreased availability mature phosphorylated app app p num consistent possibility western blot analysis antibody app p threonine num revealed cerebral levels fl app p symb p lower symbhapp mice happ mice fig num j results support notion high levels symb activity increase happ cleavage early secretory pathway depleting mature happ p transported axon terminals large proportion generation secretase complex takes place num
0.21784335.16027115.html.plaintext.txt	55	increased activity symb elicits learning deficits neurodegenerative alterations num months age symb tg mice highest expresser line num showed mild weakness spasticity hind limbs phenotype apparent num months progressed prominent spastic paraparesis num months age symb mice intermediate expresser lines num num showed obvious neurological deficits inspected num num months age although num months mild tremor
0.21784335.16027115.html.plaintext.txt	56	increased activity symb elicits learning deficits neurodegenerative alterations num months age symb tg mice highest expresser line num showed mild weakness spasticity hind limbs phenotype apparent num months progressed prominent spastic paraparesis num months age symb mice intermediate expresser lines num num showed obvious neurological deficits inspected num num months age although num months mild tremor
0.21784335.16027115.html.plaintext.txt	57	symb tg mice line num developed age dependent neurological deficits precluded assessment water maze test symb tg mice line num selected crosses happ tg mice behavioral analysis num months age symb mice line num happ mice symbhapp mice non tg littermates tested morris water maze examine spatial learning memory day num cued component test platform visible four groups achieved similar escape latencies fig num platform hidden three groups tg mice showed significant learning deficits compared non tg controls fig num trend toward severe deficits observed symbhapp mice repeated measures anova curves hidden platform different among three groups tg mice however last day test day num performance deficits symbhapp group significantly different one way anova p numnum compared symb happ tg mice
0.21784335.16027115.html.plaintext.txt	58	symb tg mice line num developed age dependent neurological deficits precluded assessment water maze test symb tg mice line num selected crosses happ tg mice behavioral analysis num months age symb mice line num happ mice symbhapp mice non tg littermates tested morris water maze examine spatial learning memory day num cued component test platform visible four groups achieved similar escape latencies fig num platform hidden three groups tg mice showed significant learning deficits compared non tg controls fig num trend toward severe deficits observed symbhapp mice repeated measures anova curves hidden platform different among three groups tg mice however last day test day num performance deficits symbhapp group significantly different one way anova p numnum compared symb happ tg mice
0.21784335.16027115.html.plaintext.txt	59	assess extent neurodegenerative alterations symb mice immunolabeling performed antibodies markers neuronal dendritic integrity compared non tg controls fig numa mice expressing high levels symb displayed shrinkage pyramidal neurons symb region hippocampus fig numb worst alterations seen mice highest expresser line num fig num b c compared non tg controls fig numd pyramidal neurons layers num num neocortex also shrunken condensed three symb tg lines fig num e f contrast normal labeling neurites antibodies neurofilament fig numg symb fig numj non tg controls axonal dendritic processes pyramidal neurons symb mice diminished disrupted vacuolized fig num h k alterations prominent num months fig num l detectable albeit lesser extent num num months age shown num months age neurodegenerative alterations symb tg mice associated reactive astrocytosis fig numn observed non tg controls fig num m o contrast non tg littermate controls fig nump symb mice line num showed collapsed neuronal cytoplasm accumulations electrodense material extensive vacuolization dendritic arbors fig numq wide spread degeneration axonal processes splinting disorganization myelin laminations fig numr significant loss alterations neuritic structures also detected happ singly tg mice symb mice symbhapp mice considerable damage also symb region hippocampus fig num compared non tg controls fig numa happ fig numb symb fig numc mice reduced levels symb immunoreactivity frontal cortex alteration even prominent symbhapp mice fig nume symb region hippocampus three tg groups showed loss dendritic complexity severe symb symbhapp mice fig num f j
0.21784335.16027115.html.plaintext.txt	60	assess extent neurodegenerative alterations symb mice immunolabeling performed antibodies markers neuronal dendritic integrity compared non tg controls fig numa mice expressing high levels symb displayed shrinkage pyramidal neurons symb region hippocampus fig numb worst alterations seen mice highest expresser line num fig num b c compared non tg controls fig numd pyramidal neurons layers num num neocortex also shrunken condensed three symb tg lines fig num e f contrast normal labeling neurites antibodies neurofilament fig numg symb fig numj non tg controls axonal dendritic processes pyramidal neurons symb mice diminished disrupted vacuolized fig num h k alterations prominent num months fig num l detectable albeit lesser extent num num months age shown num months age neurodegenerative alterations symb tg mice associated reactive astrocytosis fig numn observed non tg controls fig num m o contrast non tg littermate controls fig nump symb mice line num showed collapsed neuronal cytoplasm accumulations electrodense material extensive vacuolization dendritic arbors fig numq wide spread degeneration axonal processes splinting disorganization myelin laminations fig numr significant loss alterations neuritic structures also detected happ singly tg mice symb mice symbhapp mice considerable damage also symb region hippocampus fig num compared non tg controls fig numa happ fig numb symb fig numc mice reduced levels symb immunoreactivity frontal cortex alteration even prominent symbhapp mice fig nume symb region hippocampus three tg groups showed loss dendritic complexity severe symb symbhapp mice fig num f j
0.21784335.16027115.html.plaintext.txt	61	discussion top abstract introduction experimental procedures results discussion references present study demonstrates increased activity symb neurons tg mice sufficient elicit profound alterations app metabolism neurological deficits neurodegeneration although symb required generation high levels neuronal symb activity decreased rather increased levels symbhapp mice compared happ singly tg mice suggesting main mediator increased neuronal deficits identified doubly tg mice app deficient mice num num show neurological neuropathological alterations observed several lines symb tg mice also unlikely decrease fl secretase processed app accounts neuronal deficits seen symb tg mice likelier pathogenic mechanism involves accumulation app ctfs andor mismetabolism alternative symb substrates
0.21784335.16027115.html.plaintext.txt	62	discussion top abstract introduction experimental procedures results discussion references present study demonstrates increased activity symb neurons tg mice sufficient elicit profound alterations app metabolism neurological deficits neurodegeneration although symb required generation high levels neuronal symb activity decreased rather increased levels symbhapp mice compared happ singly tg mice suggesting main mediator increased neuronal deficits identified doubly tg mice app deficient mice num num show neurological neuropathological alterations observed several lines symb tg mice also unlikely decrease fl secretase processed app accounts neuronal deficits seen symb tg mice likelier pathogenic mechanism involves accumulation app ctfs andor mismetabolism alternative symb substrates
0.21784335.16027115.html.plaintext.txt	63	symb cleaves app two sites generating classical c terminal stub symb alternative symb fragment num num although current research ad focused potential neurotoxic effects app ctfs also shown deleterious effects example primary neuronal cultures accumulation symb fragment promotes apoptosis num tg mice overexpressing ctfs neurons develop hippocampal degeneration well deficits memory long term potentiation num num
0.21784335.16027115.html.plaintext.txt	64	symb cleaves app two sites generating classical c terminal stub symb alternative symb fragment num num although current research ad focused potential neurotoxic effects app ctfs also shown deleterious effects example primary neuronal cultures accumulation symb fragment promotes apoptosis num tg mice overexpressing ctfs neurons develop hippocampal degeneration well deficits memory long term potentiation num num
0.21784335.16027115.html.plaintext.txt	65	view larger version numk figure num neuropathological ultrastructural alterations brains symb tg mice vibratome sections num month old mice either stained cresyl violet f immunostained antibodies neurofilaments g symb j l gfap m o processed electron microscopy p r b representative images hippocampus d o images neocortex non tg symb tg line num mice b neuronal shrinkage degeneration arrows symb region symb tg mouse c quantitative assessment cell density symb revealing significant loss neurons mice lines num num n num micegroup d e neuronal shrinkage degeneration arrows layers ii iii fronto parietal region symb tg mouse f quantitative assessment cell density neocortex revealing significant loss neurons mice line num n num micegroup g h loss phosphorylated high intermediate molecular mass neurofilaments symb tg mouse revealed immunostaining symb mouse monoclonal bright field microscopy quantitation symb immunoreactivity showing significant decrease three lines symb tg mice n num micegroup j k alterations symb positive neuronal dendritic structures symb tg mouse demonstrated lscm l quantitative assessment percent area neocortex occupied symb immunoreactive dendrites neocortex revealing significant losses lines symb tg mice n num micegroup m n reactive astrocytosis symb tg mouse revealed gfap immunostaining bright field microscopy o quantitation gfap immunoreactivity neocortex showing significant increase symb tg mice line num n num micegroup p ultrastructural analysis demonstrating well preserved neuronal n dendritic axonal structures non tg mouse q contrast symb tg mouse line num showed considerable neuronal shrinkage condensation vacuolization dendrites d r axon symb mouse showing thinning degeneration myelin sheaths bars num microma b d e g h m n num micromj k num micromp q num micromr p numnum versus non tg controls dunnetts test
0.21784335.16027115.html.plaintext.txt	66	view larger version numk figure num neuropathological ultrastructural alterations brains symb tg mice vibratome sections num month old mice either stained cresyl violet f immunostained antibodies neurofilaments g symb j l gfap m o processed electron microscopy p r b representative images hippocampus d o images neocortex non tg symb tg line num mice b neuronal shrinkage degeneration arrows symb region symb tg mouse c quantitative assessment cell density symb revealing significant loss neurons mice lines num num n num micegroup d e neuronal shrinkage degeneration arrows layers ii iii fronto parietal region symb tg mouse f quantitative assessment cell density neocortex revealing significant loss neurons mice line num n num micegroup g h loss phosphorylated high intermediate molecular mass neurofilaments symb tg mouse revealed immunostaining symb mouse monoclonal bright field microscopy quantitation symb immunoreactivity showing significant decrease three lines symb tg mice n num micegroup j k alterations symb positive neuronal dendritic structures symb tg mouse demonstrated lscm l quantitative assessment percent area neocortex occupied symb immunoreactive dendrites neocortex revealing significant losses lines symb tg mice n num micegroup m n reactive astrocytosis symb tg mouse revealed gfap immunostaining bright field microscopy o quantitation gfap immunoreactivity neocortex showing significant increase symb tg mice line num n num micegroup p ultrastructural analysis demonstrating well preserved neuronal n dendritic axonal structures non tg mouse q contrast symb tg mouse line num showed considerable neuronal shrinkage condensation vacuolization dendrites d r axon symb mouse showing thinning degeneration myelin sheaths bars num microma b d e g h m n num micromj k num micromp q num micromr p numnum versus non tg controls dunnetts test
0.21784335.16027115.html.plaintext.txt	67	view larger version numk figure num neurodegenerative alterations symbhapp tg mice sections brains num month old mice immunolabeled antibody symb mouse monoclonal imaged lscm d frontal cortex f hippocampus hipp although neurons dendrites well preserved non tg controls f evidence neurodegeneration happ tg b g symb tg c h mice neurodegenerative alterations even severe symbhapp tg mice d e j quantitation percent area neuropil covered symb immunoreactive dendrites revealed significant depletion symb positive neuronal structures symb tg lines bar num microm p numnum versus non tg controls dunnetts test
0.21784335.16027115.html.plaintext.txt	68	view larger version numk figure num neurodegenerative alterations symbhapp tg mice sections brains num month old mice immunolabeled antibody symb mouse monoclonal imaged lscm d frontal cortex f hippocampus hipp although neurons dendrites well preserved non tg controls f evidence neurodegeneration happ tg b g symb tg c h mice neurodegenerative alterations even severe symbhapp tg mice d e j quantitation percent area neuropil covered symb immunoreactive dendrites revealed significant depletion symb positive neuronal structures symb tg lines bar num microm p numnum versus non tg controls dunnetts test
0.21784335.16027115.html.plaintext.txt	69	increased activity symb led increase levels app ctfs symb mice symbhapp mice consistent previous observations num num num num moreover levels app ctfs different lines symb mice related extent neurological neuropathological alterations highest levels app ctfs found severely impaired line num although previous studies num num num num shown increase symb symb decrease symb present study found significant increase levels symb whereas symb levels decreased suggests model app processing may occur preferentially cleavage site num num interestingly despite overall increase symb symb previous studies levels symb p decreased significantly symbhapp mice decrease c num phosphorylation apparent mice expressing higher levels symb num compared happ tg mice symbhapp mice showed lower levels symb symb p decreased symb overexpression phosphorylation app post translational modification necessary maturation axonal transport symb num num decrease symb p indicates app cleavage symbhapp mice might occur early compartments num
0.21784335.16027115.html.plaintext.txt	70	increased activity symb led increase levels app ctfs symb mice symbhapp mice consistent previous observations num num num num moreover levels app ctfs different lines symb mice related extent neurological neuropathological alterations highest levels app ctfs found severely impaired line num although previous studies num num num num shown increase symb symb decrease symb present study found significant increase levels symb whereas symb levels decreased suggests model app processing may occur preferentially cleavage site num num interestingly despite overall increase symb symb previous studies levels symb p decreased significantly symbhapp mice decrease c num phosphorylation apparent mice expressing higher levels symb num compared happ tg mice symbhapp mice showed lower levels symb symb p decreased symb overexpression phosphorylation app post translational modification necessary maturation axonal transport symb num num decrease symb p indicates app cleavage symbhapp mice might occur early compartments num
0.21784335.16027115.html.plaintext.txt	71	high levels symb app ctfs symbhapp mice associated decreased levels human symb x symb num determined highly quantitative elisa measurements results consistent recent study num differ results obtained symbhapp models num num num num several factors might account differences including genetic background mice analyzed however critical factor determining effects symb activity might levels symb transgene expression num although low intermediate levels symb expression enhanced amyloid production deposition doubly tg mice higher levels symb expression reduced production presumably high levels symb activity shifted subcellular location app cleavage neuronal cell body early secretory pathway resulting depletion mature app p trans golgi compartment num thus lesser amount app might targeted distal axon would preclude secretase mediated generation synaptic sites
0.21784335.16027115.html.plaintext.txt	72	high levels symb app ctfs symbhapp mice associated decreased levels human symb x symb num determined highly quantitative elisa measurements results consistent recent study num differ results obtained symbhapp models num num num num several factors might account differences including genetic background mice analyzed however critical factor determining effects symb activity might levels symb transgene expression num although low intermediate levels symb expression enhanced amyloid production deposition doubly tg mice higher levels symb expression reduced production presumably high levels symb activity shifted subcellular location app cleavage neuronal cell body early secretory pathway resulting depletion mature app p trans golgi compartment num thus lesser amount app might targeted distal axon would preclude secretase mediated generation synaptic sites
0.21784335.16027115.html.plaintext.txt	73	factors may result degeneration neurons high levels symb activity recent evidence suggests toxicity ctfs may mediated caspase generated c terminal symb fragment num num therefore interesting test whether preventing generation symb prevents neurodegeneration symbhapp mice similar vein expression symb mapp deficient mice might reveal app independent mechanisms symb induced neurotoxicity conceivably increased symb activity might trigger neurodegeneration cleavage substrates app example vitro num vivo num symb cleaves symb sialyltransferase whose cleavage product secreted recently shown symb also cleaves subunits voltage gated sodium channels num increased levels symb activity could broaden substrate specificity enzyme tg mice humans ad
0.21784335.16027115.html.plaintext.txt	74	factors may result degeneration neurons high levels symb activity recent evidence suggests toxicity ctfs may mediated caspase generated c terminal symb fragment num num therefore interesting test whether preventing generation symb prevents neurodegeneration symbhapp mice similar vein expression symb mapp deficient mice might reveal app independent mechanisms symb induced neurotoxicity conceivably increased symb activity might trigger neurodegeneration cleavage substrates app example vitro num vivo num symb cleaves symb sialyltransferase whose cleavage product secreted recently shown symb also cleaves subunits voltage gated sodium channels num increased levels symb activity could broaden substrate specificity enzyme tg mice humans ad
0.21784335.16027115.html.plaintext.txt	75	indeed recent studies identified increased levels symb immunoreactivity app ctfs ad brains num num suggesting increased symb activity may causally involved also pathogenesis ad current study supports extends notion demonstrating increased neuronal symb activity cause progressive neurodegenerative alterations vivo whereas inhibiting secretase alter secretase processing decreases production increases accumulation app ctfs num num inhibiting symb may block dependent independent pathogenic mechanisms ad
0.21784335.16027115.html.plaintext.txt	76	indeed recent studies identified increased levels symb immunoreactivity app ctfs ad brains num num suggesting increased symb activity may causally involved also pathogenesis ad current study supports extends notion demonstrating increased neuronal symb activity cause progressive neurodegenerative alterations vivo whereas inhibiting secretase alter secretase processing decreases production increases accumulation app ctfs num num inhibiting symb may block dependent independent pathogenic mechanisms ad
0.21784335.16027115.html.plaintext.txt	77	footnotes work supported national institutes health grants symb symb symb symb costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.21784335.16027115.html.plaintext.txt	78	footnotes work supported national institutes health grants symb symb symb symb costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.21784335.16027115.html.plaintext.txt	79	num correspondence addressed dept neurosciences university california san diego num gilman dr la jolla ca num num tel num num num fax num num num e mail emasliahatucsdedu u d
0.21784335.16027115.html.plaintext.txt	80	num correspondence addressed dept neurosciences university california san diego num gilman dr la jolla ca num num tel num num num fax num num num e mail emasliahatucsdedu u d
0.21784335.16027115.html.plaintext.txt	81	num abbreviations used ad alzheimer disease peptide amyloid peptide anova analysis variance app amyloid precursor protein symb site app cleaving enzyme ctf c terminal fragment elisa enzyme linked immunosorbent assay fitc fluorescein isothiocyanate fl full length fret fluorescence resonance energy transfer gfap glial fibrillary acidic protein h human ide insulin degrading enzyme lscm laser scanning confocal microscopy m mouse symb microtubule associated protein num mbp maltose binding protein p phosphorylated rpa ribonuclease protection assay sw swedish tg transgenic tricine n num hydroxy numnum bishydroxymethylethylglycine
0.21784335.16027115.html.plaintext.txt	82	acknowledgments thank dr h van der putten providing symb cassette dr e koo symb antibody dr lisa mcconlogue hbace antibody activity assay dr p seubert numsymb antibody
0.21784335.16027115.html.plaintext.txt	83	references top abstract introduction experimental procedures results discussion references sinha anderson j john v mcconlogue l basi g thorsett e schenk d num ann n y acad sci num num numfree full text kamenetz f tomita hsieh h seabrook g borchelt d iwatsubo sisodia malinow r num neuron num num numcrossrefmedline order article via infotrieve selkoe d j schenk d num annu rev pharmacol toxicol num num numcrossrefmedline order article via infotrieve selkoe d j num nature num suppl num abstr num numcrossref sinha anderson j p barbour r basi g caccavello r davis d doan m dovey h f frigon n hong j jacobson croak k jewett n keim p knops j lieberburg power m tan h tatsuno g tung j schenk d seubert p suomensaari m wang walker d john v num nature num num numcrossrefmedline order article via infotrieve vassar r bennett b d babu khan kahn mendiaz e denis p teplow d b ross amarante p loeloff r luo y fisher fuller j edenson lile j jarosinski m biere l curran e burgess louis j c collins f treanor j rogers g citron m num science num num numabstractfree full text cai h wang y mccarthy d wen h borchelt d r price d l wong p c num nat neurosci num num numcrossrefmedline order article via infotrieve luo y bolon b kahn bennett b d babu khan denis p fan w kha h zhang j gong y martin l louis j c yan q richards w g citron m vassar r num nat neurosci num num numcrossrefmedline order article via infotrieve citron m num neurobiol aging num num numcrossrefmedline order article via infotrieve xia w m wolfe m num j cell sci num num numabstractfree full text asai m hattori c szabo b sasagawa n maruyama k tanuma ishiura num biochem biophys res commun num num numcrossrefmedline order article via infotrieve kitazume tachida y oka r shirotani k saido c hashimoto y num proc natl acad sci u num num numabstractfree full text kirschling c m kolsch h frahnert c rao m l maier w heun r num neuroreport num num numcrossrefmedline order article via infotrieve holsinger r m mclean c beyreuther k masters c l evin g num ann neurol num num numcrossrefmedline order article via infotrieve huse j liu k pijak d carlin d lee v m doms r w num j biol chem num num numabstractfree full text rossner apelt j schliebs r perez polo j r bigl v num j neurosci res num num numcrossrefmedline order article via infotrieve fukumoto h cheung b hyman b irizarry m c num arch neurol num num numabstractfree full text li r lindholm k yang l b yue x citron m yan r beach sue l sabbagh m cai h wong p price d shen y num proc natl acad sci u num num numabstractfree full text lee e b zhang b liu k greenbaum e doms r w trojanowski j q lee v m num j cell biol num num numabstractfree full text bodendorf u danner fischer f stefani m sturchler pierrat c wiederhold k h staufenbiel m paganetti p num j neurochem num num numcrossrefmedline order article via infotrieve chiocco m j kulnane l younkin l younkin evin g lamb b num j biol chem num num numabstractfree full text harrison m harper j hawkins j duddy g grau e pugh p l winter p h shilliam c hughes z dawson l gonzalez m upton n pangalos m n dingwall c num mol cell neurosci num num numcrossrefmedline order article via infotrieve rockenstein e mallory m hashimoto m song d shults c w lang masliah e num j neurosci res num num numcrossrefmedline order article via infotrieve rockenstein e mcconlogue l tan h power m masliah e mucke l num j biol chem num num numabstractfree full text demattos r b bales k r cummins d j dodart j c paul m holtzman d m num proc natl acad sci u num num numabstractfree full text johnson wood k lee m motter r hu k gordon g barbour r khan k gordon m tan h games d lieberburg schenk d seubert p mcconlogue l num proc natl acad sci u num num numabstractfree full text roberds l anderson j basi g bienkowski m j branstetter d g chen k freedman b frigon n l games d hu k johnson wood k kappenman k e kawabe kola kuehn r lee m liu w motter r nichols n f power m robertson d w schenk d schoor m shopp g m shuck m e sinha svensson k tatsuno g tintrup h wijsman j wright mcconlogue l num hum mol genet num num numabstractfree full text masliah e rockenstein e veinbergs sagara y mallory m hashimoto m mucke l num proc natl acad sci u num num numabstractfree full text mucke l yu g q mcconlogue l rockenstein e m abraham c r masliah e num j pathol num num numabstractfree full text mucke l masliah e yu g q mallory m rockenstein e m tatsuno g hu k kholodenko d johnson wood k mcconlogue l num j neurosci num num numabstractfree full text rockenstein e mallory m mante m sisk masliah e num j neurosci res num num numcrossrefmedline order article via infotrieve oltersdorf ward p j henriksson beattie e c neve r lieberburg fritz l c num j biol chem num num numabstractfree full text zheng h jiang m trumbauer m e hopkins r sirinathsinghji d j stevens k conner m w slunt h h sisodia chen h y van der ploeg l h num ann n y acad sci num num numabstract masliah e rockenstein e num j neural transm suppl num num nummedline order article via infotrieve huse j pijak d leslie g j lee v m doms r w num j biol chem num num numabstractfree full text kim h park c h cha h lee j h lee kim y rah j c jeong j suh y h num faseb j num num numabstractfree full text song d k won m h jung j lee j c kang c suh h w huh o paek h kim y h kim h suh y h num j neurochem num num nummedline order article via infotrieve oster granite m mcphie d greenan j neve r num j neurosci num num numabstractfree full text berger sweeney j mcphie d l arters j greenan j oster granite m l neve r l num mol brain res num num numcrossrefmedline order article via infotrieve mohajeri m h saini k d nitsch r m num j neural transm num num numcrossref willem m dewachter smyth n van dooren borghgraef p haass c van leuven f num j pathol num num numabstractfree full text ando k oishi m takeda iijima k isohara nairn c kirino y greengard p suzuki num j neurosci num num numabstractfree full text iijima k ando k takeda satoh y seki itohara greengard p kirino y nairn c suzuki num j neurochem num num numcrossrefmedline order article via infotrieve koo e lansbury p j kelly j num proc natl acad sci u num num numfree full text bredesen d num ann neurol num num numcrossrefmedline order article via infotrieve kitazume nakagawa k oka r tachida y ogawa k luo y citron m shitara h taya c yonekawa h paulson j c miyoshi e taniguchi n hashimoto y num j biol chem num num numabstractfree full text wong h k sakurai oyama f kaneko k wada k miyazaki h kurosawa m de strooper b saftig p nukina n num j biol chem num num numabstractfree full text anderson j j holtz g baskin p p turner m rowe b wang b kounnas m z lamb b barten d felsenstein k mcdonald srinivasan k munoz b wagner l num biochem pharmacol num num numcrossrefmedline order article via infotrieve durkin j murthy husten e j trusko p savage m j rotella d p greenberg b d siman r num j biol chem num num numabstractfree full text hussain powell d howlett d r tew d g meek d chapman c gloger murphy k e southan c d ryan d m smith simmons d l walsh f dingwall c christie g num mol cell neurosci num num numcrossrefmedline order article via infotrieve sisodia koo e beyreuther k unterbeck price d num science num num nummedline order article via infotrieve sisodia koo e hoffman p perry g price d num j neurosci num num numabstract weidemann konig g bunke d fischer p salbaum j masters c beyreuther k num cell num num numcrossrefmedline order article via infotrieve koo e sisodia archer d martin l weidemann beyreuther k fischer p masters c price d num proc natl acad sci u num num numabstractfree full text kim k miller d sapienza v num neurosci res commun num num num kim k wen g bancher c num neurosci res commun num num num jung gauthier cashman n r num neurobiol aging num num numcrossrefmedline order article via infotrieve seubert p vigo pelfrey c esch f lee m dovey h davis d sinha schlossmacher m whaley j swindlehurst c mccormack r wolfert r selkoe d lieberburg schenk d num nature num num numcrossrefmedline order article via infotrieve muresan z muresan v num hum mol genet num num numabstractfree full text
0.21941808.16055825.html.plaintext.txt	0	brief psychotherapy alzheimers disease randomised controlled trial alistair burns md frcp frcpsych
0.21941808.16055825.html.plaintext.txt	1	department psychiatry wythenshawe hospital manchester
0.21941808.16055825.html.plaintext.txt	2	department psychiatry manchester royal infirmary manchester
0.21941808.16055825.html.plaintext.txt	3	federica marino francis charlotte busby mrcpsych
0.21941808.16055825.html.plaintext.txt	4	department psychiatry wythenshawe hospital manchester
0.21941808.16055825.html.plaintext.txt	5	department medical statistics wythenshawe hospital manchester
0.21941808.16055825.html.plaintext.txt	6	eve russell md mrcpsych frank margison frcpsych sean lennon frcpsych jane byrne frcpsych
0.21941808.16055825.html.plaintext.txt	7	department psychiatry wythenshawe hospital manchester uk
0.21941808.16055825.html.plaintext.txt	8	correspondence professor alistair burns department psychiatry numnd floor education research centre wythenshawe hospital southmoor road manchester symb numlt uk tel num numnum num num fax num numnum num num e mail alistairburnsatmanchesteracuk
0.21941808.16055825.html.plaintext.txt	9	correspondence professor alistair burns department psychiatry numnd floor education research centre wythenshawe hospital southmoor road manchester symb numlt uk tel num numnum num num fax num numnum num num e mail alistairburnsatmanchesteracuk
0.21941808.16055825.html.plaintext.txt	10	abstract top abstract introduction method results discussion clinical implications acknowledgments references background although good evidence interventions carers people alzheimers disease reduce stress systematic studies investigated psychotherapeutic intervention patients may important earlier stages alzheimers disease insight often preserved
0.21941808.16055825.html.plaintext.txt	11	aims aim assess randomised controlled trial whether psychotherapeutic intervention could benefit cognitive function affective symptoms global well
0.21941808.16055825.html.plaintext.txt	12	method individuals randomised receive six sessions psychodynamic interpersonal therapy treatment usual cognitive function activities daily living global measure change carer stress coping assessed prior intervention
0.21941808.16055825.html.plaintext.txt	13	results improvement found majority outcome measures suggestion therapy improved carers reactions symptoms
0.21941808.16055825.html.plaintext.txt	14	results improvement found majority outcome measures suggestion therapy improved carers reactions symptoms
0.21941808.16055825.html.plaintext.txt	15	conclusions evidence support widespread introduction brief psychotherapeutic approaches alzheimers disease however technique acceptable helpful individually
0.21941808.16055825.html.plaintext.txt	16	conclusions evidence support widespread introduction brief psychotherapeutic approaches alzheimers disease however technique acceptable helpful individually
0.21941808.16055825.html.plaintext.txt	17	introduction top abstract introduction method results discussion clinical implications acknowledgments references alzheimers disease devastating terms suffering affected individuals stress carers cost society medication effect symptomatic improvement burns et al num psychological support reduce strain carers mittelman et al num donaldson et al num cognitive behavioural therapy carers reduce carer stress burden behavioural disturbance affected individuals marriott et al num however studies investigated psychotherapeutic intervention directed alzheimers disease early stages disease psychotherapeutic interventions may beneficial insight often preserved psychological adjustment difficult may assume face future inevitable decline denial defence mechanism common affected relatives bahro et al num individual psychodynamic therapy described bahro et al num systematic research cheston num related emotion oriented therapies including validation reminiscence promising woods num cochrane review non drug therapies found benefit reality orientation koger et al num neal briggs num spector et al num
0.21941808.16055825.html.plaintext.txt	18	aim study assess randomised controlled trial whether psychotherapeutic approach directed towards individuals alzheimers disease could benefit cognitive function affective symptoms global well
0.21941808.16055825.html.plaintext.txt	19	method top abstract introduction method results discussion clinical implications acknowledgments references design study randomised controlled trial psychodynamic interpersonal therapy compared standard treatment people alzheimers disease independent assessments carried baseline num weeks num months fig num study approved local research ethics committees
0.21941808.16055825.html.plaintext.txt	20	view larger version numk fig num design trial brief psychotherapy alzheimers disease
0.21941808.16055825.html.plaintext.txt	21	view larger version numk fig num design trial brief psychotherapy alzheimers disease
0.21941808.16055825.html.plaintext.txt	22	procedure individuals carers recruited referrals memory clinic south manchester uk inclusion criteria diagnosis alzheimers disease according nincds adrda criteria mckhann et al num clinical dementia rating num morris num indicating mild dementia score num mini mental state examination folstein et al num living home carer regular contact ability communicate verbally
0.21941808.16055825.html.plaintext.txt	23	procedure individuals carers recruited referrals memory clinic south manchester uk inclusion criteria diagnosis alzheimers disease according nincds adrda criteria mckhann et al num clinical dementia rating num morris num indicating mild dementia score num mini mental state examination folstein et al num living home carer regular contact ability communicate verbally
0.21941808.16055825.html.plaintext.txt	24	following consent individuals allocated one two groups treatment control using computer generated random numbers organised independently department medical statistics south manchester allocated control group could elect therapeutic sessions study assessments therapeutic interventions conducted individuals homes taking anticholinesterase drugs treatment alzheimers disease psychotropic medication antidepressants clinically stable medications least num months prior study entry
0.21941808.16055825.html.plaintext.txt	25	following consent individuals allocated one two groups treatment control using computer generated random numbers organised independently department medical statistics south manchester allocated control group could elect therapeutic sessions study assessments therapeutic interventions conducted individuals homes taking anticholinesterase drugs treatment alzheimers disease psychotropic medication antidepressants clinically stable medications least num months prior study entry
0.21941808.16055825.html.plaintext.txt	26	therapeutic interventions treatment group received six sessions psychodynamic interpersonal therapy experienced psychotherapist control group received standard care consisted general advice regarding diagnosis treatment dementia patient review
0.21941808.16055825.html.plaintext.txt	27	therapeutic interventions treatment group received six sessions psychodynamic interpersonal therapy experienced psychotherapist control group received standard care consisted general advice regarding diagnosis treatment dementia patient review
0.21941808.16055825.html.plaintext.txt	28	psychodynamic interpersonal therapy psychodynamic interpersonal therapy formerly known conversational model psychotherapy hobson num used treat wide variety disorders including depression shapiro firth num shapiro et al num somatisation guthrie et al num hamilton et al num self harm guthrie et al num principal aim therapy brief format identification interpersonal conflicts difficulties causing helping maintain emotional distress client therapist work together find test solutions problems intrapsychic practical changes encouraged
0.21941808.16055825.html.plaintext.txt	29	psychodynamic interpersonal therapy psychodynamic interpersonal therapy formerly known conversational model psychotherapy hobson num used treat wide variety disorders including depression shapiro firth num shapiro et al num somatisation guthrie et al num hamilton et al num self harm guthrie et al num principal aim therapy brief format identification interpersonal conflicts difficulties causing helping maintain emotional distress client therapist work together find test solutions problems intrapsychic practical changes encouraged
0.21941808.16055825.html.plaintext.txt	30	adaptation technique therapy adapted people alzheimers disease full details available elsewhere brierley et al num main adaptations included delivery individuals home involving carer treatment four specific psychological areas targeted autobiographical narrative used strengthen self worth important past conflicts resonated current difficulties explored resolved illness discussed emphasis placed improving social interpersonal relationships including emphasising role partner addition individual therapy therapist spent num min session carer listening carers needs informing carer therapeutic progress
0.21941808.16055825.html.plaintext.txt	31	adaptation technique therapy adapted people alzheimers disease full details available elsewhere brierley et al num main adaptations included delivery individuals home involving carer treatment four specific psychological areas targeted autobiographical narrative used strengthen self worth important past conflicts resonated current difficulties explored resolved illness discussed emphasis placed improving social interpersonal relationships including emphasising role partner addition individual therapy therapist spent num min session carer listening carers needs informing carer therapeutic progress
0.21941808.16055825.html.plaintext.txt	32	implementation technique psychotherapy sessions lasted num min psychotherapy summarised manual shapiro firth num treatment fidelity ensured regular supervision using audiotapes one session individual therapy rated adherence model using sheffield psychotherapy rating scale shapiro startup num scale allows sessions rated according three main subscales one psychodynamic interpersonal therapy one cognitive behavioural therapy one generic aspects psychotherapy intervention showed high scores psychodynamic interpersonal therapy generic sub scales low scores cognitive behavioural therapy scale confirming adherence model
0.21941808.16055825.html.plaintext.txt	33	implementation technique psychotherapy sessions lasted num min psychotherapy summarised manual shapiro firth num treatment fidelity ensured regular supervision using audiotapes one session individual therapy rated adherence model using sheffield psychotherapy rating scale shapiro startup num scale allows sessions rated according three main subscales one psychodynamic interpersonal therapy one cognitive behavioural therapy one generic aspects psychotherapy intervention showed high scores psychodynamic interpersonal therapy generic sub scales low scores cognitive behavioural therapy scale confirming adherence model
0.21941808.16055825.html.plaintext.txt	34	assessments patients following assessments carried start therapy end therapy num weeks recruitment num months follow
0.21941808.16055825.html.plaintext.txt	35	cornell scale depression dementia num item scale assessing depressive symptoms people dementia alexopoulos et al num rated three point scale absent mild intermittent severe score num indicative significant depressive symptoms
0.21941808.16055825.html.plaintext.txt	36	cornell scale depression dementia num item scale assessing depressive symptoms people dementia alexopoulos et al num rated three point scale absent mild intermittent severe score num indicative significant depressive symptoms
0.21941808.16055825.html.plaintext.txt	37	mini mental state examination num item measure cognitive function maximum score num points folstein et al num normally takes num num min complete
0.21941808.16055825.html.plaintext.txt	38	mini mental state examination num item measure cognitive function maximum score num points folstein et al num normally takes num num min complete
0.21941808.16055825.html.plaintext.txt	39	revised memory behavior problems checklist num item questionnaire rating frequency behavioural problems dementia intensity reactions carers teri et al num frequency reaction rated six point scale
0.21941808.16055825.html.plaintext.txt	40	revised memory behavior problems checklist num item questionnaire rating frequency behavioural problems dementia intensity reactions carers teri et al num frequency reaction rated six point scale
0.21941808.16055825.html.plaintext.txt	41	bristol activities daily living scale num item questionnaire rated carer num num min bucks et al num twenty areas daily activities rated five point scale problem severe problems
0.21941808.16055825.html.plaintext.txt	42	bristol activities daily living scale num item questionnaire rated carer num num min bucks et al num twenty areas daily activities rated five point scale problem severe problems
0.21941808.16055825.html.plaintext.txt	43	assessments carers general health questionnaire num item self report questionnaire assess psychological distress psychiatric morbidity goldberg williams num completed num min less item rated four point scale
0.21941808.16055825.html.plaintext.txt	44	assessments carers general health questionnaire num item self report questionnaire assess psychological distress psychiatric morbidity goldberg williams num completed num min less item rated four point scale
0.21941808.16055825.html.plaintext.txt	45	beck depression inventory num item self report questionnaire assess depression respondent beck et al num normally takes num num min complete item scored num num total score derived total score num suggests presence depression
0.21941808.16055825.html.plaintext.txt	46	beck depression inventory num item self report questionnaire assess depression respondent beck et al num normally takes num num min complete item scored num num total score derived total score num suggests presence depression
0.21941808.16055825.html.plaintext.txt	47	ways coping checklist num item self report questionnaire assess carers coping strategies vitaliano et al num normally takes num num min complete rated four point scale applicable much used
0.21941808.16055825.html.plaintext.txt	48	ways coping checklist num item self report questionnaire assess carers coping strategies vitaliano et al num normally takes num num min complete rated four point scale applicable much used
0.21941808.16055825.html.plaintext.txt	49	global assessment clinicians interview based global impression change seven point scale used researcher external supervisor detect change patients num week num month follow guy num scale goes much improved much worse rating completed following discussion research assistant fm f senior clinician ab masked group membership treatment control
0.21941808.16055825.html.plaintext.txt	50	global assessment clinicians interview based global impression change seven point scale used researcher external supervisor detect change patients num week num month follow guy num scale goes much improved much worse rating completed following discussion research assistant fm f senior clinician ab masked group membership treatment control
0.21941808.16055825.html.plaintext.txt	51	num individuals took part treatment arm study completed satisfaction survey four statements presented patients asked reply
0.21941808.16055825.html.plaintext.txt	52	num individuals took part treatment arm study completed satisfaction survey four statements presented patients asked reply
0.21941808.16055825.html.plaintext.txt	53	statistical analysis randomisation calculation sample size analyses used intention treat principle effect intervention assessed comparing changes mean scores time continuous variables using analyses covariance baseline scores age covariants scores required natural logarithmic transformation prior analysis produce satisfactory approximation normal distribution scores geometric means detransformed log means presented rather simple arithmetic means chi squared tests appropriate performed categorical measures
0.21941808.16055825.html.plaintext.txt	54	statistical analysis randomisation calculation sample size analyses used intention treat principle effect intervention assessed comparing changes mean scores time continuous variables using analyses covariance baseline scores age covariants scores required natural logarithmic transformation prior analysis produce satisfactory approximation normal distribution scores geometric means detransformed log means presented rather simple arithmetic means chi squared tests appropriate performed categorical measures
0.21941808.16055825.html.plaintext.txt	55	current data upon base power calculation previous study marriott et al num group sizes num sufficient detect statistically significant difference based data allowed withdrawal rate num chose recruit num individuals group part rationale pilot study obtain normative data calculate sample size definitive study
0.21941808.16055825.html.plaintext.txt	56	current data upon base power calculation previous study marriott et al num group sizes num sufficient detect statistically significant difference based data allowed withdrawal rate num chose recruit num individuals group part rationale pilot study obtain normative data calculate sample size definitive study
0.21941808.16055825.html.plaintext.txt	57	results top abstract introduction method results discussion clinical implications acknowledgments references study groups fifty three consecutive referrals memory clinic south manchester satisfied inclusion criteria approached take part study num refused leaving num people enrolled common reasons refusal potential upset therapeutic sessions could cause already taken part research projects
0.21941808.16055825.html.plaintext.txt	58	table num describes study groups main results assessments num people recruited group commonly spouse cared patient num treatment group num control group antidepressants approximately two thirds group one anticholinesterase drugs alzheimers disease participants completed study follow
0.21941808.16055825.html.plaintext.txt	59	table num describes study groups main results assessments num people recruited group commonly spouse cared patient num treatment group num control group antidepressants approximately two thirds group one anticholinesterase drugs alzheimers disease participants completed study follow
0.21941808.16055825.html.plaintext.txt	60	view table table num participants characteristics participant carer assessments baseline num week num month follow
0.21941808.16055825.html.plaintext.txt	61	significant differences course study outcome measures patients including ratings cornell scale mini mental state examination activities daily living scale global rating outcome measures carers changes course study general health questionnaire beck depression inventory trend towards slight improvement carers reaction behavioural problems section num ways coping checklist showed significant decline p numnum section rates carers interaction people aid coping
0.21941808.16055825.html.plaintext.txt	62	significant differences course study outcome measures patients including ratings cornell scale mini mental state examination activities daily living scale global rating outcome measures carers changes course study general health questionnaire beck depression inventory trend towards slight improvement carers reaction behavioural problems section num ways coping checklist showed significant decline p numnum section rates carers interaction people aid coping
0.21941808.16055825.html.plaintext.txt	63	difference ratings patients divided two groups mini mental state examination score num however evidence carers less cognitive impairment score num benefited treatment blamed less problems section num ways coping checklist num months mean value numnum compared numnum pnumnum
0.21941808.16055825.html.plaintext.txt	64	difference ratings patients divided two groups mini mental state examination score num however evidence carers less cognitive impairment score num benefited treatment blamed less problems section num ways coping checklist num months mean value numnum compared numnum pnumnum
0.21941808.16055825.html.plaintext.txt	65	qualitative assessments every participant agreed statement able discuss difficulties counsellor became clear eighty three per cent agreed following three statements find things thinking much helps feel less frustrated although sometimes felt painful talking past felt good get things chest felt calm able talk things difficult talk anyone else
0.21941808.16055825.html.plaintext.txt	66	qualitative assessments every participant agreed statement able discuss difficulties counsellor became clear eighty three per cent agreed following three statements find things thinking much helps feel less frustrated although sometimes felt painful talking past felt good get things chest felt calm able talk things difficult talk anyone else
0.21941808.16055825.html.plaintext.txt	67	positive comments patients included
0.21941808.16055825.html.plaintext.txt	68	able confide talk easy friendly way drew points never realised beneficial dont know counsellor allowed bring things would discussed relatives friends
0.21941808.16055825.html.plaintext.txt	69	able confide talk easy friendly way drew points never realised beneficial dont know counsellor allowed bring things would discussed relatives friends
0.21941808.16055825.html.plaintext.txt	70	comments carers included
0.21941808.16055825.html.plaintext.txt	71	provided opportunity discuss problems attached full time carer husband b also made feel less guilty making time home c husband said enjoyed talking gone forgot afterwards would coming c chance discuss openly wifes problem
0.21941808.16055825.html.plaintext.txt	72	provided opportunity discuss problems attached full time carer husband b also made feel less guilty making time home c husband said enjoyed talking gone forgot afterwards would coming c chance discuss openly wifes problem
0.21941808.16055825.html.plaintext.txt	73	num participants received therapy visited num num months recruitment semi structured open ended interview carried five patients recollection sessions five confirmed found helpful
0.21941808.16055825.html.plaintext.txt	74	num participants received therapy visited num num months recruitment semi structured open ended interview carried five patients recollection sessions five confirmed found helpful
0.21941808.16055825.html.plaintext.txt	75	discussion top abstract introduction method results discussion clinical implications acknowledgments references main findings study shows possible adapt model psychotherapy alzheimers disease improvement found majority outcome measures participants carers however suggestion therapy improved carers ways coping symptoms disease
0.21941808.16055825.html.plaintext.txt	76	therapist clearly major source support carers patients
0.21941808.16055825.html.plaintext.txt	77	rationale trial chose target area received relatively little attention alzheimers disease traditional therapies tended pharmacological nature targeting either cognitive non cognitive symptoms tariot num non pharmacological interventions aside behavioural techniques allen burge et al num concentrated carers psychological approaches proven benefit reducing carer strain marriott et al num far aware first randomised controlled trial psychotherapeutic intervention people alzheimers disease using standardised outcome measures psychotherapeutic approach determined following pilot study adapted individual needs participants model dictates joint sessions participants carers merely helped therapist focus symptoms considered important distressing
0.21941808.16055825.html.plaintext.txt	78	rationale trial chose target area received relatively little attention alzheimers disease traditional therapies tended pharmacological nature targeting either cognitive non cognitive symptoms tariot num non pharmacological interventions aside behavioural techniques allen burge et al num concentrated carers psychological approaches proven benefit reducing carer strain marriott et al num far aware first randomised controlled trial psychotherapeutic intervention people alzheimers disease using standardised outcome measures psychotherapeutic approach determined following pilot study adapted individual needs participants model dictates joint sessions participants carers merely helped therapist focus symptoms considered important distressing
0.21941808.16055825.html.plaintext.txt	79	reasons non response finding intervention effect measures reflect core features illness cognitive function activities daily living surprising six sessions provided psychotherapeutic terms low dose treatment may partly explain lack effect addition longer study would needed assess likely benefits terms stabilisation disease beneficial effect carers indicated scores ways coping checklist showed therapy helped carers providing someone talk caring people mild dementia diminished carers sense self blame minimal involvement carers therapy beneficial effect patients inferred improvement global rating well
0.21941808.16055825.html.plaintext.txt	80	reasons non response finding intervention effect measures reflect core features illness cognitive function activities daily living surprising six sessions provided psychotherapeutic terms low dose treatment may partly explain lack effect addition longer study would needed assess likely benefits terms stabilisation disease beneficial effect carers indicated scores ways coping checklist showed therapy helped carers providing someone talk caring people mild dementia diminished carers sense self blame minimal involvement carers therapy beneficial effect patients inferred improvement global rating well
0.21941808.16055825.html.plaintext.txt	81	surprising involvement therapist appeared positive impact accordance experience field important therapy adapted use people cognitive impairment
0.21941808.16055825.html.plaintext.txt	82	surprising involvement therapist appeared positive impact accordance experience field important therapy adapted use people cognitive impairment
0.21941808.16055825.html.plaintext.txt	83	trend towards improvements carer patient outcomes attests potential benefit non pharmacological interventions group future studies area concentrate specifically approaches combine outcomes carers care interdependency aspirations outcomes people alzheimers disease carers emphasised project influence future studies area
0.21941808.16055825.html.plaintext.txt	84	trend towards improvements carer patient outcomes attests potential benefit non pharmacological interventions group future studies area concentrate specifically approaches combine outcomes carers care interdependency aspirations outcomes people alzheimers disease carers emphasised project influence future studies area
0.21941808.16055825.html.plaintext.txt	85	clinical implications limitations top abstract introduction method results discussion clinical implications acknowledgments references clinical implications psychotherapeutic approaches adapted people dementia treatments directed dementia positive effects carers people dementia appreciate psychotherapeutic interventions
0.21941808.16055825.html.plaintext.txt	86	limitations sample size small outcome measures chosen probably sensitive enough measure marginal improvements psychotherapeutic method previously validated older people
0.21941808.16055825.html.plaintext.txt	87	limitations sample size small outcome measures chosen probably sensitive enough measure marginal improvements psychotherapeutic method previously validated older people
0.21941808.16055825.html.plaintext.txt	88	acknowledgments top abstract introduction method results discussion clinical implications acknowledgments references study carried south manchester hospitals nhs trust funded generous donation sir halley stewart trust thank participants carers
0.21941808.16055825.html.plaintext.txt	89	references top abstract introduction method results discussion clinical implications acknowledgments references alexopoulos g abrams r c young r c et al num cornell scale depression dementia biological psychiatry num num numcrossrefmedline
0.21941808.16055825.html.plaintext.txt	90	cheston r num psychotherapeutic work people dementia review literature british journal medical psychology num num nummedline
0.21941808.16055825.html.plaintext.txt	91	guy w num clinical global impressions ecdeu assessment manual psychopharmacology rockville md national institute mental health
0.21941808.16055825.html.plaintext.txt	92	received publication june num num revision received october num num accepted publication november num num
0.21941808.16055825.html.plaintext.txt	93	received publication june num num revision received october num num accepted publication november num num
0.21941808.16055825.html.plaintext.txt	94	highlights issue kimberlie dean bjp num num num full text
0.22005783.15615772.html.plaintext.txt	0	elevated amyloid ss protein symb late onset alzheimers disease associated single nucleotide polymorphisms urokinase type plasminogen activator gene nilufer ertekin symb james symb lars symb jonathan symb michael symbnum linda symb maria symb shushant symb alyssa symb leah symb jason symb muthoni kihiko symbnum matthew symbnum louis symb mark symb william symb michael symb mariza de symb ronald c symb neill graff symb steve symbnum anthony j symb steven g symb
0.22005783.15615772.html.plaintext.txt	1	elevated amyloid ss protein symb late onset alzheimers disease associated single nucleotide polymorphisms urokinase type plasminogen activator gene nilufer ertekin symb james symb lars symb jonathan symb michael symbnum linda symb maria symb shushant symb alyssa symb leah symb jason symb muthoni kihiko symbnum matthew symbnum louis symb mark symb william symb michael symb mariza de symb ronald c symb neill graff symb steve symbnum anthony j symb steven g symb
0.22005783.15615772.html.plaintext.txt	2	numdepartment neuroscience numdepartment neurology mayo clinic jacksonville num san pablo road jacksonville fl num usa numcenter genomics bioinformatics karolinska institute stockholm sweden numdepartment physiology numsanders brown center aging university kentucky lexington ky usa numdepartment health sciences research numdepartment neurology mayo clinic rochester num first street sw rochester mn num usa
0.22005783.15615772.html.plaintext.txt	3	correspondence addressed email younkinstevenatmayoedu
0.22005783.15615772.html.plaintext.txt	4	received june num num revised october num num accepted december num num
0.22005783.15615772.html.plaintext.txt	5	abstract top abstract introduction results discussion materials methods references plasma amyloid ss protein symb levels late onset alzheimers disease load linked region chromosome numq plau gene within region encodes urokinase type plasminogen activator converts plasminogen plasmin ass aggregates induce plau expression thereby increasing plasmin degrades aggregated non aggregated forms ass evaluated single nucleotide polymorphisms snps plau association symb load plau snp compound genotypes composed haplotype pairs showed significant association ad three independent case control series plau snp haplotypes associated significantly plasma symb num extended load families one snps analyzed missense ct polymorphism exon num plau plaunumsymb causes proline leucine change symb analyzed plaunum association ad six case control series num extended load families ct tt plaunum genotypes showed association pnumnum overall estimated odds ratio numnum numnum numnum ct tt genotypes plaunum also associated significant age dependent elevation plasma symb num extended load families pnumnum knockout mice lacking plau gene plasma brain symb well symb significantly elevated also age dependent manner plaunum associations independent associations found among plasma symb load variants ide symb region results provide strong evidence plau nearby gene involved development load plaunum plausible pathogenic mutation could act increasing symb additional biological experiments required show definitively
0.22005783.15615772.html.plaintext.txt	6	abstract top abstract introduction results discussion materials methods references plasma amyloid ss protein symb levels late onset alzheimers disease load linked region chromosome numq plau gene within region encodes urokinase type plasminogen activator converts plasminogen plasmin ass aggregates induce plau expression thereby increasing plasmin degrades aggregated non aggregated forms ass evaluated single nucleotide polymorphisms snps plau association symb load plau snp compound genotypes composed haplotype pairs showed significant association ad three independent case control series plau snp haplotypes associated significantly plasma symb num extended load families one snps analyzed missense ct polymorphism exon num plau plaunumsymb causes proline leucine change symb analyzed plaunum association ad six case control series num extended load families ct tt plaunum genotypes showed association pnumnum overall estimated odds ratio numnum numnum numnum ct tt genotypes plaunum also associated significant age dependent elevation plasma symb num extended load families pnumnum knockout mice lacking plau gene plasma brain symb well symb significantly elevated also age dependent manner plaunum associations independent associations found among plasma symb load variants ide symb region results provide strong evidence plau nearby gene involved development load plaunum plausible pathogenic mutation could act increasing symb additional biological experiments required show definitively
0.22005783.15615772.html.plaintext.txt	7	introduction top abstract introduction results discussion materials methods references previous studies others showed plasma amyloid ss protein symb num late onset alzheimers disease load num linked locus num cm chromosome num together two independent studies provide strong evidence novel alzheimers disease ad risk gene locus acts symb urokinase type plasminogen activator gene plau located chromosome numsymb num num cm within num lod support interval linkage peak num cm urokinase type plasminogen activator serine protease converts plasminogen plasmin num plau expression induced ass aggregates plasmin degrades aggregated non aggregated ass vitro possible negative feedback loop thus plau could important role controlling ass aggregation widely believed play important role ad pathogenesis ass major proteinaceous component senile plaques one main pathologic hallmarks ad num ass composed numnum amino acids symb present senile plaques symb also found cases num symb shown elevated serum brain cell culture studies performed patients animal models familial ad due known autosomal dominant mutations num num studies also shown elevations symb though consistently degree symb thus postulated although symb symb associate one pathogenic hallmarks ad owing consistent prominent presence along biochemical properties greater fibrillogenicity aggregation potential symb pathogenic biomarker ad
0.22005783.15615772.html.plaintext.txt	8	introduction top abstract introduction results discussion materials methods references previous studies others showed plasma amyloid ss protein symb num late onset alzheimers disease load num linked locus num cm chromosome num together two independent studies provide strong evidence novel alzheimers disease ad risk gene locus acts symb urokinase type plasminogen activator gene plau located chromosome numsymb num num cm within num lod support interval linkage peak num cm urokinase type plasminogen activator serine protease converts plasminogen plasmin num plau expression induced ass aggregates plasmin degrades aggregated non aggregated ass vitro possible negative feedback loop thus plau could important role controlling ass aggregation widely believed play important role ad pathogenesis ass major proteinaceous component senile plaques one main pathologic hallmarks ad num ass composed numnum amino acids symb present senile plaques symb also found cases num symb shown elevated serum brain cell culture studies performed patients animal models familial ad due known autosomal dominant mutations num num studies also shown elevations symb though consistently degree symb thus postulated although symb symb associate one pathogenic hallmarks ad owing consistent prominent presence along biochemical properties greater fibrillogenicity aggregation potential symb pathogenic biomarker ad
0.22005783.15615772.html.plaintext.txt	9	given genomic location potential functional relevance ad tested plau candidate gene load plau relatively small num bp gene found ntnum chromosome num contig also defined symb sequence wwwncbinlmnihgov genotyped total seven single nucleotide polymorphisms snps spanning whole length gene numnd numth bp found evidence significant linkage disequilibrium ld among variants allowing complex genotype analysis article initially depict results association analyses plasma symb plau haplotypes num load families ad plau compound genotypes forming haplotype pairs three case control series establishing significant association plau variants two ad phenotypes plasma symb levels ad affected status focus single missense mutation larger data set num load families six case control series
0.22005783.15615772.html.plaintext.txt	10	given genomic location potential functional relevance ad tested plau candidate gene load plau relatively small num bp gene found ntnum chromosome num contig also defined symb sequence wwwncbinlmnihgov genotyped total seven single nucleotide polymorphisms snps spanning whole length gene numnd numth bp found evidence significant linkage disequilibrium ld among variants allowing complex genotype analysis article initially depict results association analyses plasma symb plau haplotypes num load families ad plau compound genotypes forming haplotype pairs three case control series establishing significant association plau variants two ad phenotypes plasma symb levels ad affected status focus single missense mutation larger data set num load families six case control series
0.22005783.15615772.html.plaintext.txt	11	missense mutation variant exon num symbplaunum causes proline leucine change symb within kringle domain plau junction two ss pleated sheets numnum minor variant plaunum appear affect plau activity yoshimoto et al num reported symb plau zymogen binds fibrin aggregates less efficiently symb plau zymogen suggesting possibility altered extracellular plau localization stability
0.22005783.15615772.html.plaintext.txt	12	missense mutation variant exon num symbplaunum causes proline leucine change symb within kringle domain plau junction two ss pleated sheets numnum minor variant plaunum appear affect plau activity yoshimoto et al num reported symb plau zymogen binds fibrin aggregates less efficiently symb plau zymogen suggesting possibility altered extracellular plau localization stability
0.22005783.15615772.html.plaintext.txt	13	previously finckh et al num shown significant association major cc genotype symb load series germany switzerland italy article show evidence significant association load minor allele variant discuss potential reasons discrepancy find evidence significant association plau variants extended load families independent case control series using plasma symb load affected status phenotypes addition provide functional data plau knock ko mice supporting role gene ass metabolism results depicted subsequently
0.22005783.15615772.html.plaintext.txt	14	results top abstract introduction results discussion materials methods references identification snps haplotypes compound genotypes plau identified six snps sequencing plau exons load family members additional snp exon num identified using public snp databases seven plau snps locations ncbi snp names summarized table num snps spanned numnum kb plau gene analyzed num load families used link plasma symb chromosome num num addition genotyped three independent case control series collected mayo clinic rochester mcr mayo clinic jacksonville mcj university kentucky uky snp allele frequencies deviations hardy weinberg equilibrium hwe allelic association results summarized table num given two exon num snps complete ld results one exon num snps summarized table num summary rare exon num snp showed hardy weinberg disequilibrium mcj mcr series case control groups apart one instance snp deviated significantly hwe control group exon num snpplaunum mcj controls
0.22005783.15615772.html.plaintext.txt	15	results top abstract introduction results discussion materials methods references identification snps haplotypes compound genotypes plau identified six snps sequencing plau exons load family members additional snp exon num identified using public snp databases seven plau snps locations ncbi snp names summarized table num snps spanned numnum kb plau gene analyzed num load families used link plasma symb chromosome num num addition genotyped three independent case control series collected mayo clinic rochester mcr mayo clinic jacksonville mcj university kentucky uky snp allele frequencies deviations hardy weinberg equilibrium hwe allelic association results summarized table num given two exon num snps complete ld results one exon num snps summarized table num summary rare exon num snp showed hardy weinberg disequilibrium mcj mcr series case control groups apart one instance snp deviated significantly hwe control group exon num snpplaunum mcj controls
0.22005783.15615772.html.plaintext.txt	16	view table table num plau snp frequencies plau snp genotypes family members plau snp haplotypes identified using haplotyping algorithm within computer program symb numnum three major plau snp haplotypes identified three minor haplotypes collectively six plau snp haplotypes accounted num haplotypes families frequency plau snp haplotype num ad families summarized table num profound ld d numnum snps symb numnum snps except exon num snp five seven snps required construct six haplotypes
0.22005783.15615772.html.plaintext.txt	17	table num summarizes ld parameters lewontins standardized disequilibrium coefficient num d symb estimated founders num extended load families profound ld snps easily appreciated table exon num deletion mutant complete ld exon num snp exon num snp rare yield meaningful results thus two snps omitted ld analysis ld also estimated mcr mcj uky series within cases controls yielded similar results individual carries two haplotypes termed genotype formed two haplotypes compound genotypes described subsequently compound genotype essentially unambiguously defines haplotype pair due profound ld plau snps limited haplotype diversity next tested association plasma symb levels plau haplotypes
0.22005783.15615772.html.plaintext.txt	18	table num summarizes ld parameters lewontins standardized disequilibrium coefficient num d symb estimated founders num extended load families profound ld snps easily appreciated table exon num deletion mutant complete ld exon num snp exon num snp rare yield meaningful results thus two snps omitted ld analysis ld also estimated mcr mcj uky series within cases controls yielded similar results individual carries two haplotypes termed genotype formed two haplotypes compound genotypes described subsequently compound genotype essentially unambiguously defines haplotype pair due profound ld plau snps limited haplotype diversity next tested association plasma symb levels plau haplotypes
0.22005783.15615772.html.plaintext.txt	19	view table table num plau snps ld association plau variants plasma symb levels num load families test association plasma symb plau variants family members used variance components methodology implemented computer program solar num using within pedigree identity state model hopper mathews num plau snp haplotypes initially analyzed family members ages num num years age group plasma symb linked chromosome num locus num age group significant association plau variants plasma symb levels table num inspection data suggested might association plau snp haplotypes plasma symb older family members performed second analysis using family members ages remarkably group showed significant association plau snp haplotypes plasma symb pnumnum plau association accounting estimated num total variance symb
0.22005783.15615772.html.plaintext.txt	20	view table table num association plau snp haplotypes plasma symb num load families association plau variants ad three case control series working hypothesis gene variants influencing symb likely variants influencing risk ad determine whether plau variants associated ad case control series analyzed plau snps three independent series obtained mcr mcj uky three series entirely composed caucasian subjects every ad patient age onset num years using computer program gold num analyze plau snps determined profound ld among five plau snps case control series similar load family founders data shown
0.22005783.15615772.html.plaintext.txt	21	important consequence profound ld among five plau snps analyzed relatively common genotypes num num subjects accounted num compound genotypes table num table num two haplotypes producing six num compound genotypes d f j k unambiguous one snp heterozygous remaining six genotypes produced one one pair six haplotypes identified load families table num pairs could produce categories would include least one haplotype rare never identified unambiguously case control series symb haplotype analysis load families combinations rare plau snp haplotypes num num subjects load case control series easily identified essentially unambiguous table num
0.22005783.15615772.html.plaintext.txt	22	important consequence profound ld among five plau snps analyzed relatively common genotypes num num subjects accounted num compound genotypes table num table num two haplotypes producing six num compound genotypes d f j k unambiguous one snp heterozygous remaining six genotypes produced one one pair six haplotypes identified load families table num pairs could produce categories would include least one haplotype rare never identified unambiguously case control series symb haplotype analysis load families combinations rare plau snp haplotypes num num subjects load case control series easily identified essentially unambiguous table num
0.22005783.15615772.html.plaintext.txt	23	view table table num association plau compound genotypes ad three case control series evaluate association ad compound genotypes summarized table num performed num tests series using monte carlo approach symb implemented clump determine significance three series examined genotypes showed significant association ad mcr pnumnum mcj pnumnum uky pnumnum compound genotypes tended trends two series analyzed eg numnum numnum numnum suggesting presence functional variants backbones genotypes
0.22005783.15615772.html.plaintext.txt	24	found association plau compound genotypes three case control series mcr mcj uky tested association missense plaunum snp larger data set six case control series results depicted subsequently finally went back test association plau compound genotypes three additional case control series gothenburg gothenburg postmortem scottish find significant association series data shown
0.22005783.15615772.html.plaintext.txt	25	found association plau compound genotypes three case control series mcr mcj uky tested association missense plaunum snp larger data set six case control series results depicted subsequently finally went back test association plau compound genotypes three additional case control series gothenburg gothenburg postmortem scottish find significant association series data shown
0.22005783.15615772.html.plaintext.txt	26	association plaunum snp symb plasma symb levels num load families plau variants analyzed symb internally termed plaunum relatively common missense snp leads proline leucine change kringle domain plau junction two ss pleated sheets numnum shown functional effect fibrin binding plau zymogen num determine whether plaunum genotypes associated plasma symb analyzed larger set num extended load families includes original group num families take family relationships account analyses performed using variance components methodology implemented program solar num
0.22005783.15615772.html.plaintext.txt	27	association plaunum snp symb plasma symb levels num load families plau variants analyzed symb internally termed plaunum relatively common missense snp leads proline leucine change kringle domain plau junction two ss pleated sheets numnum shown functional effect fibrin binding plau zymogen num determine whether plaunum genotypes associated plasma symb analyzed larger set num extended load families includes original group num families take family relationships account analyses performed using variance components methodology implemented program solar num
0.22005783.15615772.html.plaintext.txt	28	members num families change occurs plasma symb aging complex plasma symb elevated young subjects first decreases increases age num shown figure num plasma symb stratified plaunum genotype plotted function age non linear analysis analyzed age agenum plaunum genotype cc ct tt cttt interactions among age agenum plaunum genotype variance components framework showed significant age dependent association plasma symb plaunum ct tt genotypes ctxage ttxagenum ctttxagenum agenum significant p numnum table num main concern determine whether significant age dependent elevation plasma symb elderly subjects associated ct tt pooled cttt genotypes performed second analysis family members num years fig num analyzed using linear regression variance components framework analysis showed ctxage ttxage covariates significant effects pnumnum pnumnum respectively num load families table num ct tt variables tested single cttt variable ctttxage covariate even significant pnumnum noteworthy even correct fact three age groups tested prior analysis num age group summarized table num using conservative approach bonferroni correction still highly significant age related plau genotype effect families overall corrected p values numnum model num numnum model num
0.22005783.15615772.html.plaintext.txt	29	members num families change occurs plasma symb aging complex plasma symb elevated young subjects first decreases increases age num shown figure num plasma symb stratified plaunum genotype plotted function age non linear analysis analyzed age agenum plaunum genotype cc ct tt cttt interactions among age agenum plaunum genotype variance components framework showed significant age dependent association plasma symb plaunum ct tt genotypes ctxage ttxagenum ctttxagenum agenum significant p numnum table num main concern determine whether significant age dependent elevation plasma symb elderly subjects associated ct tt pooled cttt genotypes performed second analysis family members num years fig num analyzed using linear regression variance components framework analysis showed ctxage ttxage covariates significant effects pnumnum pnumnum respectively num load families table num ct tt variables tested single cttt variable ctttxage covariate even significant pnumnum noteworthy even correct fact three age groups tested prior analysis num age group summarized table num using conservative approach bonferroni correction still highly significant age related plau genotype effect families overall corrected p values numnum model num numnum model num
0.22005783.15615772.html.plaintext.txt	30	view larger version numk figure num plasma symb members ages num load families curves shown plaunum symb genotype polynomial function age symb cc genotype nnum b ct genotype nnum c tt genotype nnum d combined cttt genotypes nnum
0.22005783.15615772.html.plaintext.txt	31	view larger version numk figure num plasma symb members ages num load families curves shown plaunum symb genotype polynomial function age symb cc genotype nnum b ct genotype nnum c tt genotype nnum d combined cttt genotypes nnum
0.22005783.15615772.html.plaintext.txt	32	view table figure num plasma symb members num years age num load families curves shown plaunum symb genotype linear function age cc genotype nnum b ct genotype nnum c tt genotype nnum d combined cttt genotypes nnum
0.22005783.15615772.html.plaintext.txt	33	view table table num multivariate regression analysis members num years age num load families basis findings re analyzed haplotypic associations num load families subjects num years age association even significant pnumnum table num subsequently went back analyze haplotypes num families age group accounted num total variance plasma symb phenotype also significant pnumnum data shown
0.22005783.15615772.html.plaintext.txt	34	association plaunum snp symb ad six case control series initially analyzed three series two groups mcr mcj series mayo clinic uky series university kentucky analyze missense plaunum snp obtained three series collaborators karolinska institute gothenburg load control series autopsy confirmed load series gothenburg scottish early onset ad load series
0.22005783.15615772.html.plaintext.txt	35	association plaunum snp symb ad six case control series initially analyzed three series two groups mcr mcj series mayo clinic uky series university kentucky analyze missense plaunum snp obtained three series collaborators karolinska institute gothenburg load control series autopsy confirmed load series gothenburg scottish early onset ad load series
0.22005783.15615772.html.plaintext.txt	36	mcr series significant association observed ct pnumnum cttt pnumnum genotypes odds ratio numnum numnum numnum numnum numnum numnum respectively tt genotype enriched load patients mcr series enrichment achieve significance uky series first series plaunum analyzed tt genotype showed significant pnumnum association load numnum numnum numnum three four remaining series mcj gothenburg scottish showed non significant enrichment ct andor tt genotypes table num occur autopsy confirmed gothenburg series testing homogeneity breslow day showed evidence heterogeneity among six series pnumnum meta analysis gave pooled estimate cttt genotype numnum numnum numnum fixed effects pnumnum random effects pnumnum fig num
0.22005783.15615772.html.plaintext.txt	37	view table figure num ors plaunum symb cttt versus cc genotypes case control series ors shown num confidence intervals ad cases scottish series early age onset others load versus control series
0.22005783.15615772.html.plaintext.txt	38	analysis ass plau knockout mice finding plau variants associated elevated plasma symb predicts plasma symb elevated ko mice lacking functional plau gene test analyzed plasma symb num plau ko mice num num control mice genetic background comparison ko mice lacking functional neprilysin gene known involved ass degradation num analyzed parallel compared controls num num month old plau ko mice showed highly significant increase plasma symb pnumnum mann whitney test fig numa plasma symb also increased pnumnum plau ko mice fig numb num months plasma symb symb increased difference ko control mice appeared increase small number mice analyzed two plau ko versus six controls thus plau gene influences plasma symb data suggest effect may become pronounced aging consistent genetic analyses load families remarkably brain symb fig numa symb fig numb showed detectable increase plau ko mice compared control mice implications result presented discussion
0.22005783.15615772.html.plaintext.txt	39	analysis ass plau knockout mice finding plau variants associated elevated plasma symb predicts plasma symb elevated ko mice lacking functional plau gene test analyzed plasma symb num plau ko mice num num control mice genetic background comparison ko mice lacking functional neprilysin gene known involved ass degradation num analyzed parallel compared controls num num month old plau ko mice showed highly significant increase plasma symb pnumnum mann whitney test fig numa plasma symb also increased pnumnum plau ko mice fig numb num months plasma symb symb increased difference ko control mice appeared increase small number mice analyzed two plau ko versus six controls thus plau gene influences plasma symb data suggest effect may become pronounced aging consistent genetic analyses load families remarkably brain symb fig numa symb fig numb showed detectable increase plau ko mice compared control mice implications result presented discussion
0.22005783.15615772.html.plaintext.txt	40	view larger version numk figure num plasma ass plau ko plasma symb b plasma symb analyzed sandwich elisa previously described num ko mice homozygous null allele results normalized ass present num num month old control wild type mice values shown mean plus minus se numbers analyzed num num month old plau ko num nnum control mice nnum num month old plau ko mice nnum control mice nnum mice num num month old neprilysin ko num nnum control mice nnum neprilysin ko mice used additional positive control num mice plasma symb symb b increased
0.22005783.15615772.html.plaintext.txt	41	view larger version numk figure num brain ass plau ko mice brain symb b brain symb extracted directly num formic acid brain symb symb analyzed elisa following direct extraction formic acid neutralization previously described num values shown mean plus minus se numbers analyzed num num month old plau ko mice nnum control mice nnum num month old plau ko mice nnum control mice nnum num num month old neprilysin ko mice nnum control mice nnum additional positive control investigated neprilysin ko mice num mice brain symb symb increased previously reported num plasma symb fig numa symb fig numb also increased neprilysin ko mice
0.22005783.15615772.html.plaintext.txt	42	discussion top abstract introduction results discussion materials methods references identification load risk locus chromosome num num also affects plasma ass num levels extended load families led search genes good functional candidates region plau good functional good positional candidate gene converts plasminogen plasmin turn degrades ass genotyped seven snps within relatively small gene spanning almost entire length found snps profound ld leading limited haplotype diversity region analyzed finding consistent previous work num num limited haplotype diversity allowed us perform association analysis using compound genotypes make haplotype pair subject advantage approach require phase information compound genotype forms group per se nonetheless given small number compound genotypes observed series one identify underlying haplotype pair num subjects essentially unambiguously advantage compound genotype approach allows analysis haplotype pair rather individual haplotypes thus variants effective additive fashion encountered alone easier identify using approach determined significant association plau compound genotypes ad three independent case control series
0.22005783.15615772.html.plaintext.txt	43	discussion top abstract introduction results discussion materials methods references identification load risk locus chromosome num num also affects plasma ass num levels extended load families led search genes good functional candidates region plau good functional good positional candidate gene converts plasminogen plasmin turn degrades ass genotyped seven snps within relatively small gene spanning almost entire length found snps profound ld leading limited haplotype diversity region analyzed finding consistent previous work num num limited haplotype diversity allowed us perform association analysis using compound genotypes make haplotype pair subject advantage approach require phase information compound genotype forms group per se nonetheless given small number compound genotypes observed series one identify underlying haplotype pair num subjects essentially unambiguously advantage compound genotype approach allows analysis haplotype pair rather individual haplotypes thus variants effective additive fashion encountered alone easier identify using approach determined significant association plau compound genotypes ad three independent case control series
0.22005783.15615772.html.plaintext.txt	44	analyzed common missense snp plaunum symb larger set num families six case control series include initial series analyzed extended families snp associated age related elevation plasma ass levels individuals num years age plasma ass displays complex characteristic appears decline age related fashion num years age increase thereafter characteristic much pronounced subjects ct tt genotype plaunum also noteworthy significance association plau haplotypes enhanced num age group analyzed separately num families expected table num finding age related increase ass also evident plasma ass plau ko mice consistent finding humans mice significantly higher plasma ass levels compared wild type littermates however brain ass levels show significant difference finding could several explanations may suggest plau variants influence ad effect plasma brain symb conceivable likely plau influences plasma brain ass way evident ko mice thus plau may greater influence secreted cell associated ass brain ass cell associated num effects secreted ass easily detected plasma could hard detect brain alternatively compensatory changes triggered plau ko may maintain brain ass effectively plasma ass
0.22005783.15615772.html.plaintext.txt	45	analyzed common missense snp plaunum symb larger set num families six case control series include initial series analyzed extended families snp associated age related elevation plasma ass levels individuals num years age plasma ass displays complex characteristic appears decline age related fashion num years age increase thereafter characteristic much pronounced subjects ct tt genotype plaunum also noteworthy significance association plau haplotypes enhanced num age group analyzed separately num families expected table num finding age related increase ass also evident plasma ass plau ko mice consistent finding humans mice significantly higher plasma ass levels compared wild type littermates however brain ass levels show significant difference finding could several explanations may suggest plau variants influence ad effect plasma brain symb conceivable likely plau influences plasma brain ass way evident ko mice thus plau may greater influence secreted cell associated ass brain ass cell associated num effects secreted ass easily detected plasma could hard detect brain alternatively compensatory changes triggered plau ko may maintain brain ass effectively plasma ass
0.22005783.15615772.html.plaintext.txt	46	analyzed plaunum six case control series using meta analysis lohmueller et al num reported meta analyses published genetic associations various disease phenotypes num reported associations investigated meta analysis eight showed significant association replicated original study ors numnum numnum range basis findings authors recommended large collaborative genetic association studies encouraged sound studies positive negative published reports association include meta analysis available data meta analyses plaunum snp six case control series indicate plaunum cttt associated modest ornumnum marginally significant pnumnum numnum increase risk ad result similar lohmueller et al num whose meta analyses identified many common genetic variants modest significant effects disease phenotypes two groups previously published findings snp numnum finckh et al num found significant association three case control series germany switzerland italy whereas myers et al num find evidence association plau snps analyzed including plaunum interestingly former found series cc genotype associated increased risk load whereas series ct tt genotypes furthermore another group germany also found significant association ct tt genotypes m riemenschneider personal communication thus clearly heterogeneity among findings one group significant results direction series m riemenschneider another finding significance common genotype num third group finding significance clearly results need analyzed one meta analysis subsequent publication nonetheless demonstrated lohmueller et al num discrepancies frequent among studies common genetic variants complex diseases particularly effect size modest many reasons discrepancies including small sample size gene gene gene environment interactions modelled studies intra sample heterogeneitypopulation substructure analysis marker variant instead disease variant varying degrees ld tried minimize factors gathering large series age matching mayo clinic series choosing variant likely functional still plausible problems may contributing inter series variations observed plaunum
0.22005783.15615772.html.plaintext.txt	47	indeed association plaunum marginally significant confidence interval numnum numnum six series analyzed nonetheless statistical result considered presence evidence family animal data effect plau ass understanding likely exist variants plau affect risk ad suggested compound genotype data case control series furthermore given likely presence important variants genes symb ide finding highly significant p values variants modest effect complex diseases may need await identification functional mutations multiple genes analyses multiple large series
0.22005783.15615772.html.plaintext.txt	48	recently published findings significant association two genes chromosome num numnum ide symb tested key variants three genes find evidence ld joint analysis key variants demonstrates separate independent effects variants symb account linkage chromosome num plau variants different two age related effects manifest strongly age num thus genes appears act independently one another via apparent separate mechanisms unequivocal effects genes pathogenesis ad await identification functional variants testing large series findings provide evidence existence load risk variants affect ass within andor vicinity genes
0.22005783.15615772.html.plaintext.txt	49	recently published findings significant association two genes chromosome num numnum ide symb tested key variants three genes find evidence ld joint analysis key variants demonstrates separate independent effects variants symb account linkage chromosome num plau variants different two age related effects manifest strongly age num thus genes appears act independently one another via apparent separate mechanisms unequivocal effects genes pathogenesis ad await identification functional variants testing large series findings provide evidence existence load risk variants affect ass within andor vicinity genes
0.22005783.15615772.html.plaintext.txt	50	materials methods top abstract introduction results discussion materials methods references subjects initially collected num extended load families four families collected via load patient extremely high plasma symb andor symb levels extremes top numth percentile num ad patients series remaining six families ascertained via load proband multiple relatives load without prior ass measurements non extremes one probands non extreme families determined extremely high plasma ass levels family collection therefore family grouped extreme families subsequently detailed collection strategies family profiles families provided elsewhere num addition num families num independent extended load pedigrees subsequently collected additional pedigrees collected via proband first degree relative load patient except one probands num additional pedigrees elevated plasma ass levels load families studied article lacked clear autosomal dominant mode segregation ad
0.22005783.15615772.html.plaintext.txt	51	materials methods top abstract introduction results discussion materials methods references subjects initially collected num extended load families four families collected via load patient extremely high plasma symb andor symb levels extremes top numth percentile num ad patients series remaining six families ascertained via load proband multiple relatives load without prior ass measurements non extremes one probands non extreme families determined extremely high plasma ass levels family collection therefore family grouped extreme families subsequently detailed collection strategies family profiles families provided elsewhere num addition num families num independent extended load pedigrees subsequently collected additional pedigrees collected via proband first degree relative load patient except one probands num additional pedigrees elevated plasma ass levels load families studied article lacked clear autosomal dominant mode segregation ad
0.22005783.15615772.html.plaintext.txt	52	addition extended load families six different case control series analyzed study series named follows mayo clinic rochester mcr mayo clinic jacksonville mcj university kentucky uky gothenburg gothenburg postmortem scottish mcr samples collected part mayo clinic alzheimers disease patient registry community based prospective registry mayo clinic rochester memory disorders clinic case control series mcj samples collected mayo clinic jacksonville memory disorders clinic uky series collected part university kentucky memory disorders clinic brains program mcr mcj uky series consisted caucasian subjects united states gothenburg gothenburg postmortem series consisted swedish ad cases recruited prospective longitudinal study patients dementia molndal prospective dementia study swedish controls consisted healthy volunteers gothenburg autopsy cases gothenburg postmortem finally scottish samples composed eoad patients lothian psychiatric case register scottish controls consisting local church congregation volunteers lothian region eoad materials selected non familial cases common presenilin mutations screened positives found discarded test set
0.22005783.15615772.html.plaintext.txt	53	addition extended load families six different case control series analyzed study series named follows mayo clinic rochester mcr mayo clinic jacksonville mcj university kentucky uky gothenburg gothenburg postmortem scottish mcr samples collected part mayo clinic alzheimers disease patient registry community based prospective registry mayo clinic rochester memory disorders clinic case control series mcj samples collected mayo clinic jacksonville memory disorders clinic uky series collected part university kentucky memory disorders clinic brains program mcr mcj uky series consisted caucasian subjects united states gothenburg gothenburg postmortem series consisted swedish ad cases recruited prospective longitudinal study patients dementia molndal prospective dementia study swedish controls consisted healthy volunteers gothenburg autopsy cases gothenburg postmortem finally scottish samples composed eoad patients lothian psychiatric case register scottish controls consisting local church congregation volunteers lothian region eoad materials selected non familial cases common presenilin mutations screened positives found discarded test set
0.22005783.15615772.html.plaintext.txt	54	clinical ad diagnoses series made according nincds adrda criteria num neuropathologically diagnosed ad patients gothenburg postmortem also fulfilled clinical nincds criteria probable ad met neuropathological cerad criteria definitive ad ads series except scottish series ages onset num years
0.22005783.15615772.html.plaintext.txt	55	clinical ad diagnoses series made according nincds adrda criteria num neuropathologically diagnosed ad patients gothenburg postmortem also fulfilled clinical nincds criteria probable ad met neuropathological cerad criteria definitive ad ads series except scottish series ages onset num years
0.22005783.15615772.html.plaintext.txt	56	study approved appropriate institutional review boards appropriate informed consent obtained participants
0.22005783.15615772.html.plaintext.txt	57	identification genotyping plau snps eleven members selected num extended load families gave linkage signal chromosome num num genomic dna five family members two probands high plasma ass level two members two married spouses low levels sequenced samples came four different families three probands extreme high ass levels intronic primers flanking plau exons used pcr amplification coding regions num bp num untranslated region num utr num bp num utr plau sequenced sequencing done via semi automated fluorescent method using symb sequencer associated factura software packages snp databases national center biotechnology information ncbi url httpwwwncbinlmnihgovsnp university washington fred hutchinson cancer research center uw fhcrc url httppgambtwashingtonedu also screened snp identification snps identified via sequencing effort used analysis well rare missense snp exon num identified bioinformatics screen seven snps thus identified analyzed haplotype analysis determined two missense exon num snp exon num deletion snp yielded redundant information therefore remainder analysis carried five snps
0.22005783.15615772.html.plaintext.txt	58	identification genotyping plau snps eleven members selected num extended load families gave linkage signal chromosome num num genomic dna five family members two probands high plasma ass level two members two married spouses low levels sequenced samples came four different families three probands extreme high ass levels intronic primers flanking plau exons used pcr amplification coding regions num bp num untranslated region num utr num bp num utr plau sequenced sequencing done via semi automated fluorescent method using symb sequencer associated factura software packages snp databases national center biotechnology information ncbi url httpwwwncbinlmnihgovsnp university washington fred hutchinson cancer research center uw fhcrc url httppgambtwashingtonedu also screened snp identification snps identified via sequencing effort used analysis well rare missense snp exon num identified bioinformatics screen seven snps thus identified analyzed haplotype analysis determined two missense exon num snp exon num deletion snp yielded redundant information therefore remainder analysis carried five snps
0.22005783.15615772.html.plaintext.txt	59	plau snp frequencies estimated mcj mcr uky series num load families summarized table num snps tested groups rare exon num snp hardy weinberg disequilibrium control groups mcj mcr snp used compound genotype analysis addition exon num snp hardy weinberg disequilibrium mcj control series
0.22005783.15615772.html.plaintext.txt	60	plau snp frequencies estimated mcj mcr uky series num load families summarized table num snps tested groups rare exon num snp hardy weinberg disequilibrium control groups mcj mcr snp used compound genotype analysis addition exon num snp hardy weinberg disequilibrium mcj control series
0.22005783.15615772.html.plaintext.txt	61	dna extracted peripheral blood leukocytes using routine methods gothenburg gothenburg postmortem scottish series genotyped using dynamic allele specific hybridization numnum series genotyped symb instrument using taqman technology taqman assays software designing primers probes implemented within abi prism num ht sequence detection system utilized ncbi genbank plau gene sequence symb used pedigree structure phenotypic genotypic information maintained pedsys num httpwwwsfbrorgsfbrpublicsoftwarepedsyspedsyshtml also produced output files analysis performed solar explained subsequently
0.22005783.15615772.html.plaintext.txt	62	dna extracted peripheral blood leukocytes using routine methods gothenburg gothenburg postmortem scottish series genotyped using dynamic allele specific hybridization numnum series genotyped symb instrument using taqman technology taqman assays software designing primers probes implemented within abi prism num ht sequence detection system utilized ncbi genbank plau gene sequence symb used pedigree structure phenotypic genotypic information maintained pedsys num httpwwwsfbrorgsfbrpublicsoftwarepedsyspedsyshtml also produced output files analysis performed solar explained subsequently
0.22005783.15615772.html.plaintext.txt	63	analysis ld among snps measured ld snps within num extended load families using gold program num program determines various pairwise statistical parameters ld lewontins standardized disequilibrium coefficient num d symb ld detected founders married ins using expectation maximization algorithm slatkin excoffier num also detected ld within ads controls mcr mcj uky series using program
0.22005783.15615772.html.plaintext.txt	64	analysis ld among snps measured ld snps within num extended load families using gold program num program determines various pairwise statistical parameters ld lewontins standardized disequilibrium coefficient num d symb ld detected founders married ins using expectation maximization algorithm slatkin excoffier num also detected ld within ads controls mcr mcj uky series using program
0.22005783.15615772.html.plaintext.txt	65	tests association plau snp haplotypes plasma ass levels load families estimated haplotypes five plau snps genotyped members ten load families using gold num symb num highly significant ld among five plau snps crossover events observed num extended load families tested association plau haplotypes plasma symb phenotype using variance components method implemented computer program solar num
0.22005783.15615772.html.plaintext.txt	66	tests association plau snp haplotypes plasma ass levels load families estimated haplotypes five plau snps genotyped members ten load families using gold num symb num highly significant ld among five plau snps crossover events observed num extended load families tested association plau haplotypes plasma symb phenotype using variance components method implemented computer program solar num
0.22005783.15615772.html.plaintext.txt	67	method described detail elsewhere num estimates amount variance quantitative trait owing residual genetic factors symb shared family environment numh individual specific random environmental factors nume based phenotype covariance arbitrary relative pairs covariance matrix takes form
0.22005783.15615772.html.plaintext.txt	68	method described detail elsewhere num estimates amount variance quantitative trait owing residual genetic factors symb shared family environment numh individual specific random environmental factors nume based phenotype covariance arbitrary relative pairs covariance matrix takes form
0.22005783.15615772.html.plaintext.txt	69	num matrix kinship coefficients describing polygenic factors identity matrix describing sporadic environmental factors h household matrix matrix whose ijth element equal num individuals j share specified environment num otherwise family collection largely composed extended pedigrees measured plasma ass members family single batch elisas rigorously account possible assay batch batch variations may affect variance plasma ass included household matrix models almost individuals family measured one batch household matrix included element equal num individuals extended family num otherwise realize may overly conservative collection largely weighted towards families high ass segregating within family given shared family effect household overlaps kinship may corrected underestimated shared genetic effect including household term model scalars symb symb symb estimated using maximum likelihood
0.22005783.15615772.html.plaintext.txt	70	num matrix kinship coefficients describing polygenic factors identity matrix describing sporadic environmental factors h household matrix matrix whose ijth element equal num individuals j share specified environment num otherwise family collection largely composed extended pedigrees measured plasma ass members family single batch elisas rigorously account possible assay batch batch variations may affect variance plasma ass included household matrix models almost individuals family measured one batch household matrix included element equal num individuals extended family num otherwise realize may overly conservative collection largely weighted towards families high ass segregating within family given shared family effect household overlaps kinship may corrected underestimated shared genetic effect including household term model scalars symb symb symb estimated using maximum likelihood
0.22005783.15615772.html.plaintext.txt	71	formulate association model plau snp haplotypes used within pedigree association model hopper mathews num model matrix allelic sharing within pedigrees ij defined ijnum individuals j pedigree share alleles haplotype identical state ijnumnum individuals j pedigree share one allele identical state ijnum otherwise association model solar estimates variance quantitative trait owing association symb residual genetic factors symb household effects symb environmental effects symb null model association symb fixed zero difference symb likelihoods two models produces test statistic distribution lod score genetic linkage analysis one degree freedom two models association fixed association tested one sided test performed
0.22005783.15615772.html.plaintext.txt	72	formulate association model plau snp haplotypes used within pedigree association model hopper mathews num model matrix allelic sharing within pedigrees ij defined ijnum individuals j pedigree share alleles haplotype identical state ijnumnum individuals j pedigree share one allele identical state ijnum otherwise association model solar estimates variance quantitative trait owing association symb residual genetic factors symb household effects symb environmental effects symb null model association symb fixed zero difference symb likelihoods two models produces test statistic distribution lod score genetic linkage analysis one degree freedom two models association fixed association tested one sided test performed
0.22005783.15615772.html.plaintext.txt	73	tests association load case control series clump case control series tested association plau compound genotypes load using clump clump program num measures statistical significance variety numxm contingency tables simulation employed symb test within clump analyzes raw numxm table m total number categories application clump numxm table consisted two diagnostic categories m genotypic categories corresponding unique combination genotypes five plau snps
0.22005783.15615772.html.plaintext.txt	74	tests association load case control series clump case control series tested association plau compound genotypes load using clump clump program num measures statistical significance variety numxm contingency tables simulation employed symb test within clump analyzes raw numxm table m total number categories application clump numxm table consisted two diagnostic categories m genotypic categories corresponding unique combination genotypes five plau snps
0.22005783.15615772.html.plaintext.txt	75	ass analysis plasma symb symb measured previously described num relationship plasma symb age plaunum genotypes load family members initially analyzed fitting polynomial regression curves separately family members symb cc ct tt cttt genotypes using num logsymb dependent variable age agenum independent variables analyses showed genotype specific age related effects plasma symb levels indicated plasma symb increases aging beginning age num individuals ct tt genotype
0.22005783.15615772.html.plaintext.txt	76	ass analysis plasma symb symb measured previously described num relationship plasma symb age plaunum genotypes load family members initially analyzed fitting polynomial regression curves separately family members symb cc ct tt cttt genotypes using num logsymb dependent variable age agenum independent variables analyses showed genotype specific age related effects plasma symb levels indicated plasma symb increases aging beginning age num individuals ct tt genotype
0.22005783.15615772.html.plaintext.txt	77	used num num year age group previous studies found linkage plasma ass levels locus chromosome num num described previously num num year age group initially chosen observation plasma ass elevated individuals num num years old addition plasma ass appears complex likely deposition related changes individuals ad num age group study determined significant age related effects plaunum genotypes plasma ass levels individuals num years depicted subsequent thus analyses performed ages num num year old num years groups
0.22005783.15615772.html.plaintext.txt	78	used num num year age group previous studies found linkage plasma ass levels locus chromosome num num described previously num num year age group initially chosen observation plasma ass elevated individuals num num years old addition plasma ass appears complex likely deposition related changes individuals ad num age group study determined significant age related effects plaunum genotypes plasma ass levels individuals num years depicted subsequent thus analyses performed ages num num year old num years groups
0.22005783.15615772.html.plaintext.txt	79	tests association plaunum symb snp plasma ass levels load families applied variance components methodology implemented software package solar num estimate effect covariates plasma ass levels controlling pairwise genetic relationships shared family effects among family members extended load pedigrees
0.22005783.15615772.html.plaintext.txt	80	tested association plaunum genotypes plasma ass performing multivariate regression analysis including kinship identity household matrices described earlier model tested two different models significance coefficients covariates tested using polygenic screen option solar provides p value coefficient comparing model includes covariate model excludes option causes covariates stay model regardless significance model num covariates tested ct tt genotypes age ct genotypexage tt genotypexage model num ct tt genotypes pooled single cttt variable encoded one subjects ct tt genotype zero cc genotype analyses performed family members num years age selected subset determined age related increase plasma symb levels age num individuals plaunum genotypes ct tt analyses performed ass values second time excluding two extreme outliers plasma ass levels plus minus num sd beyond mean plaunum ctxage plaunum ctttxage still significant variables model num num respectively excluding outliers
0.22005783.15615772.html.plaintext.txt	81	tested association plaunum genotypes plasma ass performing multivariate regression analysis including kinship identity household matrices described earlier model tested two different models significance coefficients covariates tested using polygenic screen option solar provides p value coefficient comparing model includes covariate model excludes option causes covariates stay model regardless significance model num covariates tested ct tt genotypes age ct genotypexage tt genotypexage model num ct tt genotypes pooled single cttt variable encoded one subjects ct tt genotype zero cc genotype analyses performed family members num years age selected subset determined age related increase plasma symb levels age num individuals plaunum genotypes ct tt analyses performed ass values second time excluding two extreme outliers plasma ass levels plus minus num sd beyond mean plaunum ctxage plaunum ctttxage still significant variables model num num respectively excluding outliers
0.22005783.15615772.html.plaintext.txt	82	determine age related effect plaunum genotypes plaunum genotypes plasma symb levels load family members ages fitted two non linear regression models taking account variance components described earlier model num family members ages agenum plaunum ctxagenum plaunum ttxagenum tested covariates addition age plaunum ct plaunum tt plaunum ctxage plaunum ttxage model num agenum plaunum ctttxagenum included covariates besides age plaunum cttt plaunum ctttxage rationale testing non linear models described detail main text
0.22005783.15615772.html.plaintext.txt	83	determine age related effect plaunum genotypes plaunum genotypes plasma symb levels load family members ages fitted two non linear regression models taking account variance components described earlier model num family members ages agenum plaunum ctxagenum plaunum ttxagenum tested covariates addition age plaunum ct plaunum tt plaunum ctxage plaunum ttxage model num agenum plaunum ctttxagenum included covariates besides age plaunum cttt plaunum ctttxage rationale testing non linear models described detail main text
0.22005783.15615772.html.plaintext.txt	84	logistic regression analysis test association plaunum symb snp case controls logistic regression analysis implemented sas version num utilized test association ad plaunum genotypes initially model estimated tested effects plaunum ct tt genotypes separately utilized results analysis suggested similar risky estimates genotypes given result plaunum tt genotype relatively rare second model fitted ct tt genotypes combined one variable cttt coded num ct tt genotype num cc genotype
0.22005783.15615772.html.plaintext.txt	85	logistic regression analysis test association plaunum symb snp case controls logistic regression analysis implemented sas version num utilized test association ad plaunum genotypes initially model estimated tested effects plaunum ct tt genotypes separately utilized results analysis suggested similar risky estimates genotypes given result plaunum tt genotype relatively rare second model fitted ct tt genotypes combined one variable cttt coded num ct tt genotype num cc genotype
0.22005783.15615772.html.plaintext.txt	86	meta analysis plaunum symb snp num case control series using genotype counts plaunum cttt versus cc genotypes ad cases controls six series described article performed meta analysis implemented statsdirect statistical package breslow day test performed test heterogeneity among samples pooled estimates calculated using fixed effects random effects model implemented mantel haenszel dersimonian laird tests respectively
0.22005783.15615772.html.plaintext.txt	87	meta analysis plaunum symb snp num case control series using genotype counts plaunum cttt versus cc genotypes ad cases controls six series described article performed meta analysis implemented statsdirect statistical package breslow day test performed test heterogeneity among samples pooled estimates calculated using fixed effects random effects model implemented mantel haenszel dersimonian laird tests respectively
0.22005783.15615772.html.plaintext.txt	88	analysis plasma brain ass plau ko mice plasma symb symb analyzed sandwich elisa previously described num brain symb symb analyzed elisa following direct extraction formic acid neutralization previously described num ko mice homozygous null allele results normalized ass present num num month old control wild type mice numbers analyzed follows num num month old plau ko mice num nnum control mice nnum num month old plau ko mice nnum control nnum mice num num month old neprilysin ko mice num nnum control mice nnum neprilysin ko mice used additional positive control num
0.22005783.15615772.html.plaintext.txt	89	analysis plasma brain ass plau ko mice plasma symb symb analyzed sandwich elisa previously described num brain symb symb analyzed elisa following direct extraction formic acid neutralization previously described num ko mice homozygous null allele results normalized ass present num num month old control wild type mice numbers analyzed follows num num month old plau ko mice num nnum control mice nnum num month old plau ko mice nnum control nnum mice num num month old neprilysin ko mice num nnum control mice nnum neprilysin ko mice used additional positive control num
0.22005783.15615772.html.plaintext.txt	90	evaluate brain symb symb used methods previously employed demonstrate endogenous brain symb increases transgenic mice expressing presenilin num mutations linked early onset familial ad num
0.22005783.15615772.html.plaintext.txt	91	acknowledgements acknowledge mayo clinic uky adrc members help collection samples grateful individuals participated study without work would possible study supported nih grants symb sgy symb sgy symb net symb se numsymbnum wm grant american federation aging research grant symb net robert clarice smith fellowship net
0.22005783.15615772.html.plaintext.txt	92	acknowledgements acknowledge mayo clinic uky adrc members help collection samples grateful individuals participated study without work would possible study supported nih grants symb sgy symb sgy symb net symb se numsymbnum wm grant american federation aging research grant symb net robert clarice smith fellowship net
0.22005783.15615772.html.plaintext.txt	93	references top abstract introduction results discussion materials methods references ertekin taner n graff radford n younkin lh eckman c baker m adamson j ronald j blangero j hutton m younkin sg num linkage plasma symb quantitative locus chromosome num late onset alzheimers disease pedigrees science num num numabstractfree full text
0.22522588.11983636.html.plaintext.txt	0	genetic host factors dementia downs syndrome nicole schupf phd
0.22522588.11983636.html.plaintext.txt	1	laboratory epidemiology new york state institute basic research developmental disabilities staten island
0.22522588.11983636.html.plaintext.txt	2	center columbia university college physicians surgeons new york usa
0.22522588.11983636.html.plaintext.txt	3	correspondence nicole schupf phd new york state institute basic research num forest hill road staten island ny num tel num num num num fax num num num num e mail symbatcolumbiaedu
0.22522588.11983636.html.plaintext.txt	4	correspondence nicole schupf phd new york state institute basic research num forest hill road staten island ny num tel num num num num fax num num num num e mail symbatcolumbiaedu
0.22522588.11983636.html.plaintext.txt	5	declaration interest grants iirg num num symb num num alzheimers association federal grants symb symb symbnum funds new york state office mental retardation developmental disabilities
0.22522588.11983636.html.plaintext.txt	6	presented part blake marsh lecture annual meeting royal college psychiatrists num july num edinburgh
0.22522588.11983636.html.plaintext.txt	7	abstract top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references background high risk dementia adults downs syndrome attributed triplication overexpression gene amyloid precursor protein app wide variation age onset must due risk factors
0.22522588.11983636.html.plaintext.txt	8	aims identify factors influence age onset dementia downs syndrome
0.22522588.11983636.html.plaintext.txt	9	method studies factors influence formation beta amyloid ass reviewed including atypical karyotypes susceptibility genotypes gender oestrogen deficiency individual differences ass peptide levels
0.22522588.11983636.html.plaintext.txt	10	results apolipoprotein e num allele oestrogen deficiency high levels symb num peptide associated earlier onset dementia atypical karyotypes apolipoprotein e num allele associated reduced mortality reduced risk dementia
0.22522588.11983636.html.plaintext.txt	11	conclusions factors influence ass levels rather overexpression app may account differences age onset dementia downs syndrome
0.22522588.11983636.html.plaintext.txt	12	introduction top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references alzheimers disease associated characteristic neuropathology includes deposition extracellular beta amyloid ass neuritic plaques intracellular accumulation neurofibrillary tangles adults downs syndrome high levels ass deposition age num years early onset dementia however average age onset clinical dementia num years varies widely neuropathological manifestations alzheimers disease downs syndrome attributed triplication expression gene beta amyloid precursor protein app located chromosome num factors influencing age onset dementia unresolved factors influence formation deposition ass reviewed including atypical karyotypes susceptibility genotypes gender oestrogen deficiency individual differences ass peptide levels factors modify rate degree ass deposition rather expression app may important determinants risk dementia downs syndrome
0.22522588.11983636.html.plaintext.txt	13	amyloid cascade hypothesis top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references although controversy relative importance plaques versus tangles development alzheimers disease increasing evidence altered metabolism ass peptides amyloid deposition neuritic plaques causes alzheimers disease triggering complex pathological cascade produces dementia ass peptides symb num symb num two major species ass generated app sequential proteolytic cleavage ss secretases enzymes ones involved breakdown app secretase cleaves full length app producing soluble sapp subsequently symb processing secretase precludes production full length ass peptides anti amyloidogenic younkin num
0.22522588.11983636.html.plaintext.txt	14	several lines evidence suggest deposition ass num important initial step pathogenesis alzheimers disease symb num aggregates rapidly deposited earlier alzheimers disease plaques symb num iwatsubo et al num mutations gene app presenilin symbnum genes associated early onset familial alzheimers disease selective increase symb num borchelt et al num mann et al num scheuner et al num kosaka et al num younkin num brain levels symb num increase early development alzheimers disease strongly correlated cognitive decline cummings cotman num naslund et al num plasma levels symb num higher elderly people subsequently develop alzheimers disease remain free dementia mayeux et al num
0.22522588.11983636.html.plaintext.txt	15	several lines evidence suggest deposition ass num important initial step pathogenesis alzheimers disease symb num aggregates rapidly deposited earlier alzheimers disease plaques symb num iwatsubo et al num mutations gene app presenilin symbnum genes associated early onset familial alzheimers disease selective increase symb num borchelt et al num mann et al num scheuner et al num kosaka et al num younkin num brain levels symb num increase early development alzheimers disease strongly correlated cognitive decline cummings cotman num naslund et al num plasma levels symb num higher elderly people subsequently develop alzheimers disease remain free dementia mayeux et al num
0.22522588.11983636.html.plaintext.txt	16	virtually individuals downs syndrome neuropathological changes consistent diagnosis alzheimers disease time reach num years age including deposition ass diffuse neuritic plaques wisniewski h et al num mann num develop dementia end seventh decade life lai williams num despite nearly universal occurrence alzheimers disease pathology middle age wide variation age onset dementia prevalence alzheimers disease age num ranged num num zigman et al num studies shown average age onset dementia num num years range num num years lai williams num prasher krishnan num methodological problems may account variation estimated prevalence alzheimers disease downs syndrome diagnosis alzheimers disease population requires documentation clinically significant decline cognitive adaptive competence previously attained levels performance documentation absence condition might cause declines performance aylward et al num requirements particularly difficult address adults downs syndrome given lifelong intellectual disability wide range premorbid levels performance associated differences level intellectual disability requires specific criteria clinically significant decline indicative dementia level function beginning developed yet consensus set cognitive assessment tasks diagnostic criteria existing cognitive assessment batteries differentiate adults downs syndrome dementia early stages presently diagnoses alzheimers disease adults downs syndrome made clinically relatively late stages disease without systematic cognitive functional testing time
0.22522588.11983636.html.plaintext.txt	17	virtually individuals downs syndrome neuropathological changes consistent diagnosis alzheimers disease time reach num years age including deposition ass diffuse neuritic plaques wisniewski h et al num mann num develop dementia end seventh decade life lai williams num despite nearly universal occurrence alzheimers disease pathology middle age wide variation age onset dementia prevalence alzheimers disease age num ranged num num zigman et al num studies shown average age onset dementia num num years range num num years lai williams num prasher krishnan num methodological problems may account variation estimated prevalence alzheimers disease downs syndrome diagnosis alzheimers disease population requires documentation clinically significant decline cognitive adaptive competence previously attained levels performance documentation absence condition might cause declines performance aylward et al num requirements particularly difficult address adults downs syndrome given lifelong intellectual disability wide range premorbid levels performance associated differences level intellectual disability requires specific criteria clinically significant decline indicative dementia level function beginning developed yet consensus set cognitive assessment tasks diagnostic criteria existing cognitive assessment batteries differentiate adults downs syndrome dementia early stages presently diagnoses alzheimers disease adults downs syndrome made clinically relatively late stages disease without systematic cognitive functional testing time
0.22522588.11983636.html.plaintext.txt	18	neuropathological manifestations alzheimers disease downs syndrome attributed triplication overexpression gene app located chromosome num rumble et al num increased risk dementia downs syndrome may mediated increased substrate cellular production ass peptides recent neuropathological studies shown diffuse plaques prevalent alzheimer type lesion seen individuals downs syndrome age num associated dementia diffuse plaques contain non fibrillar amyloid appear younger ages neuritic plaques associated neuronal degeneration appear affect structure function neurons contrast increases numbers neuritic plaques containing substantial amounts fibrillised ass peptides observed adults downs syndrome predominantly num years age associated neuronal degeneration loss function wisniewski et al num examination age specific prevalence dementia downs syndrome supports hypothesis clinical manifestations alzheimers disease downs syndrome closely associated development fibrillised plaques lai williams num visser et al num holland et al num lai et al num see fig num although prevalence studies employed varying sampling diagnostic methods remarkable agreement across studies risk alzheimers disease increases primarily num years age addition adults downs syndrome develop dementia even reach ages presence high densities neuritic plaques presumed thus triplication gene app may serve increase diffuse plaques adults downs syndrome factors distinct app triplication must account individual differences susceptibility formation fibrillised plaques wide range age onset dementia central task epidemiology dementia downs syndrome identify factors may influence risk alzheimers disease accelerating formation ass several avenues investigation suggested existing findings review role atypical karyotypes b genetic susceptibility factors c gender oestrogen deficiency d individual differences ass peptide levels
0.22522588.11983636.html.plaintext.txt	19	neuropathological manifestations alzheimers disease downs syndrome attributed triplication overexpression gene app located chromosome num rumble et al num increased risk dementia downs syndrome may mediated increased substrate cellular production ass peptides recent neuropathological studies shown diffuse plaques prevalent alzheimer type lesion seen individuals downs syndrome age num associated dementia diffuse plaques contain non fibrillar amyloid appear younger ages neuritic plaques associated neuronal degeneration appear affect structure function neurons contrast increases numbers neuritic plaques containing substantial amounts fibrillised ass peptides observed adults downs syndrome predominantly num years age associated neuronal degeneration loss function wisniewski et al num examination age specific prevalence dementia downs syndrome supports hypothesis clinical manifestations alzheimers disease downs syndrome closely associated development fibrillised plaques lai williams num visser et al num holland et al num lai et al num see fig num although prevalence studies employed varying sampling diagnostic methods remarkable agreement across studies risk alzheimers disease increases primarily num years age addition adults downs syndrome develop dementia even reach ages presence high densities neuritic plaques presumed thus triplication gene app may serve increase diffuse plaques adults downs syndrome factors distinct app triplication must account individual differences susceptibility formation fibrillised plaques wide range age onset dementia central task epidemiology dementia downs syndrome identify factors may influence risk alzheimers disease accelerating formation ass several avenues investigation suggested existing findings review role atypical karyotypes b genetic susceptibility factors c gender oestrogen deficiency d individual differences ass peptide levels
0.22522588.11983636.html.plaintext.txt	20	view larger version numk fig num age specific prevalence dementia adults downs syndrome data lai williams num data visser et al num data lai et al num data holland et al num
0.22522588.11983636.html.plaintext.txt	21	view larger version numk fig num age specific prevalence dementia adults downs syndrome data lai williams num data visser et al num data lai et al num data holland et al num
0.22522588.11983636.html.plaintext.txt	22	atypical karyotypes top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references evidence case studies adults downs syndrome atypical karyotypes including translocations partial trisomies varying degrees mosaicism associated improved survival decreased risk alzheimers disease prasher et al num presented interesting case num year old woman partial trisomy num numxxrecnumdup q invnumsymbnumnum conducted comprehensive analysis clinical molecular genetic correlates partial trisomy general appearance suggestive typical downs syndrome phenotype experienced several common age related medical conditions characteristic downs syndrome including hypothyroidism cataracts hypotonia hearing impairment analysis gene sequences chromosome num using fluorescent situ hybridisation showed partial trisomy excluded region containing gene app present two copies evidence decline cognitive adaptive competence num years preceding death pneumonia evidence alzheimers disease found magnetic resonance imaging neuropathological assessment similarly two reports women downs syndrome num num disomy chromosome num respectively chicoine mcguire num w b zigman personal communication num women characteristic downs syndrome phenotype typical age related medical conditions including hypothyroidism cataracts woman num disomy chromosome num died age num following hospitalisation hip fracture free dementia death woman num disomy still living age num shows evidence dementia based evaluations cognitive adaptive behaviour
0.22522588.11983636.html.plaintext.txt	23	genetic susceptibility factors top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references four genes increase risk alzheimers disease identified mutations three genes app presenilin num symb presenilin num symb associated early onset familial forms alzheimers disease transmitted autosomal dominant goate et al num levy lehad et al num sherrington et al num homozygosity common variant symb num allele associated increased risk alzheimers disease studies higuchi et al num kehoe et al num scott et al num wragg et al num one study examined influence symb alleles risk dementia downs syndrome study adults downs syndrome significant differences allele frequencies individuals dementia age matched individuals without dementia tyrrell et al num
0.22522588.11983636.html.plaintext.txt	24	polymorphisms gene apolipoprotein e apoe associated risk common late onset alzheimers disease onset num years age three common variants gene apoe encoded three alleles num num num numerous cross sectional case control studies patients alzheimers disease found significantly likely peers one copies apoe num allele corder et al num mayeux et al num saunders et al num apoe num protein may act increasing rate process leads alzheimers disease predisposing greater accumulation ass without alzheimers disease roses et al num hyman et al num polvikoski et al num presence least common allele apoe num associated delay disease onset even protection investigators corder et al num roses et al num
0.22522588.11983636.html.plaintext.txt	25	polymorphisms gene apolipoprotein e apoe associated risk common late onset alzheimers disease onset num years age three common variants gene apoe encoded three alleles num num num numerous cross sectional case control studies patients alzheimers disease found significantly likely peers one copies apoe num allele corder et al num mayeux et al num saunders et al num apoe num protein may act increasing rate process leads alzheimers disease predisposing greater accumulation ass without alzheimers disease roses et al num hyman et al num polvikoski et al num presence least common allele apoe num associated delay disease onset even protection investigators corder et al num roses et al num
0.22522588.11983636.html.plaintext.txt	26	apolipoprotein e downs syndrome relation apoe genotype risk alzheimers disease downs syndrome difficult establish studies consistently found presence apoe num allele increases longevity reduces risk dementia role num allele controversial hardy et al num royston et al num martins et al num van gool et al num cosgrave et al num lambert et al num schupf et al num prasher et al num schupf et al num sekijima et al num tyrrell et al num lai et al num rubinszstein et al num deb et al num small sample sizes importantly failure consider differences age onset dementia among without num allele may account negative findings since effect num allele expressed midlife inclusion sufficient numbers adults num years age analysis using survival methods adjust age years follow important methodological considerations group used survival methods analysis found presence num allele associated earlier onset dementia greater decline adaptive behaviour schupf et al num compared apoe numnum genotype adults downs syndrome num allele five times likely develop dementia age num one num allele developed dementia see fig num among affected individuals mean age onset dementia numnum years num allele numnum years numnum genotype four studies found increased frequency num allele adults downs syndrome dementia compared downs syndrome without dementia martins et al num sekijima et al num rubinsztein et al num deb et al num
0.22522588.11983636.html.plaintext.txt	27	apolipoprotein e downs syndrome relation apoe genotype risk alzheimers disease downs syndrome difficult establish studies consistently found presence apoe num allele increases longevity reduces risk dementia role num allele controversial hardy et al num royston et al num martins et al num van gool et al num cosgrave et al num lambert et al num schupf et al num prasher et al num schupf et al num sekijima et al num tyrrell et al num lai et al num rubinszstein et al num deb et al num small sample sizes importantly failure consider differences age onset dementia among without num allele may account negative findings since effect num allele expressed midlife inclusion sufficient numbers adults num years age analysis using survival methods adjust age years follow important methodological considerations group used survival methods analysis found presence num allele associated earlier onset dementia greater decline adaptive behaviour schupf et al num compared apoe numnum genotype adults downs syndrome num allele five times likely develop dementia age num one num allele developed dementia see fig num among affected individuals mean age onset dementia numnum years num allele numnum years numnum genotype four studies found increased frequency num allele adults downs syndrome dementia compared downs syndrome without dementia martins et al num sekijima et al num rubinsztein et al num deb et al num
0.22522588.11983636.html.plaintext.txt	28	view larger version numk fig num cumulative incidence dementia adults downs syndrome apolipoprotein e apoe genotype unk unk apoe numnum numnum genotypes apoe numnum genotype apoe numnum numnum numnum genotypes based schupf et al num kind permission lippincott williams wilkins
0.22522588.11983636.html.plaintext.txt	29	view larger version numk fig num cumulative incidence dementia adults downs syndrome apolipoprotein e apoe genotype unk unk apoe numnum numnum genotypes apoe numnum genotype apoe numnum numnum numnum genotypes based schupf et al num kind permission lippincott williams wilkins
0.22522588.11983636.html.plaintext.txt	30	results studies apoe genotype adults downs syndrome mixed several studies found apoe num allele decreased risk dementia sample sizes small demonstrate significant effect num allele hardy et al num royston et al num wisniewski et al num two case control studies adults downs syndrome compared allele frequencies individuals without dementia found significant association apoe genotype alzheimers disease adjust age van gool et al num prasher et al num one large study examined num adults downs syndrome num num years age used survival analyses examine age onset dementia apoe genotype lai et al num cumulative incidence dementia age num num apoe numnum genotype num apoe numnum genotype num num allele effect num allele stronger younger ages consistent findings studies general population effect num allele accelerate onset alzheimers disease corder et al num saunders et al num meyer et al num cumulative incidence age num numnum among num allele numnum among apoe numnum genotype authors suggested num effect study may attenuated high rates dementia advanced ages concluded effect num allele may dependent age study sample
0.22522588.11983636.html.plaintext.txt	31	results studies apoe genotype adults downs syndrome mixed several studies found apoe num allele decreased risk dementia sample sizes small demonstrate significant effect num allele hardy et al num royston et al num wisniewski et al num two case control studies adults downs syndrome compared allele frequencies individuals without dementia found significant association apoe genotype alzheimers disease adjust age van gool et al num prasher et al num one large study examined num adults downs syndrome num num years age used survival analyses examine age onset dementia apoe genotype lai et al num cumulative incidence dementia age num num apoe numnum genotype num apoe numnum genotype num num allele effect num allele stronger younger ages consistent findings studies general population effect num allele accelerate onset alzheimers disease corder et al num saunders et al num meyer et al num cumulative incidence age num numnum among num allele numnum among apoe numnum genotype authors suggested num effect study may attenuated high rates dementia advanced ages concluded effect num allele may dependent age study sample
0.22522588.11983636.html.plaintext.txt	32	findings consistent reduced ass deposition polvikoski et al num less plaque formation benjamin et al num lippa et al num num allele acceleration ass pathology num allele hymen et al num polvikoski et al num size num effect relation presence num allele early mortality interaction apoe genotype risk factors dementia downs syndrome gender level learning disability remain resolved require larger older samples analytic procedures provide better adjustment age potential confounders
0.22522588.11983636.html.plaintext.txt	33	findings consistent reduced ass deposition polvikoski et al num less plaque formation benjamin et al num lippa et al num num allele acceleration ass pathology num allele hymen et al num polvikoski et al num size num effect relation presence num allele early mortality interaction apoe genotype risk factors dementia downs syndrome gender level learning disability remain resolved require larger older samples analytic procedures provide better adjustment age potential confounders
0.22522588.11983636.html.plaintext.txt	34	gender oestrogen deficiency top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references loss gonadal hormones following menopause may important determinant cognitive decline risk alzheimers disease ageing women menopause oestrogen promotes growth prolongs survival cholinergic neurons brain regions serving cognitive function toran allerand et al num increases cholinergic activity antioxidant properties regulates metabolism app protect formation ass jaffe et al num goodman et al num petanceska et al num
0.22522588.11983636.html.plaintext.txt	35	human studies data show higher age specific rates alzheimers disease women compared men bachman et al num approximately half risk alzheimers disease women received oestrogen replacement therapy barrett conner kritz silverstein num brenner et al num henderson et al num paganini hill henderson num mortel meyer num tang et al num findings support hypothesis oestrogen deficiency contributes aetiology alzheimers disease contrast randomised controlled clinical trials oestrogen replacement therapy women moderate severe alzheimers disease failed show cognitive improvement suggesting major effect oestrogen delay onset rather reverse cognitive functional decline henderson et al num mulnard et al num
0.22522588.11983636.html.plaintext.txt	36	human studies data show higher age specific rates alzheimers disease women compared men bachman et al num approximately half risk alzheimers disease women received oestrogen replacement therapy barrett conner kritz silverstein num brenner et al num henderson et al num paganini hill henderson num mortel meyer num tang et al num findings support hypothesis oestrogen deficiency contributes aetiology alzheimers disease contrast randomised controlled clinical trials oestrogen replacement therapy women moderate severe alzheimers disease failed show cognitive improvement suggesting major effect oestrogen delay onset rather reverse cognitive functional decline henderson et al num mulnard et al num
0.22522588.11983636.html.plaintext.txt	37	gender differences effects oestrogen downs syndrome systematically investigated work needed clarify hormonal risk factors may influence onset dementia studies presented results separately men women studies compared women men found conflicting results different studies showing earlier onset raghaven et al num lai et al num later onset farrer et al num schupf et al num difference age onset visser et al num lai williams num gender two studies employed survival methods examine age onset distributions gender adjusting age level learning disability found conflicting results colleagues found men downs syndrome three times likely women develop alzheimers disease age num see fig numa effect gender observed age groups num years schupf et al num men women downs syndrome show elevations follicle stimulating hormone fsh luteinising hormone puberty indicative primary gonadal dysfunction appear progress age frequent men women hasen et al num campbell et al num hsiang et al num hestnes et al num thus older men may benefit relative preservation oestrogen proposed account lower risk alzheimers disease men general population contrast another study found women downs syndrome approximately twice likely develop dementia men lai et al num see fig numb study effect gender seen primarily younger ages studies gender differences largest apoe numnum genotype suggesting high risk associated presence apoe num allele mask gender effects basis different results studies gender differences clear
0.22522588.11983636.html.plaintext.txt	38	gender differences effects oestrogen downs syndrome systematically investigated work needed clarify hormonal risk factors may influence onset dementia studies presented results separately men women studies compared women men found conflicting results different studies showing earlier onset raghaven et al num lai et al num later onset farrer et al num schupf et al num difference age onset visser et al num lai williams num gender two studies employed survival methods examine age onset distributions gender adjusting age level learning disability found conflicting results colleagues found men downs syndrome three times likely women develop alzheimers disease age num see fig numa effect gender observed age groups num years schupf et al num men women downs syndrome show elevations follicle stimulating hormone fsh luteinising hormone puberty indicative primary gonadal dysfunction appear progress age frequent men women hasen et al num campbell et al num hsiang et al num hestnes et al num thus older men may benefit relative preservation oestrogen proposed account lower risk alzheimers disease men general population contrast another study found women downs syndrome approximately twice likely develop dementia men lai et al num see fig numb study effect gender seen primarily younger ages studies gender differences largest apoe numnum genotype suggesting high risk associated presence apoe num allele mask gender effects basis different results studies gender differences clear
0.22522588.11983636.html.plaintext.txt	39	view larger version numk fig num cumulative incidence dementia adults downs syndrome gender based schupf et al num b based lai et al num kind permission lippincott williams wilkins
0.22522588.11983636.html.plaintext.txt	40	view larger version numk fig num cumulative incidence dementia adults downs syndrome gender based schupf et al num b based lai et al num kind permission lippincott williams wilkins
0.22522588.11983636.html.plaintext.txt	41	one published study examined influence oestrogen deficiency age onset dementia women downs syndrome cosgrave et al num menstrual profiles risk dementia num women downs syndrome studied twelve women postmenopausal diagnosed dementia significant relationship age menopause age onset dementia subsample rnumnum although sample size small results consistent hypothesis higher endogenous oestrogen levels lower risk dementia decreasing ass peptide levels maintaining cholinergic function critical neuronal populations association age menopause onset dementia confirmed supporting hormonal data provided oestrogen replacement therapy might prove important intervention delay onset dementia
0.22522588.11983636.html.plaintext.txt	42	one published study examined influence oestrogen deficiency age onset dementia women downs syndrome cosgrave et al num menstrual profiles risk dementia num women downs syndrome studied twelve women postmenopausal diagnosed dementia significant relationship age menopause age onset dementia subsample rnumnum although sample size small results consistent hypothesis higher endogenous oestrogen levels lower risk dementia decreasing ass peptide levels maintaining cholinergic function critical neuronal populations association age menopause onset dementia confirmed supporting hormonal data provided oestrogen replacement therapy might prove important intervention delay onset dementia
0.22522588.11983636.html.plaintext.txt	43	individual differences ass peptide levels top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references downs syndrome alzheimers disease deposition symb num precedes appearance symb num iwatsubo et al num symb num predominant species brains young age num years individuals downs syndrome symb num deposits observed decade later compared age matched controls general population plasma levels symb num symb num increased adults downs syndrome tokuda et al num mehta et al num one study found increase related dementia status tokuda et al num group studied plasma symb num symb num levels num adults downs syndrome without dementia compared plasma levels num adults without dementia general population schupf et al num symb num symb num levels significantly higher adults downs syndrome controls general population pnumnum highest adults dementia downs syndrome mean plasma levels symb num symb num higher individuals apoe num allele without num allele regardless dementia status see fig num effect apoe num allele symb num levels may related acceleration rate amyloid fibril formation ma et al num diminished clearance ass mcnamara et al num
0.22522588.11983636.html.plaintext.txt	44	view larger version numk fig num plasma levels symb num symb num adults downs syndrome without dementia apoe genotype num allele num allele schupf et al num permission elsevier science
0.22522588.11983636.html.plaintext.txt	45	view larger version numk fig num plasma levels symb num symb num adults downs syndrome without dementia apoe genotype num allele num allele schupf et al num permission elsevier science
0.22522588.11983636.html.plaintext.txt	46	discussion top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references factors influence formation ass apoe num allele oestrogen deficiency high levels symb num peptides associated earlier onset dementia downs syndrome factors decrease formation ass apoe num allele atypical karyotypes reduce app gene dose associated lower mortality reduced risk dementia important task future work identify sources individual variation premorbid ass levels since num people downs syndrome triplication app associated free trisomy overexpression app account differences age onset dementia within population rather joint effects variety factors including reviewed others yet identified must influence development alzheimers disease suggests need focus younger adults downs syndrome identify causes individual differences lifespan development determine begin exert effects
0.22522588.11983636.html.plaintext.txt	47	clinical implications limitations top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references clinical implications onset dementia downs syndrome modified risk factors influence formation deposition beta amyloid well triplication gene amyloid precursor protein investigation risk factor profiles considered part differential diagnosis dementia downs syndrome studies younger adults downs syndrome may help identify causes individual differences development alzheimers disease
0.22522588.11983636.html.plaintext.txt	48	limitations reliable valid cognitive assessment batteries diagnostic criteria required detect dementia early stages improve studies risk factors studies small sample sizes controlled potential confounders modifiers age gender level intellectual disability studies used prevalent rather incident cases may mask effect risk factors disease onset confounding differential survival
0.22522588.11983636.html.plaintext.txt	49	limitations reliable valid cognitive assessment batteries diagnostic criteria required detect dementia early stages improve studies risk factors studies small sample sizes controlled potential confounders modifiers age gender level intellectual disability studies used prevalent rather incident cases may mask effect risk factors disease onset confounding differential survival
0.22522588.11983636.html.plaintext.txt	50	acknowledgments top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references thank collaborators work richard mayeux md warren zigman phd wayne silverman phd benjamin tycko md pankaj mehta phd edmund jenkins phd deborah pang mph bindu patel mph
0.22522588.11983636.html.plaintext.txt	51	references top abstract introduction amyloid cascade hypothesis atypical karyotypes genetic susceptibility factors gender oestrogen deficiency individual differences discussion clinical implications acknowledgments references aylward e h burt d b thorpe l u et al num diagnosis dementia individuals intellectual disability journal intellectual disability research num num nummedline
0.22522588.11983636.html.plaintext.txt	52	received publication january num num revision received june num num accepted publication june num num
0.22522588.11983636.html.plaintext.txt	53	received publication january num num revision received june num num accepted publication june num num
0.22725685.14559775.html.plaintext.txt	0	fine mapping catenin gene quantitative trait locus chromosome num late onset alzheimers disease pedigrees nilufer ertekin symb james symb hideaki symb linda symb maria symb shushant symb eugene symb samuel symb daniel symb yasumasa symb adam symb leah symb mariza de symb ronald symb neill graff symb michael symb steven symb
0.22725685.14559775.html.plaintext.txt	1	numdepartment neuroscience mayo clinic jacksonville jacksonville fl usa numdepartment neurology neurological institute graduate school medical sciences kyushu university fukuoka japan numdepartment health sciences research division biostatistics mayo clinic rochester rochester mn usa numdepartment neurology mayo clinic rochester rochester mn usa numdepartment neurology mayo clinic jacksonville jacksonville fl usa
0.22725685.14559775.html.plaintext.txt	2	received july num num revised september num num accepted october num num
0.22725685.14559775.html.plaintext.txt	3	abstract top abstract introduction results discussion subjects methods references using plasma amyloid ss protein symb levels intermediate quantitative phenotype late onset alzheimers disease load previously obtained significant linkage num cm chromosome num linkage region obtained independently study affected load sib pairs together two studies provide strong evidence novel load locus chromosome num acts increase symb symb large numnum mb gene located num cm encodes catenin binding partner ss catenin makes symb attractive candidate gene ss catenin interacts presenilin num many mutations elevate symb cause early onset familial ad identified two intronic symb snps num num strong linkage disequilibrium ld showed highly significant association pnumnum numnum plasma symb num extended load families association clearly contributed linkage num cm lod scores decreased linkage analysis performed conditional upon symb association association replicated another independent set num load families pnumnum num pnumnum num bounding association region using multiple snps showed symb confirmed gene within region association findings indicate symb variants influence symb contribute previously reported linkage plasma symb load families
0.22725685.14559775.html.plaintext.txt	4	abstract top abstract introduction results discussion subjects methods references using plasma amyloid ss protein symb levels intermediate quantitative phenotype late onset alzheimers disease load previously obtained significant linkage num cm chromosome num linkage region obtained independently study affected load sib pairs together two studies provide strong evidence novel load locus chromosome num acts increase symb symb large numnum mb gene located num cm encodes catenin binding partner ss catenin makes symb attractive candidate gene ss catenin interacts presenilin num many mutations elevate symb cause early onset familial ad identified two intronic symb snps num num strong linkage disequilibrium ld showed highly significant association pnumnum numnum plasma symb num extended load families association clearly contributed linkage num cm lod scores decreased linkage analysis performed conditional upon symb association association replicated another independent set num load families pnumnum num pnumnum num bounding association region using multiple snps showed symb confirmed gene within region association findings indicate symb variants influence symb contribute previously reported linkage plasma symb load families
0.22725685.14559775.html.plaintext.txt	5	introduction top abstract introduction results discussion subjects methods references late onset alzheimers disease load complex genetic disorder num onset defined num num years age twin studies suggested much num risk load may due genetic factors numnum well established apoe plays important role genetics load numnum recent study estimated however four additional loci make contribution variance load age onset effect size similar greater apoe num given heterogeneity likely least five loci contribute substantially genetics load surprising large number single gene association studies performed far failed identify variants associate reproducibly load reasons failure replication possible gene gene gene environment interactions difficult account poor study design
0.22725685.14559775.html.plaintext.txt	6	introduction top abstract introduction results discussion subjects methods references late onset alzheimers disease load complex genetic disorder num onset defined num num years age twin studies suggested much num risk load may due genetic factors numnum well established apoe plays important role genetics load numnum recent study estimated however four additional loci make contribution variance load age onset effect size similar greater apoe num given heterogeneity likely least five loci contribute substantially genetics load surprising large number single gene association studies performed far failed identify variants associate reproducibly load reasons failure replication possible gene gene gene environment interactions difficult account poor study design
0.22725685.14559775.html.plaintext.txt	7	several groups num num suggested quantitative intermediate phenotypes may useful unraveling complex genetics disorders load clinical disease states load likely result uncertain complex sequence pathophysiologic events whereas intermediate phenotypes may directly related action set genes easily identified thus identification genes variants contribute specific intermediate phenotypes may tractable way identify least genes contribute diseases governed complex genetics optimize utility approach important select intermediate phenotypes highly heritable close biological link disease question
0.22725685.14559775.html.plaintext.txt	8	several groups num num suggested quantitative intermediate phenotypes may useful unraveling complex genetics disorders load clinical disease states load likely result uncertain complex sequence pathophysiologic events whereas intermediate phenotypes may directly related action set genes easily identified thus identification genes variants contribute specific intermediate phenotypes may tractable way identify least genes contribute diseases governed complex genetics optimize utility approach important select intermediate phenotypes highly heritable close biological link disease question
0.22725685.14559775.html.plaintext.txt	9	studies focused levels amyloid ss protein ass specifically symb quantitative intermediate phenotype load ass secreted protein num num derived set large precursor proteins collectively referred amyloid ss protein precursor secreted ass produced virtually cells readily detected human plasma cerebrospinal fluid secreted ass forty amino acids symb small fraction num num two additional amino acids carboxyl terminus symb num num brains patients ad large amount ass aggregates deposited senile plaques much form highly insoluble amyloid fibrils make definite diagnosis ad large numbers senile plaques neurofibrillary tangles must demonstrated brain autopsy num load patients large amount ass deposited senile plaques ends symb one third cases ass ending symb essentially form ass deposited one third predominant form one third large amount symb also deposited num worth noting synthetic symb symb spontaneously assemble amyloid fibrils vitro symb forms amyloid fibrils far rapidly symb numnum brain high levels app mrna concentration ass cerebrospinal fluid num times higher plasma mixed fetal brain cultures produce far ass types cultured cells numnumnum thus likely senile plaques form specifically brain ass levels higher brain organs
0.22725685.14559775.html.plaintext.txt	10	studies focused levels amyloid ss protein ass specifically symb quantitative intermediate phenotype load ass secreted protein num num derived set large precursor proteins collectively referred amyloid ss protein precursor secreted ass produced virtually cells readily detected human plasma cerebrospinal fluid secreted ass forty amino acids symb small fraction num num two additional amino acids carboxyl terminus symb num num brains patients ad large amount ass aggregates deposited senile plaques much form highly insoluble amyloid fibrils make definite diagnosis ad large numbers senile plaques neurofibrillary tangles must demonstrated brain autopsy num load patients large amount ass deposited senile plaques ends symb one third cases ass ending symb essentially form ass deposited one third predominant form one third large amount symb also deposited num worth noting synthetic symb symb spontaneously assemble amyloid fibrils vitro symb forms amyloid fibrils far rapidly symb numnum brain high levels app mrna concentration ass cerebrospinal fluid num times higher plasma mixed fetal brain cultures produce far ass types cultured cells numnumnum thus likely senile plaques form specifically brain ass levels higher brain organs
0.22725685.14559775.html.plaintext.txt	11	app presenilin num presenilin num genes many fully penetrant mutations cause early onset familial ad eofad num num apart early onset causation specific mutations eofad clinically pathologically indistinguishable load others shown eofad mutations increase symb sometimes increase symb well numnum num importantly observed plasma symb elevations eofad patients young cognitively normal carriers eofad mutations num also observed symb elevations plasma non demented relatives load patients ages num num num importantly elevations associated symb allele variants eofad genes num finally mayeux et al num found longitudinal study unrelated elderly individuals subsequently developed ad higher plasma levels symb remained free dementia collectively findings show symb closely linked ad investigate heritability plasma ass analyzed extended load families found plasma symb symb levels substantial heritability num
0.22725685.14559775.html.plaintext.txt	12	app presenilin num presenilin num genes many fully penetrant mutations cause early onset familial ad eofad num num apart early onset causation specific mutations eofad clinically pathologically indistinguishable load others shown eofad mutations increase symb sometimes increase symb well numnum num importantly observed plasma symb elevations eofad patients young cognitively normal carriers eofad mutations num also observed symb elevations plasma non demented relatives load patients ages num num num importantly elevations associated symb allele variants eofad genes num finally mayeux et al num found longitudinal study unrelated elderly individuals subsequently developed ad higher plasma levels symb remained free dementia collectively findings show symb closely linked ad investigate heritability plasma ass analyzed extended load families found plasma symb symb levels substantial heritability num
0.22725685.14559775.html.plaintext.txt	13	given findings level plasma symb likely useful intermediate quantitative phenotype load performed variance components linkage analysis trait group extended load pedigrees analysis showed significant linkage locus num cm chromosome num num linkage region obtained independently study affected load sib pairs num together two studies provide strong evidence novel load locus chromosome num acts increase symb sib pair group estimated effect locus equivalent apoe suggesting likely major risk factor load third group found linkage downstream region chromosome num focused insulin degrading enzyme ide possible candidate gene region num recently fourth group using age onset quantitative phenotype ad parkinsons disease pd families found suggestive linkage chromosome num num num cm num
0.22725685.14559775.html.plaintext.txt	14	given findings level plasma symb likely useful intermediate quantitative phenotype load performed variance components linkage analysis trait group extended load pedigrees analysis showed significant linkage locus num cm chromosome num num linkage region obtained independently study affected load sib pairs num together two studies provide strong evidence novel load locus chromosome num acts increase symb sib pair group estimated effect locus equivalent apoe suggesting likely major risk factor load third group found linkage downstream region chromosome num focused insulin degrading enzyme ide possible candidate gene region num recently fourth group using age onset quantitative phenotype ad parkinsons disease pd families found suggestive linkage chromosome num num num cm num
0.22725685.14559775.html.plaintext.txt	15	important advantage variance components approach employed candidate genes identified likely effect symb evaluated systematically determine much various within gene variants contribute linkage study analyzed symb variants contribute linkage signal chromosome num location function make symb strong candidate gene located num cm peak previously reported linkage signal symb encodes novel catenin catenin recently cloned jannsens et al num catenins interact closely ss catenin play important role intercellular adhesion strong intercellular adhesion depends linkage cadherins actin cytoskeleton via ss catenin complex catenin closely homologous n catenin neuron specific e catenin expressed tissues catenin expressed high levels testis heart also expressed human mouse brain num catenin overall sequence identity num num e n catenin respectively importantly jannsens et al num shown catenin interacts ss catenin functionally effective fashion makes symb strong functional candidate ss catenin interacts presenilin num num many mutations increase symb numnumnum cause early onset familial ad num zhang et al num shown loss signalling ss catenin pathway leads enhanced neuronal vulnerability ass addition ss catenin presenilin forms complex leads stabilization former destabilization complex leads ss catenin degradation enhanced neuronal apoptosis presenilin mutations shown lead destabilization ss catenin presenilin complex degradation ss catenin enhanced ass production given catenins provide link ss catenin binding counterparts presenilins actin cytoskeleton possible postulate mutations catenins could lead disruption stability ss catenin presenilin complex resulting enhanced neuronal vulnerability cells ass increased ass production
0.22725685.14559775.html.plaintext.txt	16	important advantage variance components approach employed candidate genes identified likely effect symb evaluated systematically determine much various within gene variants contribute linkage study analyzed symb variants contribute linkage signal chromosome num location function make symb strong candidate gene located num cm peak previously reported linkage signal symb encodes novel catenin catenin recently cloned jannsens et al num catenins interact closely ss catenin play important role intercellular adhesion strong intercellular adhesion depends linkage cadherins actin cytoskeleton via ss catenin complex catenin closely homologous n catenin neuron specific e catenin expressed tissues catenin expressed high levels testis heart also expressed human mouse brain num catenin overall sequence identity num num e n catenin respectively importantly jannsens et al num shown catenin interacts ss catenin functionally effective fashion makes symb strong functional candidate ss catenin interacts presenilin num num many mutations increase symb numnumnum cause early onset familial ad num zhang et al num shown loss signalling ss catenin pathway leads enhanced neuronal vulnerability ass addition ss catenin presenilin forms complex leads stabilization former destabilization complex leads ss catenin degradation enhanced neuronal apoptosis presenilin mutations shown lead destabilization ss catenin presenilin complex degradation ss catenin enhanced ass production given catenins provide link ss catenin binding counterparts presenilins actin cytoskeleton possible postulate mutations catenins could lead disruption stability ss catenin presenilin complex resulting enhanced neuronal vulnerability cells ass increased ass production
0.22725685.14559775.html.plaintext.txt	17	results top abstract introduction results discussion subjects methods references association symb snps plasma symb initial assessment symb examined three snps num ca num ag num tc intron exons num num snps table num spanned num bp genotyped num extended load families previously analyzed linkage num order minimize age dementia related environmental effects plasma symb levels performed analyses num num year age group previous studies numnum effect three symb snps analyzed encoding covariate testing effect variance plasma symb regression style approach implemented solar table num control effect linkage linkage component included null alternative models tested num tc num ag snps strong linkage disequilibrium showed strong association pnumnum numnum respectively num snp showed marginal association pnumnum table num three snps also examined second set num additional load families table num num symb num snp showed significant association pnumnum symb num snp yielded marginal association pnumnum symb num snp yield significant association pnumnum additional smaller dataset num families combined significance association reached pnumnumsymb num num numnumsymb num num snps table num figure num depicts box plots numsymb levels num families stratified significant symb num snp genotypes consistent association results genotype dependent effect plasma ass levels observed num tt genotype associated highest symb levels ct intermediate levels cc lowest levels
0.22725685.14559775.html.plaintext.txt	18	results top abstract introduction results discussion subjects methods references association symb snps plasma symb initial assessment symb examined three snps num ca num ag num tc intron exons num num snps table num spanned num bp genotyped num extended load families previously analyzed linkage num order minimize age dementia related environmental effects plasma symb levels performed analyses num num year age group previous studies numnum effect three symb snps analyzed encoding covariate testing effect variance plasma symb regression style approach implemented solar table num control effect linkage linkage component included null alternative models tested num tc num ag snps strong linkage disequilibrium showed strong association pnumnum numnum respectively num snp showed marginal association pnumnum table num three snps also examined second set num additional load families table num num symb num snp showed significant association pnumnum symb num snp yielded marginal association pnumnum symb num snp yield significant association pnumnum additional smaller dataset num families combined significance association reached pnumnumsymb num num numnumsymb num num snps table num figure num depicts box plots numsymb levels num families stratified significant symb num snp genotypes consistent association results genotype dependent effect plasma ass levels observed num tt genotype associated highest symb levels ct intermediate levels cc lowest levels
0.22725685.14559775.html.plaintext.txt	19	view table figure num dose dependent effect symb num snp plasma symb levels extended load families box plots depicting median middle part box numth percentile lower limit box numth percentile upper limit box numth percentile lower end line numth percentile upper end line numsymb levels num num year old family members num load families plots depicted separately symb num genotypes tt red ct green cc blue
0.22725685.14559775.html.plaintext.txt	20	determine snps region symb gene show stronger association analyzed num additional snps total num snps analyzed region spanning numnum kb table num symb symb snps numnum kb region linkage disequilibrium many snps region showed nominally significant association none showed association stronger observed num num table num
0.22725685.14559775.html.plaintext.txt	21	determine snps region symb gene show stronger association analyzed num additional snps total num snps analyzed region spanning numnum kb table num symb symb snps numnum kb region linkage disequilibrium many snps region showed nominally significant association none showed association stronger observed num num table num
0.22725685.14559775.html.plaintext.txt	22	view table table num p values association plasma symb num num year old subjects extended load families bounding association symb snps plasma symb bound region symb numnum association evaluated total num additional snps spaced either side num num snps snps selected several groups designed span entire symb gene num kb intervals well region num symb known exons symb numnum kb median away closest snp closest snp group meannumnum kb num num kb given extent ld human genome estimated different studies anywhere num num kb num num extent one genomic region predictable priori possible miss association signals due variants snp groups however given size symb extent coverage throughout outside gene association signals identify num num symb snps well bounded within symb snp genotyping design three six snps analyzed group linkage disequilibrium significantly associating num snp snps analyzed num combined families fig numa using covariate style regression approach snp analyzed association plasma symb num num num combined load families table num fig numb
0.22725685.14559775.html.plaintext.txt	23	view larger version numk figure num boundaries symb numnum association marker marker linkage disequilibrium snps analyzed respect num snp horizontal line shows position numnum mb symb gene dashed line shows dnumnum b marker phenotype plasma symb association horizontal line shows position numnum mb symb gene dashed line shows pnumnum
0.22725685.14559775.html.plaintext.txt	24	view larger version numk figure num boundaries symb numnum association marker marker linkage disequilibrium snps analyzed respect num snp horizontal line shows position numnum mb symb gene dashed line shows dnumnum b marker phenotype plasma symb association horizontal line shows position numnum mb symb gene dashed line shows pnumnum
0.22725685.14559775.html.plaintext.txt	25	num num sides strongly associating num snp ld flanking snps fell essentially baseline levels within large symb gene num side snp association symb also decreased baseline levels within symb gene fig numb num side significance snp association decreased num orders magnitude numnum num numnum significantly associated snp nearest snp group symb fig numb table num association baseline levels num side num num kb num margin symb
0.22725685.14559775.html.plaintext.txt	26	num num sides strongly associating num snp ld flanking snps fell essentially baseline levels within large symb gene num side snp association symb also decreased baseline levels within symb gene fig numb num side significance snp association decreased num orders magnitude numnum num numnum significantly associated snp nearest snp group symb fig numb table num association baseline levels num side num num kb num margin symb
0.22725685.14559775.html.plaintext.txt	27	bounding approach effectively limits region potential association num num sides num within symb thus data provide strong evidence association num num snps plasma symb due variants symb gene
0.22725685.14559775.html.plaintext.txt	28	bounding approach effectively limits region potential association num num sides num within symb thus data provide strong evidence association num num snps plasma symb due variants symb gene
0.22725685.14559775.html.plaintext.txt	29	given total num snps genotyped issue multiple testing raised many snps linkage disequilibrium therefore independent one another fig numb therefore simple bonferroni correction assumption num independent tests overly conservative study nonetheless even bonferroni correction applied num num snps still significant num families pnumnum numnum num combined families pnumnum numnum association smaller set num families longer significant overly conservative correction pnum num num num respectively nonetheless inclusion analysis leads improved evidence association
0.22725685.14559775.html.plaintext.txt	30	given total num snps genotyped issue multiple testing raised many snps linkage disequilibrium therefore independent one another fig numb therefore simple bonferroni correction assumption num independent tests overly conservative study nonetheless even bonferroni correction applied num num snps still significant num families pnumnum numnum num combined families pnumnum numnum association smaller set num families longer significant overly conservative correction pnum num num num respectively nonetheless inclusion analysis leads improved evidence association
0.22725685.14559775.html.plaintext.txt	31	contribution symb association linkage num cm next investigated contribution symb numnum association linkage previously reported initial linkage findings obtained using seven markers covering num cm chromosome num analyze entirety chromosome num genotyped num additional markers spanning num cm num load families num families combined best two point lod scores obtained num numnum num numnum peak described multipoint lod scores broadened flattened considerably incorporation additional markers maximum multipoint lod score continued num cm fig num
0.22725685.14559775.html.plaintext.txt	32	contribution symb association linkage num cm next investigated contribution symb numnum association linkage previously reported initial linkage findings obtained using seven markers covering num cm chromosome num analyze entirety chromosome num genotyped num additional markers spanning num cm num load families num families combined best two point lod scores obtained num numnum num numnum peak described multipoint lod scores broadened flattened considerably incorporation additional markers maximum multipoint lod score continued num cm fig num
0.22725685.14559775.html.plaintext.txt	33	view larger version numk figure num effect symb snp num multipoint lod scores mls load families effect symb num linkage plasma symb num load families black line linkage gray line linkage conditional upon association symb num snp multipoint ibds used analyses generated using num markers described text
0.22725685.14559775.html.plaintext.txt	34	view larger version numk figure num effect symb snp num multipoint lod scores mls load families effect symb num linkage plasma symb num load families black line linkage gray line linkage conditional upon association symb num snp multipoint ibds used analyses generated using num markers described text
0.22725685.14559775.html.plaintext.txt	35	reason broader flatter peak fine mapping analysis may several fold first utilized mcmc mibd estimation implemented symb package numnum multipoint linkage results presented paper opposed regression based mibd estimation algorithm implemented solar used original paper num see also subjects methods second genotyping additional markers leads information regarding recombination could potentially lead decrease original linkage signal obtained fewer markers third utilizing larger number markers increases likelihood map genotyping errors despite implementation strict genotype quality control measures indeed others also found fine mapping markers lead lowering original lod scores obtained lesser number markers numnum
0.22725685.14559775.html.plaintext.txt	36	reason broader flatter peak fine mapping analysis may several fold first utilized mcmc mibd estimation implemented symb package numnum multipoint linkage results presented paper opposed regression based mibd estimation algorithm implemented solar used original paper num see also subjects methods second genotyping additional markers leads information regarding recombination could potentially lead decrease original linkage signal obtained fewer markers third utilizing larger number markers increases likelihood map genotyping errors despite implementation strict genotype quality control measures indeed others also found fine mapping markers lead lowering original lod scores obtained lesser number markers numnum
0.22725685.14559775.html.plaintext.txt	37	evaluate extent num num snps functional snps associated tightly linked pair account linkage observed repeated linkage analysis regressing effect symb num association including covariate linkage model regressing effect snp multipoint linkage signal diminished substantially num combined families fig num marked diminution lod scores indicates substantial proportion linkage signal plasma symb accounted symb num association residual linkage signal persisted regressing symb num association indicates likely additional variants contribute linkage though residual signal may also due random variation diminution maximum multipoint lod scores upon inclusion num snp covariate also evident comparison variance component model excludes covariate table numb one includes table numc p value major gene effect maximum multipoint locus goes numnum numnum trend observed twopoint linkage num snp assessed without including num covariate table numd e p value major gene num locus loses significance pnumnum pnumnum
0.22725685.14559775.html.plaintext.txt	38	evaluate extent num num snps functional snps associated tightly linked pair account linkage observed repeated linkage analysis regressing effect symb num association including covariate linkage model regressing effect snp multipoint linkage signal diminished substantially num combined families fig num marked diminution lod scores indicates substantial proportion linkage signal plasma symb accounted symb num association residual linkage signal persisted regressing symb num association indicates likely additional variants contribute linkage though residual signal may also due random variation diminution maximum multipoint lod scores upon inclusion num snp covariate also evident comparison variance component model excludes covariate table numb one includes table numc p value major gene effect maximum multipoint locus goes numnum numnum trend observed twopoint linkage num snp assessed without including num covariate table numd e p value major gene num locus loses significance pnumnum pnumnum
0.22725685.14559775.html.plaintext.txt	39	view table table num variance components models depicting effect num snp multipoint twopoint linkage discussion top abstract introduction results discussion subjects methods references study analyzed symb gene chromosome num determine functional snps contribute linkage signal plasma symb previously reported extended load families found two symb snps num num showed significant robust association plasma symb num num year old family members extended load families two snps num bp apart strong ld give virtually identical results num num snps located num kb intron exons num num distance numnum kb exon num identified num additional snps within num kb numnum eight intron exons num num three intron exons num num none snps gave significant association numnum careful bounding showed large numnum mb symb gene confirmed gene within region numnum association analyses num used covariate null linkage models reduced multipoint lod score indicating symb numnum association contributes linkage large reduction observed num families analyzed suggests numnum association contributes substantially linkage signal observed families presence residual linkage regressing effect symb num snp indicates however num association entirely account linkage thus data provide substantial evidence symb variants contribute linkage signal previously reported though residual linkage signal may due random variation could also indicate may additional variants contribute linkage whether variants large symb gene nearby genes remains determined
0.22725685.14559775.html.plaintext.txt	40	since intronic snps located numnum kb nearest exon num num unlikely functional effect association symb presumably occurs ld one several functional symb snps sequencing symb exons reported symb transcript num failed identify potentially functional snps could account numnum association possible functional snps affect splicing known alternatively spliced exons strong ld numnum
0.22725685.14559775.html.plaintext.txt	41	since intronic snps located numnum kb nearest exon num num unlikely functional effect association symb presumably occurs ld one several functional symb snps sequencing symb exons reported symb transcript num failed identify potentially functional snps could account numnum association possible functional snps affect splicing known alternatively spliced exons strong ld numnum
0.22725685.14559775.html.plaintext.txt	42	basic premise studying plasma symb intermediate phenotype genes variants influence plasma symb genes variants influence risk load results reported useful identify symb gene variants influence plasma symb thereby increasing likelihood symb gene one genes num cm region chromosome num variants influence risk load important unanswered question well effect snp plasma symb correlate effect ad phenotype unlikely change plasma symb caused specific genetic variant directly increases risk ad increased risk ad probably produced related effect variant within brain thus conceivable perhaps even likely specific variant strong influence plasma symb may sometimes little influence ad phenotype vice versa thoroughly studying several genes elucidating effects entire set functional variants plasma symb ad phenotypes question answered may effects two phenotypes correlate well variants genes poorly others
0.22725685.14559775.html.plaintext.txt	43	basic premise studying plasma symb intermediate phenotype genes variants influence plasma symb genes variants influence risk load results reported useful identify symb gene variants influence plasma symb thereby increasing likelihood symb gene one genes num cm region chromosome num variants influence risk load important unanswered question well effect snp plasma symb correlate effect ad phenotype unlikely change plasma symb caused specific genetic variant directly increases risk ad increased risk ad probably produced related effect variant within brain thus conceivable perhaps even likely specific variant strong influence plasma symb may sometimes little influence ad phenotype vice versa thoroughly studying several genes elucidating effects entire set functional variants plasma symb ad phenotypes question answered may effects two phenotypes correlate well variants genes poorly others
0.22725685.14559775.html.plaintext.txt	44	results reported indicate symb variants significantly associate plasma symb account substantial portion linkage signal chromosome num additional analysis needed identify entire set functional variants account symb linkage num cm identified important test effects ass production symb gene function biological experiments well determine whether functional variants modify risk ad
0.22725685.14559775.html.plaintext.txt	45	results reported indicate symb variants significantly associate plasma symb account substantial portion linkage signal chromosome num additional analysis needed identify entire set functional variants account symb linkage num cm identified important test effects ass production symb gene function biological experiments well determine whether functional variants modify risk ad
0.22725685.14559775.html.plaintext.txt	46	subjects methods top abstract introduction results discussion subjects methods references subjects collected num extended load families composed num individuals num ages num num four families collected via load patient extremely high plasma symb andor symb levels extremes top numth percentile num ad patients analyzed remaining six families ascertained via load proband multiple relatives load without prior ass measurements non extremes one probands non extreme families determined extremely high plasma ass levels family collection therefore family grouped extreme families subsequently except one family distinction extreme non extreme families made priori family collection based plasma symb levels proband detailed collection strategies family profiles families provided elsewhere numnum addition num families num independent extended load pedigrees collected additional pedigrees proband first degree relative load patient elevated plasma ass levels num contributed num subjects ages num num study approved appropriate institutional review board appropriate informed consent obtained participants
0.22725685.14559775.html.plaintext.txt	47	subjects methods top abstract introduction results discussion subjects methods references subjects collected num extended load families composed num individuals num ages num num four families collected via load patient extremely high plasma symb andor symb levels extremes top numth percentile num ad patients analyzed remaining six families ascertained via load proband multiple relatives load without prior ass measurements non extremes one probands non extreme families determined extremely high plasma ass levels family collection therefore family grouped extreme families subsequently except one family distinction extreme non extreme families made priori family collection based plasma symb levels proband detailed collection strategies family profiles families provided elsewhere numnum addition num families num independent extended load pedigrees collected additional pedigrees proband first degree relative load patient elevated plasma ass levels num contributed num subjects ages num num study approved appropriate institutional review board appropriate informed consent obtained participants
0.22725685.14559775.html.plaintext.txt	48	microsatellite genotyping dna extracted peripheral blood leukocytes using routine methods genotypes microsatellites obtained using abi num num sequencers associated genescangenotyper software packages single nucleotide polymorphisms snps genotyped using taqman chemistry software designing primers probes implemented within abi prism num ht sequence detection system pedigree structure phenotypic genotypic information maintained pedsys httpwwwsfbrorgsfbrpublicsoftwarepedsyspedsyshtml num also produced output files analyses performed solar explained order location num chromosome num microsatellite markers determined marshfield linkage map two markers symbnum symbnum locations marshfield linkage map num placed linkage map according location estimates obtained map o mat program httpcompgenrutgersedumapomat num two snps found symb gene also used markers linkage analysis snps numtc numag located num num bp respectively chromosome num genomic map celera database httpwwwceleracom two snps placed linkage map based approximate centimorgan locations estimated physical maps
0.22725685.14559775.html.plaintext.txt	49	microsatellite genotyping dna extracted peripheral blood leukocytes using routine methods genotypes microsatellites obtained using abi num num sequencers associated genescangenotyper software packages single nucleotide polymorphisms snps genotyped using taqman chemistry software designing primers probes implemented within abi prism num ht sequence detection system pedigree structure phenotypic genotypic information maintained pedsys httpwwwsfbrorgsfbrpublicsoftwarepedsyspedsyshtml num also produced output files analyses performed solar explained order location num chromosome num microsatellite markers determined marshfield linkage map two markers symbnum symbnum locations marshfield linkage map num placed linkage map according location estimates obtained map o mat program httpcompgenrutgersedumapomat num two snps found symb gene also used markers linkage analysis snps numtc numag located num num bp respectively chromosome num genomic map celera database httpwwwceleracom two snps placed linkage map based approximate centimorgan locations estimated physical maps
0.22725685.14559775.html.plaintext.txt	50	identification genotyping snps symb genomic mrna sequences initially obtained national center biotechnology information ncbi web site using genomic contig ntnum symb order identify snps primers designed cover known exons num kb intronic region exons num num load cases elderly control subjects family members extended load pedigrees sequenced identify polymorphisms initial sequencing symb exons num kb intronic region identified three snps intronic num kb region num num num subsequently many additional snps symb flanking genes identified using celera database aim cover region using snp groups located every num kb group composed num num snps separated num num kb total num snps including symb num num genotyped throughout symb num symbnum num symb flanking genes snps within group found strong ld snp locations obtained celera sequence map
0.22725685.14559775.html.plaintext.txt	51	identification genotyping snps symb genomic mrna sequences initially obtained national center biotechnology information ncbi web site using genomic contig ntnum symb order identify snps primers designed cover known exons num kb intronic region exons num num load cases elderly control subjects family members extended load pedigrees sequenced identify polymorphisms initial sequencing symb exons num kb intronic region identified three snps intronic num kb region num num num subsequently many additional snps symb flanking genes identified using celera database aim cover region using snp groups located every num kb group composed num num snps separated num num kb total num snps including symb num num genotyped throughout symb num symbnum num symb flanking genes snps within group found strong ld snp locations obtained celera sequence map
0.22725685.14559775.html.plaintext.txt	52	variance components analysis employed variance components methodology implemented software package solar numnum estimate heritability plasma symb levels perform linkage association analyses detect quantitative trait loci qtls affect variance symb extended load families method described detail elsewhere numnum estimates amount variance quantitative trait due particular genetic locus symb residual genetic factors symb individual specific random environmental factors symb based phenotype covariance arbitrary relative pairs covariance matrix takes form
0.22725685.14559775.html.plaintext.txt	53	variance components analysis employed variance components methodology implemented software package solar numnum estimate heritability plasma symb levels perform linkage association analyses detect quantitative trait loci qtls affect variance symb extended load families method described detail elsewhere numnum estimates amount variance quantitative trait due particular genetic locus symb residual genetic factors symb individual specific random environmental factors symb based phenotype covariance arbitrary relative pairs covariance matrix takes form
0.22725685.14559775.html.plaintext.txt	54	matrix probabilities pair individuals share genetic material identical descent given chromosomal location estimated genetic marker data num matrix kinship coefficients describing polygenic factors identity matrix describing sporadic environmental factors
0.22725685.14559775.html.plaintext.txt	55	addition effect shared environment symb variance trait also estimated including household matrix model matrix whose ijth element equal num individuals j share specified environment num otherwise family collection largely composed extended pedigrees measured plasma ass members family single batch elisas rigorously account possible assay batch batch variations may affect variance plasma symb included household matrix models since almost individuals family measured one batch household matrix included elementnum individuals extended family num otherwise realize probably overly conservative since shared family household effect employed account potential batch batch variance assay overlaps kinship effect num inclusion household matrix almost certainly overcorrects batch batch variance underestimates shared genetic effect reason performed heritability linkage analyses without household matrix model multipoint results shown figures num num include household matrix analyses without household matrix yielded slightly better lod scores higher heritabilities general
0.22725685.14559775.html.plaintext.txt	56	addition effect shared environment symb variance trait also estimated including household matrix model matrix whose ijth element equal num individuals j share specified environment num otherwise family collection largely composed extended pedigrees measured plasma ass members family single batch elisas rigorously account possible assay batch batch variations may affect variance plasma symb included household matrix models since almost individuals family measured one batch household matrix included elementnum individuals extended family num otherwise realize probably overly conservative since shared family household effect employed account potential batch batch variance assay overlaps kinship effect num inclusion household matrix almost certainly overcorrects batch batch variance underestimates shared genetic effect reason performed heritability linkage analyses without household matrix model multipoint results shown figures num num include household matrix analyses without household matrix yielded slightly better lod scores higher heritabilities general
0.22725685.14559775.html.plaintext.txt	57	scalars symb symb symb symb estimated using maximum likelihood heritability estimations compared environmental model symb symb fixed zero symb symb estimated polygenic model symb symb symb estimated linkage analyses performed comparing polygenic model linkage model symb also estimated difference two symb likelihoods models produces lod score equivalent classical lod score linkage analysis incorporated sex age symb sexage sexsymb covariates heritability estimations none covariates significant p numnum therefore excluded multipoint linkage analysis
0.22725685.14559775.html.plaintext.txt	58	scalars symb symb symb symb estimated using maximum likelihood heritability estimations compared environmental model symb symb fixed zero symb symb estimated polygenic model symb symb symb estimated linkage analyses performed comparing polygenic model linkage model symb also estimated difference two symb likelihoods models produces lod score equivalent classical lod score linkage analysis incorporated sex age symb sexage sexsymb covariates heritability estimations none covariates significant p numnum therefore excluded multipoint linkage analysis
0.22725685.14559775.html.plaintext.txt	59	order minimize age dementia related environmental effects plasma symb levels performed analyses num num year age group previous studies numnum since variance components methods based underlying assumption quantitative trait analyzed normal distribution numlogsymb levels used phenotypes extreme outliers plasma ass levels plus minus num standard deviations beyond mean excluded analyses thus numlogsymb phenotype analyzed normal distribution plasma ass measurements done using well established sandwich elisa system described previously num samples measured duplicate elisa plate included samples five volunteers results five standard samples used normalize values obtained reduce plate plate day day variance
0.22725685.14559775.html.plaintext.txt	60	order minimize age dementia related environmental effects plasma symb levels performed analyses num num year age group previous studies numnum since variance components methods based underlying assumption quantitative trait analyzed normal distribution numlogsymb levels used phenotypes extreme outliers plasma ass levels plus minus num standard deviations beyond mean excluded analyses thus numlogsymb phenotype analyzed normal distribution plasma ass measurements done using well established sandwich elisa system described previously num samples measured duplicate elisa plate included samples five volunteers results five standard samples used normalize values obtained reduce plate plate day day variance
0.22725685.14559775.html.plaintext.txt	61	identity descent probability estimations identity descent ibd probabilities genotyped marker estimated using pairwise likelihood based estimation method implemented solar num ibd estimates used obtain twopoint lod scores multipoint ibd probabilities also estimated centimorgan pair adjacent markers using markov chain monte carlo mcmc multipoint ibd estimation approach implemented symb package numnum mcmc process run twice default length num replicates second time doubling process length multipoint linkage analyses using mibd matrices done using variance components methodology implemented solar results using shorter longer runs similar results latter presented given computation time increases marker number two upstream markers yielded evidence linkage datasets two markers symbnum symbnum omitted mibd estimations two major differences mibd estimations utilized previous report linkage chromosome num current study num results previous linkage obtained result genotyping seven markers num cm region current study utilizes num markers spread numnum numnum cm chromosome num second mibd estimation approaches used previous current studies different mcmc approach implemented symb numnum utilized study different mibd probability estimation algorithm implemented solar approach utilized initial analysis seven chromosome num markers sobel et al num demonstrated significant differences results obtained two methods using dataset concluded multipoint mcmc approach yielded accurate mibd probability estimates inter marker loci reason utilized mcmc approach study
0.22725685.14559775.html.plaintext.txt	62	identity descent probability estimations identity descent ibd probabilities genotyped marker estimated using pairwise likelihood based estimation method implemented solar num ibd estimates used obtain twopoint lod scores multipoint ibd probabilities also estimated centimorgan pair adjacent markers using markov chain monte carlo mcmc multipoint ibd estimation approach implemented symb package numnum mcmc process run twice default length num replicates second time doubling process length multipoint linkage analyses using mibd matrices done using variance components methodology implemented solar results using shorter longer runs similar results latter presented given computation time increases marker number two upstream markers yielded evidence linkage datasets two markers symbnum symbnum omitted mibd estimations two major differences mibd estimations utilized previous report linkage chromosome num current study num results previous linkage obtained result genotyping seven markers num cm region current study utilizes num markers spread numnum numnum cm chromosome num second mibd estimation approaches used previous current studies different mcmc approach implemented symb numnum utilized study different mibd probability estimation algorithm implemented solar approach utilized initial analysis seven chromosome num markers sobel et al num demonstrated significant differences results obtained two methods using dataset concluded multipoint mcmc approach yielded accurate mibd probability estimates inter marker loci reason utilized mcmc approach study
0.22725685.14559775.html.plaintext.txt	63	tests association initially tested association snps plasma symb num extended load families using regression based covariate approach variance components paradigm implemented computer program solar num order control effect linkage included linkage component symb null alternative models tested used multipoint ibd matrix yielded maximum multipoint lod score num cm num extended load families multipoint ibd probabilities matrix estimated simwalk using genetic marker information described
0.22725685.14559775.html.plaintext.txt	64	tests association initially tested association snps plasma symb num extended load families using regression based covariate approach variance components paradigm implemented computer program solar num order control effect linkage included linkage component symb null alternative models tested used multipoint ibd matrix yielded maximum multipoint lod score num cm num extended load families multipoint ibd probabilities matrix estimated simwalk using genetic marker information described
0.22725685.14559775.html.plaintext.txt	65	test effect specific snp genotypes used measured genotype approach included copy number snp allele covariate analysis regressed plasma symb phenotype covariate individual measured genotype approach classical test differences trait mean genotype described theoretically previously numnum approach also utilized previous association studies snps various quantitative traits extended families numnum individuals xx xy yy snp genotype used covariate takes value num num num respectively formulation assumes snp additive qtl model includes covariate tested model include determine effect quantitative trait interest twice difference natural log likelihoods two models distributed num distribution num degree freedom order test association beyond linkage residual genetic household effects three components included null alternative models first tested association snps symb num load families previously used describe linkage chromosome num num order control effect linkage residual genetic effects household effects group estimated effect snp background model included num cm multipoint identity descent matrix well kinship household matrices tested snp association symb second independent set num load families also analyzed combined group num families
0.22725685.14559775.html.plaintext.txt	66	test effect specific snp genotypes used measured genotype approach included copy number snp allele covariate analysis regressed plasma symb phenotype covariate individual measured genotype approach classical test differences trait mean genotype described theoretically previously numnum approach also utilized previous association studies snps various quantitative traits extended families numnum individuals xx xy yy snp genotype used covariate takes value num num num respectively formulation assumes snp additive qtl model includes covariate tested model include determine effect quantitative trait interest twice difference natural log likelihoods two models distributed num distribution num degree freedom order test association beyond linkage residual genetic household effects three components included null alternative models first tested association snps symb num load families previously used describe linkage chromosome num num order control effect linkage residual genetic effects household effects group estimated effect snp background model included num cm multipoint identity descent matrix well kinship household matrices tested snp association symb second independent set num load families also analyzed combined group num families
0.22725685.14559775.html.plaintext.txt	67	linkage analysis conditional upon association conditional linkage analysis accounts association functional polymorphism one strong ld linkage locus decrease eliminate linkage signal numnum reason performed linkage analysis conditional association strongly associating snp numtc performed test estimating proportion variance due linkage background model included snp covariate comparing linkage model excluded covariate
0.22725685.14559775.html.plaintext.txt	68	linkage analysis conditional upon association conditional linkage analysis accounts association functional polymorphism one strong ld linkage locus decrease eliminate linkage signal numnum reason performed linkage analysis conditional association strongly associating snp numtc performed test estimating proportion variance due linkage background model included snp covariate comparing linkage model excluded covariate
0.22725685.14559775.html.plaintext.txt	69	analysis linkage disequilibrium measured linkage disequilibrium ld snps haplotype groups within num extended load families using gold program num used expectation maximization algorithm slatkin excoffier num determine various pairwise statistical parameters ld lewontins standardized disequilibrium coefficient d num algorithm determines ld founders married ins ld estimated symb num snp snps
0.22725685.14559775.html.plaintext.txt	70	analysis linkage disequilibrium measured linkage disequilibrium ld snps haplotype groups within num extended load families using gold program num used expectation maximization algorithm slatkin excoffier num determine various pairwise statistical parameters ld lewontins standardized disequilibrium coefficient d num algorithm determines ld founders married ins ld estimated symb num snp snps
0.22725685.14559775.html.plaintext.txt	71	acknowledgements grateful frederick pishotta computer support thomas dyer southwest foundation biomedical research providing us scripts obtaining solar compatible mibd files simwalk acknowledge mayo clinic adrc employees help collection samples grateful individuals participated study without work would possible study supported nih grants symb sgy symb sgy symb net grant american federation aging research grant symb net robert clarice smith fellowship net
0.22725685.14559775.html.plaintext.txt	72	acknowledgements grateful frederick pishotta computer support thomas dyer southwest foundation biomedical research providing us scripts obtaining solar compatible mibd files simwalk acknowledge mayo clinic adrc employees help collection samples grateful individuals participated study without work would possible study supported nih grants symb sgy symb sgy symb net grant american federation aging research grant symb net robert clarice smith fellowship net
0.22725685.14559775.html.plaintext.txt	73	footnotes correspondence addressed mayo clinic jacksonville num san pablo road birdsall num jacksonville fl num usa tel num num fax num num email younkinstevenatmayoedu
0.22725685.14559775.html.plaintext.txt	74	footnotes correspondence addressed mayo clinic jacksonville num san pablo road birdsall num jacksonville fl num usa tel num num fax num num email younkinstevenatmayoedu
0.22725685.14559775.html.plaintext.txt	75	authors wish known opinion first two authors regarded joint first authors
0.22725685.14559775.html.plaintext.txt	76	references top abstract introduction results discussion subjects methods references schellenberg gd dsouza poorkaj p num genetics alzheimers disease curr psych rep num num num
0.227683.9700196.html.plaintext.txt	0	organization expression polymorphism human persyn gene
0.227683.9700196.html.plaintext.txt	1	numschool biomedical sciences university st andrews bute medical buildings st andrews fife symb numts uk numinstitute gene biology russian academy sciences numnum vavilov street moscow b num russia nummicrobiology tumor biology center mtc karolinska institute box num num stockholm sweden numneuropa ltd robertson building dumbarton road glasgow symb numnu uk
0.227683.9700196.html.plaintext.txt	2	received april num num revised accepted june num num
0.227683.9700196.html.plaintext.txt	3	ddbjemblgenbank accession nos symb symb
0.227683.9700196.html.plaintext.txt	4	persyn recently identified member synuclein family distinct pattern expression pre postnatal development mouse peripheral central nervous systems synucleins persyn believed involved pathogenesis human neurodegenerative diseases however contrast synucleins high levels persyn mrna expression also found advanced breast carcinomas suggesting involvement encoded protein breast tumour progression used antibody specific human persyn demonstrate level protein increased ageing cerebral cortex breast tumours cloned characterized sequenced human persyn genomic locus localized long arm chromosome num symbnum symbnum region sequence information used search specific mutations protein coding regions persyn mrna persyn gene breast tumours tumour cell lines tumour specific mutations found two linked polymorphisms coding region detected mrna exons iii iv gene results suggest development breast tumours correlates overexpression wild type persyn protein detailed characterization human persyn locus important studies involvement persyn neurodegeneration malignancy
0.227683.9700196.html.plaintext.txt	5	persyn recently identified member synuclein family distinct pattern expression pre postnatal development mouse peripheral central nervous systems synucleins persyn believed involved pathogenesis human neurodegenerative diseases however contrast synucleins high levels persyn mrna expression also found advanced breast carcinomas suggesting involvement encoded protein breast tumour progression used antibody specific human persyn demonstrate level protein increased ageing cerebral cortex breast tumours cloned characterized sequenced human persyn genomic locus localized long arm chromosome num symbnum symbnum region sequence information used search specific mutations protein coding regions persyn mrna persyn gene breast tumours tumour cell lines tumour specific mutations found two linked polymorphisms coding region detected mrna exons iii iv gene results suggest development breast tumours correlates overexpression wild type persyn protein detailed characterization human persyn locus important studies involvement persyn neurodegeneration malignancy
0.227683.9700196.html.plaintext.txt	6	three genes synuclein family recently identified human genome first two code alpha beta synucleins closely related presynaptic proteins similar patterns expression abundant evolutionarily recent regions central nervous system num num proteins believed natively unfolded random coiled numnum tend aggregate solution forming amyloid like fibrils num another important feature synucleins ability bind trigger aggregation amyloid abeta peptides num num results together detection peptide nac derived alpha synuclein senile plaques alzheimers brains numnum raise possibility synucleins involved pathogenesis alzheimers disease num although mutations polymorphisms synuclein genes yet correlated alzheimers disease numnum two point mutations human alpha synuclein gene found several families early onset autosomal dominant parkinsons disease numnum findings together immunohistochemical detection high level alpha synuclein lewy bodies parkinsons disease patient brains numnum implicates alpha synuclein pathogenesis certain forms neurodegenerative disorder
0.227683.9700196.html.plaintext.txt	7	three genes synuclein family recently identified human genome first two code alpha beta synucleins closely related presynaptic proteins similar patterns expression abundant evolutionarily recent regions central nervous system num num proteins believed natively unfolded random coiled numnum tend aggregate solution forming amyloid like fibrils num another important feature synucleins ability bind trigger aggregation amyloid abeta peptides num num results together detection peptide nac derived alpha synuclein senile plaques alzheimers brains numnum raise possibility synucleins involved pathogenesis alzheimers disease num although mutations polymorphisms synuclein genes yet correlated alzheimers disease numnum two point mutations human alpha synuclein gene found several families early onset autosomal dominant parkinsons disease numnum findings together immunohistochemical detection high level alpha synuclein lewy bodies parkinsons disease patient brains numnum implicates alpha synuclein pathogenesis certain forms neurodegenerative disorder
0.227683.9700196.html.plaintext.txt	8	recently identified member synuclein family persyn shares main structural features alpha beta synucleins distinctive pattern expression num mouse embryonic development persyn expressed primary sensory neurons motoneurons postnatally persyn expression remains high neurons becomes detectable sympathetic neurons subset neurons cerebral cortex contrast decrease alpha synuclein expression ageing cerebral cortex num persyn mrna expression increases persyn protein accumulates mouse cerebral cortex age num
0.227683.9700196.html.plaintext.txt	9	recently identified member synuclein family persyn shares main structural features alpha beta synucleins distinctive pattern expression num mouse embryonic development persyn expressed primary sensory neurons motoneurons postnatally persyn expression remains high neurons becomes detectable sympathetic neurons subset neurons cerebral cortex contrast decrease alpha synuclein expression ageing cerebral cortex num persyn mrna expression increases persyn protein accumulates mouse cerebral cortex age num
0.227683.9700196.html.plaintext.txt	10	although persyn present senile plaques lewy bodies neurofibrillary tangles clinical cases studied far high level persyn immunoreactivity detectable dot like structures characteristic axonal lesions brains patients neurodegenerative diseases vl buchman hja hunter lgp pinon j thompson em privalova nn ninkina j lowe davies submitted publication clinical findings consistent developmental regional patterns persyn expression experimental evidence suggests persyn plays role regulating neurofilament network integrity num
0.227683.9700196.html.plaintext.txt	11	persyn nearly identical protein coded expressed sequence tag est symb isolated breast cancer cdna library num although symb mrna detected normal breast tissue benign breast tumours level dramatically increases highly infiltrating malignant carcinomas num level encoded protein reflects level persynsymb mrna could useful breast cancer progression marker
0.227683.9700196.html.plaintext.txt	12	persyn nearly identical protein coded expressed sequence tag est symb isolated breast cancer cdna library num although symb mrna detected normal breast tissue benign breast tumours level dramatically increases highly infiltrating malignant carcinomas num level encoded protein reflects level persynsymb mrna could useful breast cancer progression marker
0.227683.9700196.html.plaintext.txt	13	dual role persyn neurodegeneration malignancy could involve common mechanisms changes organization cell cytoskeleton among prominent characteristics processes involvement persyn regulating neurofilament network integrity raises possibility may also affect intermediate filament network malignant breast epithelial cells important question whether breast tumour progression correlates high level expression wild type persyn presence mutations persyn coding region obligatory characteristic process multiple differences including three resulted amino acid substitutions symb isolated tumour tissue persyn isolated normal brain tissue consistent latter possibility mutations could somatic germline might reflect advanced tumour progression predisposition individual malignant progression tumour
0.227683.9700196.html.plaintext.txt	14	dual role persyn neurodegeneration malignancy could involve common mechanisms changes organization cell cytoskeleton among prominent characteristics processes involvement persyn regulating neurofilament network integrity raises possibility may also affect intermediate filament network malignant breast epithelial cells important question whether breast tumour progression correlates high level expression wild type persyn presence mutations persyn coding region obligatory characteristic process multiple differences including three resulted amino acid substitutions symb isolated tumour tissue persyn isolated normal brain tissue consistent latter possibility mutations could somatic germline might reflect advanced tumour progression predisposition individual malignant progression tumour
0.227683.9700196.html.plaintext.txt	15	clarification questions requires study human persyn gene persyn protein report organization human persyn locus chromosomal localization studies human persyn protein expression also show mutations persyn gene specific breast tumours confirmed differences result natural sequence polymorphisms
0.227683.9700196.html.plaintext.txt	16	clarification questions requires study human persyn gene persyn protein report organization human persyn locus chromosomal localization studies human persyn protein expression also show mutations persyn gene specific breast tumours confirmed differences result natural sequence polymorphisms
0.227683.9700196.html.plaintext.txt	17	results cloning analysis human persyn genomic locus
0.227683.9700196.html.plaintext.txt	18	two human persyn cdna clones previously isolated juvenile human cdna library one cdna clones clone symb used screen human genomic library lambdasymb num two identical independent clones isolated genomic library positions exons determined restriction analysis hybridization cdna oligonucleotide probes direct sequencing locus genomic southern hybridization figure num shows human persyn gene consists five exons span num kbp differences sequence cdna clone symb used probe genomic library exonic sequences genomic clones isolated however another shorter cdna clone numc isolated juvenile human cdna library two substitutions coding region found g c position num position num cdna sequence symb boxed fig num latter resulting amino acid substitution symb cdna library constructed individual juvenile brainstem likely substitutions result natural polymorphism persyn gene alleles gene transcriptionally active tissue
0.227683.9700196.html.plaintext.txt	19	two human persyn cdna clones previously isolated juvenile human cdna library one cdna clones clone symb used screen human genomic library lambdasymb num two identical independent clones isolated genomic library positions exons determined restriction analysis hybridization cdna oligonucleotide probes direct sequencing locus genomic southern hybridization figure num shows human persyn gene consists five exons span num kbp differences sequence cdna clone symb used probe genomic library exonic sequences genomic clones isolated however another shorter cdna clone numc isolated juvenile human cdna library two substitutions coding region found g c position num position num cdna sequence symb boxed fig num latter resulting amino acid substitution symb cdna library constructed individual juvenile brainstem likely substitutions result natural polymorphism persyn gene alleles gene transcriptionally active tissue
0.227683.9700196.html.plaintext.txt	20	figure num organization human persyn gene physical map locus displayed upper part figure restriction endonuclease sites ecori e saci kpni k xbai x shown exons vertical black boxes numbered roman numerals sequences exons adjacent parts introns shown lower part figure encoded amino acids one letter code shown nucleotide sequence nucleotide substitutions est symb shown nucleotide sequence deduced amino acid substitutions shown amino acid sequence two substitutions also found human persyn clone numc result gene polymorphism boxed polyadenylation site marked arrowhead full sequence human persyn locus deposited genbank accession symb persyn mrna expression tumour cell lines
0.227683.9700196.html.plaintext.txt	21	persyn gene expression various normal tumour tissues cell lines studied northern blot analysis using human persyn cdna clone symb hybridization probe single numnum kb transcript observed tumour cell lines highest level transcript detected sub line symbprime breast tumour cell line symb normally express persyn mrna fig num num similar results obtained semi quantitative rt pcr shown however increasing number amplification cycles detected low level persyn mrna tumour cell lines persyn negative northern western blots example line symb shown figs num numa num
0.227683.9700196.html.plaintext.txt	22	figure num persyn transcripts breast tumour cell lines northern hybridization total rna isolated tumour cell lines human persyn cdna probe stripping probe filter hybridized nick translated cdna fragment encoding mouse gapdh provide indication amount total rna cell line present filter cell lines derived breast cancers except symb derived ovarian carcinoma
0.227683.9700196.html.plaintext.txt	23	figure num persyn protein human tissues cell lines western blot showing expression persyn protein human tissues cell lines aliquots num microg total cellular protein separated num polyacrylamide gel transferred hybond pvdf membrane probed symb anti persyn antibody followed ecl detection proteins extracted following sources tumour cell lines designations fig num b normal breast tissues n breast tumours four patients c cerebral cortices two patients suffered alzheimers disease numnum numnum two normal individuals age group numnum numnum fetal cerebral cortex mouse spinal cord unstimulated pbl pha stimulated pbl pha peripheral blood lymphocytes
0.227683.9700196.html.plaintext.txt	24	figure num detection persyn protein breast cancer cells confocal microscope section human breast cancer cells stained antibodies persyn green channel keratin num red channel persyn protein expression human tissues
0.227683.9700196.html.plaintext.txt	25	study persyn protein expression human tissues used western blotting polyclonal antibody raised synthetic peptide human persyn protein see materials methods antibody cross react either alpha beta synuclein western blots detects single band disappears antibody preincubated excess immunizing peptide shown persyn detected human fetal cerebral cortex abundant cortex elderly individuals fig numc substantial differences level persyn noticed cerebral cortices alzheimers disease patients normal individuals age group fig numc persyn mrna persyn protein also detected unstimulated phytohaemagglutinin pha stimulated cultured lymphocytes peripheral blood normal donors figs numc num data shown
0.227683.9700196.html.plaintext.txt	26	study persyn protein expression human tissues used western blotting polyclonal antibody raised synthetic peptide human persyn protein see materials methods antibody cross react either alpha beta synuclein western blots detects single band disappears antibody preincubated excess immunizing peptide shown persyn detected human fetal cerebral cortex abundant cortex elderly individuals fig numc substantial differences level persyn noticed cerebral cortices alzheimers disease patients normal individuals age group fig numc persyn mrna persyn protein also detected unstimulated phytohaemagglutinin pha stimulated cultured lymphocytes peripheral blood normal donors figs numc num data shown
0.227683.9700196.html.plaintext.txt	27	breast cancer cell lines pattern persyn protein expression corresponded mrna detected western blotting cell lines persyn mrna detected northern hybridization figs num numa
0.227683.9700196.html.plaintext.txt	28	shown previously situ hybridization persynsymb mrna expressed normal adult breast tissue high levels mrna present advanced infiltrating breast tumours num detected persyn protein breast tumours normal breast tissue fig numb
0.227683.9700196.html.plaintext.txt	29	shown previously situ hybridization persynsymb mrna expressed normal adult breast tissue high levels mrna present advanced infiltrating breast tumours num detected persyn protein breast tumours normal breast tissue fig numb
0.227683.9700196.html.plaintext.txt	30	used immunocytochemistry anti persyn antibody localize persyn cultured breast cancer cells paraformaldehyde pfa fixed cells persyn displayed punctuate cytoplasmic staining fig num pattern usually associated markers endoplasmic reticulum vesicular structures persyn co localized cytokeratin actin tubulin arrays cells fig num data shown
0.227683.9700196.html.plaintext.txt	31	used immunocytochemistry anti persyn antibody localize persyn cultured breast cancer cells paraformaldehyde pfa fixed cells persyn displayed punctuate cytoplasmic staining fig num pattern usually associated markers endoplasmic reticulum vesicular structures persyn co localized cytokeratin actin tubulin arrays cells fig num data shown
0.227683.9700196.html.plaintext.txt	32	sequence polymorphisms human persyn coding region
0.227683.9700196.html.plaintext.txt	33	nucleotide substitutions reported sequence symb transcript num shown figure numa two positions num num cdna sequence boxed fig numa identical substitutions found cdna clone numc substitutions present clones may correlated transformed phenotype cells symb est isolated study presence frequency mutations persyn gene breast cancer cells carried rt pcr mrnas isolated breast tumours tumour cell lines control used mrna isolated post mortem cerebral cortices pha stimulated peripheral blood lymphocytes normal donors pcr amplification products digested restriction endonucleases hphi styi mnli using digestions four mutations coding region reported symb including two polymorphisms present cdna clone numc could detected studied samples digestion mnli generated pattern fragments fig numa corresponds pattern predicted sequence persyn clones identical predicted patterns also obtained styi shown results reflect absence two g consequently glu lys substitutions reported symb est studied tumour cell lines tumours control tissues contrast rt pcr products digested hphi three types fragment patterns revealed fig numa pattern represented figure numa symb cell line corresponds persyn transcripts sequence similar symb symb presence hphi site num bp num bp hphi fragment symb absence hphi site num bp num num bp fragments pattern symbprime figure numa corresponds persyn transcripts sequence similar numc symb absence hphi site num bp num bp hphi fragment symb presence hphi site num num bp num bp fragment pbl n figure numa example cells transcripts expressed direct sequencing rt pcr fragments amplified four persyn expressing breast tumours reveal alterations apart symb symb
0.227683.9700196.html.plaintext.txt	34	nucleotide substitutions reported sequence symb transcript num shown figure numa two positions num num cdna sequence boxed fig numa identical substitutions found cdna clone numc substitutions present clones may correlated transformed phenotype cells symb est isolated study presence frequency mutations persyn gene breast cancer cells carried rt pcr mrnas isolated breast tumours tumour cell lines control used mrna isolated post mortem cerebral cortices pha stimulated peripheral blood lymphocytes normal donors pcr amplification products digested restriction endonucleases hphi styi mnli using digestions four mutations coding region reported symb including two polymorphisms present cdna clone numc could detected studied samples digestion mnli generated pattern fragments fig numa corresponds pattern predicted sequence persyn clones identical predicted patterns also obtained styi shown results reflect absence two g consequently glu lys substitutions reported symb est studied tumour cell lines tumours control tissues contrast rt pcr products digested hphi three types fragment patterns revealed fig numa pattern represented figure numa symb cell line corresponds persyn transcripts sequence similar symb symb presence hphi site num bp num bp hphi fragment symb absence hphi site num bp num num bp fragments pattern symbprime figure numa corresponds persyn transcripts sequence similar numc symb absence hphi site num bp num bp hphi fragment symb presence hphi site num num bp num bp fragment pbl n figure numa example cells transcripts expressed direct sequencing rt pcr fragments amplified four persyn expressing breast tumours reveal alterations apart symb symb
0.227683.9700196.html.plaintext.txt	35	figure num detection polymorphisms human persyn gene transcripts representative examples different cell types designations fig num different combinations persyn alleles shown sizes fragments given base pairs ethidium bromide stained num metaphor agarose gels fragments amplified rt pcr human rna digested restriction endonucleases mnli upper hphi lower rnas isolated breast cancer cell lines symbprime symb peripheral blood lymphocytes donor n pbl n b ethidium bromide stained num agarose gels fragments amplified pcr human dna digested restriction endonuclease hphi products digestion num bp fragment includes human persyn exon iii shown upper panel num bp fragment includes human persyn exon iv shown lower panel
0.227683.9700196.html.plaintext.txt	36	data confirmed pcr amplification individual exons persyn gene followed digestion products restriction endonucleases hphi styi mnli polymorphic styi mnli sites found illustrated figure numb expected polymorphic hphi sites present exons three symb four symb human persyn gene alleles gene expressed heterozygotic cells instance peripheral blood lymphocytes donor n demonstrated fig numa b expected two nearby polymorphic sites genome found linked studied dna frequencies two alleles genomes breast cancer normal cells num symbsymb num symbsymb
0.227683.9700196.html.plaintext.txt	37	data confirmed pcr amplification individual exons persyn gene followed digestion products restriction endonucleases hphi styi mnli polymorphic styi mnli sites found illustrated figure numb expected polymorphic hphi sites present exons three symb four symb human persyn gene alleles gene expressed heterozygotic cells instance peripheral blood lymphocytes donor n demonstrated fig numa b expected two nearby polymorphic sites genome found linked studied dna frequencies two alleles genomes breast cancer normal cells num symbsymb num symbsymb
0.227683.9700196.html.plaintext.txt	38	assignment human persyn gene chromosome numsymbnum symbnum
0.227683.9700196.html.plaintext.txt	39	dna lambdasymb genomic clone labelled biotin used fluorescence situ hybridization fish metaphase chromosomes prepared donor peripheral blood lymphocytes unique hybridization site assigned long arm chromosome num symbnum symbnum region fig num
0.227683.9700196.html.plaintext.txt	40	dna lambdasymb genomic clone labelled biotin used fluorescence situ hybridization fish metaphase chromosomes prepared donor peripheral blood lymphocytes unique hybridization site assigned long arm chromosome num symbnum symbnum region fig num
0.227683.9700196.html.plaintext.txt	41	figure num localization persyn gene human metaphase chromosomes using fish metaphase plate arrow shows specific hybridization signals lambdasymb probe chromosome num b magnified images chromosome num different metaphase plates two images shown chromosome fish signal white arrow inverted dapi banding black arrow shows dapi band numq numnum numnum hybridized lambdasymb probe discussion
0.227683.9700196.html.plaintext.txt	42	members synuclein family implicated pathogenesis alzheimers parkinsons neurodegenerative diseases numnumnum num families hereditary form parkinsons disease point mutation gene coding alpha synuclein believed responsible development pathology numnumnum finding suggests mutations genes encoding members synuclein family could linked neurodegenerative conditions underlies need studies genes
0.227683.9700196.html.plaintext.txt	43	members synuclein family implicated pathogenesis alzheimers parkinsons neurodegenerative diseases numnumnum num families hereditary form parkinsons disease point mutation gene coding alpha synuclein believed responsible development pathology numnumnum finding suggests mutations genes encoding members synuclein family could linked neurodegenerative conditions underlies need studies genes
0.227683.9700196.html.plaintext.txt	44	cloned defined structure human gene encoding persyn recently identified member synuclein family num general organization gene terms positions exon intron junctions size introns similar mouse persyn gene unpublished data although complete structures genes synuclein family published available sequence data num deduction positions exon intron junctions known splice variants alpha beta synucleins numnumnum suggest close similarities organization synuclein genes
0.227683.9700196.html.plaintext.txt	45	cloned defined structure human gene encoding persyn recently identified member synuclein family num general organization gene terms positions exon intron junctions size introns similar mouse persyn gene unpublished data although complete structures genes synuclein family published available sequence data num deduction positions exon intron junctions known splice variants alpha beta synucleins numnumnum suggest close similarities organization synuclein genes
0.227683.9700196.html.plaintext.txt	46	addition potential involvement neurodegeneration persyn possibly involved breast tumour progression shown expression est symb nearly identical nucleotide sequence persyn mrna increased dramatically infiltrating breast cancers compared normal breast tissues benign tumours num shown expression persyn protein also follows pattern persyn could detected western blotting normal breast tissues whereas persyn protein detectable breast tumour tissue established breast cancer cell lines levels persyn protein expression found substantially different correlated levels persyn mrna find amplification persyn gene studied cell lines data shown observations suggest persyn expression regulated predominantly level persyn gene transcription andor persyn mrna stability thus breast cancer cell lines could used studies mechanisms regulate persyn expression investigate physiological consequences persyn overexpression shown previously experimental overexpression persyn cultured sensory neurons leads dramatic changes neurofilament network num interesting see acute overexpression persyn similar effect intermediate filament network epithelial cells immunocytochemical data suggest persyn could associated membranous structures cytoplasm breast cancer cells however subcellular fractionation neural tissues breast cancer cells demonstrated presence persyn cytosolic particulate fractions data shown results similar results obtained studies alpha synuclein believed loosely associated synaptic vesicle membranes presynaptic terminals numnum num interesting light recent demonstration alpha synuclein able bind synthetic membranes vitro association dramatically changes protein secondary structure natively unfolded predominantly alpha helical perhaps alters functional features protein num one features ability alpha beta synuclein inhibit phospholipase symb num inhibition dependent bulk lipid concentration reaction suggesting interaction enzyme occurs membrane surface num thus involves alpha helical natively unfolded synucleins phospholipase symb implicated various intracellular pathways including regulation cell growth differentiation interesting study effect persyn activity enzyme neurons tumour cells
0.227683.9700196.html.plaintext.txt	47	addition potential involvement neurodegeneration persyn possibly involved breast tumour progression shown expression est symb nearly identical nucleotide sequence persyn mrna increased dramatically infiltrating breast cancers compared normal breast tissues benign tumours num shown expression persyn protein also follows pattern persyn could detected western blotting normal breast tissues whereas persyn protein detectable breast tumour tissue established breast cancer cell lines levels persyn protein expression found substantially different correlated levels persyn mrna find amplification persyn gene studied cell lines data shown observations suggest persyn expression regulated predominantly level persyn gene transcription andor persyn mrna stability thus breast cancer cell lines could used studies mechanisms regulate persyn expression investigate physiological consequences persyn overexpression shown previously experimental overexpression persyn cultured sensory neurons leads dramatic changes neurofilament network num interesting see acute overexpression persyn similar effect intermediate filament network epithelial cells immunocytochemical data suggest persyn could associated membranous structures cytoplasm breast cancer cells however subcellular fractionation neural tissues breast cancer cells demonstrated presence persyn cytosolic particulate fractions data shown results similar results obtained studies alpha synuclein believed loosely associated synaptic vesicle membranes presynaptic terminals numnum num interesting light recent demonstration alpha synuclein able bind synthetic membranes vitro association dramatically changes protein secondary structure natively unfolded predominantly alpha helical perhaps alters functional features protein num one features ability alpha beta synuclein inhibit phospholipase symb num inhibition dependent bulk lipid concentration reaction suggesting interaction enzyme occurs membrane surface num thus involves alpha helical natively unfolded synucleins phospholipase symb implicated various intracellular pathways including regulation cell growth differentiation interesting study effect persyn activity enzyme neurons tumour cells
0.227683.9700196.html.plaintext.txt	48	substantial changes persyn expression accompany breast tumour progression also take place nervous system development current study shown persyn expressed human fetal cerebral cortex abundant cerebral cortices elderly individuals consistent previous observation persyn expression increased ageing mouse cerebral cortex num observe substantial differences levels persyn protein cerebral cortices patients suffered alzheimers disease normal age matched individuals results agreement immunohistochemical data implicate persyn axonal pathology neurodegenerative conditions dot like structures white matter without significant changes persyn immunoreactivity cortical neurons vl buchman hja hunter lgp pinon j thompson em privalova nn ninkina j lowe davies submitted publication
0.227683.9700196.html.plaintext.txt	49	substantial changes persyn expression accompany breast tumour progression also take place nervous system development current study shown persyn expressed human fetal cerebral cortex abundant cerebral cortices elderly individuals consistent previous observation persyn expression increased ageing mouse cerebral cortex num observe substantial differences levels persyn protein cerebral cortices patients suffered alzheimers disease normal age matched individuals results agreement immunohistochemical data implicate persyn axonal pathology neurodegenerative conditions dot like structures white matter without significant changes persyn immunoreactivity cortical neurons vl buchman hja hunter lgp pinon j thompson em privalova nn ninkina j lowe davies submitted publication
0.227683.9700196.html.plaintext.txt	50	important question whether wild type mutated persyn protein expressed breast tumours sequence analysis suggests protein tumour cells symb different protein expressed nervous system cdna clones symb numc coded genomic clone symb substitution two lysines glutamates symb changes overall charge persyn molecule disturbs ektkegv repeats highly conserved synuclein family changes serious consequences protein structure function however fact symb est generated rt pcr amplification raises question accurately sequence clone reflects sequence mrna tumour cells studied number breast tumours tumour cell lines presence mutations underlie lys glu amino acid substitutions human persyn sequence although persyn mrna exons persyn gene analysed mlui styi digestion pcr products mutations found studied tissues cell lines contrast using hphi digestion able detect two nucleotide polymorphisms initially recognized sequence differences persyn cdna clones symb numc two linked polymorphic sites discriminate two alleles human persyn gene alleles transcriptionally active expressed similar efficiency heterozygotes find obvious correlation presence particular persyn alleles pathological phenotype although limited number samples analysed two alleles breast tumours tumour cell lines occur frequencies normal cells data suggest least spontaneous breast tumours high level wild type persyn protein correlates malignant phenotype reported mutations symb est artefactual may result taq polymerase errors
0.227683.9700196.html.plaintext.txt	51	important question whether wild type mutated persyn protein expressed breast tumours sequence analysis suggests protein tumour cells symb different protein expressed nervous system cdna clones symb numc coded genomic clone symb substitution two lysines glutamates symb changes overall charge persyn molecule disturbs ektkegv repeats highly conserved synuclein family changes serious consequences protein structure function however fact symb est generated rt pcr amplification raises question accurately sequence clone reflects sequence mrna tumour cells studied number breast tumours tumour cell lines presence mutations underlie lys glu amino acid substitutions human persyn sequence although persyn mrna exons persyn gene analysed mlui styi digestion pcr products mutations found studied tissues cell lines contrast using hphi digestion able detect two nucleotide polymorphisms initially recognized sequence differences persyn cdna clones symb numc two linked polymorphic sites discriminate two alleles human persyn gene alleles transcriptionally active expressed similar efficiency heterozygotes find obvious correlation presence particular persyn alleles pathological phenotype although limited number samples analysed two alleles breast tumours tumour cell lines occur frequencies normal cells data suggest least spontaneous breast tumours high level wild type persyn protein correlates malignant phenotype reported mutations symb est artefactual may result taq polymerase errors
0.227683.9700196.html.plaintext.txt	52	mapped human persyn gene long arm chromosome num symbnum symbnum region hereditary disorders affected genes yet known located locus taking account pattern persyn expression sensory neurons peripheral nervous system motoneurons central nervous system interesting check possible involvement persyn gene infantile onset spinocerebellar ataxia sensory neuropathy iosca symb num also intriguing loss heterozygosity loh numsymb occurs high frequency different human tumours mutations ptensymb gene located region implicated many breast carcinomas germline mutations gene believed associated cowden disease rare autosomal dominant familial cancer syndrome high risk breast cancer num however families individuals cowden disease mutations ptensymb gene somatic mutations gene occur small fraction primary breast cancers loh breast cancers necessarily involve ptensymb locus num num correlation persyn expression breast tumour progression interesting search mutations coding regulatory regions gene hereditary spontaneous forms breast cancer defining organization human persyn gene reported important step towards genetic studies involvement gene neurodegenerative neoplastic disorders
0.227683.9700196.html.plaintext.txt	53	materials methods molecular cloning
0.227683.9700196.html.plaintext.txt	54	human persyn cdna clones symb numc isolated juvenile brainstem cdna library stratagene hybridization mouse persyn cdna probe low stringency described previously num symb clone labelled nick translation used probe screening genomic library southern northern hybridizations described previously num construction human genomic library lambdasymb described previously num
0.227683.9700196.html.plaintext.txt	55	human persyn cdna clones symb numc isolated juvenile brainstem cdna library stratagene hybridization mouse persyn cdna probe low stringency described previously num symb clone labelled nick translation used probe screening genomic library southern northern hybridizations described previously num construction human genomic library lambdasymb described previously num
0.227683.9700196.html.plaintext.txt	56	ecori fragments lambdasymb dna subcloned symb vector strands sequenced using specific oligonucleotide primers cycle sequencing carried abi drhodamine big dye terminators amplitaq fs abi reaction products analysed abi prism num dna sequencer
0.227683.9700196.html.plaintext.txt	57	ecori fragments lambdasymb dna subcloned symb vector strands sequenced using specific oligonucleotide primers cycle sequencing carried abi drhodamine big dye terminators amplitaq fs abi reaction products analysed abi prism num dna sequencer
0.227683.9700196.html.plaintext.txt	58	localization persyn genes human metaphase chromosomes
0.227683.9700196.html.plaintext.txt	59	fish biotin labelled lambda dna metaphase chromosomes obtained standard techniques pha stimulated human lymphocytes accomplished described elsewhere numnum signals analysed using zeiss axiophot fluorescence microscope equipped cooled ccd camera hamamatsu adobe photoshop software package
0.227683.9700196.html.plaintext.txt	60	fish biotin labelled lambda dna metaphase chromosomes obtained standard techniques pha stimulated human lymphocytes accomplished described elsewhere numnum signals analysed using zeiss axiophot fluorescence microscope equipped cooled ccd camera hamamatsu adobe photoshop software package
0.227683.9700196.html.plaintext.txt	61	rt pcr analysis human persyn mrna
0.227683.9700196.html.plaintext.txt	62	total cellular rna reverse transcribed amplified described earlier num amounts total rna samples normalized amplification num bp fragment glyceraldehyde num phosphate dehydrogenase gapdh mrna primers amplification human persyn coding region follows numprime agcagcacaaccctgcacac numprime numprime tcttcaggtcatccacgctg numprime amplification num bp fragment carried num cycles num degrees c num num degrees c num num degrees c num cells low level persyn expression amplified fragment purified agarose gel electrophoresis re amplified another num cycles amplified fragments digested appropriate restriction endonuclease analysed num metaphor agarose gel fmc
0.227683.9700196.html.plaintext.txt	63	total cellular rna reverse transcribed amplified described earlier num amounts total rna samples normalized amplification num bp fragment glyceraldehyde num phosphate dehydrogenase gapdh mrna primers amplification human persyn coding region follows numprime agcagcacaaccctgcacac numprime numprime tcttcaggtcatccacgctg numprime amplification num bp fragment carried num cycles num degrees c num num degrees c num num degrees c num cells low level persyn expression amplified fragment purified agarose gel electrophoresis re amplified another num cycles amplified fragments digested appropriate restriction endonuclease analysed num metaphor agarose gel fmc
0.227683.9700196.html.plaintext.txt	64	pcr analysis human persyn gene exons
0.227683.9700196.html.plaintext.txt	65	analysis human persyn gene exons human genomic dna amplified using primers located inside introns proximity exon intron junctions conditions amplification restriction endonuclease analysis similar conditions used rt pcr products except annealing temperatures num degrees c exon iii num degrees c exon iv primers numprime tgcgagcctgactccagcag numprime numprime ggtgtggagtggagtgatgc numprime used amplification exon iii numprime ttgaggccagggtagacaag numprime numprime ccactcaggttcagggttag numprime exon iv dna fragments analysed num agarose tbe gels
0.227683.9700196.html.plaintext.txt	66	analysis human persyn gene exons human genomic dna amplified using primers located inside introns proximity exon intron junctions conditions amplification restriction endonuclease analysis similar conditions used rt pcr products except annealing temperatures num degrees c exon iii num degrees c exon iv primers numprime tgcgagcctgactccagcag numprime numprime ggtgtggagtggagtgatgc numprime used amplification exon iii numprime ttgaggccagggtagacaag numprime numprime ccactcaggttcagggttag numprime exon iv dna fragments analysed num agarose tbe gels
0.227683.9700196.html.plaintext.txt	67	western blotting used detect persyn protein cell lysates described earlier num rabbit polyclonal antibody symb synthetic peptide human persyn vl buchman hja hunter lgp pinon j thompson em privalova nn ninkina j lowe davies submitted publication affinity purified recombinant human persyn protein bound nhs activated columns supelco used dilution numnum secondary antibody horseradish peroxidase linked donkey anti rabbit igg diluted numnum amersham ecl detection carried according manufacturers protocol amersham
0.227683.9700196.html.plaintext.txt	68	western blotting used detect persyn protein cell lysates described earlier num rabbit polyclonal antibody symb synthetic peptide human persyn vl buchman hja hunter lgp pinon j thompson em privalova nn ninkina j lowe davies submitted publication affinity purified recombinant human persyn protein bound nhs activated columns supelco used dilution numnum secondary antibody horseradish peroxidase linked donkey anti rabbit igg diluted numnum amersham ecl detection carried according manufacturers protocol amersham
0.227683.9700196.html.plaintext.txt	69	cells culture dishes washed phosphate buffered saline pbs fixed num pfa pbs num degrees c num min washed tbt num mm tris hcl ph numnum num mm nacl numnum triton x num blocked num goat serum tbt followed incubation rabbit polyclonal symb anti persyn antibody numnum mouse monoclonal anti keratin num antibody symb numnum chemicon num degrees c num h num goat serum tbt detection tritc conjugated anti rabbit fitc conjugated anti mouse secondary antibodies used dilutions recommended suppliers jackson laboratories
0.227683.9700196.html.plaintext.txt	70	thanks due jim lowe department histopathology university nottingham tissue samples alex houston dna sequencing unit university st andrews automatic dna sequencing earnshaw j allan photographic work work supported grants wellcome trust royal society
0.227683.9700196.html.plaintext.txt	71	est expression sequence tag fish fluorescence situ hybridization gapdh glyceraldehyde num phosphate dehydrogenase loh loss heterozygosity pbs phosphate buffered saline pfa paraformaldehyde pha phytohaemagglutinin
0.227683.9700196.html.plaintext.txt	72	correspondence addressed tel num num num fax num num num email vlbst andrewsacuk page run oxford university press great clarendon street oxford symb numdp part oup journals comments feedback www adminatoupcouk u d last modification num aug num copyright oxford university press num
0.227683.9700196.html.plaintext.txt	73	correspondence addressed tel num num num fax num num num email vlbst andrewsacuk page run oxford university press great clarendon street oxford symb numdp part oup journals comments feedback www adminatoupcouk u d last modification num aug num copyright oxford university press num
0.23021185.11823314.html.plaintext.txt	0	old age psychiatry alistair burns frcpsych
0.23021185.11823314.html.plaintext.txt	1	university manchester withington hospital manchester
0.23021185.11823314.html.plaintext.txt	2	newcastle general hospital newcastle upon tyne uk
0.23021185.11823314.html.plaintext.txt	3	correspondence professor alistair burns department psychiatry education research centre wythenshawe hospital southmoor road manchester symb numlt uk tel num num num num num fax num num num num num e mail aburnsatfslwithmanacuk
0.23021185.11823314.html.plaintext.txt	4	correspondence professor alistair burns department psychiatry education research centre wythenshawe hospital southmoor road manchester symb numlt uk tel num num num num num fax num num num num num e mail aburnsatfslwithmanacuk
0.23021185.11823314.html.plaintext.txt	5	fashionable necessary days start presentation declaring ones conflicts interest editors special supplement therefore declare interest old age psychiatry long ago cynically described cinderella speciality old age psychiatry past years become increasingly popular clinical career choice community oriented multi disciplinary services remain relatively unfettered excessive bureaucracy would attractive option largely demoralised health care system reasons speciality thriving least enormous advances made past decade understanding neurobiological basis late life psychiatric disorders dementia particular attracted attention top level neuroscientists applied combination classical neuropathology molecular genetics protein chemistry reveal key events underlying neurodegeneration result conceivable effective treatments delay prevent onset alzheimers disease could available within decade something virtually unthinkable num years ago old age psychiatry clinicians near enough buzz feel excited differential diagnosis dementia subtype important part assessment convergence clinical descriptions lewy body dementia frontotemporal dementia give two examples covered issue allowing increased sophistication terms diagnostic reporting clinicians distinctions lead directly important management decisions avoidance neuroleptic agents lewy body disease use cholinesterase inhibitors alzheimers disease recognition disorders hitherto regarded functional nature organic basis stimulated research uncovering aetiological factors influenced clinical practice furthermore improved methods measuring symptoms valid reliable ways enabled effects therapeutic interventions especially drug trials assessed ways sufficiently robust allow regulatory authorities convinced worth
0.23021185.11823314.html.plaintext.txt	6	fashionable necessary days start presentation declaring ones conflicts interest editors special supplement therefore declare interest old age psychiatry long ago cynically described cinderella speciality old age psychiatry past years become increasingly popular clinical career choice community oriented multi disciplinary services remain relatively unfettered excessive bureaucracy would attractive option largely demoralised health care system reasons speciality thriving least enormous advances made past decade understanding neurobiological basis late life psychiatric disorders dementia particular attracted attention top level neuroscientists applied combination classical neuropathology molecular genetics protein chemistry reveal key events underlying neurodegeneration result conceivable effective treatments delay prevent onset alzheimers disease could available within decade something virtually unthinkable num years ago old age psychiatry clinicians near enough buzz feel excited differential diagnosis dementia subtype important part assessment convergence clinical descriptions lewy body dementia frontotemporal dementia give two examples covered issue allowing increased sophistication terms diagnostic reporting clinicians distinctions lead directly important management decisions avoidance neuroleptic agents lewy body disease use cholinesterase inhibitors alzheimers disease recognition disorders hitherto regarded functional nature organic basis stimulated research uncovering aetiological factors influenced clinical practice furthermore improved methods measuring symptoms valid reliable ways enabled effects therapeutic interventions especially drug trials assessed ways sufficiently robust allow regulatory authorities convinced worth
0.23021185.11823314.html.plaintext.txt	7	reason presenting series invited papers subject old age psychiatry inform general reader major issues challenges successes speciality today following contributions intended comprehensive survey increasingly widening field chosen give flavour richness clinical practice research chosen concentrate descriptions organically based syndromes differential diagnosis effects
0.23021185.11823314.html.plaintext.txt	8	reason presenting series invited papers subject old age psychiatry inform general reader major issues challenges successes speciality today following contributions intended comprehensive survey increasingly widening field chosen give flavour richness clinical practice research chosen concentrate descriptions organically based syndromes differential diagnosis effects
0.23021185.11823314.html.plaintext.txt	9	holmes num issue summarised much current information concerning molecular biology alzheimers disease emphasising importance genes risk factors disease stepping outside often narrow way thinking tends tunnel vision equating genetics disease early onset rare mutations clearly field much promise terms treatment theme continued bullock num issue summary new drugs alzheimers disease three anticholinesterase drugs available treatment mild moderate alzheimers disease approved national institute clinical excellence uk role drugs treatment alzheimers disease become apparent continued clinical practice influenced appropriate audit use benefit patients snowden et al num issue provide date summary frontotemporal dementia drawing together clinical neuropsychological pathological expertise group instrumental clinical descriptions relatively common underrecognised cause dementia particularly younger people vascular dementia samples pips frontotemporal dementia post one common causes syndrome summarised stewart num issue lack clear blue water alzheimers disease vascular dementia plainly acknowledged problem increasingly influencing clinical practice well taxing epidemiologists theme vascular disease continued review vascular basis depression baldwin obrien num issue condition may explain elements treatment resistance practice also implications management patients subcortical dementia summarised turner et al num issue emphasise phenomenological aspects dementia aetiological importance jacoby num issue brings fore many legal aspects old age psychiatry increasingly becoming part everyday clinical practice particularly relation consent euthanasia mental capacity interface health social care highlighted challis hughes num issue current political climate distinction clinically blurred many situations becoming important administrative financial terms costs care essential underpinning considerations clinical care kavanagh knapp num issue describe models underlying many assumptions made predicting cost caring people cognitive impairment contributions concern dementia lewy bodies mckeith num issue use rating scales old age psychiatry burns et al num issue
0.23021185.11823314.html.plaintext.txt	10	holmes num issue summarised much current information concerning molecular biology alzheimers disease emphasising importance genes risk factors disease stepping outside often narrow way thinking tends tunnel vision equating genetics disease early onset rare mutations clearly field much promise terms treatment theme continued bullock num issue summary new drugs alzheimers disease three anticholinesterase drugs available treatment mild moderate alzheimers disease approved national institute clinical excellence uk role drugs treatment alzheimers disease become apparent continued clinical practice influenced appropriate audit use benefit patients snowden et al num issue provide date summary frontotemporal dementia drawing together clinical neuropsychological pathological expertise group instrumental clinical descriptions relatively common underrecognised cause dementia particularly younger people vascular dementia samples pips frontotemporal dementia post one common causes syndrome summarised stewart num issue lack clear blue water alzheimers disease vascular dementia plainly acknowledged problem increasingly influencing clinical practice well taxing epidemiologists theme vascular disease continued review vascular basis depression baldwin obrien num issue condition may explain elements treatment resistance practice also implications management patients subcortical dementia summarised turner et al num issue emphasise phenomenological aspects dementia aetiological importance jacoby num issue brings fore many legal aspects old age psychiatry increasingly becoming part everyday clinical practice particularly relation consent euthanasia mental capacity interface health social care highlighted challis hughes num issue current political climate distinction clinically blurred many situations becoming important administrative financial terms costs care essential underpinning considerations clinical care kavanagh knapp num issue describe models underlying many assumptions made predicting cost caring people cognitive impairment contributions concern dementia lewy bodies mckeith num issue use rating scales old age psychiatry burns et al num issue
0.23021185.11823314.html.plaintext.txt	11	hope useful new information practising old age psychiatry two costs rapidly changing expanding field keeping abreast new information meeting rising public expectations might done uncommon patients present one burgeoning number memory clinics uk asking early diagnosis treatment well aware recent guidance national institute clinical excellence new antidementia drugs made available within national health service recently published national service framework older people sets specific standards care aspirations good practice across wide range mental health care issues challenges plenty collection papers gives indication responding
0.23021185.11823314.html.plaintext.txt	12	hope useful new information practising old age psychiatry two costs rapidly changing expanding field keeping abreast new information meeting rising public expectations might done uncommon patients present one burgeoning number memory clinics uk asking early diagnosis treatment well aware recent guidance national institute clinical excellence new antidementia drugs made available within national health service recently published national service framework older people sets specific standards care aspirations good practice across wide range mental health care issues challenges plenty collection papers gives indication responding
0.23021185.11823314.html.plaintext.txt	13	bullock r num new drugs alzheimers disease dementias british journal psychiatry num num numabstractfree full text
0.23021185.11823314.html.plaintext.txt	14	department health num national service framework older people london department health
0.23021185.11823314.html.plaintext.txt	15	holmes c num genotype phenotype alzheimers disease british journal psychiatry num num numabstractfree full text
0.23021185.11823314.html.plaintext.txt	16	jacoby r num old age psychiatry law british journal psychiatry num num numabstractfree full text
0.23021185.11823314.html.plaintext.txt	17	stewart r num vascular dementia diagnosis running time british journal psychiatry num num numabstractfree full text
0.23021185.11823314.html.plaintext.txt	18	received publication august num num revision received august num num accepted publication august num num
0.23021185.11823314.html.plaintext.txt	19	received publication august num num revision received august num num accepted publication august num num
0.23021185.11823314.html.plaintext.txt	20	highlights issue elizabeth walsh bjp num num num full text
0.23021185.11823314.html.plaintext.txt	21	old age psychiatry law robin jacoby bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	22	costs cognitive disability modelling underlying associations shane kavanagh martin knapp bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	23	frail old people margins care recent research findings david challis jane hughes bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	24	genotype phenotype alzheimers disease clive holmes bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	25	new drugs alzheimers disease dementias roger bullock bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	26	frontotemporal dementia julie snowden david neary david m mann bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	27	frontotemporal dementia julie snowden david neary david m mann bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	28	dementia lewy bodies ian g mckeith bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	29	vascular dementia diagnosis running time robert stewart bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	30	vascular basis late onset depressive disorder robert c baldwin john obrien bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	31	vascular basis late onset depressive disorder robert c baldwin john obrien bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	32	rating scales old age psychiatry alistair burns brian lawlor sarah craig bjp num num num num abstract full text
0.23021185.11823314.html.plaintext.txt	33	article full text pdf submit response alert article cited alert eletters posted alert correction posted citation map services email article friend related articles bjp similar articles journal similar articles pubmed alert new issues journal download citation manager google scholar articles burns articles mckeith g articles citing article pubmed pubmed citation articles burns articles mckeith g
0.23021185.11823314.html.plaintext.txt	34	home help feedback subscriptions archive search table contents psychiatric bulletin advances psychiatric treatment rcpsych journals
0.23427205.14718220.html.plaintext.txt	0	relation education occupation based socioeconomic status incident alzheimer disease anita symbnum ingemar kasymb chengxuan symbnum tom symb bengt symbnum laura symbnum
0.23427205.14718220.html.plaintext.txt	1	num aging research center division geriatric epidemiology medicine neurotec karolinska institutet stockholm sweden num stockholm gerontology research center stockholm sweden num department occupational environmental health stockholm county council institute environmental medicine karolinska institutet stockholm sweden
0.23427205.14718220.html.plaintext.txt	2	num aging research center division geriatric epidemiology medicine neurotec karolinska institutet stockholm sweden num stockholm gerontology research center stockholm sweden num department occupational environmental health stockholm county council institute environmental medicine karolinska institutet stockholm sweden
0.23427205.14718220.html.plaintext.txt	3	received publication june num num accepted publication july num num
0.23427205.14718220.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references study authors evaluated whether association low educational level increased risk alzheimer disease ad dementia may explained occupation based socioeconomic status ses cohort num nondemented subjects aged bordernumnum years kungsholmen project stockholm sweden followed num years num num total num incident cases dementia num involving ad detected less educated subjects adjusted relative risk developing ad numnum num confidence interval numnum numnum subjects lower ses adjusted relative risk numnum num confidence interval numnum numnum education ses introduced model education remained significantly associated ad combinations low education low high ses associated similar increased risks ad well educated subjects low ses high risk low ses num years age even ses high age num num years associated increased risk however increase disappeared education entered model conclusion association low education increased ad risk mediated adult ses socioeconomic mobility suggests early life factors may relevant
0.23427205.14718220.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references study authors evaluated whether association low educational level increased risk alzheimer disease ad dementia may explained occupation based socioeconomic status ses cohort num nondemented subjects aged bordernumnum years kungsholmen project stockholm sweden followed num years num num total num incident cases dementia num involving ad detected less educated subjects adjusted relative risk developing ad numnum num confidence interval numnum numnum subjects lower ses adjusted relative risk numnum num confidence interval numnum numnum education ses introduced model education remained significantly associated ad combinations low education low high ses associated similar increased risks ad well educated subjects low ses high risk low ses num years age even ses high age num num years associated increased risk however increase disappeared education entered model conclusion association low education increased ad risk mediated adult ses socioeconomic mobility suggests early life factors may relevant
0.23427205.14718220.html.plaintext.txt	6	aged alzheimer disease dementia education social class
0.23427205.14718220.html.plaintext.txt	7	abbreviations abbreviations ci confidence interval ses socioeconomic status
0.23427205.14718220.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion references several studies reported increased risk dementia alzheimer disease among less educated persons num num different mechanisms suggested explain association katzman num proposed education might increase brain reserves increasing synaptic density neocortical association cortex stern et al num extended cognitive reserve hypothesis took account possible beneficial influence mental activity throughout entire life span occupational attainment along level education could influence risk alzheimer disease education might also surrogate measure intellectual outlook num well proxy intelligence turn could inversely related risk alzheimer disease num num addition issue possible detection bias due later diagnosis dementia highly educated subjects raised num num
0.23427205.14718220.html.plaintext.txt	9	introduction top abstract introduction materials methods results discussion references several studies reported increased risk dementia alzheimer disease among less educated persons num num different mechanisms suggested explain association katzman num proposed education might increase brain reserves increasing synaptic density neocortical association cortex stern et al num extended cognitive reserve hypothesis took account possible beneficial influence mental activity throughout entire life span occupational attainment along level education could influence risk alzheimer disease education might also surrogate measure intellectual outlook num well proxy intelligence turn could inversely related risk alzheimer disease num num addition issue possible detection bias due later diagnosis dementia highly educated subjects raised num num
0.23427205.14718220.html.plaintext.txt	10	known education indicator socioeconomic status ses different studies shown high num moderate num correlations education occupation based ses nevertheless two variables represent different aspects periods life course may generate differences health various mechanisms num num lynch kaplan describe education transition socio economic position largely received parents achieved socio economic position adult num p num
0.23427205.14718220.html.plaintext.txt	11	known education indicator socioeconomic status ses different studies shown high num moderate num correlations education occupation based ses nevertheless two variables represent different aspects periods life course may generate differences health various mechanisms num num lynch kaplan describe education transition socio economic position largely received parents achieved socio economic position adult num p num
0.23427205.14718220.html.plaintext.txt	12	socioeconomic factors acting life course found affect health premature death well risk cardiovascular disease num num cumulative economic hardship found lead poorer cognitive functioning num recently turrell et al num examined relation socioeconomic mobility cognitive function among finish men late middle age suggested stages life course play role influencing adult cognitive function
0.23427205.14718220.html.plaintext.txt	13	socioeconomic factors acting life course found affect health premature death well risk cardiovascular disease num num cumulative economic hardship found lead poorer cognitive functioning num recently turrell et al num examined relation socioeconomic mobility cognitive function among finish men late middle age suggested stages life course play role influencing adult cognitive function
0.23427205.14718220.html.plaintext.txt	14	studies reported association adult ses based occupation incidence alzheimer disease dementia evans et al num found investigated markers ses education occupational prestige income predicted development alzheimer disease reported manual work involves production goods could increase risk clinical alzheimer disease dementia num however studies focused principal occupation occupational periods addition relation social mobility different socioeconomic levels life course risk dementia old age studied
0.23427205.14718220.html.plaintext.txt	15	general aim study determine whether reported association low education increased risk alzheimer disease dementia could explained occupation based ses specifically examined risk alzheimer disease dementia varied different combinations num education main occupation based ses num education lifetime number years spent low occupation based ses since education occupation based ses interrelated special attention given categories deviated expected pattern combinations high educationlow occupation based ses low educationhigh occupation based ses furthermore investigated social mobility patterns explore whether later advancement setbacks occupation based ses may affect relation education alzheimer disease incidence
0.23427205.14718220.html.plaintext.txt	16	general aim study determine whether reported association low education increased risk alzheimer disease dementia could explained occupation based ses specifically examined risk alzheimer disease dementia varied different combinations num education main occupation based ses num education lifetime number years spent low occupation based ses since education occupation based ses interrelated special attention given categories deviated expected pattern combinations high educationlow occupation based ses low educationhigh occupation based ses furthermore investigated social mobility patterns explore whether later advancement setbacks occupation based ses may affect relation education alzheimer disease incidence
0.23427205.14718220.html.plaintext.txt	17	materials methods top abstract introduction materials methods results discussion references study population study population derived kungsholmen project community based longitudinal study aging dementia stockholm sweden registered inhabitants kungsholmen district stockholm aged num years older october num num invited participate project among numnum persons agreed participate signed informed consent form baseline examination num num numnum num men numnum women diagnosed free dementia baseline detection prevalent cases dementia conducted using two phase design subjects given brief psychometric test screening test dementia persons screened positive suspected dementia random sample subjects screened negative suspected dementia clinically examined num diagnostic criteria procedure diagnosing dementia used baseline follow described time follow examination num num num subjects refused participate num moved stockholm area information lifetime occupational history unavailable num subjects refusal informant therefore current study population consisted num persons
0.23427205.14718220.html.plaintext.txt	18	materials methods top abstract introduction materials methods results discussion references study population study population derived kungsholmen project community based longitudinal study aging dementia stockholm sweden registered inhabitants kungsholmen district stockholm aged num years older october num num invited participate project among numnum persons agreed participate signed informed consent form baseline examination num num numnum num men numnum women diagnosed free dementia baseline detection prevalent cases dementia conducted using two phase design subjects given brief psychometric test screening test dementia persons screened positive suspected dementia random sample subjects screened negative suspected dementia clinically examined num diagnostic criteria procedure diagnosing dementia used baseline follow described time follow examination num num num subjects refused participate num moved stockholm area information lifetime occupational history unavailable num subjects refusal informant therefore current study population consisted num persons
0.23427205.14718220.html.plaintext.txt	19	identification incident cases alzheimer disease dementia follow subjects clinically examined physicians neuropsychologically assessed psychologists interviewed nurses incident cases dementia defined developed follow period diagnosis clinical dementia made according criteria diagnostic statistical manual mental disorders third edition revised num using three step procedure first preliminary diagnosis made examining physician second cases independently reviewed specialized clinician second diagnosis made diagnoses agreement accepted final cases disagreement third opinion obtained concordant diagnosis accepted diagnosis dementia made subject completely fulfilled criteria diagnostic statistical manual mental disorders third edition revised
0.23427205.14718220.html.plaintext.txt	20	identification incident cases alzheimer disease dementia follow subjects clinically examined physicians neuropsychologically assessed psychologists interviewed nurses incident cases dementia defined developed follow period diagnosis clinical dementia made according criteria diagnostic statistical manual mental disorders third edition revised num using three step procedure first preliminary diagnosis made examining physician second cases independently reviewed specialized clinician second diagnosis made diagnoses agreement accepted final cases disagreement third opinion obtained concordant diagnosis accepted diagnosis dementia made subject completely fulfilled criteria diagnostic statistical manual mental disorders third edition revised
0.23427205.14718220.html.plaintext.txt	21	diagnosis alzheimer disease particular required gradual onset progressive deterioration cognitive functioning exclusion specific causes dementia neuroimaging autopsy data available clinical diagnosis alzheimer disease corresponds diagnosis probable alzheimer disease according nincds adrda national institute neurological communicative disorders stroke alzheimer disease related disorders association criteria num num deceased subjects preliminary diagnosis made physician consulted medical records death certificates diagnosis reviewed senior clinician discharge diagnoses hospitals n num death certificates n num available reported diagnosis accepted repeated analyses survivors cohort results similar
0.23427205.14718220.html.plaintext.txt	22	diagnosis alzheimer disease particular required gradual onset progressive deterioration cognitive functioning exclusion specific causes dementia neuroimaging autopsy data available clinical diagnosis alzheimer disease corresponds diagnosis probable alzheimer disease according nincds adrda national institute neurological communicative disorders stroke alzheimer disease related disorders association criteria num num deceased subjects preliminary diagnosis made physician consulted medical records death certificates diagnosis reviewed senior clinician discharge diagnoses hospitals n num death certificates n num available reported diagnosis accepted repeated analyses survivors cohort results similar
0.23427205.14718220.html.plaintext.txt	23	measurement educational attainment information total years formal education collected baseline study educational level divided two main categories num num years num years primary school cases num extra year practical vocational training bordernumnum years intermediate university levels dichotomization based previous analysis num different levels education examined relation alzheimer disease persons intermediate amount education num num years schooling differ university educated subjects bordernumnum years schooling terms alzheimer disease risk data educational background missing three persons subjects omitted analyses concerning education
0.23427205.14718220.html.plaintext.txt	24	measurement educational attainment information total years formal education collected baseline study educational level divided two main categories num num years num years primary school cases num extra year practical vocational training bordernumnum years intermediate university levels dichotomization based previous analysis num different levels education examined relation alzheimer disease persons intermediate amount education num num years schooling differ university educated subjects bordernumnum years schooling terms alzheimer disease risk data educational background missing three persons subjects omitted analyses concerning education
0.23427205.14718220.html.plaintext.txt	25	assessments occupation based ses main occupation based ses specially trained nurses interviewed relative another person significant subject subject full lifetime work history questionnaire developed occupational hygienist eight occupational periods specific information regarding time place listed subject longest held job considered main occupation occupations grouped according socioeconomic classification system developed statistics sweden num swedish socioeconomic classification system primarily contains dimensions ownership means production division blue collar white collar occupations assessed normal trade union affiliation also contains aspects skills subdivisions inside blue collar white collar occupational categories however customary educational requirements respective occupations used information education individual level
0.23427205.14718220.html.plaintext.txt	26	assessments occupation based ses main occupation based ses specially trained nurses interviewed relative another person significant subject subject full lifetime work history questionnaire developed occupational hygienist eight occupational periods specific information regarding time place listed subject longest held job considered main occupation occupations grouped according socioeconomic classification system developed statistics sweden num swedish socioeconomic classification system primarily contains dimensions ownership means production division blue collar white collar occupations assessed normal trade union affiliation also contains aspects skills subdivisions inside blue collar white collar occupational categories however customary educational requirements respective occupations used information education individual level
0.23427205.14718220.html.plaintext.txt	27	quite women num percent homemakers longest occupational period information husband occupation frequently used estimate ses wives available instead including homemakers category used second longest held job estimate ses eighteen subjects housewives throughout working lives excluded analyses involving main occupation
0.23427205.14718220.html.plaintext.txt	28	quite women num percent homemakers longest occupational period information husband occupation frequently used estimate ses wives available instead including homemakers category used second longest held job estimate ses eighteen subjects housewives throughout working lives excluded analyses involving main occupation
0.23427205.14718220.html.plaintext.txt	29	first analyzed relation ses incidence alzheimer disease dementia using three categories blue collar workers white collar employees self employed persons plus academic professions since two last categories similar risks two groups merged
0.23427205.14718220.html.plaintext.txt	30	first analyzed relation ses incidence alzheimer disease dementia using three categories blue collar workers white collar employees self employed persons plus academic professions since two last categories similar risks two groups merged
0.23427205.14718220.html.plaintext.txt	31	lifetime occupational ses data gathered length occupational period subject lifetime occupations classified described exception substitutions occupational periods could made homemaker work periods instead classified nonmanual periods num women often held nonmanual jobs occupational periods num generally highly educated nonhousewives finally added numbers years periods manual labor obtain sum years spent low occupation based ses current study report results analyses number years low ses less equal num versus num median amount time spent low ses low ses fraction population
0.23427205.14718220.html.plaintext.txt	32	lifetime occupational ses data gathered length occupational period subject lifetime occupations classified described exception substitutions occupational periods could made homemaker work periods instead classified nonmanual periods num women often held nonmanual jobs occupational periods num generally highly educated nonhousewives finally added numbers years periods manual labor obtain sum years spent low occupation based ses current study report results analyses number years low ses less equal num versus num median amount time spent low ses low ses fraction population
0.23427205.14718220.html.plaintext.txt	33	socioeconomic mobility computed occupation based ses ages num num num years order estimate individual socioeconomic mobility patterns information particular time period missing substituted equal number years two closest work periods sixty three persons lacked information occupational position num years age instead information concerning occupational period prior chosen represent
0.23427205.14718220.html.plaintext.txt	34	socioeconomic mobility computed occupation based ses ages num num num years order estimate individual socioeconomic mobility patterns information particular time period missing substituted equal number years two closest work periods sixty three persons lacked information occupational position num years age instead information concerning occupational period prior chosen represent
0.23427205.14718220.html.plaintext.txt	35	covariates used covariates available information database may acted confounding factors major possible confounders considered age gender vascular diseases alcohol data
0.23427205.14718220.html.plaintext.txt	36	covariates used covariates available information database may acted confounding factors major possible confounders considered age gender vascular diseases alcohol data
0.23427205.14718220.html.plaintext.txt	37	information age gender derived swedish national population register information cerebrovascular heart diseases diabetes mellitus derived computerized stockholm inpatient registry system admission discharge diagnoses every hospital stockholm recorded current study diagnoses made time num baseline examination used diseases diagnosed according international classification diseases eighth revision codes num num cerebrovascular disease codes num num coronary disease code num heart failure code num arrhythmia code num diabetes mellitus information diabetes patient register integrated self reports doctor diagnosis diabetes use oral hypoglycemic medication insulin blood glucose level greater num mmolliter arterial blood pressure measured baseline mercury sphygmomanometer trained nurses first reading abnormal systolic pressure bordernumnum mmhg diastolic pressure bordernumnum mmhg two additional readings made mean second third readings used analyses num furthermore created simple additive index ranging num num vascular diseases risk factors described
0.23427205.14718220.html.plaintext.txt	38	information age gender derived swedish national population register information cerebrovascular heart diseases diabetes mellitus derived computerized stockholm inpatient registry system admission discharge diagnoses every hospital stockholm recorded current study diagnoses made time num baseline examination used diseases diagnosed according international classification diseases eighth revision codes num num cerebrovascular disease codes num num coronary disease code num heart failure code num arrhythmia code num diabetes mellitus information diabetes patient register integrated self reports doctor diagnosis diabetes use oral hypoglycemic medication insulin blood glucose level greater num mmolliter arterial blood pressure measured baseline mercury sphygmomanometer trained nurses first reading abnormal systolic pressure bordernumnum mmhg diastolic pressure bordernumnum mmhg two additional readings made mean second third readings used analyses num furthermore created simple additive index ranging num num vascular diseases risk factors described
0.23427205.14718220.html.plaintext.txt	39	information alcohol use collected relatives specified many glasses wine bottles beer andor glasses liquor proband consumed weekly since consumption alcohol predominantly female elderly population found particularly low numnum percent persons available data alcohol reported used alcohol numnum percent consumed amount corresponding five glasses wine per week decided divide alcohol data three categories use use information latter category included analyses reporting alcohol use sometimes sensitive matter found relevant investigate whether absence information associated risk dementia
0.23427205.14718220.html.plaintext.txt	40	information alcohol use collected relatives specified many glasses wine bottles beer andor glasses liquor proband consumed weekly since consumption alcohol predominantly female elderly population found particularly low numnum percent persons available data alcohol reported used alcohol numnum percent consumed amount corresponding five glasses wine per week decided divide alcohol data three categories use use information latter category included analyses reporting alcohol use sometimes sensitive matter found relevant investigate whether absence information associated risk dementia
0.23427205.14718220.html.plaintext.txt	41	covariates controlled analyses num cognitive status baseline measured mini mental state examination num num social network baseline measured four grade index poor limited moderate rich social network defined previous study num num engagement mental physical activities baseline graded three frequency categories num
0.23427205.14718220.html.plaintext.txt	42	statistical analysis logistic regression used evaluate differences baseline characteristics participants dropouts cox proportional hazards regression analyses used estimate relative risk incident alzheimer disease dementia associated different combinations education occupation based ses well socioeconomic mobility follow time nondemented persons estimated date baseline interview date follow examination death demented persons half time calculated since dementia onset assumed midpoint baseline follow examination
0.23427205.14718220.html.plaintext.txt	43	statistical analysis logistic regression used evaluate differences baseline characteristics participants dropouts cox proportional hazards regression analyses used estimate relative risk incident alzheimer disease dementia associated different combinations education occupation based ses well socioeconomic mobility follow time nondemented persons estimated date baseline interview date follow examination death demented persons half time calculated since dementia onset assumed midpoint baseline follow examination
0.23427205.14718220.html.plaintext.txt	44	age gender vascular disease index alcohol use entered models additional models used verify possible confounding effect baseline mini mental state examination score social network leisure activities also repeated analyses excluding stroke cases purpose examining whether stroke might obscure increase diagnostic difficulties dementia due cognitive dysfunction subjects previous stroke
0.23427205.14718220.html.plaintext.txt	45	age gender vascular disease index alcohol use entered models additional models used verify possible confounding effect baseline mini mental state examination score social network leisure activities also repeated analyses excluding stroke cases purpose examining whether stroke might obscure increase diagnostic difficulties dementia due cognitive dysfunction subjects previous stroke
0.23427205.14718220.html.plaintext.txt	46	interrelation education ses explored using two stratifications first study population divided four strata characterized num high education high ses num high education low ses num low education high ses num low education low ses second used four strata combining low high education defined permanence low ses less equal num years versus num years
0.23427205.14718220.html.plaintext.txt	47	interrelation education ses explored using two stratifications first study population divided four strata characterized num high education high ses num high education low ses num low education high ses num low education low ses second used four strata combining low high education defined permanence low ses less equal num years versus num years
0.23427205.14718220.html.plaintext.txt	48	results top abstract introduction materials methods results discussion references persons dropped study comparable participants terms age num year increment odds ratio numnum num percent confidence interval ci numnum numnum gender female odds ratio numnum num percent ci numnum numnum vascular disease presence vascular disease odds ratio numnum num percent ci numnum numnum odds ratio dropping regard low level education numnum num percent ci numnum numnum however occurrence dementia among num dropouts lacking information occupational history similar among participants study
0.23427205.14718220.html.plaintext.txt	49	results top abstract introduction materials methods results discussion references persons dropped study comparable participants terms age num year increment odds ratio numnum num percent confidence interval ci numnum numnum gender female odds ratio numnum num percent ci numnum numnum vascular disease presence vascular disease odds ratio numnum num percent ci numnum numnum odds ratio dropping regard low level education numnum num percent ci numnum numnum however occurrence dementia among num dropouts lacking information occupational history similar among participants study
0.23427205.14718220.html.plaintext.txt	50	total num subjects developed clinically definite dementia follow period among dementia cases types num persons diagnosed clinically definite dementia alzheimer type table num provides characteristics participants dementia status follow
0.23427205.14718220.html.plaintext.txt	51	total num subjects developed clinically definite dementia follow period among dementia cases types num persons diagnosed clinically definite dementia alzheimer type table num provides characteristics participants dementia status follow
0.23427205.14718220.html.plaintext.txt	52	view table table num baseline characteristics study population n num dementia status follow kungsholmen project stockholm sweden num num relative risks clinical dementia alzheimer type types relation education occupation based ses reported table num compared persons high level education bordernumnum years adjusted relative risks dementia alzheimer type dementia types similar subjects intermediate amount num num years education elevated subjects low level num num years education see model numa model numb merged high intermediate levels education one reference category model numb model num subjects either low level education low occupation based ses found higher risk alzheimer disease dementia even adjustment covariates examined however education ses introduced model simultaneously table num model num low education remained significant risk factor alzheimer disease dementia results similar men women although relative risks men statistically significant probably less statistical power
0.23427205.14718220.html.plaintext.txt	53	view table table num relative risks clinically diagnosed alzheimer disease dementia associated education occupation based socioeconomic status lifetime longest held job derived separate models models num num model model num kungsholmen project stockholm sweden num num subjects low educationlow occupation based ses category often female num percent subjects high educationhigh occupation based ses category num percent number persons high educationlow occupation based ses group smaller n num comparison groups contained largest proportion women num percent housewives num percent low educationhigh occupation based ses group differed noticeably num percent members self employed whereas num percent persons high educationhigh occupation based ses group self employed
0.23427205.14718220.html.plaintext.txt	54	low education combination either low high occupation based ses associated increased risk alzheimer disease dementia even adjustment major covariates combination high education low occupation based ses associated increased risk alzheimer disease dementia table num
0.23427205.14718220.html.plaintext.txt	55	low education combination either low high occupation based ses associated increased risk alzheimer disease dementia even adjustment major covariates combination high education low occupation based ses associated increased risk alzheimer disease dementia table num
0.23427205.14718220.html.plaintext.txt	56	view table table num relative risks clinically diagnosed alzheimer disease dementia associated combinations education occupation based socioeconomic status lifetime longest held job kungsholmen project stockholm sweden num num stratified analyses relations combinations education total years low occupation based ses alzheimer disease showed results similar stratified analysis depicted table num compared persons high education less num years low ses subgroup low education num years low ses adjusted relative risk numnum num percent ci numnum numnum subgroup low education fewer num years low ses adjusted relative risk numnum num percent ci numnum numnum high education conjunction num years low ses associated increased risk alzheimer disease
0.23427205.14718220.html.plaintext.txt	57	table num model num shows relative risks alzheimer disease relation eight social mobility patterns controlling age gender low occupation based ses ages num num num years resulted borderline significant elevated risk alzheimer disease compared reference category high ses three ages low occupation based ses ages num num years age num years also associated significantly elevated risks alzheimer disease furthermore low occupation based ses num years age regardless whether ses high age num andor age num associated elevated alzheimer disease risks though statistically significantly however additional adjustment education none significant associations remained twenty eight percent subjects high occupational ses ages num num num years num percent subjects low ses ages num num num years low educational level analyses type dementia showed similar results
0.23427205.14718220.html.plaintext.txt	58	table num model num shows relative risks alzheimer disease relation eight social mobility patterns controlling age gender low occupation based ses ages num num num years resulted borderline significant elevated risk alzheimer disease compared reference category high ses three ages low occupation based ses ages num num years age num years also associated significantly elevated risks alzheimer disease furthermore low occupation based ses num years age regardless whether ses high age num andor age num associated elevated alzheimer disease risks though statistically significantly however additional adjustment education none significant associations remained twenty eight percent subjects high occupational ses ages num num num years num percent subjects low ses ages num num num years low educational level analyses type dementia showed similar results
0.23427205.14718220.html.plaintext.txt	59	view table table num relative risks clinically diagnosed alzheimer disease associated social mobility occupation based socioeconomic status ages num num num years kungsholmen project stockholm sweden num num finally baseline cognitive status variables mini mental state examination score social network engagement physical mental activities included model covariates relations ses education alzheimer disease dementia substantially change repeated analyses excluding cases stroke associations education alzheimer disease education dementia similar results showed patterns main analyses
0.23427205.14718220.html.plaintext.txt	60	discussion top abstract introduction materials methods results discussion references main finding study low level education low occupation based main ses individually associated increased risk alzheimer disease dementia low education remains risk factor variables examined simultaneously similar pattern observed numbers years work periods low ses position added together life span individual social mobility patterns studied comparison highly educated subjects high ses main occupation twofold increased risk alzheimer disease detected among less educated subjects low ses also among subjects low education high ses position addition subjects initially high occupation based ses increased risk alzheimer disease independently later ses changes persons low occupation based ses young age remained category occupational life num num percent increased risk alzheimer disease however even case low education explained associations
0.23427205.14718220.html.plaintext.txt	61	discussion top abstract introduction materials methods results discussion references main finding study low level education low occupation based main ses individually associated increased risk alzheimer disease dementia low education remains risk factor variables examined simultaneously similar pattern observed numbers years work periods low ses position added together life span individual social mobility patterns studied comparison highly educated subjects high ses main occupation twofold increased risk alzheimer disease detected among less educated subjects low ses also among subjects low education high ses position addition subjects initially high occupation based ses increased risk alzheimer disease independently later ses changes persons low occupation based ses young age remained category occupational life num num percent increased risk alzheimer disease however even case low education explained associations
0.23427205.14718220.html.plaintext.txt	62	results agreement previous findings positive association low level education increased risk alzheimer disease dementia num num evans et al num reported socioeconomic measures education income occupational prestige predicted alzheimer disease risk however included three measures model education income occupational prestige retained significant association alzheimer disease recently investigators nurses health study num reported strong association low education cognitive decline little association markers ses
0.23427205.14718220.html.plaintext.txt	63	fact association low education increased risk alzheimer disease dementia general present independently main occupation based ses fact association ses alzhei mer disease dementia mainly due ses early work life seems indicate unknown education related factors acting first two decades life may involved development alzheimer disease dementia interpretation agreement number previous reports recent article kaplan et al num concluded higher childhood socioeconomic position well greater educational attainment associated better cognitive function adulthood study education dementia italian population middle high socioeconomic level first decade life suggested critical period development dementia later life num hall et al num discussed possibility low education major risk factor alzhei mer disease rather marker accompanying deleterious socioeconomic environmental influences childhood poor quality childhood adolescent environments suggested prevent brain reaching complete levels maturation turn may put people higher risk alzheimer disease num num results paquid study num showed occupation change risk alzheimer disease instead related cognitive abilities childhood adolescence early life factors question may early socioeconomic factors mental stimulation cognitive abilities cognitive abilities may affected environmental num genetic influences num since many studies like lack independent measure intelligence importance early life cognitive abilities difficult evaluate
0.23427205.14718220.html.plaintext.txt	64	fact association low education increased risk alzheimer disease dementia general present independently main occupation based ses fact association ses alzhei mer disease dementia mainly due ses early work life seems indicate unknown education related factors acting first two decades life may involved development alzheimer disease dementia interpretation agreement number previous reports recent article kaplan et al num concluded higher childhood socioeconomic position well greater educational attainment associated better cognitive function adulthood study education dementia italian population middle high socioeconomic level first decade life suggested critical period development dementia later life num hall et al num discussed possibility low education major risk factor alzhei mer disease rather marker accompanying deleterious socioeconomic environmental influences childhood poor quality childhood adolescent environments suggested prevent brain reaching complete levels maturation turn may put people higher risk alzheimer disease num num results paquid study num showed occupation change risk alzheimer disease instead related cognitive abilities childhood adolescence early life factors question may early socioeconomic factors mental stimulation cognitive abilities cognitive abilities may affected environmental num genetic influences num since many studies like lack independent measure intelligence importance early life cognitive abilities difficult evaluate
0.23427205.14718220.html.plaintext.txt	65	number studies given special attention effect early life circumstances health mortality general early life ses reported connected cardiovascular diseases general health status later life num num disadvantaged childhood living conditions hypothesized trigger unhealthy life trajectories increased illness risk sum several health damaging factors num new results random swedish national sample indicate occupational class differences adult mortality depend fairly large extent childhood conditions num examined relation ses alzheimer disease dementia lifetime perspective ranging school retirement unfortunately lacked specific data ses family origin thus suggest involvement early life factors development alzheimer disease dementia hypothesis
0.23427205.14718220.html.plaintext.txt	66	number studies given special attention effect early life circumstances health mortality general early life ses reported connected cardiovascular diseases general health status later life num num disadvantaged childhood living conditions hypothesized trigger unhealthy life trajectories increased illness risk sum several health damaging factors num new results random swedish national sample indicate occupational class differences adult mortality depend fairly large extent childhood conditions num examined relation ses alzheimer disease dementia lifetime perspective ranging school retirement unfortunately lacked specific data ses family origin thus suggest involvement early life factors development alzheimer disease dementia hypothesis
0.23427205.14718220.html.plaintext.txt	67	alternative explanation findings education may better indicator adult lifestyle habits occupational ses lifestyle habits alcohol use smoking may explain detected association however data adjusted alcohol use additionally current social network index engagement physical mental activities entered model covariates obtained similar results smoking related alzheimer disease dementia population num
0.23427205.14718220.html.plaintext.txt	68	alternative explanation findings education may better indicator adult lifestyle habits occupational ses lifestyle habits alcohol use smoking may explain detected association however data adjusted alcohol use additionally current social network index engagement physical mental activities entered model covariates obtained similar results smoking related alzheimer disease dementia population num
0.23427205.14718220.html.plaintext.txt	69	regard cognitive function late middle age turrell et al num reported disadvantaged socioeconomic circumstances childhood may extent overcome later upward mobility however study low education remained associated increased risk alzheimer disease even adjustment adult social mobility
0.23427205.14718220.html.plaintext.txt	70	regard cognitive function late middle age turrell et al num reported disadvantaged socioeconomic circumstances childhood may extent overcome later upward mobility however study low education remained associated increased risk alzheimer disease even adjustment adult social mobility
0.23427205.14718220.html.plaintext.txt	71	potential limitations study must considered persons dropped study less educated participants since low education related alzheimer disease dementia may affected results likely skewed findings towards underestimation association towards overestimation occupational data obtained informants however single open ended question occupation without specification time place number years already posed participants baseline interview possible compare responses informant data regarding subject main job information two different sources used estimate ses agreement num percent swedish system classification ses occupation well established evaluated num however remains occupation based ses difficult evaluate education estimation ses occupation difficult housewives cohort num percent approximations likely create nondifferential misclassification ses leading dilution association performed additional analyses data shown treating housewives third occupational category affect results
0.23427205.14718220.html.plaintext.txt	72	potential limitations study must considered persons dropped study less educated participants since low education related alzheimer disease dementia may affected results likely skewed findings towards underestimation association towards overestimation occupational data obtained informants however single open ended question occupation without specification time place number years already posed participants baseline interview possible compare responses informant data regarding subject main job information two different sources used estimate ses agreement num percent swedish system classification ses occupation well established evaluated num however remains occupation based ses difficult evaluate education estimation ses occupation difficult housewives cohort num percent approximations likely create nondifferential misclassification ses leading dilution association performed additional analyses data shown treating housewives third occupational category affect results
0.23427205.14718220.html.plaintext.txt	73	finally must cautious interpreting findings reflecting direct effect education alzheimer disease risk one mediated occupation based ses fact possibility unmeasured confounders responsible patterns associations found study example work related stress may associated occupation based ses education may increase risk alzheimer disease dementia though currently clear evidence literature concerning association
0.23427205.14718220.html.plaintext.txt	74	finally must cautious interpreting findings reflecting direct effect education alzheimer disease risk one mediated occupation based ses fact possibility unmeasured confounders responsible patterns associations found study example work related stress may associated occupation based ses education may increase risk alzheimer disease dementia though currently clear evidence literature concerning association
0.23427205.14718220.html.plaintext.txt	75	main conclusion drawn study low level education directly associated increased alzheimer disease incidence mediated low adult occupation based ses regardless whether low ses occupational period extended substantial number years bordernumnum years regardless adult socioeconomic mobility pattern results inconsistent already suggested hypotheses cognitive brain reserves num num alternatively findings may partly reflect detection bias subjects low level education tend clinically diagnosed alzheimer disease dementia earlier point time num however possibility factors related early life ses may play role development alzheimer disease dementia disregarded findings support hypothesis stress importance collecting data early life conditions studying dementia old age
0.23427205.14718220.html.plaintext.txt	76	main conclusion drawn study low level education directly associated increased alzheimer disease incidence mediated low adult occupation based ses regardless whether low ses occupational period extended substantial number years bordernumnum years regardless adult socioeconomic mobility pattern results inconsistent already suggested hypotheses cognitive brain reserves num num alternatively findings may partly reflect detection bias subjects low level education tend clinically diagnosed alzheimer disease dementia earlier point time num however possibility factors related early life ses may play role development alzheimer disease dementia disregarded findings support hypothesis stress importance collecting data early life conditions studying dementia old age
0.23427205.14718220.html.plaintext.txt	77	acknowledgments research grants received swedish council work life research symbnum swedish council social research num num gamla tjanarinnor foundation solstickan foundation
0.23427205.14718220.html.plaintext.txt	78	acknowledgments research grants received swedish council work life research symbnum swedish council social research num num gamla tjanarinnor foundation solstickan foundation
0.23427205.14718220.html.plaintext.txt	79	authors thank members kungsholmen project study group cooperation data collection management
0.23427205.14718220.html.plaintext.txt	80	notes reprint requests anita karp aging research center karolinska institutet box num olivecronas vag num num num stockholm sweden e mail anitakarpatneuroteckise u d
0.23427205.14718220.html.plaintext.txt	81	references top abstract introduction materials methods results discussion references schmand b smit j lindeboom j et al low education genuine risk factor accelerated memory decline dementia j clin epidemiol numnumnum numcrossrefisimedline evans da hebert le beckett la et al education measures socioeconomic status risk incident alzheimer disease defined population older persons arch neurol numnumnum numabstract letenneur l gilleron v commenges d et al sex educational level independent predictors dementia alzheimer disease incidence data paquid project j neurol neurosurg psychiatry numnumnum numabstractfree full text qiu c backman l winblad b et al influence education clinically diagnosed dementia incidence mortality data kungsholmen project arch neurol numnumnum numabstractfree full text katzman r education prevalence dementia alzheimer disease neurology numnumnum numisimedline stern y gurland b tatemichi tk et al influence education occupation incidence alzheimer disease jama numnumnum numabstract friedland rp epidemiology education ecology alzheimer disease neurology numnumnum numisimedline plassman bl welsh ka helms m et al intelligence education predictors cognitive state late life num year follow neurology numnumnum numabstract gatz m svedberg p pedersen nl et al education risk alzheimer disease findings study dementia swedish twins j gerontol b psychol sci soc sci numnumsymb numabstractfree full text fratiglioni l viitanen m aguero torres h et al low education ad effects diagnosis rather risk abstract neurobiol aging numnumsuppl numnum winkleby ma jatulis de frank e et al socioeconomic status health education income occupation contribute risk factors cardiovascular disease j public health numnumnum numabstract davey smith g hart c hole d et al education social class important indicator mortality risk j epidemiol community health numnumnum numabstract lynch j kaplan g socioeconomic position berkman lf kawachi eds social epidemiology new york ny oxford university press numnum num smith gd hart c blane d et al lifetime socioeconomic position mortality prospective observational study bmj numnumnum numabstractfree full text power c manor o matthews duration timing exposure effects socioeconomic environment adult health j public health numnumnum numabstract lynch jw kaplan ga shema sj cumulative impact sustained economic hardship physical cognitive psychological social functioning n engl j med numnumnum numabstractfree full text turrell g lynch jw kaplan ga et al socioeconomic position across lifecourse cognitive function late middle age j gerontol b psychol sci soc sci numnumsymb numabstractfree full text qiu c karp von strauss e et al lifetime principal occupation risk alzheimer disease kungsholmen project j ind med numnumnum numcrossrefisimedline fratiglioni l viitanen m von strauss e et al old women highest risk dementia alzheimer disease incidence data kungsholmen project stockholm neurology numnumnum numabstract american psychiatric association diagnostic statistical manual mental disorders third edition revised dsm iii r washington dc american psychiatric association numnum num mckhann g drachman d folstein m et al clinical diagnosis alzheimer disease report nincds adrda work group auspices department health human services task force alzheimer disease neurology numnumnum numabstract statistics sweden swedish socioeconomic classification reports statistical co ordination stockholm sweden statistics sweden num guo z viitanen m winblad b low blood pressure five year mortality stockholm cohort old possible confounding cognitive impairment factors j public health numnumnum numabstract folstein mf folstein se mchugh pr mini mental state practical method grading cognitive state patients clinician j psychiatr res numnumnum numcrossrefisimedline fratiglioni l wang hx ericsson k et al influence social network occurrence dementia community based longitudinal study lancet numnumnum numcrossrefisimedline wang hx karp winblad b fratiglioni l late life engagement social leisure activities associated decreased risk dementia longitudinal study kungsholmen project j epidemiol numnumnum numabstractfree full text lee kawachi berkman l et al education socioeconomic indicators cognitive function j epidemiol numnumnum numabstractfree full text kaplan g turrell g lynch jw et al childhood socioeconomic position cognitive function adulthood int j epidemiol numnumnum numabstractfree full text de ronchi d fratiglioni l rucci p et al effect education dementia occurrence italian population middle high socioeconomic status neurology numnumnum numabstract hall ks gao unverzagt fw et al low education childhood rural residence risk alzheimer disease african americans neurology numnumnum numabstractfree full text moceri vm kukull wa emanuel et al early life risk factors development alzheimer disease neurology numnumnum numabstractfree full text moceri vm kukull wa emanual et al using census data birth certificates reconstruct early life socioeconomic environment relation development alzheimer disease epidemiology numnumnum numcrossrefisimedline helmer c letenneur l rouch et al occupation life risk dementia french elderly community residents j neurol neurosurg psychiatry numnumnum numabstractfree full text del ser hachinski v merskey h et al autopsy verified study effect education degenerative dementia brain numnumnum numabstractfree full text kaplan ga salonen jt socioeconomic conditions childhood ischaemic heart disease middle age bmj numnumnum numisimedline van de mheen h stronks k looman cw childhood socioeconomic status influence adult health behavioural factors int j epidemiol numnumnum numabstract wamala sp socioeconomic status cardiovascular vulnerability women psychosocial behavioral biological mediators doctoral thesis stockholm sweden karolinska institute num lundberg o impact childhood living conditions illness mortality adulthood soc sci med numnumnum numcrossrefisimedline kareholt long shadow socioeconomic conditions childhood affect class inequalities mortality jonsson jo mills c eds cradle grave life course change modern sweden durham united kingdom sociology press numnum num wang hx fratiglioni l frisoni gb et al smoking occurrence alzheimer disease cross sectional longitudinal data population based study j epidemiol numnumnum numabstract andersson lg erickson r warneryd b describe social structure evaluation num suggestion socio economic classification swedish stat tidskr numnumnum num
0.23427205.14718220.html.plaintext.txt	82	references top abstract introduction materials methods results discussion references schmand b smit j lindeboom j et al low education genuine risk factor accelerated memory decline dementia j clin epidemiol numnumnum numcrossrefisimedline evans da hebert le beckett la et al education measures socioeconomic status risk incident alzheimer disease defined population older persons arch neurol numnumnum numabstract letenneur l gilleron v commenges d et al sex educational level independent predictors dementia alzheimer disease incidence data paquid project j neurol neurosurg psychiatry numnumnum numabstractfree full text qiu c backman l winblad b et al influence education clinically diagnosed dementia incidence mortality data kungsholmen project arch neurol numnumnum numabstractfree full text katzman r education prevalence dementia alzheimer disease neurology numnumnum numisimedline stern y gurland b tatemichi tk et al influence education occupation incidence alzheimer disease jama numnumnum numabstract friedland rp epidemiology education ecology alzheimer disease neurology numnumnum numisimedline plassman bl welsh ka helms m et al intelligence education predictors cognitive state late life num year follow neurology numnumnum numabstract gatz m svedberg p pedersen nl et al education risk alzheimer disease findings study dementia swedish twins j gerontol b psychol sci soc sci numnumsymb numabstractfree full text fratiglioni l viitanen m aguero torres h et al low education ad effects diagnosis rather risk abstract neurobiol aging numnumsuppl numnum winkleby ma jatulis de frank e et al socioeconomic status health education income occupation contribute risk factors cardiovascular disease j public health numnumnum numabstract davey smith g hart c hole d et al education social class important indicator mortality risk j epidemiol community health numnumnum numabstract lynch j kaplan g socioeconomic position berkman lf kawachi eds social epidemiology new york ny oxford university press numnum num smith gd hart c blane d et al lifetime socioeconomic position mortality prospective observational study bmj numnumnum numabstractfree full text power c manor o matthews duration timing exposure effects socioeconomic environment adult health j public health numnumnum numabstract lynch jw kaplan ga shema sj cumulative impact sustained economic hardship physical cognitive psychological social functioning n engl j med numnumnum numabstractfree full text turrell g lynch jw kaplan ga et al socioeconomic position across lifecourse cognitive function late middle age j gerontol b psychol sci soc sci numnumsymb numabstractfree full text qiu c karp von strauss e et al lifetime principal occupation risk alzheimer disease kungsholmen project j ind med numnumnum numcrossrefisimedline fratiglioni l viitanen m von strauss e et al old women highest risk dementia alzheimer disease incidence data kungsholmen project stockholm neurology numnumnum numabstract american psychiatric association diagnostic statistical manual mental disorders third edition revised dsm iii r washington dc american psychiatric association numnum num mckhann g drachman d folstein m et al clinical diagnosis alzheimer disease report nincds adrda work group auspices department health human services task force alzheimer disease neurology numnumnum numabstract statistics sweden swedish socioeconomic classification reports statistical co ordination stockholm sweden statistics sweden num guo z viitanen m winblad b low blood pressure five year mortality stockholm cohort old possible confounding cognitive impairment factors j public health numnumnum numabstract folstein mf folstein se mchugh pr mini mental state practical method grading cognitive state patients clinician j psychiatr res numnumnum numcrossrefisimedline fratiglioni l wang hx ericsson k et al influence social network occurrence dementia community based longitudinal study lancet numnumnum numcrossrefisimedline wang hx karp winblad b fratiglioni l late life engagement social leisure activities associated decreased risk dementia longitudinal study kungsholmen project j epidemiol numnumnum numabstractfree full text lee kawachi berkman l et al education socioeconomic indicators cognitive function j epidemiol numnumnum numabstractfree full text kaplan g turrell g lynch jw et al childhood socioeconomic position cognitive function adulthood int j epidemiol numnumnum numabstractfree full text de ronchi d fratiglioni l rucci p et al effect education dementia occurrence italian population middle high socioeconomic status neurology numnumnum numabstract hall ks gao unverzagt fw et al low education childhood rural residence risk alzheimer disease african americans neurology numnumnum numabstractfree full text moceri vm kukull wa emanuel et al early life risk factors development alzheimer disease neurology numnumnum numabstractfree full text moceri vm kukull wa emanual et al using census data birth certificates reconstruct early life socioeconomic environment relation development alzheimer disease epidemiology numnumnum numcrossrefisimedline helmer c letenneur l rouch et al occupation life risk dementia french elderly community residents j neurol neurosurg psychiatry numnumnum numabstractfree full text del ser hachinski v merskey h et al autopsy verified study effect education degenerative dementia brain numnumnum numabstractfree full text kaplan ga salonen jt socioeconomic conditions childhood ischaemic heart disease middle age bmj numnumnum numisimedline van de mheen h stronks k looman cw childhood socioeconomic status influence adult health behavioural factors int j epidemiol numnumnum numabstract wamala sp socioeconomic status cardiovascular vulnerability women psychosocial behavioral biological mediators doctoral thesis stockholm sweden karolinska institute num lundberg o impact childhood living conditions illness mortality adulthood soc sci med numnumnum numcrossrefisimedline kareholt long shadow socioeconomic conditions childhood affect class inequalities mortality jonsson jo mills c eds cradle grave life course change modern sweden durham united kingdom sociology press numnum num wang hx fratiglioni l frisoni gb et al smoking occurrence alzheimer disease cross sectional longitudinal data population based study j epidemiol numnumnum numabstract andersson lg erickson r warneryd b describe social structure evaluation num suggestion socio economic classification swedish stat tidskr numnumnum num
0.23731914.12456513.html.plaintext.txt	0	managing behavioural psychological symptoms dementia brian lawlor frcpsych
0.23731914.12456513.html.plaintext.txt	1	jonathan swift clinic department psychiatry st jamess hospital st james street dublin num ireland
0.23731914.12456513.html.plaintext.txt	2	behavioural psychological symptoms dementia bpsd common problematic clinical practice represent significant part day day workload old age psychiatry team hospital institution community settings improving recognition management bpsd positive impact quality life patients carers potentially delay transition home institutional care
0.23731914.12456513.html.plaintext.txt	3	behavioural psychological symptoms dementia bpsd common problematic clinical practice represent significant part day day workload old age psychiatry team hospital institution community settings improving recognition management bpsd positive impact quality life patients carers potentially delay transition home institutional care
0.23731914.12456513.html.plaintext.txt	4	behavioural psychological symptoms dementia umbrella term embraces heterogeneous group non cognitive symptoms behaviours occur people dementia concept bpsd descriptive one reflect diagnostic entity rather high lights important clinical dimension dementia recently ignored research therapeutic points view one approach description bpsd use list observed behaviours wandering agitation sexually inappropriate behaviours elicited psychological symptoms depression anxiety delusions finkel et al num approach fails take account fact many called elicited symptoms depression delusions also represent observed behaviours looks depressed acts though hallucinating deluded fact symptoms behaviours occur isolation tend occur together clusters syndromes number syndromes described basis factor analytical studies using rating instruments designed measure bpsd frisoni et al num syndromes include depression psychosis psychomotor agitation aggression apathy depression psychosis included descriptors dsm iv criteria alzheimers disease american psychiatric association num recently diagnostic criteria distinct syndrome psychosis alzheimers disease related dementias depression alzheimers disease proposed jeste finkel num olin et al num likely diagnostic criteria behavioural syndromes dementia also developed near future facilitate recognition future therapeutic targeting specific aspects bpsd
0.23731914.12456513.html.plaintext.txt	5	behavioural psychological symptoms dementia umbrella term embraces heterogeneous group non cognitive symptoms behaviours occur people dementia concept bpsd descriptive one reflect diagnostic entity rather high lights important clinical dimension dementia recently ignored research therapeutic points view one approach description bpsd use list observed behaviours wandering agitation sexually inappropriate behaviours elicited psychological symptoms depression anxiety delusions finkel et al num approach fails take account fact many called elicited symptoms depression delusions also represent observed behaviours looks depressed acts though hallucinating deluded fact symptoms behaviours occur isolation tend occur together clusters syndromes number syndromes described basis factor analytical studies using rating instruments designed measure bpsd frisoni et al num syndromes include depression psychosis psychomotor agitation aggression apathy depression psychosis included descriptors dsm iv criteria alzheimers disease american psychiatric association num recently diagnostic criteria distinct syndrome psychosis alzheimers disease related dementias depression alzheimers disease proposed jeste finkel num olin et al num likely diagnostic criteria behavioural syndromes dementia also developed near future facilitate recognition future therapeutic targeting specific aspects bpsd
0.23731914.12456513.html.plaintext.txt	6	although behaviour psychological symptoms included core features definition dementia syndrome two thirds people dementia experience bpsd one time point one third community dwelling people dementia level bpsd clinically significant range lyketsos et al num figure clinically significant bpsd rises almost num people dementia residing care environments margallo lana et al num prevalence estimates bpsd vary widely heterogeneity patient populations studied terms setting type dementia different definitions used bpsd recent application standardised validated assessment instruments resulting consistent data community clinic based populations two population based studies one usa lyketsos et al num one uk burns et al num show similar prevalence figures num bpsd people alzheimers disease unlike cognitive dysfunction dementia progressively worsens time many bpsd tend fluctuate psycho motor agitation persistent devanand et al num research needed natural history longitudinal course bpsd inform clinicians appropriate duration pharmacological interventions advice information given families distressed symptoms behaviours
0.23731914.12456513.html.plaintext.txt	7	although behaviour psychological symptoms included core features definition dementia syndrome two thirds people dementia experience bpsd one time point one third community dwelling people dementia level bpsd clinically significant range lyketsos et al num figure clinically significant bpsd rises almost num people dementia residing care environments margallo lana et al num prevalence estimates bpsd vary widely heterogeneity patient populations studied terms setting type dementia different definitions used bpsd recent application standardised validated assessment instruments resulting consistent data community clinic based populations two population based studies one usa lyketsos et al num one uk burns et al num show similar prevalence figures num bpsd people alzheimers disease unlike cognitive dysfunction dementia progressively worsens time many bpsd tend fluctuate psycho motor agitation persistent devanand et al num research needed natural history longitudinal course bpsd inform clinicians appropriate duration pharmacological interventions advice information given families distressed symptoms behaviours
0.23731914.12456513.html.plaintext.txt	8	occurrence bpsd often triggering event recognition referral people dementia specialist services patients families present crisis disarray relatively late course illness development bpsd major risk factor caregiver burden coen et al num institutionalisation odonnell et al num important regard enduring cognitive deficits disease process steele et al num aspects bpsd associated caregiver burden paranoia aggression sleep wake cycle disturbance appear particularly important drivers caregiver burden institutionalisation odonnell et al num development bpsd also associated worse prognosis rapid rate illness progression paulsen et al num adds significantly direct indirect costs care expert assessment targeted treatment bpsd alleviate patient suffering promote caregiver well less effective interventions occur support system ruptured
0.23731914.12456513.html.plaintext.txt	9	occurrence bpsd often triggering event recognition referral people dementia specialist services patients families present crisis disarray relatively late course illness development bpsd major risk factor caregiver burden coen et al num institutionalisation odonnell et al num important regard enduring cognitive deficits disease process steele et al num aspects bpsd associated caregiver burden paranoia aggression sleep wake cycle disturbance appear particularly important drivers caregiver burden institutionalisation odonnell et al num development bpsd also associated worse prognosis rapid rate illness progression paulsen et al num adds significantly direct indirect costs care expert assessment targeted treatment bpsd alleviate patient suffering promote caregiver well less effective interventions occur support system ruptured
0.23731914.12456513.html.plaintext.txt	10	assessment individuals dementia stages illness careful enquiry must made regarding presence bpsd emphasis must detect bpsd caregiver burn irretrievable damage support environment occur collateral history use objective performance based test must part comprehensive cognitive assessment history assessment focus behavioural psychological symptoms given high frequency impact patient caregiver quality life
0.23731914.12456513.html.plaintext.txt	11	assessment individuals dementia stages illness careful enquiry must made regarding presence bpsd emphasis must detect bpsd caregiver burn irretrievable damage support environment occur collateral history use objective performance based test must part comprehensive cognitive assessment history assessment focus behavioural psychological symptoms given high frequency impact patient caregiver quality life
0.23731914.12456513.html.plaintext.txt	12	recognition bpsd first important step devising management plan facilitated use standardised assessment scales behavioural pathology alzheimers disease rating scale behave ad reisberg et al num neuro psychiatric inventory npi cummings et al num characteristics behaviour symptoms together frequency severity impact patient caregiver must identified formulating tailored targeted plan action likely involve pharmacological non pharmacological interventions useful identify target syndromes patient primarily psychotic syndrome hallucinations delusions main problem psycho motor agitation sleep disturbance context behaviour symptom impact also key elements assessment aggressive resistance personal activity carried patient may warrant immediate pharmacological intervention also mis identification symptoms part psychotic syndrome distressing carers patients instances education family members rather drug treatment required
0.23731914.12456513.html.plaintext.txt	13	recognition bpsd first important step devising management plan facilitated use standardised assessment scales behavioural pathology alzheimers disease rating scale behave ad reisberg et al num neuro psychiatric inventory npi cummings et al num characteristics behaviour symptoms together frequency severity impact patient caregiver must identified formulating tailored targeted plan action likely involve pharmacological non pharmacological interventions useful identify target syndromes patient primarily psychotic syndrome hallucinations delusions main problem psycho motor agitation sleep disturbance context behaviour symptom impact also key elements assessment aggressive resistance personal activity carried patient may warrant immediate pharmacological intervention also mis identification symptoms part psychotic syndrome distressing carers patients instances education family members rather drug treatment required
0.23731914.12456513.html.plaintext.txt	14	pharmacological treatments drug treatments bpsd evidence based targeted specific syndromes clinically significant frequency pervasiveness impact depression dementia although little placebo controlled evidence guide practice clinical experience indicates selective serotonin re uptake inhibitors safe effective neuroleptic agents shown effective placebo aggression psychosis agitation dementia devanand et al num de deyn et al num street et al num novel agents superior conventional neuroleptics terms tolerability side effect profile non neuroleptic treatments carbamazepine demonstrated efficacy placebo treatment agitation tariot et al num recent placebo controlled studies suggest cholinesterase inhibitors improve apathetic syndrome alzheimers disease also decrease psychotic symptoms particularly hallucinations alzheimers disease lewy body dementia cummings num mckeith et al num
0.23731914.12456513.html.plaintext.txt	15	pharmacological treatments drug treatments bpsd evidence based targeted specific syndromes clinically significant frequency pervasiveness impact depression dementia although little placebo controlled evidence guide practice clinical experience indicates selective serotonin re uptake inhibitors safe effective neuroleptic agents shown effective placebo aggression psychosis agitation dementia devanand et al num de deyn et al num street et al num novel agents superior conventional neuroleptics terms tolerability side effect profile non neuroleptic treatments carbamazepine demonstrated efficacy placebo treatment agitation tariot et al num recent placebo controlled studies suggest cholinesterase inhibitors improve apathetic syndrome alzheimers disease also decrease psychotic symptoms particularly hallucinations alzheimers disease lewy body dementia cummings num mckeith et al num
0.23731914.12456513.html.plaintext.txt	16	non pharmacological treatments dearth controlled evidence psychological interventions bpsd individualised music therapy bright light treatment specific behaviour interventions found improve certain troubling behavioural symptoms dementia evidence required area devanand lawlor num
0.23731914.12456513.html.plaintext.txt	17	non pharmacological treatments dearth controlled evidence psychological interventions bpsd individualised music therapy bright light treatment specific behaviour interventions found improve certain troubling behavioural symptoms dementia evidence required area devanand lawlor num
0.23731914.12456513.html.plaintext.txt	18	interventions carer boosting caregiver support increasing time self providing carer education training management bpsd effective decreasing burden mollifying impact carer ostwald et al num interventions carers may decrease carer burden improve tolerability particular symptom hepburn et al num also positive impact patient behaviour marriott et al num possibly delay institutionalisation brodaty et al num teri num
0.23731914.12456513.html.plaintext.txt	19	interventions carer boosting caregiver support increasing time self providing carer education training management bpsd effective decreasing burden mollifying impact carer ostwald et al num interventions carers may decrease carer burden improve tolerability particular symptom hepburn et al num also positive impact patient behaviour marriott et al num possibly delay institutionalisation brodaty et al num teri num
0.23731914.12456513.html.plaintext.txt	20	behavioural psychological symptoms dementia accepted important therapeutic target management strategies including pharmacological non pharmacological treatments together carer focused training education approaches effective decreasing bpsd require concerted multi disciplinary team input old age psychiatry team well positioned address care needs patients bpsd certain resource training needs attached delivery care degree special interest development area bpsd encouraged within multi disciplinary team adoption evidence based guidelines standardised assessments promoted ongoing training professional education team members bpsd given priority highest standards care provided patients carers
0.23731914.12456513.html.plaintext.txt	21	behavioural psychological symptoms dementia accepted important therapeutic target management strategies including pharmacological non pharmacological treatments together carer focused training education approaches effective decreasing bpsd require concerted multi disciplinary team input old age psychiatry team well positioned address care needs patients bpsd certain resource training needs attached delivery care degree special interest development area bpsd encouraged within multi disciplinary team adoption evidence based guidelines standardised assessments promoted ongoing training professional education team members bpsd given priority highest standards care provided patients carers
0.23731914.12456513.html.plaintext.txt	22	american psychiatric association num diagnostic statistical manual mental disorders numth edn dsm iv washington dc apa
0.23731914.12456513.html.plaintext.txt	23	teri l num training families provide care effects people dementia international journal geriatric psychiatry num num numnumnumconum jlinktypedoicrossrefmedline
0.23731914.12456513.html.plaintext.txt	24	received publication january num num accepted publication april num num
0.23731914.12456513.html.plaintext.txt	25	received publication january num num accepted publication april num num
0.24103056.11823327.html.plaintext.txt	0	vascular dementia diagnosis running time robert stewart mrcpsych
0.24103056.11823327.html.plaintext.txt	1	institute psychiatry de crespigny park denmark hill london symb numaf uk tel num numnum num num fax num numnum num num
0.24103056.11823327.html.plaintext.txt	2	institute psychiatry de crespigny park denmark hill london symb numaf uk tel num numnum num num fax num numnum num num
0.24103056.11823327.html.plaintext.txt	3	background concept vascular dementia long history usefulness diagnostic category called question
0.24103056.11823327.html.plaintext.txt	4	aims evaluate vascular disease risk factor dementia interface cerebrovascular pathology alzheimers disease
0.24103056.11823327.html.plaintext.txt	5	method literature topic selectively reviewed synthesised
0.24103056.11823327.html.plaintext.txt	6	results risk factors cerebrovascular disease also risk factors dementia however course dementia developed appears frequently determined alzheimers disease
0.24103056.11823327.html.plaintext.txt	7	results risk factors cerebrovascular disease also risk factors dementia however course dementia developed appears frequently determined alzheimers disease
0.24103056.11823327.html.plaintext.txt	8	conclusions public health measure modification vascular risk represents potentially powerful means prevent dementia delaying onset however effect progression dementia developed yet established traditional view vascular dementia alzheimers disease distinguishable conditions becoming steadily less tenable
0.24103056.11823327.html.plaintext.txt	9	conclusions public health measure modification vascular risk represents potentially powerful means prevent dementia delaying onset however effect progression dementia developed yet established traditional view vascular dementia alzheimers disease distinguishable conditions becoming steadily less tenable
0.24103056.11823327.html.plaintext.txt	10	upon time around first half last century late onset dementia viewed essentially homogeneous condition main underlying cause assumed atherosclerosis pathological substrate old age pioneering work around nums early nums challenged assumption establishing importance alzheimer pathological changes majority cases however multiple cerebral infarctions also appeared underlie substantial proportion led division dementia two conditions alzheimers disease multi infarct dementia system persisted day coming increasing criticism particularly wish investigate vascular disease risk factor dementia following sections current status future directions vascular dementia considered diagnostic category heading broad field research
0.24103056.11823327.html.plaintext.txt	11	upon time around first half last century late onset dementia viewed essentially homogeneous condition main underlying cause assumed atherosclerosis pathological substrate old age pioneering work around nums early nums challenged assumption establishing importance alzheimer pathological changes majority cases however multiple cerebral infarctions also appeared underlie substantial proportion led division dementia two conditions alzheimers disease multi infarct dementia system persisted day coming increasing criticism particularly wish investigate vascular disease risk factor dementia following sections current status future directions vascular dementia considered diagnostic category heading broad field research
0.24103056.11823327.html.plaintext.txt	12	research diagnostic criteria treat alzheimers disease diagnosis exclusion mckhann et al num system may useful examining issues relating disorder pure entity however may also miss potentially important influences factors vascular disease excluded definition addition begun excluding major vascular disease clinical stroke multiple cerebral infarctions computed tomographic imaging studies use diagnostic system consider evidence subtle subclinical disease white matter abnormalities seen magnetic resonance imaging increasingly sophisticated measurements cerebrovascular disease vivo raise question exclusion criteria stop detectable levels vascular disease continue excluded pure alzheimers disease group become progressively smaller defining increasingly select group persons whatever reason remained free vascular disease old age question course level vascular disease may cause dementia answered using criteria assume cause
0.24103056.11823327.html.plaintext.txt	13	research diagnostic criteria treat alzheimers disease diagnosis exclusion mckhann et al num system may useful examining issues relating disorder pure entity however may also miss potentially important influences factors vascular disease excluded definition addition begun excluding major vascular disease clinical stroke multiple cerebral infarctions computed tomographic imaging studies use diagnostic system consider evidence subtle subclinical disease white matter abnormalities seen magnetic resonance imaging increasingly sophisticated measurements cerebrovascular disease vivo raise question exclusion criteria stop detectable levels vascular disease continue excluded pure alzheimers disease group become progressively smaller defining increasingly select group persons whatever reason remained free vascular disease old age question course level vascular disease may cause dementia answered using criteria assume cause
0.24103056.11823327.html.plaintext.txt	14	major problem concept multi infarct dementia diagnostic criteria tried thing alzheimers disease define pure entity however alzheimers disease least reasonably well defined pathological basis true dementia related cerebrovascular disease vascular dementia subsumed multi infarct dementia term recognition heterogeneity large numbers subtypes subsequently proposed konno et al num range syndromes dementia appears resulted small discrete strategic infarctions bilateral thalamic infarction lesions angular gyrus dementia associated diffuse cerebrovascular disease ischaemic haemorrhagic cortical subcortical brun num diffuse disease obviously exists across spectrum severity advancing age increasingly likely comorbid alzheimers disease raising questions whether two distinguished diagnostic system additional obstacle research term vascular dementia makes assumptions causation therefore limited use comes investigating potential causes would considered particularly noteworthy study report people stroke likely hypertension diabetes similarly would surprising found higher mortality higher levels depression problem vascular dementia term comparisons alzheimers disease control groups inevitably comparisons populations different rates cerebrovascular disease impossible conclude related cerebrovascular disease related particular dementia syndrome
0.24103056.11823327.html.plaintext.txt	15	major problem concept multi infarct dementia diagnostic criteria tried thing alzheimers disease define pure entity however alzheimers disease least reasonably well defined pathological basis true dementia related cerebrovascular disease vascular dementia subsumed multi infarct dementia term recognition heterogeneity large numbers subtypes subsequently proposed konno et al num range syndromes dementia appears resulted small discrete strategic infarctions bilateral thalamic infarction lesions angular gyrus dementia associated diffuse cerebrovascular disease ischaemic haemorrhagic cortical subcortical brun num diffuse disease obviously exists across spectrum severity advancing age increasingly likely comorbid alzheimers disease raising questions whether two distinguished diagnostic system additional obstacle research term vascular dementia makes assumptions causation therefore limited use comes investigating potential causes would considered particularly noteworthy study report people stroke likely hypertension diabetes similarly would surprising found higher mortality higher levels depression problem vascular dementia term comparisons alzheimers disease control groups inevitably comparisons populations different rates cerebrovascular disease impossible conclude related cerebrovascular disease related particular dementia syndrome
0.24103056.11823327.html.plaintext.txt	16	perhaps preferable consider vascular dementia series questions rather diagnosis vascular disease cause dementia type types dementia cause
0.24103056.11823327.html.plaintext.txt	17	perhaps preferable consider vascular dementia series questions rather diagnosis vascular disease cause dementia type types dementia cause
0.24103056.11823327.html.plaintext.txt	18	vascular disease cause dementia
0.24103056.11823327.html.plaintext.txt	19	systems dementia classification major obstacle investigating question previously discussed another problem age groups dementia common contain extent healthy survivors respect vascular disease also people conditions together higher mortality therefore less likely identified cross sectional prospective studies
0.24103056.11823327.html.plaintext.txt	20	systems dementia classification major obstacle investigating question previously discussed another problem age groups dementia common contain extent healthy survivors respect vascular disease also people conditions together higher mortality therefore less likely identified cross sectional prospective studies
0.24103056.11823327.html.plaintext.txt	21	particularly high rates dementia observed following clinical stroke approximately nine fold increase risk first year followed smaller two fold raised annual risk found persist least num years later kokmen et al num vascular risk factors hypertension diabetes hypercholesterolaemia also established risk factors dementia large prospective studies stewart num early reports smoking might protective factor least alzheimers disease confirmed rigorously designed investigations anything report raised risk subtypes dementia smokers ott et al num important issue arising studies concerns stage cognitive decline factors effect raised blood pressure mid life instance strong risk factor later cognitive impairment elias et al num however blood pressure later life tends lower association dementia skoog et al num therefore hypertension appears exert effect early stage cognitive decline association may longer apparent time cognitive function deteriorated sufficiently classified dementia pattern described raised cholesterol concentrations notkola et al num important potential implications preventive therapeutic intervention
0.24103056.11823327.html.plaintext.txt	22	particularly high rates dementia observed following clinical stroke approximately nine fold increase risk first year followed smaller two fold raised annual risk found persist least num years later kokmen et al num vascular risk factors hypertension diabetes hypercholesterolaemia also established risk factors dementia large prospective studies stewart num early reports smoking might protective factor least alzheimers disease confirmed rigorously designed investigations anything report raised risk subtypes dementia smokers ott et al num important issue arising studies concerns stage cognitive decline factors effect raised blood pressure mid life instance strong risk factor later cognitive impairment elias et al num however blood pressure later life tends lower association dementia skoog et al num therefore hypertension appears exert effect early stage cognitive decline association may longer apparent time cognitive function deteriorated sufficiently classified dementia pattern described raised cholesterol concentrations notkola et al num important potential implications preventive therapeutic intervention
0.24103056.11823327.html.plaintext.txt	23	type dementia cause
0.24103056.11823327.html.plaintext.txt	24	traditional diagnostic criteria hampered investigation question increasing body epidemiological evidence suggests vascular risk factors hypertension diabetes hyperlipidaemia risk factors development vascular dementia also alzheimers disease stewart num community based research criticised neuroimaging routinely used diagnostic assessment subclinical levels cerebrovascular disease may missed mixed dementia misidentified alzheimers disease issue however consideration mechanisms vascular risk factors associated dementia rather one arbitrarily defined diagnostic categories post stroke studies found dementia appears follow alzheimers disease like course majority cases kokmen et al num approximately num people post stroke dementia gradually deteriorating cognitive function stroke occurred pohjasvaara et al num since alzheimers disease long latency period assumed substantial proportion may subclinical disease
0.24103056.11823327.html.plaintext.txt	25	traditional diagnostic criteria hampered investigation question increasing body epidemiological evidence suggests vascular risk factors hypertension diabetes hyperlipidaemia risk factors development vascular dementia also alzheimers disease stewart num community based research criticised neuroimaging routinely used diagnostic assessment subclinical levels cerebrovascular disease may missed mixed dementia misidentified alzheimers disease issue however consideration mechanisms vascular risk factors associated dementia rather one arbitrarily defined diagnostic categories post stroke studies found dementia appears follow alzheimers disease like course majority cases kokmen et al num approximately num people post stroke dementia gradually deteriorating cognitive function stroke occurred pohjasvaara et al num since alzheimers disease long latency period assumed substantial proportion may subclinical disease
0.24103056.11823327.html.plaintext.txt	26	becoming increasingly apparent dementia associated vascular disease frequently resembles alzheimers disease clinical course many cases obviously explained multiple infarction mechanism one possibility vascular processes cause gradually progressive dementia syndrome however recent pathological studies suggested isolated cerebrovascular disease ie alzheimer lesions rarely found association dementia hulette et al num findings contrast early post mortem series although borne mind people dementia late nums would expected display much florid severe cerebrovascular disease next question whether vascular disease may directly cause drive alzheimers disease processes many potential mechanisms exist proposed vascular induction alzheimers disease including amyloid deposition secondary ischaemia peri infarct inflammation microglial activation abnormal protein glycation may provide link diabetes alzheimers disease furthermore growing appreciation cerebrovascular pathology alzheimers disease vascular amyloid deposition microangiopathy apolipoprotein e apoe genotype may also provide potential explanation association however although apoe num variant associated increased vascular risk neither lipid levels vascular disease found mediating factors num risk alzheimers disease prince et al num
0.24103056.11823327.html.plaintext.txt	27	becoming increasingly apparent dementia associated vascular disease frequently resembles alzheimers disease clinical course many cases obviously explained multiple infarction mechanism one possibility vascular processes cause gradually progressive dementia syndrome however recent pathological studies suggested isolated cerebrovascular disease ie alzheimer lesions rarely found association dementia hulette et al num findings contrast early post mortem series although borne mind people dementia late nums would expected display much florid severe cerebrovascular disease next question whether vascular disease may directly cause drive alzheimers disease processes many potential mechanisms exist proposed vascular induction alzheimers disease including amyloid deposition secondary ischaemia peri infarct inflammation microglial activation abnormal protein glycation may provide link diabetes alzheimers disease furthermore growing appreciation cerebrovascular pathology alzheimers disease vascular amyloid deposition microangiopathy apolipoprotein e apoe genotype may also provide potential explanation association however although apoe num variant associated increased vascular risk neither lipid levels vascular disease found mediating factors num risk alzheimers disease prince et al num
0.24103056.11823327.html.plaintext.txt	28	although many feasible mechanisms proposed direct links vascular alzheimers disease processes pathological evidence far suggests interact principally clinical effects nun study found direct association cerebrovascular disease level alzheimer pathology instead found less alzheimer pathology required produce dementia cerebrovascular disease also present snowdon et al num one possible explanation memory impairment secondary hippocampal pathology alzheimers disease likely manifest clinical dementia also impairment executive function secondary vascular subcortical pathology executive function impairment important although frequently unmeasured factor associated memory decline decline executive function alone important potential consequence cerebrovascular disease suggested dementia syndrome right royall num
0.24103056.11823327.html.plaintext.txt	29	although many feasible mechanisms proposed direct links vascular alzheimers disease processes pathological evidence far suggests interact principally clinical effects nun study found direct association cerebrovascular disease level alzheimer pathology instead found less alzheimer pathology required produce dementia cerebrovascular disease also present snowdon et al num one possible explanation memory impairment secondary hippocampal pathology alzheimers disease likely manifest clinical dementia also impairment executive function secondary vascular subcortical pathology executive function impairment important although frequently unmeasured factor associated memory decline decline executive function alone important potential consequence cerebrovascular disease suggested dementia syndrome right royall num
0.24103056.11823327.html.plaintext.txt	30	considering length time vascular disease accepted common potentially reversible risk factor dementia evidence interventions modify risk woefully scant summarised table num likely success intervention depends crucially mechanism association particular interest clinicians extent patients dementia may benefit treatment vascular disease risk factors however optimally designed trial interventions treatment vascular risk factors may impact cognitive decline preventing stroke increasing evidence suggests may upper age limit stroke prevention staessen et al num addition would benefit vascular disease accelerating progression alzheimer lesions hand vascular disease predominantly accelerates age onset alzheimers disease treatment directed alzheimers disease rather vascular component dementia developed issue become particularly important licensing pharmacological agents use alzheimers disease stroke continues considered exclusion criterion large number people alzheimers disease fail receive appropriate treatment comorbid disease whatever lies ahead treatment dementia associated cerebro vascular disease potential prevention likely substantial since vascular risk factors high prevalence rates modest reduction vascular risk across population could therefore expected result large reduction future cases dementia delaying clinical onset supporting preliminary findings large systolic hypertension europe syst eur trial antihypertensive treatment older people suggested num reduction incident dementia principally alzheimers disease occurring treated calcium channel blocker compared placebo forette et al num
0.24103056.11823327.html.plaintext.txt	31	considering length time vascular disease accepted common potentially reversible risk factor dementia evidence interventions modify risk woefully scant summarised table num likely success intervention depends crucially mechanism association particular interest clinicians extent patients dementia may benefit treatment vascular disease risk factors however optimally designed trial interventions treatment vascular risk factors may impact cognitive decline preventing stroke increasing evidence suggests may upper age limit stroke prevention staessen et al num addition would benefit vascular disease accelerating progression alzheimer lesions hand vascular disease predominantly accelerates age onset alzheimers disease treatment directed alzheimers disease rather vascular component dementia developed issue become particularly important licensing pharmacological agents use alzheimers disease stroke continues considered exclusion criterion large number people alzheimers disease fail receive appropriate treatment comorbid disease whatever lies ahead treatment dementia associated cerebro vascular disease potential prevention likely substantial since vascular risk factors high prevalence rates modest reduction vascular risk across population could therefore expected result large reduction future cases dementia delaying clinical onset supporting preliminary findings large systolic hypertension europe syst eur trial antihypertensive treatment older people suggested num reduction incident dementia principally alzheimers disease occurring treated calcium channel blocker compared placebo forette et al num
0.24103056.11823327.html.plaintext.txt	32	view table table num pathways association vascular disease dementia implications respect preventive therapeutic interventions
0.24103056.11823327.html.plaintext.txt	33	investigation mechanisms underlying links vascular alzheimer pathological processes likely provide important avenues risk modification addition evidence adequately designed therapeutic preventive trials even negative likely provide useful information regarding underlying mechanisms may well become increasingly apparent dementia late stage considering useful intervention one challenge develop public health strategies affect large populations reducing vascular risk earlier life aim decreasing burden dementia generation num num years later however clinical standpoint directed towards individual rather population level risk also need move towards identifying cognitive decline much earlier stage dementia particular regard vascular disease focus memory decline influenced alzheimers disease need shift towards appreciation executive function impairment bowler hachinski num
0.24103056.11823327.html.plaintext.txt	34	investigation mechanisms underlying links vascular alzheimer pathological processes likely provide important avenues risk modification addition evidence adequately designed therapeutic preventive trials even negative likely provide useful information regarding underlying mechanisms may well become increasingly apparent dementia late stage considering useful intervention one challenge develop public health strategies affect large populations reducing vascular risk earlier life aim decreasing burden dementia generation num num years later however clinical standpoint directed towards individual rather population level risk also need move towards identifying cognitive decline much earlier stage dementia particular regard vascular disease focus memory decline influenced alzheimers disease need shift towards appreciation executive function impairment bowler hachinski num
0.24103056.11823327.html.plaintext.txt	35	therefore vascular dementia certainly convenient subject heading rapidly accelerating field research less clear whether retains usefulness diagnosis vascular dementia implies primary cause cerebrovascular disease linked specific consequence distinguishable dementia syndrome however increasing evidence suggests dementia associated vascular disease involves broad spectrum manifestations strategic infarct syndromes alzheimers disease addition although vascular disease powerful risk factor dementia questionable often actually sole cause dementia absence underlying vulnerability comorbid disease dementia research suffered common areas epidemiology simplistic conceptual framework risk factor outcome relationships increasingly evident many potential factors operating across entire life course possibly extending back previous generations may influence mediate others effects table num designing appropriate studies systems analysis take account multiple influences interactions likely provide major challenge future research
0.24103056.11823327.html.plaintext.txt	36	therefore vascular dementia certainly convenient subject heading rapidly accelerating field research less clear whether retains usefulness diagnosis vascular dementia implies primary cause cerebrovascular disease linked specific consequence distinguishable dementia syndrome however increasing evidence suggests dementia associated vascular disease involves broad spectrum manifestations strategic infarct syndromes alzheimers disease addition although vascular disease powerful risk factor dementia questionable often actually sole cause dementia absence underlying vulnerability comorbid disease dementia research suffered common areas epidemiology simplistic conceptual framework risk factor outcome relationships increasingly evident many potential factors operating across entire life course possibly extending back previous generations may influence mediate others effects table num designing appropriate studies systems analysis take account multiple influences interactions likely provide major challenge future research
0.24103056.11823327.html.plaintext.txt	37	view table table num life course model aetiology cognitive decline dementia
0.24103056.11823327.html.plaintext.txt	38	meantime done vascular dementia recent editorial suggested rather tinkering existing criteria discarded replaced wholesale bowler hachinski num certain syndromes reasonably considered diagnoses example dementia due strategic infarcts genetic disorders cadasil cerebral autosomal dominant arteriopathy subcortical infarcts leucoencephalopathy however majority vascular dementia syndromes arising later life although may manifest pure disorders questionable whether valid distinctions truly drawn sub categories vascular dementia alzheimers disease result clinical research diagnostic criteria vascular dementia involve high degree subjective judgement skoog aevarsson num leading inevitably poor agreement raters lopez et al num different diagnostic instruments chui et al num depression feel need define life event depression poor physical health depression rather direct treatment symptoms holding mind formulation possible underlying causes attempt modify potential maintaining factors risk factors recurrence perhaps may lessons learned cognitive impairment dementia complex picture overlapping interacting pathological entities one challenges rewards health care older age groups enthuse students trainees diagnostic system attempts separate processes artificially pure diagnoses us treat favours
0.24103056.11823327.html.plaintext.txt	39	meantime done vascular dementia recent editorial suggested rather tinkering existing criteria discarded replaced wholesale bowler hachinski num certain syndromes reasonably considered diagnoses example dementia due strategic infarcts genetic disorders cadasil cerebral autosomal dominant arteriopathy subcortical infarcts leucoencephalopathy however majority vascular dementia syndromes arising later life although may manifest pure disorders questionable whether valid distinctions truly drawn sub categories vascular dementia alzheimers disease result clinical research diagnostic criteria vascular dementia involve high degree subjective judgement skoog aevarsson num leading inevitably poor agreement raters lopez et al num different diagnostic instruments chui et al num depression feel need define life event depression poor physical health depression rather direct treatment symptoms holding mind formulation possible underlying causes attempt modify potential maintaining factors risk factors recurrence perhaps may lessons learned cognitive impairment dementia complex picture overlapping interacting pathological entities one challenges rewards health care older age groups enthuse students trainees diagnostic system attempts separate processes artificially pure diagnoses us treat favours
0.24103056.11823327.html.plaintext.txt	40	clinical implications limitations
0.24103056.11823327.html.plaintext.txt	41	clinical implications modification vascular risk status mid life likely important means reducing subsequent risk dementia population evidence lacking effect course dementia developed usefulness vascular dementia diagnostic category questionable since involves high degree subjective judgement subsumes large number potentially heterogeneous conditions overlaps considerably alzheimers disease current system classifying dementia mutually exclusive subtypes poorly reflects mixed disease older age groups become important issue since diagnoses determine eligibility pharmacological intervention
0.24103056.11823327.html.plaintext.txt	42	clinical implications modification vascular risk status mid life likely important means reducing subsequent risk dementia population evidence lacking effect course dementia developed usefulness vascular dementia diagnostic category questionable since involves high degree subjective judgement subsumes large number potentially heterogeneous conditions overlaps considerably alzheimers disease current system classifying dementia mutually exclusive subtypes poorly reflects mixed disease older age groups become important issue since diagnoses determine eligibility pharmacological intervention
0.24103056.11823327.html.plaintext.txt	43	limitations review literature selective limited review looks relationship vascular disease dementia population level rather specific discrete syndromes within vascular dementia focus review relationship cerebrovascular disease alzheimers disease two overlapping disorders take account comorbid pathology
0.24103056.11823327.html.plaintext.txt	44	limitations review literature selective limited review looks relationship vascular disease dementia population level rather specific discrete syndromes within vascular dementia focus review relationship cerebrovascular disease alzheimers disease two overlapping disorders take account comorbid pathology
0.24103056.11823327.html.plaintext.txt	45	brun num neuropathology vascular dementia cerebrovascular disease dementia pathology neuropsychiatry management eds e chiu l gustafson d ames et al pp num num london martin dunitz
0.24103056.11823327.html.plaintext.txt	46	stewart r num cardiovascular factors alzheimers disease journal neurology neurosurgery psychiatry num num numfree full text
0.24103056.11823327.html.plaintext.txt	47	received publication march num num revision received april num num accepted publication april num num
0.24103056.11823327.html.plaintext.txt	48	received publication march num num revision received april num num accepted publication april num num
0.24103056.11823327.html.plaintext.txt	49	highlights issue elizabeth walsh bjp num num num full text
0.24103056.11823327.html.plaintext.txt	50	old age psychiatry alistair burns ian g mckeith bjp num num num num full text
0.2476838.9328480.html.plaintext.txt	0	distortion allelic expression apolipoprotein e alzheimers disease
0.2476838.9328480.html.plaintext.txt	1	jean charles symbnum jordi perez symbnum marie joelle symb douglas symb david symb philippe symb john symb andre symb marie christine chartier symbnum
0.2476838.9328480.html.plaintext.txt	2	numinserm unite num place de verdun num lille cedex france numinserm symb num institut pasteur de lille num rue de calmette num lille cedex france numbirdsall building mayo clinic jacksonville num san pablo road jacksonville fl num usa numucsd medical centre pulman ambulatory care centre num campus point drive la jolla ca num usa numdepartment pathological sciences stopford building university manchester oxford road manchester symb numpt uk
0.2476838.9328480.html.plaintext.txt	3	received july num num revised accepted august num num
0.2476838.9328480.html.plaintext.txt	4	apoe epsisnum allele strong genetic susceptibility factor alzheimers disease interaction biological factors may modulate effect apoe isoforms however previous work suggested genetic variability within apoe locus influencing effect epsisnum allele may exist variability could modify expression apoe gene particular level expression apoe alleles could important determinant disease pathogenesis test hypothesis examined levels expression apoe heterozygotes ad controls using new method semi quantitation report relative epsisnum mrna expression increased ad compared controls suggest genetic variability neural expression apoe contributes disease risk introduction
0.2476838.9328480.html.plaintext.txt	5	apoe epsisnum allele strong genetic susceptibility factor alzheimers disease interaction biological factors may modulate effect apoe isoforms however previous work suggested genetic variability within apoe locus influencing effect epsisnum allele may exist variability could modify expression apoe gene particular level expression apoe alleles could important determinant disease pathogenesis test hypothesis examined levels expression apoe heterozygotes ad controls using new method semi quantitation report relative epsisnum mrna expression increased ad compared controls suggest genetic variability neural expression apoe contributes disease risk introduction
0.2476838.9328480.html.plaintext.txt	6	epsisnum allele apoe gene major risk factor late onset alzheimers disease load num also implicated risk factor early onset disease populations numnum previous studies described epsisnum homozygotes higher risk developing disease epsisnumepsisnum heterozygotes however individuals bearing one two epsisnum alleles inevitably develop disease detailed genetic analysis around apoe locus suggested existence genetic variability region could contribute disease risk num two possible explanations observations another genetically variable locus vicinity apoe gene involved pathogenesis disease ii genetic variability control expression apoe gene num
0.2476838.9328480.html.plaintext.txt	7	epsisnum allele apoe gene major risk factor late onset alzheimers disease load num also implicated risk factor early onset disease populations numnum previous studies described epsisnum homozygotes higher risk developing disease epsisnumepsisnum heterozygotes however individuals bearing one two epsisnum alleles inevitably develop disease detailed genetic analysis around apoe locus suggested existence genetic variability region could contribute disease risk num two possible explanations observations another genetically variable locus vicinity apoe gene involved pathogenesis disease ii genetic variability control expression apoe gene num
0.2476838.9328480.html.plaintext.txt	8	little examination mrna expression apoe ad numnum available evidence suggests apoe expression increased neuronal damage numnum bulk expression occurs astrocytes num expression believed part compensatory mechanism aimed aiding reafferentation reactive synaptogenesis num studies examined expression apoe protein ad cases controls relative apoe genotype numnum bertrand et al suggested amount apoe protein could inversely correlated number epsisnum alleles carried subjects higher levels observed epsisnum homozygotes lower epsisnum homozygotes intermediate levels epsisnumepsisnum heterozygotes num
0.2476838.9328480.html.plaintext.txt	9	little examination mrna expression apoe ad numnum available evidence suggests apoe expression increased neuronal damage numnum bulk expression occurs astrocytes num expression believed part compensatory mechanism aimed aiding reafferentation reactive synaptogenesis num studies examined expression apoe protein ad cases controls relative apoe genotype numnum bertrand et al suggested amount apoe protein could inversely correlated number epsisnum alleles carried subjects higher levels observed epsisnum homozygotes lower epsisnum homozygotes intermediate levels epsisnumepsisnum heterozygotes num
0.2476838.9328480.html.plaintext.txt	10	hypothesised since epsisnum homozygotes higher risk developing disease epsisnumepsisnum heterozygotes high proportion individuals latter genotype reach greater age without developing ad likely explanation genetic variability neural expression apoe locus epsisnumepsisnum heterozygote individuals high epsisnum expressors andor low epsisnum expressors likely develop ad individuals high epsisnum expressors andor low epsisnum expressors
0.2476838.9328480.html.plaintext.txt	11	identification apoe allele transcription products easily achieved rt pcr using restriction fragment length polymorphism developed semi quantitative assay measure allelic expression apoe mrna rt pcr using silver staining num method quantitation applied brains heterozygote subjects collected various centres used assess percentage epsisnum mrna expression epsisnumepsisnum epsisnumepsisnum subjects epsisnum mrna expression epsisnumepsisnum individuals carried ad cases controls results
0.2476838.9328480.html.plaintext.txt	12	identification apoe allele transcription products easily achieved rt pcr using restriction fragment length polymorphism developed semi quantitative assay measure allelic expression apoe mrna rt pcr using silver staining num method quantitation applied brains heterozygote subjects collected various centres used assess percentage epsisnum mrna expression epsisnumepsisnum epsisnumepsisnum subjects epsisnum mrna expression epsisnumepsisnum individuals carried ad cases controls results
0.2476838.9328480.html.plaintext.txt	13	selected series epsisnumepsisnum epsisnumepsisnum epsisnumepsisnum ad cases n num controls n num order measure relative level expression apoe allele frontal cortex fig num observed epsisnum mrna expression consistently greater epsisnum mrna expression cases fig num addition clear consistent difference epsisnum allelic expression ratio ad cases controls fig num ad cases showing higher relative expression epsisnum mrna controls numnum plus minus numnum versus numnum plus minus numnum respectively p numnum mann whitney test regarding heterozygous genotypes small size group prevented us reaching definite conclusion nevertheless trend towards situation observed epsisnumepsisnum group could noted increase expression epsisnum allele epsisnumepsisnum group numnum plus minus numnum ad cases versus numnum plus minus numnum control whereas nothing apparent epsisnumepsisnum group numnum plus minus numnum ad case versus numnum plus minus numnum controls furthermore difference allelic expression ratio epsisnumepsisnum epsisnumepsisnum ad cases observed since epsisnumepsisnum patients showed numnum fold increase epsisnum allele ratio p numnum mann whitney test
0.2476838.9328480.html.plaintext.txt	14	figure num semi quantitation epsisnum allele ratio control case final epsisnum allele ratio calculated data numnum
0.2476838.9328480.html.plaintext.txt	15	figure num semi quantitation epsisnum allele ratio control case final epsisnum allele ratio calculated data numnum
0.2476838.9328480.html.plaintext.txt	16	figure num differential expression apoe mrna three heterozygote genotypes alzheimers disease cases controls epsisnum mrna percentage measured epsisnumepsisnum population epsisnum mrna percentage epsisnumepsisnum epsisnumepsisnum population average level expression indicated bold line category brain sample rt pcr semi quantitation repeated three times
0.2476838.9328480.html.plaintext.txt	17	figure num differential expression apoe mrna three heterozygote genotypes alzheimers disease cases controls epsisnum mrna percentage measured epsisnumepsisnum population epsisnum mrna percentage epsisnumepsisnum epsisnumepsisnum population average level expression indicated bold line category brain sample rt pcr semi quantitation repeated three times
0.2476838.9328480.html.plaintext.txt	18	important note measurement ratio expression two alleles heterozygotes likely much robust measurement determination absolute levels mrna expression tissue since latter profoundly affected post mortem delay agonal state cell population density
0.2476838.9328480.html.plaintext.txt	19	seen figure num level expression epsisnum allele consistently higher epsisnum allele ad group well control group data suggest either differential stability different mrna species genetic variability expression two alleles disequilibrium coding polymorphism however addition clear consistent difference epsisnum allelic expression ratio ad cases controls results consistent notion part least genetic risk developing ad encoded apoe locus relates expression protein brain would seem heterozygote individuals express relatively high proportion epsisnum allele greater risk developing disease expressing relatively low proportion observation different alleles apoe equally expressed may importance formulation hypotheses relating role apoe pathogenesis ad general present much speculation experimentation designed determine nature role different alleles apoe pathogenesis ad previously suggested symb isoform may facilitate num limit num amyloid substance deposition isoform would protect oxidative stress conversely symb isoform num finally suggested symb symb isoforms may prevent aggregation tau protein symb isoform may prevent paired helical filament formation num however hypotheses based premise apoe allele isoforms equally expressed present similar concentrations brain isoform specific differences could enhanced different representation isoform individual
0.2476838.9328480.html.plaintext.txt	20	seen figure num level expression epsisnum allele consistently higher epsisnum allele ad group well control group data suggest either differential stability different mrna species genetic variability expression two alleles disequilibrium coding polymorphism however addition clear consistent difference epsisnum allelic expression ratio ad cases controls results consistent notion part least genetic risk developing ad encoded apoe locus relates expression protein brain would seem heterozygote individuals express relatively high proportion epsisnum allele greater risk developing disease expressing relatively low proportion observation different alleles apoe equally expressed may importance formulation hypotheses relating role apoe pathogenesis ad general present much speculation experimentation designed determine nature role different alleles apoe pathogenesis ad previously suggested symb isoform may facilitate num limit num amyloid substance deposition isoform would protect oxidative stress conversely symb isoform num finally suggested symb symb isoforms may prevent aggregation tau protein symb isoform may prevent paired helical filament formation num however hypotheses based premise apoe allele isoforms equally expressed present similar concentrations brain isoform specific differences could enhanced different representation isoform individual
0.2476838.9328480.html.plaintext.txt	21	date seems difficult link apoe mrna apoe protein levels several studies explored issue reporting contradictory findings brain numnum cerebrospinal fluid numnum plasma num even apoe level tested according apoe genotype none previous studies able determine relative ratio different isoforms thus results comparable development isoform specific monoclonal antibodies would help determine whether variation observed population also present protein level num
0.2476838.9328480.html.plaintext.txt	22	date seems difficult link apoe mrna apoe protein levels several studies explored issue reporting contradictory findings brain numnum cerebrospinal fluid numnum plasma num even apoe level tested according apoe genotype none previous studies able determine relative ratio different isoforms thus results comparable development isoform specific monoclonal antibodies would help determine whether variation observed population also present protein level num
0.2476838.9328480.html.plaintext.txt	23	two major findings work first expression epsisnum allele consistently higher expression epsisnum allele second expression epsisnum allele beyond certain level seems greatly influence vulnerability individual alzheimers disease
0.2476838.9328480.html.plaintext.txt	24	two major findings work first expression epsisnum allele consistently higher expression epsisnum allele second expression epsisnum allele beyond certain level seems greatly influence vulnerability individual alzheimers disease
0.2476838.9328480.html.plaintext.txt	25	interesting note apoe regulated consequence insult poirier et al showed increase level expression apoe mrna rat lesioning cerebral cortex num similarly diedrich et al showed apoe mrna increased ad brains num together results support event may lead increase apoe mrna parallel distortion allelic expression distortion allelic expression may specific brain possibly restricted certain areas num suggests neural genetic susceptibility ad associated apoe gene
0.2476838.9328480.html.plaintext.txt	26	interestingly templeton reached similar conclusion using cladistic analysis previously reported genetic data num using haplotype data markers surrounding apoe locus including apoe polymorphism templeton showed coding polymorphism apoe gene sufficient explain increased risk ad num data suggest influence non coding polymorphism apoe expression may supply rest answer materials methods rna extraction
0.2476838.9328480.html.plaintext.txt	27	interestingly templeton reached similar conclusion using cladistic analysis previously reported genetic data num using haplotype data markers surrounding apoe locus including apoe polymorphism templeton showed coding polymorphism apoe gene sufficient explain increased risk ad num data suggest influence non coding polymorphism apoe expression may supply rest answer materials methods rna extraction
0.2476838.9328480.html.plaintext.txt	28	fourteen late onset ad cases caucasian origin mean age numnum plus minus numnum years five male nine female num controls mean age numnum plus minus numnum years five male seven female selected function apoe genotype num mean age sampling numnum plus minus numnum years ad cases genotyped epsisnumepsisnum numnum plus minus numnum years controls genotyped epsisnumepsisnum diagnoses confirmed neuropathological examination
0.2476838.9328480.html.plaintext.txt	29	total rna extraction performed frontal lobe samples described gilmour et al num digested dnase eurogentec dna contamination observed dnase digestion detected pcr digested product rt pcr amplification apoe mrnas
0.2476838.9328480.html.plaintext.txt	30	total rna extraction performed frontal lobe samples described gilmour et al num digested dnase eurogentec dna contamination observed dnase digestion detected pcr digested product rt pcr amplification apoe mrnas
0.2476838.9328480.html.plaintext.txt	31	rt reaction performed num h num min num degrees c using symb primer numprime acagaattcgccccggcctggta numprime num pmol num mug total rna template m mlv reverse transcriptase following conditions described supplier gibcobrl pcr step carried symb primer numprime taagcttggcacggctgtccaagga numprime num pmol final volume num mul num cycles num min num degrees c num min num degrees c num min num degrees c cycle remain linear range reaction briefly pcr performed total volume num mul containing numnum u taq dna polymerase numnum mm dntp num mm dtt numnum mm symb numnum triton x num num vv glycerol using whole rt reaction template electrophoresis
0.2476838.9328480.html.plaintext.txt	32	rt reaction performed num h num min num degrees c using symb primer numprime acagaattcgccccggcctggta numprime num pmol num mug total rna template m mlv reverse transcriptase following conditions described supplier gibcobrl pcr step carried symb primer numprime taagcttggcacggctgtccaagga numprime num pmol final volume num mul num cycles num min num degrees c num min num degrees c num min num degrees c cycle remain linear range reaction briefly pcr performed total volume num mul containing numnum u taq dna polymerase numnum mm dntp num mm dtt numnum mm symb numnum triton x num num vv glycerol using whole rt reaction template electrophoresis
0.2476838.9328480.html.plaintext.txt	33	rt pcr dna digested num u cfoi endonuclease promega dna fragments resolved num polyacrylamide gel acrylamidebisacrylamide numnum num h num vcm range num numnum mul rt pcr product loaded silver staining
0.2476838.9328480.html.plaintext.txt	34	gel fixed num min num vv ethanol numnum vv acetic acid two washings deionised water gel placed silver nitrate solution num mgml num min gel washed twice deionised water dna polymorphism fragments stained num min numnum formaldehyde vv hydroxyde nitrate num mgml finally reaction stopped sodium carbonate solution num mgml developer silver nitrate solutions prepared extemporaneously gel digitalised sharp jx num high resolution colour scanner fragment intensity measured using image master software pharmacia appropriate background subtract allele quantitation
0.2476838.9328480.html.plaintext.txt	35	percentage epsisnum allele calculated equation described ref num
0.2476838.9328480.html.plaintext.txt	36	roman n o sup epsilon roman num m r n roman n o sup epsilon roman num m r n roman n o sup epsilon roman num o r epsilon roman num m r n roman alpha sup prime epsilon roman num m r n roman alpha sup prime epsilon roman num m r n alpha sup prime epsilon roman num o r epsilon roman num m r n
0.2476838.9328480.html.plaintext.txt	37	noepsisnum mrna noepsisnum mrna initial number epsisnum epsisnum mrnas alphaprimeepsisnum mrna alphaprimeepsisnum epsisnum mrna coefficients allowing silver staining phenomenon saturation due staining integrated normalised coefficient proportionality correcting length difference restriction fragments digestion cfoi epsisnum epsisnum epsisnum alleles characterised num num num bp fragments respectively coefficient therefore calculated numnum epsisnumepsisnum individuals numnum epsisnumepsisnum individuals numnum epsisnumepsisnum population
0.2476838.9328480.html.plaintext.txt	38	noepsisnum mrna noepsisnum mrna initial number epsisnum epsisnum mrnas alphaprimeepsisnum mrna alphaprimeepsisnum epsisnum mrna coefficients allowing silver staining phenomenon saturation due staining integrated normalised coefficient proportionality correcting length difference restriction fragments digestion cfoi epsisnum epsisnum epsisnum alleles characterised num num num bp fragments respectively coefficient therefore calculated numnum epsisnumepsisnum individuals numnum epsisnumepsisnum individuals numnum epsisnumepsisnum population
0.2476838.9328480.html.plaintext.txt	39	epsisnum epsisnum alleles give restriction length fragment num bp aodepsisnum mrna odepsisnum mrna symb bp
0.2476838.9328480.html.plaintext.txt	40	initial epsisnum allele percentage epsisnumepsisnum population calculated
0.2476838.9328480.html.plaintext.txt	41	roman n o sup epsilon roman num m r n roman n o sup epsilon roman num m r n roman n o sup epsilon roman num m r n roman alpha sup roman prime epsilon roman num m r n alpha prime sup num num roman b p
0.2476838.9328480.html.plaintext.txt	42	details calculations modelling method described ref num tested viability approach apoe alleles using genomic dna template different parameters initial concentrations dna template initial percentage allele compared another num
0.2476838.9328480.html.plaintext.txt	43	linear regressions necessary perform ratio percentage mann whitney u test performed using sas software release numnum sas institute inc cary nc usa references num saunders strittmatter wj schmechel d st george hyslop ph pericak vance ma joo sh rosi bl gusella jf crapper maclachlan dr alberts mj hulette c crain b goldgaber d roses ad num association apolipoprotein e allele epsisnum late onset familial sporadic alzheimers disease neurology num num num medline abstract
0.2476838.9328480.html.plaintext.txt	44	correspondence addressed inserm symb num institut pasteur de lille num rue de calmette num lille cedex france tel num num num num num num fax num num num num num num email marie christinechartier harlinpasteur lillefr page maintained oup admin last updated sat oct num numnumnum bst num part oup journals world wide web service copyright oxford university press num
0.2476838.9328480.html.plaintext.txt	45	correspondence addressed inserm symb num institut pasteur de lille num rue de calmette num lille cedex france tel num num num num num num fax num num num num num num email marie christinechartier harlinpasteur lillefr page maintained oup admin last updated sat oct num numnumnum bst num part oup journals world wide web service copyright oxford university press num
0.24991155.16154999.html.plaintext.txt	0	amyloid protein degraded cellular angiotensin converting enzyme ace elevated ace inhibitor matthew l hemming dennis j symb
0.24991155.16154999.html.plaintext.txt	1	center neurologic diseases brigham womens hospital harvard medical school boston massachusetts num
0.24991155.16154999.html.plaintext.txt	2	received publication august num num revised form september num num
0.24991155.16154999.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references human genetic data associated angiotensin converting enzyme ace alzheimer disease ad purified ace reported cleave synthetic amyloid protein vitro whether deficiency ace activity arising genetic alteration pharmacological inhibition decrease degradation allow accumulation intact cells unknown cloned ace human neuroblastoma cells showed posttranslational processing enzymatic activity typical endogenous protease cellular expression ace promoted degradation naturally secreted symb symb leading significant clearance species using site directed mutagenesis determined active sites within ace contribute clearance ace construct bearing mutations catalytic domain effect levels pharmacological inhibition ace widely prescribed drug captopril promoted accumulation cell derived media amyloid precursor protein expressing cells together results show ace lower levels secreted living cells effect blocked inhibiting proteases activity ace inhibitor work combined genetic studies supports hypothesis ace may modulate susceptibility progression ad via degradation data encourage analyses ace gene disease association raise question whether currently prescribed ace inhibitors could elevate cerebral levels humans
0.24991155.16154999.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references human genetic data associated angiotensin converting enzyme ace alzheimer disease ad purified ace reported cleave synthetic amyloid protein vitro whether deficiency ace activity arising genetic alteration pharmacological inhibition decrease degradation allow accumulation intact cells unknown cloned ace human neuroblastoma cells showed posttranslational processing enzymatic activity typical endogenous protease cellular expression ace promoted degradation naturally secreted symb symb leading significant clearance species using site directed mutagenesis determined active sites within ace contribute clearance ace construct bearing mutations catalytic domain effect levels pharmacological inhibition ace widely prescribed drug captopril promoted accumulation cell derived media amyloid precursor protein expressing cells together results show ace lower levels secreted living cells effect blocked inhibiting proteases activity ace inhibitor work combined genetic studies supports hypothesis ace may modulate susceptibility progression ad via degradation data encourage analyses ace gene disease association raise question whether currently prescribed ace inhibitors could elevate cerebral levels humans
0.24991155.16154999.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references early pathogenically important feature alzheimer disease adnum progressive accumulation deposition amyloid protein brain regions serving memory cognition biochemical cell biological animal modeling genetic emerging clinical data suggest upstream initiator disease process associated neuropathology num num although proven disease modifying treatments currently available recent efforts treat ad focused decreasing production enhancing clearance brain one little studied approach clearance augmenting degradation peptide various proteases expressed brain thus far metalloproteases neprilysin nep num insulin degrading enzyme ide num endothelin converting enzymes num num num implicated degrading proteases mammalian brain serine protease plasmin implicated degradation vitro num although genetic plasmin deficiency promote accumulation murine vivo num supporting role therapeutic regulation degrading proteases overexpression ide nep murine model ad decreased cerebral levels produced significant attenuation associated neuropathology num
0.24991155.16154999.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references early pathogenically important feature alzheimer disease adnum progressive accumulation deposition amyloid protein brain regions serving memory cognition biochemical cell biological animal modeling genetic emerging clinical data suggest upstream initiator disease process associated neuropathology num num although proven disease modifying treatments currently available recent efforts treat ad focused decreasing production enhancing clearance brain one little studied approach clearance augmenting degradation peptide various proteases expressed brain thus far metalloproteases neprilysin nep num insulin degrading enzyme ide num endothelin converting enzymes num num num implicated degrading proteases mammalian brain serine protease plasmin implicated degradation vitro num although genetic plasmin deficiency promote accumulation murine vivo num supporting role therapeutic regulation degrading proteases overexpression ide nep murine model ad decreased cerebral levels produced significant attenuation associated neuropathology num
0.24991155.16154999.html.plaintext.txt	7	somatic angiotensin converting enzyme ace zinc metalloprotease containing two homologous regions termed n c domains proteolytically active num ace single transmembrane domain cleaved cell surface low rate resulting secretion ectodomain media cultured cells plasma num num ace intensively characterized role regulation blood pressure cleaving angiotensin angiotensin ii inactivating bradykinin num function ace modulated pharmacologically ace inhibitors bind competitively active site zinc prevent substrate hydrolysis commonly prescribed class drugs used treatment hypertension disorders addition regulating vasoactive peptides ace shows broad substrate specificity including several neuropeptides able metabolize substrates using exopeptidase endopeptidase activities num interestingly despite homology n c domains display differential capacity degrade substrates inhibited selectively certain ace inhibitors num num recently ace found participate c jun n terminal kinase signal transduction pathway apparently independently proteolytic function num
0.24991155.16154999.html.plaintext.txt	8	somatic angiotensin converting enzyme ace zinc metalloprotease containing two homologous regions termed n c domains proteolytically active num ace single transmembrane domain cleaved cell surface low rate resulting secretion ectodomain media cultured cells plasma num num ace intensively characterized role regulation blood pressure cleaving angiotensin angiotensin ii inactivating bradykinin num function ace modulated pharmacologically ace inhibitors bind competitively active site zinc prevent substrate hydrolysis commonly prescribed class drugs used treatment hypertension disorders addition regulating vasoactive peptides ace shows broad substrate specificity including several neuropeptides able metabolize substrates using exopeptidase endopeptidase activities num interestingly despite homology n c domains display differential capacity degrade substrates inhibited selectively certain ace inhibitors num num recently ace found participate c jun n terminal kinase signal transduction pathway apparently independently proteolytic function num
0.24991155.16154999.html.plaintext.txt	9	potential relationship ace ad first suggested human genetic studies reported insertion ideletion d polymorphism within intron num ace gene associates ad num specifically allele associated increased risk ad whereas d allele associated protection num num potential mechanistic relevance inheritance d allele associated increased plasma ace levels num regarding disease specificity allele found associate positively ad vascular dementia vascular pathology num num ii genotype also linked smaller volumes hippocampus amygdala num importantly post mortem analyses ad patients determined ii genotype trend toward increased brain symb load compared dd genotype num single nucleotide polymorphisms ace gene also shown associate ad decrease prevalence ad susceptible genotype increased age consistent modulation longevity num
0.24991155.16154999.html.plaintext.txt	10	potential relationship ace ad first suggested human genetic studies reported insertion ideletion d polymorphism within intron num ace gene associates ad num specifically allele associated increased risk ad whereas d allele associated protection num num potential mechanistic relevance inheritance d allele associated increased plasma ace levels num regarding disease specificity allele found associate positively ad vascular dementia vascular pathology num num ii genotype also linked smaller volumes hippocampus amygdala num importantly post mortem analyses ad patients determined ii genotype trend toward increased brain symb load compared dd genotype num single nucleotide polymorphisms ace gene also shown associate ad decrease prevalence ad susceptible genotype increased age consistent modulation longevity num
0.24991155.16154999.html.plaintext.txt	11	post mortem studies patients ad found elevated levels ace temporal cortex specifically within pyramidal cortical neurons num num well significantly increased ace activity medial hippocampus parahippocampal gyrus frontal cortex caudate nucleus num mechanistic link ace ad suggested affinity purified ace shown degrade synthetic num num symb symb bond vitro producing truncated num residue peptide exhibited decreased aggregation cytotoxic potential num
0.24991155.16154999.html.plaintext.txt	12	post mortem studies patients ad found elevated levels ace temporal cortex specifically within pyramidal cortical neurons num num well significantly increased ace activity medial hippocampus parahippocampal gyrus frontal cortex caudate nucleus num mechanistic link ace ad suggested affinity purified ace shown degrade synthetic num num symb symb bond vitro producing truncated num residue peptide exhibited decreased aggregation cytotoxic potential num
0.24991155.16154999.html.plaintext.txt	13	plausible interpretation genetic neuropathological biochemical findings ace implicated ad via direct proteolysis peptide modulating levels within brain hypothesis suggests reduced ace activity either genetic mechanisms chronic pharmacological inhibition could increase cerebral levels symb andor symb thus presumably increase risk developing ad andor contribute progression address hypothesis intact living cells cloned characterized human neural ace determined role clearance secreted awe demonstrate ace promotes clearance naturally produced symb symb leads secondary degradation species using site directed mutagenesis context full length enzyme show n c domains ace capable promoting degradation similar capacity finally demonstrate treatment secreting cells commonly prescribed ace inhibitor prevents ace mediated clearance results accumulation peptide
0.24991155.16154999.html.plaintext.txt	14	plausible interpretation genetic neuropathological biochemical findings ace implicated ad via direct proteolysis peptide modulating levels within brain hypothesis suggests reduced ace activity either genetic mechanisms chronic pharmacological inhibition could increase cerebral levels symb andor symb thus presumably increase risk developing ad andor contribute progression address hypothesis intact living cells cloned characterized human neural ace determined role clearance secreted awe demonstrate ace promotes clearance naturally produced symb symb leads secondary degradation species using site directed mutagenesis context full length enzyme show n c domains ace capable promoting degradation similar capacity finally demonstrate treatment secreting cells commonly prescribed ace inhibitor prevents ace mediated clearance results accumulation peptide
0.24991155.16154999.html.plaintext.txt	15	materials methods top abstract introduction materials methods results discussion references cloning ace creation active site mutants numnum kb ace cdna obtained reverse transcription pcr rna isolated human neuroblastoma cell line sk n sh num num end primers used amplify sequence num ggaagcttgccgagcaccgcgcaccgc num num cagtgttcccatcccagtct num respectively coding region contains full length ace protein including signal peptide n c catalytic domains transmembrane domain cytoplasmic c terminus fig numb neurally derived ace cdna cloned symbfrt expression vector confirmed dna sequencing identical reported human ace cdna sequence full length ace cdna used template oligonucleotide directed mutagenesis quikchange xl site directed mutagenesis kit stratagene generate catalytically inactive ace constructs two ace zinc metalloprotease active site glutamates amino acids num c domain num n domain changed aspartates using following primers symb num ccacagtgcaccatgacatgggccatatacag num forward num actgtatatggcccatgtcatggtgcactgtgg num reverse symb num ggcccaccacgacatgggccacatc num forward num gatgtggcccatgtcgtggtgggcc num reverse mutant constructs cloned symbfrt screened dna sequencing ensure mutations occurred four constructs thus generated n domain mutant c domain mutant combined n c domain mutant wild type enzyme expression plasmids characterized restriction digestion dna sequencing entire ace cdna ha tagged ide construct symbfrt vector previously described num
0.24991155.16154999.html.plaintext.txt	16	materials methods top abstract introduction materials methods results discussion references cloning ace creation active site mutants numnum kb ace cdna obtained reverse transcription pcr rna isolated human neuroblastoma cell line sk n sh num num end primers used amplify sequence num ggaagcttgccgagcaccgcgcaccgc num num cagtgttcccatcccagtct num respectively coding region contains full length ace protein including signal peptide n c catalytic domains transmembrane domain cytoplasmic c terminus fig numb neurally derived ace cdna cloned symbfrt expression vector confirmed dna sequencing identical reported human ace cdna sequence full length ace cdna used template oligonucleotide directed mutagenesis quikchange xl site directed mutagenesis kit stratagene generate catalytically inactive ace constructs two ace zinc metalloprotease active site glutamates amino acids num c domain num n domain changed aspartates using following primers symb num ccacagtgcaccatgacatgggccatatacag num forward num actgtatatggcccatgtcatggtgcactgtgg num reverse symb num ggcccaccacgacatgggccacatc num forward num gatgtggcccatgtcgtggtgggcc num reverse mutant constructs cloned symbfrt screened dna sequencing ensure mutations occurred four constructs thus generated n domain mutant c domain mutant combined n c domain mutant wild type enzyme expression plasmids characterized restriction digestion dna sequencing entire ace cdna ha tagged ide construct symbfrt vector previously described num
0.24991155.16154999.html.plaintext.txt	17	cell culture chinese hamster ovary cho human embryonic kidney num symb cells grown dulbeccos modified eagles medium containing num fetal bovine serum num mm l glutamine num microgml penicillin num microgml streptomycin symb cells stably expressing symb bearing symbsymb swedish ad causing mutation num selected medium containing num microgml symb cho cells stably transfected symb symb ad causing mutation pfrtlaczeo construct enabling flp intm invitrogen competence grown num microgml symb num microgml zeocin successful genomic recombination symbfrt constructs occurred flp host cells lost zeocin resistance selected num microgml hygromycin b effects capoten captopril sigma assayed num h preincubation cells drug followed num h conditioning period cells grown serum free dulbeccos modified eagles medium invitrogen captopril
0.24991155.16154999.html.plaintext.txt	18	cell culture chinese hamster ovary cho human embryonic kidney num symb cells grown dulbeccos modified eagles medium containing num fetal bovine serum num mm l glutamine num microgml penicillin num microgml streptomycin symb cells stably expressing symb bearing symbsymb swedish ad causing mutation num selected medium containing num microgml symb cho cells stably transfected symb symb ad causing mutation pfrtlaczeo construct enabling flp intm invitrogen competence grown num microgml symb num microgml zeocin successful genomic recombination symbfrt constructs occurred flp host cells lost zeocin resistance selected num microgml hygromycin b effects capoten captopril sigma assayed num h preincubation cells drug followed num h conditioning period cells grown serum free dulbeccos modified eagles medium invitrogen captopril
0.24991155.16154999.html.plaintext.txt	19	expression cloned constructs cho symb cells transient transfections cho symb cell lines performed using geneporter num gts expression assayed num num h posttransfection cho cell lines stably expressing symb symb mutation either empty vector ace mutant ace constructs generated using flp intm system invitrogen allowed stable integration construct genomic locus single cell line
0.24991155.16154999.html.plaintext.txt	20	expression cloned constructs cho symb cells transient transfections cho symb cell lines performed using geneporter num gts expression assayed num num h posttransfection cho cell lines stably expressing symb symb mutation either empty vector ace mutant ace constructs generated using flp intm system invitrogen allowed stable integration construct genomic locus single cell line
0.24991155.16154999.html.plaintext.txt	21	immunoblotting cells tissue lysed num mm tris hcl ph numnum num mm nacl num nonidet p num protease inhibitor mixture roche applied science num mm numnum phenanthroline num mm edta extracts centrifuged numnum x g num min remove nuclei protein concentrations determined using bicinchoninic acid based assay pierce samples subject sds page western blotting ace detected using polyclonal antibody raised amino acids num num human ace sc num santa cruz biotechnology inc full length human app detected using numsymb reactive app num num symb gift p seubert app symb symb c terminal fragments detected using polyclonal antibody symb specific residues num num symb total cellular ide detected using polyclonal ide num raised amino acids num num human ide num ha tagged ide detected using anti ha monoclonal numsymb roche applied science deglycosylation performed using peptide n glycosidase f remove n linked sugars mixture o deglycosylating enzymes sialidase o glycanase num num galactosidase n acetylglucosaminidase prozyme western blots probed anti mouse anti rat anti rabbit secondary antibodies conjugated alexa fluor num molecular probes inc eugene irdye num rockland immunochemicals blots detected bands sized quantified using odyssey infrared imaging system li cor
0.24991155.16154999.html.plaintext.txt	22	immunoblotting cells tissue lysed num mm tris hcl ph numnum num mm nacl num nonidet p num protease inhibitor mixture roche applied science num mm numnum phenanthroline num mm edta extracts centrifuged numnum x g num min remove nuclei protein concentrations determined using bicinchoninic acid based assay pierce samples subject sds page western blotting ace detected using polyclonal antibody raised amino acids num num human ace sc num santa cruz biotechnology inc full length human app detected using numsymb reactive app num num symb gift p seubert app symb symb c terminal fragments detected using polyclonal antibody symb specific residues num num symb total cellular ide detected using polyclonal ide num raised amino acids num num human ide num ha tagged ide detected using anti ha monoclonal numsymb roche applied science deglycosylation performed using peptide n glycosidase f remove n linked sugars mixture o deglycosylating enzymes sialidase o glycanase num num galactosidase n acetylglucosaminidase prozyme western blots probed anti mouse anti rat anti rabbit secondary antibodies conjugated alexa fluor num molecular probes inc eugene irdye num rockland immunochemicals blots detected bands sized quantified using odyssey infrared imaging system li cor
0.24991155.16154999.html.plaintext.txt	23	ace activity assay ace proteolytic activity assayed using substrate hippuryl l histidyl l leucine hip leu sigma described previously num several modifications cells lysed num mm tris ph numnum containing numnum nonidet p num nuclei cell debris pelleted numnum x g num min assay ace activity numnum microg cell lysate incubated num mm hip leu numnum m sodium borate buffer ph numnum numnum m nacl total volume num microl num num min num degrees c assaying samples captopril num min preincubation drug performed num degrees c substrate addition time num values calculated addition edta final concentration num mm prior addition hip leu enzymatic reactions terminated addition edta num mm final concentration samples developed first addition num microl numnum m naoh followed num min room temperature incubation num microl num mgml o phthaldialdehyde sigma reaction terminated acidification num microl num n hcl fluorescence liberated o phthaldialdehyde modified leu assayed num well plate format using symb multilabel plate reader excitation num emission num perkinelmer life sciences num degradation defined maximal fluorescence signal achieved digestion num mm hip leu numnum microg ace transfected cell lysate num min
0.24991155.16154999.html.plaintext.txt	24	ace activity assay ace proteolytic activity assayed using substrate hippuryl l histidyl l leucine hip leu sigma described previously num several modifications cells lysed num mm tris ph numnum containing numnum nonidet p num nuclei cell debris pelleted numnum x g num min assay ace activity numnum microg cell lysate incubated num mm hip leu numnum m sodium borate buffer ph numnum numnum m nacl total volume num microl num num min num degrees c assaying samples captopril num min preincubation drug performed num degrees c substrate addition time num values calculated addition edta final concentration num mm prior addition hip leu enzymatic reactions terminated addition edta num mm final concentration samples developed first addition num microl numnum m naoh followed num min room temperature incubation num microl num mgml o phthaldialdehyde sigma reaction terminated acidification num microl num n hcl fluorescence liberated o phthaldialdehyde modified leu assayed num well plate format using symb multilabel plate reader excitation num emission num perkinelmer life sciences num degradation defined maximal fluorescence signal achieved digestion num mm hip leu numnum microg ace transfected cell lysate num min
0.24991155.16154999.html.plaintext.txt	25	enzyme linked immunosorbant assay conditioned medium samples harvested removing cellular debris centrifugation num x g num min protease inhibitors added final concentration num microgml leupeptin num microgml aprotinin num microgml pepstatin num mm numnum phenanthroline num mm edta elisas performed previously described num following modifications num well elisa plates costar coated numnum microgml capture antibody num num num num measured capturing antibodies specific c terminal num numsymb num numsymb residues captured detected numnum microgml biotinylated numsymb specific residues num num n terminus elisas measuring x num x num forms captured identically numsymb numsymb detected numnum microgml biotinylated num specific residues num num total measured capture antibody num detection numnum microgml biotinylated numsymb antibodies gift elan pharmaceuticals san francisco ca elisa development accomplished incubating bound biotinylated detection antibody avidin horseradish peroxidase vector followed tetramethylbenzidine elisa pierce plates washed three times num min incubation tris buffered saline numnum tween num
0.24991155.16154999.html.plaintext.txt	26	enzyme linked immunosorbant assay conditioned medium samples harvested removing cellular debris centrifugation num x g num min protease inhibitors added final concentration num microgml leupeptin num microgml aprotinin num microgml pepstatin num mm numnum phenanthroline num mm edta elisas performed previously described num following modifications num well elisa plates costar coated numnum microgml capture antibody num num num num measured capturing antibodies specific c terminal num numsymb num numsymb residues captured detected numnum microgml biotinylated numsymb specific residues num num n terminus elisas measuring x num x num forms captured identically numsymb numsymb detected numnum microgml biotinylated num specific residues num num total measured capture antibody num detection numnum microgml biotinylated numsymb antibodies gift elan pharmaceuticals san francisco ca elisa development accomplished incubating bound biotinylated detection antibody avidin horseradish peroxidase vector followed tetramethylbenzidine elisa pierce plates washed three times num min incubation tris buffered saline numnum tween num
0.24991155.16154999.html.plaintext.txt	27	statistical analyses data analyzed using one way analysis variance tukeys post hoc comparison two way analysis variance bonferroni post hoc comparison appropriate calculated comparisons p numnum considered significant
0.24991155.16154999.html.plaintext.txt	28	statistical analyses data analyzed using one way analysis variance tukeys post hoc comparison two way analysis variance bonferroni post hoc comparison appropriate calculated comparisons p numnum considered significant
0.24991155.16154999.html.plaintext.txt	29	results top abstract introduction materials methods results discussion references expression characterization transfected human ace determine regional distribution ace within brain first dissected several murine brain peripheral tissues assess relative ace content particularly ad relevant brain regions previously reported found ace highly expressed kidney lung absent liver num brain observed similar expression ace protein cerebral cortex hippocampus cerebellum basal gangliabrainstem fig numa ace brain regions found electrophorese two distinct bands consisting typical full length num kda species higher molecular weight species latter reported arise alternative glycosylation ace brain num
0.24991155.16154999.html.plaintext.txt	30	results top abstract introduction materials methods results discussion references expression characterization transfected human ace determine regional distribution ace within brain first dissected several murine brain peripheral tissues assess relative ace content particularly ad relevant brain regions previously reported found ace highly expressed kidney lung absent liver num brain observed similar expression ace protein cerebral cortex hippocampus cerebellum basal gangliabrainstem fig numa ace brain regions found electrophorese two distinct bands consisting typical full length num kda species higher molecular weight species latter reported arise alternative glycosylation ace brain num
0.24991155.16154999.html.plaintext.txt	31	characterize ace cellular level cloned full length numnum kb cdna human neuroblastoma cell line sk n sh ace cdna cloned mammalian expression vector symbfrt shown conform reported human ace sequence restriction mapping dna sequencing transient transfection ace construct cho symb cells yielded indistinguishable results assays performed fig num neither cell line expressed detectable endogenous levels ace protein western blotting although ace mrna detected symb cells reverse transcription pcr data shown
0.24991155.16154999.html.plaintext.txt	32	characterize ace cellular level cloned full length numnum kb cdna human neuroblastoma cell line sk n sh ace cdna cloned mammalian expression vector symbfrt shown conform reported human ace sequence restriction mapping dna sequencing transient transfection ace construct cho symb cells yielded indistinguishable results assays performed fig num neither cell line expressed detectable endogenous levels ace protein western blotting although ace mrna detected symb cells reverse transcription pcr data shown
0.24991155.16154999.html.plaintext.txt	33	ace predicted contain num n type glycosylation sites o type glycosylation sites determine whether transfected ace protein processed similarly tissue derived ace compared glycosylation patterns mouse kidney tissue ace ace transfected either cho symb cells expected deglycosylation several enzymes specific o linked sugars produced shift ace size whereas removal n linked modifications yielded shift ace protein num num kda fig numa ace known secreted vivo vitro cell surface low levels secretase dependent manner num concentration conditioned medium symb cho cells transiently transfected ace cdna found contain low levels ace protein whereas control cells transfected empty vector corresponding signal fig numb
0.24991155.16154999.html.plaintext.txt	34	ace predicted contain num n type glycosylation sites o type glycosylation sites determine whether transfected ace protein processed similarly tissue derived ace compared glycosylation patterns mouse kidney tissue ace ace transfected either cho symb cells expected deglycosylation several enzymes specific o linked sugars produced shift ace size whereas removal n linked modifications yielded shift ace protein num num kda fig numa ace known secreted vivo vitro cell surface low levels secretase dependent manner num concentration conditioned medium symb cho cells transiently transfected ace cdna found contain low levels ace protein whereas control cells transfected empty vector corresponding signal fig numb
0.24991155.16154999.html.plaintext.txt	35	view larger version numk figure num brain distribution schematic diagram angiotensin converting enzyme num microg murine tissue homogenates designated brain regions well peripheral tissues known lack highly express ace probed western blotting ace specific antibody note brain ace occurs doublet arising alternate glycosylation asterisk indicates nonspecific band detected liver previously reported num b schematic representation human full length ace protein wild type enzyme contains signal peptide sp two homologous catalytic domains gray boxes single transmembrane segment tm small c terminal cytoplasmic tail metalloprotease catalytic sequence domain indicated corresponding amino acid numbering first n terminal residue mature protein
0.24991155.16154999.html.plaintext.txt	36	view larger version numk figure num brain distribution schematic diagram angiotensin converting enzyme num microg murine tissue homogenates designated brain regions well peripheral tissues known lack highly express ace probed western blotting ace specific antibody note brain ace occurs doublet arising alternate glycosylation asterisk indicates nonspecific band detected liver previously reported num b schematic representation human full length ace protein wild type enzyme contains signal peptide sp two homologous catalytic domains gray boxes single transmembrane segment tm small c terminal cytoplasmic tail metalloprotease catalytic sequence domain indicated corresponding amino acid numbering first n terminal residue mature protein
0.24991155.16154999.html.plaintext.txt	37	determine whether transfected ace enzymatically active incubated lysates cells transiently transfected ace empty vector commonly used synthetic ace substrate hip leu standard assay conditions num mm substrate numnum microg cell lysate numnum m sodium borate buffer numnum m nacl ph numnum num min num degrees c lysates cells transfected ace exhibited robust degradation hip leu completely blocked num microm concentration competitive ace inhibitor captopril contrast lysates cells transfected empty vector detectable ace activity fig numc taken together results demonstrate cloned transfected ace construct processed similarly tissue ace retains proteolytic activity sensitivity ace inhibitors
0.24991155.16154999.html.plaintext.txt	38	transiently expressed ace promotes clearance secondary degradation determine whether ace modulate levels intact living cells transiently transfected equal dna amounts plasmids encoding either empty vector ide ace symbfrt symb cells stably expressing human symb bearing swedish ad causing mutation measured levels resulting conditioned medium transfection ha tagged ide served positive control proteolysis since shown lower cultured cells num num using elisa specific num num num num ide found reduce cell derived levels num num respectively control cells transfected empty vector p numnum comparisons transfections ace yielded similar results reducing num num levels num num num levels num control p numnum num num p numnum num num fig numa thus ace ide transfected cells significantly reduced levels principal species compared control significantly different
0.24991155.16154999.html.plaintext.txt	39	transiently expressed ace promotes clearance secondary degradation determine whether ace modulate levels intact living cells transiently transfected equal dna amounts plasmids encoding either empty vector ide ace symbfrt symb cells stably expressing human symb bearing swedish ad causing mutation measured levels resulting conditioned medium transfection ha tagged ide served positive control proteolysis since shown lower cultured cells num num using elisa specific num num num num ide found reduce cell derived levels num num respectively control cells transfected empty vector p numnum comparisons transfections ace yielded similar results reducing num num levels num num num levels num control p numnum num num p numnum num num fig numa thus ace ide transfected cells significantly reduced levels principal species compared control significantly different
0.24991155.16154999.html.plaintext.txt	40	view larger version numk figure num characterization processing enzymatic activity cloned human ace lysates mouse kidney cho cells transiently transfected ace cdna construct subjected deglycosylation enzymes specific n o linked sugars subject western blot analysis ace specific antibody asterisk indicates calculated molecular weight deglycosylated band b conditioned medium cho cells transiently transfected ace empty vector concentrated analyzed western blot reflecting low rate ace ectodomain secretion sace previously reported num c ace enzymatic activity measured incubating numnum microg lysate symb cells transfected indicated constructs num mm substrate hip leu num min num degrees c num degradation defined maximal fluorescence produced num min substrate incubation numnum microg lysate cells transfected ace cdna values c represent means plus minus se obtained four independent experiments blot b representative least four independent experiments deglycosylation secretion enzymatic activity assays identical transfected cho symb cell lines
0.24991155.16154999.html.plaintext.txt	41	view larger version numk figure num characterization processing enzymatic activity cloned human ace lysates mouse kidney cho cells transiently transfected ace cdna construct subjected deglycosylation enzymes specific n o linked sugars subject western blot analysis ace specific antibody asterisk indicates calculated molecular weight deglycosylated band b conditioned medium cho cells transiently transfected ace empty vector concentrated analyzed western blot reflecting low rate ace ectodomain secretion sace previously reported num c ace enzymatic activity measured incubating numnum microg lysate symb cells transfected indicated constructs num mm substrate hip leu num min num degrees c num degradation defined maximal fluorescence produced num min substrate incubation numnum microg lysate cells transfected ace cdna values c represent means plus minus se obtained four independent experiments blot b representative least four independent experiments deglycosylation secretion enzymatic activity assays identical transfected cho symb cell lines
0.24991155.16154999.html.plaintext.txt	42	ace shown cleave symb symb vitro num hypothesized remaining fragment beginning symb might either accumulate undergo secondary degradation cellular context discriminate possibilities used elisa specific internal residues num num capture either num num c termini detection measured species denoted x num x num found ide decrease x num levels num x num levels num control cells p numnum x num p numnum x num ace mirrored reduction x num decreased num x num decreased num controls p numnum x num p numnum x num fig numb x num x num values ide ace significantly different control different thus human cell line transfected human cdnas encoding app either ide ace levels significantly reduced cell derived ace transfected cells showed greater secondary degradation peptide reported vitro num result suggests ace degrades additional sites cellular context andor species cleaved ace subsequently degraded cellular proteases transfection efficiency assayed western blot analysis fig numc whereas transfected constructs resulted robust expression total ide levels increased numnum fold endogenous ide fig numc bottom panel contrast detectable endogenous ace expressed symb cells fig numc top panel
0.24991155.16154999.html.plaintext.txt	43	ace shown cleave symb symb vitro num hypothesized remaining fragment beginning symb might either accumulate undergo secondary degradation cellular context discriminate possibilities used elisa specific internal residues num num capture either num num c termini detection measured species denoted x num x num found ide decrease x num levels num x num levels num control cells p numnum x num p numnum x num ace mirrored reduction x num decreased num x num decreased num controls p numnum x num p numnum x num fig numb x num x num values ide ace significantly different control different thus human cell line transfected human cdnas encoding app either ide ace levels significantly reduced cell derived ace transfected cells showed greater secondary degradation peptide reported vitro num result suggests ace degrades additional sites cellular context andor species cleaved ace subsequently degraded cellular proteases transfection efficiency assayed western blot analysis fig numc whereas transfected constructs resulted robust expression total ide levels increased numnum fold endogenous ide fig numc bottom panel contrast detectable endogenous ace expressed symb cells fig numc top panel
0.24991155.16154999.html.plaintext.txt	44	generation catalytically inactive ace mutants ace contains two homologous catalytic regions termed n c domains containing canonical zinc metalloprotease active site fig numb determine active site mediates clearance generated three ace mutant constructs two containing one functional catalytic domain one catalytically inactive enzyme bearing mutations sites mutations made site directed mutagenesis change active site sequence hemgh hdmgh conservative mutation previously shown inactivate ace proteolysis num c domain inactivated mutating ace glutamate residue num aspartate termed symb n domain similarly mutated changing glutamate residue num aspartate termed symb singly mutated constructs combined restriction digestion ligation form catalytically inactive double mutant symbsymb construct analyzed restriction digestion dna sequencing ensure mutations made outside produced site directed mutagenesis cloned symbfrt achieve identical levels cellular expression
0.24991155.16154999.html.plaintext.txt	45	cho cell line stably expressing human symb bearing ad causing symb mutation flp acceptor locus used make stable cell lines expressing wild type ace wtace symb symb symbsymb empty vector thus stable cell line contained app well one transfected constructs integrated genomic locus site directed recombination symbfrt vector cell lines designated app x x integrated construct resulting ace stable lines produced identical levels wtace mutant ace proteins well indistinguishable levels human app fig numa notably app empty vector line expressed estimated num higher level app four app ace lines fig numa middle panel presumably result modest cytomegalovirus promoter competition app ace constructs
0.24991155.16154999.html.plaintext.txt	46	cho cell line stably expressing human symb bearing ad causing symb mutation flp acceptor locus used make stable cell lines expressing wild type ace wtace symb symb symbsymb empty vector thus stable cell line contained app well one transfected constructs integrated genomic locus site directed recombination symbfrt vector cell lines designated app x x integrated construct resulting ace stable lines produced identical levels wtace mutant ace proteins well indistinguishable levels human app fig numa notably app empty vector line expressed estimated num higher level app four app ace lines fig numa middle panel presumably result modest cytomegalovirus promoter competition app ace constructs
0.24991155.16154999.html.plaintext.txt	47	symb symb symbsymb mutant proteins posttranslationally modified secreted similar levels wtace protein fig num b canonical enzymatic activity mutant constructs confirmed degradation substrate hip leu fig numc wtace symb proteins found degrade substrate similar rates whereas symb far reduced efficiency hydrolysis conforming published kinetic parameters active site hip leu num enzymatically inactive symbsymb wtace protein incubated num microm captopril produced detectable degradation product fig numc
0.24991155.16154999.html.plaintext.txt	48	view larger version numk figure num transfected human ace promotes clearance secondary degradation cell derived human symb symb symb cells stably transfected human symb bearing ad causing swedish mutation transiently transfected empty vector well characterized degrading protease ide ace media conditioned cells num h levels determined elisa specific intact species beginning residue num ending either residue num solid barsor num hatched bars elisa specific middle region peptide residues num num denoted x either residue num solid bars num hatched bars b data represent means plus minus se num num independent experiments measured duplicate values normalized empty vector allow combination data sets compared empty vector p numnum p numnum p numnum c immunoblots transient transfections symb cells ace ide panels indicate total cellular expression protein whereas ha ide panel indicates expression tagged ide construct immunoblot representative least four independent experiments
0.24991155.16154999.html.plaintext.txt	49	view larger version numk figure num transfected human ace promotes clearance secondary degradation cell derived human symb symb symb cells stably transfected human symb bearing ad causing swedish mutation transiently transfected empty vector well characterized degrading protease ide ace media conditioned cells num h levels determined elisa specific intact species beginning residue num ending either residue num solid barsor num hatched bars elisa specific middle region peptide residues num num denoted x either residue num solid bars num hatched bars b data represent means plus minus se num num independent experiments measured duplicate values normalized empty vector allow combination data sets compared empty vector p numnum p numnum p numnum c immunoblots transient transfections symb cells ace ide panels indicate total cellular expression protein whereas ha ide panel indicates expression tagged ide construct immunoblot representative least four independent experiments
0.24991155.16154999.html.plaintext.txt	50	n c domains ace promote degradation determine effects ace active site levels conditioned medium doubly stable line analyzed total content elisa normalizing values app empty vector condition app content significant difference levels app empty vector catalytically inactive app symbsymb n c catalytic domains ace found decrease cell derived levels quantitatively similar degree wtace symb reduced levels num symb num wtace num app empty vector condition fig numd single mutants wtace enzymes significantly different app empty vector p numnum significantly different differences content could ascribed ace enzyme altering levels secretase generated app c terminal fragments since symb symb significantly changed compared app empty vector fig numa bottom panel thus using conservative mutations inactivate ace catalytic domains experiments demonstrate n c domains capable mediating clearance naturally produced cell derived intact cells
0.24991155.16154999.html.plaintext.txt	51	n c domains ace promote degradation determine effects ace active site levels conditioned medium doubly stable line analyzed total content elisa normalizing values app empty vector condition app content significant difference levels app empty vector catalytically inactive app symbsymb n c catalytic domains ace found decrease cell derived levels quantitatively similar degree wtace symb reduced levels num symb num wtace num app empty vector condition fig numd single mutants wtace enzymes significantly different app empty vector p numnum significantly different differences content could ascribed ace enzyme altering levels secretase generated app c terminal fragments since symb symb significantly changed compared app empty vector fig numa bottom panel thus using conservative mutations inactivate ace catalytic domains experiments demonstrate n c domains capable mediating clearance naturally produced cell derived intact cells
0.24991155.16154999.html.plaintext.txt	52	levels increased ace inhibition determine whether decreasing ace activity small molecule inhibitor could elevate cell derived levels preincubated cells num h presence prototypical ace inhibitor captopril conditioned media num h presence drug increasing doses captopril tested resulting conditioned media analyzed elisa total content values normalized cell line drug treatment captopril found significant effect levels catalytically inactive app symbsymb cell line expected contrast captopril treated app wtace cells accumulated nearly num fold untreated cells drug concentrations num microm p numnum numnum microm captopril lowest concentration tested levels elevated numnum fold app wtace cells compared cell line without drug p numnum results demonstrate widely prescribed ace inhibitor promote accumulation natural cell derived blocking ace proteolytic activity
0.24991155.16154999.html.plaintext.txt	53	levels increased ace inhibition determine whether decreasing ace activity small molecule inhibitor could elevate cell derived levels preincubated cells num h presence prototypical ace inhibitor captopril conditioned media num h presence drug increasing doses captopril tested resulting conditioned media analyzed elisa total content values normalized cell line drug treatment captopril found significant effect levels catalytically inactive app symbsymb cell line expected contrast captopril treated app wtace cells accumulated nearly num fold untreated cells drug concentrations num microm p numnum numnum microm captopril lowest concentration tested levels elevated numnum fold app wtace cells compared cell line without drug p numnum results demonstrate widely prescribed ace inhibitor promote accumulation natural cell derived blocking ace proteolytic activity
0.24991155.16154999.html.plaintext.txt	54	discussion top abstract introduction materials methods results discussion references experiments demonstrate ace expression leads cleavage amyloid protein cellular context ace promotes degradation naturally produced symb symb investigating role n c domains ace clearance site directed mutagenesis used conservative inactivating mutation ace metalloprotease active site found domains responsible clearance data support role putative signal transduction mechanism ace num lowering since overexpressing proteolytically inactive form ace produced change levels compared vector alone finally show captopril widely prescribed ace inhibitor promotes accumulation media cells expressing human app ace
0.24991155.16154999.html.plaintext.txt	55	discussion top abstract introduction materials methods results discussion references experiments demonstrate ace expression leads cleavage amyloid protein cellular context ace promotes degradation naturally produced symb symb investigating role n c domains ace clearance site directed mutagenesis used conservative inactivating mutation ace metalloprotease active site found domains responsible clearance data support role putative signal transduction mechanism ace num lowering since overexpressing proteolytically inactive form ace produced change levels compared vector alone finally show captopril widely prescribed ace inhibitor promotes accumulation media cells expressing human app ace
0.24991155.16154999.html.plaintext.txt	56	reported recently n domain ace c domain responsible degradation synthetic symb vitro num study ace catalytic domains cloned isolation producing recombinant truncation proteins bearing one ace active site contrast find n c domains ace able degrade naturally produced cellular context studies used conservative mutations inactivate catalytic domain molecule conserving overall structure sequence full length protein possible c domain able degrade intact cells vitro evidence catalytic domain ace regulates activity num suggesting full length protein required normal substrate recognition degradation c domain expressed outside context full length enzyme may retain tertiary structure required degrade larger substrates whereas much smaller substrates still processed num unlikely incomplete inactivation n domain symb mutant enzyme could account observed decrease domains inactivated symbsymb ace construct observe change levels compared empty vector control
0.24991155.16154999.html.plaintext.txt	57	reported recently n domain ace c domain responsible degradation synthetic symb vitro num study ace catalytic domains cloned isolation producing recombinant truncation proteins bearing one ace active site contrast find n c domains ace able degrade naturally produced cellular context studies used conservative mutations inactivate catalytic domain molecule conserving overall structure sequence full length protein possible c domain able degrade intact cells vitro evidence catalytic domain ace regulates activity num suggesting full length protein required normal substrate recognition degradation c domain expressed outside context full length enzyme may retain tertiary structure required degrade larger substrates whereas much smaller substrates still processed num unlikely incomplete inactivation n domain symb mutant enzyme could account observed decrease domains inactivated symbsymb ace construct observe change levels compared empty vector control
0.24991155.16154999.html.plaintext.txt	58	view larger version numk figure num cell derived degraded n c domains ace elevated ace inhibition cho cells stably transfected human symb bearing symb ad causing missense mutation either empty vector human wild type ace indicated ace mutant constructs immunoblots showing expression ace app app c terminal fragments stable cell lines note slightly higher expression human app happ app empty vector line resulting presumably modest cytomegalovirus promoter competition app ace constructs immunoblots representative least four independent determinations b conditioned medium stable lines concentrated probed presence secreted ace sace protein c ace activity assay incubating numnum microg cell lysate num mm hip leu indicated time points num degrees c values represent means plus minus se obtained num num independent experiments d cell lines conditioned num h media harvested probed elisa total content due elevated app expression values app empty vector condition normalized app expression app ace doubly stable lines data represent means plus minus se seven independent experiments measured duplicate values normalized app empty vector allow combination data sets p numnum compared empty vector e fold change content conditioned medium app wtace app symbsymb cell lines num h pretreatment num h conditioning presence captopril data point normalized untreated cells num microm captopril doubly transfected cell line data represent means plus minus se four independent experiments measured duplicate ace compared symbsymb dose p numnum p numnum p numnum
0.24991155.16154999.html.plaintext.txt	59	view larger version numk figure num cell derived degraded n c domains ace elevated ace inhibition cho cells stably transfected human symb bearing symb ad causing missense mutation either empty vector human wild type ace indicated ace mutant constructs immunoblots showing expression ace app app c terminal fragments stable cell lines note slightly higher expression human app happ app empty vector line resulting presumably modest cytomegalovirus promoter competition app ace constructs immunoblots representative least four independent determinations b conditioned medium stable lines concentrated probed presence secreted ace sace protein c ace activity assay incubating numnum microg cell lysate num mm hip leu indicated time points num degrees c values represent means plus minus se obtained num num independent experiments d cell lines conditioned num h media harvested probed elisa total content due elevated app expression values app empty vector condition normalized app expression app ace doubly stable lines data represent means plus minus se seven independent experiments measured duplicate values normalized app empty vector allow combination data sets p numnum compared empty vector e fold change content conditioned medium app wtace app symbsymb cell lines num h pretreatment num h conditioning presence captopril data point normalized untreated cells num microm captopril doubly transfected cell line data represent means plus minus se four independent experiments measured duplicate ace compared symbsymb dose p numnum p numnum p numnum
0.24991155.16154999.html.plaintext.txt	60	growing genetic evidence suggests ace potential risk factor ad writing approximately num published studies examined relationship majority finding significant association ace genotype ad post mortem analysis ad brain tissue shown significant elevation ace protein compared control num perhaps representing regulation clearance mechanism interestingly initiation ace mediated signal transduction substrates shown regulate enzymes expression via c jun n terminal kinase pathway num num feedback system provides hypothetical mechanism ace could modulate expression depending levels substrate leading elevated levels ace ad cortex
0.24991155.16154999.html.plaintext.txt	61	growing genetic evidence suggests ace potential risk factor ad writing approximately num published studies examined relationship majority finding significant association ace genotype ad post mortem analysis ad brain tissue shown significant elevation ace protein compared control num perhaps representing regulation clearance mechanism interestingly initiation ace mediated signal transduction substrates shown regulate enzymes expression via c jun n terminal kinase pathway num num feedback system provides hypothetical mechanism ace could modulate expression depending levels substrate leading elevated levels ace ad cortex
0.24991155.16154999.html.plaintext.txt	62	observation ace inhibition cells expressing human app ace promotes accumulation secreted may bear clinical relevance given neurons produce app ace neuronal ace regulated ad num hypothesize chronic pharmacological inhibition ace could increase levels brain reducing ace dependent proteolysis studies yet examined consequence chronic ace inhibition levels brain plasma humans clinical trials ace inhibitors analyzed effects cognitive decline ad subjects results date inconclusive num num
0.24991155.16154999.html.plaintext.txt	63	observation ace inhibition cells expressing human app ace promotes accumulation secreted may bear clinical relevance given neurons produce app ace neuronal ace regulated ad num hypothesize chronic pharmacological inhibition ace could increase levels brain reducing ace dependent proteolysis studies yet examined consequence chronic ace inhibition levels brain plasma humans clinical trials ace inhibitors analyzed effects cognitive decline ad subjects results date inconclusive num num
0.24991155.16154999.html.plaintext.txt	64	studies effects ace deficiency overexpression metabolism vivo reported studies may problematic interpretation endogenous murine amino acid differences human peptide immediately surrounding putative site cleavage ace could affect properties substrate future vivo studies examine ace inhibition deficiency overexpression mice expressing human app may instructive regarding role ace alzheimer disease
0.24991155.16154999.html.plaintext.txt	65	studies effects ace deficiency overexpression metabolism vivo reported studies may problematic interpretation endogenous murine amino acid differences human peptide immediately surrounding putative site cleavage ace could affect properties substrate future vivo studies examine ace inhibition deficiency overexpression mice expressing human app may instructive regarding role ace alzheimer disease
0.24991155.16154999.html.plaintext.txt	66	context new findings earlier studies reviewed hypothesize decreased activity ace aged human brain originating either genetic polymorphisms pharmacological inhibition may promote accumulation thus modulate likelihood development alzheimer disease andor neuropathological severity findings suggest need analyses biological effects ace genetic deficiency ace pharmacological inhibition experimental models ad large human population currently experiencing chronic ace inhibition
0.24991155.16154999.html.plaintext.txt	67	context new findings earlier studies reviewed hypothesize decreased activity ace aged human brain originating either genetic polymorphisms pharmacological inhibition may promote accumulation thus modulate likelihood development alzheimer disease andor neuropathological severity findings suggest need analyses biological effects ace genetic deficiency ace pharmacological inhibition experimental models ad large human population currently experiencing chronic ace inhibition
0.24991155.16154999.html.plaintext.txt	68	footnotes work supported national institutes health grant symb d j predoctoral fellowship harvard center neurodegeneration repair m l h costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.24991155.16154999.html.plaintext.txt	69	num correspondence addressed harvard institutes medicine num num ave louis pasteur boston ma num tel num num num fax num num num e mail dselkoeatricsbwhharvardedu u d
0.24991155.16154999.html.plaintext.txt	70	num correspondence addressed harvard institutes medicine num num ave louis pasteur boston ma num tel num num num fax num num num e mail dselkoeatricsbwhharvardedu u d
0.24991155.16154999.html.plaintext.txt	71	num abbreviations used ad alzheimer disease ace angiotensin converting enzyme app amyloid precursor protein cho chinese hamster ovary symb human embryonic kidney num amyloid protein ide insulin degrading enzyme nep neprilysin elisa enzyme linked immunosorbant assay hip leu hippuryl l histidyl l leucine ace insertion d ace deletion wtace wild type ace ha hemagglutinin
0.24991155.16154999.html.plaintext.txt	72	acknowledgments thank w farris m lavoie young g shankar b zheng rappley technical advice discussions d walsh providing cho cell line stably transfected pfrtlaczeo vector flp system especially thank l lou r w hemming n l hemming support encouragement
0.24991155.16154999.html.plaintext.txt	73	references top abstract introduction materials methods results discussion references gilman koller m black r jenkins l griffith g fox n c eisner l kirby l rovira m b forette f orgogozo j m num neurology num num numabstractfree full text selkoe d j num ann intern med num num numfree full text walsh d m selkoe d j num neuron num num numcrossrefmedline order article via infotrieve hock c konietzko u streffer j r tracy j signorell muller tillmanns b lemke u henke k moritz e garcia e wollmer m umbricht d deq uervain d j hofmann m maddalena papassotiropoulos nitsch r m num neuron num num numcrossrefmedline order article via infotrieve iwata n tsubuki takaki y shirotani k lu b gerard n p gerard c hama e lee h j saido c num science num num numabstractfree full text farris w mansourian chang y lindsley l eckman e frosch m p eckman c b tanzi r e selkoe d j guenette num proc natl acad sci u num num numabstractfree full text eckman e watson m marlow l sambamurti k eckman c b num j biol chem num num numabstractfree full text tucker h m kihiko m caldwell j n wright kawarabayashi price d walker d scheff mcgillis j p rydel r e estus num j neurosci num num numabstractfree full text tucker h m simpson j kihiko ehmann m younkin l h mcgillis j p younkin g degen j l estus num neurosci lett num num numcrossrefmedline order article via infotrieve leissring m farris w chang y walsh d m wu x sun x frosch m p selkoe d j num neuron num num numcrossrefmedline order article via infotrieve wei l alhenc gelas f corvol p clauser e num j biol chem num num numabstractfree full text beldent v michaud wei l chauvet m corvol p num j biol chem num num numabstractfree full text balyasnikova v karran e h albrecht r f ii danilov m num biochem j num num numcrossrefmedline order article via infotrieve coates d num int j biochem cell biol num num numcrossrefmedline order article via infotrieve skidgel r erdos e g num clin exp hypertens num num nummedline order article via infotrieve michaud williams chauvet m corvol p num mol pharmacol num num numabstractfree full text wei l clauser e alhenc gelas f corvol p num j biol chem num num numabstractfree full text kohlstedt k brandes r p muller esterl w busse r fleming num circ res num num numabstractfree full text kehoe p g russ c mcilory williams h holmans p holmes c liolitsa d vahidassr d powell j mcgleenon b liddell m plomin r dynan k williams n neal j cairns n j wilcock g passmore p lovestone williams j owen m j num nat genet num num numcrossrefmedline order article via infotrieve elkins j douglas v c johnston c num neurology num num numabstractfree full text lehmann d j cortina borja m warden d r smith d sleegers k prince j van duijn c m kehoe p g num j epidemiol num num numabstractfree full text rigat b hubert c alhenc gelas f cambien f corvol p soubrier f num j clin invest num num nummedline order article via infotrieve kolsch h jessen f freymann n kreis m hentschel f maier w heun r num neurosci lett num num numcrossrefmedline order article via infotrieve sleegers k den heijer van dijk e j hofman bertoli avella m koudstaal p j breteler m m van duijn c m num neurobiol aging num num numcrossrefmedline order article via infotrieve lendon c l thaker u harris j m mcdonagh m lambert j c chartier harlin m c iwatsubo pickering brown m mann d m num neurosci lett num num numcrossrefmedline order article via infotrieve katzov h bennet m kehoe p wiman b gatz m blennow k lenhard b pedersen n l de faire u prince j num hum mol genet num num numabstractfree full text savaskan e hock c olivieri g bruttel rosenberg c hulette c muller spahn f num neurobiol aging num num numcrossrefmedline order article via infotrieve barnes n m cheng c h costall b naylor r j williams j wischik c m num eur j pharmacol num num numcrossrefmedline order article via infotrieve arregui perry e k rossor m tomlinson b e num j neurochem num num nummedline order article via infotrieve hu j igarashi kamata m nakagawa h num j biol chem num num numabstractfree full text leissring m farris w wu x christodoulou d c haigis m c guarente l selkoe d j num biochem j num num numcrossrefmedline order article via infotrieve citron m oltersdorf haass c mcconlogue l hung y seubert p vigo pelfrey c lieberburg selkoe d j num nature num num numcrossrefmedline order article via infotrieve vekrellis k ye z qiu w q walsh d hartley d chesneau v rosner m r selkoe d j num j neurosci num num numabstractfree full text santos r krieger e m greene l j num hypertension num num numabstractfree full text johnson wood k lee m motter r hu k gordon g barbour r khan k gordon m tan h games d lieberburg schenk d seubert p mcconlogue l num proc natl acad sci u num num numabstractfree full text fuchs xiao h d cole j m adams j w frenzel k michaud zhao h keshelava g capecchi m r corvol p bernstein k e num j biol chem num num numabstractfree full text hooper n m turner j num biochem j num num nummedline order article via infotrieve woodman z l oppong y cook hooper n m schwager l brandt w f ehlers m r sturrock e d num biochem j num num numcrossrefmedline order article via infotrieve farris w leissring m hemming m l chang y selkoe d j num biochemistry num num numcrossrefmedline order article via infotrieve oba r igarashi kamata m nagata k takano nakagawa h num eur j neurosci num num numcrossrefmedline order article via infotrieve binevski p v sizova e pozdnev v f kost o num febs lett num num numcrossrefmedline order article via infotrieve kohlstedt k busse r fleming num hypertension num num numabstractfree full text ohrui tomita n sato nakagawa matsui maruyama m niwa k arai h sasaki h num neurology num num numfree full text knopman d num neurology num numfree full text birkenhager w h forette f staessen j num curr opin nephrol hypertens num num nummedline order article via infotrieve cole j quach du l sundaram k corvol p capecchi m r bernstein k e num circ res num num numabstractfree full text
0.2581098.12411259.html.plaintext.txt	0	brain ageing dementia makes difference lawrence j whalley frcpsych
0.2581098.12411259.html.plaintext.txt	1	university aberdeen clinical research centre royal cornhill hospital aberdeen symb numzh uk
0.2581098.12411259.html.plaintext.txt	2	correspondence tel num num e mail ljwhalleyatabdnacuk
0.2581098.12411259.html.plaintext.txt	3	boundaries non pathological brain ageing dementias unclear contentious neuropathological examination detect occasional individuals microscopic features typical late onset alzheimers disease present yet clinical history dementia absent occasions converse seems true individuals seriously disabled life dementia show death mild pathological features alzheimers disease observations type although often made experienced neuropathologists widely discussed molecular neurobiologists among assumption largely prevailed alzheimers disease well validated nosological entity discontinuous ageing discrete molecular pathology reasoning extends repeated proposition understanding pathogenesis amyloid deposition provide sound sufficient basis develop novel therapies alzheimers disease selkoe num
0.2581098.12411259.html.plaintext.txt	4	boundaries non pathological brain ageing dementias unclear contentious neuropathological examination detect occasional individuals microscopic features typical late onset alzheimers disease present yet clinical history dementia absent occasions converse seems true individuals seriously disabled life dementia show death mild pathological features alzheimers disease observations type although often made experienced neuropathologists widely discussed molecular neurobiologists among assumption largely prevailed alzheimers disease well validated nosological entity discontinuous ageing discrete molecular pathology reasoning extends repeated proposition understanding pathogenesis amyloid deposition provide sound sufficient basis develop novel therapies alzheimers disease selkoe num
0.2581098.12411259.html.plaintext.txt	5	findings medical research council cognitive function ageing study mrc cfas challenge assumptions least two fronts first encourage dementia researchers re examine basis belief valid boundaries non pathological normal ageing absence dementia dementias second suggest central role often assigned amyloid deposition requires review longitudinal follow studies mrc cfas raise important issues nature phenomena explained editorial considers early contributions brain development influences cognitive decline later life turn approach requires deeper understanding yet available brain mechanisms processes affected ageing
0.2581098.12411259.html.plaintext.txt	6	findings medical research council cognitive function ageing study mrc cfas challenge assumptions least two fronts first encourage dementia researchers re examine basis belief valid boundaries non pathological normal ageing absence dementia dementias second suggest central role often assigned amyloid deposition requires review longitudinal follow studies mrc cfas raise important issues nature phenomena explained editorial considers early contributions brain development influences cognitive decline later life turn approach requires deeper understanding yet available brain mechanisms processes affected ageing
0.2581098.12411259.html.plaintext.txt	7	margaret esiri colleagues esiri et al num described large community based neuropathological study distinction dementia brain ageing absence dementia shortage data impossible accept validity contemporary neuropathological criteria dementia definitions boundary existed dementias normal ageing study showed num old people weighted contain num people met clinical criteria dementia death majority showed mixed alzheimer vascular pathologies postmortem examination brains dementia non dementia subjects overlapped neuritic diffuse plaque density single pathological criterion reliably distinguished groups coexistent vascular lesions provide sufficient explanation presence dementia encourage view interactions alzheimer vascular pathologies may critical determinants progression clinical dementia
0.2581098.12411259.html.plaintext.txt	8	margaret esiri colleagues esiri et al num described large community based neuropathological study distinction dementia brain ageing absence dementia shortage data impossible accept validity contemporary neuropathological criteria dementia definitions boundary existed dementias normal ageing study showed num old people weighted contain num people met clinical criteria dementia death majority showed mixed alzheimer vascular pathologies postmortem examination brains dementia non dementia subjects overlapped neuritic diffuse plaque density single pathological criterion reliably distinguished groups coexistent vascular lesions provide sufficient explanation presence dementia encourage view interactions alzheimer vascular pathologies may critical determinants progression clinical dementia
0.2581098.12411259.html.plaintext.txt	9	mrc cfas data provide strongest evidence yet relationship normal brain ageing dementias best represented continuum also much weaken pivotal position claimed amyloid deposition pathogenesis alzheimers disease without inclusion factor factors amyloid cascade hypothesis alzheimers disease longer tenable mrc cfas programme may yet identify factors sample size doubled improved descriptions quantifications vascular lesions possible begin disentangle pathological processes contribute clinical presentations dementia critically establish true relationships age
0.2581098.12411259.html.plaintext.txt	10	mrc cfas data provide strongest evidence yet relationship normal brain ageing dementias best represented continuum also much weaken pivotal position claimed amyloid deposition pathogenesis alzheimers disease without inclusion factor factors amyloid cascade hypothesis alzheimers disease longer tenable mrc cfas programme may yet identify factors sample size doubled improved descriptions quantifications vascular lesions possible begin disentangle pathological processes contribute clinical presentations dementia critically establish true relationships age
0.2581098.12411259.html.plaintext.txt	11	rate cognitive change caseness
0.2581098.12411259.html.plaintext.txt	12	longitudinal psychological studies cognitive ageing identify single point transition normal ageing dementia several cognitive domains used predict later onset dementia cognitive decline typically non uniform across domains exception early memory impairment largely inclusion among criteria dementia chen et al num presymptomatic patterns cognitive decline reliably distinguished normal variation cognitive function late life almost half attributable original childhood iq deary num
0.2581098.12411259.html.plaintext.txt	13	longitudinal psychological studies cognitive ageing identify single point transition normal ageing dementia several cognitive domains used predict later onset dementia cognitive decline typically non uniform across domains exception early memory impairment largely inclusion among criteria dementia chen et al num presymptomatic patterns cognitive decline reliably distinguished normal variation cognitive function late life almost half attributable original childhood iq deary num
0.2581098.12411259.html.plaintext.txt	14	psychologists psychiatrists alike familiar problems type comfortable search antecedents may extend earlier developmental epochs links increased late life dementia risk lower educational attainment suggest association dementia childhood iq reported whalley et al num explanations associations type complex mutually exclusive least strong intergenerational lifelong continuities material advantage award entry safer healthier environment mentally able youngster usual concept mature brain possesses sufficient reserve redundancy withstand age related pathologies described esiri et al num reserve determined early life experiences belief childhood educational attainment mental ability could determine threshold brain ageing dementia pathology must sufficient exceed cause dementia supported data reported whalley et al num association lower childhood iq dementia confined late onset cases marked presenting age num years
0.2581098.12411259.html.plaintext.txt	15	psychologists psychiatrists alike familiar problems type comfortable search antecedents may extend earlier developmental epochs links increased late life dementia risk lower educational attainment suggest association dementia childhood iq reported whalley et al num explanations associations type complex mutually exclusive least strong intergenerational lifelong continuities material advantage award entry safer healthier environment mentally able youngster usual concept mature brain possesses sufficient reserve redundancy withstand age related pathologies described esiri et al num reserve determined early life experiences belief childhood educational attainment mental ability could determine threshold brain ageing dementia pathology must sufficient exceed cause dementia supported data reported whalley et al num association lower childhood iq dementia confined late onset cases marked presenting age num years
0.2581098.12411259.html.plaintext.txt	16	mrc cfas programme represents successful application epidemiological neuropathological methods study distinctions clinical cases non cases ages disease onset occur usual contemporary approach age related disease disease interest case dementia defined present absent contrasts second potentially powerful research method investigates rate change premorbid characteristics specified age interval national institute aging working group aging genetic epidemiology num risk factors dementia examined simply contributing duration survival becoming case dementia possible determinants rate timing change parameters believed closely linked pathogenesis dementia
0.2581098.12411259.html.plaintext.txt	17	mrc cfas programme represents successful application epidemiological neuropathological methods study distinctions clinical cases non cases ages disease onset occur usual contemporary approach age related disease disease interest case dementia defined present absent contrasts second potentially powerful research method investigates rate change premorbid characteristics specified age interval national institute aging working group aging genetic epidemiology num risk factors dementia examined simply contributing duration survival becoming case dementia possible determinants rate timing change parameters believed closely linked pathogenesis dementia
0.2581098.12411259.html.plaintext.txt	18	age related abnormalities glucose metabolism one hypothetical parameters diabetes mellitus risk factor stroke possible risk factor alzheimers disease vascular dementia luchsinger et al num matureonset type num diabetes also associated cardiovascular risk factors include hypertension hyperlipidaemia may cause accelerate unrecognised progressive cerebrovascular disease least two plausible biological mechanisms link enduring age related abnormalities glucose metabolism neuronal death formation advanced glycation end products ages hyperinsulinaemia separate strands evidence link foetal growth adult hypertension impaired glucose tolerance age num years hales et al num taken together observations advocate longitudinal studies individual differences glucose metabolism age related cognitive variation studies type extend across life span subsumed title life course approaches late onset dementia dementia associated traits sometimes suggest parallel experimental routes better understanding mechanisms age related cognitive impairment strachan et al num
0.2581098.12411259.html.plaintext.txt	19	age related abnormalities glucose metabolism one hypothetical parameters diabetes mellitus risk factor stroke possible risk factor alzheimers disease vascular dementia luchsinger et al num matureonset type num diabetes also associated cardiovascular risk factors include hypertension hyperlipidaemia may cause accelerate unrecognised progressive cerebrovascular disease least two plausible biological mechanisms link enduring age related abnormalities glucose metabolism neuronal death formation advanced glycation end products ages hyperinsulinaemia separate strands evidence link foetal growth adult hypertension impaired glucose tolerance age num years hales et al num taken together observations advocate longitudinal studies individual differences glucose metabolism age related cognitive variation studies type extend across life span subsumed title life course approaches late onset dementia dementia associated traits sometimes suggest parallel experimental routes better understanding mechanisms age related cognitive impairment strachan et al num
0.2581098.12411259.html.plaintext.txt	20	explanations associations suboptimal foetal infant growth late onset disease include failure acquire lasting control complex central regulatory systems brain development foetal nutritional hormonal environments also important critical roles expression specific genes dauncey et al num major differences foetal infant nutritional environment induce large differences expression hormonal receptor isoforms may provide means whereby dietary micro nutrients affect cognitive functions across life span nutritional influences apparently diverse contributions folate vitamin symb neurodevelopment greater age related cognitive impairment linked dietary plasma folate concentrations miller num duthie et al num
0.2581098.12411259.html.plaintext.txt	21	explanations associations suboptimal foetal infant growth late onset disease include failure acquire lasting control complex central regulatory systems brain development foetal nutritional hormonal environments also important critical roles expression specific genes dauncey et al num major differences foetal infant nutritional environment induce large differences expression hormonal receptor isoforms may provide means whereby dietary micro nutrients affect cognitive functions across life span nutritional influences apparently diverse contributions folate vitamin symb neurodevelopment greater age related cognitive impairment linked dietary plasma folate concentrations miller num duthie et al num
0.2581098.12411259.html.plaintext.txt	22	diversity timing nature single nutritional influences represents important obstacle taking life course approach understanding dementia obscure best route elucidate molecular mechanisms early nutritional experience affects neurodevelopment later cognitive performance example observational studies late life suggest hyperhomocysteinaemia attributed reduced transformation homocysteine methionine folate vitamin symb possible risk factor cerebrovascular disease miller num dementia seshadri et al num polymorphisms gene encoding methylenetetrahydrofolate reductase mthfr enzyme essential folate metabolism therefore possible susceptibility factors age related cognitive decline however possess potential influence brain metabolism throughout life similar critiques made studies interactions genes early nutrition may specific influences peripheral insulin sensitivity neuro development factors might influence synaptogenesis late life
0.2581098.12411259.html.plaintext.txt	23	diversity timing nature single nutritional influences represents important obstacle taking life course approach understanding dementia obscure best route elucidate molecular mechanisms early nutritional experience affects neurodevelopment later cognitive performance example observational studies late life suggest hyperhomocysteinaemia attributed reduced transformation homocysteine methionine folate vitamin symb possible risk factor cerebrovascular disease miller num dementia seshadri et al num polymorphisms gene encoding methylenetetrahydrofolate reductase mthfr enzyme essential folate metabolism therefore possible susceptibility factors age related cognitive decline however possess potential influence brain metabolism throughout life similar critiques made studies interactions genes early nutrition may specific influences peripheral insulin sensitivity neuro development factors might influence synaptogenesis late life
0.2581098.12411259.html.plaintext.txt	24	brain ageing cognitive decline
0.2581098.12411259.html.plaintext.txt	25	association brain ageing age related cognitive decline uncertain largely ageing studies beginning brain ageing yet linked informatively known neurobiological basis cognitive decline higher brain functions comprise abilities like language learning memory planning abstract reasoning self awareness impaired age related cognitive decline progresses dementia neural foundations higher functions supported complex organisation synaptic connections one current paradigm attaches central role modulation synaptic functions enduring majority especially brain areas serving higher functions require constant remodelling respond optimally environmental demands
0.2581098.12411259.html.plaintext.txt	26	association brain ageing age related cognitive decline uncertain largely ageing studies beginning brain ageing yet linked informatively known neurobiological basis cognitive decline higher brain functions comprise abilities like language learning memory planning abstract reasoning self awareness impaired age related cognitive decline progresses dementia neural foundations higher functions supported complex organisation synaptic connections one current paradigm attaches central role modulation synaptic functions enduring majority especially brain areas serving higher functions require constant remodelling respond optimally environmental demands
0.2581098.12411259.html.plaintext.txt	27	brain areas provide higher functions appear susceptible effects ageing alzheimers disease one disease model progression age related cognitive decline dementia best represented reversal corticogenesis arendt num develop models requires better understanding ageing processes available biological components ageing certainly involve complex interplay intrinsic mostly genetic extrinsic mostly environmental factors recent progress encourages optimism small number highly conserved genes affect life span similarly small number metabolic processes view contrasts previous degenerative position held biological ageing haphazard amenable study generation metabolites oxygen termed reactive oxygen species ros important cause oxidative stress ros intimately involved biology ageing finkel holbrook num parallels ageing altered metabolic states induced lower organisms adverse circumstances surprisingly similar yeasts nematodes fruit flies mammals guarente kenyon num permit postponement reproduction unfavourable environmental conditions control expression genes protect ros damage genes involved insulin signalling finch ruvkun num reduced expression ageing genes involved insulin like receptor signalling extends life span may specific property neurons boulianne num
0.2581098.12411259.html.plaintext.txt	28	brain areas provide higher functions appear susceptible effects ageing alzheimers disease one disease model progression age related cognitive decline dementia best represented reversal corticogenesis arendt num develop models requires better understanding ageing processes available biological components ageing certainly involve complex interplay intrinsic mostly genetic extrinsic mostly environmental factors recent progress encourages optimism small number highly conserved genes affect life span similarly small number metabolic processes view contrasts previous degenerative position held biological ageing haphazard amenable study generation metabolites oxygen termed reactive oxygen species ros important cause oxidative stress ros intimately involved biology ageing finkel holbrook num parallels ageing altered metabolic states induced lower organisms adverse circumstances surprisingly similar yeasts nematodes fruit flies mammals guarente kenyon num permit postponement reproduction unfavourable environmental conditions control expression genes protect ros damage genes involved insulin signalling finch ruvkun num reduced expression ageing genes involved insulin like receptor signalling extends life span may specific property neurons boulianne num
0.2581098.12411259.html.plaintext.txt	29	extrinsic contributions brain ageing poorly understood lag way behind elegant scientific studies intrinsic components acquired defences ros damage largely derived dietary antioxidants oppose ros production ros defences falter additional burdens placed brains capacity maintain structural integrity often threatened increased peroxidation neuronal lipid membranes oxidative damage dna large regulatory molecules whalley num terminally differentiated cells neurons dispose dna damage cell division must rely dna repair enzymes type damage may compromise performance neuronal sub populations provide higher mental functions also impair capacity make good compensate performance decrements
0.2581098.12411259.html.plaintext.txt	30	extrinsic contributions brain ageing poorly understood lag way behind elegant scientific studies intrinsic components acquired defences ros damage largely derived dietary antioxidants oppose ros production ros defences falter additional burdens placed brains capacity maintain structural integrity often threatened increased peroxidation neuronal lipid membranes oxidative damage dna large regulatory molecules whalley num terminally differentiated cells neurons dispose dna damage cell division must rely dna repair enzymes type damage may compromise performance neuronal sub populations provide higher mental functions also impair capacity make good compensate performance decrements
0.2581098.12411259.html.plaintext.txt	31	arendt num summarised much available evidence support hypothesis age related cognitive decline alzheimers disease best understood progressive failure synaptic remodelling view much compelling evidence accept first abnormal dendritic sprouting occurs alzheimers disease second morphoregulatory molecules involved neurodevelopment re emerge part alzheimer molecular pathology suggests example conserved functions amyloid precursor protein app presenilins apolipoprotein e implicated alzheimers disease key roles morphoregulatory molecules synaptic formation turnover stabilisation preferentially expressed adult brain areas retain capacity modify synaptic function morphogenesis neurons enormous relevance understanding neurodevelopment differential survival cell types arendt num extends significance late life first argues molecular processes underpin functional sculpting used immature brain self organise acquisition higher functions language second identifies among detritus dementia features imply reactivation brain self organising molecular machinery arendts view reactivation triggers cascade events results eventually selective loss cortical neurons
0.2581098.12411259.html.plaintext.txt	32	arendt num summarised much available evidence support hypothesis age related cognitive decline alzheimers disease best understood progressive failure synaptic remodelling view much compelling evidence accept first abnormal dendritic sprouting occurs alzheimers disease second morphoregulatory molecules involved neurodevelopment re emerge part alzheimer molecular pathology suggests example conserved functions amyloid precursor protein app presenilins apolipoprotein e implicated alzheimers disease key roles morphoregulatory molecules synaptic formation turnover stabilisation preferentially expressed adult brain areas retain capacity modify synaptic function morphogenesis neurons enormous relevance understanding neurodevelopment differential survival cell types arendt num extends significance late life first argues molecular processes underpin functional sculpting used immature brain self organise acquisition higher functions language second identifies among detritus dementia features imply reactivation brain self organising molecular machinery arendts view reactivation triggers cascade events results eventually selective loss cortical neurons
0.2581098.12411259.html.plaintext.txt	33	model arendt num adds lifelong accumulation noxious influences brain function sources diverse malnutrition neurotoxins cerebrovascular disease age related endogenous oxidative damage neurons summarised stresses brain adaptive mechanisms gradual pervasive result jeopardise high investment made neurons retain capacity synaptic remodelling completion brain maturation missing arendts model mechanisms account individual gender differences rate change traits associated dementia dilemma familiar developmental neuroscientists strong likeness current research problems molecular genetics cognition plomin craig num potentially hormonal genetic contributions synaptic remodelling could relevant example evidence oestrogens induce synapse formation rat hippocampus induction dependent apolipoprotein e stone et al num diversity efficiency self organisation may contribute variation childhood mental ability differences may extend late life leading divergence brain ageing dementia
0.2581098.12411259.html.plaintext.txt	34	model arendt num adds lifelong accumulation noxious influences brain function sources diverse malnutrition neurotoxins cerebrovascular disease age related endogenous oxidative damage neurons summarised stresses brain adaptive mechanisms gradual pervasive result jeopardise high investment made neurons retain capacity synaptic remodelling completion brain maturation missing arendts model mechanisms account individual gender differences rate change traits associated dementia dilemma familiar developmental neuroscientists strong likeness current research problems molecular genetics cognition plomin craig num potentially hormonal genetic contributions synaptic remodelling could relevant example evidence oestrogens induce synapse formation rat hippocampus induction dependent apolipoprotein e stone et al num diversity efficiency self organisation may contribute variation childhood mental ability differences may extend late life leading divergence brain ageing dementia
0.2581098.12411259.html.plaintext.txt	35	understanding individual differences age related cognitive decline beset difficulty neuropathological evidence hypothetical discontinuity normal ageing dementia lacking best available evidence suggests boundary detection sources variation rate cognitive decline requires considerable investment longitudinal population based studies mrc cfas findings outcome longitudinal study continue informative many years quite rightly study focused dementia outcomes age interval risk dementia high
0.2581098.12411259.html.plaintext.txt	36	understanding individual differences age related cognitive decline beset difficulty neuropathological evidence hypothetical discontinuity normal ageing dementia lacking best available evidence suggests boundary detection sources variation rate cognitive decline requires considerable investment longitudinal population based studies mrc cfas findings outcome longitudinal study continue informative many years quite rightly study focused dementia outcomes age interval risk dementia high
0.2581098.12411259.html.plaintext.txt	37	problem boundary brain ageing dementia remains demand detailed attention analysis current longitudinal databases future research design clarification seems certain recommendations national institute aging working group aging genetic epidemiology num come influence brain ageing research goals practice precise tools molecular biology applied phenomena ageing boundaries may brought focus far seems boundaries clinical data suggested ultimate research goal postpone perhaps even prevent dementia research type certain inform timing successful intervention
0.2581098.12411259.html.plaintext.txt	38	problem boundary brain ageing dementia remains demand detailed attention analysis current longitudinal databases future research design clarification seems certain recommendations national institute aging working group aging genetic epidemiology num come influence brain ageing research goals practice precise tools molecular biology applied phenomena ageing boundaries may brought focus far seems boundaries clinical data suggested ultimate research goal postpone perhaps even prevent dementia research type certain inform timing successful intervention
0.2581098.12411259.html.plaintext.txt	39	arendt num alzheimers disease disorder mechanisms underlying structural brain self organization neuroscience num num numcrossrefmedline
0.2581098.12411259.html.plaintext.txt	40	national institute aging working group aging genetic epidemiology num genetic epidemiologic studies age specified traits american journal epidemiology num num numabstractfree full text
0.2581098.12411259.html.plaintext.txt	41	national institute aging working group aging genetic epidemiology num genetic epidemiologic studies age specified traits american journal epidemiology num num numabstractfree full text
0.2581098.12411259.html.plaintext.txt	42	received publication december num num revision received april num num accepted publication april num num
0.2581098.12411259.html.plaintext.txt	43	received publication december num num revision received april num num accepted publication april num num
0.2582762.9751483.html.plaintext.txt	0	regulation multicatalytic enzyme activity insulin insulin degrading symb frederick g hamel robert g bennett william c duckworth
0.2582762.9751483.html.plaintext.txt	1	veterans affairs medical center departments medicine pharmacology fgh biochemistry molecular biology rgb wcd university nebraska medical center omaha nebraska num num
0.2582762.9751483.html.plaintext.txt	2	address correspondence requests reprints william c duckworth md university nebraska medical center num south numnd street omaha nebraska num num
0.2582762.9751483.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references insulin degrading enzyme ide plays important role cellular metabolism insulin recent studies also suggested regulatory role protein controlling activity cytoplasmic protein complexes including proteasome multicatalytic proteinase mcp glucocorticoid androgen receptors binding ide complexes increases activity whereas addition substrates ide inhibits activity provides potential mechanism action internalized insulin ide substrates control protein turnover examine interactions partially purified ide mcp complex treated edta egta activity measured absence presence various divalent cations symb symb symb symb insulin edta treatment reduced mcp activity eliminated effect insulin complex divalent cations partially completely restored mcp activity restore effect insulin egta treatment lesser effect mcp activity abolished insulin inhibition activity divalent cations restored insulin effect inhibitors ide also blocked insulin effect mcp activity treatment sds findings suggest conformational changes complex may play role insulin control mcp activity
0.2582762.9751483.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references insulin degrading enzyme ide plays important role cellular metabolism insulin recent studies also suggested regulatory role protein controlling activity cytoplasmic protein complexes including proteasome multicatalytic proteinase mcp glucocorticoid androgen receptors binding ide complexes increases activity whereas addition substrates ide inhibits activity provides potential mechanism action internalized insulin ide substrates control protein turnover examine interactions partially purified ide mcp complex treated edta egta activity measured absence presence various divalent cations symb symb symb symb insulin edta treatment reduced mcp activity eliminated effect insulin complex divalent cations partially completely restored mcp activity restore effect insulin egta treatment lesser effect mcp activity abolished insulin inhibition activity divalent cations restored insulin effect inhibitors ide also blocked insulin effect mcp activity treatment sds findings suggest conformational changes complex may play role insulin control mcp activity
0.2582762.9751483.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references insulin degrading enzyme ide ec numnumnumnum intracellular protein binding regulatory degradative functions vitro characteristic function proteolytic activity relatively high specificity insulin thus leading name num although insulin substrate highest affinity ide also degrades number peptides hormones including glucagon num insulin like growth factor ii num atrial natriuretic peptide num transforming growth factor num general proteinase degrade wide variety similarly sized peptides specific amino acid sequence required proteolysis num findings led conclusion ide recognizes three dimensional structure binding degradation num num requirement specific ligand structure reflected binding properties ide protein binds proinsulin insulin like growth factor epidermal growth factor high affinities little degrading activity toward num fact ide first identified drosophila binding properties considered new intracellular growth factor receptor num
0.2582762.9751483.html.plaintext.txt	6	regulatory properties ide relatively new finding ide associates activates cytosolic glucocorticoid androgen receptors num num ide also complexes proteasome regulates activity num substrates bind ide including insulin various growth factors inhibit proteasome activity ide complexed multicatalytic proteinase mcp separation two proteins num num furthermore insulin inhibits proteasome activity toward artificial substrate intact cells num led hypothesis intracellular actions insulin growth factors cellular protein turnover due interactions ide inhibition proteolysis proteasome
0.2582762.9751483.html.plaintext.txt	7	regulatory properties ide relatively new finding ide associates activates cytosolic glucocorticoid androgen receptors num num ide also complexes proteasome regulates activity num substrates bind ide including insulin various growth factors inhibit proteasome activity ide complexed multicatalytic proteinase mcp separation two proteins num num furthermore insulin inhibits proteasome activity toward artificial substrate intact cells num led hypothesis intracellular actions insulin growth factors cellular protein turnover due interactions ide inhibition proteolysis proteasome
0.2582762.9751483.html.plaintext.txt	8	ide metalloenzyme containing symb possibly symb num degradative activity requires one divalent cations num addition symb symb symb shown affect degradative activity ide vitro intact cells num num symb divalent cations implicated activities insulin num present study directed examination ide binding regulatory degradative functions special emphasis effect metals
0.2582762.9751483.html.plaintext.txt	9	ide metalloenzyme containing symb possibly symb num degradative activity requires one divalent cations num addition symb symb symb shown affect degradative activity ide vitro intact cells num num symb divalent cations implicated activities insulin num present study directed examination ide binding regulatory degradative functions special emphasis effect metals
0.2582762.9751483.html.plaintext.txt	10	materials methods top abstract introduction materials methods results discussion references numiiodoinsulin specifically labeled symb provided dr bruce frank eli lilly research laboratory indianapolis num crystalline porcine insulin provided dr ronald chance eli lilly research laboratory enzyme grade ammonium sulfate purchased icn biomedicals costa mesa ca succinyl leu leu val tyr num amino num methylcoumarin llvy boc leu ser thr arg num amino num methylcoumarin lstr cbz leu leu glu ss napthylamide lle purchased sigma st louis mo chemicals reagent grade better enzyme preparation used partially purified ammonium sulfate fractionation num enzyme dialyzed overnight least num vol sodium acetate ph numnum addition num mm edta num mm egta three changes egta specific symb edta egta binding symb numnum times tightly num conversely edta binds divalent cations including symb symb symb num numnum times tightly egta acetate salts divalent cations added concentrations indicated
0.2582762.9751483.html.plaintext.txt	11	materials methods top abstract introduction materials methods results discussion references numiiodoinsulin specifically labeled symb provided dr bruce frank eli lilly research laboratory indianapolis num crystalline porcine insulin provided dr ronald chance eli lilly research laboratory enzyme grade ammonium sulfate purchased icn biomedicals costa mesa ca succinyl leu leu val tyr num amino num methylcoumarin llvy boc leu ser thr arg num amino num methylcoumarin lstr cbz leu leu glu ss napthylamide lle purchased sigma st louis mo chemicals reagent grade better enzyme preparation used partially purified ammonium sulfate fractionation num enzyme dialyzed overnight least num vol sodium acetate ph numnum addition num mm edta num mm egta three changes egta specific symb edta egta binding symb numnum times tightly num conversely edta binds divalent cations including symb symb symb num numnum times tightly egta acetate salts divalent cations added concentrations indicated
0.2582762.9751483.html.plaintext.txt	12	measurement degradative activity insulin degradation measured trichloroacetic acid precipitation num expressed percent soluble per num min degradations llvy lstr lle measured incubating enzyme sample num microm fluorogenic peptide numnum m tris buffer ph numnum assay volume num ml num min num c metabolic shaker num inhibitors activators included concentrations indicated reaction stopped addition numnum ml ethanol ice increase fluorescence measured fluorometer excitation emission wavelengths num num nm llvy lstr num num nm lle data expressed change fluorescence units per num min normalized respect activity untreated uninhibited enzyme
0.2582762.9751483.html.plaintext.txt	13	measurement degradative activity insulin degradation measured trichloroacetic acid precipitation num expressed percent soluble per num min degradations llvy lstr lle measured incubating enzyme sample num microm fluorogenic peptide numnum m tris buffer ph numnum assay volume num ml num min num c metabolic shaker num inhibitors activators included concentrations indicated reaction stopped addition numnum ml ethanol ice increase fluorescence measured fluorometer excitation emission wavelengths num num nm llvy lstr num num nm lle data expressed change fluorescence units per num min normalized respect activity untreated uninhibited enzyme
0.2582762.9751483.html.plaintext.txt	14	results top abstract introduction materials methods results discussion references insulin degradation ide reduced treatment edta fig num symb restores insulin degradative activity edta treated ide concentrations low num num m high symb concentrations num num m activity increased untreated enzyme fig num
0.2582762.9751483.html.plaintext.txt	15	view larger version numk figure num restoration symb edta inhibited insulin degrading enzyme edta treatment ide inhibits enzyme almost half readdition symb restores activity even increases num num m values mean plus minus sem ide activity expressed percentage ide without edta treatment
0.2582762.9751483.html.plaintext.txt	16	view larger version numk figure num restoration symb edta inhibited insulin degrading enzyme edta treatment ide inhibits enzyme almost half readdition symb restores activity even increases num num m values mean plus minus sem ide activity expressed percentage ide without edta treatment
0.2582762.9751483.html.plaintext.txt	17	regulatory function ide also affected edta figure numa shows insulin inhibits llvy degradation untreated ide mcp complex addition symb slightly increases activity untreated complex alter effect insulin edta treatment ide mcp complex decreases chymotrypsin like activity mcp reflected decreased degradation llvy fig numb addition num num num num m symb restores llvy degradation insulin effect although wide variability results seen
0.2582762.9751483.html.plaintext.txt	18	regulatory function ide also affected edta figure numa shows insulin inhibits llvy degradation untreated ide mcp complex addition symb slightly increases activity untreated complex alter effect insulin edta treatment ide mcp complex decreases chymotrypsin like activity mcp reflected decreased degradation llvy fig numb addition num num num num m symb restores llvy degradation insulin effect although wide variability results seen
0.2582762.9751483.html.plaintext.txt	19	view larger version numk figure num effect symb readdition mcp edta treated mcp egta treated mcp addition symb slight stimulatory effect llvy degradation effect insulin inhibition b edta treatment reduces llvy activity num eliminates response insulin calcium addition reactivates llvy degradation restore insulin sensitivity c egta treatment reduces llvy activity essentially eliminates response insulin calcium addition restores degrading activity response insulin values shown mean plus minus sem llvy activity expressed percentage untreated enzyme
0.2582762.9751483.html.plaintext.txt	20	view larger version numk figure num effect symb readdition mcp edta treated mcp egta treated mcp addition symb slight stimulatory effect llvy degradation effect insulin inhibition b edta treatment reduces llvy activity num eliminates response insulin calcium addition reactivates llvy degradation restore insulin sensitivity c egta treatment reduces llvy activity essentially eliminates response insulin calcium addition restores degrading activity response insulin values shown mean plus minus sem llvy activity expressed percentage untreated enzyme
0.2582762.9751483.html.plaintext.txt	21	evidence ide contains one divalent cation num tightly bound symb easily dissociable symb different cations may different effects ide activities thus effect different chelator egta examined fig numc llvy degradation decreased slight effect insulin symb however restored llvy degradative activity effect insulin
0.2582762.9751483.html.plaintext.txt	22	evidence ide contains one divalent cation num tightly bound symb easily dissociable symb different cations may different effects ide activities thus effect different chelator egta examined fig numc llvy degradation decreased slight effect insulin symb however restored llvy degradative activity effect insulin
0.2582762.9751483.html.plaintext.txt	23	similar studies edta egta treated ide mcp complex performed readdition cations symb symb symb alter ide degradative activity figs num num effects symb shown comparison metals variable effects restoring mcp activity edta treated complex none restores insulin effect however symb symb symb restore regulatory function ide mcp activity egta treated material manganese appeared restore insulin sensitivity reach statistical significance p numnum one tailed test
0.2582762.9751483.html.plaintext.txt	24	view larger version numk figure num effect edta treatment metal readdition llvy degrading activity inhibition insulin graph shows activity ide mcp complex toward llvy various treatments without open bars closed bars addition num microm insulin partially purified ide mcp complex dialyzed overnight sodium acetate sodium acetate num mm edta readdition various metals values shown mean plus minus sem llvy degrading activity normalized activity untreated enzyme insulin added metal chloride concentrations used maximally restored ide activity toward radiolabeled insulin follows symb num num m symb num num m symb num x num num m symb num num m
0.2582762.9751483.html.plaintext.txt	25	view larger version numk figure num effect edta treatment metal readdition llvy degrading activity inhibition insulin graph shows activity ide mcp complex toward llvy various treatments without open bars closed bars addition num microm insulin partially purified ide mcp complex dialyzed overnight sodium acetate sodium acetate num mm edta readdition various metals values shown mean plus minus sem llvy degrading activity normalized activity untreated enzyme insulin added metal chloride concentrations used maximally restored ide activity toward radiolabeled insulin follows symb num num m symb num num m symb num x num num m symb num num m
0.2582762.9751483.html.plaintext.txt	26	view larger version numk figure num effect egta treatment metal readdition llvy degrading activity inhibition insulin graph shows activity ide mcp complex toward llvy various treatments without open bars closed bars addition num microm insulin partially purified ide mcp complex dialyzed overnight sodium acetate sodium acetate num mm egta readdition various metals values shown mean plus minus sem llvy degrading activity normalized activity untreated enzyme insulin added egta treatment little effect insulin degrading activities metal concentrations used used edta treated enzyme symb num num m symb num num m symb num x num num m symb num num m
0.2582762.9751483.html.plaintext.txt	27	view larger version numk figure num effect egta treatment metal readdition llvy degrading activity inhibition insulin graph shows activity ide mcp complex toward llvy various treatments without open bars closed bars addition num microm insulin partially purified ide mcp complex dialyzed overnight sodium acetate sodium acetate num mm egta readdition various metals values shown mean plus minus sem llvy degrading activity normalized activity untreated enzyme insulin added egta treatment little effect insulin degrading activities metal concentrations used used edta treated enzyme symb num num m symb num num m symb num x num num m symb num num m
0.2582762.9751483.html.plaintext.txt	28	mcp multiple catalytic sites insulin ide regulate trypsin like lstr degradation well chymotrypsin like llvy degradation activity edta treatment dramatically decreases lstr degradation eliminates insulin effect fig num readdition divalent cations symb symb restores degrading activity insulin effect egta treatment reduces lstr activity change achieve significance remove insulin inhibition mcp activity fig num
0.2582762.9751483.html.plaintext.txt	29	mcp multiple catalytic sites insulin ide regulate trypsin like lstr degradation well chymotrypsin like llvy degradation activity edta treatment dramatically decreases lstr degradation eliminates insulin effect fig num readdition divalent cations symb symb restores degrading activity insulin effect egta treatment reduces lstr activity change achieve significance remove insulin inhibition mcp activity fig num
0.2582762.9751483.html.plaintext.txt	30	view larger version numk figure num effects edta treatment metal readdition lstr degrading activity inhibition insulin see fig num details
0.2582762.9751483.html.plaintext.txt	31	view larger version numk figure num effects edta treatment metal readdition lstr degrading activity inhibition insulin see fig num details
0.2582762.9751483.html.plaintext.txt	32	view larger version numk figure num effects egta treatment metal readdition lstr degrading activity inhibition insulin see fig num details
0.2582762.9751483.html.plaintext.txt	33	view larger version numk figure num effects egta treatment metal readdition lstr degrading activity inhibition insulin see fig num details
0.2582762.9751483.html.plaintext.txt	34	data figs num num support role easily dissociable divalent cation essential insulin effect complex egta effects edta treatment however results profound alterations perhaps due partial removal tightly bound cation subsequent conformational changes simple addition individual cations restore functional control complex insulin
0.2582762.9751483.html.plaintext.txt	35	explore regulatory role ide control mcp selected inhibitors examined table num metalloproteinase inhibitor numnum phenanthroline inhibited ide abolished insulin effect llvy degradation similar edta n ethylmaleimide bacitracin known inhibitors ide also blocked effect insulin phenylmethylsulfonylfluoride low concentrations appreciable effect
0.2582762.9751483.html.plaintext.txt	36	explore regulatory role ide control mcp selected inhibitors examined table num metalloproteinase inhibitor numnum phenanthroline inhibited ide abolished insulin effect llvy degradation similar edta n ethylmaleimide bacitracin known inhibitors ide also blocked effect insulin phenylmethylsulfonylfluoride low concentrations appreciable effect
0.2582762.9751483.html.plaintext.txt	37	view table table num effects various inhibitors ide mcp complex
0.2582762.9751483.html.plaintext.txt	38	table num compares effects inhibitors ide proteolytic activity ide mcp complex purified mcp phenanthroline n ethylmaleimide bacitracin inhibit llvy degradation mcp complexed ide agents ineffective purified mcp findings support regulatory activating effect ide mcp activity
0.2582762.9751483.html.plaintext.txt	39	table num compares effects inhibitors ide proteolytic activity ide mcp complex purified mcp phenanthroline n ethylmaleimide bacitracin inhibit llvy degradation mcp complexed ide agents ineffective purified mcp findings support regulatory activating effect ide mcp activity
0.2582762.9751483.html.plaintext.txt	40	view table table num effects inhibitors ide mcp activity
0.2582762.9751483.html.plaintext.txt	41	importance activation mcp ide supported effect removal ide purification reported previously num num ide mcp llvy degradation copurify various standard affinity procedures separated ion exchange columns ide mcp complex purified ammonium sulfate fractionation diethylaminoethyl batch separation phenyl sepharose symb chromatofocusing preparation chromatographed mono q hplc column llvy degrading activity eluting sharp symmetrical peak shown recovery llvy degrading activity ion exchange column numnum specific activity decreased numnum numnum fluorescent units per microg proteinh
0.2582762.9751483.html.plaintext.txt	42	importance activation mcp ide supported effect removal ide purification reported previously num num ide mcp llvy degradation copurify various standard affinity procedures separated ion exchange columns ide mcp complex purified ammonium sulfate fractionation diethylaminoethyl batch separation phenyl sepharose symb chromatofocusing preparation chromatographed mono q hplc column llvy degrading activity eluting sharp symmetrical peak shown recovery llvy degrading activity ion exchange column numnum specific activity decreased numnum numnum fluorescent units per microg proteinh
0.2582762.9751483.html.plaintext.txt	43	ide control mcp activity may due conformational change mcp enzyme responsive reagents alter conformation num sds low concentrations increases activity higher concentrations inhibiting num explore dose response curves sds performed ide mcp complex without insulin effects llvy lstr lle activities examined fig num llvy degrading activity stimulated sds concentrations numnum numnum insulin inhibited llvy lstr lle degradation absence sds effect even slight stimulatory effect presence sds
0.2582762.9751483.html.plaintext.txt	44	ide control mcp activity may due conformational change mcp enzyme responsive reagents alter conformation num sds low concentrations increases activity higher concentrations inhibiting num explore dose response curves sds performed ide mcp complex without insulin effects llvy lstr lle activities examined fig num llvy degrading activity stimulated sds concentrations numnum numnum insulin inhibited llvy lstr lle degradation absence sds effect even slight stimulatory effect presence sds
0.2582762.9751483.html.plaintext.txt	45	view larger version numk figure num insulin effect peptide degradation sds activated multicatalytic proteinase enzyme ammonium sulfate purified complex incubated increasing concentrations sds num numnum wtvol presence absence num microm insulin degradation peptides expressed fluorescence liberated arbitrary units per num min lle degradation expressed thousands
0.2582762.9751483.html.plaintext.txt	46	view larger version numk figure num insulin effect peptide degradation sds activated multicatalytic proteinase enzyme ammonium sulfate purified complex incubated increasing concentrations sds num numnum wtvol presence absence num microm insulin degradation peptides expressed fluorescence liberated arbitrary units per num min lle degradation expressed thousands
0.2582762.9751483.html.plaintext.txt	47	determine insulin effect complex could restored ide mcp activated sds sds removed table num degradation llvy monitored continuously insulin added achieve sequential concentrations num num num num num num m seen mcp activity inhibited insulin concentrations removal sds
0.2582762.9751483.html.plaintext.txt	48	determine insulin effect complex could restored ide mcp activated sds sds removed table num degradation llvy monitored continuously insulin added achieve sequential concentrations num num num num num num m seen mcp activity inhibited insulin concentrations removal sds
0.2582762.9751483.html.plaintext.txt	49	view table table num effect insulin mcp treatment removal sds
0.2582762.9751483.html.plaintext.txt	50	discussion top abstract introduction materials methods results discussion references although role ide cellular insulin metabolism firmly established num many factors mitigate sole physiological activity enzyme although insulin sensitive tissues contain enzyme also found noninsulin sensitive tissues multiple subcellular compartments ide found peroxisomes num num num cytosol num endosomes num plasma membranes num cellular content ide developmentally regulated ide implicated cellular differentiation num num num num growth factor binding num diverse properties become less confusing ide recognized multifunctional protein complex variety subcellular components proteasome steroid receptor peroxisomes alter activities complexes
0.2582762.9751483.html.plaintext.txt	51	discussion top abstract introduction materials methods results discussion references although role ide cellular insulin metabolism firmly established num many factors mitigate sole physiological activity enzyme although insulin sensitive tissues contain enzyme also found noninsulin sensitive tissues multiple subcellular compartments ide found peroxisomes num num num cytosol num endosomes num plasma membranes num cellular content ide developmentally regulated ide implicated cellular differentiation num num num num growth factor binding num diverse properties become less confusing ide recognized multifunctional protein complex variety subcellular components proteasome steroid receptor peroxisomes alter activities complexes
0.2582762.9751483.html.plaintext.txt	52	stimulatory effects ide proteasomes glucocorticoid androgen receptors established present previous reports num num mechanism reversible nature activation argues proteolytic activation complex ide possibilities include conformational changes complex ide degradation ligand proteolytic products generated ide combination
0.2582762.9751483.html.plaintext.txt	53	stimulatory effects ide proteasomes glucocorticoid androgen receptors established present previous reports num num mechanism reversible nature activation argues proteolytic activation complex ide possibilities include conformational changes complex ide degradation ligand proteolytic products generated ide combination
0.2582762.9751483.html.plaintext.txt	54	present study provides evidence divalent cations involved activity control ide mcp complex treatment partially purified enzyme edta significantly reduced activity ide restored addition symb little num num m effect presumably mediated removal symb found active site ide required activity treatment also reduces chymotrypsin like trypsin like activities proteasome eliminates ability insulin inhibit activities addition symb symb restores chymotrypsin like trypsin like activities fails restore insulin responsiveness symb symb show relatively little effect
0.2582762.9751483.html.plaintext.txt	55	present study provides evidence divalent cations involved activity control ide mcp complex treatment partially purified enzyme edta significantly reduced activity ide restored addition symb little num num m effect presumably mediated removal symb found active site ide required activity treatment also reduces chymotrypsin like trypsin like activities proteasome eliminates ability insulin inhibit activities addition symb symb restores chymotrypsin like trypsin like activities fails restore insulin responsiveness symb symb show relatively little effect
0.2582762.9751483.html.plaintext.txt	56	also examined effect egta complex egta slightly higher affinity numnum times symb edta num numnum times less affinity cations including symb num conditions experiments egta effect ide activity data shown reduce chymotrypsin like activity proteasome effectively eliminated insulin effect similar reduction seen trypsin like activity although reach statistical significance insulin ability inhibit restored cations symb symb data suggest two metals involved complex reported previously num
0.2582762.9751483.html.plaintext.txt	57	also examined effect egta complex egta slightly higher affinity numnum times symb edta num numnum times less affinity cations including symb num conditions experiments egta effect ide activity data shown reduce chymotrypsin like activity proteasome effectively eliminated insulin effect similar reduction seen trypsin like activity although reach statistical significance insulin ability inhibit restored cations symb symb data suggest two metals involved complex reported previously num
0.2582762.9751483.html.plaintext.txt	58	propose one metal zinc tightly bound ide essential activity possibly symb symb loosely bound required productive interaction ide proteasome edta chelate tightly bound symb loosely bound metal associated complex inhibits ide thereby lessening stimulatory effect proteasome loss symb molecule causes conformational change ide dissociating proteasome disrupting ability insulin alter proteasome activity readdition divalent cation restores ide activity longer part complex ide alter proteasome function however egta effects loosely bound metal disrupts ide ability affect chymotrypsin like activity cause ide dissociate complex thus addition cations restore insulin sensitivity
0.2582762.9751483.html.plaintext.txt	59	propose one metal zinc tightly bound ide essential activity possibly symb symb loosely bound required productive interaction ide proteasome edta chelate tightly bound symb loosely bound metal associated complex inhibits ide thereby lessening stimulatory effect proteasome loss symb molecule causes conformational change ide dissociating proteasome disrupting ability insulin alter proteasome activity readdition divalent cation restores ide activity longer part complex ide alter proteasome function however egta effects loosely bound metal disrupts ide ability affect chymotrypsin like activity cause ide dissociate complex thus addition cations restore insulin sensitivity
0.2582762.9751483.html.plaintext.txt	60	fact ide must active complex proteasome mediate regulatory effects supported data presented tables num num agents inhibit ide lessen proteasome activity effectively eliminate insulin inhibitory effect
0.2582762.9751483.html.plaintext.txt	61	fact ide must active complex proteasome mediate regulatory effects supported data presented tables num num agents inhibit ide lessen proteasome activity effectively eliminate insulin inhibitory effect
0.2582762.9751483.html.plaintext.txt	62	finally studied ide proteasome interactions using sds shown alter proteasome conformation shown fig num chymotrypsin trypsin like activities proteasome insulin sensitive absence sds lose sensitivity considerable activity numnum sds presumably due sds altering interaction ide proteasome higher concentrations sds alters conformation proteasome stimulates chymotrypsin like peptidyl glutamyl degrading activities however high concentrations ide still unable interact proteasomes insulin inhibit effect reversible
0.2582762.9751483.html.plaintext.txt	63	data presented characterize support idea ide serve regulator proteasome metal ions play important roles interaction first ide metalloproteinase must active insulin inhibitory effect second loosely bound divalent cation required ide mediate effects changes protein conformation important illustrated loss activity ide active site metal removed changes activity induced sds
0.2582762.9751483.html.plaintext.txt	64	data presented characterize support idea ide serve regulator proteasome metal ions play important roles interaction first ide metalloproteinase must active insulin inhibitory effect second loosely bound divalent cation required ide mediate effects changes protein conformation important illustrated loss activity ide active site metal removed changes activity induced sds
0.2582762.9751483.html.plaintext.txt	65	physiological effect insulin inhibit cellular protein degradation greater effects catabolic states eg starvation diabetes traumatic stress cell survival requires continued protein turnover would expected insulin could totally inhibit mcp activity completely block protein degradation rather ide mcp interaction may serve activator basal cellular protein degradation analogous activation glucocorticoid androgen receptors ide num insulin substrates acting inhibit stimulated process thus selective effects cellular protein degradation insulin sensitive cells control insulin ide interactions mcp comprises relatively large proportion protein many cells num ide although expressed high levels tissues num present sufficient quantities tissues universal regulator mcp activities results show insulin substantially inhibits two activities mcp chymotrypsin trypsin like activities proteasome may many five different proteolytic activities num also remains determined whether degradation ubiquitinylated proteins inhibited insulin ide
0.2582762.9751483.html.plaintext.txt	66	although widely appreciated many studies shown biological activity intracellular insulin num num alterations insulin activity inhibition cellular insulin processing num num recent studies provided potential mechanism previously unexplained observations scheme ide portion complex acts intracellular receptor insulin possibly growth factors insulin ide interaction alters activity protein complex ie mcp glucocorticoid receptor androgen receptor perhaps others contributes biological actions insulin insulin effect mcp prevented altering activity ide although speculative cellular activity regulated ide complexes may affected cellular redox state divalent cation distribution due changes ide alterations insulin action associated ion flux redistribution redox state effects could explained part regulatory effects ide studies required
0.2582762.9751483.html.plaintext.txt	67	although widely appreciated many studies shown biological activity intracellular insulin num num alterations insulin activity inhibition cellular insulin processing num num recent studies provided potential mechanism previously unexplained observations scheme ide portion complex acts intracellular receptor insulin possibly growth factors insulin ide interaction alters activity protein complex ie mcp glucocorticoid receptor androgen receptor perhaps others contributes biological actions insulin insulin effect mcp prevented altering activity ide although speculative cellular activity regulated ide complexes may affected cellular redox state divalent cation distribution due changes ide alterations insulin action associated ion flux redistribution redox state effects could explained part regulatory effects ide studies required
0.2582762.9751483.html.plaintext.txt	68	acknowledgments authors thank janet corr preparation manuscript
0.2582762.9751483.html.plaintext.txt	69	footnotes num work supported department veterans affairs research service bly memorial research fund
0.2582762.9751483.html.plaintext.txt	70	references top abstract introduction materials methods results discussion references duckworth wc hamel fg bennett rg ryan mp roth ra num human red blood cell insulin degrading enzyme rat skeletal muscle insulin protease share antigenic sites generate identical products insulin j biol chem numnum numabstractfree full text authier f posner bi bergeron jjm num insulin degrading enzyme clin invest med numnum nummedline roth ra mesirow ml yokono k baba num degradation insulin like growth factors ii human insulin degrading enzyme endocr res numnum nummedline muller d baumeister h buck f richter d num atrial natriuretic peptide anp high affinity substrate rat insulin degrading enzyme eur j biochem numnum numabstract hamel fg gehm bd rosner rg duckworth wc num identification cleavage sites transforming growth factor insulin degrading enzymes biochim biophys acta numnum nummedline duckworth wc hamel fg peavy de liepnieks jj ryan mp hermodson ma frank bh num degradation products insulin generated hepatocytes insulin protease j biol chem numnum numabstractfree full text duckworth wc num insulin degradation mechanisms products significance endocr rev numnum numabstract garcia jv stoppelli mp thompson kl decker sj rosner mr num characterization drosophila protein binds epidermal growth factor insulin related growth factors j cell biol numnum numabstract kupfer marschke k wilson e french f num receptor accessory factor enhances specific dna binding androgen glucocorticoid receptors j biol chem numnum numabstractfree full text kupfer sr wilson em french fs num androgen glucocorticoid receptors interact insulin degrading enzyme j biol chem numnum numabstractfree full text bennett rg hamel fg duckworth wc num identification isolation cytosolic proteolytic complex containing insulin degrading enzyme multicatalytic proteinase biochem biophys res commun numnum numcrossrefmedline duckworth wc bennett rg hamel fg num direct inhibitory effect insulin cytosolic proteolytic complex containing insulin degrading enzyme multicatalytic proteinase j biol chem numnum numabstractfree full text bennett rg hamel fg duckworth wc num characterization insulin inhibition peptidolytic activities insulin degrading enzyme proteasome complex diabetes numnum numabstract hamel f bennett r harmon k duckworth w num insulin inhibition proteasome activity intact cells biochem biophys res commun numnum numcrossrefmedline ebrahim hamel fg bennett rg duckworth wc num identification metal associated insulin degrading enzyme biochem biophys res commun numnum nummedline ryan mp duckworth wc num partial characterization endogenous inhibitor calcium dependent form insulin protease biochem biophys res commun numnum nummedline ryan mp gifford jd solomon ss duckworth wc num calcium dependence insulin degradation rat skeletal muscle endocrinology numnum numabstract pershadsingh h shade d delfert d mcdonald j num chelation intracellular calcium blocks insulin action adipocyte proc natl acad sci usa numnum numabstract frank bh peavy de hooker cs duckworth wc num receptor binding properties monoiodotyrosyl insulin isomers purified high performance liquid chromatography diabetes numnum nummedline duckworth w heinemann m kitabchi num purification insulin specific protease affinity chromatography proc natl acad sci usa numnum numabstract blanchard j num buffers enzymes methods enzymol numnum nummedline duckworth w heinemann m kitabchi num proteolytic degradation insulin glucagon biochim biophys acta numnum nummedline saitoh y yokusawa h ishii num sodium dodecyl sulfate induced conformational enzymatic changes multicatalytic proteinase biochem biophys res commun numnum nummedline arribas j castano j num kinetic studies differential effect detergents peptidase activities multicatalytic proteinase rat liver j biol chem numnum numabstractfree full text authier f bergeron jj ou wj rachubinski ra posner bi walton pa num degradation cleaved leader peptide thiolase peroxisomal proteinase proc natl acad sci usa numnum numabstractfree full text kuo wl gehm bd rosner mr li w keller g num inducible expression cellular localization insulin degrading enzyme stably transfected cell line j biol chem numnum numabstractfree full text rabkin r birn h shi j roth r christensen e num insulin degrading enzyme ide renal proximal tubules diabetes numnuma hamel fg mahoney mj duckworth wc num degradation intraendosomal insulin insulin degrading enzyme without acidification diabetes numnum numabstract roth r mesirow m cassell d yokono k baba num characterization insulin degrading enzyme cultured human lymphocytes diabetes res clin pract numnum nummedline gehm bd rosner mr num regulation insulin epidermal growth factor transforming growth factor levels growth factor degrading enzymes endocrinology numnum numabstract kayalar c wong wt hendrickson l num differentiation symbnum primary skeletal muscle cells activity endogenous insulin degrading enzyme inhibited metalloendoprotease inhibitors j cell biochem numnum nummedline kayalar c wong w num metalloendoprotease inhibitors block differentiation symb myoblasts inhibit insulin degradation endogenous insulin degrading enzyme j biol chem numnum numabstractfree full text kuo wl montag ag rosner mr num insulin degrading enzyme differentially expressed developmentally regulated various rat tissues endocrinology numnum numabstract rivett num multicatalytic proteinase mammalian cells arch biochem biophys numnum nummedline hofmann ca lotan rm ku ww oeltmann tn num insulin ricin b hybrid molecules mediate insulin associated effect cells bind insulin j biol chem numnum numabstractfree full text miller ds num stimulation rna protein synthesis intracellular insulin science numnum nummedline draznin b trowbridge m num inhibition intracellular proteolysis insulin isolated rat hepatocytes possible role internalized hormone j biol chem numnum numabstractfree full text peavy de edmondson jw duckworth wc num selective effects inhibitors hormone processing insulin action isolated hepatocytes endocrinology numnum numabstract
0.2582762.9751483.html.plaintext.txt	71	references top abstract introduction materials methods results discussion references duckworth wc hamel fg bennett rg ryan mp roth ra num human red blood cell insulin degrading enzyme rat skeletal muscle insulin protease share antigenic sites generate identical products insulin j biol chem numnum numabstractfree full text authier f posner bi bergeron jjm num insulin degrading enzyme clin invest med numnum nummedline roth ra mesirow ml yokono k baba num degradation insulin like growth factors ii human insulin degrading enzyme endocr res numnum nummedline muller d baumeister h buck f richter d num atrial natriuretic peptide anp high affinity substrate rat insulin degrading enzyme eur j biochem numnum numabstract hamel fg gehm bd rosner rg duckworth wc num identification cleavage sites transforming growth factor insulin degrading enzymes biochim biophys acta numnum nummedline duckworth wc hamel fg peavy de liepnieks jj ryan mp hermodson ma frank bh num degradation products insulin generated hepatocytes insulin protease j biol chem numnum numabstractfree full text duckworth wc num insulin degradation mechanisms products significance endocr rev numnum numabstract garcia jv stoppelli mp thompson kl decker sj rosner mr num characterization drosophila protein binds epidermal growth factor insulin related growth factors j cell biol numnum numabstract kupfer marschke k wilson e french f num receptor accessory factor enhances specific dna binding androgen glucocorticoid receptors j biol chem numnum numabstractfree full text kupfer sr wilson em french fs num androgen glucocorticoid receptors interact insulin degrading enzyme j biol chem numnum numabstractfree full text bennett rg hamel fg duckworth wc num identification isolation cytosolic proteolytic complex containing insulin degrading enzyme multicatalytic proteinase biochem biophys res commun numnum numcrossrefmedline duckworth wc bennett rg hamel fg num direct inhibitory effect insulin cytosolic proteolytic complex containing insulin degrading enzyme multicatalytic proteinase j biol chem numnum numabstractfree full text bennett rg hamel fg duckworth wc num characterization insulin inhibition peptidolytic activities insulin degrading enzyme proteasome complex diabetes numnum numabstract hamel f bennett r harmon k duckworth w num insulin inhibition proteasome activity intact cells biochem biophys res commun numnum numcrossrefmedline ebrahim hamel fg bennett rg duckworth wc num identification metal associated insulin degrading enzyme biochem biophys res commun numnum nummedline ryan mp duckworth wc num partial characterization endogenous inhibitor calcium dependent form insulin protease biochem biophys res commun numnum nummedline ryan mp gifford jd solomon ss duckworth wc num calcium dependence insulin degradation rat skeletal muscle endocrinology numnum numabstract pershadsingh h shade d delfert d mcdonald j num chelation intracellular calcium blocks insulin action adipocyte proc natl acad sci usa numnum numabstract frank bh peavy de hooker cs duckworth wc num receptor binding properties monoiodotyrosyl insulin isomers purified high performance liquid chromatography diabetes numnum nummedline duckworth w heinemann m kitabchi num purification insulin specific protease affinity chromatography proc natl acad sci usa numnum numabstract blanchard j num buffers enzymes methods enzymol numnum nummedline duckworth w heinemann m kitabchi num proteolytic degradation insulin glucagon biochim biophys acta numnum nummedline saitoh y yokusawa h ishii num sodium dodecyl sulfate induced conformational enzymatic changes multicatalytic proteinase biochem biophys res commun numnum nummedline arribas j castano j num kinetic studies differential effect detergents peptidase activities multicatalytic proteinase rat liver j biol chem numnum numabstractfree full text authier f bergeron jj ou wj rachubinski ra posner bi walton pa num degradation cleaved leader peptide thiolase peroxisomal proteinase proc natl acad sci usa numnum numabstractfree full text kuo wl gehm bd rosner mr li w keller g num inducible expression cellular localization insulin degrading enzyme stably transfected cell line j biol chem numnum numabstractfree full text rabkin r birn h shi j roth r christensen e num insulin degrading enzyme ide renal proximal tubules diabetes numnuma hamel fg mahoney mj duckworth wc num degradation intraendosomal insulin insulin degrading enzyme without acidification diabetes numnum numabstract roth r mesirow m cassell d yokono k baba num characterization insulin degrading enzyme cultured human lymphocytes diabetes res clin pract numnum nummedline gehm bd rosner mr num regulation insulin epidermal growth factor transforming growth factor levels growth factor degrading enzymes endocrinology numnum numabstract kayalar c wong wt hendrickson l num differentiation symbnum primary skeletal muscle cells activity endogenous insulin degrading enzyme inhibited metalloendoprotease inhibitors j cell biochem numnum nummedline kayalar c wong w num metalloendoprotease inhibitors block differentiation symb myoblasts inhibit insulin degradation endogenous insulin degrading enzyme j biol chem numnum numabstractfree full text kuo wl montag ag rosner mr num insulin degrading enzyme differentially expressed developmentally regulated various rat tissues endocrinology numnum numabstract rivett num multicatalytic proteinase mammalian cells arch biochem biophys numnum nummedline hofmann ca lotan rm ku ww oeltmann tn num insulin ricin b hybrid molecules mediate insulin associated effect cells bind insulin j biol chem numnum numabstractfree full text miller ds num stimulation rna protein synthesis intracellular insulin science numnum nummedline draznin b trowbridge m num inhibition intracellular proteolysis insulin isolated rat hepatocytes possible role internalized hormone j biol chem numnum numabstractfree full text peavy de edmondson jw duckworth wc num selective effects inhibitors hormone processing insulin action isolated hepatocytes endocrinology numnum numabstract
0.26019153.11581097.html.plaintext.txt	0	diabetes mellitus risk alzheimers disease dementia stroke multiethnic cohort
0.26019153.11581097.html.plaintext.txt	1	jose symbnum ming xin symbnum yaakov symbnumnum steven symbnum richard symbnum num
0.26019153.11581097.html.plaintext.txt	2	num taub institute research alzheimers disease aging brain columbia university new york ny num division general medicine department medicine college physicians surgeons columbia university new york ny num division biostatistics joseph p mailman school public health columbia university new york ny num gertrude h sergievsky center columbia university new york ny num department psychiatry college physicians surgeons columbia university new york ny num division epidemiology joseph p mailman school public health columbia university new york ny num department neurology college physicians surgeons columbia university new york ny
0.26019153.11581097.html.plaintext.txt	3	num taub institute research alzheimers disease aging brain columbia university new york ny num division general medicine department medicine college physicians surgeons columbia university new york ny num division biostatistics joseph p mailman school public health columbia university new york ny num gertrude h sergievsky center columbia university new york ny num department psychiatry college physicians surgeons columbia university new york ny num division epidemiology joseph p mailman school public health columbia university new york ny num department neurology college physicians surgeons columbia university new york ny
0.26019153.11581097.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references research relation diabetes mellitus dementia produced conflicting results relation investigated among blacks hispanics study cox proportional hazards models used analyze longitudinal data numnum elderly subjects without dementia baseline num num followed average numnum years num num outcomes incident alzheimers disease dementia associated stroke prevalence diabetes num baseline adjusted relative risk alzheimers disease among persons diabetes compared without diabetes numnum num confidence interval ci numnum numnum adjusted relative risk composite outcome alzheimers disease cognitive impairment without dementia without stroke subjects diabetes numnum num ci numnum numnum adjusted relative risk stroke associated dementia persons diabetes numnum num ci numnum numnum among blacks hispanics approximately one third risk stroke associated dementia attributable diabetes num num ci num num num num ci num num respectively compared num num ci num num among whites finding association diabetes composite outcome alzheimers disease cognitive impairment without dementia without stroke consistent prior reports modest relation diabetes alzheimers disease
0.26019153.11581097.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references research relation diabetes mellitus dementia produced conflicting results relation investigated among blacks hispanics study cox proportional hazards models used analyze longitudinal data numnum elderly subjects without dementia baseline num num followed average numnum years num num outcomes incident alzheimers disease dementia associated stroke prevalence diabetes num baseline adjusted relative risk alzheimers disease among persons diabetes compared without diabetes numnum num confidence interval ci numnum numnum adjusted relative risk composite outcome alzheimers disease cognitive impairment without dementia without stroke subjects diabetes numnum num ci numnum numnum adjusted relative risk stroke associated dementia persons diabetes numnum num ci numnum numnum among blacks hispanics approximately one third risk stroke associated dementia attributable diabetes num num ci num num num num ci num num respectively compared num num ci num num among whites finding association diabetes composite outcome alzheimers disease cognitive impairment without dementia without stroke consistent prior reports modest relation diabetes alzheimers disease
0.26019153.11581097.html.plaintext.txt	6	alzheimer disease dementia diabetes mellitus survival analysis
0.26019153.11581097.html.plaintext.txt	7	abbreviations ci confidence interval nincds adrda national institute neurological communicative disorders stroke alzheimers disease related disorders association ninds airen national institute neurological disorders stroke association internationale pour la recherche et lenseignement en neurosciences
0.26019153.11581097.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion references dementia diabetes mellitus two prevalent problems elderly num percent people age num years develop dementia prevalence dementia increases num percent people age num num num num percent elderly suffer diabetes prevalence increasing num num dementia diabetes common among blacks hispanics num num differences predictive ability known risk factors dementia across ethnic groups num num num
0.26019153.11581097.html.plaintext.txt	9	introduction top abstract introduction materials methods results discussion references dementia diabetes mellitus two prevalent problems elderly num percent people age num years develop dementia prevalence dementia increases num percent people age num num num num percent elderly suffer diabetes prevalence increasing num num dementia diabetes common among blacks hispanics num num differences predictive ability known risk factors dementia across ethnic groups num num num
0.26019153.11581097.html.plaintext.txt	10	association diabetes vascular dementia may depend presence subclinical cerebrovascular disease frank stroke num num may mediated traditional cardiovascular disease risk factors specifically hyperlipidemia hypertension num num relation diabetes alzheimers disease less obvious although role glycated end products pathogenesis alzheimers disease hypothesized num num
0.26019153.11581097.html.plaintext.txt	11	association diabetes vascular dementia may depend presence subclinical cerebrovascular disease frank stroke num num may mediated traditional cardiovascular disease risk factors specifically hyperlipidemia hypertension num num relation diabetes alzheimers disease less obvious although role glycated end products pathogenesis alzheimers disease hypothesized num num
0.26019153.11581097.html.plaintext.txt	12	several longitudinal studies demonstrated association history diabetes cognitive deficits num num dementia num num finding associa tion diabetes alzheimers disease inconsistent two reports rotterdam study showed relation diabetes alzheimers disease relative risks numnum num percent confidence interval ci numnum numnum numnum num percent ci numnum numnum num num relative risk alzheimers disease among subjects treated insulin higher among subjects treated oral hypoglycemic agents compared subjects without diabetes one studies num recent report cohort risk alzheimers disease elevated among diabetic subjects treated insulin risk elevated among subjects treated oral hypoglycemic agents num one study rochester minnesota num reported doubling risk alzheimers disease among men diabetes compared men without diabetes relative risk numnum num percent ci numnum numnum non statistically significant increased risk among women relative risk numnum num percent ci numnum numnum another study british cohort also reported higher risk alzheimers disease among subjects diabetes compared subjects without relative risk numnum num percent ci numnum numnum num studies relative risk alzheimers disease lower overall dementia vascular dementia risk attenuated cases stroke excluded
0.26019153.11581097.html.plaintext.txt	13	several longitudinal studies demonstrated association history diabetes cognitive deficits num num dementia num num finding associa tion diabetes alzheimers disease inconsistent two reports rotterdam study showed relation diabetes alzheimers disease relative risks numnum num percent confidence interval ci numnum numnum numnum num percent ci numnum numnum num num relative risk alzheimers disease among subjects treated insulin higher among subjects treated oral hypoglycemic agents compared subjects without diabetes one studies num recent report cohort risk alzheimers disease elevated among diabetic subjects treated insulin risk elevated among subjects treated oral hypoglycemic agents num one study rochester minnesota num reported doubling risk alzheimers disease among men diabetes compared men without diabetes relative risk numnum num percent ci numnum numnum non statistically significant increased risk among women relative risk numnum num percent ci numnum numnum another study british cohort also reported higher risk alzheimers disease among subjects diabetes compared subjects without relative risk numnum num percent ci numnum numnum num studies relative risk alzheimers disease lower overall dementia vascular dementia risk attenuated cases stroke excluded
0.26019153.11581097.html.plaintext.txt	14	incidence vascular dementia varies considerably depending criteria used num cases vascular dementia classified alzheimers disease finding weak relation diabetes alzheimers disease may due misclassification one study used sensitive criteria detection vascular dementia found association diabetes alzheimers disease relative risks alzheimers disease subjects diabetes compared subjects without diabetes numnum num percent ci numnum numnum numnum num percent ci numnum numnum researchers considered num year history diabetes num year history diabetes respectively num thus finding relation diabetes dementia specifically alzheimers disease vascular dementia may depend criteria used define vascular dementia accuracy diagnostic procedures employed none previous studies examining relation diabetes dementia included large numbers blacks hispanics
0.26019153.11581097.html.plaintext.txt	15	incidence vascular dementia varies considerably depending criteria used num cases vascular dementia classified alzheimers disease finding weak relation diabetes alzheimers disease may due misclassification one study used sensitive criteria detection vascular dementia found association diabetes alzheimers disease relative risks alzheimers disease subjects diabetes compared subjects without diabetes numnum num percent ci numnum numnum numnum num percent ci numnum numnum researchers considered num year history diabetes num year history diabetes respectively num thus finding relation diabetes dementia specifically alzheimers disease vascular dementia may depend criteria used define vascular dementia accuracy diagnostic procedures employed none previous studies examining relation diabetes dementia included large numbers blacks hispanics
0.26019153.11581097.html.plaintext.txt	16	objective study clarify association diabetes different types dementia prevalence diabetes blacks hispanics higher whites num num also examined whether difference could account higher risk dementia reported non whites num num
0.26019153.11581097.html.plaintext.txt	17	objective study clarify association diabetes different types dementia prevalence diabetes blacks hispanics higher whites num num also examined whether difference could account higher risk dementia reported non whites num num
0.26019153.11581097.html.plaintext.txt	18	materials methods top abstract introduction materials methods results discussion references study population participants washington heights inwood columbia aging project cohort drawn random sampling healthy medicare beneficiaries aged num years residing within geographically defined area northern manhattan new york city sampling procedures described elsewhere num subject underwent person structured interview health function time study entry followed completion standard medical history physical neurologic examinations battery neuropsychological tests num subjects recruited num num followed annually evaluations used baseline repeated follow subjects followed average numnum years num num persons completed least num year follow included analysis numnum persons underwent baseline assessment num persons excluded prevalent dementia num persons available follow num died num refused follow moved num excluded persons slightly older analytical sample mean age num years vs num years similar regard gender ethnic distributions lower prevalence diabetes num percent vs num percent final sample comprised numnum subjects
0.26019153.11581097.html.plaintext.txt	19	materials methods top abstract introduction materials methods results discussion references study population participants washington heights inwood columbia aging project cohort drawn random sampling healthy medicare beneficiaries aged num years residing within geographically defined area northern manhattan new york city sampling procedures described elsewhere num subject underwent person structured interview health function time study entry followed completion standard medical history physical neurologic examinations battery neuropsychological tests num subjects recruited num num followed annually evaluations used baseline repeated follow subjects followed average numnum years num num persons completed least num year follow included analysis numnum persons underwent baseline assessment num persons excluded prevalent dementia num persons available follow num died num refused follow moved num excluded persons slightly older analytical sample mean age num years vs num years similar regard gender ethnic distributions lower prevalence diabetes num percent vs num percent final sample comprised numnum subjects
0.26019153.11581097.html.plaintext.txt	20	diagnosis dementia cognitive impairment diagnosis dementia assignment specific cause made group neurologists psychiatrists neuropsychologists consensus basis information gathered initial visit follow visits dementia diagnosis based criteria diagnostic statistical manual mental disorders fourth edition num required evidence cognitive deficits neuropsychological test battery well evidence impairment social occupational functioning clinical dementia rating numnum num diagnosis alzheimers disease based criteria national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda num diagnosis dementia associated stroke hereafter called stroke associated dementia made subjects dementia stroke judged main cause dementia based evidence focal effects stroke temporal relation dementia brain imaging available num percent cases stroke remainder world health organization criteria used define stroke num subjects without dementia history stroke baseline examination included analyses diagnosis cognitive impairment without dementia hereafter called nondementia cognitive impairment made neuropsychological testing detected memory impairment one standard deviation lower normal subjects age individual reported impairment mild impairment social occupational activities clinical dementia rating numnum num
0.26019153.11581097.html.plaintext.txt	21	diagnosis dementia cognitive impairment diagnosis dementia assignment specific cause made group neurologists psychiatrists neuropsychologists consensus basis information gathered initial visit follow visits dementia diagnosis based criteria diagnostic statistical manual mental disorders fourth edition num required evidence cognitive deficits neuropsychological test battery well evidence impairment social occupational functioning clinical dementia rating numnum num diagnosis alzheimers disease based criteria national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda num diagnosis dementia associated stroke hereafter called stroke associated dementia made subjects dementia stroke judged main cause dementia based evidence focal effects stroke temporal relation dementia brain imaging available num percent cases stroke remainder world health organization criteria used define stroke num subjects without dementia history stroke baseline examination included analyses diagnosis cognitive impairment without dementia hereafter called nondementia cognitive impairment made neuropsychological testing detected memory impairment one standard deviation lower normal subjects age individual reported impairment mild impairment social occupational activities clinical dementia rating numnum num
0.26019153.11581097.html.plaintext.txt	22	diagnosis diabetes covariates presence diabetes based reported use insulin oral hypoglycemic agents clinical history diabetes hypertension heart disease smoking based self report clinical history ethnic group based self report using format num us census num individuals asked whether hispanic origin subjects assigned one three ethnic groups non hispanic black hispanic non hispanic white years education obtained self report apolipoprotein e genotyping obtained amplification genomic dna polymerase chain reaction subjected cfoi restriction analysis using apolipoprotein e primers conditions similar described hixson vernier num fasting plasma total cholesterol triglyceride levels determined initial assessment using standard enzymatic techniques high density lipoprotein cholesterol determined precipitation apolipoprotein b containing lipoproteins phosphotungstic acid num low density lipoprotein cholesterol levels calculated using formula friedewald et al num
0.26019153.11581097.html.plaintext.txt	23	diagnosis diabetes covariates presence diabetes based reported use insulin oral hypoglycemic agents clinical history diabetes hypertension heart disease smoking based self report clinical history ethnic group based self report using format num us census num individuals asked whether hispanic origin subjects assigned one three ethnic groups non hispanic black hispanic non hispanic white years education obtained self report apolipoprotein e genotyping obtained amplification genomic dna polymerase chain reaction subjected cfoi restriction analysis using apolipoprotein e primers conditions similar described hixson vernier num fasting plasma total cholesterol triglyceride levels determined initial assessment using standard enzymatic techniques high density lipoprotein cholesterol determined precipitation apolipoprotein b containing lipoproteins phosphotungstic acid num low density lipoprotein cholesterol levels calculated using formula friedewald et al num
0.26019153.11581097.html.plaintext.txt	24	data analysis prevalences diabetes covariates compared subjects without alzheimers disease subjects without stroke associated dementia continuous variables compared analysis variance categorical variables compared num test cox proportional hazards modeling used multivariate analyses time event variable age onset dementia models stratified year entry cohort order control period effects recommended longitudinal studies num one model outcome mentioned covariates treated time constant covariates using baseline values num num subjects diabetes diagnosis made baseline persons treated diabetes baseline additional analysis carried treating diabetes time dependent covariate taking account date reporting diabetes diagnosis analysis conducted examine definition diabetes baseline vs follow affected analysis similar analysis carried treating variables time dependent covariates beginning exposure used beginning observation later num subjects diagnosed diabetes baseline compare results time constant covariate model subjects without outcome censored time last follow visit subjects type dementia different one considered specific model censored time onset dementia example alzheimers disease examined outcome persons stroke associated dementia censored time dementia onset additional analyses performed using nondementia cognitive impairment without stroke nondementia cognitive impairment stroke outcomes persons nondementia cognitive impairment baseline excluded
0.26019153.11581097.html.plaintext.txt	25	data analysis prevalences diabetes covariates compared subjects without alzheimers disease subjects without stroke associated dementia continuous variables compared analysis variance categorical variables compared num test cox proportional hazards modeling used multivariate analyses time event variable age onset dementia models stratified year entry cohort order control period effects recommended longitudinal studies num one model outcome mentioned covariates treated time constant covariates using baseline values num num subjects diabetes diagnosis made baseline persons treated diabetes baseline additional analysis carried treating diabetes time dependent covariate taking account date reporting diabetes diagnosis analysis conducted examine definition diabetes baseline vs follow affected analysis similar analysis carried treating variables time dependent covariates beginning exposure used beginning observation later num subjects diagnosed diabetes baseline compare results time constant covariate model subjects without outcome censored time last follow visit subjects type dementia different one considered specific model censored time onset dementia example alzheimers disease examined outcome persons stroke associated dementia censored time dementia onset additional analyses performed using nondementia cognitive impairment without stroke nondementia cognitive impairment stroke outcomes persons nondementia cognitive impairment baseline excluded
0.26019153.11581097.html.plaintext.txt	26	population attributable risk par diabetes relation dementia calculated ethnic group using formula par prhr numnum prhr num hr adjusted hazard ratio obtained multivariate models pr prevalence diabetes ethnic group cohort num percent confidence intervals calculated population attributable risk using methods described prospective studies num sas windows version num sas institute inc cary north carolina used analyses
0.26019153.11581097.html.plaintext.txt	27	population attributable risk par diabetes relation dementia calculated ethnic group using formula par prhr numnum prhr num hr adjusted hazard ratio obtained multivariate models pr prevalence diabetes ethnic group cohort num percent confidence intervals calculated population attributable risk using methods described prospective studies num sas windows version num sas institute inc cary north carolina used analyses
0.26019153.11581097.html.plaintext.txt	28	results top abstract introduction materials methods results discussion references mean age cohort numnum years standard deviation numnum numnum percent subjects women forty five percent subjects hispanic num percent black prevalence diabetes numnum percent whites numnum percent blacks numnum percent hispanics num incident cases dementia cohort num cases num percent due alzheimers disease num cases num percent due stroke num cases num percent due causes incidence dementia numnum per numnum person years whites num cases num alzheimers disease four stroke associated dementia six numnum per numnum person years blacks num cases num alzheimers disease num stroke associated dementia four numnum per numnum person years hispanics num cases num alzheimers disease num stroke associated dementia num
0.26019153.11581097.html.plaintext.txt	29	table num shows comparison characteristics subjects sample subjects alzheimers disease stroke associated dementia nondementia cognitive impairment without stroke nondementia cognitive impairment stroke persons alzheimers disease older fewer years education higher proportion blacks higher prevalence heart disease persons without alzheimers disease persons stroke associated dementia older higher prevalence diabetes higher level low density lipoprotein cholesterol higher prevalence hypertension higher prevalence heart disease persons without stroke associated dementia exclusion num cases nondementia cognitive impairment baseline numnum persons left analysis nondementia cognitive impairment persons nondementia cognitive impairment without stroke older fewer years education higher proportion ever smokers higher proportion hispanics persons without persons nondementia cognitive impairment stroke higher prevalence hypertension heart disease persons without
0.26019153.11581097.html.plaintext.txt	30	table num shows comparison characteristics subjects sample subjects alzheimers disease stroke associated dementia nondementia cognitive impairment without stroke nondementia cognitive impairment stroke persons alzheimers disease older fewer years education higher proportion blacks higher prevalence heart disease persons without alzheimers disease persons stroke associated dementia older higher prevalence diabetes higher level low density lipoprotein cholesterol higher prevalence hypertension higher prevalence heart disease persons without stroke associated dementia exclusion num cases nondementia cognitive impairment baseline numnum persons left analysis nondementia cognitive impairment persons nondementia cognitive impairment without stroke older fewer years education higher proportion ever smokers higher proportion hispanics persons without persons nondementia cognitive impairment stroke higher prevalence hypertension heart disease persons without
0.26019153.11581097.html.plaintext.txt	31	view table table num characteristics subjects baseline washington heights inwood columbia aging project new york city num num
0.26019153.11581097.html.plaintext.txt	32	multivariate adjusted hazard ratio alzheimers disease relation diabetes compared absence diabetes numnum num percent ci numnum numnum hazard ratio stroke associated dementia relation diabetes numnum num percent ci numnum numnum table num population attributable risk diabetes relation stroke associated dementia num percent num percent ci num num among hispanics num percent num percent ci num num among non hispanic blacks num percent num percent ci num num among non hispanic whites
0.26019153.11581097.html.plaintext.txt	33	view table table num hazard ratios dementia cognitive impairment persons diabetes mellitus compared persons without diabetes washington heights inwood columbia aging project new york city num num
0.26019153.11581097.html.plaintext.txt	34	hazard ratio nondementia cognitive impairment without stroke persons diabetes compared persons without diabetes numnum num percent ci numnum numnum hazard ratio nondementia cognitive impairment stroke relation diabetes numnum num percent ci numnum numnum table num persons nondementia cognitive impairment increased risk developing alzheimers disease compared persons without nondementia cognitive impairment num therefore conducted analysis examining relation diabetes composite outcome alzheimers disease nondementia cognitive impairment without stroke hazard ratio composite outcome relation diabetes compared absence diabetes numnum num percent ci numnum numnum
0.26019153.11581097.html.plaintext.txt	35	performed subgroup analysis examining relation diabetes stroke associated dementia num persons stroke estimate effect diabetes independent stroke adjusted hazard ratio stroke associated dementia relation diabetes compared absence diabetes numnum num percent ci numnum numnum
0.26019153.11581097.html.plaintext.txt	36	performed subgroup analysis examining relation diabetes stroke associated dementia num persons stroke estimate effect diabetes independent stroke adjusted hazard ratio stroke associated dementia relation diabetes compared absence diabetes numnum num percent ci numnum numnum
0.26019153.11581097.html.plaintext.txt	37	performed another analysis reclassifying num cases alzheimers disease stroke cases stroke associated dementia hazard ratio alzheimers disease relation diabetes compared absence diabetes unchanged relative risk numnum num percent ci numnum numnum hazard ratio alzheimers disease relation diabetes also remained unchanged excluded cases stroke analysis
0.26019153.11581097.html.plaintext.txt	38	performed additional analysis examining effect diabetes treatment relation diabetes alzheimers disease previous studies reported increased risk alzheimers disease among subjects treated insulin smaller increase increase risk among subjects using oral hypoglycemic agents comparison subjects without diabetes num num models built including dummy variables insulin oral hypoglycemic agents subjects without diabetes used reference group hazard ratio alzheimers disease relation diabetes compared absence diabetes numnum num percent ci numnum numnum persons reporting insulin use numnum num percent ci numnum numnum persons reporting use oral hypoglycemic agents hazard ratio stroke associated dementia among insulin using subjects diabetes numnum num percent ci numnum numnum hazard ratio among diabetic subjects using oral hypoglycemic agents numnum num percent ci numnum numnum hazard ratios composite outcome alzheimers disease nondementia cognitive impairment without stroke among subjects using insulin subjects using oral hypoglycemic agents compared subjects without diabetes materially different hazard ratio subjects diabetes
0.26019153.11581097.html.plaintext.txt	39	performed additional analysis examining effect diabetes treatment relation diabetes alzheimers disease previous studies reported increased risk alzheimers disease among subjects treated insulin smaller increase increase risk among subjects using oral hypoglycemic agents comparison subjects without diabetes num num models built including dummy variables insulin oral hypoglycemic agents subjects without diabetes used reference group hazard ratio alzheimers disease relation diabetes compared absence diabetes numnum num percent ci numnum numnum persons reporting insulin use numnum num percent ci numnum numnum persons reporting use oral hypoglycemic agents hazard ratio stroke associated dementia among insulin using subjects diabetes numnum num percent ci numnum numnum hazard ratio among diabetic subjects using oral hypoglycemic agents numnum num percent ci numnum numnum hazard ratios composite outcome alzheimers disease nondementia cognitive impairment without stroke among subjects using insulin subjects using oral hypoglycemic agents compared subjects without diabetes materially different hazard ratio subjects diabetes
0.26019153.11581097.html.plaintext.txt	40	models covariates hypertension diabetes treated time constant covariates assume lifetime exposure may thereby overestimated exposure therefore also fitted models specifying covariates time dependent covariates beginning exposure set beginning observation num subjects diabetes cohort num diagnosis diabetes made baseline examination thus fitted another model time dependent covariates taking account time diabetes diagnosis num subjects hazard ratios two models using time dependent covariates close main models
0.26019153.11581097.html.plaintext.txt	41	models covariates hypertension diabetes treated time constant covariates assume lifetime exposure may thereby overestimated exposure therefore also fitted models specifying covariates time dependent covariates beginning exposure set beginning observation num subjects diabetes cohort num diagnosis diabetes made baseline examination thus fitted another model time dependent covariates taking account time diabetes diagnosis num subjects hazard ratios two models using time dependent covariates close main models
0.26019153.11581097.html.plaintext.txt	42	discussion top abstract introduction materials methods results discussion references longitudinal data numnum subjects multiethnic community cohort numnum years follow diabetes related stroke associated dementia hazard ratio numnum num percent ci numnum numnum composite outcome alzheimers disease cognitive deficit without dementia without stroke hazard ratio numnum num percent ci numnum numnum association diabetes incident alzheimers disease statistically significant hazard ratio numnum num percent ci numnum numnum relations diabetes nondementia cognitive impairment without stroke paralleled relations diabetes stroke associated dementia alzheimers disease respectively population attributable risk diabetes relation stroke associated dementia varied ethnic group approximately twice great hispanics blacks whites
0.26019153.11581097.html.plaintext.txt	43	discussion top abstract introduction materials methods results discussion references longitudinal data numnum subjects multiethnic community cohort numnum years follow diabetes related stroke associated dementia hazard ratio numnum num percent ci numnum numnum composite outcome alzheimers disease cognitive deficit without dementia without stroke hazard ratio numnum num percent ci numnum numnum association diabetes incident alzheimers disease statistically significant hazard ratio numnum num percent ci numnum numnum relations diabetes nondementia cognitive impairment without stroke paralleled relations diabetes stroke associated dementia alzheimers disease respectively population attributable risk diabetes relation stroke associated dementia varied ethnic group approximately twice great hispanics blacks whites
0.26019153.11581097.html.plaintext.txt	44	risk vascular dementia increases greatly stroke num num may caused large small vessel disease num num associated diabetes likely diabetes affects risk vascular dementia partly contributing dyslipidemia hypertension hyperlipidemia hypertension reported investigators associated vascular dementia num num num associations also present data strong though statistically nonsignificant hazard ratio stroke associated dementia diabetic persons compared nondiabetic persons among subjects stroke hazard ratio numnum num percent ci numnum numnum suggests diabetes contributes risk stroke associated dementia additional mechanisms one mechanism proposed diabetes related impairment cerebral vasoreactivity accompanying changes blood flow num num
0.26019153.11581097.html.plaintext.txt	45	risk vascular dementia increases greatly stroke num num may caused large small vessel disease num num associated diabetes likely diabetes affects risk vascular dementia partly contributing dyslipidemia hypertension hyperlipidemia hypertension reported investigators associated vascular dementia num num num associations also present data strong though statistically nonsignificant hazard ratio stroke associated dementia diabetic persons compared nondiabetic persons among subjects stroke hazard ratio numnum num percent ci numnum numnum suggests diabetes contributes risk stroke associated dementia additional mechanisms one mechanism proposed diabetes related impairment cerebral vasoreactivity accompanying changes blood flow num num
0.26019153.11581097.html.plaintext.txt	46	mechanisms underlying possible association diabetes alzheimers disease remain unclear one possibility production glycation end products num num however reductions plasma amyloid precursor protein reported elevation plasma levels glucose insulin num insulin reported decrease ss amyloid neurotoxicity vitro num findings raise possibility hyperinsulinemia one characteristics type ii diabetes may decrease deposition amyloid protein brain key step pathogenesis alzheimers disease num num mechanisms underlying weak relation diabetes alzheimers disease remain clarified
0.26019153.11581097.html.plaintext.txt	47	mechanisms underlying possible association diabetes alzheimers disease remain unclear one possibility production glycation end products num num however reductions plasma amyloid precursor protein reported elevation plasma levels glucose insulin num insulin reported decrease ss amyloid neurotoxicity vitro num findings raise possibility hyperinsulinemia one characteristics type ii diabetes may decrease deposition amyloid protein brain key step pathogenesis alzheimers disease num num mechanisms underlying weak relation diabetes alzheimers disease remain clarified
0.26019153.11581097.html.plaintext.txt	48	three longitudinal studies reported increased risk dementia including alzheimers disease among persons diabetes num num two studies used nincds adrda criteria diagnosis alzheimers disease num num num one showed risk alzheimers disease lower risk overall dementia persons diabetes num showed risk alzheimers disease subjects decreased excluding subjects stroke although risk remained significant num third study used criteria diagnostic statistical manual mental disorders third edition revised diagnosis dementia based medical record review autopsy data num studies limited ability detect vascular dementia definition vascular dementia controversial depending criteria used incidence vascular dementia vary severalfold num cases stroke associated dementia misclassified cases alzheimers disease risk factors stroke associated dementia appear predict alzheimers disease one study used nincds adrda criteria diagnosis alzheimers disease criteria california state alzheimers disease diagnostic treatment centers diagnosis vascular dementia found relation diabetes vascular dementia alzheimers disease num
0.26019153.11581097.html.plaintext.txt	49	three longitudinal studies reported increased risk dementia including alzheimers disease among persons diabetes num num two studies used nincds adrda criteria diagnosis alzheimers disease num num num one showed risk alzheimers disease lower risk overall dementia persons diabetes num showed risk alzheimers disease subjects decreased excluding subjects stroke although risk remained significant num third study used criteria diagnostic statistical manual mental disorders third edition revised diagnosis dementia based medical record review autopsy data num studies limited ability detect vascular dementia definition vascular dementia controversial depending criteria used incidence vascular dementia vary severalfold num cases stroke associated dementia misclassified cases alzheimers disease risk factors stroke associated dementia appear predict alzheimers disease one study used nincds adrda criteria diagnosis alzheimers disease criteria california state alzheimers disease diagnostic treatment centers diagnosis vascular dementia found relation diabetes vascular dementia alzheimers disease num
0.26019153.11581097.html.plaintext.txt	50	criteria california alzheimers disease diagnostic treatment centers sensitive diagnosis vascular dementia num would therefore classify fewer cases stroke associated dementia cases alzheimers disease thus appears relation diabetes alzheimers disease sensitive criteria used define vascular dementia addressed issue reclassifying subjects alzheimers disease also stroke subjects stroke associated dementia including cases temporal relation dementia stroke unclear hazard ratios analysis remained essentially unchanged criteria diagnosis stroke associated dementia used last analysis consistent national institute neurological disorders stroke association internationale pour la recherche et lenseignement en neurosciences ninds airen num ninds airen criteria sensitive detection vascular dementia california criteria used study found relation diabetes alzheimers disease num however misclassification cases stroke associated dementia cases alzheimers disease unlikely explanation finding relation diabetes alzheimers disease results unchanged exclusion stroke cases analyses reclassification dementia subtypes described finding slightly greater risk alzheimers disease among subjects using insulin among using oral hypoglycemic agents consistent findings rotterdam study num num may reflect possibility diabetic subjects used insulin severe prolonged diabetes
0.26019153.11581097.html.plaintext.txt	51	criteria california alzheimers disease diagnostic treatment centers sensitive diagnosis vascular dementia num would therefore classify fewer cases stroke associated dementia cases alzheimers disease thus appears relation diabetes alzheimers disease sensitive criteria used define vascular dementia addressed issue reclassifying subjects alzheimers disease also stroke subjects stroke associated dementia including cases temporal relation dementia stroke unclear hazard ratios analysis remained essentially unchanged criteria diagnosis stroke associated dementia used last analysis consistent national institute neurological disorders stroke association internationale pour la recherche et lenseignement en neurosciences ninds airen num ninds airen criteria sensitive detection vascular dementia california criteria used study found relation diabetes alzheimers disease num however misclassification cases stroke associated dementia cases alzheimers disease unlikely explanation finding relation diabetes alzheimers disease results unchanged exclusion stroke cases analyses reclassification dementia subtypes described finding slightly greater risk alzheimers disease among subjects using insulin among using oral hypoglycemic agents consistent findings rotterdam study num num may reflect possibility diabetic subjects used insulin severe prolonged diabetes
0.26019153.11581097.html.plaintext.txt	52	performed additional analyses using nondementia cognitive impairment outcome analyses yielded results similar dementia inconsistent reports association diabetes cognitive impairment num num num subjects cognitive deficits functional disability determined higher risk dementia num thus association diabetes cognitive impairment would expected similar diabetes dementia findings nondementia cognitive impairment support results main analyses
0.26019153.11581097.html.plaintext.txt	53	performed additional analyses using nondementia cognitive impairment outcome analyses yielded results similar dementia inconsistent reports association diabetes cognitive impairment num num num subjects cognitive deficits functional disability determined higher risk dementia num thus association diabetes cognitive impairment would expected similar diabetes dementia findings nondementia cognitive impairment support results main analyses
0.26019153.11581097.html.plaintext.txt	54	one explanation finding nonsignificant weak association diabetes alzheimers disease may relation truly exists study lacked statistical power detect analysis using composite outcome alzheimers disease nondementia cognitive impairment without stroke showing statistically significant association diabetes compared absence diabetes hazard ratio numnum num percent ci numnum numnum consistent interpretation another possible explanation nonsignificant finding misclassification error diabetes alzheimers disease may diluted relation diabetes alzheimers disease self reported diabetes used study almost certainly underestimated true prevalence diabetes true prevalence reported twice prevalence self reported disease subjects undiagnosed diabetes considered num
0.26019153.11581097.html.plaintext.txt	55	one explanation finding nonsignificant weak association diabetes alzheimers disease may relation truly exists study lacked statistical power detect analysis using composite outcome alzheimers disease nondementia cognitive impairment without stroke showing statistically significant association diabetes compared absence diabetes hazard ratio numnum num percent ci numnum numnum consistent interpretation another possible explanation nonsignificant finding misclassification error diabetes alzheimers disease may diluted relation diabetes alzheimers disease self reported diabetes used study almost certainly underestimated true prevalence diabetes true prevalence reported twice prevalence self reported disease subjects undiagnosed diabetes considered num
0.26019153.11581097.html.plaintext.txt	56	study important strengths longitudinal study nondemented elderly subjects three ethnic groups used standardized procedures diagnosis dementia subtypes prospective fashion main limitations study lack data duration diabetes severity diabetes presence undiagnosed diabetes multivariate models assumed lifetime duration exposure could resulted error measurement exposures diabetes lipid levels hypertension however noted appreciably affect hazard ratios diabetes relation alzheimers disease stroke associated dementia
0.26019153.11581097.html.plaintext.txt	57	study important strengths longitudinal study nondemented elderly subjects three ethnic groups used standardized procedures diagnosis dementia subtypes prospective fashion main limitations study lack data duration diabetes severity diabetes presence undiagnosed diabetes multivariate models assumed lifetime duration exposure could resulted error measurement exposures diabetes lipid levels hypertension however noted appreciably affect hazard ratios diabetes relation alzheimers disease stroke associated dementia
0.26019153.11581097.html.plaintext.txt	58	findings study support previous longitudinal studies reported weak association diabetes alzheimers disease strong association diabetes stroke associated dementia extend observations minority population groups population attributable risk diabetes relation stroke associated dementia significantly greater blacks hispanics whites
0.26019153.11581097.html.plaintext.txt	59	findings study support previous longitudinal studies reported weak association diabetes alzheimers disease strong association diabetes stroke associated dementia extend observations minority population groups population attributable risk diabetes relation stroke associated dementia significantly greater blacks hispanics whites
0.26019153.11581097.html.plaintext.txt	60	acknowledgments support work provided grants national institute aging symb symb charles robertson memorial gift fund research alzheimers disease blanchette hooker rockefeller foundation
0.26019153.11581097.html.plaintext.txt	61	acknowledgments support work provided grants national institute aging symb symb charles robertson memorial gift fund research alzheimers disease blanchette hooker rockefeller foundation
0.26019153.11581097.html.plaintext.txt	62	notes reprint requests dr richard mayeux gertrude h sergievsky center ph num columbia university num west numth street new york ny num e mail symbatcolumbiaedusymbcolumbiaedu
0.26019153.11581097.html.plaintext.txt	63	references top abstract introduction materials methods results discussion references evans da funkenstein hh albert ms et al prevalence alzheimers disease community population older persons higher previously reported jama numnumnum numabstract geldmacher ds whitehouse pj evaluation dementia n engl j med numnumnum numfree full text harris mi flegal km cowie cc et al prevalence diabetes impaired fasting glucose impaired glucose tolerance us adults third national health nutrition examination survey num num diabetes care numnumnum numabstract harris mi diabetes america epidemiology scope problem diabetes care numnumsuppl numsymb numisimedline tang m stern y marder k et al apoe num allele risk alzheimers disease among african americans whites hispanics jama numnumnum numabstractfree full text gurland b wilder d lantigua r et al relative rates dementia multiple case definitions num prevalence periods num cultural groups j geriatr psychiatry numnumnum numisi gurland bj wilder de lantigua r et al differences rates dementia ethnoracial groups martin lg soldo bj eds racial ethnic difference health older americans washington dc national academy press num num num mayeux r stern y ottman r et al apolipoprotein num allele patients alzheimers disease ann neurol numnumnum numisimedline maestre g ottman r stern y et al apolipoprotein e alzheimers disease ethnic variation genotypic risks ann neurol numnumnum numisimedline tang m x maestre g tsai w y et al relative risk alzheimers disease age onset base apoe genotypes among elderly african americans caucasians hispanics new york city j hum genet numnumnum num sahota yang m gao et al apolipoprotein e associated risk alzheimers disease african american population genotype dependent ann neurol numnumnum numisimedline osuntukun bo sahota ogunniyi ao et al lack association apolipoprotein e num alzheimers disease elderly nigerians ann neurol numnumnum numisimedline tatemichi tk desmond dw mayeux r et al dementia stroke baseline frequency risks clinical features hospitalized cohort neurology numnumnum numabstract tatemichi tk paik m bagiella e et al risk dementia stroke hospitalized cohort results longitudinal study neurology numnumnum numabstract esiri mm wilcock gk morris jh neuropathological assessment lesions significance vascular dementia j neurol neurosurg psychiatry numnumnum numabstractfree full text moroney jt tang m berglund l et al low density lipoprotein cholesterol risk dementia stroke jama numnumnum numabstractfree full text gorelick pb status risk factors dementia associated stroke stroke numnumnum numabstractfree full text oleary dh polak jf kronmal r et al distribution correlates sonographically detected carotid artery disease cardiovascular health study cardiovascular health study collaborative group stroke numnumnum numabstract sasaki n fukatsu r tsusuki k et al advanced glycation end products alzheimers disease neurodegenerative diseases j pathol numnumnum numabstractfree full text smith ma sayre lm perry g diabetes alzheimers disease glycation biochemical link letter diabetologia numnumnummedline elias pk elias mf dagostino rb et al niddm blood pressure risk factors poor cognitive performance framingham study diabetes care numnumnum numabstract gregg ew yaffe k cauley ja et al diabetes associated cognitive impairment cognitive decline among older women arch intern med numnumnum numabstractfree full text ott stolk rp hoffman et al association diabetes mellitus dementia rotterdam study diabetologia numnumnum numisimedline leibson cl rocca wa hanson va et al risk dementia among persons diabetes mellitus population based cohort study j epidemiol numnumnum numabstract brayne c gill c huppert fa et al vascular risks incident dementia results cohort study old dement geriatr cogn disord numnumnum numisimedline ott stolk rp van harskamp f et al diabetes mellitus risk dementia rotterdam study neurology numnumnum numabstractfree full text chui hc mack w jackson e et al clinical criteria diagnosis vascular dementia multicenter study comparability interrater reliability arch neurol numnumnum numabstractfree full text curb jd rodriguez bl abbott rd et al longitudinal association vascular alzheimers dementias diabetes glucose tolerance neurology numnumnum numabstractfree full text stern y andrews h pittman j et al diagnosis dementia heterogeneous population development neuropsychological paradigm quantified correction education arch neurol numnumnum numabstract american psychiatric association diagnostic statistical manual mental disorders fourth edition dsm iv washington dc american psychiatric association numnum num hughes cp berg l danzinger w et al new clinical scale staging dementia br j psychiatry numnumnum numabstract mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology numnumnum numabstract world health organization icd num classification mental behavioral disorders diagnostic criteria research geneva switzerland world health organization numnum num bureau census num census population housing summary tape file num technical documentation stf numa database computer diskette washington dc bureau census us department commerce num hixson j vernier d restriction isotyping human lipoprotein e gene amplification cleavage hhai j lipid res numnumnum numabstract lopes virella mf stone p ellis et al cholesterol determination high density lipoproteins separated three different methods clin chem numnumnum numabstractfree full text friedewald wt levy ri frederickson ds estimation concentration low density lipoprotein cholesterol plasma without use preparative ultracentrifuge clin chem numnumnum numabstractfree full text korn el graubard bi midthune d time event analysis longitudinal follow survey choice time scale j epidemiol numnumnum numabstract kahn ha sempos ct statistical methods epidemiology new york ny oxford university press numnum num ritchie k touchon j mild cognitive impairment conceptual basis current nosological status lancet numnumnum numisimedline mast h thompson jl lee sh et al hypertension diabetes mellitus determinants multiple lacunar infarcts stroke numnumnum numabstractfree full text tatemichi tk desmond dw paik m et al clinical determinants dementia related stroke ann neurol numnumnum numisimedline desmond dw tatemichi tk paik m et al risk factors cerebrovascular disease correlates cognitive function stroke free cohort arch neurol numnumnum numabstract albert sg gomez cr russell et al cerebral ophthalmic artery hemodynamic responses diabetes mellitus diabetes care numnumnum numabstract fulesdi b limburg m bereczki d et al impairment cerebrovascular reactivity long term type num diabetes diabetes numnumnum numabstract boyt aa taddei k hallmayer j et al effect insulin glucose plasma concentration alzheimers amyloid precursor protein neuroscience numnumnum numisimedline takadera sakura n mohri et al toxic effects beta amyloid peptide beta num num hippocampal neuron prevention neuroscience numnumnum num ko l sheu kr blass jp inmunohistochemical colocalization amyloid precursor protein cerebrovascular amyloid alzheimers disease j pathol numnumnum numabstract martins rn robinson pj chleboun jp et al molecular pathology amyloid deposition alzheimers disease mol neurobiol numnumnum numisimedline masters cl multhaup g simms g et al neuronal origin cerebral amyloid neurofibrillary tangles alzheimers disease contain protein amyloid plaque cores blood vessels eur mol biol org numnumnum numabstract masters cl simms g weinman na et al amyloid plaque core protein alzheimers disease downs syndrome proc natl acad sci u numnumnum numabstract murphy m molecular pathogenesis alzheimers disease clinical prospects lancet numnumnum numisimedline naslund j haroutunian v mohs r et al correlation elevated levels amyloid ss peptide brain cognitive decline jama numnumnum numabstractfree full text roman gc tatemichi tk erkinjuntti et al vascular dementia diagnostic criteria research studies report ninds airen international workshop neurology numnum num numabstract vanhanen m kuusisto j koivisto k et al type num diabetes cognitive function non demented population acta neurol scand numnumnum numisimedline received publication august num num accepted publication april num num
0.26019153.11581097.html.plaintext.txt	64	references top abstract introduction materials methods results discussion references evans da funkenstein hh albert ms et al prevalence alzheimers disease community population older persons higher previously reported jama numnumnum numabstract geldmacher ds whitehouse pj evaluation dementia n engl j med numnumnum numfree full text harris mi flegal km cowie cc et al prevalence diabetes impaired fasting glucose impaired glucose tolerance us adults third national health nutrition examination survey num num diabetes care numnumnum numabstract harris mi diabetes america epidemiology scope problem diabetes care numnumsuppl numsymb numisimedline tang m stern y marder k et al apoe num allele risk alzheimers disease among african americans whites hispanics jama numnumnum numabstractfree full text gurland b wilder d lantigua r et al relative rates dementia multiple case definitions num prevalence periods num cultural groups j geriatr psychiatry numnumnum numisi gurland bj wilder de lantigua r et al differences rates dementia ethnoracial groups martin lg soldo bj eds racial ethnic difference health older americans washington dc national academy press num num num mayeux r stern y ottman r et al apolipoprotein num allele patients alzheimers disease ann neurol numnumnum numisimedline maestre g ottman r stern y et al apolipoprotein e alzheimers disease ethnic variation genotypic risks ann neurol numnumnum numisimedline tang m x maestre g tsai w y et al relative risk alzheimers disease age onset base apoe genotypes among elderly african americans caucasians hispanics new york city j hum genet numnumnum num sahota yang m gao et al apolipoprotein e associated risk alzheimers disease african american population genotype dependent ann neurol numnumnum numisimedline osuntukun bo sahota ogunniyi ao et al lack association apolipoprotein e num alzheimers disease elderly nigerians ann neurol numnumnum numisimedline tatemichi tk desmond dw mayeux r et al dementia stroke baseline frequency risks clinical features hospitalized cohort neurology numnumnum numabstract tatemichi tk paik m bagiella e et al risk dementia stroke hospitalized cohort results longitudinal study neurology numnumnum numabstract esiri mm wilcock gk morris jh neuropathological assessment lesions significance vascular dementia j neurol neurosurg psychiatry numnumnum numabstractfree full text moroney jt tang m berglund l et al low density lipoprotein cholesterol risk dementia stroke jama numnumnum numabstractfree full text gorelick pb status risk factors dementia associated stroke stroke numnumnum numabstractfree full text oleary dh polak jf kronmal r et al distribution correlates sonographically detected carotid artery disease cardiovascular health study cardiovascular health study collaborative group stroke numnumnum numabstract sasaki n fukatsu r tsusuki k et al advanced glycation end products alzheimers disease neurodegenerative diseases j pathol numnumnum numabstractfree full text smith ma sayre lm perry g diabetes alzheimers disease glycation biochemical link letter diabetologia numnumnummedline elias pk elias mf dagostino rb et al niddm blood pressure risk factors poor cognitive performance framingham study diabetes care numnumnum numabstract gregg ew yaffe k cauley ja et al diabetes associated cognitive impairment cognitive decline among older women arch intern med numnumnum numabstractfree full text ott stolk rp hoffman et al association diabetes mellitus dementia rotterdam study diabetologia numnumnum numisimedline leibson cl rocca wa hanson va et al risk dementia among persons diabetes mellitus population based cohort study j epidemiol numnumnum numabstract brayne c gill c huppert fa et al vascular risks incident dementia results cohort study old dement geriatr cogn disord numnumnum numisimedline ott stolk rp van harskamp f et al diabetes mellitus risk dementia rotterdam study neurology numnumnum numabstractfree full text chui hc mack w jackson e et al clinical criteria diagnosis vascular dementia multicenter study comparability interrater reliability arch neurol numnumnum numabstractfree full text curb jd rodriguez bl abbott rd et al longitudinal association vascular alzheimers dementias diabetes glucose tolerance neurology numnumnum numabstractfree full text stern y andrews h pittman j et al diagnosis dementia heterogeneous population development neuropsychological paradigm quantified correction education arch neurol numnumnum numabstract american psychiatric association diagnostic statistical manual mental disorders fourth edition dsm iv washington dc american psychiatric association numnum num hughes cp berg l danzinger w et al new clinical scale staging dementia br j psychiatry numnumnum numabstract mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology numnumnum numabstract world health organization icd num classification mental behavioral disorders diagnostic criteria research geneva switzerland world health organization numnum num bureau census num census population housing summary tape file num technical documentation stf numa database computer diskette washington dc bureau census us department commerce num hixson j vernier d restriction isotyping human lipoprotein e gene amplification cleavage hhai j lipid res numnumnum numabstract lopes virella mf stone p ellis et al cholesterol determination high density lipoproteins separated three different methods clin chem numnumnum numabstractfree full text friedewald wt levy ri frederickson ds estimation concentration low density lipoprotein cholesterol plasma without use preparative ultracentrifuge clin chem numnumnum numabstractfree full text korn el graubard bi midthune d time event analysis longitudinal follow survey choice time scale j epidemiol numnumnum numabstract kahn ha sempos ct statistical methods epidemiology new york ny oxford university press numnum num ritchie k touchon j mild cognitive impairment conceptual basis current nosological status lancet numnumnum numisimedline mast h thompson jl lee sh et al hypertension diabetes mellitus determinants multiple lacunar infarcts stroke numnumnum numabstractfree full text tatemichi tk desmond dw paik m et al clinical determinants dementia related stroke ann neurol numnumnum numisimedline desmond dw tatemichi tk paik m et al risk factors cerebrovascular disease correlates cognitive function stroke free cohort arch neurol numnumnum numabstract albert sg gomez cr russell et al cerebral ophthalmic artery hemodynamic responses diabetes mellitus diabetes care numnumnum numabstract fulesdi b limburg m bereczki d et al impairment cerebrovascular reactivity long term type num diabetes diabetes numnumnum numabstract boyt aa taddei k hallmayer j et al effect insulin glucose plasma concentration alzheimers amyloid precursor protein neuroscience numnumnum numisimedline takadera sakura n mohri et al toxic effects beta amyloid peptide beta num num hippocampal neuron prevention neuroscience numnumnum num ko l sheu kr blass jp inmunohistochemical colocalization amyloid precursor protein cerebrovascular amyloid alzheimers disease j pathol numnumnum numabstract martins rn robinson pj chleboun jp et al molecular pathology amyloid deposition alzheimers disease mol neurobiol numnumnum numisimedline masters cl multhaup g simms g et al neuronal origin cerebral amyloid neurofibrillary tangles alzheimers disease contain protein amyloid plaque cores blood vessels eur mol biol org numnumnum numabstract masters cl simms g weinman na et al amyloid plaque core protein alzheimers disease downs syndrome proc natl acad sci u numnumnum numabstract murphy m molecular pathogenesis alzheimers disease clinical prospects lancet numnumnum numisimedline naslund j haroutunian v mohs r et al correlation elevated levels amyloid ss peptide brain cognitive decline jama numnumnum numabstractfree full text roman gc tatemichi tk erkinjuntti et al vascular dementia diagnostic criteria research studies report ninds airen international workshop neurology numnum num numabstract vanhanen m kuusisto j koivisto k et al type num diabetes cognitive function non demented population acta neurol scand numnumnum numisimedline received publication august num num accepted publication april num num
0.26308063.11581098.html.plaintext.txt	0	mortality dementia results french prospective community based cohort
0.26308063.11581098.html.plaintext.txt	1	inserm u num universite de bordeaux ii bordeaux france
0.26308063.11581098.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references despite magnitude problem little known duration dementia survival risk factors mortality dementia impact dementia risk death investigated using personnes agees quid paquid prospective population based cohort study num num statistical models dealing interval censoring performed among numnum participants aged num years older initially nondemented numnum followed num years num persons incident dementia actively diagnosed mean age onset dementia numnum years total population relative risk dying developing dementia estimated numnum num confidence interval ci numnum numnum adjusted sociodemographic variables comorbidity deaths cerebrovascular diseases respiratory diseases particularly increased among persons dementia compared without median survival time persons dementia estimated numnum years women dementia longer survival men dementia particularly alzheimer type dementia relative risk numnum num ci numnum numnum educational level significantly associated survival persons dementia results provide evidence malignancy dementia challenge numst century
0.26308063.11581098.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references despite magnitude problem little known duration dementia survival risk factors mortality dementia impact dementia risk death investigated using personnes agees quid paquid prospective population based cohort study num num statistical models dealing interval censoring performed among numnum participants aged num years older initially nondemented numnum followed num years num persons incident dementia actively diagnosed mean age onset dementia numnum years total population relative risk dying developing dementia estimated numnum num confidence interval ci numnum numnum adjusted sociodemographic variables comorbidity deaths cerebrovascular diseases respiratory diseases particularly increased among persons dementia compared without median survival time persons dementia estimated numnum years women dementia longer survival men dementia particularly alzheimer type dementia relative risk numnum num ci numnum numnum educational level significantly associated survival persons dementia results provide evidence malignancy dementia challenge numst century
0.26308063.11581098.html.plaintext.txt	4	alzheimer disease dementia mortality prognosis
0.26308063.11581098.html.plaintext.txt	5	abbreviations cep certificat detudes primaires ci confidence interval dsm iii r diagnostic statistical manual mental disorders third edition revised paquid personnes agees quid rr relative risk
0.26308063.11581098.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references major public health problems duration disease key factor dementia family practitioner society despite magnitude problem knowledge serious dementia consequences population remains imprecise dementia major source disability population num precise knowledge survival dementia useful family practitioner decide manage patient society survival time persons dementia affects burden due therefore health policy decision makers need precise data survival dementia health care planning
0.26308063.11581098.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references major public health problems duration disease key factor dementia family practitioner society despite magnitude problem knowledge serious dementia consequences population remains imprecise dementia major source disability population num precise knowledge survival dementia useful family practitioner decide manage patient society survival time persons dementia affects burden due therefore health policy decision makers need precise data survival dementia health care planning
0.26308063.11581098.html.plaintext.txt	8	num studies carried survival dementia found increased risk dying among persons dementia compared without however data often obtained community based studies selected groups institutions clinical settings applied general population indeed review literature van dijk et al num found survival conditioned reference population lower survival studies conducted institution community based studies addition even among community based studies num year survival found vary num percent num percent probably depending study designs num majority studies conducted community based samples num num based prevalent cases onset disease known onset dementia insidious progressive thus determined exactly onset often considered either time first symptoms disease time first consultation however earlier one sees patient onset precise estimation onset thus onset estimated precisely incident prevalent cases
0.26308063.11581098.html.plaintext.txt	9	num studies carried survival dementia found increased risk dying among persons dementia compared without however data often obtained community based studies selected groups institutions clinical settings applied general population indeed review literature van dijk et al num found survival conditioned reference population lower survival studies conducted institution community based studies addition even among community based studies num year survival found vary num percent num percent probably depending study designs num majority studies conducted community based samples num num based prevalent cases onset disease known onset dementia insidious progressive thus determined exactly onset often considered either time first symptoms disease time first consultation however earlier one sees patient onset precise estimation onset thus onset estimated precisely incident prevalent cases
0.26308063.11581098.html.plaintext.txt	10	community based studies used incident cases dementia num num dementia cases actively screened one num active detection dementia makes possible take account cases undiagnosed practitioner scenario frequent france num recent study sweden based kungsholmen project num risk death among alzheimers disease cases estimated numnum compared nondemented persons however latter study onset disease considered time diagnosis statistical analyses take account problem interval censoring cohort studies participants followed continually receive repeated cross sectional screenings time intervals could bias results particularly lack accuracy determination disease onset
0.26308063.11581098.html.plaintext.txt	11	community based studies used incident cases dementia num num dementia cases actively screened one num active detection dementia makes possible take account cases undiagnosed practitioner scenario frequent france num recent study sweden based kungsholmen project num risk death among alzheimers disease cases estimated numnum compared nondemented persons however latter study onset disease considered time diagnosis statistical analyses take account problem interval censoring cohort studies participants followed continually receive repeated cross sectional screenings time intervals could bias results particularly lack accuracy determination disease onset
0.26308063.11581098.html.plaintext.txt	12	aim paper evaluate survival risk factors mortality dementia quantify impact dementia total mortality using statistical models dealing interval censoring french prospective population based cohort active search incident cases dementia follow screening
0.26308063.11581098.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references study population information study gathered personnes agees quid paquid cohort paquid research program prospective cohort study representative sample community residents aged num years living southwestern france departments gironde dordogne cohort began num three criteria met inclusion least num years age december num num living home time initial data collection phase give written informed consent participate study sample randomly chosen electoral rolls french citizen except guardianship register three step procedure stratification size urban unit age sex used among numnum persons selected numnum num percent agreed participate study numnum participants numnum gironde num dordogne representative age sex distribution elderly area num nonresponders differ responders age gender educational level general methodology paquid study described previously num ethical review committee approved paquid study
0.26308063.11581098.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references study population information study gathered personnes agees quid paquid cohort paquid research program prospective cohort study representative sample community residents aged num years living southwestern france departments gironde dordogne cohort began num three criteria met inclusion least num years age december num num living home time initial data collection phase give written informed consent participate study sample randomly chosen electoral rolls french citizen except guardianship register three step procedure stratification size urban unit age sex used among numnum persons selected numnum num percent agreed participate study numnum participants numnum gironde num dordogne representative age sex distribution elderly area num nonresponders differ responders age gender educational level general methodology paquid study described previously num ethical review committee approved paquid study
0.26308063.11581098.html.plaintext.txt	15	data collection data collected means questionnaire administered home trained psychologists initial interview included items sociodemographic characteristics objective subjective physical health functional assessment depressive symptomatology battery neuropsychological tests including evaluation global mental status mini mental state examination num physical health evaluated self reported diseases symptoms treated diabetes history heart disease stroke hypertension dyspnea considered variable comorbidity created participants reported history least one diseases symptoms functional status evaluated using activities daily living scale excluding item maintaining continence num participants needed help least one five activities classified disabled
0.26308063.11581098.html.plaintext.txt	16	data collection data collected means questionnaire administered home trained psychologists initial interview included items sociodemographic characteristics objective subjective physical health functional assessment depressive symptomatology battery neuropsychological tests including evaluation global mental status mini mental state examination num physical health evaluated self reported diseases symptoms treated diabetes history heart disease stroke hypertension dyspnea considered variable comorbidity created participants reported history least one diseases symptoms functional status evaluated using activities daily living scale excluding item maintaining continence num participants needed help least one five activities classified disabled
0.26308063.11581098.html.plaintext.txt	17	initial interview participants followed baseline procedure num num num num years gironde num num num years dordogne
0.26308063.11581098.html.plaintext.txt	18	data vital status collected throughout follow dates causes death collected death certificates way national registry mortality statistics causes death classified according international classification diseases ninth revision num cancer codes num num num num cardiovascular diseases excluding cerebrovascular diseases codes num num num num cerebrovascular disease codes num num respiratory disease codes num num
0.26308063.11581098.html.plaintext.txt	19	data vital status collected throughout follow dates causes death collected death certificates way national registry mortality statistics causes death classified according international classification diseases ninth revision num cancer codes num num num num cardiovascular diseases excluding cerebrovascular diseases codes num num num num cerebrovascular disease codes num num respiratory disease codes num num
0.26308063.11581098.html.plaintext.txt	20	diagnosis dementia baseline intellectual functioning examined series psychometric tests shown among sensitive assessing cognitive decline elderly persons psychologists systematically filled standardized questionnaire designed obtain memory impairment b impairment least one cognitive function c interference social professional life criteria dementia according diagnostic statistical manual mental disorders third edition revised dsm iii r num second stage participants met dsm iii r criteria seen senior neurologist confirmed completed dsm iii r criteria dementia filled national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda criteria alzheimers disease num hachinski score vascular dementia num document dementia diagnosis etiology probable possible alzheimers disease vascular dementia alzheimers disease cerebrovascular disease types dementia informant consulted neurologist available ancillary information considered including medical charts brain imaging available finally consensus meeting allowed us definitely classify case comparable procedures screening dementia usually used cohort studies num diagnosis incident dementia cases followed procedure follow assessment baseline screening order increase screening sensitivity another criterion added qualify neurologic examination participants selected stage met b c dsm iii r criteria dementia lost three points mini mental state examination score
0.26308063.11581098.html.plaintext.txt	21	diagnosis dementia baseline intellectual functioning examined series psychometric tests shown among sensitive assessing cognitive decline elderly persons psychologists systematically filled standardized questionnaire designed obtain memory impairment b impairment least one cognitive function c interference social professional life criteria dementia according diagnostic statistical manual mental disorders third edition revised dsm iii r num second stage participants met dsm iii r criteria seen senior neurologist confirmed completed dsm iii r criteria dementia filled national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda criteria alzheimers disease num hachinski score vascular dementia num document dementia diagnosis etiology probable possible alzheimers disease vascular dementia alzheimers disease cerebrovascular disease types dementia informant consulted neurologist available ancillary information considered including medical charts brain imaging available finally consensus meeting allowed us definitely classify case comparable procedures screening dementia usually used cohort studies num diagnosis incident dementia cases followed procedure follow assessment baseline screening order increase screening sensitivity another criterion added qualify neurologic examination participants selected stage met b c dsm iii r criteria dementia lost three points mini mental state examination score
0.26308063.11581098.html.plaintext.txt	22	statistical analysis mortality dementia analyzed according age sex educational level educational level divided two categories least primary school level validated diploma certificat detudes primaires cep versus diploma num analyses performed dementia due causes alzheimers disease
0.26308063.11581098.html.plaintext.txt	23	statistical analysis mortality dementia analyzed according age sex educational level educational level divided two categories least primary school level validated diploma certificat detudes primaires cep versus diploma num analyses performed dementia due causes alzheimers disease
0.26308063.11581098.html.plaintext.txt	24	first impact mortality dementia general population considered comparing mortality among persons incident dementia without partitioning competing causes death analyzed mortality dementia among persons incident dementia num quantify impact dementia total mortality performed cox model delayed entry time scale age participants num taking occurrence dementia time dependent variable considering age onset dementia middle interval last follow without dementia first follow dementia relative risks death dementia alzheimers disease provided num percent confidence intervals relative risks competing causes death provided num mortality among persons incident dementia onset clinical stage death analyzed using multistate approach semi markov model performed statistical model dealing interval censoring common problem cohort studies indeed paquid study participants followed continuously cross sectional screenings discrete times thus onset disease known exactly information available onset occurred two follow times therefore used semi markov model includes two transitions first transition represents age specific incidence rates dementia second transition represents mortality rates persons dementia model uses information incidence data people cohort fact time onset dementia known taken account penalized likelihood approach num
0.26308063.11581098.html.plaintext.txt	25	first impact mortality dementia general population considered comparing mortality among persons incident dementia without partitioning competing causes death analyzed mortality dementia among persons incident dementia num quantify impact dementia total mortality performed cox model delayed entry time scale age participants num taking occurrence dementia time dependent variable considering age onset dementia middle interval last follow without dementia first follow dementia relative risks death dementia alzheimers disease provided num percent confidence intervals relative risks competing causes death provided num mortality among persons incident dementia onset clinical stage death analyzed using multistate approach semi markov model performed statistical model dealing interval censoring common problem cohort studies indeed paquid study participants followed continuously cross sectional screenings discrete times thus onset disease known exactly information available onset occurred two follow times therefore used semi markov model includes two transitions first transition represents age specific incidence rates dementia second transition represents mortality rates persons dementia model uses information incidence data people cohort fact time onset dementia known taken account penalized likelihood approach num
0.26308063.11581098.html.plaintext.txt	26	results top abstract introduction materials methods results discussion references description baseline numnum participants included cohort among num already dementia excluded among numnum initially without dementia least one complete follow examination performed numnum numnum percent num numnum percent remaining participants participate follow died n num numnum percent refused follow screenings n num numnum percent participants lost follow n num numnum percent description participants follow according sociodemographic characteristics given table num
0.26308063.11581098.html.plaintext.txt	27	results top abstract introduction materials methods results discussion references description baseline numnum participants included cohort among num already dementia excluded among numnum initially without dementia least one complete follow examination performed numnum numnum percent num numnum percent remaining participants participate follow died n num numnum percent refused follow screenings n num numnum percent participants lost follow n num numnum percent description participants follow according sociodemographic characteristics given table num
0.26308063.11581098.html.plaintext.txt	28	view table table num distribution participants interviewed follow according diagnosis dementia sociodemographic characteristics paquid cohort france num num
0.26308063.11581098.html.plaintext.txt	29	numnum reevaluated participants included numnum numnum percent women numnum num percent participants aged num years older mean delay two follow evaluations numnum years follow num participants developed incident dementia including num alzheimer type dementia num vascular mixed dementia num types dementia persons incident dementia included num numnum percent women mean age onset dementia num standard deviation numnum years among men numnum standard deviation numnum years among women
0.26308063.11581098.html.plaintext.txt	30	numnum reevaluated participants included numnum numnum percent women numnum num percent participants aged num years older mean delay two follow evaluations numnum years follow num participants developed incident dementia including num alzheimer type dementia num vascular mixed dementia num types dementia persons incident dementia included num numnum percent women mean age onset dementia num standard deviation numnum years among men numnum standard deviation numnum years among women
0.26308063.11581098.html.plaintext.txt	31	end study numnum percent persons dementia died versus numnum percent among without persons dementia died cardiovascular pathology numnum percent stroke numnum percent cancer numnum percent respiratory pathology numnum percent symptoms signs ill defined conditions including senile dementia numnum percent proportions respectively numnum percent numnum percent numnum percent numnum percent numnum percent persons without dementia
0.26308063.11581098.html.plaintext.txt	32	impact dementia mortality impact dementia total mortality analyzed using cox proportional hazards model delayed entry adjusted sex educational level index comorbidity baseline dependency activities daily living scale comparing participants dementia without total population relative risk dying developing dementia estimated numnum num percent confidence interval ci numnum numnum alzheimers disease risk numnum num percent ci numnum numnum however significant interaction dementia age relative risk rr numnum num percent ci numnum numnum lower impact dementia mortality increasing age relative risk dying dementia estimated numnum num percent ci numnum numnum among participants aged num years older numnum num percent ci numnum numnum among participants aged num years older risks similar men women
0.26308063.11581098.html.plaintext.txt	33	impact dementia mortality impact dementia total mortality analyzed using cox proportional hazards model delayed entry adjusted sex educational level index comorbidity baseline dependency activities daily living scale comparing participants dementia without total population relative risk dying developing dementia estimated numnum num percent confidence interval ci numnum numnum alzheimers disease risk numnum num percent ci numnum numnum however significant interaction dementia age relative risk rr numnum num percent ci numnum numnum lower impact dementia mortality increasing age relative risk dying dementia estimated numnum num percent ci numnum numnum among participants aged num years older numnum num percent ci numnum numnum among participants aged num years older risks similar men women
0.26308063.11581098.html.plaintext.txt	34	according causes death relative risks significantly increased cancer rr numnum num percent ci numnum numnum cardiovascular disease rr numnum num percent ci numnum numnum among persons dementia whereas relative risk numnum num percent ci numnum numnum cerebrovascular disease numnum num percent ci numnum numnum respiratory disease tendency alzheimers disease increased risk respiratory disease rr numnum num percent ci numnum numnum risk cerebrovascular disease reach significance rr numnum num percent ci numnum numnum
0.26308063.11581098.html.plaintext.txt	35	survival dementia risk factors median survival time onset disease estimated numnum years among persons incident dementia model provides results age dementia onset chose provide results persons developing dementia num num years median times survival according risk factors summarized table num whatever age onset dementia median times survival higher among women among men among persons alzheimers disease protective effect female sex risk dying adjusted educational level comorbidity activities daily living scale dependency time diagnosis rr numnum num percent ci numnum numnum tendency dementia causes although relative risk reach statistical significance rr numnum num percent ci numnum numnum
0.26308063.11581098.html.plaintext.txt	36	survival dementia risk factors median survival time onset disease estimated numnum years among persons incident dementia model provides results age dementia onset chose provide results persons developing dementia num num years median times survival according risk factors summarized table num whatever age onset dementia median times survival higher among women among men among persons alzheimers disease protective effect female sex risk dying adjusted educational level comorbidity activities daily living scale dependency time diagnosis rr numnum num percent ci numnum numnum tendency dementia causes although relative risk reach statistical significance rr numnum num percent ci numnum numnum
0.26308063.11581098.html.plaintext.txt	37	view table table num median times survival persons dementia alzheimers disease according sex educational level paquid cohort france num num
0.26308063.11581098.html.plaintext.txt	38	dementia alzheimers disease median survival time shorter participants cep without dementia began num years difference survival observed according cep num years table num educational level significantly influence survival among persons dementia relative risk dying participants without cep estimated numnum num percent ci numnum numnum dementia numnum num percent ci numnum numnum alzheimers disease adjustment sex comorbidity activities daily living scale dependency time diagnosis modify relative risks numnum dementia numnum alzheimers disease
0.26308063.11581098.html.plaintext.txt	39	dementia alzheimers disease median survival time shorter participants cep without dementia began num years difference survival observed according cep num years table num educational level significantly influence survival among persons dementia relative risk dying participants without cep estimated numnum num percent ci numnum numnum dementia numnum num percent ci numnum numnum alzheimers disease adjustment sex comorbidity activities daily living scale dependency time diagnosis modify relative risks numnum dementia numnum alzheimers disease
0.26308063.11581098.html.plaintext.txt	40	although effect sex educational level seemed differ according age dementia onset significant interaction found either age sex rr numnum num percent ci numnum numnum age cep rr numnum num percent ci numnum numnum
0.26308063.11581098.html.plaintext.txt	41	discussion top abstract introduction materials methods results discussion references follow num persons incident dementia allowed us accurately define mortality dementia general population median survival dementia numnum years survival longer women compared men particularly alzheimers disease however educational level significantly modify survival dementia relative risk dying estimated numnum persons dementia compared without among persons dementia risks dying cerebrovascular respiratory diseases particularly increased
0.26308063.11581098.html.plaintext.txt	42	discussion top abstract introduction materials methods results discussion references follow num persons incident dementia allowed us accurately define mortality dementia general population median survival dementia numnum years survival longer women compared men particularly alzheimers disease however educational level significantly modify survival dementia relative risk dying estimated numnum persons dementia compared without among persons dementia risks dying cerebrovascular respiratory diseases particularly increased
0.26308063.11581098.html.plaintext.txt	43	studying mortality dementia general population raises special difficulties first one needs conduct study community dementia diagnosed hospital nursing home setting representative cases general population second dementia actively screened widely underdiagnosed population num num third necessary use incident cases dementia disease onset better known finally incident cases dementia followed long time observe death methodological difficulties previous studies investigated mortality dementia community using incident cases dementia num num even studies onset disease difficult assess indeed unless participants screened dementia continuously onset dementia always imprecise clearly insidious onset also interval censoring last time participant considered dementia free first time diagnosed dementia thus onset estimated even incident cases dementia paquid study opportunity analyze actively screened incident cases dementia prospectively followed several years addition applied statistical models taking account fact disease onset known precisely
0.26308063.11581098.html.plaintext.txt	44	studying mortality dementia general population raises special difficulties first one needs conduct study community dementia diagnosed hospital nursing home setting representative cases general population second dementia actively screened widely underdiagnosed population num num third necessary use incident cases dementia disease onset better known finally incident cases dementia followed long time observe death methodological difficulties previous studies investigated mortality dementia community using incident cases dementia num num even studies onset disease difficult assess indeed unless participants screened dementia continuously onset dementia always imprecise clearly insidious onset also interval censoring last time participant considered dementia free first time diagnosed dementia thus onset estimated even incident cases dementia paquid study opportunity analyze actively screened incident cases dementia prospectively followed several years addition applied statistical models taking account fact disease onset known precisely
0.26308063.11581098.html.plaintext.txt	45	several methodological issues may influenced results twenty percent participants cohort never reevaluated among large part num percent died follow others refused follow examinations participants refused follow examinations could higher risk developing dementia thus nonresponse could lead underestimation incidence dementia however could bias prognosis group persons dementia mortality among persons dementia refused follow differed mortality among persons dementia evaluated unlikely
0.26308063.11581098.html.plaintext.txt	46	several methodological issues may influenced results twenty percent participants cohort never reevaluated among large part num percent died follow others refused follow examinations participants refused follow examinations could higher risk developing dementia thus nonresponse could lead underestimation incidence dementia however could bias prognosis group persons dementia mortality among persons dementia refused follow differed mortality among persons dementia evaluated unlikely
0.26308063.11581098.html.plaintext.txt	47	participants short survival onset dementia occurred two follow ups died rapidly onset diagnosed cohort thus included survival analysis persons incident dementia studies could overestimate survival time dementia however specific illness death model dealing interval censoring taking account cases dementia short survival could establish extent survival overestimated model developed
0.26308063.11581098.html.plaintext.txt	48	participants short survival onset dementia occurred two follow ups died rapidly onset diagnosed cohort thus included survival analysis persons incident dementia studies could overestimate survival time dementia however specific illness death model dealing interval censoring taking account cases dementia short survival could establish extent survival overestimated model developed
0.26308063.11581098.html.plaintext.txt	49	another methodological problem due difficulties diagnosis dementia subgroups persons particularly old people persons living institution illiterate deaf depressive persons lead either false diagnosis dementia delay diagnosis among persons could bias survival among persons incident dementia
0.26308063.11581098.html.plaintext.txt	50	another methodological problem due difficulties diagnosis dementia subgroups persons particularly old people persons living institution illiterate deaf depressive persons lead either false diagnosis dementia delay diagnosis among persons could bias survival among persons incident dementia
0.26308063.11581098.html.plaintext.txt	51	demonstrate possible bias problem interval censoring taken account results three state approach compared using standard models kaplan meier curves describe survival among incident participants dementia cox models delayed entry analyze effect sex educational level risk mortality among standard models onset dementia considered middle interval last follow without dementia first follow although differences two models slight median survival developing dementia num months longer standard models three state approach larger interval two follow evaluations greater overestimation survival addition using standard models tended increase effect risk factors mortality among persons dementia also slightly underestimate confidence intervals particularly visible effect sex led erroneous significant factors
0.26308063.11581098.html.plaintext.txt	52	demonstrate possible bias problem interval censoring taken account results three state approach compared using standard models kaplan meier curves describe survival among incident participants dementia cox models delayed entry analyze effect sex educational level risk mortality among standard models onset dementia considered middle interval last follow without dementia first follow although differences two models slight median survival developing dementia num months longer standard models three state approach larger interval two follow evaluations greater overestimation survival addition using standard models tended increase effect risk factors mortality among persons dementia also slightly underestimate confidence intervals particularly visible effect sex led erroneous significant factors
0.26308063.11581098.html.plaintext.txt	53	impact dementia mortality three state approach used describe mortality among persons dementia takes account fact time disease onset known could applied evaluate impact dementia mortality among general population indeed estimate date onset participant cohort however although estimation onset dementia prime importance describe survival dementia affect time survival several years depending number years two follow evaluations estimation less important evaluation impact dementia mortality age participant time scale model
0.26308063.11581098.html.plaintext.txt	54	impact dementia mortality three state approach used describe mortality among persons dementia takes account fact time disease onset known could applied evaluate impact dementia mortality among general population indeed estimate date onset participant cohort however although estimation onset dementia prime importance describe survival dementia affect time survival several years depending number years two follow evaluations estimation less important evaluation impact dementia mortality age participant time scale model
0.26308063.11581098.html.plaintext.txt	55	relative risks dying study estimated numnum dementia numnum alzheimers disease decreased age results agreement slightly lower found previous community based studies ranging numnum numnum alzheimers disease numnum numnum dementia num num num num num even higher rr numnum among younger participants num num explained inclusion incident rather prevalent cases dementia study fact took account morbidity evaluating risk death
0.26308063.11581098.html.plaintext.txt	56	two causes death particularly increased among persons dementia cerebrovascular respiratory diseases increase death cerebrovascular diseases essentially due vascular dementia however even among persons alzheimers disease trend increased risk cerebrovascular diseases concordant implication vascular mechanisms alzheimer pathology num death due respiratory diseases already found important cause death among alzheimers persons num num also increased persons dementia alzheimers disease compared without dementia
0.26308063.11581098.html.plaintext.txt	57	two causes death particularly increased among persons dementia cerebrovascular respiratory diseases increase death cerebrovascular diseases essentially due vascular dementia however even among persons alzheimers disease trend increased risk cerebrovascular diseases concordant implication vascular mechanisms alzheimer pathology num death due respiratory diseases already found important cause death among alzheimers persons num num also increased persons dementia alzheimers disease compared without dementia
0.26308063.11581098.html.plaintext.txt	58	survival among persons dementia general population median duration survival among persons dementia dependent sex age participants median survival times observed study longer reported previous studies prevalent cases community num num num num even studies incident cases num incident cases considered leads automatically longer survival however clinical studies alzheimer center studies reported median survival times long longer num num num year survival several explanations may account longer survival first persons referred clinical settings memory probably interested health others may less medical comorbidity second treatment management persons dementia present clinical settings could increase survival finally mean age patients clinical settings often lower community based studies
0.26308063.11581098.html.plaintext.txt	59	survival among persons dementia general population median duration survival among persons dementia dependent sex age participants median survival times observed study longer reported previous studies prevalent cases community num num num num even studies incident cases num incident cases considered leads automatically longer survival however clinical studies alzheimer center studies reported median survival times long longer num num num year survival several explanations may account longer survival first persons referred clinical settings memory probably interested health others may less medical comorbidity second treatment management persons dementia present clinical settings could increase survival finally mean age patients clinical settings often lower community based studies
0.26308063.11581098.html.plaintext.txt	60	effect sex survival protective effect female sex observed study particularly alzheimers disease concordant results several studies done different methodologies num num num num num num general population women dementia lower risk mortality men although interaction age sex risk dying among persons dementia significant effect sex seemed decrease age greater difference women men num years num years results concordant observed kungsholmen project sex affected survival among persons dementia num years num factors explain longer survival among women general population could remain unchanged course disease trials currently progress test hypothesis estrogen replacement therapy could affect progression alzheimers disease however paquid study women taken therapy explain longer survival women dementia sample
0.26308063.11581098.html.plaintext.txt	61	effect sex survival protective effect female sex observed study particularly alzheimers disease concordant results several studies done different methodologies num num num num num num general population women dementia lower risk mortality men although interaction age sex risk dying among persons dementia significant effect sex seemed decrease age greater difference women men num years num years results concordant observed kungsholmen project sex affected survival among persons dementia num years num factors explain longer survival among women general population could remain unchanged course disease trials currently progress test hypothesis estrogen replacement therapy could affect progression alzheimers disease however paquid study women taken therapy explain longer survival women dementia sample
0.26308063.11581098.html.plaintext.txt	62	effect education survival effect educational level survival dementia low study observed among participants developed dementia youngest age previous results concerning relation education mortality among persons dementia controversial authors found increased risk mortality associated high educational level num num whereas others replicated findings num even found opposite num hypothesis brain reserve capacity according development cerebral lesions alzheimers disease time diagnosis advanced among highly educated people others proposed explain association high educational level increased risk mortality num num also observed tendency although slight nonsignificant lower survival persons dementia cep among youngest possible bias detecting dementia according educational level excluded indeed participants low educational level low premorbid cognitive performances thus could detected earlier highly educated participants however bias probably reduced taking account dsm iii r criteria also loss mini mental state examination score screening procedure
0.26308063.11581098.html.plaintext.txt	63	effect education survival effect educational level survival dementia low study observed among participants developed dementia youngest age previous results concerning relation education mortality among persons dementia controversial authors found increased risk mortality associated high educational level num num whereas others replicated findings num even found opposite num hypothesis brain reserve capacity according development cerebral lesions alzheimers disease time diagnosis advanced among highly educated people others proposed explain association high educational level increased risk mortality num num also observed tendency although slight nonsignificant lower survival persons dementia cep among youngest possible bias detecting dementia according educational level excluded indeed participants low educational level low premorbid cognitive performances thus could detected earlier highly educated participants however bias probably reduced taking account dsm iii r criteria also loss mini mental state examination score screening procedure
0.26308063.11581098.html.plaintext.txt	64	conclusion data provide evidence malignancy dementia strong predictor death short survival time disease onset high risk dying associated future data survival dementia make possible evaluate whether development medical social therapies dementia leads increased survival persons pathology
0.26308063.11581098.html.plaintext.txt	65	conclusion data provide evidence malignancy dementia strong predictor death short survival time disease onset high risk dying associated future data survival dementia make possible evaluate whether development medical social therapies dementia leads increased survival persons pathology
0.26308063.11581098.html.plaintext.txt	66	acknowledgments study supported grants fondation de france novartis pharma axa insurance group caisse nationale dassurance maladie caisse primaire dassurance maladie de dordogne conseil general de la dordogne conseil general de la gironde conseil regional daquitaine danone ministere de la recherche et de la technologie mutualite sociale agricole de gironde et dordogne mutuelle generale de leducation nationale societe pechiney num media caisse de retraite interentreprise capimmec institut du cerveau direction regionale des affaires sanitaires et sociales daquitaine
0.26308063.11581098.html.plaintext.txt	67	notes correspondence dr catherine helmer case num inserm u num universite de bordeaux ii num rue leo saignat num bordeaux cedex france e mail catherinehelmeratispedu symbfr u d
0.26308063.11581098.html.plaintext.txt	68	notes correspondence dr catherine helmer case num inserm u num universite de bordeaux ii num rue leo saignat num bordeaux cedex france e mail catherinehelmeratispedu symbfr u d
0.26308063.11581098.html.plaintext.txt	69	references top abstract introduction materials methods results discussion references aguero torres h fratiglioni l guo z et al dementia major cause functional dependence elderly num year follow data population based study j public health numnumnum num van dijk ptm dippel dwj habbema jfd survival patients dementia j geriatr soc numnumnum numisimedline molsa pk marttila rj rinne uk survival cause death alzheimers disease multi infarct dementia acta neurol scand numnumnum numisimedline evans da smith la scherr pa et al risk death alzheimers disease community population older persons j epidemiol numnumnum numabstract heeren tj van hemert rooymans hgm community based study survival dementia acta psychiatr scand numnumnum numisimedline tsuji minami y fukao et al dementia physical disability competing risks mortality community based sample elderly japanese tohoku j exp med numnumnum numisimedline jagger c clarke m stone predictors survival alzheimers disease community based study psychol med numnumnum numisimedline molsa pk marttila rj rinne uk long term survival predictors mortality alzheimers disease multi infarct dementia acta neurol scand numnumnum numisimedline stern y tang mx denaro j et al increased risk mortality alzheimers disease patients advanced educational occupational attainment ann neurol numnumnum numisimedline geerlings mi deeg djh schmand b et al increased risk mortality alzheimers disease patients higher education replication study neurology numnumnum numabstract ostbye hill g steenhuis r mortality elderly canadians without dementia num year follow neurology numnumnum numabstractfree full text aronson mk ooi wl geva dl et al dementia age dependent incidence prevalence mortality old old arch intern med numnumnum numabstract bowen jd malter ad sheppard l et al predictors mortality patients diagnosed probable alzheimers disease neurology numnumnum numabstract aguero torres h fratiglioni l guo z et al mortality dementia advanced age num year follow study incident dementia cases j clin epidemiol numnumnum numisimedline dartigues j f gagnon m michel p et al le programme de recherche paquid sur lepidemiologie de la demence methodologie et resultats initiaux french rev neurol numnumnum nummedline dartigues j f gagnon m letenneur l et al principal lifetime occupation cognitive impairment french elderly cohort j epidemiol numnumnum numabstract folstein mf folstein se mchugh pr mini mental state practical method grading cognitive state patients clinician j psychiatr res numnumnum numisimedline katz downs td cash hr et al progress development index adl gerontologist numnumnum numisimedline health care financing administration international classification diseases ninth revision clinical modification washington dc government printing office num dhhs publication phs num num american psychiatric association diagnostic statistical manual mental disorders dsm iiir numrd ed rev washington dc american psychiatric association num mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology numnumnum numabstract hachinski vc iliff ld zilhka f et al cerebral blood flow dementia arch neurol numnumnum numabstract launer lj andersen k dewey et al rates risk factors dementia alzheimers disease results eurodem pooled analyses neurology numnumnum numabstractfree full text letenneur l gilleron v commenges d et al sex educational level independent predictors dementia alzheimers disease incidence data paquid project j neurol neurosurg psychiatry numnumnum numabstractfree full text commenges d letenneur l joly p et al modelling age specific risk application dementia stat med numnumnum numisimedline joly p commenges d penalized likelihood approach progressive three state model censored truncated data application aids biometrics numnumnum numisimedline ross gw abbott rd petrovitch h et al frequency characteristics silent dementia among elderly japanese american men jama numnumnum numabstract katzman r hill lr yu esh et al malignancy dementia predictors mortality clinically diagnosed dementia population survey shanghai china arch neurol numnumnum numabstract hofman ott breteler mmb et al atherosclerosis apolipoprotein e prevalence dementia alzheimers disease rotterdam study lancet numnumnum numisimedline burns jacoby r luthert p et al cause death alzheimers disease age ageing numnumnum numabstract olichney jm hofstetter cr galasko d et al death certificate reporting dementia mortality alzheimers disease research center cohort j geriatr soc numnumnum numisimedline beard cm kokmen e obrien pc et al patients alzheimers disease surviving longer recent years neurology numnumnum numabstract heyman peterson b fillenbaum g et al consortium establish registry alzheimers disease cerad part xiv demographic clinical predictors survival patients alzheimers disease neurology numnumnum numabstract claus jj walstra gjm bossuyt pm et al simple test copying ability sex define survival patients early alzheimers disease psychol med numnumnum numisimedline burns lewis g jacoby r et al factors affecting survival alzheimers disease psychol med numnumnum numisimedline gambassi g landi f lapane k et al predictors mortality patients alzheimers disease living nursing homes j neurol neurosurg psychiatry numnumnum numabstractfree full text aguero torres h fratiglioni l guo z et al prognostic factors old demented adults seven year follow population based survey stockholm j geriatr soc numnumnum numisimedline geerlings mi deeg djh penninx wjh et al cognitive reserve mortality dementia role cognition functional ability depression psychol med numnumnum numisimedline stern y albert tang m et al rate memory decline ad related education occupation cognitive reserve neurology numnumnum numabstractfree full text received publication july num num accepted publication april num num
0.26308063.11581098.html.plaintext.txt	70	references top abstract introduction materials methods results discussion references aguero torres h fratiglioni l guo z et al dementia major cause functional dependence elderly num year follow data population based study j public health numnumnum num van dijk ptm dippel dwj habbema jfd survival patients dementia j geriatr soc numnumnum numisimedline molsa pk marttila rj rinne uk survival cause death alzheimers disease multi infarct dementia acta neurol scand numnumnum numisimedline evans da smith la scherr pa et al risk death alzheimers disease community population older persons j epidemiol numnumnum numabstract heeren tj van hemert rooymans hgm community based study survival dementia acta psychiatr scand numnumnum numisimedline tsuji minami y fukao et al dementia physical disability competing risks mortality community based sample elderly japanese tohoku j exp med numnumnum numisimedline jagger c clarke m stone predictors survival alzheimers disease community based study psychol med numnumnum numisimedline molsa pk marttila rj rinne uk long term survival predictors mortality alzheimers disease multi infarct dementia acta neurol scand numnumnum numisimedline stern y tang mx denaro j et al increased risk mortality alzheimers disease patients advanced educational occupational attainment ann neurol numnumnum numisimedline geerlings mi deeg djh schmand b et al increased risk mortality alzheimers disease patients higher education replication study neurology numnumnum numabstract ostbye hill g steenhuis r mortality elderly canadians without dementia num year follow neurology numnumnum numabstractfree full text aronson mk ooi wl geva dl et al dementia age dependent incidence prevalence mortality old old arch intern med numnumnum numabstract bowen jd malter ad sheppard l et al predictors mortality patients diagnosed probable alzheimers disease neurology numnumnum numabstract aguero torres h fratiglioni l guo z et al mortality dementia advanced age num year follow study incident dementia cases j clin epidemiol numnumnum numisimedline dartigues j f gagnon m michel p et al le programme de recherche paquid sur lepidemiologie de la demence methodologie et resultats initiaux french rev neurol numnumnum nummedline dartigues j f gagnon m letenneur l et al principal lifetime occupation cognitive impairment french elderly cohort j epidemiol numnumnum numabstract folstein mf folstein se mchugh pr mini mental state practical method grading cognitive state patients clinician j psychiatr res numnumnum numisimedline katz downs td cash hr et al progress development index adl gerontologist numnumnum numisimedline health care financing administration international classification diseases ninth revision clinical modification washington dc government printing office num dhhs publication phs num num american psychiatric association diagnostic statistical manual mental disorders dsm iiir numrd ed rev washington dc american psychiatric association num mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology numnumnum numabstract hachinski vc iliff ld zilhka f et al cerebral blood flow dementia arch neurol numnumnum numabstract launer lj andersen k dewey et al rates risk factors dementia alzheimers disease results eurodem pooled analyses neurology numnumnum numabstractfree full text letenneur l gilleron v commenges d et al sex educational level independent predictors dementia alzheimers disease incidence data paquid project j neurol neurosurg psychiatry numnumnum numabstractfree full text commenges d letenneur l joly p et al modelling age specific risk application dementia stat med numnumnum numisimedline joly p commenges d penalized likelihood approach progressive three state model censored truncated data application aids biometrics numnumnum numisimedline ross gw abbott rd petrovitch h et al frequency characteristics silent dementia among elderly japanese american men jama numnumnum numabstract katzman r hill lr yu esh et al malignancy dementia predictors mortality clinically diagnosed dementia population survey shanghai china arch neurol numnumnum numabstract hofman ott breteler mmb et al atherosclerosis apolipoprotein e prevalence dementia alzheimers disease rotterdam study lancet numnumnum numisimedline burns jacoby r luthert p et al cause death alzheimers disease age ageing numnumnum numabstract olichney jm hofstetter cr galasko d et al death certificate reporting dementia mortality alzheimers disease research center cohort j geriatr soc numnumnum numisimedline beard cm kokmen e obrien pc et al patients alzheimers disease surviving longer recent years neurology numnumnum numabstract heyman peterson b fillenbaum g et al consortium establish registry alzheimers disease cerad part xiv demographic clinical predictors survival patients alzheimers disease neurology numnumnum numabstract claus jj walstra gjm bossuyt pm et al simple test copying ability sex define survival patients early alzheimers disease psychol med numnumnum numisimedline burns lewis g jacoby r et al factors affecting survival alzheimers disease psychol med numnumnum numisimedline gambassi g landi f lapane k et al predictors mortality patients alzheimers disease living nursing homes j neurol neurosurg psychiatry numnumnum numabstractfree full text aguero torres h fratiglioni l guo z et al prognostic factors old demented adults seven year follow population based survey stockholm j geriatr soc numnumnum numisimedline geerlings mi deeg djh penninx wjh et al cognitive reserve mortality dementia role cognition functional ability depression psychol med numnumnum numisimedline stern y albert tang m et al rate memory decline ad related education occupation cognitive reserve neurology numnumnum numabstractfree full text received publication july num num accepted publication april num num
0.2649917.9811940.html.plaintext.txt	0	genetic association alphanum macroglobulin symb polymorphism alzheimers disease
0.2649917.9811940.html.plaintext.txt	1	alzheimer research unit neurology service massachusetts general hospital num numth street cny num charlestown ma num usa numuniversity hamburg hamburg germany numirccs giovanni de dio fbf brescia italy numuniversity basel basel switzerland
0.2649917.9811940.html.plaintext.txt	2	alzheimer research unit neurology service massachusetts general hospital num numth street cny num charlestown ma num usa numuniversity hamburg hamburg germany numirccs giovanni de dio fbf brescia italy numuniversity basel basel switzerland
0.2649917.9811940.html.plaintext.txt	3	received july num num revised accepted august num num
0.2649917.9811940.html.plaintext.txt	4	alphanum macroglobulin symb proteinase inhibitor found association senile plaques sp alzheimers disease ad symb implicated biochemically binding degradation amyloid beta abeta protein accumulates sp studied relationship alzheimers disease common symb polymorphism symb gtcsymb atc occurs near thiolester active site molecule initial exploratory data set num controls num alzheimers disease noted increased frequency gg genotype numnum numnum therefore tested hypothesis gg genotype represented alzheimers disease additional independent data set group num controls num alzheimers disease patients hypothesis testing cohort gg genotype increased numnum controls numnum alzheimers disease p numnum fishers exact test odds ratio alzheimers disease associated gg genotype numnum numnum numnum p numnum combination symb numnum num ci numnum numnum p numnum presence g allele associated increase abeta burden small series symb receptor symb rlrp multifunctional receptor whose ligands include apolipoprotein e amyloid precursor protein four proteins genetically linked alzheimers disease suggesting may participate common disease pathway
0.2649917.9811940.html.plaintext.txt	5	alphanum macroglobulin symb proteinase inhibitor found association senile plaques sp alzheimers disease ad symb implicated biochemically binding degradation amyloid beta abeta protein accumulates sp studied relationship alzheimers disease common symb polymorphism symb gtcsymb atc occurs near thiolester active site molecule initial exploratory data set num controls num alzheimers disease noted increased frequency gg genotype numnum numnum therefore tested hypothesis gg genotype represented alzheimers disease additional independent data set group num controls num alzheimers disease patients hypothesis testing cohort gg genotype increased numnum controls numnum alzheimers disease p numnum fishers exact test odds ratio alzheimers disease associated gg genotype numnum numnum numnum p numnum combination symb numnum num ci numnum numnum p numnum presence g allele associated increase abeta burden small series symb receptor symb rlrp multifunctional receptor whose ligands include apolipoprotein e amyloid precursor protein four proteins genetically linked alzheimers disease suggesting may participate common disease pathway
0.2649917.9811940.html.plaintext.txt	6	alphanum macroglobulin symb proteinase inhibitor inhibits proteinases classes steric trapping mechanism tetrameric symb structure undergoes conformational change upon cleavage peptide bond bait region proteinase conformational change traps proteinase symb implicated several pathophysiological processes alzheimers disease symb immunostains senile plaques sp num num binds amyloid beta protein abeta num num high affinity apparent kd numnum nm num moreover recent data suggest serine proteinase symb complex degrade abeta num trypsin activated symb efficiently degrades abeta vitro prevents vitro formation thioflavin positive abeta fibrils well abeta induced toxicity cultured human cortical neuronal cells num
0.2649917.9811940.html.plaintext.txt	7	alphanum macroglobulin symb proteinase inhibitor inhibits proteinases classes steric trapping mechanism tetrameric symb structure undergoes conformational change upon cleavage peptide bond bait region proteinase conformational change traps proteinase symb implicated several pathophysiological processes alzheimers disease symb immunostains senile plaques sp num num binds amyloid beta protein abeta num num high affinity apparent kd numnum nm num moreover recent data suggest serine proteinase symb complex degrade abeta num trypsin activated symb efficiently degrades abeta vitro prevents vitro formation thioflavin positive abeta fibrils well abeta induced toxicity cultured human cortical neuronal cells num
0.2649917.9811940.html.plaintext.txt	8	activated symb cleared symb rlow density lipoprotein receptor related protein symb rlrp symb rlrp multifunctional receptor interestingly also primary neuronal apolipoprotein e apoe receptor numnum lrp also binds clears kunitz proteinase inhibitor containing isoforms amyloid precursor protein app num thus symb potentially impacts apoe app metabolism brain
0.2649917.9811940.html.plaintext.txt	9	activated symb cleared symb rlow density lipoprotein receptor related protein symb rlrp symb rlrp multifunctional receptor interestingly also primary neuronal apolipoprotein e apoe receptor numnum lrp also binds clears kunitz proteinase inhibitor containing isoforms amyloid precursor protein app num thus symb potentially impacts apoe app metabolism brain
0.2649917.9811940.html.plaintext.txt	10	biological links alzheimers disease studied possible association previously reported polymorphism symb gene alzheimers disease poller et al num screened num normal num pulmonary disease patients symb polymorphisms near active site reported three symb polymorphisms common occurred num amino acids downstream thiolester site interchanging symb gtc symb atc num numbering based cdna sequence includes num amino acid signal peptide corresponds valsymb mature protein allele frequencies num probands numnum gtc numnum atc difference symb serum levels associated two alleles polymorphism especially interesting potential biologically relevant function symb proteinase inhibitor occurs near thiolester active site molecule
0.2649917.9811940.html.plaintext.txt	11	initial exploratory experiment tested possibility less common form symb g allele would associated alzheimers disease potential error due multiple hypothesis testing planned use initial data set exploratory data set intent formulate specific hypotheses would tested formally second independent data set genotyped num non alzheimers individuals either undergone screening tests blessed dementia scale num whose dna isolated autopsy material demonstrated alzheimers disease num individuals either clinical diagnosis alzheimers disease neuropathologically proven alzheimers disease table num genotypes determined pcr amplification dna restriction enzyme digestion fig num control series g allele frequency numnum six num individuals contained gg genotype numnum alzheimers disease set g allele frequency numnum noticed gg genotype frequency increased alzheimers group numnum table num results suggest possible influence symb polymorphism genetic risk factor alzheimers disease
0.2649917.9811940.html.plaintext.txt	12	initial exploratory experiment tested possibility less common form symb g allele would associated alzheimers disease potential error due multiple hypothesis testing planned use initial data set exploratory data set intent formulate specific hypotheses would tested formally second independent data set genotyped num non alzheimers individuals either undergone screening tests blessed dementia scale num whose dna isolated autopsy material demonstrated alzheimers disease num individuals either clinical diagnosis alzheimers disease neuropathologically proven alzheimers disease table num genotypes determined pcr amplification dna restriction enzyme digestion fig num control series g allele frequency numnum six num individuals contained gg genotype numnum alzheimers disease set g allele frequency numnum noticed gg genotype frequency increased alzheimers group numnum table num results suggest possible influence symb polymorphism genetic risk factor alzheimers disease
0.2649917.9811940.html.plaintext.txt	13	figure num electrophoresis pattern restriction digest demonstrating bands representing g num bp alleles num bp
0.2649917.9811940.html.plaintext.txt	14	table num representation symb gg genotype alzheimers disease n g allele gg genotype exploratory data set control num numnum numnum ad num numnum numnum hypothesis testing data set control num numnum numnum ad num numnum numnuma combined data set total control num numnum numnum ad num numnum numnumb ap numnum bp numnum
0.2649917.9811940.html.plaintext.txt	15	formally test hypothesis gg genotype symb represented alzheimers disease collected genotyped additional independent groups patients controls power analysis showed num alzheimers disease control individuals would necessary num chance showing difference genotype frequencies numnum numnum therefore collected cases controls several sites order approximate number samples second data set consisted individuals met criteria alzheimers disease control hypothesis generating set derived sporadic alzheimers disease patients massachusetts three european centers probands multicenter us study sib pairs small families results second data set supported hypothesis gg genotype frequencies numnum controls numnum alzheimers disease p numnum fishers exact test table num g allele represented data set control numnum alzheimers disease numnum difference age onset gg non gg found second data set multivariate analysis showed site collection influence genotype frequencies also compared rate controls subset num clinic based alzheimers disease cases gg frequency numnum p numnum subset num familial alzheimers disease samples gg frequency numnum p numnum found essentially equal representation gg data support association gg genotype alzheimers disease
0.2649917.9811940.html.plaintext.txt	16	formally test hypothesis gg genotype symb represented alzheimers disease collected genotyped additional independent groups patients controls power analysis showed num alzheimers disease control individuals would necessary num chance showing difference genotype frequencies numnum numnum therefore collected cases controls several sites order approximate number samples second data set consisted individuals met criteria alzheimers disease control hypothesis generating set derived sporadic alzheimers disease patients massachusetts three european centers probands multicenter us study sib pairs small families results second data set supported hypothesis gg genotype frequencies numnum controls numnum alzheimers disease p numnum fishers exact test table num g allele represented data set control numnum alzheimers disease numnum difference age onset gg non gg found second data set multivariate analysis showed site collection influence genotype frequencies also compared rate controls subset num clinic based alzheimers disease cases gg frequency numnum p numnum subset num familial alzheimers disease samples gg frequency numnum p numnum found essentially equal representation gg data support association gg genotype alzheimers disease
0.2649917.9811940.html.plaintext.txt	17	carried series exploratory analyses using pooled data individuals num alzheimers disease patients num controls gg genotype present numnum alzheimer patients numnum controls p numnum fishers exact test genotype frequency controls consistent hardy weinberg equilibrium age onset different alzheimers disease patients gg numnum plus minus numnum mean plus minus sd non gg carriers numnum plus minus numnum multivariate logistic model controlled presence symb allele gender showed odds ratio numnum num ci numnum numnum p numnum presence symb gg genotype presence symb model associated odds ratio numnum num ci numnum numnum p numnum odds ratio combination gg symb numnum num ci numnum numnum p numnum relative neither risk factor explore whether gg mediated risk influenced presence absence symb stratified sample presence absence symb similar representations gg genotype seen strata without symb suggesting effects two risk factors independent multivariate analysis interaction gg genotype either symb gender demonstrated interactions p numnum interaction terms analysis based mantel haenszel estimator suggested heterogeneity odds ratios strata without symb p numnum consistent absence interaction symb symb logistic regression model
0.2649917.9811940.html.plaintext.txt	18	carried series exploratory analyses using pooled data individuals num alzheimers disease patients num controls gg genotype present numnum alzheimer patients numnum controls p numnum fishers exact test genotype frequency controls consistent hardy weinberg equilibrium age onset different alzheimers disease patients gg numnum plus minus numnum mean plus minus sd non gg carriers numnum plus minus numnum multivariate logistic model controlled presence symb allele gender showed odds ratio numnum num ci numnum numnum p numnum presence symb gg genotype presence symb model associated odds ratio numnum num ci numnum numnum p numnum odds ratio combination gg symb numnum num ci numnum numnum p numnum relative neither risk factor explore whether gg mediated risk influenced presence absence symb stratified sample presence absence symb similar representations gg genotype seen strata without symb suggesting effects two risk factors independent multivariate analysis interaction gg genotype either symb gender demonstrated interactions p numnum interaction terms analysis based mantel haenszel estimator suggested heterogeneity odds ratios strata without symb p numnum consistent absence interaction symb symb logistic regression model
0.2649917.9811940.html.plaintext.txt	19	next turned attention possible biological effects inheritance symb gg genotype previous studies symb immunohistochemistry alzheimer brain suggested sp different cases stained varying intensity num explored possibility variability due different genotypes immunostaining eight alzheimers disease cases known gg aa genotype instances symb immunoreactivity present robustly sp astrocytes neurons qualitative differences observed genotype groups
0.2649917.9811940.html.plaintext.txt	20	next turned attention possible biological effects inheritance symb gg genotype previous studies symb immunohistochemistry alzheimer brain suggested sp different cases stained varying intensity num explored possibility variability due different genotypes immunostaining eight alzheimers disease cases known gg aa genotype instances symb immunoreactivity present robustly sp astrocytes neurons qualitative differences observed genotype groups
0.2649917.9811940.html.plaintext.txt	21	also explored effect inheritance symb gg genotype neuropathological phenotype alzheimers disease table num previously used stereological techniques quantitative image analysis measure amount abeta present amyloid burden neocortical association area surrounding superior temporal sulcus number neurofibrillary tangles present region num thirty one previously analyzed alzheimers disease cases symb genotyped selected analysis initial inspection data suggested increase abeta individuals ag gg difference two groups statistically significant increase abeta deposition seen comparing g containing cases non g containing cases numnum plus minus numnum versus numnum plus minus numnum p numnum unpaired test effect appears primarily due presence least one g allele difference ag gg genotypes observed although sample size limits power comparison statistically significant differences neurofibrillary tangle number g alleles suggesting specific effect abeta deposition
0.2649917.9811940.html.plaintext.txt	22	also explored effect inheritance symb gg genotype neuropathological phenotype alzheimers disease table num previously used stereological techniques quantitative image analysis measure amount abeta present amyloid burden neocortical association area surrounding superior temporal sulcus number neurofibrillary tangles present region num thirty one previously analyzed alzheimers disease cases symb genotyped selected analysis initial inspection data suggested increase abeta individuals ag gg difference two groups statistically significant increase abeta deposition seen comparing g containing cases non g containing cases numnum plus minus numnum versus numnum plus minus numnum p numnum unpaired test effect appears primarily due presence least one g allele difference ag gg genotypes observed although sample size limits power comparison statistically significant differences neurofibrillary tangle number g alleles suggesting specific effect abeta deposition
0.2649917.9811940.html.plaintext.txt	23	table num neuropathological correlates symb genotype genotype n amyloid burden neurofibrillary tangles x num aa num numnum plus minus numnuma numnum plus minus numnum ag gg num numnum plus minus numnumb numnum plus minus numnumc amean plus minus sd bp numnum test cn num measurement discussion
0.2649917.9811940.html.plaintext.txt	24	exploratory studies genetic risk factors run risk type errors large number hypotheses either explicitly implicitly tested alternatively type ii errors occur sample size insufficient order overcome difficulties inherent exploratory studies genetic risk factors used independent data sets first generate test hypothesis gg genotype associated alzheimers disease two separate control populations gave identical genotype frequencies hypothesis testing data set made two groups sporadic ad probands multicenter study alzheimers disease sib pairs small families gave essentially identical genotype frequencies representation gg genotype symb gg effect dependent apoe genotype effect additive substantial odds ratio gg presence symb allele showed almost num fold increased risk power analysis using size effect observed combined data set using num samples suggests group size num controls num alzheimers disease patients would necessary alpha numnum beta num hypothesis gg genotype increased numnum numnum alzheimers disease
0.2649917.9811940.html.plaintext.txt	25	exploratory studies genetic risk factors run risk type errors large number hypotheses either explicitly implicitly tested alternatively type ii errors occur sample size insufficient order overcome difficulties inherent exploratory studies genetic risk factors used independent data sets first generate test hypothesis gg genotype associated alzheimers disease two separate control populations gave identical genotype frequencies hypothesis testing data set made two groups sporadic ad probands multicenter study alzheimers disease sib pairs small families gave essentially identical genotype frequencies representation gg genotype symb gg effect dependent apoe genotype effect additive substantial odds ratio gg presence symb allele showed almost num fold increased risk power analysis using size effect observed combined data set using num samples suggests group size num controls num alzheimers disease patients would necessary alpha numnum beta num hypothesis gg genotype increased numnum numnum alzheimers disease
0.2649917.9811940.html.plaintext.txt	26	association gg symb genotype risk factor alzheimers disease leads several interesting mechanistic interpretations previous data shown symb immunostains sp implicated symb amyloid precursor protein metabolism num well possible interactions binding abeta num mediation degradation abeta numnum symb abeta complexes undergo endocytosis via symb rlrp receptor num symb associates abeta prevents fibril formation num addition symb viewed subacute phase reactive molecule potent proteinase inhibitor might participate inflammatory response alzheimer brain interestingly symb also implicated trophic factor possibly result binding transporting number polypeptide growth factors cytokines num like apoe symb may serve binding protein targeting various bioactive molecules site action clearing num finally fact apoe app two ligands symb rlrp receptor clearly involved pathophysiology alzheimers disease support plausibility idea symb polymorphism might contribute risk alzheimers disease fact polymorphism symb rlrp recently reported two studies show genetic association alzheimers disease numnum
0.2649917.9811940.html.plaintext.txt	27	association gg symb genotype risk factor alzheimers disease leads several interesting mechanistic interpretations previous data shown symb immunostains sp implicated symb amyloid precursor protein metabolism num well possible interactions binding abeta num mediation degradation abeta numnum symb abeta complexes undergo endocytosis via symb rlrp receptor num symb associates abeta prevents fibril formation num addition symb viewed subacute phase reactive molecule potent proteinase inhibitor might participate inflammatory response alzheimer brain interestingly symb also implicated trophic factor possibly result binding transporting number polypeptide growth factors cytokines num like apoe symb may serve binding protein targeting various bioactive molecules site action clearing num finally fact apoe app two ligands symb rlrp receptor clearly involved pathophysiology alzheimers disease support plausibility idea symb polymorphism might contribute risk alzheimers disease fact polymorphism symb rlrp recently reported two studies show genetic association alzheimers disease numnum
0.2649917.9811940.html.plaintext.txt	28	although strong biological rationale involvement symb polymorphism alzheimers disease possibility remains genetic association observe reflects linkage another mutation polymorphism either symb gene nearby gene chromosome num symb gene resides num cm distal marker symbnum yielded maximal lod score recent linkage study suggesting chromosome num contains alzheimer risk factor num however likelihood symb risk factor supported results recent separate study observed association intronic numprime splice site exon num pentanucleotide deletion allele num within symb gene alzheimers disease sibship analysis alzheimers disease sib pairs small alzheimers disease families num current results extend observation showing linkage missense mutation case control sample rather family based association currently studying two symb polymorphisms relate one another preliminary results consistent hypothesis act independent risk factors initial study group evaluated polymorphisms suggests g allele inherited num allele num g chromosomes examined num gg individuals num allele num num allele num compared allele num frequency num p numnum chinum analysis yates correction
0.2649917.9811940.html.plaintext.txt	29	although strong biological rationale involvement symb polymorphism alzheimers disease possibility remains genetic association observe reflects linkage another mutation polymorphism either symb gene nearby gene chromosome num symb gene resides num cm distal marker symbnum yielded maximal lod score recent linkage study suggesting chromosome num contains alzheimer risk factor num however likelihood symb risk factor supported results recent separate study observed association intronic numprime splice site exon num pentanucleotide deletion allele num within symb gene alzheimers disease sibship analysis alzheimers disease sib pairs small alzheimers disease families num current results extend observation showing linkage missense mutation case control sample rather family based association currently studying two symb polymorphisms relate one another preliminary results consistent hypothesis act independent risk factors initial study group evaluated polymorphisms suggests g allele inherited num allele num g chromosomes examined num gg individuals num allele num num allele num compared allele num frequency num p numnum chinum analysis yates correction
0.2649917.9811940.html.plaintext.txt	30	taken together believe polymorphisms symb gene may contribute risk alzheimers disease moreover data focus attention mechanisms pathophysiology impact symb rlrp ligands including clearance mechanisms mediated symb rlrp numnum suggest symb rlrp ligands may candidate alzheimers disease genes well
0.2649917.9811940.html.plaintext.txt	31	taken together believe polymorphisms symb gene may contribute risk alzheimers disease moreover data focus attention mechanisms pathophysiology impact symb rlrp ligands including clearance mechanisms mediated symb rlrp numnum suggest symb rlrp ligands may candidate alzheimers disease genes well
0.2649917.9811940.html.plaintext.txt	32	initial hypothesis generating data set established num alzheimers disease patients clinical history probable alzheimers disease num age compatible control individuals primarily spouses patients second hypothesis testing data set collected several sources attempt approximate num patients controls estimated power analysis adequately test hypothesis gg genotype represented alzheimers disease individuals included additional cases num sporadic alzheimer disease num controls matched site primarily cognitively tested spouses collected massachusetts general hospital memory disorder unit consortium european centers university hamburg germany university basel switzerland cuore fatebenefratelli hospital brescia italy num probands multicenter study alzheimer disease sib pairs small alzheimers disease families num
0.2649917.9811940.html.plaintext.txt	33	initial hypothesis generating data set established num alzheimers disease patients clinical history probable alzheimers disease num age compatible control individuals primarily spouses patients second hypothesis testing data set collected several sources attempt approximate num patients controls estimated power analysis adequately test hypothesis gg genotype represented alzheimers disease individuals included additional cases num sporadic alzheimer disease num controls matched site primarily cognitively tested spouses collected massachusetts general hospital memory disorder unit consortium european centers university hamburg germany university basel switzerland cuore fatebenefratelli hospital brescia italy num probands multicenter study alzheimer disease sib pairs small alzheimers disease families num
0.2649917.9811940.html.plaintext.txt	34	genomic dna isolated brain tissue blood amplified pcr presence oligonucleotide sense primer symb numprime atc cct gaa act gcc acc aa numprime antisense primer symb numprime gta act gaa acc tac tgg aa numprime num mm tris symb num mm symb ph numnum numnum mm symb num mm dntps num pmol primer numnum u taq dna polymerase pcr carried touchdown procedure stepped annealing temperature increase primer specificity follows one cycle num degrees c num min four cycles num degrees c num num degrees c num num degrees c num min four cycles num degrees c num num degrees c num num degrees c num min four cycles num degrees c num num degrees c num num degrees c num min num cycles num degrees c num num degrees c num num degrees c num min one cycle num degrees c num min
0.2649917.9811940.html.plaintext.txt	35	reaction mixture mboi added amplified product num bp digestion carried num degrees c num h producing fragments num g allele num bp allele digested product loaded onto num agarose gel treated ethidium bromide numnum electrophoresed num h constant voltage num v sufficient separate digested product num num bp bands distinguished electrophoresis dna fragments visualized uv illumination using bio rad gel doc system incomplete digestion monitored continued presence num bp product
0.2649917.9811940.html.plaintext.txt	36	reaction mixture mboi added amplified product num bp digestion carried num degrees c num h producing fragments num g allele num bp allele digested product loaded onto num agarose gel treated ethidium bromide numnum electrophoresed num h constant voltage num v sufficient separate digested product num num bp bands distinguished electrophoresis dna fragments visualized uv illumination using bio rad gel doc system incomplete digestion monitored continued presence num bp product
0.2649917.9811940.html.plaintext.txt	37	immunohistochemical analysis used anti symb antibody numnum zymed goat symb linked secondary antibody jackson immunoresearch used visualize immunostaining instances double immunofluorescence carried abeta counterstain antibody numsymb courtesy dr d schenk athena neurosciences using bodipy fluorescein linked secondary antibody molecular probes second fluorochrome quantitative neuropathological techniques measuring abeta burden neurofibrillary tangles number superior temporal sulcus area previously published num
0.2649917.9811940.html.plaintext.txt	38	immunohistochemical analysis used anti symb antibody numnum zymed goat symb linked secondary antibody jackson immunoresearch used visualize immunostaining instances double immunofluorescence carried abeta counterstain antibody numsymb courtesy dr d schenk athena neurosciences using bodipy fluorescein linked secondary antibody molecular probes second fluorochrome quantitative neuropathological techniques measuring abeta burden neurofibrillary tangles number superior temporal sulcus area previously published num
0.2649917.9811940.html.plaintext.txt	39	comparisons symb allele frequency proportion chromosomes allele present genotype frequency proportion individuals genotype performed num x num tables using fishers exact test significance age onset alzheimers disease normally distributed compared test multivariate analysis odds alzheimers disease performed logistic regression apoe genotype coded according presence absence symb similar results obtained group symb coded separately heterozygotes homozygotes allele odds ratios presented num confidence intervals cis analyses performed stata software college park tx significance tests two tailed
0.2649917.9811940.html.plaintext.txt	40	comparisons symb allele frequency proportion chromosomes allele present genotype frequency proportion individuals genotype performed num x num tables using fishers exact test significance age onset alzheimers disease normally distributed compared test multivariate analysis odds alzheimers disease performed logistic regression apoe genotype coded according presence absence symb similar results obtained group symb coded separately heterozygotes homozygotes allele odds ratios presented num confidence intervals cis analyses performed stata software college park tx significance tests two tailed
0.2649917.9811940.html.plaintext.txt	41	thank c maschke technical assistance thank massachusetts alzheimers research center symb brain bank dr et hedley whyte neuropathological specimens additional neurological pathological specimens obtained brain tissue research center mhns num work supported nih grants symb symb
0.2649917.9811940.html.plaintext.txt	42	correspondence addressed tel num num num num fax num num num num email bhymanhelixmghharvardedu page run oxford university press great clarendon street oxford symb numdp part oup journals comments feedback www adminatoupcouk u d last modification num nov num copyright oxford university press num
0.2649917.9811940.html.plaintext.txt	43	correspondence addressed tel num num num num fax num num num num email bhymanhelixmghharvardedu page run oxford university press great clarendon street oxford symb numdp part oup journals comments feedback www adminatoupcouk u d last modification num nov num copyright oxford university press num
0.2674377.16162502.html.plaintext.txt	0	resveratrol promotes clearance alzheimers disease amyloid peptides philippe symb haitian zhao peter davies
0.2674377.16162502.html.plaintext.txt	1	litwin zucker research center study alzheimers disease memory disorders north shore long island jewish institute medical research manhasset new york num
0.2674377.16162502.html.plaintext.txt	2	received publication july num num revised form september num num
0.2674377.16162502.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references several epidemiological studies indicate moderate consumption wine associated lower incidence alzheimers disease wine enriched antioxidant compounds potential neuroprotective activities however exact molecular mechanisms involved beneficial effects wine intake neurodegenerative process alzheimers disease brain remain clearly defined show resveratrol trans numnumnum trihydroxystilbene naturally occurring polyphenol mainly found grapes red wine markedly lowers levels secreted intracellular amyloid peptides produced different cell lines resveratrol inhibit production effect producing enzymes secretases promotes instead intracellular degradation via mechanism involves proteasome indeed resveratrol induced decrease could prevented several selective proteasome inhibitors sirna directed silencing proteasome subunit num findings demonstrate proteasome dependent anti amyloidogenic activity resveratrol suggest natural compound therapeutic potential alzheimers disease
0.2674377.16162502.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references several epidemiological studies indicate moderate consumption wine associated lower incidence alzheimers disease wine enriched antioxidant compounds potential neuroprotective activities however exact molecular mechanisms involved beneficial effects wine intake neurodegenerative process alzheimers disease brain remain clearly defined show resveratrol trans numnumnum trihydroxystilbene naturally occurring polyphenol mainly found grapes red wine markedly lowers levels secreted intracellular amyloid peptides produced different cell lines resveratrol inhibit production effect producing enzymes secretases promotes instead intracellular degradation via mechanism involves proteasome indeed resveratrol induced decrease could prevented several selective proteasome inhibitors sirna directed silencing proteasome subunit num findings demonstrate proteasome dependent anti amyloidogenic activity resveratrol suggest natural compound therapeutic potential alzheimers disease
0.2674377.16162502.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references alzheimers disease adnum progressive neurodegenerative disorder leading common form dementia compelling evidence supports central role pathogenesis disease num core component senile plaque classical lesion found neocortex hippocampus ad brains excessive production highly insoluble num amino acid long symb peptide almost invariably observed presence mutations three genes linked early onset autosomal dominant familial forms ad num
0.2674377.16162502.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references alzheimers disease adnum progressive neurodegenerative disorder leading common form dementia compelling evidence supports central role pathogenesis disease num core component senile plaque classical lesion found neocortex hippocampus ad brains excessive production highly insoluble num amino acid long symb peptide almost invariably observed presence mutations three genes linked early onset autosomal dominant familial forms ad num
0.2674377.16162502.html.plaintext.txt	7	amyloidogenic pathway amyloid precursor protein app cleaved aspartic protease secretasesymb yield membrane anchored c terminal fragments symb symb symb endoproteolyzed secretase proteolytic complex produce various peptides major cleavage takes place val num producing symb alternative nonamyloidogenic pathway app endoproteolyzed within region secretase generate c terminal fragment symb soluble n terminal fragment secreted app finally secretase mediated cleavage app allows intracellular release transcriptionally active app intracellular domain aid num aicd num num
0.2674377.16162502.html.plaintext.txt	8	amyloidogenic pathway amyloid precursor protein app cleaved aspartic protease secretasesymb yield membrane anchored c terminal fragments symb symb symb endoproteolyzed secretase proteolytic complex produce various peptides major cleavage takes place val num producing symb alternative nonamyloidogenic pathway app endoproteolyzed within region secretase generate c terminal fragment symb soluble n terminal fragment secreted app finally secretase mediated cleavage app allows intracellular release transcriptionally active app intracellular domain aid num aicd num num
0.2674377.16162502.html.plaintext.txt	9	epidemiological studies shown moderate wine intake reduces risk developing ad num num resveratrol polyphenol occurs abundance grapes red wine suspected afford antioxidant neuroprotective properties therefore contribute beneficial effect wine consumption neurodegenerative process num num report resveratrol potent anti amyloidogenic activity reducing levels produced different cell lines expressing wild type swedish mutant symb show resveratrol acts promoting intracellular degradation mechanism implicates proteasome
0.2674377.16162502.html.plaintext.txt	10	epidemiological studies shown moderate wine intake reduces risk developing ad num num resveratrol polyphenol occurs abundance grapes red wine suspected afford antioxidant neuroprotective properties therefore contribute beneficial effect wine consumption neurodegenerative process num num report resveratrol potent anti amyloidogenic activity reducing levels produced different cell lines expressing wild type swedish mutant symb show resveratrol acts promoting intracellular degradation mechanism implicates proteasome
0.2674377.16162502.html.plaintext.txt	11	experimental procedures top abstract introduction experimental procedures results discussion references materials antibodies quercetin catechin resveratrol piceatannol phosphoramidon thiorphan insulin n succinyl llvy num amido num methylcoumarin suc llvy amc suc aaf amc obtained sigma trimethoxy resveratrol tms trans numnumnumnum tetramethoxystilbene cayman chemical l numnum lactacystin z gpfl cho symb n acetyl ll norleucinal cho alln calbiochem purified human num proteasome biomol anti num num numsymb anti num num numsymb pure biotinylated antibodies signet anti app num num numsymb antibody chemicon anti app c terminal domain symb antibody provided dr p d mehta institute basic research developmental disabilities staten island ny polyclonal antibodies specific symb symb symb symb num obtained dr f checler ipmc centre national de la recherche scientifique valbonne france anti n cadherin symb anti catenin antibodies bd transduction laboratories anti num proteasome subunit num antibody abr affinity bioreagents polyclonal antibody directed subunits num num num num numi num num proteasome biomol anti tubulin antibody santa cruz biotechnology
0.2674377.16162502.html.plaintext.txt	12	experimental procedures top abstract introduction experimental procedures results discussion references materials antibodies quercetin catechin resveratrol piceatannol phosphoramidon thiorphan insulin n succinyl llvy num amido num methylcoumarin suc llvy amc suc aaf amc obtained sigma trimethoxy resveratrol tms trans numnumnumnum tetramethoxystilbene cayman chemical l numnum lactacystin z gpfl cho symb n acetyl ll norleucinal cho alln calbiochem purified human num proteasome biomol anti num num numsymb anti num num numsymb pure biotinylated antibodies signet anti app num num numsymb antibody chemicon anti app c terminal domain symb antibody provided dr p d mehta institute basic research developmental disabilities staten island ny polyclonal antibodies specific symb symb symb symb num obtained dr f checler ipmc centre national de la recherche scientifique valbonne france anti n cadherin symb anti catenin antibodies bd transduction laboratories anti num proteasome subunit num antibody abr affinity bioreagents polyclonal antibody directed subunits num num num num numi num num proteasome biomol anti tubulin antibody santa cruz biotechnology
0.2674377.16162502.html.plaintext.txt	13	cell lines transfections drug treatments symb cells stably transfected human symb provided dr l dadamio albert einstein college medicine bronx ny symb cells stably transfected wild type swedish mutant human symb cdnas obtained dr n k robakis mount sinai school medicine new york ny symb symb transfectants grown dulbeccos modified eagles medium plus num fetal bovine serum penicillin streptomycin num microgml puromycin symb symb cells maintained numnum dulbeccos modified eagles mediumopti mem supplemented num fetal bovine serum penicillin streptomycin numnum mgml symb drug treatments cells treated confluence indicated concentrations incubation times medium changed treatments continued another num h allow secretion sirna directed silencing num pmol purified sirna directed proteasome subunit num smartpool dharmacon transfected num microl lipofectamine num invitrogen symb symb cells plated num mm dishes num h post transfection cells incubated absence presence num microm resveratrol another num h cells conditioned medium harvested analyzed western blotting wb proteasome activity assays described
0.2674377.16162502.html.plaintext.txt	14	western blotting cells washed phosphate buffered saline solubilized ice cold hepes buffer num mm hepes ph numnum num mm nacl numx complete protease inhibitor mixture roche applied science containing num sds ten micrograms extracts analyzed sds page total sa wb conditioned medium subjected numnum microm filtration twenty microliters medium electrophoresed numnum tris tricine gels transferred onto numnum microm nitrocellulose membranes membranes microwaved num min phosphate buffered saline blocked num fat free milk tbs incubated numsymb numnum pierce superblock overnight num degrees c standard ecl detection procedure used
0.2674377.16162502.html.plaintext.txt	15	western blotting cells washed phosphate buffered saline solubilized ice cold hepes buffer num mm hepes ph numnum num mm nacl numx complete protease inhibitor mixture roche applied science containing num sds ten micrograms extracts analyzed sds page total sa wb conditioned medium subjected numnum microm filtration twenty microliters medium electrophoresed numnum tris tricine gels transferred onto numnum microm nitrocellulose membranes membranes microwaved num min phosphate buffered saline blocked num fat free milk tbs incubated numsymb numnum pierce superblock overnight num degrees c standard ecl detection procedure used
0.2674377.16162502.html.plaintext.txt	16	immunoprecipitations ips cells solubilized ice cold ripa buffer num mm tris hcl ph num num mm nacl numnum sds num nonidet p num numnum sodium deoxycholate numx complete five hundred micrograms cell extracts total intracellular ip num ml corresponding conditioned medium diluted numx ripa buffer symb symb ips precleared protein protein g sepharose amersham biosciences num h num degrees c supernatants incubated overnight num degrees c num microl antibodies numsymb total intracellular ip symb symb ip symb symb ip supernatants treated num h num degrees c protein sepharose polyclonal antibodies protein g sepharose monoclonal antibodies ips washed ice cold ripa buffer analyzed wb using numsymb antibody described
0.2674377.16162502.html.plaintext.txt	17	enzyme linked immunosorbent assay elisa numsymb capture antibody coated num microgml coating buffer numnum gliter symbnum numnum gliter symbnum ph numnum num gliter nacl numnum gliter edta numnum gliter symb num well immunoassay plates num h num degrees c plates washed numnum tween num tbs ttbs blocked pierce tbs starting block buffer num h room temperature samples conditioned medium symb num standards biotinylated numsymb reporter antibody numnum microgml num pierce superblock added plates incubated room temperature num h following washing ttbs streptavidin horseradish peroxidase southern biotech numnum microgml num superblock added wells num h room temperature fluorogenic substrate amplex ultra red molecular probes added plates incubated num min reaction products quantified using tecan genios pro plate reader num nm excitation num nm emission
0.2674377.16162502.html.plaintext.txt	18	enzymatic activity assays neprilysin nep activity assays intact cells incubated num degrees c num h opti mem containing num microm suc aaf amc absence presence num microm thiorphan cells homogenized protein concentrations determined using bradford assay bio rad chymotrypsin like activity endogenous proteasome determined solubilizing cells activity assay buffer num mm hepes ph numnum numnum mm edta numnum nonidet p num numnum sds cell extracts num microg incubated num degrees c num h num microl activity assay buffer containing num microm suc llvy amc absence presence num microm alln purified proteasome activity assays numnum microgml purified human num proteasome incubated num degrees c num h num microl activity assay buffer containing num microm suc llvy amc release amc measured fluorescence spectrophotometry using wavelengths num nm excitation num nm emission tecan genios pro enzymatic activities expressed nmol amcminmg protein
0.2674377.16162502.html.plaintext.txt	19	enzymatic activity assays neprilysin nep activity assays intact cells incubated num degrees c num h opti mem containing num microm suc aaf amc absence presence num microm thiorphan cells homogenized protein concentrations determined using bradford assay bio rad chymotrypsin like activity endogenous proteasome determined solubilizing cells activity assay buffer num mm hepes ph numnum numnum mm edta numnum nonidet p num numnum sds cell extracts num microg incubated num degrees c num h num microl activity assay buffer containing num microm suc llvy amc absence presence num microm alln purified proteasome activity assays numnum microgml purified human num proteasome incubated num degrees c num h num microl activity assay buffer containing num microm suc llvy amc release amc measured fluorescence spectrophotometry using wavelengths num nm excitation num nm emission tecan genios pro enzymatic activities expressed nmol amcminmg protein
0.2674377.16162502.html.plaintext.txt	20	view larger version numk figure num structure quercetin catechin resveratrol
0.2674377.16162502.html.plaintext.txt	21	view larger version numk figure num structure quercetin catechin resveratrol
0.2674377.16162502.html.plaintext.txt	22	view larger version numk figure num effect resveratrol quercetin catechin levels symb symb cells b cells treated num h indicated concentrations polyphenols dissolved symb medium changed drug treatments continued another num h allow secretion total sa analyzed elisa wb b panel b symb b symb c total intracellular panel d total ia analyzed ip wb see experimental procedures full length app b panel e analyzed wb c cells treated different periods time indicated concentrations resveratrol total sa analyzed b final concentration symb adjusted numnum vv conditions histogram shows mean plus minus sd num num independent experiments western blots shown representative least three independent experiments
0.2674377.16162502.html.plaintext.txt	23	view larger version numk figure num effect resveratrol quercetin catechin levels symb symb cells b cells treated num h indicated concentrations polyphenols dissolved symb medium changed drug treatments continued another num h allow secretion total sa analyzed elisa wb b panel b symb b symb c total intracellular panel d total ia analyzed ip wb see experimental procedures full length app b panel e analyzed wb c cells treated different periods time indicated concentrations resveratrol total sa analyzed b final concentration symb adjusted numnum vv conditions histogram shows mean plus minus sd num num independent experiments western blots shown representative least three independent experiments
0.2674377.16162502.html.plaintext.txt	24	view larger version numk figure num effect resveratrol app processing symb cells expressing wild type swedish symb wild type symb symb cells treated num h increasing concentrations resveratrol num microm secretase inhibitor l numnum first lane medium changed drug treatments continued another num h allow secretion total sa levels analyzed wb panel app c terminal fragments symb symb symb panel b short film exposure panel c long film exposure app intracellular domain aicd panel d analyzed wb using symb antibody full length app panel e secreted app sapp panel f probed antibodies numsymb numsymb respectively b swedish symb symb cells treated resveratrol l numnum described total sa analyzed western blots shown representative least three independent experiments
0.2674377.16162502.html.plaintext.txt	25	view larger version numk figure num effect resveratrol app processing symb cells expressing wild type swedish symb wild type symb symb cells treated num h increasing concentrations resveratrol num microm secretase inhibitor l numnum first lane medium changed drug treatments continued another num h allow secretion total sa levels analyzed wb panel app c terminal fragments symb symb symb panel b short film exposure panel c long film exposure app intracellular domain aicd panel d analyzed wb using symb antibody full length app panel e secreted app sapp panel f probed antibodies numsymb numsymb respectively b swedish symb symb cells treated resveratrol l numnum described total sa analyzed western blots shown representative least three independent experiments
0.2674377.16162502.html.plaintext.txt	26	vitro secretase assays vitro assays performed described previously num briefly cells resuspended numnum mlnum mm dish hypotonic buffer num mm mops ph numnum num mm kcl homogenized ice postnuclear supernatant prepared centrifugation num x g num min num degrees c crude membranes isolated postnuclear supernatant centrifugation numnum x g num min num degrees c membranes resuspended num microlof assay buffer num mm sodium citrate ph numnum numx complete incubated num degrees c num h absence presence indicated drugs samples analyzed wb
0.2674377.16162502.html.plaintext.txt	27	vitro secretase assays vitro assays performed described previously num briefly cells resuspended numnum mlnum mm dish hypotonic buffer num mm mops ph numnum num mm kcl homogenized ice postnuclear supernatant prepared centrifugation num x g num min num degrees c crude membranes isolated postnuclear supernatant centrifugation numnum x g num min num degrees c membranes resuspended num microlof assay buffer num mm sodium citrate ph numnum numx complete incubated num degrees c num h absence presence indicated drugs samples analyzed wb
0.2674377.16162502.html.plaintext.txt	28	results top abstract introduction experimental procedures results discussion references evidence increasing moderate wine intake reduces risk developing ad num num sought determine whether three powerful antioxidant polyphenols found red wine resveratrol trans numnumnum trihydroxystilbene see fig num quercetin numnumnumnumnum pentahydroxyflavone catechin trans numnumnumnumnum pentahydroxyflavane modulate levels end treated symb transfected symb cells increasing concentrations different polyphenols analyzed levels elisa wb total secreted fig num b panel including secreted symb fig numb panel b symb fig numb panel c markedly reduced num num microm resveratrol num h incubation whereas quercetin catechin apparently ineffective concentrations fig num b panel concentration range resveratrol also reduced total intracellular fig numb panel d resveratrol treatment lead intracellular accumulation fig numb panel d concluded secretion impaired determine whether effect resveratrol time dependent symb symb cells treated different periods time num num microm polyphenol fig numc shows although resveratrol affect levels num h incubation inhibitory effect levels gradually strengthened longer incubation periods num num h
0.2674377.16162502.html.plaintext.txt	29	results top abstract introduction experimental procedures results discussion references evidence increasing moderate wine intake reduces risk developing ad num num sought determine whether three powerful antioxidant polyphenols found red wine resveratrol trans numnumnum trihydroxystilbene see fig num quercetin numnumnumnumnum pentahydroxyflavone catechin trans numnumnumnumnum pentahydroxyflavane modulate levels end treated symb transfected symb cells increasing concentrations different polyphenols analyzed levels elisa wb total secreted fig num b panel including secreted symb fig numb panel b symb fig numb panel c markedly reduced num num microm resveratrol num h incubation whereas quercetin catechin apparently ineffective concentrations fig num b panel concentration range resveratrol also reduced total intracellular fig numb panel d resveratrol treatment lead intracellular accumulation fig numb panel d concluded secretion impaired determine whether effect resveratrol time dependent symb symb cells treated different periods time num num microm polyphenol fig numc shows although resveratrol affect levels num h incubation inhibitory effect levels gradually strengthened longer incubation periods num num h
0.2674377.16162502.html.plaintext.txt	30	view larger version numk figure num resveratrol affect secretase activity vitro panel membrane preparations symb symb cells see experimental procedures incubated vitro num degrees c lane num num degrees c lanes num num num h absence presence indicated drugs total produced vitro analyzed wb numsymb antibody panels b c membranes symb symb cells treated culture num h absence presence indicated drugs incubated described total n cadherin derived c terminal fragments n cadsymb n cadsymb analyzed wb antibodies numsymb panel b symb panel c respectively
0.2674377.16162502.html.plaintext.txt	31	view larger version numk figure num resveratrol affect secretase activity vitro panel membrane preparations symb symb cells see experimental procedures incubated vitro num degrees c lane num num degrees c lanes num num num h absence presence indicated drugs total produced vitro analyzed wb numsymb antibody panels b c membranes symb symb cells treated culture num h absence presence indicated drugs incubated described total n cadherin derived c terminal fragments n cadsymb n cadsymb analyzed wb antibodies numsymb panel b symb panel c respectively
0.2674377.16162502.html.plaintext.txt	32	exclude cell line specific effect also treated symb transfected mouse neuroblastoma symb cells resveratrol showed resveratrol inhibited total secreted concentration range another cell line fig numa panel secreted produced symb cells overexpressing symb bearing familial ad swedish mutation also reduced similar treatments fig numb determine whether resveratrol affects app metabolism monitored wb levels app holoprotein proteolytic fragments concentrations resveratrol neither affected full length app levels fig numb panel e fig numa panel e reduced secreted app immunoreactivity fig numa panel f addition resveratrol affect steady state levels app c terminal fragments symb symb symb fig numa panels b c app intracellular domain aicd fig numa panel d together data indicate resveratrol effect secretase mediated cleavages app stability app c terminal fragments therefore resveratrol affect app metabolism production
0.2674377.16162502.html.plaintext.txt	33	exclude cell line specific effect also treated symb transfected mouse neuroblastoma symb cells resveratrol showed resveratrol inhibited total secreted concentration range another cell line fig numa panel secreted produced symb cells overexpressing symb bearing familial ad swedish mutation also reduced similar treatments fig numb determine whether resveratrol affects app metabolism monitored wb levels app holoprotein proteolytic fragments concentrations resveratrol neither affected full length app levels fig numb panel e fig numa panel e reduced secreted app immunoreactivity fig numa panel f addition resveratrol affect steady state levels app c terminal fragments symb symb symb fig numa panels b c app intracellular domain aicd fig numa panel d together data indicate resveratrol effect secretase mediated cleavages app stability app c terminal fragments therefore resveratrol affect app metabolism production
0.2674377.16162502.html.plaintext.txt	34	confirm resveratrol inhibit secretase directly resveratrol used cell free assay designed produce vitro vitro assay membrane preparations isolated symb symb cells incubated num degrees c num h absence presence increasing concentrations resveratrol production affected presence resveratrol vitro fig numa however levels produced vitro membranes isolated cells treated culture polyphenol significantly reduced fig numb indicating resveratrol promoted reduction without directly affecting secretases
0.2674377.16162502.html.plaintext.txt	35	confirm resveratrol inhibit secretase directly resveratrol used cell free assay designed produce vitro vitro assay membrane preparations isolated symb symb cells incubated num degrees c num h absence presence increasing concentrations resveratrol production affected presence resveratrol vitro fig numa however levels produced vitro membranes isolated cells treated culture polyphenol significantly reduced fig numb indicating resveratrol promoted reduction without directly affecting secretases
0.2674377.16162502.html.plaintext.txt	36	view larger version numk figure num proteasome inhibition prevents resveratrol mediated decrease symb symb cells incubated num h increasing concentrations resveratrol thiorphan sensitive endoproteolytic activity nep activity determined intact cells described experimental procedures b symb symb cells treated num h resveratrol num microm vehicle dimethyl sulfoxide dmso absence control presence phosphoramidon num microm thiorphan num microm insulin num microm lactacystin num microm z gpfl cho num microm symb num microm total sa analyzed elisa described fig numa c symb symb cells transfected num sirnas buffer control treated num h resveratrol num microm vehicle dimethyl sulfoxide dmso cells harvested analyzed wb anti num antibody panel anti tubulin antibody panel c total sa panel b analyzed wb described fig numb alln sensitive endoproteolytic activity proteasome activity determined described experimental procedures d purified human num proteasome incubated num min lactacystin num microm dimethyl sulfoxide resveratrol num microm proteasome activity monitored c e symb symb cells treated num h dimethyl sulfoxide resveratrol num microm cells harvested analyzed wb anti num proteasome subunits antibody panel anti catenin antibody panel b five hundred nanograms purified human num proteasome analyzed wb panel last lane values mean plus minus sd num num independent experiments p numnum p numnum students test
0.2674377.16162502.html.plaintext.txt	37	view larger version numk figure num proteasome inhibition prevents resveratrol mediated decrease symb symb cells incubated num h increasing concentrations resveratrol thiorphan sensitive endoproteolytic activity nep activity determined intact cells described experimental procedures b symb symb cells treated num h resveratrol num microm vehicle dimethyl sulfoxide dmso absence control presence phosphoramidon num microm thiorphan num microm insulin num microm lactacystin num microm z gpfl cho num microm symb num microm total sa analyzed elisa described fig numa c symb symb cells transfected num sirnas buffer control treated num h resveratrol num microm vehicle dimethyl sulfoxide dmso cells harvested analyzed wb anti num antibody panel anti tubulin antibody panel c total sa panel b analyzed wb described fig numb alln sensitive endoproteolytic activity proteasome activity determined described experimental procedures d purified human num proteasome incubated num min lactacystin num microm dimethyl sulfoxide resveratrol num microm proteasome activity monitored c e symb symb cells treated num h dimethyl sulfoxide resveratrol num microm cells harvested analyzed wb anti num proteasome subunits antibody panel anti catenin antibody panel b five hundred nanograms purified human num proteasome analyzed wb panel last lane values mean plus minus sd num num independent experiments p numnum p numnum students test
0.2674377.16162502.html.plaintext.txt	38	secretase targets several type proteins including cell cell adhesion receptors e n cadherins num num cleavage n cadherin secretase produces transcriptionally active intracellular fragment n cadsymb proteolytic cleavage intermediate c terminal fragment n cadsymb num using similar cell free assay determined production n cadsymb affected resveratrol treatment fig numc confirming absence inhibitory effect resveratrol secretase activity together observation resveratrol affect levels app holoprotein c terminal proteolytic fragments data indicate resveratrol target producing activity rather promoted clearance
0.2674377.16162502.html.plaintext.txt	39	secretase targets several type proteins including cell cell adhesion receptors e n cadherins num num cleavage n cadherin secretase produces transcriptionally active intracellular fragment n cadsymb proteolytic cleavage intermediate c terminal fragment n cadsymb num using similar cell free assay determined production n cadsymb affected resveratrol treatment fig numc confirming absence inhibitory effect resveratrol secretase activity together observation resveratrol affect levels app holoprotein c terminal proteolytic fragments data indicate resveratrol target producing activity rather promoted clearance
0.2674377.16162502.html.plaintext.txt	40	based observations aimed determine whether resveratrol treatment promotes degradation peptides degraded vivo least four metalloendopeptidases nep endothelin converting enzyme num num ece num num insulin degrading enzyme ide num recent evidence indicates long term treatment resveratrol promotes nep activity sk n sh cells num using thiorphan sensitive enzymatic assays intact symb cells confirmed nep activity significantly increased upon resveratrol treatment fig numa however inhibition nep phosphoramidon thiorphan symb symb cells could prevent decrease levels triggered resveratrol fig numb phosphoramidon also inhibits ece num num concluded enzymatic activities also involved resveratrol mediated decrease pretreatment insulin acts competitive inhibitor ide rescue levels resveratrol treatment fig numb thus resveratrol promote degradation nep ece num num ide symb cells
0.2674377.16162502.html.plaintext.txt	41	based observations aimed determine whether resveratrol treatment promotes degradation peptides degraded vivo least four metalloendopeptidases nep endothelin converting enzyme num num ece num num insulin degrading enzyme ide num recent evidence indicates long term treatment resveratrol promotes nep activity sk n sh cells num using thiorphan sensitive enzymatic assays intact symb cells confirmed nep activity significantly increased upon resveratrol treatment fig numa however inhibition nep phosphoramidon thiorphan symb symb cells could prevent decrease levels triggered resveratrol fig numb phosphoramidon also inhibits ece num num concluded enzymatic activities also involved resveratrol mediated decrease pretreatment insulin acts competitive inhibitor ide rescue levels resveratrol treatment fig numb thus resveratrol promote degradation nep ece num num ide symb cells
0.2674377.16162502.html.plaintext.txt	42	converging evidence indicates resveratrol promotes proteasomal degradation specific subset proteins including cyclin symb num estrogen receptor num hypoxia inducible factor num num proteasome shown modulate levels num asked whether proteasome inhibition rescues levels upon resveratrol treatment fig numb shows treatments selective proteasome inhibitors lactacystin z gpfl cho symb significantly prevented resveratrol induced decrease confirm involvement proteasome anti amyloidogenic effect resveratrol sought regulate proteasome activity sirna directed silencing proteasome multicatalytic protease complex formed different subunits encoded several genes num symb highly selective chymotrypsin like activity proteasome num subunit num critical proteolytic activity num asked whether sirna directed silencing proteasome subunit num prevents resveratrol induced decrease transfection sirnas directed subunit num strongly decreased num protein expression fig numc panel inhibited num chymotrypsin like activity proteasome fig numc conditions observed strong inhibition resveratrol induced decrease fig numc panel b
0.2674377.16162502.html.plaintext.txt	43	converging evidence indicates resveratrol promotes proteasomal degradation specific subset proteins including cyclin symb num estrogen receptor num hypoxia inducible factor num num proteasome shown modulate levels num asked whether proteasome inhibition rescues levels upon resveratrol treatment fig numb shows treatments selective proteasome inhibitors lactacystin z gpfl cho symb significantly prevented resveratrol induced decrease confirm involvement proteasome anti amyloidogenic effect resveratrol sought regulate proteasome activity sirna directed silencing proteasome multicatalytic protease complex formed different subunits encoded several genes num symb highly selective chymotrypsin like activity proteasome num subunit num critical proteolytic activity num asked whether sirna directed silencing proteasome subunit num prevents resveratrol induced decrease transfection sirnas directed subunit num strongly decreased num protein expression fig numc panel inhibited num chymotrypsin like activity proteasome fig numc conditions observed strong inhibition resveratrol induced decrease fig numc panel b
0.2674377.16162502.html.plaintext.txt	44	view larger version numk figure num effect resveratrol analogues levels symb symb cells treated num h indicated concentrations resveratrol analogues dissolved symb total sa analyzed fig numb final concentration symb adjusted numnum vv conditions histogram shows relative amounts total sa detected wb upper panel
0.2674377.16162502.html.plaintext.txt	45	view larger version numk figure num effect resveratrol analogues levels symb symb cells treated num h indicated concentrations resveratrol analogues dissolved symb total sa analyzed fig numb final concentration symb adjusted numnum vv conditions histogram shows relative amounts total sa detected wb upper panel
0.2674377.16162502.html.plaintext.txt	46	investigated whether resveratrol directly stimulates proteasome activity fig numd chymotrypsin like activity purified proteasome monitored upon vitro incubation resveratrol activity also assessed endogenous proteasome cell extracts treatment polyphenol cell cultures fig numc significant effect resveratrol chymotrypsin like activity purified endogenous proteasome observed histograms fig num d c respectively resveratrol effectively reduced levels num h incubation also asked whether resveratrol modifies proteasome subunit transcription found resveratrol treatment markedly affect steady state levels several proteasome subunits symb cells fig numc panel fig nume panel together results demonstrate resveratrol promotes proteasome dependent intracellular degradation via mechanism increase total proteasome activity consistent conclusion levels catenin cytosolic protein degraded ubiquitin proteasome system num affected resveratrol symb cells fig nume panel b
0.2674377.16162502.html.plaintext.txt	47	investigated anti amyloidogenic effect several resveratrol analogues three analogues tested piceatannol trans numnumnumnum tetrahydroxystilbene contains additional hydroxyl group c num two methoxy analogues trimethoxy resveratrol trans numnumnum trimethoxystilbene tms interestingly three analogues able decrease levels fig num however compared resveratrol fig numa piceatannol trimethoxy resveratrol less potent whereas tms comparable potency reducing amounts fig num
0.2674377.16162502.html.plaintext.txt	48	investigated anti amyloidogenic effect several resveratrol analogues three analogues tested piceatannol trans numnumnumnum tetrahydroxystilbene contains additional hydroxyl group c num two methoxy analogues trimethoxy resveratrol trans numnumnum trimethoxystilbene tms interestingly three analogues able decrease levels fig num however compared resveratrol fig numa piceatannol trimethoxy resveratrol less potent whereas tms comparable potency reducing amounts fig num
0.2674377.16162502.html.plaintext.txt	49	discussion top abstract introduction experimental procedures results discussion references data show resveratrol strongly reduces produced different cell lines expressing wild type swedish mutant symb resveratrol acts promoting intracellular degradation amyloid peptide mechanism implicates proteasome pharmacological studies show none previously reported degrading metalloendopeptidases nep ece num num ide involved clearance finally demonstrate anti amyloidogenic activity two methoxy analogues resveratrol trimethoxy resveratrol tms suggesting chemical modifications resveratrol done context improving potency stability bioavailability therefore therapeutic use
0.2674377.16162502.html.plaintext.txt	50	discussion top abstract introduction experimental procedures results discussion references data show resveratrol strongly reduces produced different cell lines expressing wild type swedish mutant symb resveratrol acts promoting intracellular degradation amyloid peptide mechanism implicates proteasome pharmacological studies show none previously reported degrading metalloendopeptidases nep ece num num ide involved clearance finally demonstrate anti amyloidogenic activity two methoxy analogues resveratrol trimethoxy resveratrol tms suggesting chemical modifications resveratrol done context improving potency stability bioavailability therefore therapeutic use
0.2674377.16162502.html.plaintext.txt	51	additional studies needed fully elucidate role proteasome mechanism intracellular clearance number possible functions proteasome regulation metabolism ascribed multicatalytic complex num proteasome targets degradation symb three core components secretase complex presenilins aph num pen num num suggesting proteasome activation may decrease levels reducing amounts symb available altering secretase activity data show reduction symb levels fig numa panel c alteration secretase mediated cleavages app n cadherin upon resveratrol treatment figs num num thus excluding possibility resveratrol lowers promoting proteasomal degradation symb secretase components recent evidence also suggests degraded proteasome dependent endoplasmic reticulum er associated degradation num using cell free reconstitutions er derived brain microsomes schmitz et al num show translocate er cytosol directly degraded proteasome conceivable resveratrol promotes clearance mechanism however er represents small fraction total produced small pool produced er appears controlled er associated degradation unlikely severe reduction levels observed presence resveratrol entirely due increase clearance mechanism therefore hypothesize resveratrol may act indirectly selectively stimulating proteasomal degradation yet identified critical regulators clearance
0.2674377.16162502.html.plaintext.txt	52	additional studies needed fully elucidate role proteasome mechanism intracellular clearance number possible functions proteasome regulation metabolism ascribed multicatalytic complex num proteasome targets degradation symb three core components secretase complex presenilins aph num pen num num suggesting proteasome activation may decrease levels reducing amounts symb available altering secretase activity data show reduction symb levels fig numa panel c alteration secretase mediated cleavages app n cadherin upon resveratrol treatment figs num num thus excluding possibility resveratrol lowers promoting proteasomal degradation symb secretase components recent evidence also suggests degraded proteasome dependent endoplasmic reticulum er associated degradation num using cell free reconstitutions er derived brain microsomes schmitz et al num show translocate er cytosol directly degraded proteasome conceivable resveratrol promotes clearance mechanism however er represents small fraction total produced small pool produced er appears controlled er associated degradation unlikely severe reduction levels observed presence resveratrol entirely due increase clearance mechanism therefore hypothesize resveratrol may act indirectly selectively stimulating proteasomal degradation yet identified critical regulators clearance
0.2674377.16162502.html.plaintext.txt	53	also important determine molecular targets resveratrol pathway clearance resveratrol interacts several proteins including members sirtuin family sirtuins evolutionarily conserved deacetylases important functions longevity num resveratrol found act potent activator human sirtuin symb vitro yeast homologue symb vivo mechanism may extend life span yeast num moreover resveratrol symb activation recently linked neuroprotective pathways models axonal degeneration num neuronal dysfunctions caused mutant polyglutamines num would therefore interest determine whether symb involved resveratrol induced decrease
0.2674377.16162502.html.plaintext.txt	54	also important determine molecular targets resveratrol pathway clearance resveratrol interacts several proteins including members sirtuin family sirtuins evolutionarily conserved deacetylases important functions longevity num resveratrol found act potent activator human sirtuin symb vitro yeast homologue symb vivo mechanism may extend life span yeast num moreover resveratrol symb activation recently linked neuroprotective pathways models axonal degeneration num neuronal dysfunctions caused mutant polyglutamines num would therefore interest determine whether symb involved resveratrol induced decrease
0.2674377.16162502.html.plaintext.txt	55	evidence compelling decrease proteasome activity occurs ad brains num num unclear however whether decrease proteasome activity parallel increase levels proposed may lead proteasome inhibition num suggesting high levels ad brain may create vicious cycle inhibiting proteasome blocking degradation critical regulators clearance context data reveal important mechanism selective proteasome activation anti amyloidogenic effect resveratrol support therapeutic potential natural polyphenol
0.2674377.16162502.html.plaintext.txt	56	evidence compelling decrease proteasome activity occurs ad brains num num unclear however whether decrease proteasome activity parallel increase levels proposed may lead proteasome inhibition num suggesting high levels ad brain may create vicious cycle inhibiting proteasome blocking degradation critical regulators clearance context data reveal important mechanism selective proteasome activation anti amyloidogenic effect resveratrol support therapeutic potential natural polyphenol
0.2674377.16162502.html.plaintext.txt	57	footnotes work supported national institute mental health grant num grant american health assistance foundation costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.2674377.16162502.html.plaintext.txt	58	footnotes work supported national institute mental health grant num grant american health assistance foundation costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.2674377.16162502.html.plaintext.txt	59	num correspondence addressed litwin zucker research center study alzheimers disease memory disorders north shore long island jewish institute medical research num community dr manhasset ny num tel num num num e mail pmarambaataecomyuedu u d
0.2674377.16162502.html.plaintext.txt	60	num abbreviations used ad alzheimers disease suc succinyl tms trans numnumnumnum tetramethoxystilbene alln n acetyl ll norleucinal cho elisa enzyme linked immunosorbent assay ece endothelin converting enzyme ide insulin degrading enzyme amyloid app amyloid precursor protein amc amido num methylcoumarin tricine n num hydroxy numnum bishydroxymethylethylglycine wb western blotting ip immunoprecipitation nep neprilysin mops num morpholinepropanesulfonic acid er endoplasmic reticulum sirna small interfering rna tbs tris buffered saline sa secreted amyloid z benzyloxycarbonyl
0.2674377.16162502.html.plaintext.txt	61	acknowledgments thank drs f checler n k robakis l dadamio p d mehta generously providing us antibodies cdnas cell lines
0.2674377.16162502.html.plaintext.txt	62	references top abstract introduction experimental procedures results discussion references hardy j selkoe d j num science num num numabstractfree full text tanzi r e bertram l num cell num num numcrossrefmedline order article via infotrieve passer b pellegrini l russo c siegel r m lenardo m j schettini g bachmann m tabaton m dadamio l num j alzheimers dis num num nummedline order article via infotrieve checler f num j neurochem num num nummedline order article via infotrieve annaert w de strooper b num annu rev cell dev biol num num numcrossrefmedline order article via infotrieve marambaud p robakis n k num genes brain behav num num numcrossrefmedline order article via infotrieve luchsinger j tang m x siddiqui m shea mayeux r num j geriatr soc num num numcrossrefmedline order article via infotrieve lindsay j laurin d verreault r hebert r helliwell b hill g b mcdowell num j epidemiol num num numabstractfree full text orgogozo j m dartigues j f lafont letenneur l commenges d salamon r renaud breteler m b num rev neurol paris num num nummedline order article via infotrieve truelsen thudium d gronbaek m num neurology num num numabstractfree full text savaskan e olivieri g meier f seifritz e wirz justice muller spahn f num gerontology num num numcrossrefmedline order article via infotrieve jang j h surh y j num free radic biol med num num numcrossrefmedline order article via infotrieve han y zheng w h bastianetto chabot j g quirion r num br j pharmacol num num numcrossrefmedline order article via infotrieve barelli h lebeau vizzavona j delaere p chevallier n drouot c marambaud p ancolio k buxbaum j d khorkova o heroux j sahasrabudhe martinez j warter j m mohr m checler f num mol med num num nummedline order article via infotrieve marambaud p wen p h dutt shioi j takashima siman r robakis n k num cell num num numcrossrefmedline order article via infotrieve marambaud p shioi j serban g georgakopoulos sarner nagy v baki l wen p efthimiopoulos shao z wisniewski robakis n k num embo j num num numabstractfree full text turner j fisk l nalivaeva n n num ann n y acad sci num num numabstractfree full text melzig m f escher f num pharmazie num num nummedline order article via infotrieve joe k liu h suzui m vural m e xiao d weinstein b num clin cancer res num num numabstractfree full text pozo guisado e lorenzo benayas m j fernandez salguero p m num int j cancer num num numcrossrefmedline order article via infotrieve cao z fang j xia c shi x jiang b h num clin cancer res num num numabstractfree full text de vrij f m fischer d f van leeuwen f w hol e m num prog neurobiol num num numcrossrefmedline order article via infotrieve orlowski m wilk num arch biochem biophys num num numcrossrefmedline order article via infotrieve elofsson m splittgerber u myung j mohan r crews c m num chem biol num num numcrossrefmedline order article via infotrieve aberle h bauer stappert j kispert kemler r num embo j num num numabstractfree full text schmitz schneider kummer m p herzog v num traffic num num numcrossrefmedline order article via infotrieve guarente l num trends genet num num numcrossrefmedline order article via infotrieve howitz k bitterman k j cohen h y lamming d w lavu wood j g zipkin r e chung p kisielewski zhang l l scherer b sinclair d num nature num num numcrossrefmedline order article via infotrieve araki sasaki y milbrandt j num science num num numabstractfree full text parker j arango m abderrahmane lambert e tourette c catoire h neri c num nat genet num num numcrossrefmedline order article via infotrieve keller j n hanni k b markesbery w r num j neurochem num num numcrossrefmedline order article via infotrieve lopez salon m morelli l castano e m soto e f pasquini j m num j neurosci res num num numnumconum c numabstractfree full text article abstract full text pdf versions article numnumnum recent symbnum purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager copyright permissions google scholar articles marambaud p articles davies p pubmed pubmed citation articles marambaud p articles davies p
0.2674377.16162502.html.plaintext.txt	63	home help feedback subscriptions archive search table contents asbmb journals molecular cellular proteomics journal lipid research biochemistry molecular biology education copyright num american society biochemistry molecular biology
0.2710359.15003956.html.plaintext.txt	0	meta analysis association cathepsin d symb gene polymorphism risk alzheimer disease huge gene disease association review christos symb anastasia symb john p symbnumnum
0.2710359.15003956.html.plaintext.txt	1	num clinical molecular epidemiology unit department hygiene epidemiology university ioannina school medicine ioannina greece num biomedical research institute foundation research technology hellas ioannina greece num institute clinical research health policy studies department medicine tufts new england medical center tufts university school medicine boston ma
0.2710359.15003956.html.plaintext.txt	2	num clinical molecular epidemiology unit department hygiene epidemiology university ioannina school medicine ioannina greece num biomedical research institute foundation research technology hellas ioannina greece num institute clinical research health policy studies department medicine tufts new england medical center tufts university school medicine boston ma
0.2710359.15003956.html.plaintext.txt	3	received publication august num num accepted publication october num num
0.2710359.15003956.html.plaintext.txt	4	abstract top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references c polymorphism exon num cathepsin d gene encoding cathepsin d ctsd implicated risk factor alzheimer disease authors performed meta analysis num studies num comparisons ctsd genotyping numnum alzheimer disease cases numnum controls overall random effects odds ratio versus c allele numnum num confidence interval ci numnum numnum study heterogeneity p numnum significant study heterogeneity evidence significant association first hypothesis generating study excluded calculations odds ratio numnum num ci numnum numnum p numnum summary odds ratio carriers versus noncarriers similar subjects carrying carrying apolipoprotein e num allele apoenum increased susceptibility alzheimer disease conferred apoenum carriage tended prominent presence allele random effects numnum num ci numnum numnum numnum num ci numnum numnum carriers noncarriers respectively meta analysis shows ctsd polymorphism major risk factor alzheimer disease although small effect enhancement apoenum effect excluded
0.2710359.15003956.html.plaintext.txt	5	abstract top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references c polymorphism exon num cathepsin d gene encoding cathepsin d ctsd implicated risk factor alzheimer disease authors performed meta analysis num studies num comparisons ctsd genotyping numnum alzheimer disease cases numnum controls overall random effects odds ratio versus c allele numnum num confidence interval ci numnum numnum study heterogeneity p numnum significant study heterogeneity evidence significant association first hypothesis generating study excluded calculations odds ratio numnum num ci numnum numnum p numnum summary odds ratio carriers versus noncarriers similar subjects carrying carrying apolipoprotein e num allele apoenum increased susceptibility alzheimer disease conferred apoenum carriage tended prominent presence allele random effects numnum num ci numnum numnum numnum num ci numnum numnum carriers noncarriers respectively meta analysis shows ctsd polymorphism major risk factor alzheimer disease although small effect enhancement apoenum effect excluded
0.2710359.15003956.html.plaintext.txt	6	alzheimer disease cathepsin d ctsd epidemiology genetics meta analysis polymorphism genetics
0.2710359.15003956.html.plaintext.txt	7	abbreviations abbreviations ci confidence interval odds ratio
0.2710359.15003956.html.plaintext.txt	8	introduction top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references editor note paper also available website human genome epidemiology network httpwwwcdcgovgenomicshugenetdefaulthtm
0.2710359.15003956.html.plaintext.txt	9	gene top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references cathepsin d intracellular acid protease exhibits beta secretase activity vitro implicated processing amyloid precursor protein tau protein num num cathepsin d gene ctsd located short arm chromosome num numsymbnum consists nine exons synthesis beta amyloid peptide putative key event pathogenesis alzheimer disease beta amyloid derives precursor protein via proteolytic cleavage secretases therefore postulated variants genes coding enzymes involved proteolytic cleavage amyloid precursor protein degradation clearance beta amyloid central nervous system may potential risk factors alzheimer disease
0.2710359.15003956.html.plaintext.txt	10	gene top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references cathepsin d intracellular acid protease exhibits beta secretase activity vitro implicated processing amyloid precursor protein tau protein num num cathepsin d gene ctsd located short arm chromosome num numsymbnum consists nine exons synthesis beta amyloid peptide putative key event pathogenesis alzheimer disease beta amyloid derives precursor protein via proteolytic cleavage secretases therefore postulated variants genes coding enzymes involved proteolytic cleavage amyloid precursor protein degradation clearance beta amyloid central nervous system may potential risk factors alzheimer disease
0.2710359.15003956.html.plaintext.txt	11	gene variants top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references ctsd gene contains polymorphic c transition site position num exon num polymorphism results symb val substitution cathepsin d profragment num polymorphism associated increased secretion altered intracellular maturation cathep sin d profragment one study num moreover allele associated num percent decrease beta amyloid peptide num num levels cerebrospinal fluid patients alzheimer disease num finally polymorphism recently reported significantly associated general intelligence healthy elderly people num
0.2710359.15003956.html.plaintext.txt	12	gene variants top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references ctsd gene contains polymorphic c transition site position num exon num polymorphism results symb val substitution cathepsin d profragment num polymorphism associated increased secretion altered intracellular maturation cathep sin d profragment one study num moreover allele associated num percent decrease beta amyloid peptide num num levels cerebrospinal fluid patients alzheimer disease num finally polymorphism recently reported significantly associated general intelligence healthy elderly people num
0.2710359.15003956.html.plaintext.txt	13	molecular epidemiologic studies presented seemingly contradictory results concerning potential role ctsd polymorphism alzheimer disease num num also controversy whether polymorphism may interact apolipoprotein e num allele apoenum best known genetic determinant sporadic alzhei mer disease num single studies may underpowered detect interactions even overall effects given amount accumulated data deemed important perform quantitative synthesis evidence using rigorous methods thus conducted comprehensive meta analysis available studies relating ctsd polymorphism risk alzheimer disease
0.2710359.15003956.html.plaintext.txt	14	molecular epidemiologic studies presented seemingly contradictory results concerning potential role ctsd polymorphism alzheimer disease num num also controversy whether polymorphism may interact apolipoprotein e num allele apoenum best known genetic determinant sporadic alzhei mer disease num single studies may underpowered detect interactions even overall effects given amount accumulated data deemed important perform quantitative synthesis evidence using rigorous methods thus conducted comprehensive meta analysis available studies relating ctsd polymorphism risk alzheimer disease
0.2710359.15003956.html.plaintext.txt	15	disease top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references alzheimer disease common cause progressive cognitive impairment elderly annual incidence approximately num percent num num years increasing num percent elderly num years age num num mutations amyloid precursor protein presenilin num presenilin num genes account num percent cases result autosomally dominant pattern expressed complete penetrance early manifestations num alzheimer disease probably slightly common females num proven postulated risk factors include head injury particular among males num well family history low income low education low occupational status depression exposure aluminum drinking water hypertension syndrome num num conversely use nonsteroidal antiinflammatory drugs treat arthritis associated reduced risk alzhei mer disease estrogen use postmenopausal women num physical activity diets high levels vitamins symb symb folate red wine moderate quantities may protective num prevalence alzheimer disease varies considerably among different population groups num least dozens polymorphisms examined relation sporadic alzheimer disease published reviews available num num among conclusive evidence several studies meta analysis thereof apoenum strong risk factor developing alzheimer disease male female subjects early onset num years late onset disease num approximately fivefold increase odds developing alzheimer disease single studies also implicated polymorphisms important although reported odds ratios much smaller seen apoenum attempts replication subsequent research conclusive meta analyses polymorphisms already appeared literature num num suggest significant overall associations several polymorphisms including myeloperoxidase gene promoter polymorphism num intronic promoter region polymorphisms presenilin num late onset disease num insertion deletion polymorphism missense mutation alpha num macroglobulin gene num several polymorphisms protein tau gene num associations modest effect size odds ratios ors numnum numnum claimed meta analyses low density lipoprotein receptor related protein gene exon num polymorphism num insertion deletion polymorphism angiotensin converting enzyme gene num
0.2710359.15003956.html.plaintext.txt	16	disease top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references alzheimer disease common cause progressive cognitive impairment elderly annual incidence approximately num percent num num years increasing num percent elderly num years age num num mutations amyloid precursor protein presenilin num presenilin num genes account num percent cases result autosomally dominant pattern expressed complete penetrance early manifestations num alzheimer disease probably slightly common females num proven postulated risk factors include head injury particular among males num well family history low income low education low occupational status depression exposure aluminum drinking water hypertension syndrome num num conversely use nonsteroidal antiinflammatory drugs treat arthritis associated reduced risk alzhei mer disease estrogen use postmenopausal women num physical activity diets high levels vitamins symb symb folate red wine moderate quantities may protective num prevalence alzheimer disease varies considerably among different population groups num least dozens polymorphisms examined relation sporadic alzheimer disease published reviews available num num among conclusive evidence several studies meta analysis thereof apoenum strong risk factor developing alzheimer disease male female subjects early onset num years late onset disease num approximately fivefold increase odds developing alzheimer disease single studies also implicated polymorphisms important although reported odds ratios much smaller seen apoenum attempts replication subsequent research conclusive meta analyses polymorphisms already appeared literature num num suggest significant overall associations several polymorphisms including myeloperoxidase gene promoter polymorphism num intronic promoter region polymorphisms presenilin num late onset disease num insertion deletion polymorphism missense mutation alpha num macroglobulin gene num several polymorphisms protein tau gene num associations modest effect size odds ratios ors numnum numnum claimed meta analyses low density lipoprotein receptor related protein gene exon num polymorphism num insertion deletion polymorphism angiotensin converting enzyme gene num
0.2710359.15003956.html.plaintext.txt	17	meta analysis methods top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references identification eligibility relevant studies considered studies examined association ctsd polymorphism alzheimer disease sources included medline embase january num september num search strategy based combinations alzheimer disease ctsd cathepsin d polymorphism allele genetics references retrieved articles also screened
0.2710359.15003956.html.plaintext.txt	18	meta analysis methods top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references identification eligibility relevant studies considered studies examined association ctsd polymorphism alzheimer disease sources included medline embase january num september num search strategy based combinations alzheimer disease ctsd cathepsin d polymorphism allele genetics references retrieved articles also screened
0.2710359.15003956.html.plaintext.txt	19	case control studies eligible determined distribution ctsd genotypes alzheimer disease cases regardless age onset concurrent control group dementia free subjects using molecular method genotyping cases alzheimer disease eligible regardless whether family history alzhei mer disease however excluded family based studies pedigrees several affected cases per family analysis based linkage considerations
0.2710359.15003956.html.plaintext.txt	20	case control studies eligible determined distribution ctsd genotypes alzheimer disease cases regardless age onset concurrent control group dementia free subjects using molecular method genotyping cases alzheimer disease eligible regardless whether family history alzhei mer disease however excluded family based studies pedigrees several affected cases per family analysis based linkage considerations
0.2710359.15003956.html.plaintext.txt	21	data extraction two investigators independently extracted data reached consensus items following information sought report authors journal year publication country origin selection characteristics alzheimer disease cases controls demographics ethnic group study population eligible genotyped cases controls number cases controls ctsd genotype studies including subjects different ethnic groups data extracted separately ethnicity whenever possible furthermore examined whether matching used whether specific mention blinding personnel performed genotyping clinical status subjects whether genotyping method validated
0.2710359.15003956.html.plaintext.txt	22	data extraction two investigators independently extracted data reached consensus items following information sought report authors journal year publication country origin selection characteristics alzheimer disease cases controls demographics ethnic group study population eligible genotyped cases controls number cases controls ctsd genotype studies including subjects different ethnic groups data extracted separately ethnicity whenever possible furthermore examined whether matching used whether specific mention blinding personnel performed genotyping clinical status subjects whether genotyping method validated
0.2710359.15003956.html.plaintext.txt	23	meta analysis primary analysis compared alzheimer disease cases controls contrast versus c alleles analysis aims detect overall differences also examined contrast extremes homozygotes tt versus cc finally examined contrast tt versus ct cc contrast ct tt versus cc contrasts correspond recessive dominant effects respectively allele
0.2710359.15003956.html.plaintext.txt	24	meta analysis primary analysis compared alzheimer disease cases controls contrast versus c alleles analysis aims detect overall differences also examined contrast extremes homozygotes tt versus cc finally examined contrast tt versus ct cc contrast ct tt versus cc contrasts correspond recessive dominant effects respectively allele
0.2710359.15003956.html.plaintext.txt	25	odds ratio used metric choice genetic contrast estimated study heterogeneity across eligible comparisons using chi square based q statistic num heterogeneity considered significant p numnum data combined using fixed effects mantel haenszel random effects dersimonian laird models num random effects incorporate estimate study variance tend provide wider confidence intervals results constituent studies differ among absence study heterogeneity two methods provide identical results random effects appropriate heterogeneity present num
0.2710359.15003956.html.plaintext.txt	26	odds ratio used metric choice genetic contrast estimated study heterogeneity across eligible comparisons using chi square based q statistic num heterogeneity considered significant p numnum data combined using fixed effects mantel haenszel random effects dersimonian laird models num random effects incorporate estimate study variance tend provide wider confidence intervals results constituent studies differ among absence study heterogeneity two methods provide identical results random effects appropriate heterogeneity present num
0.2710359.15003956.html.plaintext.txt	27	also performed cumulative meta analysis num recursive cumulative meta analysis num num evaluate whether summary odds ratio versus c contrast changed time data accumulated whether strength association changed first hypothesis generating study excluded calculations num inverted funnel plots begg mazumdar publication bias diagnostic nonparametric correlation coefficient num evaluated whether magnitude observed association related variance study whether large studies gave different results compared smaller ones num finally evaluated whether summary results different analysis limited studies intensive efforts exclude alzheimer disease controls clearly performed neuropsychological testing controls
0.2710359.15003956.html.plaintext.txt	28	also performed cumulative meta analysis num recursive cumulative meta analysis num num evaluate whether summary odds ratio versus c contrast changed time data accumulated whether strength association changed first hypothesis generating study excluded calculations num inverted funnel plots begg mazumdar publication bias diagnostic nonparametric correlation coefficient num evaluated whether magnitude observed association related variance study whether large studies gave different results compared smaller ones num finally evaluated whether summary results different analysis limited studies intensive efforts exclude alzheimer disease controls clearly performed neuropsychological testing controls
0.2710359.15003956.html.plaintext.txt	29	previous investigations alluded possibility allele may interact apoenum allele conferring susceptibility alzheimer disease num num thus also evaluated effect allele carriage risk alzheimer disease separately apoenum positive apoenum negative subjects moreover evaluated genetic effect conferred presence apoenum separately subjects carrying allele carrying allele odds ratios combined fixed random effects models described data reported communicated primary investigators obtain information whenever possible
0.2710359.15003956.html.plaintext.txt	30	previous investigations alluded possibility allele may interact apoenum allele conferring susceptibility alzheimer disease num num thus also evaluated effect allele carriage risk alzheimer disease separately apoenum positive apoenum negative subjects moreover evaluated genetic effect conferred presence apoenum separately subjects carrying allele carrying allele odds ratios combined fixed random effects models described data reported communicated primary investigators obtain information whenever possible
0.2710359.15003956.html.plaintext.txt	31	analyses performed spss numnum spss inc chicago illinois meta analyst joseph lau boston massachusetts software whenever num values num x num table added numnum four cells odds ratio could calculated p values two tailed
0.2710359.15003956.html.plaintext.txt	32	meta analysis results top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references eligible studies fourteen studies probing relation ctsd polymorphism alzheimer disease susceptibility identified num num profiled table num two eligible studies num num contained subjects two different ethnic groups total num separate comparisons considered considerable diversity ethnic groups eleven studies num num num selected alzheimer disease cases according criteria national institute neurological communicative disorders stroke alzheimer disease related disorders association nincds adrda two studies num num selected alzhei mer disease cases according diagnostic statistical manual mental disorders dsm iiir dsm iv criteria one study num clarify exact criteria used diagnosis alzheimer disease five studies num num also included autopsy confirmed alzheimer disease cases two studies num num mentioned included cases family history alzheimer disease eight studies num num num num specifically excluded patients remaining clarify background family history one study num mentioned num percent alzheimer disease cases late onset disease age onset num years five studies num num num num specifically included late onset alzheimer disease cases one study num specifically excluded patients remaining clarify age onset controls diagnosis alzheimer disease amount additional screening general physical neurologic examination psychiatric interview neuropsychological testing blood cerebrospinal fluid studies computed tomography scan mini mental state examination score exclude alzheimer disease differed substantially across studies
0.2710359.15003956.html.plaintext.txt	33	meta analysis results top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references eligible studies fourteen studies probing relation ctsd polymorphism alzheimer disease susceptibility identified num num profiled table num two eligible studies num num contained subjects two different ethnic groups total num separate comparisons considered considerable diversity ethnic groups eleven studies num num num selected alzheimer disease cases according criteria national institute neurological communicative disorders stroke alzheimer disease related disorders association nincds adrda two studies num num selected alzhei mer disease cases according diagnostic statistical manual mental disorders dsm iiir dsm iv criteria one study num clarify exact criteria used diagnosis alzheimer disease five studies num num also included autopsy confirmed alzheimer disease cases two studies num num mentioned included cases family history alzheimer disease eight studies num num num num specifically excluded patients remaining clarify background family history one study num mentioned num percent alzheimer disease cases late onset disease age onset num years five studies num num num num specifically included late onset alzheimer disease cases one study num specifically excluded patients remaining clarify age onset controls diagnosis alzheimer disease amount additional screening general physical neurologic examination psychiatric interview neuropsychological testing blood cerebrospinal fluid studies computed tomography scan mini mental state examination score exclude alzheimer disease differed substantially across studies
0.2710359.15003956.html.plaintext.txt	34	view table table num characteristics studies included meta analysis specific matching age described five studies num num num one study also matched sex num one study num specifically mentioned blinding personnel performed genotyping appropriate molecular methods genotyping used studies used polymerase chain reaction two studies num num also used dynamic allele specific hybridization
0.2710359.15003956.html.plaintext.txt	35	meta analysis database eligible studies summarized table num included total numnum cases alzheimer disease numnum controls numnum numnum respectively genotype data allele highly represented among controls american descent overall prevalence numnum percent num percent confidence interval ci numnum numnum controls european numnum percent num percent ci numnum numnum asian numnum percent num percent ci numnum numnum descent significant heterogeneity prevalence rates allele even across control subjects european descent rate numnum percent among hispanic americans numnum percent italy numnum percent spain lower rates northern european countries numnum percent united kingdom numnum percent sweden numnum percent germany lowest prevalence rate numnum percent polish population overall prevalence tt homozygosity numnum percent numnum percent numnum percent control subjects american european asian descent respectively respective prevalence rates ct heterozygosity numnum percent numnum percent numnum percent respective rates cc homozygosity numnum percent numnum percent numnum percent distribution genotypes control groups consistent hardy weinberg equilibrium studies
0.2710359.15003956.html.plaintext.txt	36	meta analysis database eligible studies summarized table num included total numnum cases alzheimer disease numnum controls numnum numnum respectively genotype data allele highly represented among controls american descent overall prevalence numnum percent num percent confidence interval ci numnum numnum controls european numnum percent num percent ci numnum numnum asian numnum percent num percent ci numnum numnum descent significant heterogeneity prevalence rates allele even across control subjects european descent rate numnum percent among hispanic americans numnum percent italy numnum percent spain lower rates northern european countries numnum percent united kingdom numnum percent sweden numnum percent germany lowest prevalence rate numnum percent polish population overall prevalence tt homozygosity numnum percent numnum percent numnum percent control subjects american european asian descent respectively respective prevalence rates ct heterozygosity numnum percent numnum percent numnum percent respective rates cc homozygosity numnum percent numnum percent numnum percent distribution genotypes control groups consistent hardy weinberg equilibrium studies
0.2710359.15003956.html.plaintext.txt	37	view table table num distribution ctsd alleles among alzheimer disease cases controls included studies overall effects trend suggesting allele may confer increased susceptibility alzheimer disease figure num shown table num summary odds ratio numnum random effects p numnum significant heterogeneity among num study comparisons p numnum heterogeneity found evidence association tt genotype risk alzheimer disease relative cc genotype significant study heterogeneity evidence association alzhei mer disease discerned also recessive model examined effect trend association seen dominant model random effects numnum num percent ci numnum numnum p numnum study heterogeneity recessive model contrast significant heterogeneity p numnum still seen dominant model contrast subgroup analysis studies cases controls european descent yielded similar results num comparisons numnum alleles numnum num percent ci numnum numnum p numnum p numnum heterogeneity
0.2710359.15003956.html.plaintext.txt	38	view larger version numk figure num meta analysis effect allele versus c allele risk alzheimer disease comparison presented name first author year publication h signifies hispanic subjects j signifies japanese subjects comparison point estimate odds ratio accompanying num confidence interval ci shown represents summary random effects estimate comparison along respective num confidence interval values num denote increased risk alzheimer disease allele
0.2710359.15003956.html.plaintext.txt	39	view larger version numk figure num meta analysis effect allele versus c allele risk alzheimer disease comparison presented name first author year publication h signifies hispanic subjects j signifies japanese subjects comparison point estimate odds ratio accompanying num confidence interval ci shown represents summary random effects estimate comparison along respective num confidence interval values num denote increased risk alzheimer disease allele
0.2710359.15003956.html.plaintext.txt	40	view table table num summary odds ratios various contrasts bias diagnostics cumulative meta analysis recursive cumulative meta analysis magnitude summary odds ratio stable time changed considerably per year apparent dissipation postulated effect random effects summary vs c numnum end num numnum end num numnum end num numnum end num numnum num excluding first hypothesis generating study num found summary odds ratio became numnum num percent ci numnum numnum p numnum significant study heterogeneity p numnum evidence association even comparison homozygotes tt vs cc numnum num percent ci numnum numnum p numnum study heterogeneity relation effect size variance study suggesting larger studies agreed results smaller studies analyses limited studies intensive efforts exclude alzheimer disease controls yielded similar results num comparisons numnum alleles numnum num percent ci numnum numnum p numnum p numnum heterogeneity
0.2710359.15003956.html.plaintext.txt	41	interaction apoe genotype nine studies num num num num num num obtained data ctsd apoe genotypes one study num separating male female subjects num comparisons became available
0.2710359.15003956.html.plaintext.txt	42	interaction apoe genotype nine studies num num num num num num obtained data ctsd apoe genotypes one study num separating male female subjects num comparisons became available
0.2710359.15003956.html.plaintext.txt	43	nine comparative studies tended gave slightly inflated effect allele compared full meta analysis num comparisons summary random effects numnum vs numnum complete meta analysis thus inferences cautious among carriers high risk apoenum allele allele carriers random effects odds ratio numnum num percent ci numnum numnum alzheimer disease compared subjects carrying allele among subjects carrying apoenum allele respective odds ratio numnum num percent ci numnum numnum significant study heterogeneity apoenum positive group p numnum two effect sizes overlapped widely
0.2710359.15003956.html.plaintext.txt	44	among carriers allele presence apoenum increased risk alzheimer disease numnum fold num percent ci numnum numnum study heterogeneity among subjects without allele presence apoenum increased risk alzheimer disease numnum fold num percent ci numnum numnum significant study heterogeneity p numnum two estimates overlapped widely individual studies overall typically odds ratios larger group allele carriers figure num
0.2710359.15003956.html.plaintext.txt	45	view larger version numk figure num meta analysis effect apoenum allele carriers noncarriers risk alzheimer disease ad comparison presented name first author m signifies male subjects f signifies female subjects comparison point estimate odds ratio accompanying num confidence interval ci shown filled squares represent carriers open circles represent noncarriers represents summary random effects estimate comparison along respective num confidence interval papassotiropoulos num num pertain following respective references num num
0.2710359.15003956.html.plaintext.txt	46	view larger version numk figure num meta analysis effect apoenum allele carriers noncarriers risk alzheimer disease ad comparison presented name first author m signifies male subjects f signifies female subjects comparison point estimate odds ratio accompanying num confidence interval ci shown filled squares represent carriers open circles represent noncarriers represents summary random effects estimate comparison along respective num confidence interval papassotiropoulos num num pertain following respective references num num
0.2710359.15003956.html.plaintext.txt	47	discussion top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references meta analysis includes data num case control studies numnum genotyped alzheimer disease cases controls proves ctsd polymorphism strong risk factor alzheimer disease current evidence exclude allele ctsd polymorphism may increase modestly risk alzheimer disease significant heterogeneity results various studies however found bias might exist decreasing effect size data accumulated time moreover meta analysis also exclude possibility presence ctsd allele may enhance increased susceptibility toward alzheimer disease conferred apoenum however even true would pertain relatively small group subjects carry apoenum ctsd alleles impact allele population level would small present
0.2710359.15003956.html.plaintext.txt	48	discussion top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references meta analysis includes data num case control studies numnum genotyped alzheimer disease cases controls proves ctsd polymorphism strong risk factor alzheimer disease current evidence exclude allele ctsd polymorphism may increase modestly risk alzheimer disease significant heterogeneity results various studies however found bias might exist decreasing effect size data accumulated time moreover meta analysis also exclude possibility presence ctsd allele may enhance increased susceptibility toward alzheimer disease conferred apoenum however even true would pertain relatively small group subjects carry apoenum ctsd alleles impact allele population level would small present
0.2710359.15003956.html.plaintext.txt	49	meta analysis findings may interpreted postulated biologic context ctsd polymorphism cathepsin d intracellular acid protease beta secretase activity vitro num num cleave amyloid precursor protein tau protein generate fragments intact microtubule binding domains num might play role pathogenesis paired helical filaments one study shown ctsd polymorphism associated increased secretion altered intracellular maturation procathepsin d num noted clear whether ctsd polymorphism functional consequences mature form enzyme although exclude biologic effect ctsd polymorphism findings accordance results recent full genome scan showing significant linkage alzheimer disease short arm chromosome num region ctsd gene located num num
0.2710359.15003956.html.plaintext.txt	50	meta analysis findings may interpreted postulated biologic context ctsd polymorphism cathepsin d intracellular acid protease beta secretase activity vitro num num cleave amyloid precursor protein tau protein generate fragments intact microtubule binding domains num might play role pathogenesis paired helical filaments one study shown ctsd polymorphism associated increased secretion altered intracellular maturation procathepsin d num noted clear whether ctsd polymorphism functional consequences mature form enzyme although exclude biologic effect ctsd polymorphism findings accordance results recent full genome scan showing significant linkage alzheimer disease short arm chromosome num region ctsd gene located num num
0.2710359.15003956.html.plaintext.txt	51	attention given design individual studies results meta analyses may affected methodological problems potential biases designs constituent studies nondifferential misclassification errors may dilute strength observed association alzheimer disease cases generally selected according appropriate criteria however young control subjects may developed alzheimer disease older ages choice appropriate age window assessing postulated genetic risk factor alzheimer disease difficult studies younger subjects may suitable identifying risk factors result early onset alzhei mer disease conversely selection younger subjects may less appropriate influence postulated genetic risk factor important late onset alzhei mer disease
0.2710359.15003956.html.plaintext.txt	52	attention given design individual studies results meta analyses may affected methodological problems potential biases designs constituent studies nondifferential misclassification errors may dilute strength observed association alzheimer disease cases generally selected according appropriate criteria however young control subjects may developed alzheimer disease older ages choice appropriate age window assessing postulated genetic risk factor alzheimer disease difficult studies younger subjects may suitable identifying risk factors result early onset alzhei mer disease conversely selection younger subjects may less appropriate influence postulated genetic risk factor important late onset alzhei mer disease
0.2710359.15003956.html.plaintext.txt	53	subgroup effects effect modification eg differential effects genetic polymorphism early vs late onset alzheimer disease cases familial vs sporadic disease complex interactions genes may also need considered num analyses addressed interactions apoenum major known genetic determinant alzhei mer disease interactions genetic environmental factors studied trend stronger effect apoenum presence allele carriage interesting light data suggesting carriage may affect general intelligence num however subgroup interaction analyses interpreted cautiously since differences subgroups may occur chance num validation would require studies even larger sample sizes several thousand included meta analysis finally population stratification may theoretically affected results constituent studies meta analysis num since documented frequency allele varied considerably among different ethnic groups even among different ethnic groups european descent however studies strictly ethnically defined population stratification effect unlikely considerable magnitude
0.2710359.15003956.html.plaintext.txt	54	increasing prevalence alzheimer disease worldwide crucial identify genetic risk factors neurodegenerative disease thus list identified polymorphisms may influence risk alzheimer disease continuously expanding num num reported associations candidate genes date remain nonreplicated least controversial subsequent investigation early small genetic association studies may come spurious findings num num num even genetic associations replicated usually major public health impact would lead screening recommendations num nevertheless knowledge could improve understanding pathogenesis complex diseases alzheimer disease
0.2710359.15003956.html.plaintext.txt	55	increasing prevalence alzheimer disease worldwide crucial identify genetic risk factors neurodegenerative disease thus list identified polymorphisms may influence risk alzheimer disease continuously expanding num num reported associations candidate genes date remain nonreplicated least controversial subsequent investigation early small genetic association studies may come spurious findings num num num even genetic associations replicated usually major public health impact would lead screening recommendations num nevertheless knowledge could improve understanding pathogenesis complex diseases alzheimer disease
0.2710359.15003956.html.plaintext.txt	56	laboratory tests top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references methods used ctsd genotyping analyzed studies straightforward include polymerase chain reaction num dynamic allele specific hybridization num error rate due misclassification likely small future studies nevertheless ensure clearly report assessment genotyping performed blinded clinical status patient
0.2710359.15003956.html.plaintext.txt	57	laboratory tests top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references methods used ctsd genotyping analyzed studies straightforward include polymerase chain reaction num dynamic allele specific hybridization num error rate due misclassification likely small future studies nevertheless ensure clearly report assessment genotyping performed blinded clinical status patient
0.2710359.15003956.html.plaintext.txt	58	population testing top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references date population testing ctsd polymorphism based results meta analysis testing would indicated given currently available data
0.2710359.15003956.html.plaintext.txt	59	population testing top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references date population testing ctsd polymorphism based results meta analysis testing would indicated given currently available data
0.2710359.15003956.html.plaintext.txt	60	acknowledgments authors thank jonathan prince patrizia mecocci anthony j brookes providing additional data studies
0.2710359.15003956.html.plaintext.txt	61	acknowledgments authors thank jonathan prince patrizia mecocci anthony j brookes providing additional data studies
0.2710359.15003956.html.plaintext.txt	62	notes correspondence dr john p ioannidis department hygiene epidemiology university ioannina school medicine ioannina num greece e mail jioannidatccuoigr u d
0.2710359.15003956.html.plaintext.txt	63	references top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references mcdermott jr gibson degradation alzheimer beta amyloid protein human cathepsin d neuroreport numnumnum numisimedline chevalier n vizzavona j marambaud p et al cathepsin d displays vitro beta secretase like specificity brain res numnumnum numcrossrefisimedline touitou capony f brouillet jp et al missense polymorphism csymb human cathepsin d pro fragment determined polymerase chain reaction single strand conformational polymorphism analysis possible consequences cancer cells eur j cancer numnumanum numisimedline papassotiropoulos lewis hd bagli m et al cerebrospinal fluid levels ss amyloidnum patients alzheimer disease related exon num polymorphism cathepsin d gene neuroreport numnumnum numcrossrefisimedline payton holland f diggle p et al cathepsin d exon num polymorphism associated general intelligence healthy older population mol psychiatry numnumnum numcrossrefisimedline crawford fc freeman mj schinka j et al genetic association cathepsin d alzheimer disease neurosci lett numnumnum numcrossrefisimedline papassotiropoulos bagli m kurz et al genetic variation cathepsin d major risk factor alzheimer disease ann neurol numnumnum numnumnumconum num numnum numcrossrefisimedline papassotiropoulos bagli m feder o et al genetic polymorphism cathepsin d strongly associated risk developing sporadic alzheimer disease neurosci lett numnumnum numcrossrefisimedline mcilroy sp dynan kb mcgleenon bm et al cathepsin d gene exon num polymorphism sporadic alzheimer disease neurosci lett numnumnum numcrossrefisimedline mateo sanchez guerra m combarros o et al lack association cathepsin d genetic polymorphism alzheimer disease spanish sample j med genet numnumnum numcrossrefisimedline ingegni nocentini g mariani e et al cathepsin d polymorphism italian elderly subjects sporadic late onset alzheimer disease dement geriatr cogn disord numnumnum numcrossrefisimedline bhojak tj dekosky st ganguli m et al genetic polymorphisms cathespin d interleukin num genes risk alzheimer disease neurosci lett numnumnum numcrossrefisimedline prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis num polymorphisms prior candidate genes sporadic alzheimer disease eur j hum genet numnumnum numcrossrefisimedline matsui morikawa y tojo m et al cathepsin d polymorphism associated alzheimer disease japanese ann neurol numnumnum num bagnoli nacmias b tedde et al cathepsin d polymorphism italian sporadic familial alzheimer disease neurosci lett numnumnum numcrossrefisimedline bertram l guenette jones j et al evidence genetic association linkage cathepsin d ctsd exon num polymorphism alzheimer disease ann neurol numnumnum numnumnumconum m disease highlight problems complex disease analysis trends genet numnumnum numcrossrefisimedline styczynska m religa d pfeffer et al simultaneous analysis five genetic risk factors polish patients alzheimer disease neurosci lett numnumnum numcrossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis apoe alzheimer disease meta analysis consortium jama numnumnum numabstract hebert le scherr pa beckett la et al age specific incidence alzheimer disease community population jama numnumnum numabstract cummings jl cole g alzheimer disease jama numnumnum numfree full text st george hyslop ph molecular genetics alzheimer disease biol psychiatry numnumnum numcrossrefisimedline gao hendrie hc hall ks et al relationships age sex incidence dementia alzheimer disease meta analysis arch gen psychiatry numnumnum numabstractfree full text fleminger oliver dl lovestone et al head injury risk factor alzheimer disease evidence num years partial replication j neurol neurosurg psychiatry numnumnum numabstractfree full text launer lj andersen k dewey et al rates risk factors dementia alzheimer disease neurology numnumnum numabstractfree full text mcdowell alzheimer disease insights epidemiology aging milano numnumnum numisimedline hendrie hc ogunniyi hall ks et al incidence dementia alzheimer disease num communities jama numnumnum numabstractfree full text combarros o alvarez arcaya sanchez guerra m et al candidate gene association studies sporadic alzheimer disease dement geriatr cogn disord numnumnum numcrossrefisimedline combarros o infante j llorca j et al myeloperoxidase gene alzheimer disease case control study meta analysis neurosci lett numnumnum numcrossrefisimedline dermaut b roks g theuns j et al variable expression presenilin num major determinant risk late onset alzheimer disease j neurol numnumnum numcrossrefisimedline koster mn dermaut b cruts m et al num macroglobulin gene ad population based study meta analysis neurology numnumnum numabstractfree full text russ c powell jf zhao j et al microtubule associated protein tau gene alzheimer disease association study meta analysis neurosci lett numnumnum numcrossrefisimedline sanchez guerra m combarros o infante j et al case control study meta analysis low density lipoprotein receptor related protein gene exon num polymorphism alzheimer disease neurosci lett numnumnum numcrossrefisimedline kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimer disease hum mol genet numnumnum numabstractfree full text lau j ioannidis jp schmid ch quantitative synthesis systematic reviews ann intern med numnumnum numabstractfree full text petitti db meta analysis decision analysis cost effectiveness analysis new york ny oxford university press num lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n engl j med numnumnum numabstract ioannidis jp contopoulos ioannidis dg lau j recursive cumulative meta analysis diagnostic evolution total randomized evidence group individual patient data j clin epidemiol numnumnum numcrossrefisimedline ioannidis j lau j evolution treatment effects time empirical insight recursive cumulative metaanalyses proc natl acad sci u numnumnum numabstractfree full text ioannidis jp ntzani ee trikalinos ta et al replication validity genetic association studies nat genet numnumnum numcrossrefisimedline begg cb mazumdar m operating characteristics rank correlation test publication bias biometrics numnumnum numisimedline ioannidis jp trikalinos ta ntzani ee et al genetic associations large versus small studies empirical assessment lancet numnumnum numcrossrefisimedline kenessey nacharaju p ko lw et al degradation tau lysosomal enzyme cathepsin d implication alzheimer neurofibrillary degeneration j neurochem numnumnum numisimedline kehoe p wavrant de vrieze f crook r et al full genome scan late onset alzheimer disease hum mol genet numnumnum numabstractfree full text collins js perry rt watson b jr et al association haplotype tumor necrosis factor siblings late onset alzheimer disease nimh alzheimer disease genetics initiative j med genet numnumnum numnumnumconum num numnum numabstractfree full text lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimer disease identify high risk subgroups neuroscience numnumnum numcrossrefisimedline oxman ad guyatt gh consumer guide subgroup analyses ann intern med numnumnum numisimedline cardon lr palmer lj population stratification spurious allelic association lancet numnumnum numcrossrefisimedline lohmueller ke pearce cl pike m et al meta analysis genetic association studies supports contribution common variants susceptibility common disease nat genet numnumnum numcrossrefisimedline ioannidis jpa genetic associations false true trends mol med numnumnum numcrossrefisimedline little j khoury mj bradley l et al human genome project complete develop handle pump j epidemiol numnumnum numfree full text
0.2710359.15003956.html.plaintext.txt	64	references top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references mcdermott jr gibson degradation alzheimer beta amyloid protein human cathepsin d neuroreport numnumnum numisimedline chevalier n vizzavona j marambaud p et al cathepsin d displays vitro beta secretase like specificity brain res numnumnum numcrossrefisimedline touitou capony f brouillet jp et al missense polymorphism csymb human cathepsin d pro fragment determined polymerase chain reaction single strand conformational polymorphism analysis possible consequences cancer cells eur j cancer numnumanum numisimedline papassotiropoulos lewis hd bagli m et al cerebrospinal fluid levels ss amyloidnum patients alzheimer disease related exon num polymorphism cathepsin d gene neuroreport numnumnum numcrossrefisimedline payton holland f diggle p et al cathepsin d exon num polymorphism associated general intelligence healthy older population mol psychiatry numnumnum numcrossrefisimedline crawford fc freeman mj schinka j et al genetic association cathepsin d alzheimer disease neurosci lett numnumnum numcrossrefisimedline papassotiropoulos bagli m kurz et al genetic variation cathepsin d major risk factor alzheimer disease ann neurol numnumnum numnumnumconum num numnum numcrossrefisimedline papassotiropoulos bagli m feder o et al genetic polymorphism cathepsin d strongly associated risk developing sporadic alzheimer disease neurosci lett numnumnum numcrossrefisimedline mcilroy sp dynan kb mcgleenon bm et al cathepsin d gene exon num polymorphism sporadic alzheimer disease neurosci lett numnumnum numcrossrefisimedline mateo sanchez guerra m combarros o et al lack association cathepsin d genetic polymorphism alzheimer disease spanish sample j med genet numnumnum numcrossrefisimedline ingegni nocentini g mariani e et al cathepsin d polymorphism italian elderly subjects sporadic late onset alzheimer disease dement geriatr cogn disord numnumnum numcrossrefisimedline bhojak tj dekosky st ganguli m et al genetic polymorphisms cathespin d interleukin num genes risk alzheimer disease neurosci lett numnumnum numcrossrefisimedline prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis num polymorphisms prior candidate genes sporadic alzheimer disease eur j hum genet numnumnum numcrossrefisimedline matsui morikawa y tojo m et al cathepsin d polymorphism associated alzheimer disease japanese ann neurol numnumnum num bagnoli nacmias b tedde et al cathepsin d polymorphism italian sporadic familial alzheimer disease neurosci lett numnumnum numcrossrefisimedline bertram l guenette jones j et al evidence genetic association linkage cathepsin d ctsd exon num polymorphism alzheimer disease ann neurol numnumnum numnumnumconum m disease highlight problems complex disease analysis trends genet numnumnum numcrossrefisimedline styczynska m religa d pfeffer et al simultaneous analysis five genetic risk factors polish patients alzheimer disease neurosci lett numnumnum numcrossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis apoe alzheimer disease meta analysis consortium jama numnumnum numabstract hebert le scherr pa beckett la et al age specific incidence alzheimer disease community population jama numnumnum numabstract cummings jl cole g alzheimer disease jama numnumnum numfree full text st george hyslop ph molecular genetics alzheimer disease biol psychiatry numnumnum numcrossrefisimedline gao hendrie hc hall ks et al relationships age sex incidence dementia alzheimer disease meta analysis arch gen psychiatry numnumnum numabstractfree full text fleminger oliver dl lovestone et al head injury risk factor alzheimer disease evidence num years partial replication j neurol neurosurg psychiatry numnumnum numabstractfree full text launer lj andersen k dewey et al rates risk factors dementia alzheimer disease neurology numnumnum numabstractfree full text mcdowell alzheimer disease insights epidemiology aging milano numnumnum numisimedline hendrie hc ogunniyi hall ks et al incidence dementia alzheimer disease num communities jama numnumnum numabstractfree full text combarros o alvarez arcaya sanchez guerra m et al candidate gene association studies sporadic alzheimer disease dement geriatr cogn disord numnumnum numcrossrefisimedline combarros o infante j llorca j et al myeloperoxidase gene alzheimer disease case control study meta analysis neurosci lett numnumnum numcrossrefisimedline dermaut b roks g theuns j et al variable expression presenilin num major determinant risk late onset alzheimer disease j neurol numnumnum numcrossrefisimedline koster mn dermaut b cruts m et al num macroglobulin gene ad population based study meta analysis neurology numnumnum numabstractfree full text russ c powell jf zhao j et al microtubule associated protein tau gene alzheimer disease association study meta analysis neurosci lett numnumnum numcrossrefisimedline sanchez guerra m combarros o infante j et al case control study meta analysis low density lipoprotein receptor related protein gene exon num polymorphism alzheimer disease neurosci lett numnumnum numcrossrefisimedline kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimer disease hum mol genet numnumnum numabstractfree full text lau j ioannidis jp schmid ch quantitative synthesis systematic reviews ann intern med numnumnum numabstractfree full text petitti db meta analysis decision analysis cost effectiveness analysis new york ny oxford university press num lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n engl j med numnumnum numabstract ioannidis jp contopoulos ioannidis dg lau j recursive cumulative meta analysis diagnostic evolution total randomized evidence group individual patient data j clin epidemiol numnumnum numcrossrefisimedline ioannidis j lau j evolution treatment effects time empirical insight recursive cumulative metaanalyses proc natl acad sci u numnumnum numabstractfree full text ioannidis jp ntzani ee trikalinos ta et al replication validity genetic association studies nat genet numnumnum numcrossrefisimedline begg cb mazumdar m operating characteristics rank correlation test publication bias biometrics numnumnum numisimedline ioannidis jp trikalinos ta ntzani ee et al genetic associations large versus small studies empirical assessment lancet numnumnum numcrossrefisimedline kenessey nacharaju p ko lw et al degradation tau lysosomal enzyme cathepsin d implication alzheimer neurofibrillary degeneration j neurochem numnumnum numisimedline kehoe p wavrant de vrieze f crook r et al full genome scan late onset alzheimer disease hum mol genet numnumnum numabstractfree full text collins js perry rt watson b jr et al association haplotype tumor necrosis factor siblings late onset alzheimer disease nimh alzheimer disease genetics initiative j med genet numnumnum numnumnumconum num numnum numabstractfree full text lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimer disease identify high risk subgroups neuroscience numnumnum numcrossrefisimedline oxman ad guyatt gh consumer guide subgroup analyses ann intern med numnumnum numisimedline cardon lr palmer lj population stratification spurious allelic association lancet numnumnum numcrossrefisimedline lohmueller ke pearce cl pike m et al meta analysis genetic association studies supports contribution common variants susceptibility common disease nat genet numnumnum numcrossrefisimedline ioannidis jpa genetic associations false true trends mol med numnumnum numcrossrefisimedline little j khoury mj bradley l et al human genome project complete develop handle pump j epidemiol numnumnum numfree full text
0.2731872.12196314.html.plaintext.txt	0	risk factors alzheimer disease prospective analysis canadian study health aging joan symbnum danielle symbnum rene symbnum rejean symb barbara symb gerry b symbnum ian symb
0.2731872.12196314.html.plaintext.txt	1	num department epidemiology community medicine faculty medicine university ottawa ottawa canada num surveillance risk assessment division health canada ottawa canada num laval university geriatric research unit beauport qc canada num department social preventive medicine laval university quebec qc canada num sherbrooke university geriatric institute sherbrooke qc canada num elisabeth bruyere health centre ottawa canada
0.2731872.12196314.html.plaintext.txt	2	num department epidemiology community medicine faculty medicine university ottawa ottawa canada num surveillance risk assessment division health canada ottawa canada num laval university geriatric research unit beauport qc canada num department social preventive medicine laval university quebec qc canada num sherbrooke university geriatric institute sherbrooke qc canada num elisabeth bruyere health centre ottawa canada
0.2731872.12196314.html.plaintext.txt	3	received publication december num num accepted publication may num num
0.2731872.12196314.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references prospective analysis risk factors alzheimer disease major objective canadian study health aging nationwide population based study numnum eligible subjects aged num years older num numnum alive num participated follow study participants cognitively normal num completed risk factor questionnaire cognitive status reassessed num years later using similar two phase procedure including screening interview followed clinical examination indicated analysis included num alzheimer disease cases numnum cognitively normal controls increasing age fewer years education apolipoprotein e num allele significantly associated increased risk alzheimer disease use nonsteroidal anti inflammatory drugs wine consumption coffee consumption regular physical activity associated reduced risk alzheimer disease statistically significant association found family history dementia sex history depression estrogen replacement therapy head trauma antiperspirant antacid use smoking high blood pressure heart disease stroke protective associations warrant study particular regular physical activity could important component preventive strategy alzheimer disease many conditions
0.2731872.12196314.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references prospective analysis risk factors alzheimer disease major objective canadian study health aging nationwide population based study numnum eligible subjects aged num years older num numnum alive num participated follow study participants cognitively normal num completed risk factor questionnaire cognitive status reassessed num years later using similar two phase procedure including screening interview followed clinical examination indicated analysis included num alzheimer disease cases numnum cognitively normal controls increasing age fewer years education apolipoprotein e num allele significantly associated increased risk alzheimer disease use nonsteroidal anti inflammatory drugs wine consumption coffee consumption regular physical activity associated reduced risk alzheimer disease statistically significant association found family history dementia sex history depression estrogen replacement therapy head trauma antiperspirant antacid use smoking high blood pressure heart disease stroke protective associations warrant study particular regular physical activity could important component preventive strategy alzheimer disease many conditions
0.2731872.12196314.html.plaintext.txt	6	alzheimer disease anti inflammatory agents non steroidal apolipoproteins cohort studies education exercise risk factors wine
0.2731872.12196314.html.plaintext.txt	7	abbreviations abbreviations apoe apolipoprotein e symb apolipoprotein e num allele ci confidence interval csha canadian study health aging eurodem european community concerted action epidemiology prevention dementia nsaids nonsteroidal anti inflammatory drugs odds ratio numms modified mini mental state
0.2731872.12196314.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion references dementia growing problem aging populations impact health services society increasing concern health policy makers service providers life expectancy increases particularly baby boom generation ages among canadians aged num years older alzheimer disease accounts almost two thirds prevalent cases dementia num majority epidemiologic studies risk factors alzheimer disease date retrospective case control studies compared prevalent alzheimer disease cases nondemented controls num retrospective studies subject methodological problems including survival bias recall bias addition collecting detailed exposure information difficult information must obtained proxies num risk protective factors alzheimer disease suggested prevalence studies family history dementia upheld prospective studies
0.2731872.12196314.html.plaintext.txt	9	introduction top abstract introduction materials methods results discussion references dementia growing problem aging populations impact health services society increasing concern health policy makers service providers life expectancy increases particularly baby boom generation ages among canadians aged num years older alzheimer disease accounts almost two thirds prevalent cases dementia num majority epidemiologic studies risk factors alzheimer disease date retrospective case control studies compared prevalent alzheimer disease cases nondemented controls num retrospective studies subject methodological problems including survival bias recall bias addition collecting detailed exposure information difficult information must obtained proxies num risk protective factors alzheimer disease suggested prevalence studies family history dementia upheld prospective studies
0.2731872.12196314.html.plaintext.txt	10	even though investigations using prospective designs reveal defined picture pathogenesis alzheimer disease results obtained far consistent european community concerted action epidemiology prevention dementia eurodem group associated smoking higher risk alzheimer disease num whereas studies observe significant relation smoking onset alzheimer disease num num eurodem group also found female sex low educational level associated increased risks alzheimer disease conversely sex education reported risk factors incident alzheimer disease studies num num methodological differences duration follow selection number study participants may account discrepancies
0.2731872.12196314.html.plaintext.txt	11	even though investigations using prospective designs reveal defined picture pathogenesis alzheimer disease results obtained far consistent european community concerted action epidemiology prevention dementia eurodem group associated smoking higher risk alzheimer disease num whereas studies observe significant relation smoking onset alzheimer disease num num eurodem group also found female sex low educational level associated increased risks alzheimer disease conversely sex education reported risk factors incident alzheimer disease studies num num methodological differences duration follow selection number study participants may account discrepancies
0.2731872.12196314.html.plaintext.txt	12	canadian study health aging csha large national multicenter longitudinal study dementia elderly people focusing prevalence num incidence num risk factors num num part first phase csha num case control study conducted age family history dementia educational level arthritis use nonsteroidal anti inflammatory drugs nsaids significantly related alzheimer disease num report results prospective analysis risk factors incident cases late onset alzheimer disease based risk factor data collected csha num cognitively normal diagnosis incident alzheimer disease num years later csha num
0.2731872.12196314.html.plaintext.txt	13	canadian study health aging csha large national multicenter longitudinal study dementia elderly people focusing prevalence num incidence num risk factors num num part first phase csha num case control study conducted age family history dementia educational level arthritis use nonsteroidal anti inflammatory drugs nsaids significantly related alzheimer disease num report results prospective analysis risk factors incident cases late onset alzheimer disease based risk factor data collected csha num cognitively normal diagnosis incident alzheimer disease num years later csha num
0.2731872.12196314.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references study methods described detail elsewhere num num summarized eighteen field centers across canada participated national study coordinated jointly university ottawa health canada
0.2731872.12196314.html.plaintext.txt	15	materials methods top abstract introduction materials methods results discussion references study methods described detail elsewhere num num summarized eighteen field centers across canada participated national study coordinated jointly university ottawa health canada
0.2731872.12196314.html.plaintext.txt	16	initial assessment csha num num num representative samples men women aged num years older drawn num urban surrounding rural areas num canadian provinces covered numnum participants numnum lived community numnum resided institutions excluded analysis community interviewed health presence specific disorders limitations performing basic instrumental activities daily living based older americans resources services activities daily living scale num participants screened dementia using modified mini mental state numms examination num num screened positive numms examination score numnum random sample screened negative score num invited participate extensive clinical evaluation followed three stage protocol nurse first readministered numms examination collected information participant medical family history next physician conducted standardized physical neurologic examination finally participants deemed testable numms examination score num psychometrist administered series neuropsychological tests num interpreted later neuropsychologist
0.2731872.12196314.html.plaintext.txt	17	initial assessment csha num num num representative samples men women aged num years older drawn num urban surrounding rural areas num canadian provinces covered numnum participants numnum lived community numnum resided institutions excluded analysis community interviewed health presence specific disorders limitations performing basic instrumental activities daily living based older americans resources services activities daily living scale num participants screened dementia using modified mini mental state numms examination num num screened positive numms examination score numnum random sample screened negative score num invited participate extensive clinical evaluation followed three stage protocol nurse first readministered numms examination collected information participant medical family history next physician conducted standardized physical neurologic examination finally participants deemed testable numms examination score num psychometrist administered series neuropsychological tests num interpreted later neuropsychologist
0.2731872.12196314.html.plaintext.txt	18	independent preliminary diagnoses made physician neuropsychologist followed case conference consensus diagnosis reached according diagnostic statistical manual mental disorders third edition revised criteria dementia num national institute neurological communicative disorders stroke alzheimer disease related disorders association nincds adrda criteria alzheimer disease num specific criteria cognitive impairment num vascular dementia num diagnoses comprised following categories cognitive impairment cognitive impairment dementia probable possible alzheimer disease vascular dementia specific dementia unclassifiable dementia
0.2731872.12196314.html.plaintext.txt	19	independent preliminary diagnoses made physician neuropsychologist followed case conference consensus diagnosis reached according diagnostic statistical manual mental disorders third edition revised criteria dementia num national institute neurological communicative disorders stroke alzheimer disease related disorders association nincds adrda criteria alzheimer disease num specific criteria cognitive impairment num vascular dementia num diagnoses comprised following categories cognitive impairment cognitive impairment dementia probable possible alzheimer disease vascular dementia specific dementia unclassifiable dementia
0.2731872.12196314.html.plaintext.txt	20	detailed information risk factors gathered self administered questionnaire completed csha num participants found cognitively normal basis either screening test clinical examination risk factor questionnaire covered sociodemographic characteristics occupational environmental exposures lifestyle smoking alcohol consumption intake selected food items regular exercise family medical history prior head injury without loss consciousness chronic diseases medication use participants asked whether engaged regular exercise yesno regular explicitly defined regular consumption beer wine spirits defined least week regular consumption tea coffee defined nearly every day
0.2731872.12196314.html.plaintext.txt	21	detailed information risk factors gathered self administered questionnaire completed csha num participants found cognitively normal basis either screening test clinical examination risk factor questionnaire covered sociodemographic characteristics occupational environmental exposures lifestyle smoking alcohol consumption intake selected food items regular exercise family medical history prior head injury without loss consciousness chronic diseases medication use participants asked whether engaged regular exercise yesno regular explicitly defined regular consumption beer wine spirits defined least week regular consumption tea coffee defined nearly every day
0.2731872.12196314.html.plaintext.txt	22	follow study csha num num num subjects could contacted agreed participate second wave study interviewed measure changes health status functioning average num years csha num participants took part diagnostic process one used csha num including screening test nurse evaluation clinical evaluation two diagnoses dementia made consensus conference one according criteria used csha num according recent diagnostic statistical manual mental disorders fourth edition criteria num alzheimer disease national institute neurological disorders stroke association internationale pour la recherche et l enseignement en neurosciences ninds airen criteria vascular dementia num recent criteria used define cases current analysis blood samples collected apolipoprotein e apoe allele status determined subsample subjects examined clinically num
0.2731872.12196314.html.plaintext.txt	23	follow study csha num num num subjects could contacted agreed participate second wave study interviewed measure changes health status functioning average num years csha num participants took part diagnostic process one used csha num including screening test nurse evaluation clinical evaluation two diagnoses dementia made consensus conference one according criteria used csha num according recent diagnostic statistical manual mental disorders fourth edition criteria num alzheimer disease national institute neurological disorders stroke association internationale pour la recherche et l enseignement en neurosciences ninds airen criteria vascular dementia num recent criteria used define cases current analysis blood samples collected apolipoprotein e apoe allele status determined subsample subjects examined clinically num
0.2731872.12196314.html.plaintext.txt	24	participants died follow study conducted date cause death obtained relevant provincial registrar vital statistics relative informant interviewed assess subject physical cognitive status num months prior death subjects died follow probability dementia estimated three different sources num num mention dementia death certificates num information proxies diagnosis memory problems alzheimer disease senile dementia prior death num logistic regression model based analysis num people died within num num months complete diagnostic evaluation estimating probability deceased person demented prior death estimates available numnum decedents numnum percent procedure permit diagnosis type dementia decedents omitted main analysis secondary analysis conducted assess potential impact omitting decedents deaths classified due dementia included alzheimer disease cases deaths due dementia considered controls
0.2731872.12196314.html.plaintext.txt	25	participants died follow study conducted date cause death obtained relevant provincial registrar vital statistics relative informant interviewed assess subject physical cognitive status num months prior death subjects died follow probability dementia estimated three different sources num num mention dementia death certificates num information proxies diagnosis memory problems alzheimer disease senile dementia prior death num logistic regression model based analysis num people died within num num months complete diagnostic evaluation estimating probability deceased person demented prior death estimates available numnum decedents numnum percent procedure permit diagnosis type dementia decedents omitted main analysis secondary analysis conducted assess potential impact omitting decedents deaths classified due dementia included alzheimer disease cases deaths due dementia considered controls
0.2731872.12196314.html.plaintext.txt	26	phases csha approved ethics review committees num participating study centers well coordinating center participants proxies provided informed consent component study however residents province newfoundland omitted prospective analysis num legal interpretation province advance directives legislation prohibited use proxy consent persons unable give full informed consent participate research studies interpretation meant people dementia could provide consent clinical examination ie outcome measure could obtained therefore newfoundland participants excluded
0.2731872.12196314.html.plaintext.txt	27	phases csha approved ethics review committees num participating study centers well coordinating center participants proxies provided informed consent component study however residents province newfoundland omitted prospective analysis num legal interpretation province advance directives legislation prohibited use proxy consent persons unable give full informed consent participate research studies interpretation meant people dementia could provide consent clinical examination ie outcome measure could obtained therefore newfoundland participants excluded
0.2731872.12196314.html.plaintext.txt	28	analysis analysis included participants living community csha num case control analysis conducted incident cases controls selected csha num included participants initial screening results negative csha num participants clinically diagnosed without num cognitive impairment dementia num dementia cases diagnosed probable possible alzheimer disease csha num comparisons made controls csha num remained without cognitive impairment dementia dementia according clinical evaluation screening test follow
0.2731872.12196314.html.plaintext.txt	29	analysis analysis included participants living community csha num case control analysis conducted incident cases controls selected csha num included participants initial screening results negative csha num participants clinically diagnosed without num cognitive impairment dementia num dementia cases diagnosed probable possible alzheimer disease csha num comparisons made controls csha num remained without cognitive impairment dementia dementia according clinical evaluation screening test follow
0.2731872.12196314.html.plaintext.txt	30	differences cases controls regarding means proportions compared using test chi square test respectively univariate multivariate logistic regression models used calculate crude adjusted odds ratios various risk factors rare disease assumption odds ratio considered valid estimate relative risk age sex education age education continuous variables num year increments introduced multivariate models potential confounders modification risk age sex apoe num allele symb status examined using interaction terms
0.2731872.12196314.html.plaintext.txt	31	differences cases controls regarding means proportions compared using test chi square test respectively univariate multivariate logistic regression models used calculate crude adjusted odds ratios various risk factors rare disease assumption odds ratio considered valid estimate relative risk age sex education age education continuous variables num year increments introduced multivariate models potential confounders modification risk age sex apoe num allele symb status examined using interaction terms
0.2731872.12196314.html.plaintext.txt	32	results top abstract introduction materials methods results discussion references community participants overall response rates screening interview clinical examination numnum percent num percent respectively num figure num shows categories ineligible study subjects excluded analysis leaving num cases numnum controls apoe allele status available num subjects num cases num controls table num presents selected characteristics csha num cases controls decedents considered demented demented subjects refused participate data missing cases including decedents older subjects categories percentage female controls including decedents smaller living cases lower numms examination scores living cases controls somewhat fewer chronic conditions
0.2731872.12196314.html.plaintext.txt	33	results top abstract introduction materials methods results discussion references community participants overall response rates screening interview clinical examination numnum percent num percent respectively num figure num shows categories ineligible study subjects excluded analysis leaving num cases numnum controls apoe allele status available num subjects num cases num controls table num presents selected characteristics csha num cases controls decedents considered demented demented subjects refused participate data missing cases including decedents older subjects categories percentage female controls including decedents smaller living cases lower numms examination scores living cases controls somewhat fewer chronic conditions
0.2731872.12196314.html.plaintext.txt	34	view larger version numk figure num study sample analysis risk factors incident alzheimer disease canadian study health aging csha num num csha num num num csha num clinical clinical examination cind cognitive impairment dementia
0.2731872.12196314.html.plaintext.txt	35	view larger version numk figure num study sample analysis risk factors incident alzheimer disease canadian study health aging csha num num csha num num num csha num clinical clinical examination cind cognitive impairment dementia
0.2731872.12196314.html.plaintext.txt	36	view table table num characteristics participants decedents subjects refused data missing risk factor analysis alzheimer disease canadian study health aging num num using recent criteria diagnosing alzheimer disease resulted change status fewer num percent cases included analysis new criteria identified num incident cases probable alzheimer disease compared num cases old criteria used num cases possible alzheimer disease compared num results analyses conducted including cases probable alzheimer disease consistent results presented
0.2731872.12196314.html.plaintext.txt	37	demographic characteristics subjects summarized table num distributions age sex education across cases controls significantly different cases older controls median age range csha num screening num years range num num vs num years range num num cases also completed fewer years education median num vs num years table num also presents adjusted odds ratios age sex education expected advanced age strongly associated higher risk alzheimer disease controlled sex education age treated continuous variable risk alzheimer disease increased num percent num percent confidence interval ci numnum numnum per additional year age age sex adjusted risk alzheimer disease lowest level education almost twice educated participants association observed sex risk alzheimer disease
0.2731872.12196314.html.plaintext.txt	38	demographic characteristics subjects summarized table num distributions age sex education across cases controls significantly different cases older controls median age range csha num screening num years range num num vs num years range num num cases also completed fewer years education median num vs num years table num also presents adjusted odds ratios age sex education expected advanced age strongly associated higher risk alzheimer disease controlled sex education age treated continuous variable risk alzheimer disease increased num percent num percent confidence interval ci numnum numnum per additional year age age sex adjusted risk alzheimer disease lowest level education almost twice educated participants association observed sex risk alzheimer disease
0.2731872.12196314.html.plaintext.txt	39	view table table num distributions alzheimer disease risk estimates age sex education canadian study health aging num num table num shows odds ratios selected putative risk factors adjustment age sex education family history alzheimer disease senile dementia associated late onset alzheimer disease participants least one symb allele numnum times risk alzheimer disease compared two num alleles antecedent coexisting chronic conditions included risk factor questionnaire arthritis significantly related reduced risk alzheimer disease statistically significant relation observed alzheimer disease risk high blood pressure stroke heart disease depression head trauma diabetes thyroid condition cancer type stomach ulcer use nsaids reduced risk alzheimer disease num percent effect due mostly nonsalicylates inclusion nsaid use arthritis along age sex education model yielded similar odds ratio estimates factors remained protective alzheimer disease testing interaction nsaids arthritis significant p numnum association alzheimer disease antihypertensive agents antacids corticosteroids estrogen therapy found
0.2731872.12196314.html.plaintext.txt	40	view table table num association selected risk factors alzheimer disease canadian study health aging num num table num shows age sex education adjusted risk estimates alzheimer disease lifestyle related variables num year follow smoking significantly associated alzheimer disease risk regular alcohol consumption associated reduced risk alzheimer disease particularly wine consumption reduced risk num percent variables observed significantly associated lower risk alzheimer disease daily coffee consumption regular physical activity num percent reductions association tea drinking antiperspirant use depression noted reported risk factors evidence found modification risk age sex symb status furthermore relation risk alzheimer disease observed marital status parental age subject birth birth order occupational history exposure inks paints solvents rubbers glues pesticides fumigants radiation anesthetics family history syndrome mental retardation parkinson disease thyroid disease data shown
0.2731872.12196314.html.plaintext.txt	41	view table table num association specific lifestyle variables risk alzheimer disease canadian study health aging num num table num presents estimates odds ratios selected risk factors decedents excluded addition deaths classified due dementia included alzheimer disease cases deaths due dementia included controls beneficial effect regular physical activity remained strong highly significant whereas associations arthritis nsaid use wine consumption coffee consumption remained numnum longer statistically significant
0.2731872.12196314.html.plaintext.txt	42	view table table num risk alzheimer disease num num num num associated selected variables according original analysis assumption concerning decedents canada discussion top abstract introduction materials methods results discussion references csha large scale cohort study based representative nationwide sample canadian population aged num years older prospective nature analysis high response rates careful standardization screening clinical assessments thorough checking questionnaires well coding editing data constitute strengths study
0.2731872.12196314.html.plaintext.txt	43	found increasing age low educational level symb allele associated increased risks incident alzheimer disease arthritis regular use nsaids wine consumption coffee consumption regular physical activity associated reduced risks note family history dementia smoking related risk alzheimer disease addition estrogen shown protective
0.2731872.12196314.html.plaintext.txt	44	found increasing age low educational level symb allele associated increased risks incident alzheimer disease arthritis regular use nsaids wine consumption coffee consumption regular physical activity associated reduced risks note family history dementia smoking related risk alzheimer disease addition estrogen shown protective
0.2731872.12196314.html.plaintext.txt	45	however results subject potential limitations first eligible community subjects baseline risk factor questionnaire available numnum numnum percent died num year follow period included main analyses group decedents included proportionately men generally older less educated suffered frequently chronic diseases subjects completed follow exclusion participants may distorted results example subjects frequently exposed particular risk factor higher risk developing alzheimer disease results simulation included subjects died suggest although arthritis nsaid use wine consumption coffee consumption might potentially valid protective factors alzheimer disease bias due exclusion decedents follow might also partially explain associations
0.2731872.12196314.html.plaintext.txt	46	however results subject potential limitations first eligible community subjects baseline risk factor questionnaire available numnum numnum percent died num year follow period included main analyses group decedents included proportionately men generally older less educated suffered frequently chronic diseases subjects completed follow exclusion participants may distorted results example subjects frequently exposed particular risk factor higher risk developing alzheimer disease results simulation included subjects died suggest although arthritis nsaid use wine consumption coffee consumption might potentially valid protective factors alzheimer disease bias due exclusion decedents follow might also partially explain associations
0.2731872.12196314.html.plaintext.txt	47	another limitation analysis possibility bias assessing risk factor exposures spite prospective nature study results could explained least part preclinical cognitive decline yet detectable screening clinical evaluations csha num among subjects developed alzheimer disease csha num although ruled explanation seems improbable view extensive screening clinical evaluation process used csha num diagnose cognitive impairment dementia well dementia along relatively long follow period nevertheless test possibility results reanalyzed excluding cases whose symptoms alzheimer disease reported proxies started within num years csha num end num persistence protective effect alzheimer disease nsaids odds ratio numnum num percent ci numnum numnum wine numnum num percent ci numnum numnum coffee numnum num percent ci numnum numnum physical activity numnum num percent ci numnum numnum support hypothesis preclinical decline explains results
0.2731872.12196314.html.plaintext.txt	48	another limitation analysis possibility bias assessing risk factor exposures spite prospective nature study results could explained least part preclinical cognitive decline yet detectable screening clinical evaluations csha num among subjects developed alzheimer disease csha num although ruled explanation seems improbable view extensive screening clinical evaluation process used csha num diagnose cognitive impairment dementia well dementia along relatively long follow period nevertheless test possibility results reanalyzed excluding cases whose symptoms alzheimer disease reported proxies started within num years csha num end num persistence protective effect alzheimer disease nsaids odds ratio numnum num percent ci numnum numnum wine numnum num percent ci numnum numnum coffee numnum num percent ci numnum numnum physical activity numnum num percent ci numnum numnum support hypothesis preclinical decline explains results
0.2731872.12196314.html.plaintext.txt	49	since multiple comparisons performed possible statistically significant associations may occurred chance new associations found example protective effect coffee drinking replication studies needed determine validity association results generalizable populations largely european descent inclusion different ethnic groups living canada determined ability speak either english french
0.2731872.12196314.html.plaintext.txt	50	since multiple comparisons performed possible statistically significant associations may occurred chance new associations found example protective effect coffee drinking replication studies needed determine validity association results generalizable populations largely european descent inclusion different ethnic groups living canada determined ability speak either english french
0.2731872.12196314.html.plaintext.txt	51	family history dementia similar advancing age symb allele frequently associated increased risk alzheimer disease generally considered definite risk factor num csha num case control study found increased risk alzheimer disease increased significantly two threefold family history dementia num however eurodem pooled data set num prospective analysis csha data find association contradictory findings might reflect misclassification information recall bias andor uncertainty information collected help informants retrospective investigations compared longitudinal studies case control study mayeux et al num observed relatives patients whose onset alzheimer disease began age num years older increased risk alzheimer disease whereas increased risk first degree relatives patients whose onset occurred prior age num years thus would seem reasonable observe association older cohort may surprising family history dementia associated alzheimer disease increased risk alzheimer disease observed subjects symb allele since family history dementia believed potential indicator genetic factor however suggested symb allele explain large part family history dementia num study num percent least one symb allele reported parent dementia compared num percent num allele
0.2731872.12196314.html.plaintext.txt	52	family history dementia similar advancing age symb allele frequently associated increased risk alzheimer disease generally considered definite risk factor num csha num case control study found increased risk alzheimer disease increased significantly two threefold family history dementia num however eurodem pooled data set num prospective analysis csha data find association contradictory findings might reflect misclassification information recall bias andor uncertainty information collected help informants retrospective investigations compared longitudinal studies case control study mayeux et al num observed relatives patients whose onset alzheimer disease began age num years older increased risk alzheimer disease whereas increased risk first degree relatives patients whose onset occurred prior age num years thus would seem reasonable observe association older cohort may surprising family history dementia associated alzheimer disease increased risk alzheimer disease observed subjects symb allele since family history dementia believed potential indicator genetic factor however suggested symb allele explain large part family history dementia num study num percent least one symb allele reported parent dementia compared num percent num allele
0.2731872.12196314.html.plaintext.txt	53	association low educational level risk alzheimer disease consistent findings several retrospective prospective studies num num num num large scale population based studies csha cases ascertained means two phase diagnostic procedure screening clinical examination cutpoint screening numms examination chosen achieve high sensitivity even though cutpoint could missed mild cases alzheimer disease people higher levels education could still perform well cognitive screening tests whether risk alzheimer disease associated less education corresponds artifact represents true risk factor still unclear explanations education effect include increased brain reserve num selection bias resulting selective attrition use two phase diagnostic procedure num num confounding indicators socioeconomic status linked education diet lifestyle occupational history num num
0.2731872.12196314.html.plaintext.txt	54	association low educational level risk alzheimer disease consistent findings several retrospective prospective studies num num num num large scale population based studies csha cases ascertained means two phase diagnostic procedure screening clinical examination cutpoint screening numms examination chosen achieve high sensitivity even though cutpoint could missed mild cases alzheimer disease people higher levels education could still perform well cognitive screening tests whether risk alzheimer disease associated less education corresponds artifact represents true risk factor still unclear explanations education effect include increased brain reserve num selection bias resulting selective attrition use two phase diagnostic procedure num num confounding indicators socioeconomic status linked education diet lifestyle occupational history num num
0.2731872.12196314.html.plaintext.txt	55	present analysis supports hypothesis negative association nsaids risk alzheimer disease protective relation also found several population based case control studies including csha num analysis num least one longitudinal study supports protective effect anti inflammatory drugs alzheimer disease dementia num studies remain inconclusive num num
0.2731872.12196314.html.plaintext.txt	56	present analysis supports hypothesis negative association nsaids risk alzheimer disease protective relation also found several population based case control studies including csha num analysis num least one longitudinal study supports protective effect anti inflammatory drugs alzheimer disease dementia num studies remain inconclusive num num
0.2731872.12196314.html.plaintext.txt	57	regular wine consumption also associated reduced risk alzheimer disease results paquid study longitudinal study community residents showed similar negative relation wine consumption alzheimer disease num protective effect remained significant depth statistical analyses conducted num suggested specific substances wine alcoholic beverages could responsible positive effect nerve cells dementia num
0.2731872.12196314.html.plaintext.txt	58	regular wine consumption also associated reduced risk alzheimer disease results paquid study longitudinal study community residents showed similar negative relation wine consumption alzheimer disease num protective effect remained significant depth statistical analyses conducted num suggested specific substances wine alcoholic beverages could responsible positive effect nerve cells dementia num
0.2731872.12196314.html.plaintext.txt	59	analysis regular consumption coffee seemed protective alzheimer disease low coffee intake reported related mental disability num year follow num finnish men num without confirmation prospective studies alzheimer disease finding may due chance
0.2731872.12196314.html.plaintext.txt	60	analysis regular consumption coffee seemed protective alzheimer disease low coffee intake reported related mental disability num year follow num finnish men num without confirmation prospective studies alzheimer disease finding may due chance
0.2731872.12196314.html.plaintext.txt	61	potential protective effect regular physical activity risk alzheimer disease important represents modifiable lifestyle habit epidemiologic studies evaluated possible protective role regular physical activity risk cognitive impairment dementia elderly results inconsistent num num however clinical trials exercise shown benefit cognitive function num num recently regular physical activity found protective cognitive impairment well types dementia including alzheimer disease interaction sex reported suggesting greater protection women men num
0.2731872.12196314.html.plaintext.txt	62	potential protective effect regular physical activity risk alzheimer disease important represents modifiable lifestyle habit epidemiologic studies evaluated possible protective role regular physical activity risk cognitive impairment dementia elderly results inconsistent num num however clinical trials exercise shown benefit cognitive function num num recently regular physical activity found protective cognitive impairment well types dementia including alzheimer disease interaction sex reported suggesting greater protection women men num
0.2731872.12196314.html.plaintext.txt	63	conclusion large scale prospective study older age onset alzheimer disease confirmed frequently suggested etiologic hypotheses disease intriguing protective associations observed study warrant research preventive strategies alzheimer disease explored regular physical activity could represent novel safe preventive strategy alzheimer disease many conditions examined
0.2731872.12196314.html.plaintext.txt	64	conclusion large scale prospective study older age onset alzheimer disease confirmed frequently suggested etiologic hypotheses disease intriguing protective associations observed study warrant research preventive strategies alzheimer disease explored regular physical activity could represent novel safe preventive strategy alzheimer disease many conditions examined
0.2731872.12196314.html.plaintext.txt	65	acknowledgments data reported paper collected part csha study core study funded seniors independence research program national health research development program nhrdp health canada project num num mc additional funding provided pfizer canada incorporated medical research councilpharmaceutical manufacturers association canada health activity program nhrdp project num num num r bayer incorporated british columbia health research foundation project num num num num num num study coordinated university ottawa division aging seniors health canada dr rene verreault supported laval university chair geriatric research dr danielle laurin supported part national health phd fellowship provided nhrdp project num num num laval university chair geriatric research
0.2731872.12196314.html.plaintext.txt	66	acknowledgments data reported paper collected part csha study core study funded seniors independence research program national health research development program nhrdp health canada project num num mc additional funding provided pfizer canada incorporated medical research councilpharmaceutical manufacturers association canada health activity program nhrdp project num num num r bayer incorporated british columbia health research foundation project num num num num num num study coordinated university ottawa division aging seniors health canada dr rene verreault supported laval university chair geriatric research dr danielle laurin supported part national health phd fellowship provided nhrdp project num num num laval university chair geriatric research
0.2731872.12196314.html.plaintext.txt	67	authors grateful richard aylesworth louis rochette statistical assistance
0.2731872.12196314.html.plaintext.txt	68	notes reprint requests dr joan lindsay department epidemiology community medicine university ottawa num smyth road ottawa symb numsymb canada e mail joanlindsayathc scgcca u d
0.2731872.12196314.html.plaintext.txt	69	notes reprint requests dr joan lindsay department epidemiology community medicine university ottawa num smyth road ottawa symb numsymb canada e mail joanlindsayathc scgcca u d
0.2731872.12196314.html.plaintext.txt	70	references top abstract introduction materials methods results discussion references canadian study health aging study methods prevalence dementia cmaj numnumnum numabstract van duijn cm epidemiology dementias recent developments new approaches j neurol neurosurg psychiatry numnumnum numisimedline launer lj andersen k dewey et al rates risk factors dementia alzheimer disease results eurodem pooled analyses neurology numnumnum numabstractfree full text hebert le scherr pa beckett la et al relation smoking alcohol consumption incident alzheimer disease j epidemiol numnumnum numabstract wang hx fratiglioni l frisoni gb et al smoking occurrence alzheimer disease cross sectional longitudinal data population based study j epidemiol numnumnum numabstract doll r peto r boreham j et al smoking dementia male british doctors prospective study bmj numnumnum numabstractfree full text yoshitake kiyohara y kato et al incidence risk factors vascular dementia alzheimer disease defined elderly japanese population hisayama study neurology numnumnum numabstract cobb jl wolf pa au r et al effect education incidence dementia alzheimer disease framingham study neurology numnumnum numabstract canadian study health aging working group incidence dementia canada neurology numnumnum numabstractfree full text canadian study health aging risk factors alzheimer disease canada neurology numnumnum numabstract lindsay j hebert r rockwood k canadian study health aging risk factors vascular dementia stroke numnumnum numabstractfree full text hebert r lindsay j verreault r et al vascular dementia incidence risk factors canadian study health aging stroke numnumnum numabstractfree full text mcdowell newell c measuring health guide rating scales questionnaires numnd ed new york ny oxford university press num teng el chui hc modified mini mental state numms examination j clin psychiatry numnumnum numisimedline hebert r bravo g girouard d validation de l adaptation francaise du modified mini mental state numms french rev geriatrie numnumnum num tuokko h kristjansson e miller j neuropsychological detection dementia overview neuropsychological component canadian study health aging j clin exp neuropsychol numnumnum numisimedline american psychiatric association diagnostic statistical manual mental disorders dsm iii r numrd ed rev washington dc american psychiatric association num mckhann g drachman d folstein m et al clinical diagnosis alzheimer disease report nincds adrda work group auspices department health human services task force alzheimer disease neurology numnumnum numabstract graham je rockwood k beattie bl et al prevalence severity cognitive impairment without dementia elderly population lancet numnumnum numisimedline world health organization icd num classification mental behavioural disorders diagnostic criteria research geneva switzerland world health organization num american psychiatric association diagnostic statistical manual mental disorders dsm iv numth ed washington dc american psychiatric association num roman gc tatemichi tk erkinjuntti et al vascular dementia diagnostic criteria research studies report ninds airen international workshop neurology numnumnum numabstract mcleod da arnott b gaudreault n et al comparison two methods routine accurate determination apolipoprotein e genotypes alzheimer rep numnumnum numisi fratiglioni l epidemiology alzheimer disease current possibilities prevention acta neurol scand suppl numnumnum nummedline mayeux r ottman r tang mx et al genetic susceptibility head injury risk factors alzheimer disease among community dwelling elderly persons first degree relatives ann neurol numnumnum numisimedline danet brousseau richard f et al risk dementia parents probands without apolipoprotein symb allele eva study j epidemiol community health numnumnum numabstract stern y gurland b tatemichi tk et al influence education occupation incidence alzheimer disease jama numnumnum numabstract ott breteler mm van harskamp f et al prevalence alzheimer disease vascular dementia association education rotterdam study bmj numnumnum numabstractfree full text letenneur l gilleron v commenges d et al sex educational level independent predictors dementia alzheimer disease incidence data paquid project j neurol neurosurg psychiatry numnumnum numabstractfree full text katzman r education prevalence dementia alzheimer disease neurology numnumnum numisimedline geerlings mi schmand b jonker c et al education incident alzheimer disease biased association due selective attrition use two step diagnostic procedure int j epidemiol numnumnum numabstract mortimer ja graves ab education socioeconomic determinants dementia alzheimer disease neurology numnumsuppl numsymb numabstract stern y alexander ge prohovnik et al relationship lifetime occupation parietal flow implications reserve alzheimer disease pathology neurology numnumnum numabstract mcgeer pl schulzer m mcgeer eg arthritis anti inflammatory agents possible protective factors alzheimer disease review num epidemiologic studies neurology numnumnum numabstract stewart wf kawas c corrada m et al risk alzheimer disease duration nsaid use neurology numnumnum numabstract veld ba launer lj hoes aw et al nsaids incident alzheimer disease rotterdam study neurobiol aging numnumnum numisimedline fourrier letenneur l begaud b et al nonsteroidal antiinflammatory drug use cognitive function elderly inconclusive results population based cohort study j clin epidemiol numnumnum orgogozo jm dartigues jf lafont et al wine consumption dementia elderly prospective community study bordeaux area rev neurol paris numnumnum nummedline lemeshow letenneur l dartigues jf et al illustration analysis taking account complex survey considerations association wine consumption dementia paquid study j epidemiol numnumnum numabstract tredici g miloso m nicolini g et al resveratrol map kinases neuronal cells might wine neuroprotectant drugs exp clin res numnumnum numisimedline lammi uk kivela sl nissinen et al mental disability among elderly men finland prevalence predictors correlates acta psychiatr scand numnumnum numisimedline broe ga creasey h jorm af et al health habits risk cognitive impairment dementia old age prospective study effects exercise smoking alcohol consumption aust n z j public health numnumnum numisimedline emery cf huppert fa schein rl relationships among age exercise health cognitive function british sample gerontologist numnumnum numabstract rogers rl meyer js mortel kf reaching retirement age physical activity sustains cerebral perfusion cognition j geriatr soc numnumnum numisimedline laurin d verreault r lindsay j et al physical activity risk cognitive impairment dementia elderly persons arch neurol numnumnum numabstractfree full text
0.28510132.11581121.html.plaintext.txt	0	nice guidelines treatment alzheimers disease evidence based medicine may discriminatory r stewart
0.28510132.11581121.html.plaintext.txt	1	institute psychiatry de crespigny park london symb numaf uk
0.28510132.11581121.html.plaintext.txt	2	arshad et al num raise important concerns uk guidelines treatment alzheimers disease national institute clinical excellence nice num may counterproductive patients learning disabilities potential discrimination means stop particular difficulty highlight central role mini mental state examination mmse instrument determining treatment eligibility response scores mmse strongly influenced previous education cross cultural validity poor guidelines therefore unhelpful people lower educational attainment growing numbers older people minority ethnic groups uk comorbid cerebrovascular disease also frequent people disadvantaged backgrounds particular minority ethnic groups african caribbean populations stewart et al num reduces likelihood diagnosis alzheimers disease therefore eligibility anti cholinesterase treatment according standard diagnostic criteria mckhann et al num despite growing evidence overlapping pathological processes dementia holmes et al num
0.28510132.11581121.html.plaintext.txt	3	arshad et al num raise important concerns uk guidelines treatment alzheimers disease national institute clinical excellence nice num may counterproductive patients learning disabilities potential discrimination means stop particular difficulty highlight central role mini mental state examination mmse instrument determining treatment eligibility response scores mmse strongly influenced previous education cross cultural validity poor guidelines therefore unhelpful people lower educational attainment growing numbers older people minority ethnic groups uk comorbid cerebrovascular disease also frequent people disadvantaged backgrounds particular minority ethnic groups african caribbean populations stewart et al num reduces likelihood diagnosis alzheimers disease therefore eligibility anti cholinesterase treatment according standard diagnostic criteria mckhann et al num despite growing evidence overlapping pathological processes dementia holmes et al num
0.28510132.11581121.html.plaintext.txt	4	sub populations represented clinical trial samples minority ethnic groups people lower educational attainment people learning disability people comorbid cerebrovascular disease best hoped considerably weaker evidence base might emerge years future time large numbers people may failed receive potentially beneficial treatment problem lie treatment guidelines applied level individuals services particular regarding groups alzheimers disease num year old cognitive screen andor num year old diagnostic criteria unhelpful evidence based medicine noble ideal however clinical practice restricted evidence base may amount institutionalised discrimination
0.28510132.11581121.html.plaintext.txt	5	sub populations represented clinical trial samples minority ethnic groups people lower educational attainment people learning disability people comorbid cerebrovascular disease best hoped considerably weaker evidence base might emerge years future time large numbers people may failed receive potentially beneficial treatment problem lie treatment guidelines applied level individuals services particular regarding groups alzheimers disease num year old cognitive screen andor num year old diagnostic criteria unhelpful evidence based medicine noble ideal however clinical practice restricted evidence base may amount institutionalised discrimination
0.28510132.11581121.html.plaintext.txt	6	national institute clinical excellence num guidance use donepezil rivastigmine galantamine treatment alzheimers disease london nice
0.29024228.15781953.html.plaintext.txt	0	physical activity apoe genotype dementia risk findings cardiovascular health cognition study laura jean symb eliseo symbnum lewis h symb linda p symb oscar l symb michelle symb constantine g symb
0.29024228.15781953.html.plaintext.txt	1	num department epidemiology johns hopkins bloomberg school public health baltimore md num welch center prevention epidemiology clinical research johns hopkins medical institutions baltimore md num department epidemiology university pittsburgh graduate school public health pittsburgh pa num department medicine center aging health johns hopkins medical institutions baltimore md num department neurology university pittsburgh school medicine pittsburgh pa num department mental health center aging health johns hopkins medical institutions baltimore md num division geriatric psychiatry neuropsychiatry department psychiatry behavioral sciences johns hopkins medical institutions baltimore md
0.29024228.15781953.html.plaintext.txt	2	received publication january num num accepted publication november num num
0.29024228.15781953.html.plaintext.txt	3	received publication january num num accepted publication november num num
0.29024228.15781953.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references physical activity may help preserve cognitive function decrease dementia risk epidemiologic findings inconsistent authors conducted prospective study determine association physical activity risk dementia alzheimers disease vascular dementia us study population comprised numnum men women aged num years older free dementia baseline participated cardiovascular health cognition study num num leisure time energy expenditure activity index reflecting number different physical activities calculated analyses based cox proportional hazards models num incident cases dementia average numnum years follow multivariate adjustment participants highest quartile physical energy expenditure relative risk dementia numnum num confidence interval numnum numnum compared lowest quartile participants engaging num activities relative risk dementia numnum num confidence interval numnum numnum compared engaging num num activity associations marked apolipoprotein e genotype apoe num allele noncarriers absent carriers similar pattern observed alzheimers disease vascular dementia mechanisms explain observed relations deserve study
0.29024228.15781953.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references physical activity may help preserve cognitive function decrease dementia risk epidemiologic findings inconsistent authors conducted prospective study determine association physical activity risk dementia alzheimers disease vascular dementia us study population comprised numnum men women aged num years older free dementia baseline participated cardiovascular health cognition study num num leisure time energy expenditure activity index reflecting number different physical activities calculated analyses based cox proportional hazards models num incident cases dementia average numnum years follow multivariate adjustment participants highest quartile physical energy expenditure relative risk dementia numnum num confidence interval numnum numnum compared lowest quartile participants engaging num activities relative risk dementia numnum num confidence interval numnum numnum compared engaging num num activity associations marked apolipoprotein e genotype apoe num allele noncarriers absent carriers similar pattern observed alzheimers disease vascular dementia mechanisms explain observed relations deserve study
0.29024228.15781953.html.plaintext.txt	6	aged alzheimer disease dementia exercise motor activity physical fitness risk factors
0.29024228.15781953.html.plaintext.txt	7	abbreviations apoe apolipoprotein e genotype chcs cardiovascular health cognition study chs cardiovascular health study mri magnetic resonance imaging numms modified mini mental state
0.29024228.15781953.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion references dementia condition characterized global decline cognitive functioning major public health problem worldwide estimated numnum num million persons currently living alzheimers disease common type dementia united states alone num unless effective preventive strategy realized number dementia cases expected expand number persons living later decades continues increase num advancing age family history dementia educational level presence apolipoprotein e genotype apoe num allele remain established risk factors alzheimers disease num
0.29024228.15781953.html.plaintext.txt	9	mounting body evidence supports role physical activity means maintain cognitive performance physical activity may preserve neuronal plasticity increase synapses dendritic receptors following injury release hormonal factors may assist neuronal creation function brain derived neurotrophic factor epinephrine num addition physical activity lowers cardiovascular risk decreases blood pressure increases high density lipoprotein cholesterol levels glucose tolerance num may related neuronal integrity cognitive function num num finally engaging physical activity may indicate enriched social environment may decrease dementia risk num
0.29024228.15781953.html.plaintext.txt	10	mounting body evidence supports role physical activity means maintain cognitive performance physical activity may preserve neuronal plasticity increase synapses dendritic receptors following injury release hormonal factors may assist neuronal creation function brain derived neurotrophic factor epinephrine num addition physical activity lowers cardiovascular risk decreases blood pressure increases high density lipoprotein cholesterol levels glucose tolerance num may related neuronal integrity cognitive function num num finally engaging physical activity may indicate enriched social environment may decrease dementia risk num
0.29024228.15781953.html.plaintext.txt	11	several randomized trials reported enhanced neurocognitive function following exercise training num addition observational studies num num shown inverse association physical activity cognitive decline among older adults however inverse association physical activity alzheimers disease found num num num num num studies diminished physical activity may also different roles various forms dementia
0.29024228.15781953.html.plaintext.txt	12	several randomized trials reported enhanced neurocognitive function following exercise training num addition observational studies num num shown inverse association physical activity cognitive decline among older adults however inverse association physical activity alzheimers disease found num num num num num studies diminished physical activity may also different roles various forms dementia
0.29024228.15781953.html.plaintext.txt	13	study examined relation physical activity incident dementia subtypes alzheimers disease vascular dementia using data large community based cohort older adults also assessed possibility association physical activity dementia may different apoe num carriers versus noncarriers
0.29024228.15781953.html.plaintext.txt	14	study examined relation physical activity incident dementia subtypes alzheimers disease vascular dementia using data large community based cohort older adults also assessed possibility association physical activity dementia may different apoe num carriers versus noncarriers
0.29024228.15781953.html.plaintext.txt	15	materials methods top abstract introduction materials methods results discussion references subject selection cardiovascular health study chs population based prospective cohort study initiated num identify factors related cardiovascular disease older adults num target population consisted adults aged num years older residing one four us communities sacramento county california washington county maryland forsyth county north carolina pittsburgh pennsylvania eligible persons drawn health care financing administration medicare enrollment lists random sampling three age strata num num num num num years total numnum men women agreed participate initial recruiting phase num num additional num african americans joined study num num total n numnum
0.29024228.15781953.html.plaintext.txt	16	materials methods top abstract introduction materials methods results discussion references subject selection cardiovascular health study chs population based prospective cohort study initiated num identify factors related cardiovascular disease older adults num target population consisted adults aged num years older residing one four us communities sacramento county california washington county maryland forsyth county north carolina pittsburgh pennsylvania eligible persons drawn health care financing administration medicare enrollment lists random sampling three age strata num num num num num years total numnum men women agreed participate initial recruiting phase num num additional num african americans joined study num num total n numnum
0.29024228.15781953.html.plaintext.txt	17	cardiovascular health cognition study chcs num num ancillary study chs started num chs participants invited undergo cerebral magnetic resonance imaging mri participate cognitive testing chcs cohort consisted numnum numnum percent participation rate num persons brain mris available numnum persons mri measures cognition assessed time compared nonparticipants chcs participants younger educated less likely cardiovascular disease num institutional review boards participating institution approved research protocols chs chcs participants provided written informed consent
0.29024228.15781953.html.plaintext.txt	18	cardiovascular health cognition study chcs num num ancillary study chs started num chs participants invited undergo cerebral magnetic resonance imaging mri participate cognitive testing chcs cohort consisted numnum numnum percent participation rate num persons brain mris available numnum persons mri measures cognition assessed time compared nonparticipants chcs participants younger educated less likely cardiovascular disease num institutional review boards participating institution approved research protocols chs chcs participants provided written informed consent
0.29024228.15781953.html.plaintext.txt	19	data collection physical activity information physical activity collected trained interviewers chs baseline num num chcs baseline num num modified minnesota leisure time activity questionnaire num num asked participants frequency duration num different types activities previous num weeks activities selected previously shown common among older adults num included walking household chores mowing raking gardening hiking jogging biking exercise cycling dancing aerobics bowling golfing general exercise swimming
0.29024228.15781953.html.plaintext.txt	20	data collection physical activity information physical activity collected trained interviewers chs baseline num num chcs baseline num num modified minnesota leisure time activity questionnaire num num asked participants frequency duration num different types activities previous num weeks activities selected previously shown common among older adults num included walking household chores mowing raking gardening hiking jogging biking exercise cycling dancing aerobics bowling golfing general exercise swimming
0.29024228.15781953.html.plaintext.txt	21	activities assigned metabolic equivalents ml symbminute mets according intensity num leisure time energy expenditure kilocaloriesweek estimated person kilocalorie expenditure chs baseline chcs baseline averaged obtain estimate habitual physical activity levels older adulthood used current analysis single measure physical activity used participants values missing one testing periods n num
0.29024228.15781953.html.plaintext.txt	22	activities assigned metabolic equivalents ml symbminute mets according intensity num leisure time energy expenditure kilocaloriesweek estimated person kilocalorie expenditure chs baseline chcs baseline averaged obtain estimate habitual physical activity levels older adulthood used current analysis single measure physical activity used participants values missing one testing periods n num
0.29024228.15781953.html.plaintext.txt	23	express diversity physical activity activity index calculated number different activities subject participated previous num weeks raking mowing collapsed single category represent yard work resulting potential range index num num activities activity indices chs baseline chcs baseline averaged represent activity index used present study similar aggregate scores physical activity used previous studies dementia risk num num
0.29024228.15781953.html.plaintext.txt	24	express diversity physical activity activity index calculated number different activities subject participated previous num weeks raking mowing collapsed single category represent yard work resulting potential range index num num activities activity indices chs baseline chcs baseline averaged represent activity index used present study similar aggregate scores physical activity used previous studies dementia risk num num
0.29024228.15781953.html.plaintext.txt	25	apoe genotyping methods apoe genotyping chs described elsewhere num briefly genomic dna extracted whole blood samples amplified using polymerase chain reaction cleaving electrophoresis agarose gels restriction patterns determined according methods hixson vernier num apoe genotypes grouped apoe num carriers numnum numnum numnum genotypes noncarriers numnum numnum numnum genotypes
0.29024228.15781953.html.plaintext.txt	26	covariates measurements obtained chcs baseline examination also considered sociodemographic variables included age gender educational level ethnicity information smoking alcohol intake postmenopausal hormone replacement therapy use self reported prevalent cases myocardial infarction angina stroke transient ischemic attack congestive heart failure baseline ascertained participant self report physicians diagnosis functional impairment measured using modified version instrument assessing basic activities daily living instrumental activities daily living national health interview survey num social network assessed using lubben social network scale num series questions asking participants life satisfaction personal relationships summed represent measure social support center epidemiologic studies depression scale num administered chcs baseline sensitive version mini mental state examination modified mini mental state numms examination num administered annually numms assesses several domains cognition greater detail mini mental state examination scores ranging num num higher scores reflect better performance person receive clinical evaluation attempts made evaluate cognition using telephone interview cognitive status num participants died examinations information obtained using informant questionnaire cognitive decline elderly num data concerning circumstances death
0.29024228.15781953.html.plaintext.txt	27	self reported weight height also recorded chcs baseline body mass index calculated weight kilograms per height meters squared blood pressure measured standardized manner trained personnel participant seated num minutes average two readings calculated analysis hypertension defined previous diagnosis hypertension taking hypertensive medication current systolic blood pressure num mmhg diastolic blood pressure num mmhg total cholesterol high density lipoprotein cholesterol triglycerides determined fasting samples using standard methods low density lipoprotein cholesterol estimated friedewald formula num persons considered diabetic validated medical diagnosis diabetes fasting glucose level num mgdl higher
0.29024228.15781953.html.plaintext.txt	28	self reported weight height also recorded chcs baseline body mass index calculated weight kilograms per height meters squared blood pressure measured standardized manner trained personnel participant seated num minutes average two readings calculated analysis hypertension defined previous diagnosis hypertension taking hypertensive medication current systolic blood pressure num mmhg diastolic blood pressure num mmhg total cholesterol high density lipoprotein cholesterol triglycerides determined fasting samples using standard methods low density lipoprotein cholesterol estimated friedewald formula num persons considered diabetic validated medical diagnosis diabetes fasting glucose level num mgdl higher
0.29024228.15781953.html.plaintext.txt	29	cerebral mris conducted chcs baseline scored overall severity white matter lesions according scale developed chs researchers num white matter lesion severity score num considered within normal limits group older adults whereas score num considered indicative neurodegenerative changes
0.29024228.15781953.html.plaintext.txt	30	cerebral mris conducted chcs baseline scored overall severity white matter lesions according scale developed chs researchers num white matter lesion severity score num considered within normal limits group older adults whereas score num considered indicative neurodegenerative changes
0.29024228.15781953.html.plaintext.txt	31	diagnosis dementia dementia status type chcs classified num num using multistage process num num initially participants classified local study site dementia risk stratum high low persons deemed high risk num numms score num within last two study visits num decline num points numms within follow period num telephone interview cognitive status score num informant questionnaire cognitive decline elderly score numnum num incident stroke num diagnosis dementia documented medical records num resided nursing home study period
0.29024228.15781953.html.plaintext.txt	32	diagnosis dementia dementia status type chcs classified num num using multistage process num num initially participants classified local study site dementia risk stratum high low persons deemed high risk num numms score num within last two study visits num decline num points numms within follow period num telephone interview cognitive status score num informant questionnaire cognitive decline elderly score numnum num incident stroke num diagnosis dementia documented medical records num resided nursing home study period
0.29024228.15781953.html.plaintext.txt	33	pittsburgh site participants alive could traced invited center num num full neuropsychiatric examination regardless dementia risk three remaining sites high risk participants described minority participants participants cognitive data incomplete invited comprehensive evaluation attend clinic visit medical records proxy previous telephone interviews used diagnosis diagnosis based deficit performance two cognitive domains sufficiently severe affect subjects activities daily living history normal intellectual function dementia criteria designed identify subjects syndromes could include relatively preserved memory functions eg frontotemporal dementia thus memory deficit required diagnosis dementia num
0.29024228.15781953.html.plaintext.txt	34	pittsburgh site participants alive could traced invited center num num full neuropsychiatric examination regardless dementia risk three remaining sites high risk participants described minority participants participants cognitive data incomplete invited comprehensive evaluation attend clinic visit medical records proxy previous telephone interviews used diagnosis diagnosis based deficit performance two cognitive domains sufficiently severe affect subjects activities daily living history normal intellectual function dementia criteria designed identify subjects syndromes could include relatively preserved memory functions eg frontotemporal dementia thus memory deficit required diagnosis dementia num
0.29024228.15781953.html.plaintext.txt	35	participants identified dementia reviewed adjudication committee made neurology psychiatry experts diagnosis alzheimers disease based national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda num criteria diagnosis vascular dementia based alzheimers disease diagnostic treatment centers criteria num time dementia onset established first diagnosis recorded medical records otherwise midpoint two annual chs follow interviews marked change cognition leading final dementia diagnosis
0.29024228.15781953.html.plaintext.txt	36	participants identified dementia reviewed adjudication committee made neurology psychiatry experts diagnosis alzheimers disease based national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda num criteria diagnosis vascular dementia based alzheimers disease diagnostic treatment centers criteria num time dementia onset established first diagnosis recorded medical records otherwise midpoint two annual chs follow interviews marked change cognition leading final dementia diagnosis
0.29024228.15781953.html.plaintext.txt	37	statistical analyses survival analysis used assess association activity level time onset dementia using cox proportional hazards regression multivariate models adjusted age gender race apoe genotype educational level difficulty activities daily living instrumental activities daily living lubben social network scale social support baseline numms score white matter grade hazard ratios num percent confidence intervals computed tests linear trend across quartiles physical activity computed introducing cox models variable median quartile continuous variable effect modification assessed stratification introducing product terms multivariate cox models statistical analyses performed using stata software version numnum num
0.29024228.15781953.html.plaintext.txt	38	statistical analyses survival analysis used assess association activity level time onset dementia using cox proportional hazards regression multivariate models adjusted age gender race apoe genotype educational level difficulty activities daily living instrumental activities daily living lubben social network scale social support baseline numms score white matter grade hazard ratios num percent confidence intervals computed tests linear trend across quartiles physical activity computed introducing cox models variable median quartile continuous variable effect modification assessed stratification introducing product terms multivariate cox models statistical analyses performed using stata software version numnum num
0.29024228.15781953.html.plaintext.txt	39	results top abstract introduction materials methods results discussion references numnum chcs participants excluded num dementia baseline six whose dementia status could determined remaining numnum subjects num developed incident dementia numnum years follow median numnum range numnum numnum years figure num
0.29024228.15781953.html.plaintext.txt	40	results top abstract introduction materials methods results discussion references numnum chcs participants excluded num dementia baseline six whose dementia status could determined remaining numnum subjects num developed incident dementia numnum years follow median numnum range numnum numnum years figure num
0.29024228.15781953.html.plaintext.txt	41	view larger version numk figure num cardiovascular health cognition study sample selection num num follow num num united states vad vascular dementia ad alzheimers disease
0.29024228.15781953.html.plaintext.txt	42	view larger version numk figure num cardiovascular health cognition study sample selection num num follow num num united states vad vascular dementia ad alzheimers disease
0.29024228.15781953.html.plaintext.txt	43	table num describes participant characteristics chcs baseline developed dementia compared older lower educational level likely carry apoe num allele poorer cognitive performance numms baseline physical difficulties likely show white matter disease cerebral mri incident dementia cases also likely history stroke cardiovascular disease hypertension
0.29024228.15781953.html.plaintext.txt	44	table num describes participant characteristics chcs baseline developed dementia compared older lower educational level likely carry apoe num allele poorer cognitive performance numms baseline physical difficulties likely show white matter disease cerebral mri incident dementia cases also likely history stroke cardiovascular disease hypertension
0.29024228.15781953.html.plaintext.txt	45	view table table num baseline characteristics participants cardiovascular health cognition study united states num num
0.29024228.15781953.html.plaintext.txt	46	average leisure time physical activity expenditure numnum kcal per week standard deviation numnum num participants completely sedentary leisure time kilocalorie expenditure num persons reported engaging num num different activities mean numnum standard deviation numnum walking household chores common numnum percent numnum percent active persons engaging activities respectively approximately one third sample engaged activities gardening yard work organized exercise program
0.29024228.15781953.html.plaintext.txt	47	average leisure time physical activity expenditure numnum kcal per week standard deviation numnum num participants completely sedentary leisure time kilocalorie expenditure num persons reported engaging num num different activities mean numnum standard deviation numnum walking household chores common numnum percent numnum percent active persons engaging activities respectively approximately one third sample engaged activities gardening yard work organized exercise program
0.29024228.15781953.html.plaintext.txt	48	relation physical activity participant characteristics displayed table num males caucasians participants higher educational levels persons fewer functional difficulties activities daily livinginstrumental activities daily living levels physical activity higher relatively sedentary participants quartile num likely hypertensive diabetic smoke higher levels high density lipoprotein cholesterol triglycerides compared active participants similar associations found baseline characteristics activity index number activities table num spearman correlation energy expenditure activity index numnum p numnum
0.29024228.15781953.html.plaintext.txt	49	relation physical activity participant characteristics displayed table num males caucasians participants higher educational levels persons fewer functional difficulties activities daily livinginstrumental activities daily living levels physical activity higher relatively sedentary participants quartile num likely hypertensive diabetic smoke higher levels high density lipoprotein cholesterol triglycerides compared active participants similar associations found baseline characteristics activity index number activities table num spearman correlation energy expenditure activity index numnum p numnum
0.29024228.15781953.html.plaintext.txt	50	view table table num participant characteristics quartile leisure time energy expenditure cardiovascular health cognition study united states num num
0.29024228.15781953.html.plaintext.txt	51	view table table num participant characteristics activity index activities previous num weeks cardiovascular health cognition study united states num num
0.29024228.15781953.html.plaintext.txt	52	leisure time energy expenditure inversely associated risk dementia although adjustment age covariates trend longer significant table num point estimates suggested inverse relation alzheimers disease vascular dementia none analyses vascular dementia reached significance
0.29024228.15781953.html.plaintext.txt	53	leisure time energy expenditure inversely associated risk dementia although adjustment age covariates trend longer significant table num point estimates suggested inverse relation alzheimers disease vascular dementia none analyses vascular dementia reached significance
0.29024228.15781953.html.plaintext.txt	54	view table table num hazard ratios incident dementia level leisure time energy expenditure cardiovascular health cognition study united states num num
0.29024228.15781953.html.plaintext.txt	55	number physical activities inversely associated dementia risk table num inverse association persisted multivariate adjustment adjusted hazard ratios cause dementia incidence numnum reference numnum numnum numnum num num num num num activities respectively p trend numnum trend remained significant models adjusted total energy expenditure data shown
0.29024228.15781953.html.plaintext.txt	56	number physical activities inversely associated dementia risk table num inverse association persisted multivariate adjustment adjusted hazard ratios cause dementia incidence numnum reference numnum numnum numnum num num num num num activities respectively p trend numnum trend remained significant models adjusted total energy expenditure data shown
0.29024228.15781953.html.plaintext.txt	57	view table table num hazard ratios incident dementia activity index activities previous num weeks cardiovascular health cognition study united states num num
0.29024228.15781953.html.plaintext.txt	58	analyses stratified apoe num carrier state inverse association energy expenditure activity index dementia risk limited apoe num noncarriers table num figure num multivariate adjusted hazard ratios type dementia comparing highest lowest quartile energy expenditure apoe num noncarriers numnum p trend numnum hazard ratio comparing highest lowest quartile activity index numnum p trend numnum corresponding hazard ratios energy expenditure activity index apoe num carriers numnum p trend numnum numnum p trend numnum p values interaction energy expenditure activity index apoe num carrier status numnum numnum respectively pattern observed alzheimers disease vascular dementia figure num
0.29024228.15781953.html.plaintext.txt	59	analyses stratified apoe num carrier state inverse association energy expenditure activity index dementia risk limited apoe num noncarriers table num figure num multivariate adjusted hazard ratios type dementia comparing highest lowest quartile energy expenditure apoe num noncarriers numnum p trend numnum hazard ratio comparing highest lowest quartile activity index numnum p trend numnum corresponding hazard ratios energy expenditure activity index apoe num carriers numnum p trend numnum numnum p trend numnum p values interaction energy expenditure activity index apoe num carrier status numnum numnum respectively pattern observed alzheimers disease vascular dementia figure num
0.29024228.15781953.html.plaintext.txt	60	view table table num hazard ratios incident dementia level physical activity stratified apoe cardiovascular health cognition study united states num num
0.29024228.15781953.html.plaintext.txt	61	view larger version numk figure num five year cumulative incidence dementia function leisure time energy expenditure activity index among apolipoprotein e genotype apoe num carriers noncarriers united states cardiovascular health cognition study num num bold curves cause dementia thin solid curves alzheimers disease dashed curves vascular dementia bars frequency distribution physical activity within apoe genotype stratum
0.29024228.15781953.html.plaintext.txt	62	view larger version numk figure num five year cumulative incidence dementia function leisure time energy expenditure activity index among apolipoprotein e genotype apoe num carriers noncarriers united states cardiovascular health cognition study num num bold curves cause dementia thin solid curves alzheimers disease dashed curves vascular dementia bars frequency distribution physical activity within apoe genotype stratum
0.29024228.15781953.html.plaintext.txt	63	persons may less active less physically able active therefore repeated analysis excluding subjects one instrumental activities daily living impairments one activities daily living impairments associations energy expenditure activity index dementia risk effect modification apoe carrier status similar
0.29024228.15781953.html.plaintext.txt	64	persons may less active less physically able active therefore repeated analysis excluding subjects one instrumental activities daily living impairments one activities daily living impairments associations energy expenditure activity index dementia risk effect modification apoe carrier status similar
0.29024228.15781953.html.plaintext.txt	65	discussion top abstract introduction materials methods results discussion references large prospective cohort study community dwelling older adults identified inverse association physical activity dementia risk apoe num noncarriers found association apoe num carriers associations similar alzheimers disease vascular dementia results also suggest participating number different activities may important frequency intensity duration physical activity respect dementia risk
0.29024228.15781953.html.plaintext.txt	66	discussion top abstract introduction materials methods results discussion references large prospective cohort study community dwelling older adults identified inverse association physical activity dementia risk apoe num noncarriers found association apoe num carriers associations similar alzheimers disease vascular dementia results also suggest participating number different activities may important frequency intensity duration physical activity respect dementia risk
0.29024228.15781953.html.plaintext.txt	67	findings prospective studies physical activity dementia inconsistent num num num num num num num among japanese elders regular physical activity associated lower risk alzheimers disease vascular dementia incidence num similarly older french participants engaged three social leisure activities versus none num percent lower overall dementia risk num num canadian study health aging physical activity inversely associated cause dementia alzheimers disease num inverse association vascular dementia observed women num wang et al num however observe association physical activity dementia incidence social mental productive activities accounted although investigators examined three types physical activities subjects participated activities religious orders study num bronx aging study num also failed identify relation activities physical per se risk dementia report association cognitive activity reduced dementia incidence neither studies accounted apoe genotype analysis however although measure cognitive activities directly physical activities often occur conjunction social cognitive stimulation
0.29024228.15781953.html.plaintext.txt	68	findings prospective studies physical activity dementia inconsistent num num num num num num num among japanese elders regular physical activity associated lower risk alzheimers disease vascular dementia incidence num similarly older french participants engaged three social leisure activities versus none num percent lower overall dementia risk num num canadian study health aging physical activity inversely associated cause dementia alzheimers disease num inverse association vascular dementia observed women num wang et al num however observe association physical activity dementia incidence social mental productive activities accounted although investigators examined three types physical activities subjects participated activities religious orders study num bronx aging study num also failed identify relation activities physical per se risk dementia report association cognitive activity reduced dementia incidence neither studies accounted apoe genotype analysis however although measure cognitive activities directly physical activities often occur conjunction social cognitive stimulation
0.29024228.15781953.html.plaintext.txt	69	physical activity may protect dementia risk several mechanisms experimental studies demonstrated physical exercise activity facilitates learning increasing expression genes promoting neurogenesis neural plasticity num num although several neural substrates may mediate exercise induced effects neuronal structure integrity research suggests central role brain derived neurotrophic factor num num levels factor hippocampi diminished patients alzheimers disease num nonneural vascular adaptations also enhanced exercise including increased cerebral blood flow substrate exchange num increased cerebral capillary density num decreased accumulation radical oxidative proteins num
0.29024228.15781953.html.plaintext.txt	70	physical activity may protect dementia risk several mechanisms experimental studies demonstrated physical exercise activity facilitates learning increasing expression genes promoting neurogenesis neural plasticity num num although several neural substrates may mediate exercise induced effects neuronal structure integrity research suggests central role brain derived neurotrophic factor num num levels factor hippocampi diminished patients alzheimers disease num nonneural vascular adaptations also enhanced exercise including increased cerebral blood flow substrate exchange num increased cerebral capillary density num decreased accumulation radical oxidative proteins num
0.29024228.15781953.html.plaintext.txt	71	addition physical activity may surrogate overall life engagement greater social activity persons developed social networks lower risk cause mortality persons socially isolated social supports attenuate rate cognitive decline older adults num social networks may also promote overall health particularly cardiovascular risk factors thereby may impact dementia risk similarly involvement physical activities associated mastery self efficacy num turn attributes may motivate persons attentive health needs health behaviors adjusted social network social support multivariate models however activity index continued associated dementia risk physical activity operating social mechanisms appears level captured two measures social functioning
0.29024228.15781953.html.plaintext.txt	72	addition physical activity may surrogate overall life engagement greater social activity persons developed social networks lower risk cause mortality persons socially isolated social supports attenuate rate cognitive decline older adults num social networks may also promote overall health particularly cardiovascular risk factors thereby may impact dementia risk similarly involvement physical activities associated mastery self efficacy num turn attributes may motivate persons attentive health needs health behaviors adjusted social network social support multivariate models however activity index continued associated dementia risk physical activity operating social mechanisms appears level captured two measures social functioning
0.29024228.15781953.html.plaintext.txt	73	involvement number different activities likely requires organization memory skills necessary flexibly schedule attend shift among activities organizational executive memory processes regulated neuroanatomical regions adversely affected aging dementing illnesses exercising may help buffer preserve cognitive reserves face cognitive decline via continued use corresponding cortical synaptic stimulation intact neurons num cross sectional studies variety lifestyle activities positively associated indices cognition among nondemented older women particularly domain memory m carlson johns hopkins medical institutions unpublished manuscript
0.29024228.15781953.html.plaintext.txt	74	involvement number different activities likely requires organization memory skills necessary flexibly schedule attend shift among activities organizational executive memory processes regulated neuroanatomical regions adversely affected aging dementing illnesses exercising may help buffer preserve cognitive reserves face cognitive decline via continued use corresponding cortical synaptic stimulation intact neurons num cross sectional studies variety lifestyle activities positively associated indices cognition among nondemented older women particularly domain memory m carlson johns hopkins medical institutions unpublished manuscript
0.29024228.15781953.html.plaintext.txt	75	alternatively physical activity may index healthier lifestyle resulting less exposure factors affect cognitive function precipitate dementia current study engaging larger number different activities generally associated favorable health profile health behaviors
0.29024228.15781953.html.plaintext.txt	76	alternatively physical activity may index healthier lifestyle resulting less exposure factors affect cognitive function precipitate dementia current study engaging larger number different activities generally associated favorable health profile health behaviors
0.29024228.15781953.html.plaintext.txt	77	previous studies num num apoe num carriers attain benefit noncarriers physical activity terms blood pressure lipid patterns similarly findings suggest differing risk patterns dementia physical activity apoe genotype imply potential protective effect associated physical activity enough overcome effect apoe num alleles physical activity dementia simply unrelated persons apoe num genotypes however findings contrast previous study inverse association physical activity cognitive decline observed predominantly apoe num carriers num difficult know whether findings extend dementia elderly persons experience cognitive decline progress clinical dementia note however interaction physical activity apoe num study based num cases cognitive decline thus subject considerable variability replication findings larger studies required resolve apparent discrepancy
0.29024228.15781953.html.plaintext.txt	78	previous studies num num apoe num carriers attain benefit noncarriers physical activity terms blood pressure lipid patterns similarly findings suggest differing risk patterns dementia physical activity apoe genotype imply potential protective effect associated physical activity enough overcome effect apoe num alleles physical activity dementia simply unrelated persons apoe num genotypes however findings contrast previous study inverse association physical activity cognitive decline observed predominantly apoe num carriers num difficult know whether findings extend dementia elderly persons experience cognitive decline progress clinical dementia note however interaction physical activity apoe num study based num cases cognitive decline thus subject considerable variability replication findings larger studies required resolve apparent discrepancy
0.29024228.15781953.html.plaintext.txt	79	chcs one largest prospective studies older adults comprehensive information subclinical clinical cognitive functioning dementia status cardiovascular factors addition physical activity collected using standardized methods num prospective design chcs enabled us collect information physical activity advance dementia diagnosis therefore minimizing selection recall biases
0.29024228.15781953.html.plaintext.txt	80	chcs one largest prospective studies older adults comprehensive information subclinical clinical cognitive functioning dementia status cardiovascular factors addition physical activity collected using standardized methods num prospective design chcs enabled us collect information physical activity advance dementia diagnosis therefore minimizing selection recall biases
0.29024228.15781953.html.plaintext.txt	81	update information physical activity follow preclinical symptoms may reduce activity levels compromising ability establish temporality although misclassification exposure possible participants present analysis cognitively stable numms score num time physical activity information collected furthermore able adjust baseline numms cognitive scores analyses basis considerations reasonable suggest misclassification exposure would nondifferential would biased results toward null
0.29024228.15781953.html.plaintext.txt	82	update information physical activity follow preclinical symptoms may reduce activity levels compromising ability establish temporality although misclassification exposure possible participants present analysis cognitively stable numms score num time physical activity information collected furthermore able adjust baseline numms cognitive scores analyses basis considerations reasonable suggest misclassification exposure would nondifferential would biased results toward null
0.29024228.15781953.html.plaintext.txt	83	findings without limitations able assess physical activity levels older adult life unclear period life physical activity relevant preserving cognition impacting dementia risk finding number activities stronger association dementia risk kilocalorie expenditure may artifact measurement reliability minnesota leisure time activity questionnaire may lower low moderate levels activity num levels older adults participate therefore possible number activities may sensitive indicator levels furthermore persons established physical activity habits may precise recall persons exercise sporadically similarly recall number activities may reliable specifics exercise frequency duration factors heavily weighted calculating total energy expenditure sample number activities significantly positively correlated total physical activity energy expenditure understanding components physical activity reduce dementia risk deserves attention
0.29024228.15781953.html.plaintext.txt	84	findings without limitations able assess physical activity levels older adult life unclear period life physical activity relevant preserving cognition impacting dementia risk finding number activities stronger association dementia risk kilocalorie expenditure may artifact measurement reliability minnesota leisure time activity questionnaire may lower low moderate levels activity num levels older adults participate therefore possible number activities may sensitive indicator levels furthermore persons established physical activity habits may precise recall persons exercise sporadically similarly recall number activities may reliable specifics exercise frequency duration factors heavily weighted calculating total energy expenditure sample number activities significantly positively correlated total physical activity energy expenditure understanding components physical activity reduce dementia risk deserves attention
0.29024228.15781953.html.plaintext.txt	85	must also consider possibility reduction number different physical activities early symptom dementia addressed possibility using several different approaches first excluded persons numms score less num prevalent dementia baseline however possible numms sensitive enough detect persons subclinical dementing illness persons included study second adjusted analyses baseline cognitive function inverse association number physical activities dementia risk persisted third reran analysis excluding persons developed incident dementia within first year follow results essentially unchanged furthermore used information physical activity two time points approximately num years apart obtain stable estimate regular physical activity older adulthood prior dementia onset finally also evaluated association physical activity dementia risk excluding persons one difficulties activities daily living instrumental activities daily living results similar
0.29024228.15781953.html.plaintext.txt	86	must also consider possibility reduction number different physical activities early symptom dementia addressed possibility using several different approaches first excluded persons numms score less num prevalent dementia baseline however possible numms sensitive enough detect persons subclinical dementing illness persons included study second adjusted analyses baseline cognitive function inverse association number physical activities dementia risk persisted third reran analysis excluding persons developed incident dementia within first year follow results essentially unchanged furthermore used information physical activity two time points approximately num years apart obtain stable estimate regular physical activity older adulthood prior dementia onset finally also evaluated association physical activity dementia risk excluding persons one difficulties activities daily living instrumental activities daily living results similar
0.29024228.15781953.html.plaintext.txt	87	summary study provides support hypothesis engaging number different physical activities protects subsequent risk cause dementia alzheimers disease vascular dementia average numnum year follow although potential benefits exercise may limited apoe num noncarriers physical activity already recommended enhance cardiovascular health help maintain independence quality life older adults num confirmation findings substantiation biologic mechanism activity reduces dementia risk may provide additional impetus persons remain become active number activities later life
0.29024228.15781953.html.plaintext.txt	88	summary study provides support hypothesis engaging number different physical activities protects subsequent risk cause dementia alzheimers disease vascular dementia average numnum year follow although potential benefits exercise may limited apoe num noncarriers physical activity already recommended enhance cardiovascular health help maintain independence quality life older adults num confirmation findings substantiation biologic mechanism activity reduces dementia risk may provide additional impetus persons remain become active number activities later life
0.29024228.15781953.html.plaintext.txt	89	acknowledgments research reported article supported contracts symb hc num symb hc num symb hc num symb hc num national heart lung blood institute nhlbi grant symb national institute aging
0.29024228.15781953.html.plaintext.txt	90	authors thank corrine dulberg annette fitzpatrick assistance data used analysis roberto pastor barriuso help preparing figures
0.29024228.15781953.html.plaintext.txt	91	chs conducted supported nhlbi collaboration chs investigators manuscript reviewed chs nhlbi scientific content consistency data interpretation previous chs publications significant comments incorporated prior submission publication
0.29024228.15781953.html.plaintext.txt	92	chs conducted supported nhlbi collaboration chs investigators manuscript reviewed chs nhlbi scientific content consistency data interpretation previous chs publications significant comments incorporated prior submission publication
0.29024228.15781953.html.plaintext.txt	93	participating chs investigators institutions investigators listed provided signed permission acknowledged steering committee chairman dr curt d furberg wake forest university school medicine winston salem north carolina nhlbi project office dr jean olson wake forest university school medicine dr gregory l burke wake forest university ecg reading center dr pentti m rautaharju university california davis dr john robbins johns hopkins university baltimore maryland dr linda p fried johns hopkins university mri reading center dr nick bryan dr norman j beauchamp university pittsburgh pittsburgh pennsylvania dr lewis h kuller university california irvine echocardiography reading center baseline dr julius m gardin georgetown medical center echocardiography reading center washington dc follow dr john gottdiener new england medical center boston ultrasound reading center massachusetts dr daniel h oleary university vermont central blood analysis laboratory burlington vermont dr russell p tracy university arizona tucson pulmonary reading center dr paul enright retinal reading center university wisconsin madison dr ronald klein university washington coordinating center seattle dr richard kronmal full list participating chs investigators institutions found following website httpwwwchs nhlbiorg
0.29024228.15781953.html.plaintext.txt	94	participating chs investigators institutions investigators listed provided signed permission acknowledged steering committee chairman dr curt d furberg wake forest university school medicine winston salem north carolina nhlbi project office dr jean olson wake forest university school medicine dr gregory l burke wake forest university ecg reading center dr pentti m rautaharju university california davis dr john robbins johns hopkins university baltimore maryland dr linda p fried johns hopkins university mri reading center dr nick bryan dr norman j beauchamp university pittsburgh pittsburgh pennsylvania dr lewis h kuller university california irvine echocardiography reading center baseline dr julius m gardin georgetown medical center echocardiography reading center washington dc follow dr john gottdiener new england medical center boston ultrasound reading center massachusetts dr daniel h oleary university vermont central blood analysis laboratory burlington vermont dr russell p tracy university arizona tucson pulmonary reading center dr paul enright retinal reading center university wisconsin madison dr ronald klein university washington coordinating center seattle dr richard kronmal full list participating chs investigators institutions found following website httpwwwchs nhlbiorg
0.29024228.15781953.html.plaintext.txt	95	references top abstract introduction materials methods results discussion references us general accounting office alzheimers disease estimates prevalence united states report secretary health human services washington dc health education human services division num report gaohehs num num post sg future scenarios prevention delay alzheimer disease onset high risk groups ethical perspective j prev med numnumnum numcrossrefisimedline cummings jl cole g alzheimer disease jama numnumnum numfree full text cotman cw engesser cesar c exercise enhances protects brain function exerc sport sci rev numnumnum numcrossrefisimedline pate rr pratt m blair sn et al physical activity public health recommendation centers disease control prevention american college sports medicine jama numnumnum numabstract crawford jg alzheimers disease risk factors related cerebral blood flow med hypotheses numnumnum numcrossrefisimedline crawford jg alzheimers disease risk factors related cerebral blood flow additional evidence med hypotheses numnumnum numisimedline fratiglioni l wang hx ericsson k et al influence social network occurrence dementia community based longitudinal study lancet numnumnum numcrossrefisimedline anstey k christensen h education activity health blood pressure apolipoprotein e predictors cognitive change old age review gerontology numnumnum numcrossrefisimedline laurin d verreault r lindsay j et al physical activity risk cognitive impairment dementia elderly persons arch neurol numnumnum numabstractfree full text yaffe k barnes d nevitt m et al prospective study physical activity cognitive decline elderly women women walk arch intern med numnumnum numabstractfree full text rogers rl meyer js mortel kf reaching retirement age physical activity sustains cerebral perfusion cognition j geriatr soc numnumnum numisimedline schuit aj feskens ej launer lj et al physical activity cognitive decline role apolipoprotein symb allele med sci sports exerc numnumnum numisimedline broe ga henderson creasey h et al case control study alzheimers disease australia neurology numnumnum numabstract yoshitake kiyohara y kato et al incidence risk factors vascular dementia alzheimers disease defined elderly japanese population hisayama study neurology numnumnum numabstract fabrigoule c letenneur l dartigues jf et al social leisure activities risk dementia prospective longitudinal study j geriatr soc numnumnum numisimedline helmer c damon d letenneur l et al marital status risk alzheimers disease french population based cohort study neurology numnumnum numabstractfree full text friedland rp fritsch smyth ka et al patients alzheimers disease reduced activities midlife compared healthy control group members proc natl acad sci u numnumnum numabstractfree full text scarmeas n levy g tang mx et al influence leisure activity incidence alzheimers disease neurology numnumnum numabstractfree full text broe ga creasey h jorm af et al health habits risk cognitive impairment dementia old age prospective study effects exercise smoking alcohol consumption aust n z j public health numnumnum numisimedline verghese j lipton rb katz mj et al leisure activities risk dementia elderly n engl j med numnumnum numabstractfree full text wang hx karp winblad b et al late life engagement social leisure activities associated decreased risk dementia longitudinal study kungsholmen project j epidemiol numnumnum numabstractfree full text wilson rs mendes de leon cf barnes ll et al participation cognitively stimulating activities risk incident alzheimer disease jama numnumnum numabstractfree full text fried lp borhani enright p et al cardiovascular health study design rationale ann epidemiol numnumnum nummedline lyketsos cg lopez o jones b et al prevalence neuropsychiatric symptoms dementia mild cognitive impairment results cardiovascular health study jama numnumnum numabstractfree full text lopez ol kuller lh fitzpatrick et al evaluation dementia cardiovascular health cognition study neuroepidemiology numnumnum numcrossrefisimedline kuller lh lopez ol newman et al risk factors dementia cardiovascular health cognition study neuroepidemiology numnumnum numcrossrefisimedline price tr manolio ta kronmal ra et al silent brain infarction magnetic resonance imaging neurological abnormalities community dwelling older adults cardiovascular health study chs collaborative research group stroke numnumnum numabstractfree full text kuller lh shemanski l manolio et al relationship apoe mri findings cognitive function cardiovascular health study stroke numnumnum numabstractfree full text taylor hl jacobs dr schucker b et al questionnaire assessment leisure time physical activities j chronic dis numnumnum numcrossrefisimedline siscovick ds fried l mittelmark m et al exercise intensity subclinical cardiovascular disease elderly cardiovascular health study j epidemiol numnumnum numabstract mcphillips jb pellettera km barrett connor e et al exercise patterns population older adults j prev med numnumnum numisimedline hixson j vernier d restriction isotyping human apolipoprotein e gene amplification cleavage hhai j lipid res numnumnum numabstract fitti je kovar mg supplement aging num national health interview survey vital health stat num numjunnum num lubben je assessing social networks among elderly populations fam community health numnumnum num radloff ls ces d scale self report depression scale research general population appl psychol meas numnumnum num teng el chui hc modified mini mental state numms examination j clin psychiatry numnumnum numisimedline brandt j spencer m folstein m telephone interview cognitive status neuropsychiatry neuropsychol behav neurol numnumnum num jorm af korten ae assessment cognitive decline elderly informant interview br j psychiatry numnumnum numabstract friedewald wt levy ri fredrickson ds estimation concentration low density lipoprotein cholesterol plasma without use preparative ultracentrifuge clin chem numnumnum numabstractfree full text bryan rn manolio ta scherz ld et al method using mr evaluate effects cardiovascular disease brain cardiovascular health study j radiol numnumnum num mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology numnumnum numabstract chui hc victoroff ji margolin d et al criteria diagnosis ischemic vascular dementia proposed state california alzheimers disease diagnostic treatment centers neurology numnumnum numabstract stata corporation stata statistical software version numnum college station tx stata corporation num hebert r lindsay j verreault r et al vascular dementia incidence risk factors canadian study health aging stroke numnumnum numabstractfree full text molteni r ying z gomez pinilla f differential effects acute chronic exercise plasticity related genes rat hippocampus revealed microarray eur j neurosci numnumnum numcrossrefisimedline phillips hs hains jm armanini m et al bdnf mrna decreased hippocampus individuals alzheimers disease neuron numnumnum numisimedline ide k secher nh cerebral blood flow metabolism exercise prog neurobiol numnumnum numcrossrefisimedline black je isaacs kr anderson bj et al learning causes synaptogenesis whereas motor activity causes angiogenesis cerebellar cortex adult rats proc natl acad sci u numnumnum numabstractfree full text radak z taylor aw ohno h et al adaptation exercise induced oxidative stress muscle brain exerc immunol rev numnumnum numisimedline seemen te crimmins e social environment effects health aging integrating epidemiologic demographic approaches perspectives ann n y acad sci numnumnum numabstractfree full text american college sports medicine position stand exercise physical activity older adults med sci sports exerc numnumnum numisimedline swaab df lucassen pj salehi et al reduced neuronal activity reactivation alzheimers disease prog brain res numnumnum numisimedline hagberg jm ferrell re dengel dr et al exercise training induced blood pressure plasma lipid improvements hypertensives may genotype dependent hypertension numnumnum numabstractfree full text hagberg jm ferrell re katzel li et al apolipoprotein e genotype exercise training induced increases plasma high density lipoprotein hdl hdl num cholesterol levels overweight men metabolism numnumnum numisimedline st amand j prudhomme d moorjani et al apolipoprotein e polymorphism relationships physical fitness plasma lipoprotein lipid levels men women med sci sports exerc numnumnum numisimedline richardson mt leon jacobs dr jr et al comprehensive evaluation minnesota leisure time physical activity questionnaire j clin epidemiol numnumnum numisimedline
0.29024228.15781953.html.plaintext.txt	96	references top abstract introduction materials methods results discussion references us general accounting office alzheimers disease estimates prevalence united states report secretary health human services washington dc health education human services division num report gaohehs num num post sg future scenarios prevention delay alzheimer disease onset high risk groups ethical perspective j prev med numnumnum numcrossrefisimedline cummings jl cole g alzheimer disease jama numnumnum numfree full text cotman cw engesser cesar c exercise enhances protects brain function exerc sport sci rev numnumnum numcrossrefisimedline pate rr pratt m blair sn et al physical activity public health recommendation centers disease control prevention american college sports medicine jama numnumnum numabstract crawford jg alzheimers disease risk factors related cerebral blood flow med hypotheses numnumnum numcrossrefisimedline crawford jg alzheimers disease risk factors related cerebral blood flow additional evidence med hypotheses numnumnum numisimedline fratiglioni l wang hx ericsson k et al influence social network occurrence dementia community based longitudinal study lancet numnumnum numcrossrefisimedline anstey k christensen h education activity health blood pressure apolipoprotein e predictors cognitive change old age review gerontology numnumnum numcrossrefisimedline laurin d verreault r lindsay j et al physical activity risk cognitive impairment dementia elderly persons arch neurol numnumnum numabstractfree full text yaffe k barnes d nevitt m et al prospective study physical activity cognitive decline elderly women women walk arch intern med numnumnum numabstractfree full text rogers rl meyer js mortel kf reaching retirement age physical activity sustains cerebral perfusion cognition j geriatr soc numnumnum numisimedline schuit aj feskens ej launer lj et al physical activity cognitive decline role apolipoprotein symb allele med sci sports exerc numnumnum numisimedline broe ga henderson creasey h et al case control study alzheimers disease australia neurology numnumnum numabstract yoshitake kiyohara y kato et al incidence risk factors vascular dementia alzheimers disease defined elderly japanese population hisayama study neurology numnumnum numabstract fabrigoule c letenneur l dartigues jf et al social leisure activities risk dementia prospective longitudinal study j geriatr soc numnumnum numisimedline helmer c damon d letenneur l et al marital status risk alzheimers disease french population based cohort study neurology numnumnum numabstractfree full text friedland rp fritsch smyth ka et al patients alzheimers disease reduced activities midlife compared healthy control group members proc natl acad sci u numnumnum numabstractfree full text scarmeas n levy g tang mx et al influence leisure activity incidence alzheimers disease neurology numnumnum numabstractfree full text broe ga creasey h jorm af et al health habits risk cognitive impairment dementia old age prospective study effects exercise smoking alcohol consumption aust n z j public health numnumnum numisimedline verghese j lipton rb katz mj et al leisure activities risk dementia elderly n engl j med numnumnum numabstractfree full text wang hx karp winblad b et al late life engagement social leisure activities associated decreased risk dementia longitudinal study kungsholmen project j epidemiol numnumnum numabstractfree full text wilson rs mendes de leon cf barnes ll et al participation cognitively stimulating activities risk incident alzheimer disease jama numnumnum numabstractfree full text fried lp borhani enright p et al cardiovascular health study design rationale ann epidemiol numnumnum nummedline lyketsos cg lopez o jones b et al prevalence neuropsychiatric symptoms dementia mild cognitive impairment results cardiovascular health study jama numnumnum numabstractfree full text lopez ol kuller lh fitzpatrick et al evaluation dementia cardiovascular health cognition study neuroepidemiology numnumnum numcrossrefisimedline kuller lh lopez ol newman et al risk factors dementia cardiovascular health cognition study neuroepidemiology numnumnum numcrossrefisimedline price tr manolio ta kronmal ra et al silent brain infarction magnetic resonance imaging neurological abnormalities community dwelling older adults cardiovascular health study chs collaborative research group stroke numnumnum numabstractfree full text kuller lh shemanski l manolio et al relationship apoe mri findings cognitive function cardiovascular health study stroke numnumnum numabstractfree full text taylor hl jacobs dr schucker b et al questionnaire assessment leisure time physical activities j chronic dis numnumnum numcrossrefisimedline siscovick ds fried l mittelmark m et al exercise intensity subclinical cardiovascular disease elderly cardiovascular health study j epidemiol numnumnum numabstract mcphillips jb pellettera km barrett connor e et al exercise patterns population older adults j prev med numnumnum numisimedline hixson j vernier d restriction isotyping human apolipoprotein e gene amplification cleavage hhai j lipid res numnumnum numabstract fitti je kovar mg supplement aging num national health interview survey vital health stat num numjunnum num lubben je assessing social networks among elderly populations fam community health numnumnum num radloff ls ces d scale self report depression scale research general population appl psychol meas numnumnum num teng el chui hc modified mini mental state numms examination j clin psychiatry numnumnum numisimedline brandt j spencer m folstein m telephone interview cognitive status neuropsychiatry neuropsychol behav neurol numnumnum num jorm af korten ae assessment cognitive decline elderly informant interview br j psychiatry numnumnum numabstract friedewald wt levy ri fredrickson ds estimation concentration low density lipoprotein cholesterol plasma without use preparative ultracentrifuge clin chem numnumnum numabstractfree full text bryan rn manolio ta scherz ld et al method using mr evaluate effects cardiovascular disease brain cardiovascular health study j radiol numnumnum num mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology numnumnum numabstract chui hc victoroff ji margolin d et al criteria diagnosis ischemic vascular dementia proposed state california alzheimers disease diagnostic treatment centers neurology numnumnum numabstract stata corporation stata statistical software version numnum college station tx stata corporation num hebert r lindsay j verreault r et al vascular dementia incidence risk factors canadian study health aging stroke numnumnum numabstractfree full text molteni r ying z gomez pinilla f differential effects acute chronic exercise plasticity related genes rat hippocampus revealed microarray eur j neurosci numnumnum numcrossrefisimedline phillips hs hains jm armanini m et al bdnf mrna decreased hippocampus individuals alzheimers disease neuron numnumnum numisimedline ide k secher nh cerebral blood flow metabolism exercise prog neurobiol numnumnum numcrossrefisimedline black je isaacs kr anderson bj et al learning causes synaptogenesis whereas motor activity causes angiogenesis cerebellar cortex adult rats proc natl acad sci u numnumnum numabstractfree full text radak z taylor aw ohno h et al adaptation exercise induced oxidative stress muscle brain exerc immunol rev numnumnum numisimedline seemen te crimmins e social environment effects health aging integrating epidemiologic demographic approaches perspectives ann n y acad sci numnumnum numabstractfree full text american college sports medicine position stand exercise physical activity older adults med sci sports exerc numnumnum numisimedline swaab df lucassen pj salehi et al reduced neuronal activity reactivation alzheimers disease prog brain res numnumnum numisimedline hagberg jm ferrell re dengel dr et al exercise training induced blood pressure plasma lipid improvements hypertensives may genotype dependent hypertension numnumnum numabstractfree full text hagberg jm ferrell re katzel li et al apolipoprotein e genotype exercise training induced increases plasma high density lipoprotein hdl hdl num cholesterol levels overweight men metabolism numnumnum numisimedline st amand j prudhomme d moorjani et al apolipoprotein e polymorphism relationships physical fitness plasma lipoprotein lipid levels men women med sci sports exerc numnumnum numisimedline richardson mt leon jacobs dr jr et al comprehensive evaluation minnesota leisure time physical activity questionnaire j clin epidemiol numnumnum numisimedline
0.29792902.15632261.html.plaintext.txt	0	meta analysis nonsteroidal antiinflammatory drug use risk dementia anton j m de craen jacobijn gussekloo bram vrijsen rudi g j westendorp
0.29792902.15632261.html.plaintext.txt	1	section gerontology geriatrics department general internal medicine leiden university medical center leiden netherlands
0.29792902.15632261.html.plaintext.txt	2	received publication march num num accepted publication august num num
0.29792902.15632261.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references authors performed systematic review summarize epidemiologic evidence association use nonsteroidal antiinflammatory drugs nsaids risk dementia total num case control cohort studies reported odds ratiorelative risk included study specific log relative risks weighted inverse variances obtain pooled relative risks num confidence intervals authors divided reports studies prevalent dementia cases studies incident dementia cases studies cognitive decline used clinical endpoint pooled relative risks three groups studies numnum num confidence interval ci numnum numnum numnum num ci numnum numnum numnum num ci numnum numnum respectively within subgroups heterogeneity present studies prevalent cases p numnum benefit nsaids preventing dementia cognitive impairment num studies prevalent dementia cases declined num studies incident dementia cases absent studies cognitive decline used endpoint authors conclude reported beneficial effects nsaids may result various forms bias recall bias prescription bias publication bias
0.29792902.15632261.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references authors performed systematic review summarize epidemiologic evidence association use nonsteroidal antiinflammatory drugs nsaids risk dementia total num case control cohort studies reported odds ratiorelative risk included study specific log relative risks weighted inverse variances obtain pooled relative risks num confidence intervals authors divided reports studies prevalent dementia cases studies incident dementia cases studies cognitive decline used clinical endpoint pooled relative risks three groups studies numnum num confidence interval ci numnum numnum numnum num ci numnum numnum numnum num ci numnum numnum respectively within subgroups heterogeneity present studies prevalent cases p numnum benefit nsaids preventing dementia cognitive impairment num studies prevalent dementia cases declined num studies incident dementia cases absent studies cognitive decline used endpoint authors conclude reported beneficial effects nsaids may result various forms bias recall bias prescription bias publication bias
0.29792902.15632261.html.plaintext.txt	5	alzheimer disease anti inflammatory agents non steroidal dementia meta analysis
0.29792902.15632261.html.plaintext.txt	6	abbreviations ci confidence interval nsaids nonsteroidal antiinflammatory drugs
0.29792902.15632261.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references many observational studies investigated association use nonsteroidal antiinflammatory drugs nsaids risk alzheimer disease dementia cognitive decline num num studies differed greatly design population exposure many found inverse association others found association recently results number secondary prevention studies reported showed beneficial effect use nsaids cognitive function num num results primary prevention trials available hence whether nsaids truly favorable effect preventing dementia remains controversial num performed systematic review literature summarize epidemiologic evidence association use nsaids risk dementia identify possible sources heterogeneity studies
0.29792902.15632261.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion references many observational studies investigated association use nonsteroidal antiinflammatory drugs nsaids risk alzheimer disease dementia cognitive decline num num studies differed greatly design population exposure many found inverse association others found association recently results number secondary prevention studies reported showed beneficial effect use nsaids cognitive function num num results primary prevention trials available hence whether nsaids truly favorable effect preventing dementia remains controversial num performed systematic review literature summarize epidemiologic evidence association use nsaids risk dementia identify possible sources heterogeneity studies
0.29792902.15632261.html.plaintext.txt	9	materials methods top abstract introduction materials methods results discussion references systematic search started using widely quoted num review nsaids risk alzheimer disease num two ways num evaluated articles included review num used science citation index identify studies cited review next searched medline database using search term nsaid combined alzheimer disease dementia cognitive decline limited studies humans apply language restriction titles abstracts search strategies independently examined eligibility two us j m c j g case doubt full article retrieved eligibility discussed original articles reviews retrieved whole process repeated references identified studies reviews
0.29792902.15632261.html.plaintext.txt	10	materials methods top abstract introduction materials methods results discussion references systematic search started using widely quoted num review nsaids risk alzheimer disease num two ways num evaluated articles included review num used science citation index identify studies cited review next searched medline database using search term nsaid combined alzheimer disease dementia cognitive decline limited studies humans apply language restriction titles abstracts search strategies independently examined eligibility two us j m c j g case doubt full article retrieved eligibility discussed original articles reviews retrieved whole process repeated references identified studies reviews
0.29792902.15632261.html.plaintext.txt	11	eligibility criteria data collection studies eligible inclusion satisfied following three criteria num case control cohort study humans num exposure defined use nsaid num cases defined alzheimer disease dementia cognitive impairment
0.29792902.15632261.html.plaintext.txt	12	data independently extracted study two reviewers j m c j g using preprinted forms recorded study design characteristics exposure definitions cases controls prevalent incident case ascertainment total number cases exposed group total number cases unexposed group measure association odds ratio relative risk hazard ratio magnitude association corresponding num percent confidence interval variables adjusted analysis separate results reported within one study alzheimer disease dementia results dementia recorded varying levels nsaid use reported took results largest group nsaid users
0.29792902.15632261.html.plaintext.txt	13	statistical analysis results cohort studies typically expressed relative risk hazard ratio results case control studies usually expressed odds ratio hazard ratio ratio instantaneous probability outcome event alzheimer disease dementia cognitive decline exposed group compared nonexposed group considered relative risk dementia rare event num percent odds ratios case control studies also good estimates relative risk simplicity refer relative risk three types measures association logarithm relative risk corresponding standard error taken directly studies calculated reported num percent confidence interval provided data points meta analysis used dersimonian laird num random effects model compute pooled relative risks assess statistical heterogeneity exclude outliers simply basis statistical test heterogeneity expected meta analysis epidemiologic studies searched sources ie methodological biologic subgroup sensitivity analyses carried appropriate evaluated publication bias means visual inspection funnel plots formal statistical testing num funnel plot relative risk study displayed weight study inverse square standard error funnel plots generally show peak point studies smaller standard errors found usually represents point approximate true effect formal statistical assessment funnel plot asymmetry done linear regression analysis log odds ratio divided standard error regressed inverse standard error num reported p values intercept regression analysis provides measure asymmetry case control studies incident dementia cases cohort studies classified studies incident cases studies cognition main outcome interest among users nonusers nsaids classified studies cognitive decline cases
0.29792902.15632261.html.plaintext.txt	14	statistical analysis results cohort studies typically expressed relative risk hazard ratio results case control studies usually expressed odds ratio hazard ratio ratio instantaneous probability outcome event alzheimer disease dementia cognitive decline exposed group compared nonexposed group considered relative risk dementia rare event num percent odds ratios case control studies also good estimates relative risk simplicity refer relative risk three types measures association logarithm relative risk corresponding standard error taken directly studies calculated reported num percent confidence interval provided data points meta analysis used dersimonian laird num random effects model compute pooled relative risks assess statistical heterogeneity exclude outliers simply basis statistical test heterogeneity expected meta analysis epidemiologic studies searched sources ie methodological biologic subgroup sensitivity analyses carried appropriate evaluated publication bias means visual inspection funnel plots formal statistical testing num funnel plot relative risk study displayed weight study inverse square standard error funnel plots generally show peak point studies smaller standard errors found usually represents point approximate true effect formal statistical assessment funnel plot asymmetry done linear regression analysis log odds ratio divided standard error regressed inverse standard error num reported p values intercept regression analysis provides measure asymmetry case control studies incident dementia cases cohort studies classified studies incident cases studies cognition main outcome interest among users nonusers nsaids classified studies cognitive decline cases
0.29792902.15632261.html.plaintext.txt	15	results top abstract introduction materials methods results discussion references searching science citation index yielded num publications referring review mcgeer et al num medline search yielded num publications retrieval potential articles subsequent discussion found num studies meeting eligibility criteria num num four studies num num excluded relative risk could extracted report one study report association num two studies found association num num one study compared cognitive function patients alzheimer disease taking nsaids patients alzheimer disease taking nsaids num one study num excluded based data another publication descriptive details remaining num studies included meta analysis presented table num eleven studies used prevalent cases num num num studies used incident cases num num four studies used cognitive decline clinical outcome num num definition length exposure use nsaids varied among studies
0.29792902.15632261.html.plaintext.txt	16	results top abstract introduction materials methods results discussion references searching science citation index yielded num publications referring review mcgeer et al num medline search yielded num publications retrieval potential articles subsequent discussion found num studies meeting eligibility criteria num num four studies num num excluded relative risk could extracted report one study report association num two studies found association num num one study compared cognitive function patients alzheimer disease taking nsaids patients alzheimer disease taking nsaids num one study num excluded based data another publication descriptive details remaining num studies included meta analysis presented table num eleven studies used prevalent cases num num num studies used incident cases num num four studies used cognitive decline clinical outcome num num definition length exposure use nsaids varied among studies
0.29792902.15632261.html.plaintext.txt	17	view table table num description studies use nonsteroidal antiinflammatory drugs risk dementia table num presents individual relative risks num retrieved studies divided reports studies prevalent cases studies incident cases studies cognitive decline endpoint funnel plot figure num shows relative risks num studies plotted weights relative risk smaller one indicates use nsaids beneficial pooled relative risks three groups studies numnum num percent confidence interval ci numnum numnum studies prevalent dementia cases numnum num percent ci numnum numnum studies incident dementia cases numnum num percent ci numnum numnum studies cognitive decline endpoint within subgroups heterogeneity present studies prevalent cases p numnum studies incident cases p numnum statistical testing heterogeneity studies cognitive decline used endpoint gave p value numnum within three subgroups indication presence publication bias studies prevalent cases p numnum whereas indication studies incident cases p numnum studies cognitive decline used endpoint p numnum
0.29792902.15632261.html.plaintext.txt	18	view table figure num funnel plot relative risks num studies use nonsteroidal antiinflammatory drugs risk dementia weight study weight calculated inverse square standard error log relative risk
0.29792902.15632261.html.plaintext.txt	19	furthermore analyzed case control studies incident dementia cases cohort studies separately case control studies incident dementia cases gave pooled relative risk numnum num percent ci numnum numnum cohort studies gave pooled relative risk estimate numnum num percent ci numnum numnum
0.29792902.15632261.html.plaintext.txt	20	furthermore analyzed case control studies incident dementia cases cohort studies separately case control studies incident dementia cases gave pooled relative risk numnum num percent ci numnum numnum cohort studies gave pooled relative risk estimate numnum num percent ci numnum numnum
0.29792902.15632261.html.plaintext.txt	21	finally results randomized clinical trials evaluated efficacy nsaid placebo presented table num trials included patients alzheimer disease patients probable alzheimer disease none trials showed statistically significant reduction cognitive decline
0.29792902.15632261.html.plaintext.txt	22	finally results randomized clinical trials evaluated efficacy nsaid placebo presented table num trials included patients alzheimer disease patients probable alzheimer disease none trials showed statistically significant reduction cognitive decline
0.29792902.15632261.html.plaintext.txt	23	view table table num summary results placebo controlled trials use nonsteroidal antiinflammatory drugs alzheimer disease discussion top abstract introduction materials methods results discussion references results study indicate benefit nsaids preventing dementia cognitive impairment num percent studies prevalent dementia cases declined num percent studies incident dementia cases absent studies cognitive decline used endpoint
0.29792902.15632261.html.plaintext.txt	24	least three forms bias could explain benefit nsaids larger studies prevalent cases studies incident cases recall bias prescription bias publication bias first subjects studies prevalent cases impaired memory time study makes data collection cases controls likely different resulting recall bias second prescription bias occurs frequently studies prevalent cases demented patients reduced perception pain num num possibly leading reduced use nsaids moreover adverse effects nsaids physicians might less inclined prescribe nsaids demented subjects hence studies prevalent cases reduced intake nsaids might consequence dementia cause third apparent funnel plot studies prevalent cases heterogeneous skewed left follow studies resulting larger pooled estimates benefit nsaid use studies
0.29792902.15632261.html.plaintext.txt	25	least three forms bias could explain benefit nsaids larger studies prevalent cases studies incident cases recall bias prescription bias publication bias first subjects studies prevalent cases impaired memory time study makes data collection cases controls likely different resulting recall bias second prescription bias occurs frequently studies prevalent cases demented patients reduced perception pain num num possibly leading reduced use nsaids moreover adverse effects nsaids physicians might less inclined prescribe nsaids demented subjects hence studies prevalent cases reduced intake nsaids might consequence dementia cause third apparent funnel plot studies prevalent cases heterogeneous skewed left follow studies resulting larger pooled estimates benefit nsaid use studies
0.29792902.15632261.html.plaintext.txt	26	found difference relative risk case control studies incident dementia cases cohort studies although potential recall bias case control studies theoretically higher however total number num studies investigate presence recall bias rather small therefore interpretation absence significant difference two types design incident dementia cases interpreted caution
0.29792902.15632261.html.plaintext.txt	27	found difference relative risk case control studies incident dementia cases cohort studies although potential recall bias case control studies theoretically higher however total number num studies investigate presence recall bias rather small therefore interpretation absence significant difference two types design incident dementia cases interpreted caution
0.29792902.15632261.html.plaintext.txt	28	num studies incident cases dementia within num studies four case control studies incident dementia cases six cohort studies types study gave similar pooled estimate relative risk recall bias major form bias relative risk case control studies smaller however wide confidence intervals around estimates small number studies difficult ascertain whether studies truly equal estimates
0.29792902.15632261.html.plaintext.txt	29	num studies incident cases dementia within num studies four case control studies incident dementia cases six cohort studies types study gave similar pooled estimate relative risk recall bias major form bias relative risk case control studies smaller however wide confidence intervals around estimates small number studies difficult ascertain whether studies truly equal estimates
0.29792902.15632261.html.plaintext.txt	30	significant association nsaid use studies incident cases dementia significant association studies cognitive decline used outcome prescription bias might also cause difference incident subjects cognitive decline relatively free cognitive dysfunction baseline incident cases dementia relatively later stage disease earlier stages disease prescription bias might present explore whether prescription bias cause observed association nsaid use alzheimer disease whether true beneficial effect decided upon randomized clinical trials whose patients without early signs alzheimer disease num
0.29792902.15632261.html.plaintext.txt	31	significant association nsaid use studies incident cases dementia significant association studies cognitive decline used outcome prescription bias might also cause difference incident subjects cognitive decline relatively free cognitive dysfunction baseline incident cases dementia relatively later stage disease earlier stages disease prescription bias might present explore whether prescription bias cause observed association nsaid use alzheimer disease whether true beneficial effect decided upon randomized clinical trials whose patients without early signs alzheimer disease num
0.29792902.15632261.html.plaintext.txt	32	period nsaid use disease onset relatively short difficult differentiate cause effect short period exposure outcome reduced intake nsaids among subjects dementia could also consequence disease four studies num num num num tried avoid bias evaluating use acetaminophen control differing patterns drug use demented nondemented subjects many authors argued demented nondemented subjects differ acetaminophen use vary nsaid use nsaids must associated better cognitive function think however demented patients might report less pain nondemented subjects nsaids first drugs prescribed less frequently means studies prevalent cases likely suffer prescription bias studies incident cases
0.29792902.15632261.html.plaintext.txt	33	period nsaid use disease onset relatively short difficult differentiate cause effect short period exposure outcome reduced intake nsaids among subjects dementia could also consequence disease four studies num num num num tried avoid bias evaluating use acetaminophen control differing patterns drug use demented nondemented subjects many authors argued demented nondemented subjects differ acetaminophen use vary nsaid use nsaids must associated better cognitive function think however demented patients might report less pain nondemented subjects nsaids first drugs prescribed less frequently means studies prevalent cases likely suffer prescription bias studies incident cases
0.29792902.15632261.html.plaintext.txt	34	alzheimer disease common dementia insidious onset also important know different studies used index date studies prevalent cases took date diagnosis dementia three studies incident dementia cases took date first symptoms disease num num num seven studies incident dementia cases used date diagnosis dementia three studies date onset symptoms used similar relative risk estimates seven studies date diagnosis used
0.29792902.15632261.html.plaintext.txt	35	alzheimer disease common dementia insidious onset also important know different studies used index date studies prevalent cases took date diagnosis dementia three studies incident dementia cases took date first symptoms disease num num num seven studies incident dementia cases used date diagnosis dementia three studies date onset symptoms used similar relative risk estimates seven studies date diagnosis used
0.29792902.15632261.html.plaintext.txt	36	publications used meta analysis originate one cohort example canadian study health aging rotterdam study contributed two publications however cases one publication addressed association prevalent dementia cases publication addressed association incident dementia cases hence decided include articles analyses moreover study named established populations epidemiologic studies elderly consists four cohorts analyses used estimates reported separate cohorts study reported saag et al num uses data iowa cohort hanlon et al num use data duke cohort study reported rozzini et al num uses data east boston massachusetts new haven connecticut iowa cohorts discussing results rozzini et al indicate study saag et al substantially different measure cognitive functioning analytical approach making comparability study study problematic num p num including study rozzini et al analyses would overweighted data iowa cohort established populations epidemiologic studies elderly could chosen include study reported rozzini et al analyses instead study saag et al would resulted lower pooled relative risk however including study reported rozzini et al instead study saag et al affect interpretation data
0.29792902.15632261.html.plaintext.txt	37	publications used meta analysis originate one cohort example canadian study health aging rotterdam study contributed two publications however cases one publication addressed association prevalent dementia cases publication addressed association incident dementia cases hence decided include articles analyses moreover study named established populations epidemiologic studies elderly consists four cohorts analyses used estimates reported separate cohorts study reported saag et al num uses data iowa cohort hanlon et al num use data duke cohort study reported rozzini et al num uses data east boston massachusetts new haven connecticut iowa cohorts discussing results rozzini et al indicate study saag et al substantially different measure cognitive functioning analytical approach making comparability study study problematic num p num including study rozzini et al analyses would overweighted data iowa cohort established populations epidemiologic studies elderly could chosen include study reported rozzini et al analyses instead study saag et al would resulted lower pooled relative risk however including study reported rozzini et al instead study saag et al affect interpretation data
0.29792902.15632261.html.plaintext.txt	38	five studies used cognitive decline endpoint used different cognitive measures hence exclude nsaids might beneficial effect specific cognitive domain however average effect use nsaids cognitive decline null consistent finding randomized trials far shown beneficial effect course dementia measured cognitive subscale alzheimer disease assessment scale moreover two studies excluded meta analysis num num relative risk could extracted showed association use nsaid cognitive decline
0.29792902.15632261.html.plaintext.txt	39	five studies used cognitive decline endpoint used different cognitive measures hence exclude nsaids might beneficial effect specific cognitive domain however average effect use nsaids cognitive decline null consistent finding randomized trials far shown beneficial effect course dementia measured cognitive subscale alzheimer disease assessment scale moreover two studies excluded meta analysis num num relative risk could extracted showed association use nsaid cognitive decline
0.29792902.15632261.html.plaintext.txt	40	recent meta analysis nsaids risk dementia concluded nsaids offer protection development alzheimer disease num p num conclusion based mainly observation short term users num month far less risk reduction long term users num months relative risk numnum vs numnum respectively authors address possible confounding factors num explain discrepancy studies prevalent cases studies incident cases discrepancy risk reduction short term long term users well explained recall bias prescription bias including studies cognitive decline endpoint thereby creating distance exposure effect demonstrate bias confounding likely explanations observed association
0.29792902.15632261.html.plaintext.txt	41	traditional teaching holds alzheimer disease vascular dementia two separate clinical entities differentiated careful clinical necropsy evaluation several recent observations however suggest situation might different vascular risk factors also contribute alzheimer disease num conversely ss amyloid depositions also frequently found subjects vascular dementia num hence likely alzheimer disease vascular dementia two extreme expressions one disease entity dementia num prominent feature disease entities progressive cognitive decline hence combining comparing various endpoints one analysis gives good indication possible benefits nsaids various stages disease
0.29792902.15632261.html.plaintext.txt	42	traditional teaching holds alzheimer disease vascular dementia two separate clinical entities differentiated careful clinical necropsy evaluation several recent observations however suggest situation might different vascular risk factors also contribute alzheimer disease num conversely ss amyloid depositions also frequently found subjects vascular dementia num hence likely alzheimer disease vascular dementia two extreme expressions one disease entity dementia num prominent feature disease entities progressive cognitive decline hence combining comparing various endpoints one analysis gives good indication possible benefits nsaids various stages disease
0.29792902.15632261.html.plaintext.txt	43	randomized clinical trials found beneficial effect nsaids preventing cognitive decline num num might three explanations negative studies first protective effect nsaids second studies carried subjects early signs cognitive impairment administration antiinflammatory drugs point disease process might simply late third recently demonstrated various nsaids differential propensities inflammatory response deposition ss amyloid num finding calls identification critical pathways inflammatory response corresponding drugs capable interfering pathway
0.29792902.15632261.html.plaintext.txt	44	randomized clinical trials found beneficial effect nsaids preventing cognitive decline num num might three explanations negative studies first protective effect nsaids second studies carried subjects early signs cognitive impairment administration antiinflammatory drugs point disease process might simply late third recently demonstrated various nsaids differential propensities inflammatory response deposition ss amyloid num finding calls identification critical pathways inflammatory response corresponding drugs capable interfering pathway
0.29792902.15632261.html.plaintext.txt	45	conclusion benefit nsaids preventing dementia cognitive impairment num percent studies prevalent dementia cases declined num percent studies incident dementia cases absent studies cognitive decline used endpoint indicates beneficial effects nsaids observational studies likely result recall bias prescription bias publication bias large costly trials designed assess potential protective effects nsaids specific critical pathways inflammatory process dementia amendable drug intervention identified
0.29792902.15632261.html.plaintext.txt	46	conclusion benefit nsaids preventing dementia cognitive impairment num percent studies prevalent dementia cases declined num percent studies incident dementia cases absent studies cognitive decline used endpoint indicates beneficial effects nsaids observational studies likely result recall bias prescription bias publication bias large costly trials designed assess potential protective effects nsaids specific critical pathways inflammatory process dementia amendable drug intervention identified
0.29792902.15632261.html.plaintext.txt	47	notes correspondence dr j m de craen section gerontology geriatrics symb r leiden university medical center po box num leiden num rc netherlands e mail craenatlumcnl u d
0.29792902.15632261.html.plaintext.txt	48	references top abstract introduction materials methods results discussion references mackenzie ira munoz dg nonsteroidal anti inflammatory drug use alzheimer type pathology aging neurology numnumnum numabstract may fe moore mt stewart rb et al lack association nonsteroidal anti inflammatory drug use cognitive decline elderly gerontology numnumnum numisimedline prince m rabe hesketh brennan p antiarthritic drugs decrease risk cognitive decline neurology numnumnum numabstract rich jb rasmusson dx folstein mf et al nonsteroidal anti inflammatory drugs alzheimer disease neurology numnumnum numabstract rozzini r ferrucci l losonczy k et al protective effect chronic nsaid use cognitive decline older persons j geriatr soc numnumnum numisimedline mcgeer pl harada n kimura h et al prevalence dementia amongst elderly japanese leprosy apparent effect chronic drug therapy dementia numnumnum numisi breitner jcs gau ba welsh ka et al inverse association anti inflammatory treatments alzheimer disease initial results co twin control study neurology numnumnum numabstract canadian study health aging risk factors alzheimer disease canada neurology numnumnum numabstract lucca u tettamanti m forloni g et al nonsteroidal antiinflammatory drug use alzheimer disease biol psychiatry numnumnum numcrossrefisimedline andersen k launer lj ott et al nonsteroidal anti inflammatory drugs decrease risk alzheimer disease rotterdam study neurology numnumnum numabstract breitner jcs welsh ka helms mj et al delayed onset alzheimer disease nonsteroidal anti inflammatory histamine symb blocking drugs neurobiol aging numnumnum numcrossrefisimedline endoh m kunishita tabira effect anti leprosy drugs prevention alzheimer disease ss amyloid neurotoxicity j neurol sci numnumnum numcrossrefisimedline anthony jc breitner jcs zandi pp et al reduced prevalence ad users nsaids symb receptor antagonists neurology numnumnum numabstractfree full text broe ga grayson da creasey hm et al anti inflammatory drugs protect alzheimer disease low doses arch neurol numnumnum numabstractfree full text landi f cesari m onder g et al non steroidal anti inflammatory drug nsaid use alzheimer disease community dwelling elderly patients j geriatr psychiatry numnumnum numabstractfree full text nilsson se johansson b takkinen et al aspirin protect alzheimer dementia study swedish population based sample aged num years eur j clin pharmacol numnumnum numcrossref kukull wa larson eb stergachis et al non steroidal anti inflammatory drug use risk alzheimer disease abstract neurology numnumsuppl numsymb fourrier letenneur l begaud b et al nonsteroidal antiinflammatory drug use cognitive function elderly inconclusive results population based cohort study j clin epidemiol numnumnumcrossrefisimedline henderson jorm af christensen h et al aspirin anti inflammatory drugs risk dementia int j geriat psychiatry numnumnum numnumnumconum y disease duration nsaid use neurology numnumnum numabstract beard cm waring sc o brien pc et al nonsteroidal anti inflammatory drug use alzheimer disease case control study rochester minnesota num num mayo clin proc numnumnum numisimedline cornelius c fratiglioni l fastbom j et al support protective effect nsaids alzheimer disease follow population based study abstract neurobiol aging numnumsuppl numsymb veld ba ruitenberg hofman et al nonsteroidal antiinflammatory drugs risk alzheimer disease n engl j med numnumnum numabstractfree full text wolfson c perrault moride et al case control analysis nonsteroidal anti inflammatory drugs alzheimer disease protective neuroepidemiology numnumnum numcrossrefisimedline lindsay j laurin d verreault r et al risk factors alzheimer disease prospective analysis canadian study health aging j epidemiol numnumnum numabstractfree full text zandi pp anthony jc hayden km et al reduced incidence ad nsaid symb receptor antgonists cache county study neurology numnumnum numabstractfree full text saag kg rubenstein lm chrischilles ea et al nonsteroidal antiinflammatory drugs cognitive decline elderly j rheumatol numnumnum numisimedline hanlon jt schmader ke landerman lr et al relation prescription nonsteroidal antiinflammatory drug use cognitive function among community dwelling elderly ann epidemiol numnumnum numcrossrefisimedline jonker c comijs hc smit jh aspirin nsaids reduce risk cognitive decline elderly persons results form population based study neurobiol aging numnumnum numcrossrefisimedline hee kang j grodstein f regular use nonsteroidal anti inflammatory drugs cognitive function aging women neurology numnumnum numabstractfree full text scharf mander ugoni et al double blind placebo controlled trial diclofenacmisoprostol alzheimer disease neurology numnumnum numabstractfree full text aisen p schmeidler j pasinetti gm randomized pilot study nimesulide treatment alzheimer disease neurology numnumnum numabstractfree full text aisen ps schafer ka grundman m et al effects rofecoxib naproxen vs placebo alzheimer disease progression randomized controlled trial jama numnumnum numabstractfree full text helmuth l nsaids prevention protecting brain killing pain science numnumnum numabstractfree full text mcgeer pl schulzer m mcgeer eg arthritis anti inflammatory agents possible protective factors alzheimer disease review num epidemiologic studies neurology numnumnum numabstract dersimonian r laird n meta analysis clinical trials control clin trials numnumnum numcrossrefisimedline egger m davey smith g schneider m et al bias meta analysis detected simple graphical test bmj numnumnum numabstractfree full text benedetti f vighetti ricco c et al pain threshold tolerance alzheimer disease pain numnumnum numcrossrefisimedline scherder e bouma slaets j et al repeated pain assessment alzheimer disease dement geriatr cogn disord numnumnum numcrossrefisimedline martin bk meinert cl breitner jc et al double placebo design prevention trial alzheimer disease control clin trials numnumnum numcrossrefisimedline etminan m gill samii effect non steroidal anti inflammatory drugs risk alzheimer disease systematic review meta analysis observational studies bmj numnumnum numabstractfree full text robertson m effect nsaids risk alzheimer disease confounding factors discussed letter bmj numnumnumfree full text haan m shemanski l jagust wj et al predictors cognitive change cardiovascular health study role cardiovascular genetic risk factors jama numnumnum numabstractfree full text ince pg pathological correlates late onset dementia multicentre community based population england wales neuropathology group medical research council cognitive function ageing study mrc cfas lancet numnumnum numcrossrefisimedline kalaria rn role cerebral ischemia alzheimer disease neurobiol aging numnumnum numcrossrefisimedline weggen eriksen jl das p et al subset nsaids lower amyloidogenic symb independently cyclooxygenase activity nature numnumnum numcrossrefisimedline article abstract free full text pdf alert article cited alert correction posted services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal add personal archive download citation manager search citing articles isi web science num disclaimer request permissions google scholar articles de craen j m articles westendorp r g j pubmed pubmed citation articles de craen j m articles westendorp r g j online issn num num print issn num num copyright num johns hopkins bloomberg school public health oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.29792902.15632261.html.plaintext.txt	49	references top abstract introduction materials methods results discussion references mackenzie ira munoz dg nonsteroidal anti inflammatory drug use alzheimer type pathology aging neurology numnumnum numabstract may fe moore mt stewart rb et al lack association nonsteroidal anti inflammatory drug use cognitive decline elderly gerontology numnumnum numisimedline prince m rabe hesketh brennan p antiarthritic drugs decrease risk cognitive decline neurology numnumnum numabstract rich jb rasmusson dx folstein mf et al nonsteroidal anti inflammatory drugs alzheimer disease neurology numnumnum numabstract rozzini r ferrucci l losonczy k et al protective effect chronic nsaid use cognitive decline older persons j geriatr soc numnumnum numisimedline mcgeer pl harada n kimura h et al prevalence dementia amongst elderly japanese leprosy apparent effect chronic drug therapy dementia numnumnum numisi breitner jcs gau ba welsh ka et al inverse association anti inflammatory treatments alzheimer disease initial results co twin control study neurology numnumnum numabstract canadian study health aging risk factors alzheimer disease canada neurology numnumnum numabstract lucca u tettamanti m forloni g et al nonsteroidal antiinflammatory drug use alzheimer disease biol psychiatry numnumnum numcrossrefisimedline andersen k launer lj ott et al nonsteroidal anti inflammatory drugs decrease risk alzheimer disease rotterdam study neurology numnumnum numabstract breitner jcs welsh ka helms mj et al delayed onset alzheimer disease nonsteroidal anti inflammatory histamine symb blocking drugs neurobiol aging numnumnum numcrossrefisimedline endoh m kunishita tabira effect anti leprosy drugs prevention alzheimer disease ss amyloid neurotoxicity j neurol sci numnumnum numcrossrefisimedline anthony jc breitner jcs zandi pp et al reduced prevalence ad users nsaids symb receptor antagonists neurology numnumnum numabstractfree full text broe ga grayson da creasey hm et al anti inflammatory drugs protect alzheimer disease low doses arch neurol numnumnum numabstractfree full text landi f cesari m onder g et al non steroidal anti inflammatory drug nsaid use alzheimer disease community dwelling elderly patients j geriatr psychiatry numnumnum numabstractfree full text nilsson se johansson b takkinen et al aspirin protect alzheimer dementia study swedish population based sample aged num years eur j clin pharmacol numnumnum numcrossref kukull wa larson eb stergachis et al non steroidal anti inflammatory drug use risk alzheimer disease abstract neurology numnumsuppl numsymb fourrier letenneur l begaud b et al nonsteroidal antiinflammatory drug use cognitive function elderly inconclusive results population based cohort study j clin epidemiol numnumnumcrossrefisimedline henderson jorm af christensen h et al aspirin anti inflammatory drugs risk dementia int j geriat psychiatry numnumnum numnumnumconum y disease duration nsaid use neurology numnumnum numabstract beard cm waring sc o brien pc et al nonsteroidal anti inflammatory drug use alzheimer disease case control study rochester minnesota num num mayo clin proc numnumnum numisimedline cornelius c fratiglioni l fastbom j et al support protective effect nsaids alzheimer disease follow population based study abstract neurobiol aging numnumsuppl numsymb veld ba ruitenberg hofman et al nonsteroidal antiinflammatory drugs risk alzheimer disease n engl j med numnumnum numabstractfree full text wolfson c perrault moride et al case control analysis nonsteroidal anti inflammatory drugs alzheimer disease protective neuroepidemiology numnumnum numcrossrefisimedline lindsay j laurin d verreault r et al risk factors alzheimer disease prospective analysis canadian study health aging j epidemiol numnumnum numabstractfree full text zandi pp anthony jc hayden km et al reduced incidence ad nsaid symb receptor antgonists cache county study neurology numnumnum numabstractfree full text saag kg rubenstein lm chrischilles ea et al nonsteroidal antiinflammatory drugs cognitive decline elderly j rheumatol numnumnum numisimedline hanlon jt schmader ke landerman lr et al relation prescription nonsteroidal antiinflammatory drug use cognitive function among community dwelling elderly ann epidemiol numnumnum numcrossrefisimedline jonker c comijs hc smit jh aspirin nsaids reduce risk cognitive decline elderly persons results form population based study neurobiol aging numnumnum numcrossrefisimedline hee kang j grodstein f regular use nonsteroidal anti inflammatory drugs cognitive function aging women neurology numnumnum numabstractfree full text scharf mander ugoni et al double blind placebo controlled trial diclofenacmisoprostol alzheimer disease neurology numnumnum numabstractfree full text aisen p schmeidler j pasinetti gm randomized pilot study nimesulide treatment alzheimer disease neurology numnumnum numabstractfree full text aisen ps schafer ka grundman m et al effects rofecoxib naproxen vs placebo alzheimer disease progression randomized controlled trial jama numnumnum numabstractfree full text helmuth l nsaids prevention protecting brain killing pain science numnumnum numabstractfree full text mcgeer pl schulzer m mcgeer eg arthritis anti inflammatory agents possible protective factors alzheimer disease review num epidemiologic studies neurology numnumnum numabstract dersimonian r laird n meta analysis clinical trials control clin trials numnumnum numcrossrefisimedline egger m davey smith g schneider m et al bias meta analysis detected simple graphical test bmj numnumnum numabstractfree full text benedetti f vighetti ricco c et al pain threshold tolerance alzheimer disease pain numnumnum numcrossrefisimedline scherder e bouma slaets j et al repeated pain assessment alzheimer disease dement geriatr cogn disord numnumnum numcrossrefisimedline martin bk meinert cl breitner jc et al double placebo design prevention trial alzheimer disease control clin trials numnumnum numcrossrefisimedline etminan m gill samii effect non steroidal anti inflammatory drugs risk alzheimer disease systematic review meta analysis observational studies bmj numnumnum numabstractfree full text robertson m effect nsaids risk alzheimer disease confounding factors discussed letter bmj numnumnumfree full text haan m shemanski l jagust wj et al predictors cognitive change cardiovascular health study role cardiovascular genetic risk factors jama numnumnum numabstractfree full text ince pg pathological correlates late onset dementia multicentre community based population england wales neuropathology group medical research council cognitive function ageing study mrc cfas lancet numnumnum numcrossrefisimedline kalaria rn role cerebral ischemia alzheimer disease neurobiol aging numnumnum numcrossrefisimedline weggen eriksen jl das p et al subset nsaids lower amyloidogenic symb independently cyclooxygenase activity nature numnumnum numcrossrefisimedline article abstract free full text pdf alert article cited alert correction posted services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal add personal archive download citation manager search citing articles isi web science num disclaimer request permissions google scholar articles de craen j m articles westendorp r g j pubmed pubmed citation articles de craen j m articles westendorp r g j online issn num num print issn num num copyright num johns hopkins bloomberg school public health oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.3005403.12566388.html.plaintext.txt	0	identification multiple loci alzheimer disease consanguineous israeli arab community lindsay symbnumnumnumnum abdalla symb robert p symb kristin symb amos d symb clinton symbnum
0.3005403.12566388.html.plaintext.txt	1	identification multiple loci alzheimer disease consanguineous israeli arab community lindsay symbnumnumnumnum abdalla symb robert p symb kristin symb amos d symb clinton symbnum
0.3005403.12566388.html.plaintext.txt	2	numdepartment medicine genetics program numdepartment neurology numdepartment genetics genomics numdepartment epidemiology numdepartment biostatistics numcenter human genetics boston university schools medicine public health boston ma num usa numdepartment neurology case western reserve university cleveland oh num usa numdepartment neurology tel aviv university tel aviv israel
0.3005403.12566388.html.plaintext.txt	3	received october num num accepted december num num
0.3005403.12566388.html.plaintext.txt	4	abstract top abstract introduction results discussion materials methods references observed unusually high prevalence dementia alzheimer type dat wadi ara inbred arab community northern israel comprising num persons age num years family studies revealed one third dat cases members one hamula tribal group within wadi ara map chromosomal loci contributing dat susceptibility conducted num cm scan series five cases five controls selected hamula markers num chromosomal regions showed significant allelic association dat p numnum locations chromosomes num num num remained significant testing additional affected non demented individuals significant associations also observed markers chromosome num overlap locus implicated previous genome scans analysis allele frequency distributions num markers spanning num cm chromosome num narrowed possible location dat susceptibility gene num cm interval symbnum symbnum significant result pnumnumsymb num analysis num markers spanning num cm chromosome num narrowed possible location num cm interval distal symb locus significant result pnumnumsymb num evidence linkage chromosome num stemmed primarily excess homozygosity marker alleles cases compared controls suggesting gene location behaves either recessive additive fashion unique characteristics community together emergent human genome data allow rapid identification dat genes candidate regions
0.3005403.12566388.html.plaintext.txt	5	abstract top abstract introduction results discussion materials methods references observed unusually high prevalence dementia alzheimer type dat wadi ara inbred arab community northern israel comprising num persons age num years family studies revealed one third dat cases members one hamula tribal group within wadi ara map chromosomal loci contributing dat susceptibility conducted num cm scan series five cases five controls selected hamula markers num chromosomal regions showed significant allelic association dat p numnum locations chromosomes num num num remained significant testing additional affected non demented individuals significant associations also observed markers chromosome num overlap locus implicated previous genome scans analysis allele frequency distributions num markers spanning num cm chromosome num narrowed possible location dat susceptibility gene num cm interval symbnum symbnum significant result pnumnumsymb num analysis num markers spanning num cm chromosome num narrowed possible location num cm interval distal symb locus significant result pnumnumsymb num evidence linkage chromosome num stemmed primarily excess homozygosity marker alleles cases compared controls suggesting gene location behaves either recessive additive fashion unique characteristics community together emergent human genome data allow rapid identification dat genes candidate regions
0.3005403.12566388.html.plaintext.txt	6	introduction top abstract introduction results discussion materials methods references alzheimers disease ad progressive neurodegenerative disease characterized memory loss language deterioration impaired visuo spatial skills poor judgment neuropathologically extracellular amyloid plaque deposition intra neuronal neurofibrillary tangles neuronal loss ad usually begins age num however onset may occur early age num early onset forms disease appear strong genetic component mutations several genes identified including amyloid precursor gene app num presenilin num symb num presenilin num symb num
0.3005403.12566388.html.plaintext.txt	7	introduction top abstract introduction results discussion materials methods references alzheimers disease ad progressive neurodegenerative disease characterized memory loss language deterioration impaired visuo spatial skills poor judgment neuropathologically extracellular amyloid plaque deposition intra neuronal neurofibrillary tangles neuronal loss ad usually begins age num however onset may occur early age num early onset forms disease appear strong genetic component mutations several genes identified including amyloid precursor gene app num presenilin num symb num presenilin num symb num
0.3005403.12566388.html.plaintext.txt	8	basis common late onset form ad less well understood genetic risk factor highest attributable risk ad num allele apoe gene chromosome numq num among caucasians odds ad num homozygotes numnum heterozygotes numnum numnum respectively greater associated num homozygotes num many genes studied possible role gene products disease proximity known ad loci evidence implicating susceptibility genes much less compelling associations reported fewer num genes numnum yet none clearly established ad risk factor linkage studies implicated regions chromosomes num num num num num num num num candidate genes regions include insulin degrading enzyme ide chromosome num num macroglobulin symb low density lipoprotein receptor related gene symb chromosome num numnumnum although none proven ad gene num num
0.3005403.12566388.html.plaintext.txt	9	basis common late onset form ad less well understood genetic risk factor highest attributable risk ad num allele apoe gene chromosome numq num among caucasians odds ad num homozygotes numnum heterozygotes numnum numnum respectively greater associated num homozygotes num many genes studied possible role gene products disease proximity known ad loci evidence implicating susceptibility genes much less compelling associations reported fewer num genes numnum yet none clearly established ad risk factor linkage studies implicated regions chromosomes num num num num num num num num candidate genes regions include insulin degrading enzyme ide chromosome num num macroglobulin symb low density lipoprotein receptor related gene symb chromosome num numnumnum although none proven ad gene num num
0.3005403.12566388.html.plaintext.txt	10	report examined genetic basis dementia alzheimer type dat unique community population based study screened residents ages num years older nnum wadi ara arab community near tel aviv northern israel observed prevalence higher found israel china europe usa even adjustment age education gender numnum unusually high prevalence apparently due increased frequency apoe num allele actually reduced community numnum non demented elders compared caucasians num hypothesized increased prevalence dat wadi ara associated limited number unique susceptibility alleles whose frequency enriched inbreeding current residents wadi ara members num hamulas family groups recently minimal immigration emigration community designed carried efficient num cm genome scan exploiting unique population structure results study confirm existence dat loci chromosomes num num num provide evidence new dat locus chromosome num
0.3005403.12566388.html.plaintext.txt	11	report examined genetic basis dementia alzheimer type dat unique community population based study screened residents ages num years older nnum wadi ara arab community near tel aviv northern israel observed prevalence higher found israel china europe usa even adjustment age education gender numnum unusually high prevalence apparently due increased frequency apoe num allele actually reduced community numnum non demented elders compared caucasians num hypothesized increased prevalence dat wadi ara associated limited number unique susceptibility alleles whose frequency enriched inbreeding current residents wadi ara members num hamulas family groups recently minimal immigration emigration community designed carried efficient num cm genome scan exploiting unique population structure results study confirm existence dat loci chromosomes num num num provide evidence new dat locus chromosome num
0.3005403.12566388.html.plaintext.txt	12	results top abstract introduction results discussion materials methods references genome scan high prevalence dat wadi ara may course explained environmental genetic factors genetic hypothesis bolstered examination num pedigrees showing smaller number surnames families containing dat cases without dat cases fact one third num prevalent dat cases one num hamulas despite large concentration dat cases hamula individual pedigrees contained one living affected member therefore traditional family based linkage study approaches feasible however given high degree inbreeding wadi ara evidenced frequent first cousin second cousin marriages limited number founders reasoned prevalent dat susceptibility alleles may identical descent therefore frequency distributions alleles genotypes markers linked dat locus would differ dat cases controls num cm genome scan conducted genotyping num markers abi genome scan panel dnas five dat cases ages num num years five non demented controls ages num num years different families hamula highest disease prevalence markers num linkage regions num different chromosomes showed significant difference allele frequency distribution dat cases controls table num many instances difference attributable specific allele evidence either excess marker homozygosity cases compared controls association genotype level
0.3005403.12566388.html.plaintext.txt	13	results top abstract introduction results discussion materials methods references genome scan high prevalence dat wadi ara may course explained environmental genetic factors genetic hypothesis bolstered examination num pedigrees showing smaller number surnames families containing dat cases without dat cases fact one third num prevalent dat cases one num hamulas despite large concentration dat cases hamula individual pedigrees contained one living affected member therefore traditional family based linkage study approaches feasible however given high degree inbreeding wadi ara evidenced frequent first cousin second cousin marriages limited number founders reasoned prevalent dat susceptibility alleles may identical descent therefore frequency distributions alleles genotypes markers linked dat locus would differ dat cases controls num cm genome scan conducted genotyping num markers abi genome scan panel dnas five dat cases ages num num years five non demented controls ages num num years different families hamula highest disease prevalence markers num linkage regions num different chromosomes showed significant difference allele frequency distribution dat cases controls table num many instances difference attributable specific allele evidence either excess marker homozygosity cases compared controls association genotype level
0.3005403.12566388.html.plaintext.txt	14	view table table num markers showing association ad genome wide scan follow studies markers whose allele frequency distribution differed significantly p numnum cases controls genotyped enlarged sample num dat cases num controls selected entire cohort results remained significant enlarged sample pursued analysis additional markers flanking positive signals significant allelic association remained locations chromosomes num num num fig num also genotyped several markers region chromosome num implicated linkage studies numnumnumnum genome scan evidence allelic association also found location fig num
0.3005403.12566388.html.plaintext.txt	15	view larger version numk figure num association ad markers chromosomes num num num num allelic association test results plotted significance levels expressed log scale
0.3005403.12566388.html.plaintext.txt	16	view larger version numk figure num association ad markers chromosomes num num num num allelic association test results plotted significance levels expressed log scale
0.3005403.12566388.html.plaintext.txt	17	region showing association chromosome num numnum cm interval symbnum symbnum significant allelic distribution difference observed symbnum global pnumnum position numnum see fig num genotype level remarkable difference found symbnum located num cm away marker num dat cases num controls carriers num bp allele pnumnum
0.3005403.12566388.html.plaintext.txt	18	region showing association chromosome num numnum cm interval symbnum symbnum significant allelic distribution difference observed symbnum global pnumnum position numnum see fig num genotype level remarkable difference found symbnum located num cm away marker num dat cases num controls carriers num bp allele pnumnum
0.3005403.12566388.html.plaintext.txt	19	chromosome num significant allelic association observed four markers located interval num num cm fig num associations three markers symbnum symbnum symbnum due representation specific allele examination revealed significant excess homozygosity marker alleles marker allele symbnum dat cases compared non demented subjects table num observation alleles sizes num bp greater numnum dat cases none controls contributed highly significant association symbnum pnumnumsymb num
0.3005403.12566388.html.plaintext.txt	20	view table table num evidence additive recessive ad locus chromosome num taking account results genome scan previous linkage studies evaluated intensively num cm interval chromosome num fig num although significant allelic associations observed markers located separate linkage groups eg symbnum num cm pnumnum symbnum numnum cm p numnum symbnum numnum cm pnumnum conservative conclusion dat susceptibility gene located interval num cm numnum cm contains four contiguous markers symbnum symbnum symbnum symbnum showing evidence allelic association fig num genotypic association involving carriers associated allele data shown concomitant allelic genotypic association observed two chromosome num markers symbnum symbnum
0.3005403.12566388.html.plaintext.txt	21	genotyping efforts chromosome num focused region near distal symb implicated linkage association studies outbred populations numnumnum whereas association evident among markers within num cm symb six markers num num cm distal symb associated dat population fig num allele num symbnum present num dat cases num controls pnumnum three alleles numnumnum symbnum accounted num dat chromosomes absent controls pnumnumsymb num allele num symbnum significantly represented pnumnum chromosomes dat cases num compared controls num
0.3005403.12566388.html.plaintext.txt	22	genotyping efforts chromosome num focused region near distal symb implicated linkage association studies outbred populations numnumnum whereas association evident among markers within num cm symb six markers num num cm distal symb associated dat population fig num allele num symbnum present num dat cases num controls pnumnum three alleles numnumnum symbnum accounted num dat chromosomes absent controls pnumnumsymb num allele num symbnum significantly represented pnumnum chromosomes dat cases num compared controls num
0.3005403.12566388.html.plaintext.txt	23	discussion top abstract introduction results discussion materials methods references designed unconventional num cm genome scan identify loci dat highly inbred israeli arab community highest known prevalence dat world num history region suggests residents community descendants small number founder individuals since remained relatively closed society high degree consanguinity num distantly related individuals five dat cases five non demented controls one extended kindred genotyped approach efficient economical relying course assumption genes contributing dat wadi ara identical descent prevalent among affected members genome scan num microsatellite markers revealed evidence association p numnum num locations however testing additional markers larger number people association chromosomes num num num remained
0.3005403.12566388.html.plaintext.txt	24	discussion top abstract introduction results discussion materials methods references designed unconventional num cm genome scan identify loci dat highly inbred israeli arab community highest known prevalence dat world num history region suggests residents community descendants small number founder individuals since remained relatively closed society high degree consanguinity num distantly related individuals five dat cases five non demented controls one extended kindred genotyped approach efficient economical relying course assumption genes contributing dat wadi ara identical descent prevalent among affected members genome scan num microsatellite markers revealed evidence association p numnum num locations however testing additional markers larger number people association chromosomes num num num remained
0.3005403.12566388.html.plaintext.txt	25	arguably strategy genome scan high false negative rate failed detect dat locus chromosome num motivated linkage findings previous studies outbred populations genotyped many closely spaced markers region adjacent distal symb observed significant association dat careful inspection results genome scan revealed two markers flanking linked region symbnum numnum cm symbnum numnum cm failed show association genome scan follow fig num unfortunately genotyping assay one marker interval symbnum numnum cm yielded significant result follow analysis failed genome scan thus accounting false negative result locus large number alleles per locus table num may increased false negative rate observations illustrate potentially serious limitation num cm genome scan using subjects nonetheless strategy successfully detected loci chromosomes num num num
0.3005403.12566388.html.plaintext.txt	26	arguably strategy genome scan high false negative rate failed detect dat locus chromosome num motivated linkage findings previous studies outbred populations genotyped many closely spaced markers region adjacent distal symb observed significant association dat careful inspection results genome scan revealed two markers flanking linked region symbnum numnum cm symbnum numnum cm failed show association genome scan follow fig num unfortunately genotyping assay one marker interval symbnum numnum cm yielded significant result follow analysis failed genome scan thus accounting false negative result locus large number alleles per locus table num may increased false negative rate observations illustrate potentially serious limitation num cm genome scan using subjects nonetheless strategy successfully detected loci chromosomes num num num
0.3005403.12566388.html.plaintext.txt	27	view table table num polymorphism characteristics among markers regions showing linkage results study attest utility genetic isolates including region middle east num num mapping genes responsible disease susceptibility outbred caucasian populations strategy evaluating linkage disequilibrium microsatellite marker alleles dat differs traditional linkage approaches genetic isolates several respects first focused efforts regions identified genome scan including num individuals second dat patients current cohort purportedly descendants num founder matings members distinct pedigrees gene mapping designs rely linkage family based association approaches num num thus suitable situation relationships individuals sample distant unclear third although efficacy linkage disequilibrium mapping isolated founder populations recessive traits demonstrated hastbacka colleagues num efficacy approach proven complex traits notably allele frequency dependent homozygosity mapping method enabled localization gene recessive deafness bali using num affected individuals num require evaluation dna parents thus perhaps well suited wadi ara population however effectively limited recessive traits
0.3005403.12566388.html.plaintext.txt	28	four chromosomal regions implicated study reported previously suggesting may authentic loci rather chance findings marker chromosome num showing significant association dat symbnum located num num cm two markers showing linkage disequilibrium case control sample finland num chromosome num location overlaps peaks observed two studies overlapping data sets numnum chromosome num location several studies numnumnumnum detected evidence association chromosome num population precise region num num cm distal linkage peaks observed others num numnumnum thus unclear region identified chromosome num reported studies
0.3005403.12566388.html.plaintext.txt	29	four chromosomal regions implicated study reported previously suggesting may authentic loci rather chance findings marker chromosome num showing significant association dat symbnum located num num cm two markers showing linkage disequilibrium case control sample finland num chromosome num location overlaps peaks observed two studies overlapping data sets numnum chromosome num location several studies numnumnumnum detected evidence association chromosome num population precise region num num cm distal linkage peaks observed others num numnumnum thus unclear region identified chromosome num reported studies
0.3005403.12566388.html.plaintext.txt	30	multiple markers tested chromosomes num num num num findings reconsidered transforming p values significant result location lod scores z according guidelines interpreting linkage results num locations chromosomes num num highly significant znumnum numnum respectively chromosome num locus certainly suggestive linkage znumnum significant result chromosome num znumnum falls cutoff numnum proposed suggestive linkage however finding would still considered significant replicates prior linkage finding num
0.3005403.12566388.html.plaintext.txt	31	multiple markers tested chromosomes num num num num findings reconsidered transforming p values significant result location lod scores z according guidelines interpreting linkage results num locations chromosomes num num highly significant znumnum numnum respectively chromosome num locus certainly suggestive linkage znumnum significant result chromosome num znumnum falls cutoff numnum proposed suggestive linkage however finding would still considered significant replicates prior linkage finding num
0.3005403.12566388.html.plaintext.txt	32	identification multiple loci genetic isolate unexpected one loci might represent false positive result although discussed four loci correspond approximate locations identified studies populations likely explanation unfortunate aggregation multiple susceptibility loci single community heterogeneity consistent remarkably high prevalence dat wadi ara num alternatively high prevalence dat explained oligogenic mode transmission requiring coincident inheritance susceptibility alleles multiple loci discrimination among hypotheses require simultaneous examination marker haplotypes preferably actual susceptibility alleles locus groups affected non demented individuals
0.3005403.12566388.html.plaintext.txt	33	identification multiple loci genetic isolate unexpected one loci might represent false positive result although discussed four loci correspond approximate locations identified studies populations likely explanation unfortunate aggregation multiple susceptibility loci single community heterogeneity consistent remarkably high prevalence dat wadi ara num alternatively high prevalence dat explained oligogenic mode transmission requiring coincident inheritance susceptibility alleles multiple loci discrimination among hypotheses require simultaneous examination marker haplotypes preferably actual susceptibility alleles locus groups affected non demented individuals
0.3005403.12566388.html.plaintext.txt	34	wadi ara one highest prevalence rates dat world num low frequency apoe num allele non demented individuals numnum dat cases numnum indicates genetic basis disorder population due entirely loci num low impact apoe ad risk reported yoruba living nigeria baseline frequency num num incidence ad low numnum contrast pericak vance colleagues observed apoe numnum genotype among ad cases amish inbred religious sect num however amish lower prevalence dementia wadi ara even outbred caucasian populations european origin non genetic factors including diet low levels education physical activity may also partly responsible high prevalence disease wadi ara num
0.3005403.12566388.html.plaintext.txt	35	surprised high degree marker polymorphism suggesting might greater degree admixture populations predicted see table num alternatively large number alleles may due relative instability microsatellilte markers generation generation interestingly substantial marker polymorphism also observed study ad num members genetic isolate finland num finnish study global tests allelic association significant numnum level num num markers tested genome wide two thirds regions confirmed follow analysis additional linked markers high proportion marker heterozygosity perhaps enabling detection individual marker association hindered meaningful haplotype analysis without parental data establish linkage phase power estimating haplotypes sample poor even assistance maximum likelihood approaches num efficacious strategy assessing linkage disequilibrium small intervals defined haplotypes ultimately identifying candidate genes evaluation single nucleotide polymorphisms snps
0.3005403.12566388.html.plaintext.txt	36	surprised high degree marker polymorphism suggesting might greater degree admixture populations predicted see table num alternatively large number alleles may due relative instability microsatellilte markers generation generation interestingly substantial marker polymorphism also observed study ad num members genetic isolate finland num finnish study global tests allelic association significant numnum level num num markers tested genome wide two thirds regions confirmed follow analysis additional linked markers high proportion marker heterozygosity perhaps enabling detection individual marker association hindered meaningful haplotype analysis without parental data establish linkage phase power estimating haplotypes sample poor even assistance maximum likelihood approaches num efficacious strategy assessing linkage disequilibrium small intervals defined haplotypes ultimately identifying candidate genes evaluation single nucleotide polymorphisms snps
0.3005403.12566388.html.plaintext.txt	37	results study implicate several potential ad genes apob symb located candidate region chromosome num apob main apolipoprotein chylomicrons low density lipoproteins ldl important lipid cholesterol metabolism symb disintegrin metalloprotease responsible symb cleavage symb cleavage makes symb susceptible cleavage gamma secretase like protease leading activation notch pathway num analogous action presenilins also act notch pathway peak chromosome num symbnum symbnum includes several genes previously associated ad including cholesterol num hydroxylase symb encodes membrane protein synthesizes oxysterol regulators lipid metabolism num insulin degrading enzyme ide neutral metalloproteinase shown degrade beta amyloid num important protein found plaques seen ad urinary plasminogen activator plau protease converts plasminogen plasmin elevated ad patients num
0.3005403.12566388.html.plaintext.txt	38	results study implicate several potential ad genes apob symb located candidate region chromosome num apob main apolipoprotein chylomicrons low density lipoproteins ldl important lipid cholesterol metabolism symb disintegrin metalloprotease responsible symb cleavage symb cleavage makes symb susceptible cleavage gamma secretase like protease leading activation notch pathway num analogous action presenilins also act notch pathway peak chromosome num symbnum symbnum includes several genes previously associated ad including cholesterol num hydroxylase symb encodes membrane protein synthesizes oxysterol regulators lipid metabolism num insulin degrading enzyme ide neutral metalloproteinase shown degrade beta amyloid num important protein found plaques seen ad urinary plasminogen activator plau protease converts plasminogen plasmin elevated ad patients num
0.3005403.12566388.html.plaintext.txt	39	observation excess chromosome num marker homozygosity among dat patients consistent recessive inheritance known genes familial early onset ad ie app symb symb expressed autosomal dominant fashion effect apoe num one bona fide gene late onset ad ad risk additive numnum although genetic modeling studies based data outbred families found evidence recessive inheritance num num recessive model rejected analysis families lacking apoe num allele num consanguineous populations provide unique opportunity discern recessively behaving genes diseases manifesting late life
0.3005403.12566388.html.plaintext.txt	40	observation excess chromosome num marker homozygosity among dat patients consistent recessive inheritance known genes familial early onset ad ie app symb symb expressed autosomal dominant fashion effect apoe num one bona fide gene late onset ad ad risk additive numnum although genetic modeling studies based data outbred families found evidence recessive inheritance num num recessive model rejected analysis families lacking apoe num allele num consanguineous populations provide unique opportunity discern recessively behaving genes diseases manifesting late life
0.3005403.12566388.html.plaintext.txt	41	potential caveat study lack neuropathological evidence ad patient community unfortunately brain autopsy could performed violates religious customs therefore possible subjects dementing illnesses especially vascular dementia may misclassified dat however concern lessened corroborating evidence brain mri scans performed portion dat patients see methods diagnostic validity also supported finding linkage three regions previously implicated harboring ad loci
0.3005403.12566388.html.plaintext.txt	42	potential caveat study lack neuropathological evidence ad patient community unfortunately brain autopsy could performed violates religious customs therefore possible subjects dementing illnesses especially vascular dementia may misclassified dat however concern lessened corroborating evidence brain mri scans performed portion dat patients see methods diagnostic validity also supported finding linkage three regions previously implicated harboring ad loci
0.3005403.12566388.html.plaintext.txt	43	identification chromosomal segments showing association linkage first step toward discovery genetic defects increase susceptibility ad together large amount gene information available feasible systematically identify snps potential candidate genes evaluate association ad given snp map considerably dense microsatellite marker map likely candidate regions reduced significantly haplotype analysis using small blocks snps
0.3005403.12566388.html.plaintext.txt	44	identification chromosomal segments showing association linkage first step toward discovery genetic defects increase susceptibility ad together large amount gene information available feasible systematically identify snps potential candidate genes evaluate association ad given snp map considerably dense microsatellite marker map likely candidate regions reduced significantly haplotype analysis using small blocks snps
0.3005403.12566388.html.plaintext.txt	45	materials methods top abstract introduction results discussion materials methods references subjects subjects ascertained prevalence study dementia conducted wadi ara geographically defined area northern israel comprising three arab villages num among num residents ages num years older prevalence day october num num num available consented participate study subjects interviewed examined arabic speaking physician ab previously trained memory clinic subject underwent battery standard cognitive tests modified fit cultural linguistic characteristics community num diagnosis dat determined using dsm iv criteria num diagnosis ad conventionally reserved patients diagnosed using nincdsadrda criteria num persons mild cognitive impairment demented subjects whose medical history laboratory cognitive test results suggested presence illnesses vascular dementia parkinson disease normal pressure hydrocephalus pseudodementia depression excluded evidence ischemic stroke white matter disease present numnum dat patients ages ranging num num years brain mri scan suggesting relatively subjects misclassified peripheral blood samples obtained num num num survivors dna biochemical analysis
0.3005403.12566388.html.plaintext.txt	46	materials methods top abstract introduction results discussion materials methods references subjects subjects ascertained prevalence study dementia conducted wadi ara geographically defined area northern israel comprising three arab villages num among num residents ages num years older prevalence day october num num num available consented participate study subjects interviewed examined arabic speaking physician ab previously trained memory clinic subject underwent battery standard cognitive tests modified fit cultural linguistic characteristics community num diagnosis dat determined using dsm iv criteria num diagnosis ad conventionally reserved patients diagnosed using nincdsadrda criteria num persons mild cognitive impairment demented subjects whose medical history laboratory cognitive test results suggested presence illnesses vascular dementia parkinson disease normal pressure hydrocephalus pseudodementia depression excluded evidence ischemic stroke white matter disease present numnum dat patients ages ranging num num years brain mri scan suggesting relatively subjects misclassified peripheral blood samples obtained num num num survivors dna biochemical analysis
0.3005403.12566388.html.plaintext.txt	47	dna analysis dna extracted whole blood according procedures described previously num fluorescently labeled primers microsatellite markers used study purchased applied biosytem abi used num microl pcr reaction num ng genomic dna products different size fluorescent label combined applied either abi num gel based dna sequencer abi num capillary dna sequencer genotyper program abi used determine allele sizes laboratory technicians blinded subject identifying information associated sample id number plate contained multiple control samples ensure quality genotyping allele determination
0.3005403.12566388.html.plaintext.txt	48	dna analysis dna extracted whole blood according procedures described previously num fluorescently labeled primers microsatellite markers used study purchased applied biosytem abi used num microl pcr reaction num ng genomic dna products different size fluorescent label combined applied either abi num gel based dna sequencer abi num capillary dna sequencer genotyper program abi used determine allele sizes laboratory technicians blinded subject identifying information associated sample id number plate contained multiple control samples ensure quality genotyping allele determination
0.3005403.12566388.html.plaintext.txt	49	statistical analysis allele genotype associations assessed using sas version numnum software exact tests used evaluate associations genome scan global num tests used follow studies enlarged sample number alleles genotypes microsatellite markers far exceeded expected genetic isolate many num alleles num genotypes frequency distributions global tests inspected visually suggest one two single allele collapsed genotype group tests reported significant p values symbnum based latter tests unless indicated otherwise adjusted multiple testing correct testing multiple markers chromosome follow studies p values transformed lod scores using equivalence
0.3005403.12566388.html.plaintext.txt	50	adapted allele sharing models developed kong cox num lod scores interpreted according criteria recommended lander kruglyak num marker positions obtained online genethon linkage map available wwwncbinlmnihgovmapviewmapsearchcgi
0.3005403.12566388.html.plaintext.txt	51	adapted allele sharing models developed kong cox num lod scores interpreted according criteria recommended lander kruglyak num marker positions obtained online genethon linkage map available wwwncbinlmnihgovmapviewmapsearchcgi
0.3005403.12566388.html.plaintext.txt	52	acknowledgements thank dr yoav chapman dr miriam birnbaum performing dna extraction apoe genotyping many samples corey adams initiating genotyping effort study work supported part grants national institutes health symb symb institute study aging
0.3005403.12566388.html.plaintext.txt	53	acknowledgements thank dr yoav chapman dr miriam birnbaum performing dna extraction apoe genotyping many samples corey adams initiating genotyping effort study work supported part grants national institutes health symb symb institute study aging
0.3005403.12566388.html.plaintext.txt	54	footnotes correspondence addressed genetics program l num boston university school medicine num albany street boston ma num usa tel num num num fax num num email farreratbuedu
0.3005403.12566388.html.plaintext.txt	55	footnotes correspondence addressed genetics program l num boston university school medicine num albany street boston ma num usa tel num num num fax num num email farreratbuedu
0.3005403.12566388.html.plaintext.txt	56	references top abstract introduction results discussion materials methods references corder eh saunders strittmatter wj schmechel de gaskell pc small gw roses ad haines jl pericak vance ma num gene dose apolipoprotein e type num allele risk alzheimers disease late onset families science num num numisimedline
0.3005403.12566388.html.plaintext.txt	57	apa num diagnostic statistical manual mental disorders numth edn american psychiatric association washington dc
0.3005403.12566388.html.plaintext.txt	58	apa num diagnostic statistical manual mental disorders numth edn american psychiatric association washington dc
0.30746758.9300660.html.plaintext.txt	0	genetics parkinsons disease genetics parkinsons disease robert l nussbaum mihael h polymeropoulos
0.30746758.9300660.html.plaintext.txt	1	laboratory genetic diseases research national human genome research institute bethesda md num num usa
0.30746758.9300660.html.plaintext.txt	2	past num years research parkinsons disease pd predominantly province epidemiologists interested pursuing connection disease environmental factors viral infection neurotoxins hereditary influences actually discounted high monozygotic twin discordance rate found studies later shown inadequate inconclusive recently resurgence interest investigating hereditary factors pd became apparent positive family history major risk factor disease meanwhile also became increasingly apparent neuropathological studies common idiopathic form parkinsons disease fact pathological correlate ie existence lewy bodies eosinophilic cytoplasmic inclusion body distributed diffusely throughout substnatia nigra hypothalamus hippocampus autonomic ganglia olfactory tracts although candidate gene approaches linkage pd families rewarding genome wide scan mapped pd numsymb num one large family pd diffuse lewy bodies candidate gene alpha synuclein resides gene encodes presynaptic protein peptide fragment known constituent alzheimers disease plaques identification missense mutation alpha synuclein gene four independent pd families suggests least fraction familial pd diffuse lewy bodies result abnormal protein interferes normal protein degradation leading development inclusions ultimately neuronal cell death may common pathogenetic mechanisms involved alpha synuclein mutations pd beta amyloid presenilin gene mutations alzheimers disease introduction
0.30746758.9300660.html.plaintext.txt	3	past num years research parkinsons disease pd predominantly province epidemiologists interested pursuing connection disease environmental factors viral infection neurotoxins hereditary influences actually discounted high monozygotic twin discordance rate found studies later shown inadequate inconclusive recently resurgence interest investigating hereditary factors pd became apparent positive family history major risk factor disease meanwhile also became increasingly apparent neuropathological studies common idiopathic form parkinsons disease fact pathological correlate ie existence lewy bodies eosinophilic cytoplasmic inclusion body distributed diffusely throughout substnatia nigra hypothalamus hippocampus autonomic ganglia olfactory tracts although candidate gene approaches linkage pd families rewarding genome wide scan mapped pd numsymb num one large family pd diffuse lewy bodies candidate gene alpha synuclein resides gene encodes presynaptic protein peptide fragment known constituent alzheimers disease plaques identification missense mutation alpha synuclein gene four independent pd families suggests least fraction familial pd diffuse lewy bodies result abnormal protein interferes normal protein degradation leading development inclusions ultimately neuronal cell death may common pathogenetic mechanisms involved alpha synuclein mutations pd beta amyloid presenilin gene mutations alzheimers disease introduction
0.30746758.9300660.html.plaintext.txt	4	parkinsons disease pd first described james parkinson num num num years diagnosis remained primarily clinical one disease common prevalence num num num num num united states num life time risk num num making pd second common neurodegenerative disease alzheimers disease ad num well num years neurologists aware significant role heredity development pd number factors quite recently hampered genetic research pd
0.30746758.9300660.html.plaintext.txt	5	parkinsons disease pd first described james parkinson num num num years diagnosis remained primarily clinical one disease common prevalence num num num num num united states num life time risk num num making pd second common neurodegenerative disease alzheimers disease ad num well num years neurologists aware significant role heredity development pd number factors quite recently hampered genetic research pd
0.30746758.9300660.html.plaintext.txt	6	first factor lack agreement precisely constitutes typical pd whether familial forms disease real pd attitude typified one medical school professor hospital rounds colleague asserted lack family history diagnostic criterion pd result research pd emphasized familial forms disease seen mark directed real pd idea little genetic contribution etiology pd strengthened series twin studies num num nums failed demonstrate increased concordance rates pd monozygotic versus dizygotic twins
0.30746758.9300660.html.plaintext.txt	7	first factor lack agreement precisely constitutes typical pd whether familial forms disease real pd attitude typified one medical school professor hospital rounds colleague asserted lack family history diagnostic criterion pd result research pd emphasized familial forms disease seen mark directed real pd idea little genetic contribution etiology pd strengthened series twin studies num num nums failed demonstrate increased concordance rates pd monozygotic versus dizygotic twins
0.30746758.9300660.html.plaintext.txt	8	second reason research efforts may emphasized role heredity pd striking results epidemiological studies linking pd environmental agents viruses neurotoxins much research communitys energies efforts became focused identifying nature effects environmental agents thought responsible causing disease num influenza pandemic associated encephalitis lethargica late sequela post encephalitic pd pointed viral infection major cause pd num significance association seemed strong one point one investigator suggested pd would disappear num clinical entity survivors pandemic grew old died num strong support environmental cause pd occurrence irreversible symptoms signs pd occurring injection illicit drug preparations contaminated n methyl num phenyl numnumnumnum tetrahydropyridine mptp num num mptp metabolites interfere complex electron transport chain thus depleting cells products oxidative phosphorylation exposing dopaminergic neurons substantia nigra irreversible damage energy depletion oxidative stress free radicals num num
0.30746758.9300660.html.plaintext.txt	9	second reason research efforts may emphasized role heredity pd striking results epidemiological studies linking pd environmental agents viruses neurotoxins much research communitys energies efforts became focused identifying nature effects environmental agents thought responsible causing disease num influenza pandemic associated encephalitis lethargica late sequela post encephalitic pd pointed viral infection major cause pd num significance association seemed strong one point one investigator suggested pd would disappear num clinical entity survivors pandemic grew old died num strong support environmental cause pd occurrence irreversible symptoms signs pd occurring injection illicit drug preparations contaminated n methyl num phenyl numnumnumnum tetrahydropyridine mptp num num mptp metabolites interfere complex electron transport chain thus depleting cells products oxidative phosphorylation exposing dopaminergic neurons substantia nigra irreversible damage energy depletion oxidative stress free radicals num num
0.30746758.9300660.html.plaintext.txt	10	although viral encephalitis environmental toxin mptp clearly capable damaging substantia nigra nums seen re emergence interest genetic causes idiopathic pd primarily efforts neurologists r duvoisin z wszolek result currently much research investigating role heredity gene environment interactions causing pd rather choosing false dichotomy exclusive environmental genetic etiology geneticists attempting synthesis epidemiological genetic data focusing three areas inquiry inherited somatic mitochondrial genome abnormalities causing defects energy metabolism ii candidate gene linkage association studies genes encoding drug metabolizing enzymes iii whole genome scans locate identify genes involved families highly penetrant autosomal dominant pd two excellent relatively recent reviews genetic aspects parkinsons disease published num num clinical phenotype
0.30746758.9300660.html.plaintext.txt	11	many areas genetics definition phenotype one difficult contentious obstacles facing geneticist accurate clinical diagnosis crucial trying categorize patients families genetic studies certainly heterogeneous disorder multiple etiologies generally accepted motor symptoms pd parkinsonism result deficiency dysfunction dopamine neurons producing dopamine pars compacta substantia nigra regardless etiology however idiopathic pd common form disease difficult approach genetic study name mean different things different researchers
0.30746758.9300660.html.plaintext.txt	12	many areas genetics definition phenotype one difficult contentious obstacles facing geneticist accurate clinical diagnosis crucial trying categorize patients families genetic studies certainly heterogeneous disorder multiple etiologies generally accepted motor symptoms pd parkinsonism result deficiency dysfunction dopamine neurons producing dopamine pars compacta substantia nigra regardless etiology however idiopathic pd common form disease difficult approach genetic study name mean different things different researchers
0.30746758.9300660.html.plaintext.txt	13	clinician diagnosis parkinsons disease based finding least two four primary motor signs disease tremor bradykinesia muscular rigidity postural instability also frequently seen considered primary diagnostic criteria dementia defects gastrointestinal motility dysautonomia responsiveness l dopa therapy disease progressive usually insidious onset mid late adulthood one study num num patients three quarters patients carrying diagnosis pd determined qualified neurologists actually disease confirmed autopsy study clinical diagnostic criteria made stringent retrospectively specificity rose num expense drop sensitivity num
0.30746758.9300660.html.plaintext.txt	14	clinician diagnosis parkinsons disease based finding least two four primary motor signs disease tremor bradykinesia muscular rigidity postural instability also frequently seen considered primary diagnostic criteria dementia defects gastrointestinal motility dysautonomia responsiveness l dopa therapy disease progressive usually insidious onset mid late adulthood one study num num patients three quarters patients carrying diagnosis pd determined qualified neurologists actually disease confirmed autopsy study clinical diagnostic criteria made stringent retrospectively specificity rose num expense drop sensitivity num
0.30746758.9300660.html.plaintext.txt	15	neuropathologist autopsy demonstration diffuse lewy body disease come hallmark pd num diffuse lewy body disease lewy body characteristic intracellular cytoplasmic inclusion named beginning numth century discoverer found many regions brain particularly neurons substantia nigra nuclei brain stem hypothalamus hippocampus autonomic neurons esophagus gastrointestinal tract occasionally cortex num lewy bodies frequently found brains patients dying pd even though extreme variation age onset severity clinical manifestations pd num patients carrying diagnosis pd came autopsy num patients lewy bodies found pd instead causes clinical signs num however presence lewy bodies per se uniquely pathognomic pd form alzheimers disease known lewy body variant ad described lewy bodies found brain cortex along pathognomic amyloid plaques neurofibrillary tangles ad num conversely possible motor dysfunction characteristic pd even familial basis without pathological process whose characteristic marker lewy body reviewed num examples hereditary parkinsonism syndromes without diffuse lewy body disease include juvenile autosomal recessive parkinsonism mapping chromosome numsymb num num rapidly progressive autosomal dominant parkinsonism associated dementia dystonia disinhibition located chromosome numsymb x linked dystonia parkinsonism num num well defined rare familial disorders motor signs parkinsonism common diffuse lewy body pd certainly different diseases case acquired parkinsonism due mptp toxicity typical lewy body pathology pd seen acute mptp exposure humans monkeys undergoing chronic mptp administration although atypical inclusions reported brains animals num num thus past num years neurologists come accept highly prevalent disorder idiopathic pd distinctive disorder usually occurring middle late adulthood characteristic pathology diffuse lewy body disease classical motor central nervous system manifestations parkinsonism num num num purposes review concentrate genetics common form disease genetic epidemiology pd
0.30746758.9300660.html.plaintext.txt	16	neuropathologist autopsy demonstration diffuse lewy body disease come hallmark pd num diffuse lewy body disease lewy body characteristic intracellular cytoplasmic inclusion named beginning numth century discoverer found many regions brain particularly neurons substantia nigra nuclei brain stem hypothalamus hippocampus autonomic neurons esophagus gastrointestinal tract occasionally cortex num lewy bodies frequently found brains patients dying pd even though extreme variation age onset severity clinical manifestations pd num patients carrying diagnosis pd came autopsy num patients lewy bodies found pd instead causes clinical signs num however presence lewy bodies per se uniquely pathognomic pd form alzheimers disease known lewy body variant ad described lewy bodies found brain cortex along pathognomic amyloid plaques neurofibrillary tangles ad num conversely possible motor dysfunction characteristic pd even familial basis without pathological process whose characteristic marker lewy body reviewed num examples hereditary parkinsonism syndromes without diffuse lewy body disease include juvenile autosomal recessive parkinsonism mapping chromosome numsymb num num rapidly progressive autosomal dominant parkinsonism associated dementia dystonia disinhibition located chromosome numsymb x linked dystonia parkinsonism num num well defined rare familial disorders motor signs parkinsonism common diffuse lewy body pd certainly different diseases case acquired parkinsonism due mptp toxicity typical lewy body pathology pd seen acute mptp exposure humans monkeys undergoing chronic mptp administration although atypical inclusions reported brains animals num num thus past num years neurologists come accept highly prevalent disorder idiopathic pd distinctive disorder usually occurring middle late adulthood characteristic pathology diffuse lewy body disease classical motor central nervous system manifestations parkinsonism num num num purposes review concentrate genetics common form disease genetic epidemiology pd
0.30746758.9300660.html.plaintext.txt	17	familial clustering pd observed century ago num num num num pd patients reported positive family history accurate measurement frequency pd among relatives affected patients made difficult inaccuracy making diagnosis pd history relative insensitivity lack specificity clinical exam variability age onset rarity autopsy data required making diagnosis diffuse lewy body disease relatives reported pd nums genetic contribution pd thought highly unlikely series twin studies failed demonstrate increased concordance pd monozygotic versus dizygotic twins num num pointed however num studies interpretable number twins studied duration observation either support reject genetic contribution pd inadequate nearly num function dopaminergic neurons substantia nigra must lost symptoms occur num reliance clinical diagnosis alone lack follow makes determination concordance extremely insensitive evidence clinical evaluation determine concordance twin studies far insensitive comes use positron emission tomography measure numfluorodopa uptake basal ganglia num concordance rate among monozygotic twins increased numfluorodopa uptake basal ganglia used diagnosis preclinical dysfunction substantia nigra num result lack increased concordance twin studies essentially discounted result inconclusive insensitive methodology
0.30746758.9300660.html.plaintext.txt	18	familial clustering pd observed century ago num num num num pd patients reported positive family history accurate measurement frequency pd among relatives affected patients made difficult inaccuracy making diagnosis pd history relative insensitivity lack specificity clinical exam variability age onset rarity autopsy data required making diagnosis diffuse lewy body disease relatives reported pd nums genetic contribution pd thought highly unlikely series twin studies failed demonstrate increased concordance pd monozygotic versus dizygotic twins num num pointed however num studies interpretable number twins studied duration observation either support reject genetic contribution pd inadequate nearly num function dopaminergic neurons substantia nigra must lost symptoms occur num reliance clinical diagnosis alone lack follow makes determination concordance extremely insensitive evidence clinical evaluation determine concordance twin studies far insensitive comes use positron emission tomography measure numfluorodopa uptake basal ganglia num concordance rate among monozygotic twins increased numfluorodopa uptake basal ganglia used diagnosis preclinical dysfunction substantia nigra num result lack increased concordance twin studies essentially discounted result inconclusive insensitive methodology
0.30746758.9300660.html.plaintext.txt	19	recently number epidemiological studies num num differing methodological approaches study populations published found support familial contribution pd case control studies positive family history found single greatest risk factor pd num num num family studies family history positive pd found num num patients relative risk pd first degree relatives pd patients ranged num num largest studies frequency pd num num first degree relatives num pd patients significantly higher frequency num seen num first degree relatives num age matched controls num
0.30746758.9300660.html.plaintext.txt	20	recently number epidemiological studies num num differing methodological approaches study populations published found support familial contribution pd case control studies positive family history found single greatest risk factor pd num num num family studies family history positive pd found num num patients relative risk pd first degree relatives pd patients ranged num num largest studies frequency pd num num first degree relatives num pd patients significantly higher frequency num seen num first degree relatives num age matched controls num
0.30746758.9300660.html.plaintext.txt	21	attempt integrate current knowledge familial nature pd possible role defects energy metabolism causing disease toxicity mptp research proceeded two parallel tracks looking mitochondrial genome abnormalities pd applying linkage association methods affected individuals using polymorphisms drug metabolizing enzymes modest deficiencies complex electron transport chain reviewed num reported substantia nigra num muscle num num peripheral blood cells num num pd patients whether abnormalities primary secondary disease process unknown mitochondrial genome aging brain demonstrate striking departures normal num num analysis mitochondrial genome blood brain pd patients failed reveal consistent hereditary somatic deletion pd patients compared age matched control blood brain samples reviewed num small studies suggested significant association certain mitochondrial dna polymorphisms pd sample sizes small replication ongoing num num thus appears consistent abnormalities oxidative phosphorylation particularly complex pd direct causative role inherited acquired mutation mitochondrial genome remains unproved
0.30746758.9300660.html.plaintext.txt	22	attempt integrate current knowledge familial nature pd possible role defects energy metabolism causing disease toxicity mptp research proceeded two parallel tracks looking mitochondrial genome abnormalities pd applying linkage association methods affected individuals using polymorphisms drug metabolizing enzymes modest deficiencies complex electron transport chain reviewed num reported substantia nigra num muscle num num peripheral blood cells num num pd patients whether abnormalities primary secondary disease process unknown mitochondrial genome aging brain demonstrate striking departures normal num num analysis mitochondrial genome blood brain pd patients failed reveal consistent hereditary somatic deletion pd patients compared age matched control blood brain samples reviewed num small studies suggested significant association certain mitochondrial dna polymorphisms pd sample sizes small replication ongoing num num thus appears consistent abnormalities oxidative phosphorylation particularly complex pd direct causative role inherited acquired mutation mitochondrial genome remains unproved
0.30746758.9300660.html.plaintext.txt	23	view possible involvement neurotoxins pd research also directed towards identifying variation certain drug metabolizing enzymes might predispose certain individuals greater toxicity environmental agents association studies pd focused polymorphisms drug metabolizing enzymes cytochrome symbnum encoded symb gene debrisoquine num hydroxylase cytochrome symb encoded symbnum gene well monoamine oxidase b enzymes encoded maoa maob association studies always fraught difficulties arising unrecognized ascertainment bias stratification unfortunately nature late onset disease means parental genotypes required permit use dependable transmission disequilibrium test association usually available num nonetheless number studies suggested significant association pd loci encoding cytochrome symb enzymes monoamine oxidase japan mspi restriction fragment length polymorphism symb found associated num fold higher risk pd heterozygotes numnum fold higher homozygotes num association studies symbnum gene revealed highly significant num fold increased risk among patients disease onset age num spanish population although association seen united states british samples num num particular haplotype maoa locus found num fold common among pd patients compared controls another haplotype num fold less common among affected patients num associations found maob locus num num thus preliminary data support modest association certain alleles loci pd history many association studies replication findings difficult requires larger carefully controlled studies accepted definite
0.30746758.9300660.html.plaintext.txt	24	view possible involvement neurotoxins pd research also directed towards identifying variation certain drug metabolizing enzymes might predispose certain individuals greater toxicity environmental agents association studies pd focused polymorphisms drug metabolizing enzymes cytochrome symbnum encoded symb gene debrisoquine num hydroxylase cytochrome symb encoded symbnum gene well monoamine oxidase b enzymes encoded maoa maob association studies always fraught difficulties arising unrecognized ascertainment bias stratification unfortunately nature late onset disease means parental genotypes required permit use dependable transmission disequilibrium test association usually available num nonetheless number studies suggested significant association pd loci encoding cytochrome symb enzymes monoamine oxidase japan mspi restriction fragment length polymorphism symb found associated num fold higher risk pd heterozygotes numnum fold higher homozygotes num association studies symbnum gene revealed highly significant num fold increased risk among patients disease onset age num spanish population although association seen united states british samples num num particular haplotype maoa locus found num fold common among pd patients compared controls another haplotype num fold less common among affected patients num associations found maob locus num num thus preliminary data support modest association certain alleles loci pd history many association studies replication findings difficult requires larger carefully controlled studies accepted definite
0.30746758.9300660.html.plaintext.txt	25	view association apolipoprotein e allele num late onset ad num clearly interest investigate whether similar association exists pd either without dementia apolipoprotein symb allele least two studies failed show association num num note one study find significant association symb lewy body variant ad pd supporting idea lewy body variant ad pd distinct disorders num
0.30746758.9300660.html.plaintext.txt	26	view association apolipoprotein e allele num late onset ad num clearly interest investigate whether similar association exists pd either without dementia apolipoprotein symb allele least two studies failed show association num num note one study find significant association symb lewy body variant ad pd supporting idea lewy body variant ad pd distinct disorders num
0.30746758.9300660.html.plaintext.txt	27	genetic contribution pd received substantial support identification number families pd diffuse lewy body disease inherited autosomal dominant trait num num num num penetrance appeared age dependent rising num early adulthood num age num one family town contursi near salerno italy num linkage analysis allowed gene pd autopsy proven diffuse lewy body disease mapped long arm chromosome num numsymb symb num positive mapping studies published date although essentially negative linkage studies reported variety candidate genes pedigrees apparent autosomal dominant inheritance lewy body positive pd num note anticipation seen families multiple generations affected pd num num ascribed primarily ascertainment bias families num repeat expansion detection method failed show evidence expanded cag trinucleotide repeat contursi pd kindred num
0.30746758.9300660.html.plaintext.txt	28	genetic contribution pd received substantial support identification number families pd diffuse lewy body disease inherited autosomal dominant trait num num num num penetrance appeared age dependent rising num early adulthood num age num one family town contursi near salerno italy num linkage analysis allowed gene pd autopsy proven diffuse lewy body disease mapped long arm chromosome num numsymb symb num positive mapping studies published date although essentially negative linkage studies reported variety candidate genes pedigrees apparent autosomal dominant inheritance lewy body positive pd num note anticipation seen families multiple generations affected pd num num ascribed primarily ascertainment bias families num repeat expansion detection method failed show evidence expanded cag trinucleotide repeat contursi pd kindred num
0.30746758.9300660.html.plaintext.txt	29	figure num sequence exon num alpha synuclein gene control individual b sequence exon num mutant allele individual affected parkinsons disease contursi kindred arrows indicate transition mutation g resulting missense mutation ala thr position num protein
0.30746758.9300660.html.plaintext.txt	30	particularly prescient paper published num sommer rocca suggested autosomal dominant pd might caused missense mutation cellular protein changes physical chemical properties leading accumulation abnormal protein neuronal death num hypothesis received substantial support linkage mapping pd numsymb symb contursi pedigree suggested number candidate genes pd mapped region one alpha synuclein particularly good candidate protein neuron specific presynaptic membrane protein num originally identified encodes peptide named nacp non abeta component ad amyloid isolated plaques ad num num sequencing alpha synuclein gene affected individuals contursi kindred fig num revealed affected members kindred heterozygous missense mutation alanine threonine position num protein segregated pd family num missense mutation found three additional unrelated pd families greek origin absent num chromosomes control european populations including nearly num chromosomes obtained random controls area near contursi evidence mutation causes pd based entirely finding mutation four unrelated families finding absent large set controls definitive proof requires elucidation mechanism mutation causes disease
0.30746758.9300660.html.plaintext.txt	31	particularly prescient paper published num sommer rocca suggested autosomal dominant pd might caused missense mutation cellular protein changes physical chemical properties leading accumulation abnormal protein neuronal death num hypothesis received substantial support linkage mapping pd numsymb symb contursi pedigree suggested number candidate genes pd mapped region one alpha synuclein particularly good candidate protein neuron specific presynaptic membrane protein num originally identified encodes peptide named nacp non abeta component ad amyloid isolated plaques ad num num sequencing alpha synuclein gene affected individuals contursi kindred fig num revealed affected members kindred heterozygous missense mutation alanine threonine position num protein segregated pd family num missense mutation found three additional unrelated pd families greek origin absent num chromosomes control european populations including nearly num chromosomes obtained random controls area near contursi evidence mutation causes pd based entirely finding mutation four unrelated families finding absent large set controls definitive proof requires elucidation mechanism mutation causes disease
0.30746758.9300660.html.plaintext.txt	32	note nearly num different proteins identified immunologically lewy bodies pd lewy body variant ad num including ubiquitin beta amyloid precursor protein implicated ad date however published data indicating whether lewy bodies contain peptides derived alpha synuclein interesting note nacp peptide fragment alpha synuclein unusual protein adopts extended non globular conformation known natively unfolded random coil vitro random coil domains promote protein protein interactions make protein amyloidogenic vitro num discovery alpha synuclein mutated predisposes high probability development pd families autosomal dominant disease suggests structural abnormality protein either changing conformation altering normal proteolytic processing may inciting event protein aggregation leading pd similar pathogenic mechanism hypothesized mutant cellular proteins presenilins beta amyloid causing ad num future
0.30746758.9300660.html.plaintext.txt	33	note nearly num different proteins identified immunologically lewy bodies pd lewy body variant ad num including ubiquitin beta amyloid precursor protein implicated ad date however published data indicating whether lewy bodies contain peptides derived alpha synuclein interesting note nacp peptide fragment alpha synuclein unusual protein adopts extended non globular conformation known natively unfolded random coil vitro random coil domains promote protein protein interactions make protein amyloidogenic vitro num discovery alpha synuclein mutated predisposes high probability development pd families autosomal dominant disease suggests structural abnormality protein either changing conformation altering normal proteolytic processing may inciting event protein aggregation leading pd similar pathogenic mechanism hypothesized mutant cellular proteins presenilins beta amyloid causing ad num future
0.30746758.9300660.html.plaintext.txt	34	last years major shift thinking focus pd research resulted rebirth interest investigating genetic contribution disease change focus already begun bear fruit form developing consensus relationship diffuse lewy body disease pd leading much improved genetic epidemiological investigations disorder identification families clear autosomal dominant inheritance patterns identification least one gene particular missense mutation predisposes high probability development disease pd research poised begin ask fundamental questions pathogenesis human patients classical parkinsons disease references num parkinson j num essay shaking palsy sherwood neely jones london
0.30746758.9300660.html.plaintext.txt	35	last years major shift thinking focus pd research resulted rebirth interest investigating genetic contribution disease change focus already begun bear fruit form developing consensus relationship diffuse lewy body disease pd leading much improved genetic epidemiological investigations disorder identification families clear autosomal dominant inheritance patterns identification least one gene particular missense mutation predisposes high probability development disease pd research poised begin ask fundamental questions pathogenesis human patients classical parkinsons disease references num parkinson j num essay shaking palsy sherwood neely jones london
0.30746758.9300660.html.plaintext.txt	36	num vieregge p num genetic factors etiology idiopathic parkinsons disease j neural transm park dis dement sect num num num medline abstract
0.30746758.9300660.html.plaintext.txt	37	num haass c num presenile presenilin presenilin genes early onset alzheimers disease curr opin neurol num num num medline abstract
0.30746758.9300660.html.plaintext.txt	38	correspondence addressed tel num num num num fax num num num num email rlnussnhgrinihgov
0.30746758.9300660.html.plaintext.txt	39	correspondence addressed tel num num num num fax num num num num email rlnussnhgrinihgov
0.30746758.9300660.html.plaintext.txt	40	page maintained oup admin last updated fri sep num numnumnum bst num part oup journals world wide web service copyright oxford university press num
0.30746758.9300660.html.plaintext.txt	41	page maintained oup admin last updated fri sep num numnumnum bst num part oup journals world wide web service copyright oxford university press num
0.31976065.12765971.html.plaintext.txt	0	polymorphisms insulin degrading enzyme gene associated type num diabetes men nhlbi framingham heart study samer symb serkalem symb jeannine symb chunyu symb nancy heard symb jun symb christina m symb carolien symb james b symb peter symb larry d symbnum l adrienne symb alan symb
0.31976065.12765971.html.plaintext.txt	1	num framingham heart study genetics laboratory department neurology boston university school medicine boston massachusetts num department biostatistics boston university school public health boston massachusetts num department medicine boston university school medicine boston massachusetts num general internal medicine clinical epidemiology units general medicine division department medicine massachusetts general hospital harvard medical school boston massachusetts
0.31976065.12765971.html.plaintext.txt	2	abstract top abstract introduction research design methods references linkage studies mapped susceptibility gene type num diabetes long arm chromosome num previously identified quantitative trait locus affects fasting blood glucose within framingham heart study cohort one candidate gene region insulin degrading enzyme ide gk rat model associated nonobese type num diabetes single nucleotide polymorphisms snps used map haplotype block num end ide revealed association symb fasting plasma glucose fpg mean fasting plasma glucose mfpg measured num years strongest associations found sample unrelated men lowest trait values associated haplotype tt symbnum containing minor allele symb major allele symb snp fpg p numnum mfpg p numnum symb p numnum another haplotype cc symbnum associated elevated symb p numnum type num diabetes p numnum odds ratio numnum num ci numnum numnum evidence presented supports possibility ide susceptibility gene diabetes populations european descent
0.31976065.12765971.html.plaintext.txt	3	abstract top abstract introduction research design methods references linkage studies mapped susceptibility gene type num diabetes long arm chromosome num previously identified quantitative trait locus affects fasting blood glucose within framingham heart study cohort one candidate gene region insulin degrading enzyme ide gk rat model associated nonobese type num diabetes single nucleotide polymorphisms snps used map haplotype block num end ide revealed association symb fasting plasma glucose fpg mean fasting plasma glucose mfpg measured num years strongest associations found sample unrelated men lowest trait values associated haplotype tt symbnum containing minor allele symb major allele symb snp fpg p numnum mfpg p numnum symb p numnum another haplotype cc symbnum associated elevated symb p numnum type num diabetes p numnum odds ratio numnum num ci numnum numnum evidence presented supports possibility ide susceptibility gene diabetes populations european descent
0.31976065.12765971.html.plaintext.txt	4	introduction top abstract introduction research design methods references previous studies identified linkage chromosome numsymb symb fasting plasma glucose fpg num mean fasting plasma glucose mfpg levels measured num years num symb num type num diabetes num ratio fasting insulin fasting glucose num apparent replication linkage different studies using populations mixed european descent made region attractive investigation
0.31976065.12765971.html.plaintext.txt	5	introduction top abstract introduction research design methods references previous studies identified linkage chromosome numsymb symb fasting plasma glucose fpg num mean fasting plasma glucose mfpg levels measured num years num symb num type num diabetes num ratio fasting insulin fasting glucose num apparent replication linkage different studies using populations mixed european descent made region attractive investigation
0.31976065.12765971.html.plaintext.txt	6	one candidate gene numsymb symb falls edge linkage peak num beneath reported groups numnum insulin degrading enzyme ide insulysin ec numnumnumnum polymorphisms ide associated type num diabetes goto kakizaki gk rat model num ide degrade number peptides including insulin igf ii transforming growth factor atrial natriuretic peptide oxidatively damaged proteins num
0.31976065.12765971.html.plaintext.txt	7	examine association ide variants fpg mfpg symb analyzed single nucleotide polymorphisms snps within near ide gene sample unrelated subjects set families framingham heart study fhs tables num num num snp positions minor allele frequencies fa november num draft university california santa cruz genome browser given table num shown fig num assess completeness map linkage disequilibrium ld region evaluated using ldmap program based malecot model one ld unit ldu defined distance kilobases association two markers falls e num fig num num flat line indicates complete ld markers defines haplotype block one haplotype block observed num end ide agreement previously published report num another num end fig num map thus gives reasonably complete view recombination history region sample
0.31976065.12765971.html.plaintext.txt	8	examine association ide variants fpg mfpg symb analyzed single nucleotide polymorphisms snps within near ide gene sample unrelated subjects set families framingham heart study fhs tables num num num snp positions minor allele frequencies fa november num draft university california santa cruz genome browser given table num shown fig num assess completeness map linkage disequilibrium ld region evaluated using ldmap program based malecot model one ld unit ldu defined distance kilobases association two markers falls e num fig num num flat line indicates complete ld markers defines haplotype block one haplotype block observed num end ide agreement previously published report num another num end fig num map thus gives reasonably complete view recombination history region sample
0.31976065.12765971.html.plaintext.txt	9	view table table num descriptive statistics numnum unrelated individuals sex
0.31976065.12765971.html.plaintext.txt	10	view table table num descriptive statistics num families numnum participants sex
0.31976065.12765971.html.plaintext.txt	11	view table table num marker positions chromosone num relative ide
0.31976065.12765971.html.plaintext.txt	12	view larger version numk fig num physical map ld snp association ide locus region ld estimates made using program ldmap httpcedargeneticssotonacukpublichtml num one ldu corresponds distance association two markers reduced e num position ide shown direction transcription indicated arrow b snp map unrelated male subjects base location snp names given table num plotted negative logarithm p values given table num position ide shown direction transcription indicated arrow
0.31976065.12765971.html.plaintext.txt	13	examined association snps fpg n numnum symb n numnum unrelated subjects highly significant association observed symb genotypes fa numnum subjects symb levels p numnum table num snp also associated fpg p numnum mfpg p numnum snp num ide gene symb fa numnum showed similar less significant pattern association levels fpg p numnum symb p numnum markers placed num ide gene revealed significant association
0.31976065.12765971.html.plaintext.txt	14	examined association snps fpg n numnum symb n numnum unrelated subjects highly significant association observed symb genotypes fa numnum subjects symb levels p numnum table num snp also associated fpg p numnum mfpg p numnum snp num ide gene symb fa numnum showed similar less significant pattern association levels fpg p numnum symb p numnum markers placed num ide gene revealed significant association
0.31976065.12765971.html.plaintext.txt	15	view table table num global p values test association three genotypes snp traits unrelated subjects men women
0.31976065.12765971.html.plaintext.txt	16	stronger associations found symb sex specific analyses unrelated men pooled sample table num results shown fig num negative logarithms p values logp table num plotted snp positions table num significance association diminished slightly adjustment bmi results shown
0.31976065.12765971.html.plaintext.txt	17	view table table num global p values unrelated male subjects test association genotypes snp trait values
0.31976065.12765971.html.plaintext.txt	18	attempted replicate symb results different sample methodology testing family set using fbat num additive model borderline associations found symb levels fpg p numnum symb p numnum found significant associations symb family set might expected due weaker associations observed unrelated sample
0.31976065.12765971.html.plaintext.txt	19	attempted replicate symb results different sample methodology testing family set using fbat num additive model borderline associations found symb levels fpg p numnum symb p numnum found significant associations symb family set might expected due weaker associations observed unrelated sample
0.31976065.12765971.html.plaintext.txt	20	evaluate whether particular polymorphisms ide accounted linkage previously reported num num adjusted linkage model symb polymorphism change either peak height peak position found results shown suggesting another gene present region accounts linkage signal
0.31976065.12765971.html.plaintext.txt	21	evaluate whether particular polymorphisms ide accounted linkage previously reported num num adjusted linkage model symb polymorphism change either peak height peak position found results shown suggesting another gene present region accounts linkage signal
0.31976065.12765971.html.plaintext.txt	22	tested whether common polymorphisms associated type num diabetes unrelated subjects considered symb snp revealed borderline association type num diabetes p numnum table num sex specific analyses men conducted table num significant association type num diabetes seen p numnum
0.31976065.12765971.html.plaintext.txt	23	tested whether common polymorphisms associated type num diabetes unrelated subjects considered symb snp revealed borderline association type num diabetes p numnum table num sex specific analyses men conducted table num significant association type num diabetes seen p numnum
0.31976065.12765971.html.plaintext.txt	24	also analyzed traits using haplotypes based snps symb minor allele symb minor allele c within sample unrelated men statistical significance directionality association traits haplotypes indicated z scores presented fig numa num tt haplotype associated lower trait levels cc haplotype associated higher levels estimated regression coefficients trait presented fig numb reveal consistent trend lower trait values traits associated tt haplotype higher values cc haplotype
0.31976065.12765971.html.plaintext.txt	25	also analyzed traits using haplotypes based snps symb minor allele symb minor allele c within sample unrelated men statistical significance directionality association traits haplotypes indicated z scores presented fig numa num tt haplotype associated lower trait levels cc haplotype associated higher levels estimated regression coefficients trait presented fig numb reveal consistent trend lower trait values traits associated tt haplotype higher values cc haplotype
0.31976065.12765971.html.plaintext.txt	26	view larger version numk fig num two four locus haplotype analysis sample unrelated men haplotypes constructed using symb symb association traits fpg n num mfpg n num symb n num determined empirically permutation using haploscore num global haplotype specific p values given test values significant p numnum bold b regression coefficient estimates ss quantitative traits odds ratio estimates qualitative traits measure association particular haplotype trait num values derived using inferred haplotype probabilities individual predictors values significant p numnum bold c haplotypes based four locus model symb values global p numnum output score haploscore num shown lower associations observed snps symb symb analyzed individually explained presence major allele haplotypes high low trait values thus diminishing contrast minor allele trait values
0.31976065.12765971.html.plaintext.txt	27	adding snps symb minor allele symb minor allele improve model revealed haplotype tatt symb associated lowest trait values haplotype ccgc symb associated highest trait values fig numc consistent two locus analysis lower associations observed snps symb symb analyzed individually may explained presence major allele haplotypes high low trait values thus diminishing contrasts minor allele trait values fig numc haplotype analysis performed families due problems obtaining estimated haplotypes presence ld num
0.31976065.12765971.html.plaintext.txt	28	adding snps symb minor allele symb minor allele improve model revealed haplotype tatt symb associated lowest trait values haplotype ccgc symb associated highest trait values fig numc consistent two locus analysis lower associations observed snps symb symb analyzed individually may explained presence major allele haplotypes high low trait values thus diminishing contrasts minor allele trait values fig numc haplotype analysis performed families due problems obtaining estimated haplotypes presence ld num
0.31976065.12765971.html.plaintext.txt	29	also tested association two locus haplotypes type num diabetes global model significant whole sample tested contrast global models sex specific analyses men significant indicated cc haplotype associated increased risk type num diabetes p numnum global simulated p value model numnum odds ratio type num diabetes cc haplotype relative tt haplotype numnum num ci numnum numnum
0.31976065.12765971.html.plaintext.txt	30	also tested association two locus haplotypes type num diabetes global model significant whole sample tested contrast global models sex specific analyses men significant indicated cc haplotype associated increased risk type num diabetes p numnum global simulated p value model numnum odds ratio type num diabetes cc haplotype relative tt haplotype numnum num ci numnum numnum
0.31976065.12765971.html.plaintext.txt	31	evaluate whether subjects type num diabetes prediabetes accounted sex specific associations observed men met criterion impaired plasma glucose ipg excluded analysis significant global associations symb snp glycemic trait levels still seen subsidiary male dataset fpg p numnum symb p numnum mfpg similarly haplotype tt associated low trait values symb p numnum global p model numnum cc haplotype high trait values symb p numnum results indicate role ide locus normal glucose homeostasis
0.31976065.12765971.html.plaintext.txt	32	evaluate whether subjects type num diabetes prediabetes accounted sex specific associations observed men met criterion impaired plasma glucose ipg excluded analysis significant global associations symb snp glycemic trait levels still seen subsidiary male dataset fpg p numnum symb p numnum mfpg similarly haplotype tt associated low trait values symb p numnum global p model numnum cc haplotype high trait values symb p numnum results indicate role ide locus normal glucose homeostasis
0.31976065.12765971.html.plaintext.txt	33	thus present evidence association polymorphic markers ide gene numsymb symb levels fpg mfpg symb type num diabetes effect symb symb trait levels individual snps pronounced men may partly due increased number men ipg unrelated set compared women however associations still statistically significant following exclusion men ipg analysis men suggesting explanation male specific susceptibility reported two murine models type num diabetes associated obesity numnum one model based crosses nonlt obese nzohi mice number susceptibility genes determine threshold type num diabetes mapped none lie y chromosome num android obesity previously described major risk factor type num diabetes num although associations reported persist adjustment bmi
0.31976065.12765971.html.plaintext.txt	34	thus present evidence association polymorphic markers ide gene numsymb symb levels fpg mfpg symb type num diabetes effect symb symb trait levels individual snps pronounced men may partly due increased number men ipg unrelated set compared women however associations still statistically significant following exclusion men ipg analysis men suggesting explanation male specific susceptibility reported two murine models type num diabetes associated obesity numnum one model based crosses nonlt obese nzohi mice number susceptibility genes determine threshold type num diabetes mapped none lie y chromosome num android obesity previously described major risk factor type num diabetes num although associations reported persist adjustment bmi
0.31976065.12765971.html.plaintext.txt	35	tt haplotype representing minor allele symb major allele symb associated lowered trait values suggesting encodes ide variant reduced activity increases efficiency insulin signaling less insulin would therefore needed reduce blood glucose levels contrast cc haplotype ide variant may diminish insulin action leading higher trait values type num diabetes
0.31976065.12765971.html.plaintext.txt	36	tt haplotype representing minor allele symb major allele symb associated lowered trait values suggesting encodes ide variant reduced activity increases efficiency insulin signaling less insulin would therefore needed reduce blood glucose levels contrast cc haplotype ide variant may diminish insulin action leading higher trait values type num diabetes
0.31976065.12765971.html.plaintext.txt	37	associations symb fpg map num region ide unlikely involve protease domain enzyme lies num end gene num similarly mutations ide gk rat model type num diabetes affect protease activity num number alternative molecular mechanisms provide plausible explanations delayed diminished action ide example change num untranslated region ide may affect stability translation message altering levels ide protein produced alternatively coding polymorphisms carboxyl terminal region protein may modify cellular localization homodimerization num interaction protein partners
0.31976065.12765971.html.plaintext.txt	38	associations symb fpg map num region ide unlikely involve protease domain enzyme lies num end gene num similarly mutations ide gk rat model type num diabetes affect protease activity num number alternative molecular mechanisms provide plausible explanations delayed diminished action ide example change num untranslated region ide may affect stability translation message altering levels ide protein produced alternatively coding polymorphisms carboxyl terminal region protein may modify cellular localization homodimerization num interaction protein partners
0.31976065.12765971.html.plaintext.txt	39	genes numsymb symb appear contribute linkage region reported previously others us glycemic traits num num signal fpg diminished adjustment symb snp association studies may efficient linkage studies identifying genetic determinants complex traits allele frequency relatively high effect small num finding consistent associations see ide cc haplotype symb twice likely associated type num diabetes tt haplotype typing additional snps necessary identify gene variants numsymb num affect glucose homeostasis
0.31976065.12765971.html.plaintext.txt	40	genes numsymb symb appear contribute linkage region reported previously others us glycemic traits num num signal fpg diminished adjustment symb snp association studies may efficient linkage studies identifying genetic determinants complex traits allele frequency relatively high effect small num finding consistent associations see ide cc haplotype symb twice likely associated type num diabetes tt haplotype typing additional snps necessary identify gene variants numsymb num affect glucose homeostasis
0.31976065.12765971.html.plaintext.txt	41	proposed typing one snp per haplotype block sufficient genome wide association studies numnum show two snps symb symb haplotype block vary association trait values due different haplotypes minor allele found typing one snp per haplotype block may sufficient cases reliably detect exclude associations candidate loci complex diseases
0.31976065.12765971.html.plaintext.txt	42	proposed typing one snp per haplotype block sufficient genome wide association studies numnum show two snps symb symb haplotype block vary association trait values due different haplotypes minor allele found typing one snp per haplotype block may sufficient cases reliably detect exclude associations candidate loci complex diseases
0.31976065.12765971.html.plaintext.txt	43	research design methods top abstract introduction research design methods references subjects used subjects two samples num group unrelated subjects framingham offspring cohort recruited early nums num subgroup num families coming largest num pedigrees fhs latter group contains majority included genome scan results reported meigs et al num descriptive statistics presented tables num num study approved boston university irb written informed consent obtained subject
0.31976065.12765971.html.plaintext.txt	44	research design methods top abstract introduction research design methods references subjects used subjects two samples num group unrelated subjects framingham offspring cohort recruited early nums num subgroup num families coming largest num pedigrees fhs latter group contains majority included genome scan results reported meigs et al num descriptive statistics presented tables num num study approved boston university irb written informed consent obtained subject
0.31976065.12765971.html.plaintext.txt	45	traits trait measurements previously described num sample unrelated subjects fpg measured exam cycle num available numnum offspring participants mfpg average fpg value numnum offspring three measures fpg five exams spanned num years symb determined numnum individuals exam num family set fpg available num individuals mfpg num individuals symb num individuals diabetes status type num diabetes defined either hypoglycemic medication two fpg levels num mmoll num mgdl time exams num num using criterion numnum men unrelated sample num women classified diabetic subjects tables num num less stringent criterion ipg defined fpg numnum mmoll num mgdl num h postchallenge plasma glucose numnum mmoll num mgdl anyone treated type num diabetes questionnaire used collect information alcohol cigarette consumption hormone therapy physical activity index calculated weighted average hours spent various activity levels num
0.31976065.12765971.html.plaintext.txt	46	genotyping snps scored sequenom maldi tof mass spectrometer num
0.31976065.12765971.html.plaintext.txt	47	statistical analysis standardized residuals calculated using linear regression models incorporated age age squared age cubed sex smoking physical activity bmi alcohol consumption covariates separate regression models used men women residuals models ranked normalized num transformation diminished slightly significance results reported sample unrelated subjects associations traits genotypes snp evaluated using regression models additionally association haplotypes tested using haploscore num haplotype effects estimated using regression logistic procedures sas haplotype effects estimated two stage procedure first individual haplotypes inferred em algorithm using snphap d clayton httpwww genecimrcamacukclaytonsoftware inferred haplotype probabilities used predictors regression models effect measures analyses compare haplotype haplotypes global significance haplotype phenotype associations determined using empirical p values numnum permutations obtained haploscore num related individuals family based empirical test association implemented program fbat used additive model num
0.31976065.12765971.html.plaintext.txt	48	acknowledgments fhs supported subcontract national heart lung blood institute nhlbi national institutes health nih dr p wolf principal investigator nihnhlbi contracts symb hc num nihnhlbi symb hc num study also supported part grant american diabetes association ada dr herbert principal investigator jbm supported ada career development award
0.31976065.12765971.html.plaintext.txt	49	thank staff fhs genetics laboratory work performed support study dr christopher o donnell careful reading manuscript earlier version manuscript reviewed dr mark mccarthy thank providing preprint manuscript diabetes num press ide polymorphisms uk study
0.31976065.12765971.html.plaintext.txt	50	thank staff fhs genetics laboratory work performed support study dr christopher o donnell careful reading manuscript earlier version manuscript reviewed dr mark mccarthy thank providing preprint manuscript diabetes num press ide polymorphisms uk study
0.31976065.12765971.html.plaintext.txt	51	footnotes address correspondence reprint requests alan herbert framingham heart study genetics laboratory department neurology boston university school medicine num albany st boston ma num e mail aherbertatbuedu u d
0.31976065.12765971.html.plaintext.txt	52	received publication num october num accepted revised form num february num
0.31976065.12765971.html.plaintext.txt	53	fhs framingham heart study fpg fasting plasma glucose ide insulin degrading enzyme ipg impaired plasma glucose ld linkage disequilibrium ldu ld unit mfpg mean fpg snp single nucleotide polymorphism
0.31976065.12765971.html.plaintext.txt	54	references top abstract introduction research design methods references meigs jb panhuysen ci myers rh wilson pw cupples la genome wide scan loci linked plasma levels glucose hbanumc community based sample caucasian pedigrees framingham offspring study symb num numnumabstractfree full text wiltshire hattersley hitman ga walker m levy jc sampson m o rahilly frayling tm bell ji lathrop gm bennett dhillon r fletcher c groves cj jones e prestwich p simecek n rao pv wishart m bottazzo gf foxon r howell smedley d cardon lr menzel mccarthy mi genomewide scan loci predisposing type num diabetes uk population diabetes uk warren num repository analysis num pedigrees provides independent replication susceptibility locus chromosome numq j hum symb num numnummedline ghosh watanabe rm valle tt hauser er magnuson vl langefeld cd ally ds mohlke kl silander k kohtamaki k chines p balow jr j birznieks g chang j eldridge w erdos mr karanjawala ze knapp ji kudelko k martin c morales mena musick musick pfahl c porter r rayman jb finland united states investigation non insulin dependent diabetes mellitus genetics fusion study autosomal genome scan genes predispose type num diabetes j hum symb num numnummedline fakhrai rad h nikoshkov kamel fernstrom m zierath jr norgren luthman h galli j insulin degrading enzyme identified candidate diabetes susceptibility gene gk rats hum mol symb num numnumabstractfree full text duckworth wc bennett rg hamel fg insulin degradation progress potential endocr symb num numnumabstractfree full text kannel wb feinleib m mcnamara pm garrison rj castelli wp investigation coronary heart disease families framingham offspring study j symb num numnumabstract maniatis n collins xu cf mccarthy lc hewett dr tapper w ennis ke x morton ne first linkage disequilibrium ld maps delineation hot cold blocks diplotype analysis proc natl acad sci u symb num numnumabstractfree full text abraham r myers wavrant devrieze f hamshere ml thomas hv marshall h compton d spurlock g turic d hoogendoorn b kwon jm petersen rc tangalos e norton j morris jc bullock r liolitsa d lovestone hardy j goate o donovan m williams j owen mj jones l substantial linkage disequilibrium across insulin degrading enzyme locus association late onset alzheimer disease hum symb num numnummedline horvath xu x laird nm family based association test method strategies studying general genotype phenotype associations eur j hum symb num numnummedline schaid dj rowland cm tines de jacobson rm poland ga score tests association traits haplotypes linkage phase ambiguous j hum symb num numnummedline schaid dj mcdonnell sk wang l cunningham jm thibodeau sn caution pedigree haplotype inference software assumes linkage equilibrium j hum symb num numnummedline leiter eh reifsnyder pc flurkey k partke hj junger e herberg l niddm genes mice deleterious synergism parental genomes contributes diabetogenic thresholds symb num numnumabstract leiter eh kintner j flurkey k beamer wg naggert jk physiologic endocrinologic characterization male sex biased diabetes symbj mice congenic fat mutation carboxypeptidease e locus symb num numnummedline wajchenberg bl subcutaneous visceral adipose tissue relation metabolic syndrome endocr symb num numnumabstractfree full text chesneau v rosner mr functional human insulin degrading enzyme expressed bacteria protein expr symb num numnummedline ardlie kg kruglyak l seielstad m patterns linkage disequilibrium human genome nat rev symb num numnummedline gabriel sb schaffner sf nguyen h moore jm roy j blumenstiel b higgins j defelice m lochner faggart m liu cordero sn rotimi c adeyemo cooper r ward r lander es daly mj altshuler d structure haplotype blocks human genome symb num numnumabstractfree full text risch n merikangas k future genetic studies complex human diseases letter symb num numnummedline kannel wb sorlie p health benefits physical activity framingham study arch intern symb num numnummedline buetow kh edmonson m macdonald r clifford r yip p kelley j little dp strausberg r koester h cantor cr braun high throughput development characterization genomewide collection gene based single nucleotide polymorphism markers chip based matrix assisted laser desorptionionization time flight mass spectrometry proc natl acad sci u symb num numnumabstractfree full text
0.32454574.11823323.html.plaintext.txt	0	new drugs alzheimers disease dementias roger bullock mrcpsych
0.32454574.11823323.html.plaintext.txt	1	department old age psychiatry kingshill research centre avon wiltshire mental health trust victoria hospital swindon sni numhz uk tel num numnum num num fax num numnum num num
0.32454574.11823323.html.plaintext.txt	2	department old age psychiatry kingshill research centre avon wiltshire mental health trust victoria hospital swindon sni numhz uk tel num numnum num num fax num numnum num num
0.32454574.11823323.html.plaintext.txt	3	background alzheimers disease management involves symptomatic drug treatments passed national institute clinical excellence disease modification goal
0.32454574.11823323.html.plaintext.txt	4	background alzheimers disease management involves symptomatic drug treatments passed national institute clinical excellence disease modification goal
0.32454574.11823323.html.plaintext.txt	5	aims review current developmental drugs alzheimers disease usage clinical context known facts proposed specific models
0.32454574.11823323.html.plaintext.txt	6	method brief evidence based review made using literature available evidence consensus groups absent
0.32454574.11823323.html.plaintext.txt	7	results good evidence support use cholinesterase inhibitors perhaps vitamin e oestrogen anti inflammatory agents show possibility enough evidence support routine use
0.32454574.11823323.html.plaintext.txt	8	results good evidence support use cholinesterase inhibitors perhaps vitamin e oestrogen anti inflammatory agents show possibility enough evidence support routine use
0.32454574.11823323.html.plaintext.txt	9	conclusions symptomatic treatments exist alzheimers disease observational studies increasing knowledge brain biology leading towards treatment options old age psychiatrists valuable treatments learn use
0.32454574.11823323.html.plaintext.txt	10	conclusions symptomatic treatments exist alzheimers disease observational studies increasing knowledge brain biology leading towards treatment options old age psychiatrists valuable treatments learn use
0.32454574.11823323.html.plaintext.txt	11	cholinergic hypothesis alzheimers disease davies maloney num led development number strategies enhance failing cholinergic neurons thus neurotransmitter acetylcholine consistent therapeutic effect seen using inhibitors enzyme acetylcholinesterase cleaves transmitter cholinergic synapse three compounds licensed treatment alzheimers disease donepezil rivastigmine galantamine increased awareness alzheimers disease unfortunately cost pressures hindered development uk even though experienced users donepezil rivastigmine found consistent results cameron et al num evans et al num matthews et al num acetylcholinesterase inhibitors acheis considered stepping stone better disease modifying compounds bullock num although undoubtedly class drug yet reached clinic acheis remain main treatment option time variety protocols treatment harvey num superseded uk national institute clinical excellence num guidelines use three drugs
0.32454574.11823323.html.plaintext.txt	12	cholinergic hypothesis alzheimers disease davies maloney num led development number strategies enhance failing cholinergic neurons thus neurotransmitter acetylcholine consistent therapeutic effect seen using inhibitors enzyme acetylcholinesterase cleaves transmitter cholinergic synapse three compounds licensed treatment alzheimers disease donepezil rivastigmine galantamine increased awareness alzheimers disease unfortunately cost pressures hindered development uk even though experienced users donepezil rivastigmine found consistent results cameron et al num evans et al num matthews et al num acetylcholinesterase inhibitors acheis considered stepping stone better disease modifying compounds bullock num although undoubtedly class drug yet reached clinic acheis remain main treatment option time variety protocols treatment harvey num superseded uk national institute clinical excellence num guidelines use three drugs
0.32454574.11823323.html.plaintext.txt	13	practical dilemmas use acetylcholinesterase inhibitors
0.32454574.11823323.html.plaintext.txt	14	achei class drugs affect measured domains dementia much way consistency effect evident fig num shows cognition scores averaged pivotal trials three licensed compounds symptomatic response lasting approximately num months followed decline remains significantly placebo group longer periods supports preclinical cholinergic hypotheses davies maloney num exciting symptomatic treatment end complex disease process analogous use levodopa parkinsons disease achei class continues present practical scientific challenges clinicians need resolved meanwhile different treatments continue development
0.32454574.11823323.html.plaintext.txt	15	achei class drugs affect measured domains dementia much way consistency effect evident fig num shows cognition scores averaged pivotal trials three licensed compounds symptomatic response lasting approximately num months followed decline remains significantly placebo group longer periods supports preclinical cholinergic hypotheses davies maloney num exciting symptomatic treatment end complex disease process analogous use levodopa parkinsons disease achei class continues present practical scientific challenges clinicians need resolved meanwhile different treatments continue development
0.32454574.11823323.html.plaintext.txt	16	view larger version numk fig num combined clinical trial data three licensed acetylcholinesterase inhibitors rivastigmine donepezil galantamine versus placebo graph shows change cognition scores patients assessed num week intervals positive change improvement adas cog alzheimers disease assessment scale cognitive section
0.32454574.11823323.html.plaintext.txt	17	view larger version numk fig num combined clinical trial data three licensed acetylcholinesterase inhibitors rivastigmine donepezil galantamine versus placebo graph shows change cognition scores patients assessed num week intervals positive change improvement adas cog alzheimers disease assessment scale cognitive section
0.32454574.11823323.html.plaintext.txt	18	trials acheis response measured scales used found average num patients studied corey bloom et al num rogers et al num raskind et al num compares favourably drugs chronic illness acheis low numbers needed treat nnts livingston katona num using scores published data donepezil nnt num rivastigmine num galantamine num high placebo response often questioned common mental health studies masks large non drug treatment effect responders non responders identified criteria may harsh nature response needs research definition currently hard predictor response non response identified schneider farlow num symb allele suggested marker poor response subsequent studies suggested correlation
0.32454574.11823323.html.plaintext.txt	19	trials acheis response measured scales used found average num patients studied corey bloom et al num rogers et al num raskind et al num compares favourably drugs chronic illness acheis low numbers needed treat nnts livingston katona num using scores published data donepezil nnt num rivastigmine num galantamine num high placebo response often questioned common mental health studies masks large non drug treatment effect responders non responders identified criteria may harsh nature response needs research definition currently hard predictor response non response identified schneider farlow num symb allele suggested marker poor response subsequent studies suggested correlation
0.32454574.11823323.html.plaintext.txt	20	absence valid biological markers alzheimers disease measuring effect intervention may disease requires patients treated reasonable length time perhaps num months reality depends economics uk prescribers tend work subsets mild moderate dementia excluding institutional patients advanced disease prescribing community based patients medication supervised ratified nice guidelines
0.32454574.11823323.html.plaintext.txt	21	absence valid biological markers alzheimers disease measuring effect intervention may disease requires patients treated reasonable length time perhaps num months reality depends economics uk prescribers tend work subsets mild moderate dementia excluding institutional patients advanced disease prescribing community based patients medication supervised ratified nice guidelines
0.32454574.11823323.html.plaintext.txt	22	various models prescribing exist involving titration dose minimise side effects particularly gastrointestinal ones donepezil advantage two dose steps rivastigmine galantamine offer wider range making tailoring individual patients perhaps precise whichever drug chosen dose taken maximum tolerated within licence least num months treatment given considering whether inadequate response rigidity may mean late responders miss potential benefit within limited budget allow patients exposure treatment
0.32454574.11823323.html.plaintext.txt	23	various models prescribing exist involving titration dose minimise side effects particularly gastrointestinal ones donepezil advantage two dose steps rivastigmine galantamine offer wider range making tailoring individual patients perhaps precise whichever drug chosen dose taken maximum tolerated within licence least num months treatment given considering whether inadequate response rigidity may mean late responders miss potential benefit within limited budget allow patients exposure treatment
0.32454574.11823323.html.plaintext.txt	24	one drug work intolerable side effects another tried although three drugs belong class different published information switching drugs convention switching drugs leave interval five times half life first drug commencing second num hours rivastigmine num days donepezil consensus suggests num days left treatment rivastigmine galantamine week left following donepezil treatment based clinical practice controlled trial published
0.32454574.11823323.html.plaintext.txt	25	one drug work intolerable side effects another tried although three drugs belong class different published information switching drugs convention switching drugs leave interval five times half life first drug commencing second num hours rivastigmine num days donepezil consensus suggests num days left treatment rivastigmine galantamine week left following donepezil treatment based clinical practice controlled trial published
0.32454574.11823323.html.plaintext.txt	26	three drugs similar yet different individual characteristics table num clinically relevant differences unproven interesting hypotheses arising
0.32454574.11823323.html.plaintext.txt	27	three drugs similar yet different individual characteristics table num clinically relevant differences unproven interesting hypotheses arising
0.32454574.11823323.html.plaintext.txt	28	view table table num attributes three licensed acetylcholinesterase inhibitors
0.32454574.11823323.html.plaintext.txt	29	donepezil donepezil selective acetylcholinesterase ache selectivity claimed reduce side effect profile published clinical data shown increased tolerability paradoxically alzheimers disease level ache falls disease progresses arendt num matched rise butyrylcholinesterase buche function unknown forms part plaques appears come activated glial cells buche inhibition means unclear rivastigmine galantamine inhibit donepezil may work differently later disease although published evidence supported
0.32454574.11823323.html.plaintext.txt	30	donepezil donepezil selective acetylcholinesterase ache selectivity claimed reduce side effect profile published clinical data shown increased tolerability paradoxically alzheimers disease level ache falls disease progresses arendt num matched rise butyrylcholinesterase buche function unknown forms part plaques appears come activated glial cells buche inhibition means unclear rivastigmine galantamine inhibit donepezil may work differently later disease although published evidence supported
0.32454574.11823323.html.plaintext.txt	31	rivastigmine rivastigmine preferentially inhibits one four ache subtypes symb found particularly hypothalamus cortex subtype implicated plaque maturation whether added clinical benefit specificity unproven
0.32454574.11823323.html.plaintext.txt	32	rivastigmine rivastigmine preferentially inhibits one four ache subtypes symb found particularly hypothalamus cortex subtype implicated plaque maturation whether added clinical benefit specificity unproven
0.32454574.11823323.html.plaintext.txt	33	galantamine galantamine produces effect presynaptic nicotinic receptors called allosteric modulation physostigmine codeine produces increased amounts acetylcholine synapse direct effect presynaptic release clinical impact unknown published evidence significance desirability required may modulation rather agonism protects downregulation post synaptic receptors may allow drug work longer studies needed confirm modulation also improves attention demonstrated galantamine donepezil rivastigmine alzheimers disease
0.32454574.11823323.html.plaintext.txt	34	galantamine galantamine produces effect presynaptic nicotinic receptors called allosteric modulation physostigmine codeine produces increased amounts acetylcholine synapse direct effect presynaptic release clinical impact unknown published evidence significance desirability required may modulation rather agonism protects downregulation post synaptic receptors may allow drug work longer studies needed confirm modulation also improves attention demonstrated galantamine donepezil rivastigmine alzheimers disease
0.32454574.11823323.html.plaintext.txt	35	drugs licensed mild moderate alzheimers disease patients mild disease already significant illness receive treatment even minimal symptoms treating mildly affected patients mean smaller responses protocols reflect long term follow needed show continuing effect beyond expected clinical trials moderate disease covers wide range morbidity trials mini mental state examination mmse folstein et al num score num nice guidelines num patients scoring lower end range host symptoms acheis may valuable symptomatic effects behaviour effect underlying disease trial data metrifonate another achei withdrawn side effects showed improvement neuropsychiatric symptoms alzheimers disease especially apathy hallucinations agitation cummings et al num effect noticeable dementia lewy bodies improvements mmse scores neuropsychiatric symptoms demonstrated rivastigmine mckeith et al num suggests dementia treated time symptomatic delay retention qualify life aim early disease moving towards symptomatic relief progression occurs published results available severe dementia though open label follow trials suggests drugs continue working cholinergic deficit increases
0.32454574.11823323.html.plaintext.txt	36	drugs licensed mild moderate alzheimers disease patients mild disease already significant illness receive treatment even minimal symptoms treating mildly affected patients mean smaller responses protocols reflect long term follow needed show continuing effect beyond expected clinical trials moderate disease covers wide range morbidity trials mini mental state examination mmse folstein et al num score num nice guidelines num patients scoring lower end range host symptoms acheis may valuable symptomatic effects behaviour effect underlying disease trial data metrifonate another achei withdrawn side effects showed improvement neuropsychiatric symptoms alzheimers disease especially apathy hallucinations agitation cummings et al num effect noticeable dementia lewy bodies improvements mmse scores neuropsychiatric symptoms demonstrated rivastigmine mckeith et al num suggests dementia treated time symptomatic delay retention qualify life aim early disease moving towards symptomatic relief progression occurs published results available severe dementia though open label follow trials suggests drugs continue working cholinergic deficit increases
0.32454574.11823323.html.plaintext.txt	37	acheis dementias plus cholinergic therapies clinical trials ongoing acheis vascular dementia mixed dementia result available yet cholinergic system implicated disorders hoped findings positive study rivastigmine dementia lewy bodies produced positive results mckeith et al num acetylcholinesterases studied potential treatment mild cognitive impairment rational assumption num patients problem go develop alzheimers disease intervention may profound effect burden disease overall study anticholinergic therapy frontotemporal dementia way present
0.32454574.11823323.html.plaintext.txt	38	acheis dementias plus cholinergic therapies clinical trials ongoing acheis vascular dementia mixed dementia result available yet cholinergic system implicated disorders hoped findings positive study rivastigmine dementia lewy bodies produced positive results mckeith et al num acetylcholinesterases studied potential treatment mild cognitive impairment rational assumption num patients problem go develop alzheimers disease intervention may profound effect burden disease overall study anticholinergic therapy frontotemporal dementia way present
0.32454574.11823323.html.plaintext.txt	39	muscarinic agonists tried alzheimers disease drugs narrow therapeutic window side effects become intolerable date clinical trial shown significant effects cognition nicotinic drugs also still early trial stages similar tolerability problems overcome promising efficacy data
0.32454574.11823323.html.plaintext.txt	40	muscarinic agonists tried alzheimers disease drugs narrow therapeutic window side effects become intolerable date clinical trial shown significant effects cognition nicotinic drugs also still early trial stages similar tolerability problems overcome promising efficacy data
0.32454574.11823323.html.plaintext.txt	41	research alzheimers disease led understanding pathological mechanisms involved inflammation occurs evidenced inflammatory markers found example complement attack complex levels similar found ischaemic heart disease mcgeer mcgeer num basic science coupled observation sufferers rheumatoid arthritis lower rate alzheimers disease stewart et al num led trials anti inflammatory drugs treatment alzheimers disease trials prednisolone successful ongoing work cyclo oxygenase inhibitors especially cox num animal human clinical trials may show benefit drugs without long term side effects current practice recommend use routinely
0.32454574.11823323.html.plaintext.txt	42	research alzheimers disease led understanding pathological mechanisms involved inflammation occurs evidenced inflammatory markers found example complement attack complex levels similar found ischaemic heart disease mcgeer mcgeer num basic science coupled observation sufferers rheumatoid arthritis lower rate alzheimers disease stewart et al num led trials anti inflammatory drugs treatment alzheimers disease trials prednisolone successful ongoing work cyclo oxygenase inhibitors especially cox num animal human clinical trials may show benefit drugs without long term side effects current practice recommend use routinely
0.32454574.11823323.html.plaintext.txt	43	another observational study shown women hormone replacement therapy hrt reduced rate alzheimers disease robinson et al num protective effect oestrogen nervous system vasculature well documented birge num clinical trials progress test efficacy oestrogen therapy num oestradiol particularly early treatment study results encouraging mulnard et al num absence published positive studies hrt recommended use treatment alzheimers disease although seem use increasing alzheimers disease prophylaxis particularly usa
0.32454574.11823323.html.plaintext.txt	44	another observational study shown women hormone replacement therapy hrt reduced rate alzheimers disease robinson et al num protective effect oestrogen nervous system vasculature well documented birge num clinical trials progress test efficacy oestrogen therapy num oestradiol particularly early treatment study results encouraging mulnard et al num absence published positive studies hrt recommended use treatment alzheimers disease although seem use increasing alzheimers disease prophylaxis particularly usa
0.32454574.11823323.html.plaintext.txt	45	antioxidants shown benefit several areas chronic ill health including alzheimers disease study selegiline vitamin e effect disease progression sano et al num showed positive effect rate increasing dependency delayed institutionalisation however yet replicated vitamin e inexpensive relatively safe trial high dosage num iu institutionalisation expensive return treatment potentially high rigorously proven many clinics routinely suggesting use vitamin e patients alzheimers disease usually num iu possible may benefit dementias neurodegenerative disease well
0.32454574.11823323.html.plaintext.txt	46	antioxidants shown benefit several areas chronic ill health including alzheimers disease study selegiline vitamin e effect disease progression sano et al num showed positive effect rate increasing dependency delayed institutionalisation however yet replicated vitamin e inexpensive relatively safe trial high dosage num iu institutionalisation expensive return treatment potentially high rigorously proven many clinics routinely suggesting use vitamin e patients alzheimers disease usually num iu possible may benefit dementias neurodegenerative disease well
0.32454574.11823323.html.plaintext.txt	47	nootropic drugs available prescription germany best known gingko biloba extract nicergoline piracetam precise modes action unclear yet seem produce effect well controlled studies
0.32454574.11823323.html.plaintext.txt	48	nootropic drugs available prescription germany best known gingko biloba extract nicergoline piracetam precise modes action unclear yet seem produce effect well controlled studies
0.32454574.11823323.html.plaintext.txt	49	glutamate increasingly implicated dementia pathogenesis n methyl d aspartate nmda blockade putative therapy memantine nmda blocker positive results reported severe alzheimers disease eg winblad poritis num leading application regulatory approval use dementia
0.32454574.11823323.html.plaintext.txt	50	glutamate increasingly implicated dementia pathogenesis n methyl d aspartate nmda blockade putative therapy memantine nmda blocker positive results reported severe alzheimers disease eg winblad poritis num leading application regulatory approval use dementia
0.32454574.11823323.html.plaintext.txt	51	nerve cell destruction seems secondary activation glial cells stabilisation glial cells may reduce rate alzheimers disease dementias several compounds propentofylline purportedly effect especially vitro date shown therapeutic effect clinically remains potential area research
0.32454574.11823323.html.plaintext.txt	52	nerve cell destruction seems secondary activation glial cells stabilisation glial cells may reduce rate alzheimers disease dementias several compounds propentofylline purportedly effect especially vitro date shown therapeutic effect clinically remains potential area research
0.32454574.11823323.html.plaintext.txt	53	cortical cholinergic system diffusely spread long way cell bodies therefore dependent nerve growth factor ngf sustain reduction ngf may associated alzheimers disease studies injecting ngf cannulae cerebrospinal fluid showed effect practical solution attempts formulate active portion ngf oral preparation crosses blood brain barrier ongoing meanwhile xanthine derivative leteprinim potassium seems stimulating effect ngf start clinical trial
0.32454574.11823323.html.plaintext.txt	54	cortical cholinergic system diffusely spread long way cell bodies therefore dependent nerve growth factor ngf sustain reduction ngf may associated alzheimers disease studies injecting ngf cannulae cerebrospinal fluid showed effect practical solution attempts formulate active portion ngf oral preparation crosses blood brain barrier ongoing meanwhile xanthine derivative leteprinim potassium seems stimulating effect ngf start clinical trial
0.32454574.11823323.html.plaintext.txt	55	pathological basis alzheimers disease presence amyloid plaques neurofibrillary tangles work focused amyloid cascade produces plaques various drugs development modify amyloid metabolism imminent clinical trial injection beta amyloid protein vaccinate individual produce antibody response might remove amyloid nervous tissue mice procedure relieved symptoms genetic alzheimers disease animal models schenk et al num prevented plaque formation younger mice method tried humans uk usa represents first true attempt disease modification
0.32454574.11823323.html.plaintext.txt	56	pathological basis alzheimers disease presence amyloid plaques neurofibrillary tangles work focused amyloid cascade produces plaques various drugs development modify amyloid metabolism imminent clinical trial injection beta amyloid protein vaccinate individual produce antibody response might remove amyloid nervous tissue mice procedure relieved symptoms genetic alzheimers disease animal models schenk et al num prevented plaque formation younger mice method tried humans uk usa represents first true attempt disease modification
0.32454574.11823323.html.plaintext.txt	57	classical pathological change development tangles made abnormal tau protein tau pathology known exist neurodegenerative conditions important area research treating dementing diseases frontotemporal dementia progressive supranuclear palsy hyperphosphorylation occurs alzheimers disease may amenable therapeutic intervention experimental models support drugs clinical trials yet
0.32454574.11823323.html.plaintext.txt	58	classical pathological change development tangles made abnormal tau protein tau pathology known exist neurodegenerative conditions important area research treating dementing diseases frontotemporal dementia progressive supranuclear palsy hyperphosphorylation occurs alzheimers disease may amenable therapeutic intervention experimental models support drugs clinical trials yet
0.32454574.11823323.html.plaintext.txt	59	basic science research gradually unlocking pathological sequences dementia especially alzheimers disease provide theoretical treatment opportunities began acheis stage amyloid modification first time therapeutic options exist alzheimers disease soon available dementias may simple using vitamin e combinations therapy maximise benefit table num although treatments still predominantly symptomatic offer relief patients increased clinicians awareness condition taken old age psychiatry roots social psychiatry point psychopharmacology important role challenge learn use treatments effectively means everyone speciality uses treatments opportunity contribute debate prospects development next num years make one exciting dynamic areas medicine work
0.32454574.11823323.html.plaintext.txt	60	basic science research gradually unlocking pathological sequences dementia especially alzheimers disease provide theoretical treatment opportunities began acheis stage amyloid modification first time therapeutic options exist alzheimers disease soon available dementias may simple using vitamin e combinations therapy maximise benefit table num although treatments still predominantly symptomatic offer relief patients increased clinicians awareness condition taken old age psychiatry roots social psychiatry point psychopharmacology important role challenge learn use treatments effectively means everyone speciality uses treatments opportunity contribute debate prospects development next num years make one exciting dynamic areas medicine work
0.32454574.11823323.html.plaintext.txt	61	view table table num current potential treatments dementia
0.32454574.11823323.html.plaintext.txt	62	clinical implications limitations
0.32454574.11823323.html.plaintext.txt	63	clinical implications anticholinesterase therapy major contribution therapeutic treatment regimen alzheimers disease endorsed national institute clinical excellence psychopharmacology alzheimers disease important addition old age psychiatrists skills professional development requirements services need move towards diagnosis early mild dementia rather intervene moderate severe stages
0.32454574.11823323.html.plaintext.txt	64	clinical implications anticholinesterase therapy major contribution therapeutic treatment regimen alzheimers disease endorsed national institute clinical excellence psychopharmacology alzheimers disease important addition old age psychiatrists skills professional development requirements services need move towards diagnosis early mild dementia rather intervene moderate severe stages
0.32454574.11823323.html.plaintext.txt	65	limitations funding new drugs may hard obtain especially areas basic service needs unmet require attention first symptomatic treatments need drugs change course illness single therapy likely solution alzheimers disease need learn best use cholinesterase inhibitors combine new drugs arrive initiated level primary care
0.32454574.11823323.html.plaintext.txt	66	limitations funding new drugs may hard obtain especially areas basic service needs unmet require attention first symptomatic treatments need drugs change course illness single therapy likely solution alzheimers disease need learn best use cholinesterase inhibitors combine new drugs arrive initiated level primary care
0.32454574.11823323.html.plaintext.txt	67	author thanks colleagues used drugs date participation various consensus groups order fill gaps review evidence remains weak
0.32454574.11823323.html.plaintext.txt	68	arendt num changes acetylcholinesterase butyrylcholinesterase alzheimers disease resemble embryonic development study molecular forms neurochemistry international num num nummedline
0.32454574.11823323.html.plaintext.txt	69	bullock r num drug treatment early alzheimers disease advances psychiatric treatment num num num
0.32454574.11823323.html.plaintext.txt	70	national institute clinical excellence num guidance use donepezil rivastigmine galantamine treatment alzheimers disease london nice
0.32454574.11823323.html.plaintext.txt	71	received publication april num num revision received may num num accepted publication june num num
0.32454574.11823323.html.plaintext.txt	72	received publication april num num revision received may num num accepted publication june num num
0.32454574.11823323.html.plaintext.txt	73	highlights issue elizabeth walsh bjp num num num full text
0.32454574.11823323.html.plaintext.txt	74	old age psychiatry alistair burns ian g mckeith bjp num num num num full text
0.34450078.11823322.html.plaintext.txt	0	genotype phenotype alzheimers disease clive holmes mrcpsych
0.34450078.11823322.html.plaintext.txt	1	thornhill research unit university southampton moorgreen hospital botley road west end southampton symb numjb uk
0.34450078.11823322.html.plaintext.txt	2	background patients alzheimers disease show wide variation clinical phenotype genetic research largely concerned role mutations common variants risk factors disease genetic factors also influence clinical phenotype
0.34450078.11823322.html.plaintext.txt	3	background patients alzheimers disease show wide variation clinical phenotype genetic research largely concerned role mutations common variants risk factors disease genetic factors also influence clinical phenotype
0.34450078.11823322.html.plaintext.txt	4	aims examine evidence genetic factors influence clinical expression disease addition influencing risk
0.34450078.11823322.html.plaintext.txt	5	method selective review made key literature
0.34450078.11823322.html.plaintext.txt	6	results mutations three genes coding amyloid precursor protein presenilin num presenilin num common variation num another gene apoe shown lead earlier development disease recently genetic association twin studies suggested role genetic factors development aspects clinical phenotype notably appearance non cognitive symptoms
0.34450078.11823322.html.plaintext.txt	7	results mutations three genes coding amyloid precursor protein presenilin num presenilin num common variation num another gene apoe shown lead earlier development disease recently genetic association twin studies suggested role genetic factors development aspects clinical phenotype notably appearance non cognitive symptoms
0.34450078.11823322.html.plaintext.txt	8	conclusions alzheimers disease genetic variation influences number aspects clinical phenotype
0.34450078.11823322.html.plaintext.txt	9	early family twin studies indicated number genes important part play development alzheimers disease variation genes including rare mutations common polymorphisms appears confer increased risk development disease however apparent increased risk may largely explained effects genetic variation clinical phenotype alzheimers disease particularly age disease presents recently proposed genetic variation may also explain features clinical phenotype including development non cognitive symptoms
0.34450078.11823322.html.plaintext.txt	10	early family twin studies indicated number genes important part play development alzheimers disease variation genes including rare mutations common polymorphisms appears confer increased risk development disease however apparent increased risk may largely explained effects genetic variation clinical phenotype alzheimers disease particularly age disease presents recently proposed genetic variation may also explain features clinical phenotype including development non cognitive symptoms
0.34450078.11823322.html.plaintext.txt	11	clearest evidence genetic contribution aetiology alzheimers disease existence families disease transmitted clear autosomal dominant pattern study one large pedigrees revealed transmission generation generation single point mutation gene amyloid precursor protein app found chromosome num family members developing early onset alzheimers disease studies families led discovery point mutations gene later presence mutations two genes encoding presenilin num ps num presenilin num ps num found chromosomes num num respectively date num alzheimers disease related mutations discovered app gene num mutations ps num gene num mutations ps num gene significantly research suggests different mutations three genes lead common result increase ss symb peptide fragment app forms core neuritic plaques found brains people alzheimers disease
0.34450078.11823322.html.plaintext.txt	12	clearest evidence genetic contribution aetiology alzheimers disease existence families disease transmitted clear autosomal dominant pattern study one large pedigrees revealed transmission generation generation single point mutation gene amyloid precursor protein app found chromosome num family members developing early onset alzheimers disease studies families led discovery point mutations gene later presence mutations two genes encoding presenilin num ps num presenilin num ps num found chromosomes num num respectively date num alzheimers disease related mutations discovered app gene num mutations ps num gene num mutations ps num gene significantly research suggests different mutations three genes lead common result increase ss symb peptide fragment app forms core neuritic plaques found brains people alzheimers disease
0.34450078.11823322.html.plaintext.txt	13	findings immense importance terms elucidating biological pathogenesis alzheimers diease important recognise three causal genes may account num num autosomal dominant early onset cases around num familial early onset cases cruts et al num thus given majority cases num alzheimers disease occurs age num years clear genetic mutations make small contribution risk developing disease general
0.34450078.11823322.html.plaintext.txt	14	findings immense importance terms elucidating biological pathogenesis alzheimers diease important recognise three causal genes may account num num autosomal dominant early onset cases around num familial early onset cases cruts et al num thus given majority cases num alzheimers disease occurs age num years clear genetic mutations make small contribution risk developing disease general
0.34450078.11823322.html.plaintext.txt	15	inheritance late onset alzheimers disease complex early onset form cross sectional studies presence positive family history late onset alzheimers disease consistent risk factor subjects late onset form clear autosomal dominant pattern inheritance rare twin family studies suggest polygenic multifactorial mode inheritance consequence elucidation genetic risk factors late onset alzheimers disease requires different methods used early onset disease simple mendelian patterns inheritance association studies far dominated genetics late onset alzheimers disease studies look variation frequency allele samples unrelated patients late onset alzheimers disease compared unrelated control subjects studies resulted number candidate genes proposed importance risk factors late onset alzheimers disease include associations variation genes encoding low density lipoprotein vldl receptor ps num intronic mutation associated early onset alzheimers disease butyrylcholinesterase angiotensin num converting enzyme num antichymotrypsin human leucocyte antigen hla complex num macroglobulin low density lipoprotein like receptor serotonin transporter interleukin num typically interest candidates diminished independent replication forthcoming little evidence remains important role genetic variation vldl receptor ps num num antichymotrypsin genes development late onset alzheimers disease candidate genes still advocates remain hotly disputed
0.34450078.11823322.html.plaintext.txt	16	inheritance late onset alzheimers disease complex early onset form cross sectional studies presence positive family history late onset alzheimers disease consistent risk factor subjects late onset form clear autosomal dominant pattern inheritance rare twin family studies suggest polygenic multifactorial mode inheritance consequence elucidation genetic risk factors late onset alzheimers disease requires different methods used early onset disease simple mendelian patterns inheritance association studies far dominated genetics late onset alzheimers disease studies look variation frequency allele samples unrelated patients late onset alzheimers disease compared unrelated control subjects studies resulted number candidate genes proposed importance risk factors late onset alzheimers disease include associations variation genes encoding low density lipoprotein vldl receptor ps num intronic mutation associated early onset alzheimers disease butyrylcholinesterase angiotensin num converting enzyme num antichymotrypsin human leucocyte antigen hla complex num macroglobulin low density lipoprotein like receptor serotonin transporter interleukin num typically interest candidates diminished independent replication forthcoming little evidence remains important role genetic variation vldl receptor ps num num antichymotrypsin genes development late onset alzheimers disease candidate genes still advocates remain hotly disputed
0.34450078.11823322.html.plaintext.txt	17	recently results number linkage studies become available methods used linkage studies complex non mendelian diseases late onset alzheimers disease less powerful used early onset form however studies reveal areas interest genome might later explored association studies complete genomic screen series multiplex families affected late onset alzheimers disease revealed five regions interest chromosomes num num num num num excluding effects symb locus maximum log likelihood ratio lod score study occurred region located short arm chromosome num pericak vance et al num however two subsequent studies following similar methods blacker et al num wu et al num unable confirm linkage area large sibpair study kehoe et al num revealed many possible loci showing linkage late onset alzheimers disease include loci chromosomes num num num num num num num close apoe num close app gene currently main focus attention chromosome num two independent studies showing evidence susceptibility locus region ertekin taner et al num myers et al num however clear large number loci implicated disagreement studies predicted areas interest findings demonstrate limitations approach also serve emphasise polygenic nature late onset alzheimers disease exploration areas association studies positional candidate approach likely dominate genetics alzheimers disease future
0.34450078.11823322.html.plaintext.txt	18	recently results number linkage studies become available methods used linkage studies complex non mendelian diseases late onset alzheimers disease less powerful used early onset form however studies reveal areas interest genome might later explored association studies complete genomic screen series multiplex families affected late onset alzheimers disease revealed five regions interest chromosomes num num num num num excluding effects symb locus maximum log likelihood ratio lod score study occurred region located short arm chromosome num pericak vance et al num however two subsequent studies following similar methods blacker et al num wu et al num unable confirm linkage area large sibpair study kehoe et al num revealed many possible loci showing linkage late onset alzheimers disease include loci chromosomes num num num num num num num close apoe num close app gene currently main focus attention chromosome num two independent studies showing evidence susceptibility locus region ertekin taner et al num myers et al num however clear large number loci implicated disagreement studies predicted areas interest findings demonstrate limitations approach also serve emphasise polygenic nature late onset alzheimers disease exploration areas association studies positional candidate approach likely dominate genetics alzheimers disease future
0.34450078.11823322.html.plaintext.txt	19	genetic risk factors advocated role development late onset alzheimers disease least controversial remains increased risk associated possession one copies symb allele coding apolipoprotein e apoe variant num significantly importance symb determined using positional candidate gene approach since finding studies artiga et al num bullido et al num lambert et al num also suggested association number polymorphisms within transcriptional regulatory region apoe gene late onset alzheimers disease independent apoe num status based data suggested two independent mechanisms risk late onset alzheimers disease modified apoe gene first variations coding regions alter functional properties apoe second presence promoter variants result quantitative differences apoe expression artiga et al num however hypothesis controversial recent studies helisalmi et al num zurutuza et al num failed support independence apoe promoter variants development alzheimers disease
0.34450078.11823322.html.plaintext.txt	20	genetic risk factors advocated role development late onset alzheimers disease least controversial remains increased risk associated possession one copies symb allele coding apolipoprotein e apoe variant num significantly importance symb determined using positional candidate gene approach since finding studies artiga et al num bullido et al num lambert et al num also suggested association number polymorphisms within transcriptional regulatory region apoe gene late onset alzheimers disease independent apoe num status based data suggested two independent mechanisms risk late onset alzheimers disease modified apoe gene first variations coding regions alter functional properties apoe second presence promoter variants result quantitative differences apoe expression artiga et al num however hypothesis controversial recent studies helisalmi et al num zurutuza et al num failed support independence apoe promoter variants development alzheimers disease
0.34450078.11823322.html.plaintext.txt	21	genetic influences clinical phenotype
0.34450078.11823322.html.plaintext.txt	22	age onset families carrying mutations app gene ages onset largely within range num num years date app mutation carrier reported unaffected beyond age num years families carrying mutations ps num gene earliest ages onset fall largely within range num num years although one family member recently recorded onset num years wisniewski et al num mutations largely associated early onset familial alzheimers disease least two mutations symb symb observed late onset alzheimers disease may non penetrant cruts et al num families carrying mutations ps num gene ages onset largely within range num num years thus show overlap late onset alzheimers disease penetrance high may num least two reported cases non penetrance age num years bird et al num
0.34450078.11823322.html.plaintext.txt	23	age onset families carrying mutations app gene ages onset largely within range num num years date app mutation carrier reported unaffected beyond age num years families carrying mutations ps num gene earliest ages onset fall largely within range num num years although one family member recently recorded onset num years wisniewski et al num mutations largely associated early onset familial alzheimers disease least two mutations symb symb observed late onset alzheimers disease may non penetrant cruts et al num families carrying mutations ps num gene ages onset largely within range num num years thus show overlap late onset alzheimers disease penetrance high may num least two reported cases non penetrance age num years bird et al num
0.34450078.11823322.html.plaintext.txt	24	familial influence age onset late onset alzheimers disease may substantial thus one study affected sib pairs suggests shared familial effects may account num variance tunstall et al num indeed studies shown late onset disease age onset approximately num years earlier individuals carry two copies symb allele compared non carriers led suggestion symb allele risk factor alzheimers disease mainly old age alzheimers disease death competing risks factor leading earlier age onset alzheimers disease elderly hence development disease prior death associated alzheimers disease evidence confirming hypothesis come large study approximately num individuals meyer et al num study showed clear decline relative risk developing late onset alzheimers disease subjects increasing age clear plateau beyond new cases disease reported age plateau reached earlier carriers symb allele thus appears clear symb allele predominant effect determining individual develops late onset alzheimers disease meyer et al num
0.34450078.11823322.html.plaintext.txt	25	familial influence age onset late onset alzheimers disease may substantial thus one study affected sib pairs suggests shared familial effects may account num variance tunstall et al num indeed studies shown late onset disease age onset approximately num years earlier individuals carry two copies symb allele compared non carriers led suggestion symb allele risk factor alzheimers disease mainly old age alzheimers disease death competing risks factor leading earlier age onset alzheimers disease elderly hence development disease prior death associated alzheimers disease evidence confirming hypothesis come large study approximately num individuals meyer et al num study showed clear decline relative risk developing late onset alzheimers disease subjects increasing age clear plateau beyond new cases disease reported age plateau reached earlier carriers symb allele thus appears clear symb allele predominant effect determining individual develops late onset alzheimers disease meyer et al num
0.34450078.11823322.html.plaintext.txt	26	non cognitive features genetic risk factors alzheimers disease associated non cognitive symptoms one might anticipate subjects family history disease increased frequency symptoms likewise one would expect association known genetic risk factors alzheimers disease including genes app ps num ps num apoe num allele symptoms alzheimers disease
0.34450078.11823322.html.plaintext.txt	27	non cognitive features genetic risk factors alzheimers disease associated non cognitive symptoms one might anticipate subjects family history disease increased frequency symptoms likewise one would expect association known genetic risk factors alzheimers disease including genes app ps num ps num apoe num allele symptoms alzheimers disease
0.34450078.11823322.html.plaintext.txt	28	fact appears little consistent evidence association either positive family history alzheimers disease variation known candidate genes increase frequency non cognitive symptoms occurring first time within disease thus seems unlikely major genetic risk factors development late onset alzheimers disease substantial role play development non cognitive symptoms within late onset disease however mean symptoms genetic basis since genes may influence phenotypic expression disease without involved directly aetiology indeed early studies shown evidence association positive family history depressive illness increase frequency depressive symptoms occurring first time within alzheimers disease pearlson et al num early findings supported sib pair study tunstall et al num showing familial factors role development depressive illness late onset alzheimers disease addition small study also suggests role familial factors wide variety non cognitive symptoms including agitation aggression psychosis
0.34450078.11823322.html.plaintext.txt	29	fact appears little consistent evidence association either positive family history alzheimers disease variation known candidate genes increase frequency non cognitive symptoms occurring first time within disease thus seems unlikely major genetic risk factors development late onset alzheimers disease substantial role play development non cognitive symptoms within late onset disease however mean symptoms genetic basis since genes may influence phenotypic expression disease without involved directly aetiology indeed early studies shown evidence association positive family history depressive illness increase frequency depressive symptoms occurring first time within alzheimers disease pearlson et al num early findings supported sib pair study tunstall et al num showing familial factors role development depressive illness late onset alzheimers disease addition small study also suggests role familial factors wide variety non cognitive symptoms including agitation aggression psychosis
0.34450078.11823322.html.plaintext.txt	30	direct approach also adopted whereby common genetic polymorphisms previously showing associations neuropsychiatric conditions found associated non cognitive symptoms late onset alzheimers disease example one study holmes et al num people late onset alzheimers disease found association common polymorphic variations num symb num symb serotonin receptor genes num tc symb polymorphisms respectively previously implicated schizophrenia bipolar affective disorder psychotic symptoms alzheimers disease associations found presence symb allele presence visual auditory hallucinations presence symb allele visual hallucinations another study sweet et al num found evidence suggest association psychosis aggression patients alzheimers disease carry common polymorphisms dopamine receptor genes symb symb studies need replicated suggest common receptor polymorphisms may role genesis psychotic non cognitive symptoms implicated genetic risk factors late onset alzheimers disease
0.34450078.11823322.html.plaintext.txt	31	direct approach also adopted whereby common genetic polymorphisms previously showing associations neuropsychiatric conditions found associated non cognitive symptoms late onset alzheimers disease example one study holmes et al num people late onset alzheimers disease found association common polymorphic variations num symb num symb serotonin receptor genes num tc symb polymorphisms respectively previously implicated schizophrenia bipolar affective disorder psychotic symptoms alzheimers disease associations found presence symb allele presence visual auditory hallucinations presence symb allele visual hallucinations another study sweet et al num found evidence suggest association psychosis aggression patients alzheimers disease carry common polymorphisms dopamine receptor genes symb symb studies need replicated suggest common receptor polymorphisms may role genesis psychotic non cognitive symptoms implicated genetic risk factors late onset alzheimers disease
0.34450078.11823322.html.plaintext.txt	32	cognitive decline study date looked rates decline carriers app ps num ps num mutations patients late onset alzheimers disease positive family history alzheimers disease show evidence increased rates decline majority studies also failed show relationships possession symb allele increased rates decline lack association interesting since implies genetic factors may determine disease starts rate degeneration clearly caution required interpreting negative finding may associations always difficult establish large number confounding factors may influence cognitive deterioration well difficulties use psychometric scales short periods indeed study craft et al num suggested increased rate cognitive decline symb carriers may detectable using long follow period
0.34450078.11823322.html.plaintext.txt	33	cognitive decline study date looked rates decline carriers app ps num ps num mutations patients late onset alzheimers disease positive family history alzheimers disease show evidence increased rates decline majority studies also failed show relationships possession symb allele increased rates decline lack association interesting since implies genetic factors may determine disease starts rate degeneration clearly caution required interpreting negative finding may associations always difficult establish large number confounding factors may influence cognitive deterioration well difficulties use psychometric scales short periods indeed study craft et al num suggested increased rate cognitive decline symb carriers may detectable using long follow period
0.34450078.11823322.html.plaintext.txt	34	duration mean duration illness families ps num mutations significantly shorter range numnum numnum years families ps num range numnum numnum years app mutations range numnum num years reflecting severity ps num associated alzheimers disease studies late onset alzheimers disease suggest duration illness tends longer people positive family history carriers symb allele however since shown relationship longer holds true confounding effects age onset taken account thus late onset alzheimers disease increased survival directly related earlier age onset influenced number factors exclusively genetic
0.34450078.11823322.html.plaintext.txt	35	clinical implications limitations
0.34450078.11823322.html.plaintext.txt	36	clinical implications number genes implicated risk factors development alzheimers disease variation genes appears major effect determining disease develop aspects clinical phenotype notably non cognitive symptoms also influenced genetic variation
0.34450078.11823322.html.plaintext.txt	37	clinical implications number genes implicated risk factors development alzheimers disease variation genes appears major effect determining disease develop aspects clinical phenotype notably non cognitive symptoms also influenced genetic variation
0.34450078.11823322.html.plaintext.txt	38	limitations number risk genes yet identified influence unknown genes clinical phenotype yet undetermined influence genetic variation non cognitive symptoms relatively unexplored
0.34450078.11823322.html.plaintext.txt	39	limitations number risk genes yet identified influence unknown genes clinical phenotype yet undetermined influence genetic variation non cognitive symptoms relatively unexplored
0.34450078.11823322.html.plaintext.txt	40	received publication may num num revision received may num num accepted publication may num num
0.34450078.11823322.html.plaintext.txt	41	received publication may num num revision received may num num accepted publication may num num
0.34450078.11823322.html.plaintext.txt	42	highlights issue elizabeth walsh bjp num num num full text
0.34450078.11823322.html.plaintext.txt	43	old age psychiatry alistair burns ian g mckeith bjp num num num num full text
0.3856874.12716770.html.plaintext.txt	0	association haplotype analysis insulin degrading enzyme ide gene strong positional biological candidate type num diabetes susceptibility christopher j symbnum steven symbnum damian symb katherine r symb timothy m symb mark symb graham symb jonathan c symb stephen o symb stephan symb andrew symb mark symbnumnum
0.3856874.12716770.html.plaintext.txt	1	association haplotype analysis insulin degrading enzyme ide gene strong positional biological candidate type num diabetes susceptibility christopher j symbnum steven symbnum damian symb katherine r symb timothy m symb mark symb graham symb jonathan c symb stephen o symb stephan symb andrew symb mark symbnumnum
0.3856874.12716770.html.plaintext.txt	2	num oxford centre diabetes endocrinology metabolism oxford uk num wellcome trust centre human genetics oxford uk num genetics genomics research institute imperial college faculty medicine hammersmith hospital london uk num centre molecular genetics peninsular medical school exeter uk num school clinical medical sciences university newcastle newcastle uk num department diabetes metabolic medicine bart london queen mary school medicine dentistry london uk num departments medicine clinical biochemistry addenbrooke hospital cambridge uk
0.3856874.12716770.html.plaintext.txt	3	abstract top abstract research design methods references gene insulin degrading enzyme ide represents strong positional biological candidate type num diabetes susceptibility ide maps chromosome numsymbnum region linked diabetes several populations rat homolog directly implicated diabetes susceptibility known functions ide support important role glucose homeostasis sought evidence association ide variation diabetes mutation screening defining local haplotype structure genotyping variants delineating common haplotypic diversity initial case control analysis num diabetic probands multiplex sibships num control subjects found haplotypic associations although one variant symb numtc showed modest association diabetes odds ratio ornumnum p numnum linkage partitioning analyses failed support association provided borderline evidence different variant symb symb numag p numnum neither variant associated diabetes replication sought num early onset diabetic subjects num control subjects though combined analysis typed cohorts indicated nominally significant effect symb numnum numnum numnum p numnum absence convincing support association linkage partitioning analyses continuous measures glycemia conclude analysis numnum samples provides compelling evidence variation ide contributes diabetes susceptibility humans
0.3856874.12716770.html.plaintext.txt	4	linkage disequilibrium analysis within candidate genes represents final common pathway identification diabetes susceptibility genes candidate selection typically based positional information linkage studies humans rodent models andor perceived match gene function pathophysiology condition
0.3856874.12716770.html.plaintext.txt	5	linkage disequilibrium analysis within candidate genes represents final common pathway identification diabetes susceptibility genes candidate selection typically based positional information linkage studies humans rodent models andor perceived match gene function pathophysiology condition
0.3856874.12716770.html.plaintext.txt	6	several independent lines evidence suggest role gene encoding insulin degrading enzyme ide locuslink reference num ec reference numnumnumnum type num diabetes pathogenesis making promising candidate analysis first ide maps region chromosome numq showing evidence linkage type num diabetes several populations genomewide scan num uk type num diabetic pedigrees evidence linkage multipoint logarithm odds lod numnum peaked near symbnum num mb ide conditional analyses suggested epistatic interaction well replicated susceptibility locus chromosome numq num linkage numq also reported finns num north american europeans num mexican americans num french num though latter two map num num cm telomeric may reflect distinct locus
0.3856874.12716770.html.plaintext.txt	7	second rat homolog ide directly implicated type num diabetes susceptibility gk rat model numnum locus poststimulation glycemia mapped region rat chromosome num syntenic human numsymb num numnum subsequently localized num cm region around ide num two amino acid substitutions ide found susceptible congenic strains together conferred postprandial hyperglycemia reduced insulin degradation isolated muscle cells diabetes related phenotypes num
0.3856874.12716770.html.plaintext.txt	8	second rat homolog ide directly implicated type num diabetes susceptibility gk rat model numnum locus poststimulation glycemia mapped region rat chromosome num syntenic human numsymb num numnum subsequently localized num cm region around ide num two amino acid substitutions ide found susceptible congenic strains together conferred postprandial hyperglycemia reduced insulin degradation isolated muscle cells diabetes related phenotypes num
0.3856874.12716770.html.plaintext.txt	9	third known presumed functions ide consistent role type num diabetes pathogenesis ide num kda symb regulated metalloproteinase displays wide expression profile including insulin responsive tissues strong species conservation attests important biological functions diverse cellular metabolic roles proposed numnum although remain controversial num ide seems play major role breakdown insulin insulin responsive tissues num thereby influencing extent cellular response insulin num association ide activity insulin clearance resistance supported vitro clinical studies num num furthermore substrate specificity ide coincides peptides capable amyloid formation including amylin insulin indicating ide may prevent accumulation amyloidogenic peptides num disruption scavenging function might thereby promote aggregation islet amyloid characteristic type num diabetes contribute deficient ss cell capacity
0.3856874.12716770.html.plaintext.txt	10	third known presumed functions ide consistent role type num diabetes pathogenesis ide num kda symb regulated metalloproteinase displays wide expression profile including insulin responsive tissues strong species conservation attests important biological functions diverse cellular metabolic roles proposed numnum although remain controversial num ide seems play major role breakdown insulin insulin responsive tissues num thereby influencing extent cellular response insulin num association ide activity insulin clearance resistance supported vitro clinical studies num num furthermore substrate specificity ide coincides peptides capable amyloid formation including amylin insulin indicating ide may prevent accumulation amyloidogenic peptides num disruption scavenging function might thereby promote aggregation islet amyloid characteristic type num diabetes contribute deficient ss cell capacity
0.3856874.12716770.html.plaintext.txt	11	congruence positional biological candicacy led us evaluate role ide variation diabetes susceptibility humans mutation screening exons adjacent intronic sequence num bp num sequence probands numq linked pedigrees identified six confirmed variants table num fig num convenience termed ide single nucleotide polymorphisms snps num num num num num num accordance previous nomenclature num detect uncommon symb symb variants previously reported num symb symb mapped outside sequence surveyed none variants appeared strong functional credentials based sequence context putative nonsynonymous exon num coding polymorphism reported dbsnp symb validated sequencing direct genotyping analysis num european collection cell cultures ecacc control samples confirmed extensive linkage disequilibrium across gene pairwise d values numnum fig num six common haplotypes symb symb identified accounting num chromosomes fig num basis allele frequencies symb symb symb num intermarker linkage disequilibrium patterns symb concordant symb snps num num num num num num selected genotyping
0.3856874.12716770.html.plaintext.txt	12	congruence positional biological candicacy led us evaluate role ide variation diabetes susceptibility humans mutation screening exons adjacent intronic sequence num bp num sequence probands numq linked pedigrees identified six confirmed variants table num fig num convenience termed ide single nucleotide polymorphisms snps num num num num num num accordance previous nomenclature num detect uncommon symb symb variants previously reported num symb symb mapped outside sequence surveyed none variants appeared strong functional credentials based sequence context putative nonsynonymous exon num coding polymorphism reported dbsnp symb validated sequencing direct genotyping analysis num european collection cell cultures ecacc control samples confirmed extensive linkage disequilibrium across gene pairwise d values numnum fig num six common haplotypes symb symb identified accounting num chromosomes fig num basis allele frequencies symb symb symb num intermarker linkage disequilibrium patterns symb concordant symb snps num num num num num num selected genotyping
0.3856874.12716770.html.plaintext.txt	13	view table table num ide variants relevant study
0.3856874.12716770.html.plaintext.txt	14	view larger version numk fig num genomic position linkage disequilibrium relationships haplotype frequencies variants within ide gene depiction ide gene displays exon distribution scale see distances provided genomic location snps examined study middle panel details linkage disequilibrium parameters d diagonal p value calculated num random uk samples ecacc sample six snps genotyped lower panel lists ten frequent haplotypes estimated typed data sets frequencies symb control subjects made ecacc dif samples symb case set
0.3856874.12716770.html.plaintext.txt	15	snps hardy weinberg equilibrium data sets except symb p numnum symb p numnum diabetes families study dif control sample samples retyped num concordance haplotype patterns provided indication mistyping novel haplotypes generated modest departures equilibrium likely therefore reflect stochastic variation exceptional given number tests performed
0.3856874.12716770.html.plaintext.txt	16	allele genotype frequencies warren num proband symb cases n num control group symb subjects n num shown table num see research design methods group characteristics nominally significant association detected symb symb samples symb genotypes p numnum alleles p numnum odds ratio c allele numnum num ci numnum numnum global difference haplotype frequency distribution fig num groups p numnum however since symb defined c allele symb haplotype also frequent probands symb control subjects p numnum uncorrected males females differ snp haplotype frequencies additional associations uncovered sex stratified analyses
0.3856874.12716770.html.plaintext.txt	17	allele genotype frequencies warren num proband symb cases n num control group symb subjects n num shown table num see research design methods group characteristics nominally significant association detected symb symb samples symb genotypes p numnum alleles p numnum odds ratio c allele numnum num ci numnum numnum global difference haplotype frequency distribution fig num groups p numnum however since symb defined c allele symb haplotype also frequent probands symb control subjects p numnum uncorrected males females differ snp haplotype frequencies additional associations uncovered sex stratified analyses
0.3856874.12716770.html.plaintext.txt	18	view table table num genotype allele frequencies ide haplotype tag ht snps
0.3856874.12716770.html.plaintext.txt	19	determine whether associations might evident families apparent numq linkage subdivided symb sample according family nonparametric linkage npl score numq locus linkage partitioning methods applied several recent type num diabetes studies num num used linkage partitioning purely exploratory capacity given uncertainties statistical properties methods evidence linkage confirmed well possible consequences partitioning bias stratifying proband genotype alone difference evident linked unlinked probands ide haplotype frequencies p numnum symb genotypes p numnum symb genotypes p numnum association previously seen symb symb symb attenuated linked probands considered genotypes p numnum alleles p numnum difference symb genotype frequencies numq linked probands symb control subjects p numnum however complementary analysis testing whether ide genotype partitioned evidence numq linkage encouraging families proband carried weakly associated symb genotypes ct cc lod score symbnum increased numnum numnum p numnum increment analysis based symb genotype grouping ga gg yielded lod numnum p numnum
0.3856874.12716770.html.plaintext.txt	20	determine whether associations might evident families apparent numq linkage subdivided symb sample according family nonparametric linkage npl score numq locus linkage partitioning methods applied several recent type num diabetes studies num num used linkage partitioning purely exploratory capacity given uncertainties statistical properties methods evidence linkage confirmed well possible consequences partitioning bias stratifying proband genotype alone difference evident linked unlinked probands ide haplotype frequencies p numnum symb genotypes p numnum symb genotypes p numnum association previously seen symb symb symb attenuated linked probands considered genotypes p numnum alleles p numnum difference symb genotype frequencies numq linked probands symb control subjects p numnum however complementary analysis testing whether ide genotype partitioned evidence numq linkage encouraging families proband carried weakly associated symb genotypes ct cc lod score symbnum increased numnum numnum p numnum increment analysis based symb genotype grouping ga gg yielded lod numnum p numnum
0.3856874.12716770.html.plaintext.txt	21	clarification role symb symb variants sought genotyping early onset type num diabetic cases symb warren num trios symb large control resource symb young onset case groups similar clinical characteristics table num genotypes combined appropriate tests homogeneity replication cohorts average age diagnosis num years earlier sibpair probands however rigorous exclusion non type num diabetes high parental prevalence typical late onset type num diabetes cohorts numnum argue appreciable qualitative differences genetic basis type num diabetes susceptibility initial replication cohorts typing symb symb effectively reduces ide haplotypic diversity three common haplotypes fig num genotype allele counts shown table num data hardy weinberg equilibrium replication cohorts found significant association either snp symb genotypes p numnum alleles p numnum c allele numnumnumnum numnum symb p numnum num num haplotype p numnum regardless whether data stratified sex full exeter family study efs cohort n num association either snp fasting plasma glucose combined sex stratified analyses
0.3856874.12716770.html.plaintext.txt	22	clarification role symb symb variants sought genotyping early onset type num diabetic cases symb warren num trios symb large control resource symb young onset case groups similar clinical characteristics table num genotypes combined appropriate tests homogeneity replication cohorts average age diagnosis num years earlier sibpair probands however rigorous exclusion non type num diabetes high parental prevalence typical late onset type num diabetes cohorts numnum argue appreciable qualitative differences genetic basis type num diabetes susceptibility initial replication cohorts typing symb symb effectively reduces ide haplotypic diversity three common haplotypes fig num genotype allele counts shown table num data hardy weinberg equilibrium replication cohorts found significant association either snp symb genotypes p numnum alleles p numnum c allele numnumnumnum numnum symb p numnum num num haplotype p numnum regardless whether data stratified sex full exeter family study efs cohort n num association either snp fasting plasma glucose combined sex stratified analyses
0.3856874.12716770.html.plaintext.txt	23	view table table num clinical characteristics populations studied
0.3856874.12716770.html.plaintext.txt	24	selected ide basis positional biological candidacy type num diabetes susceptibility gene undertaken detailed survey variation within gene unable compile clear evidence association ide variation type num diabetes despite fact analyses utilized several large well characterized populations selection diabetic individuals early onset positive family history designed enhance detection type num diabetes susceptibility alleles snp showing association initial case control analysis symb associated replication set however worth noting combined symb across initial replication sets achieve nominal significance combined allele c numnum numnum numnum p numnum result demands cautious interpretation given allowance low though unquantifiable prior odds even strong biological candidates ide harbor substantial susceptibility effects lack support analyses performed variant emerging initial analyses symb showed ability partition evidence linkage showed evidence association type num diabetes combined allele numnum numnum numnum p numnum
0.3856874.12716770.html.plaintext.txt	25	selected ide basis positional biological candidacy type num diabetes susceptibility gene undertaken detailed survey variation within gene unable compile clear evidence association ide variation type num diabetes despite fact analyses utilized several large well characterized populations selection diabetic individuals early onset positive family history designed enhance detection type num diabetes susceptibility alleles snp showing association initial case control analysis symb associated replication set however worth noting combined symb across initial replication sets achieve nominal significance combined allele c numnum numnum numnum p numnum result demands cautious interpretation given allowance low though unquantifiable prior odds even strong biological candidates ide harbor substantial susceptibility effects lack support analyses performed variant emerging initial analyses symb showed ability partition evidence linkage showed evidence association type num diabetes combined allele numnum numnum numnum p numnum
0.3856874.12716770.html.plaintext.txt	26	survey ide variation covered exons adjacent intronic sequence promoter none variants identified earlier screen uk subjects num strong credentials impact ide structure andor function clearly findings support hypothesis variation within ide exclusively responsible linkage signal detected chromosome numq however association study exclude possibility variants typed especially symb lesser susceptibility role present study estimate num power detect association symb type num diabetes multiplicative model genotypic relative risk numnum threshold p value numnum falls num stringent significance threshold p numnum designed reflect modest prior odds candidate selected plays biologically significant susceptibility role furthermore entirely exclude possibility ide variants studied marked contribution type num diabetes susceptibility variants must lie outside regions surveyed display limited linkage disequilibrium typed variants current understanding linkage disequilibrium patterns within human populations indicates analyses seek associations using snps capturing haplotypic diversity within gene interest good power detect associations yet unidentified common variants within gene num
0.3856874.12716770.html.plaintext.txt	27	survey ide variation covered exons adjacent intronic sequence promoter none variants identified earlier screen uk subjects num strong credentials impact ide structure andor function clearly findings support hypothesis variation within ide exclusively responsible linkage signal detected chromosome numq however association study exclude possibility variants typed especially symb lesser susceptibility role present study estimate num power detect association symb type num diabetes multiplicative model genotypic relative risk numnum threshold p value numnum falls num stringent significance threshold p numnum designed reflect modest prior odds candidate selected plays biologically significant susceptibility role furthermore entirely exclude possibility ide variants studied marked contribution type num diabetes susceptibility variants must lie outside regions surveyed display limited linkage disequilibrium typed variants current understanding linkage disequilibrium patterns within human populations indicates analyses seek associations using snps capturing haplotypic diversity within gene interest good power detect associations yet unidentified common variants within gene num
0.3856874.12716770.html.plaintext.txt	28	research design methods top abstract research design methods references subjects clinical characteristics cohorts studied provided table num initial case control analyses compared unrelated index probands n num diabetes uk warren num sibpair repository symb num control samples two sources num num random uk population samples camr salisbury uk ecacc num num uk subjects ascertained diabetes families study dif subjects latter normoglycemic fasting glucose numnummmoll without family history diabetes combined control samples designated symb replication analyses combined two collections young onset type num diabetes subjects similar clinical characteristics num offspring parent offspring trios n num ascertained type num diabetes symb num num young onset num years type num diabetic subjects n num symb num cases compared num unrelated parents consecutive birth cohort efs num normoglycemic symb num case samples therefore selected inherited type num diabetes via early onset andor positive family history non type num diabetes excluded using combination clinical immunological genetic criteria numnum confirmation glycemic status control populations limited fasting plasma glucose measures dif efs samples subjects exclusively britishirish caucasian origin except small proportion non british european ancestry symb set
0.3856874.12716770.html.plaintext.txt	29	research design methods top abstract research design methods references subjects clinical characteristics cohorts studied provided table num initial case control analyses compared unrelated index probands n num diabetes uk warren num sibpair repository symb num control samples two sources num num random uk population samples camr salisbury uk ecacc num num uk subjects ascertained diabetes families study dif subjects latter normoglycemic fasting glucose numnummmoll without family history diabetes combined control samples designated symb replication analyses combined two collections young onset type num diabetes subjects similar clinical characteristics num offspring parent offspring trios n num ascertained type num diabetes symb num num young onset num years type num diabetic subjects n num symb num cases compared num unrelated parents consecutive birth cohort efs num normoglycemic symb num case samples therefore selected inherited type num diabetes via early onset andor positive family history non type num diabetes excluded using combination clinical immunological genetic criteria numnum confirmation glycemic status control populations limited fasting plasma glucose measures dif efs samples subjects exclusively britishirish caucasian origin except small proportion non british european ancestry symb set
0.3856874.12716770.html.plaintext.txt	30	gene structure mutation detection genomic structure ide determined blast alignment human mrna sequence symb finished genomic sequence bac clone symb confirmed ide num exons distributed positions numnum numnum mb symb assembly chromosome num variant detection performed direct sequencing directions big dye terminator chemistry perkin elmer applied biosystems warrington uk symb capillary sequencer included exons num bp flanking introns num bp num untranslated region utr num amplicons primer sequences provided online table num httpdiabetesdiabetesjournalsorg total num individuals sequenced eight type num diabetic probands sibships affected identical descent chromosomes flanking microsatellites symbnum symbnum probands assuming numq linkage enriched numq susceptibility variants estimate num power detect disease associated variants assuming multiplicative models genotype relative risk numnum allele frequencies numnum three unaffected siblings families doubly discordant numq haplotypes covering ide compared affected sibs
0.3856874.12716770.html.plaintext.txt	31	gene structure mutation detection genomic structure ide determined blast alignment human mrna sequence symb finished genomic sequence bac clone symb confirmed ide num exons distributed positions numnum numnum mb symb assembly chromosome num variant detection performed direct sequencing directions big dye terminator chemistry perkin elmer applied biosystems warrington uk symb capillary sequencer included exons num bp flanking introns num bp num untranslated region utr num amplicons primer sequences provided online table num httpdiabetesdiabetesjournalsorg total num individuals sequenced eight type num diabetic probands sibships affected identical descent chromosomes flanking microsatellites symbnum symbnum probands assuming numq linkage enriched numq susceptibility variants estimate num power detect disease associated variants assuming multiplicative models genotype relative risk numnum allele frequencies numnum three unaffected siblings families doubly discordant numq haplotypes covering ide compared affected sibs
0.3856874.12716770.html.plaintext.txt	32	snp genotyping selected ide snps genotyped using combination approaches including restriction fragment length polymorphism detection artificial induced restriction sites tetra primer amplification refractory mutation methods assays first two types included obligate restriction sites internal digest controls assay details see online table num httpdiabetesdiabetesjournalsorg
0.3856874.12716770.html.plaintext.txt	33	statistical methods genotype allele frequency distributions compared standard contingency table methods exact probability estimation using statxact cytel cambridge ma genotype comparisons used kruskal wallis statistic given ordinal categorization separate data sets eg symb symb sets combined contingency table analyses appropriate homogeneity testing haplotype patterns estimated maximum likelihood methods snphap www genecimrcamacukclaytonsoftware haplotype frequency distributions compared likelihood ratio testing significance determined permutation numnum replicates measures linkage disequilibrium snps derived using pm permutation model free analysis program num assess evidence linkage partitioning num num two complementary approaches adopted first symb probands subdivided linked positive family npl score ide unlinked variant frequency comparisons repeated second evidence linkage numq recomputed using genehunter plus num conditioning proband ide genotype significance changes linkage statistic determined permutation numnum replicates power calculations described assume simplicity cases ascertained affected sibpairs incorporate ascertainment selection control samples population based
0.3856874.12716770.html.plaintext.txt	34	acknowledgments work supported diabetes uk also supported ascertainment many samples collected european union gift consortium symb ct num num south west national health service research directorate
0.3856874.12716770.html.plaintext.txt	35	thank participated collections many health professionals contributed thank dr sian ellard laboratory organization diane jarvis dna extraction dr lesley jones cardiff sharing ide variant data prof paul burton colleagues leicester valuable statistical insights
0.3856874.12716770.html.plaintext.txt	36	footnotes address correspondence reprint requests prof mark mccarthy robert turner professor diabetes oxford centre diabetes endocrinology metabolism churchill site old road headington oxford symb numlj uk e mail markmccarthyatdrloxacuk u d
0.3856874.12716770.html.plaintext.txt	37	footnotes address correspondence reprint requests prof mark mccarthy robert turner professor diabetes oxford centre diabetes endocrinology metabolism churchill site old road headington oxford symb numlj uk e mail markmccarthyatdrloxacuk u d
0.3856874.12716770.html.plaintext.txt	38	received publication num november num accepted revised form num february num
0.3856874.12716770.html.plaintext.txt	39	additional information article found online appendix httpdiabetesdiabetesjournalsorg
0.3856874.12716770.html.plaintext.txt	40	con control dif diabetes families study ecacc european collection cell cultures hap haplotype ide insulin degrading enzyme lod logarithm odds ncbi national center biotechnology information npl nonparametric linkage odds ratio snp single nucleotide polymorphism utr untranslated region symb warren num probands symb warren num trios symb young type num diabetes
0.3856874.12716770.html.plaintext.txt	41	references top abstract research design methods references wiltshire hattersley hitman ga walker m levy jc sampson m o rahilly frayling tm bell ji lathrop gm bennett dhillon r fletcher c groves cj jones e prestwich p simecek n subba rao pv wishart m foxon r howell smedley d cardon lr menzel mccarthy mi genome wide scan loci predisposing type num diabetes uk population diabetes uk warren num repository analysis num pedigrees provides independent replication susceptibility locus chromosome numq j hum symb num numnummedline ghosh watanabe rm valle tt hauser er magnuson vl langefeld cd ally dsmohlke kl silander k kohtamaki k chines p balow jr j birznieks g chang j eldridge w erdos mr karanjawala ze knapp ji kudelko k martin c morales mena musick musick pfahl c porter r rayman jb rha d segal l shapiro sharaf r shurtleff b tannenbaum j te c tovar j unni welch c whiten r witt blaschak harvan j douglas ja duren wl epstein mp fingerlin te kaleta hs langer em li c mceachin rc stringham hm trager e white pp eriksson j toivanen l vidgren g nylund sj tuomilehto wolf e ross eh demirchyan e hagopian wa buchanan ta tuomilehto j bergman rn collins fs boehnke m finland united states investigation non insulin dependent diabetes mellitus genetics fusion study autosomal genome scan genes predispose type num diabetes j hum symb num numnummedline meigs jb panhuysen ci myers rh wilson pw cupples la genome wide scan loci linked plasma levels glucose symb community based sample caucasian pedigrees framingham offspring study symb num numnumabstractfree full text duggirala r blangero j almasy l dyer td williams kl leach rj o connell p stern mp linkage type num diabetes mellitus age onset genetic location chromosome numq mexican americans j hum symb num numnummedline vionnet n hani eh dupont gallina francke dotte de matos f durand e lepetre f lecouer c gallina p zekiri l dina c froguel p genomewide search type num diabetes susceptibility genes french whites evidence novel susceptibility locus early onset diabetes chromosome numsymb qter independent replication type num diabetes locus chromosome numsymb symb j hum symb num numnummedline galli j li ls glaser ostenson cg jiao h fakhrai rad h jacob hj lander es luthman h genetic analysis non insulin dependent diabetes mellitus gk rat nat symb num numnummedline gauguier d froguel p parent v bernard c bihoreau mt portha b james mr penicaud l lathrop m ktorza chromosomal mapping genetic loci associated non insulin dependent diabetes gk rat nat symb num numnummedline galli j fakhrai rad h kamel marcus c norgren luthman h pathophysiological genetic characterization major diabetes locus gk rats symb num numnumabstract kaisaki pj rouard m danoy pa wallis rh collins sc rice m levy er lathrop m bihoreau mt gauguier d detailed comparative gene map rat chromosome num mouse human genomes physical mapping evolutionary chromosomal breakpoint symb num numnummedline fakhrai rad h nikoshkov kamel fernstrom m zierath jr norgren luthman h galli j insulin degrading enzyme identified candidate diabetes susceptibility gene gk rats hum mol symb num numnumabstractfree full text duckworth wc bennett rg hamel fg insulin degradation progress potential endocr symb num numnumabstractfree full text kurochkin iv insulin degrading enzyme embarking amyloid destruction trends biochem symb num numnummedline authier f posner bi bergeron jjm insulin degrading enzyme clin invest symb num numnummedline seta ka roth ra overexpression insulin degrading enzyme cellular localization effects insulin signalling biochem biophys res symb num numnummedline jones cn pei d staris p polonsky ks chen yd reaven gm alterations glucose stimulated insulin secretory dose response curve insulin clearance nondiabetic insulin resistant individuals j clin endocrinol symb num numnumabstractfree full text misbin ri almira ec cleman mw insulin degradation serum patient apparent insulin resistance j clin endocrinol symb num numnumabstract abraham r myers devrieze fw hamshere mv thomas hm marshall h compton d spurlock g turic d hoogendoorn b kwon jm petersen rc tangalos e norton j morris jc bullock r liolitsa d lovestone hardy j goate o donovan m williams j owen mj jones l substantial linkage disequilibrium across insulin degrading enzyme locus association late onset alzheimer disease hum symb num numnummedline horikawa y oda n cox nj li x orho melander m hara m hinokio y lindner tm mashima h schwarz peh del bosque plata l horikawa y oda y yoshiuchi colilla polonsky ks wei concannon p iwasaki n schulze j baier lj bogardus c groop l boerwinkle e hanis cl bell gi genetic variation gene encoding calpain num associated type num diabetes mellitus nat symb num numnummedline sun l cox nj mcpeek ms statistical method identification polymorphisms explain linkage results j hum symb num numnummedline li c scott lj boehnke m allele sharing linkage analysis subsets families stratified based associated allele abstract j hum symb suppl num num farook vs hanson rl wolford jk bogardus c prochazka m molecular analysis symb numq candidate gene type num diabetes pima indians symb num numnumabstractfree full text frayling tm walker m mccarthy mi evans jc ayres allen li ellard lynn turner rc o rahilly hitman ga hattersley parent offspring trios resource facilitate identification type num diabetes genes symb num numnumabstract minton j hattersley owen kr mccarthy mi walker m barrett frayling tm association studies genetic variation symb gene type num diabetes uk populations symb num numnumabstractfree full text gabriel sb schaffner sf nguyen h moore jm roy j blumenstiel b higgins j defelice m lochner faggart m liu cordero sn rotimi c adeyemo cooper r ward r lander es daly mj altshuler d structure haplotype blocks human genome symb num numnumabstractfree full text zhao jh curtis d sham pc model free analysis permutation test allelic association hum symb num numnummedline
0.39201447.15277398.html.plaintext.txt	0	quantitative trait loci near insulin degrading enzyme ide gene contribute variation plasma insulin levels harvest f symb suad symb sofia symb claes goran symb kerstin symb anthony j symb jonathan symb
0.39201447.15277398.html.plaintext.txt	1	quantitative trait loci near insulin degrading enzyme ide gene contribute variation plasma insulin levels harvest f symb suad symb sofia symb claes goran symb kerstin symb anthony j symb jonathan symb
0.39201447.15277398.html.plaintext.txt	2	num department molecular medicine rolf luft center diabetes research karolinska hospital stockholm sweden num center genomics bioinformatics karolinska institute stockholm sweden
0.39201447.15277398.html.plaintext.txt	3	abstract top abstract research design methods references insulin degrading enzyme ide plays principal role proteolysis several peptides addition insulin encoded ide resides region chromosome numq linked type num diabetes two recent studies presented genetic association data ide type num diabetes one positive negative neither explored fundamental question whether polymorphism ide measurable influence insulin levels human populations address possibility num single nucleotide polymorphisms snps linkage disequilibrium block encompassing ide genotyped sample num impaired glucose tolerant num nondiabetic control subjects analyses based haplotypic genotypes diplotypes constructed snps differentiate common extant haplotypes extending across ide provided compelling evidence association fasting insulin levels p numnum num h insulin levels p numnum homeostasis model assessment insulin resistance p numnum bmi p numnum effects exclusively evident men strongest evidence effect single marker obtained symb located near num untranslated region ide num h insulin levels p numnum diplotype analyses however suggest presence multiple interacting trait modifying sequences region results indicate polymorphism innear ide contributes large proportion variance plasma insulin levels correlated traits questions sex specificity allelic heterogeneity need taken consideration molecular basis observed phenotypic effects unfolds
0.39201447.15277398.html.plaintext.txt	4	abstract top abstract research design methods references insulin degrading enzyme ide plays principal role proteolysis several peptides addition insulin encoded ide resides region chromosome numq linked type num diabetes two recent studies presented genetic association data ide type num diabetes one positive negative neither explored fundamental question whether polymorphism ide measurable influence insulin levels human populations address possibility num single nucleotide polymorphisms snps linkage disequilibrium block encompassing ide genotyped sample num impaired glucose tolerant num nondiabetic control subjects analyses based haplotypic genotypes diplotypes constructed snps differentiate common extant haplotypes extending across ide provided compelling evidence association fasting insulin levels p numnum num h insulin levels p numnum homeostasis model assessment insulin resistance p numnum bmi p numnum effects exclusively evident men strongest evidence effect single marker obtained symb located near num untranslated region ide num h insulin levels p numnum diplotype analyses however suggest presence multiple interacting trait modifying sequences region results indicate polymorphism innear ide contributes large proportion variance plasma insulin levels correlated traits questions sex specificity allelic heterogeneity need taken consideration molecular basis observed phenotypic effects unfolds
0.39201447.15277398.html.plaintext.txt	5	gene encoding insulin degrading enzyme ide located chromosome numsymb symb within region linked type num diabetes related quantitative traits num num ide major enzyme responsible insulin proteolysis vitro num shares structural functional homology bacterial protease iii may function termination insulin response numnum mice ide hypofunction induced ide gene disruption leads hyperinsulinemia num furthermore ide activity diabetic goto kakizaki gk rat reduced num polymorphism ide likely main contributing factor num congruence positional functional data indicates sequence variation ide may play role modifying insulin metabolism human populations two recent genetic association studies investigated ide region relation type num diabetes one produced significant evidence effects type num diabetes plasma glucose levels num whereas explored case control models obtained evidence association num neither studies however attempted directly relate ide variants measures insulin metabolism
0.39201447.15277398.html.plaintext.txt	6	gene encoding insulin degrading enzyme ide located chromosome numsymb symb within region linked type num diabetes related quantitative traits num num ide major enzyme responsible insulin proteolysis vitro num shares structural functional homology bacterial protease iii may function termination insulin response numnum mice ide hypofunction induced ide gene disruption leads hyperinsulinemia num furthermore ide activity diabetic goto kakizaki gk rat reduced num polymorphism ide likely main contributing factor num congruence positional functional data indicates sequence variation ide may play role modifying insulin metabolism human populations two recent genetic association studies investigated ide region relation type num diabetes one produced significant evidence effects type num diabetes plasma glucose levels num whereas explored case control models obtained evidence association num neither studies however attempted directly relate ide variants measures insulin metabolism
0.39201447.15277398.html.plaintext.txt	7	evaluate potential influence genetic variation ide insulin levels correlated quantitative traits haplotype tagging strategy used num swedish sample consisting num impaired glucose tolerance igt num nondiabetic control subjects table num study follows recent report num examined num polymorphic markers extending across ide relation alzheimer disease large swedish population used define regional linkage disequilibrium ld structure highlighted ld block spanning num kb around ide three single nucleotide polymorphism snp markers identified capable delineating common haplotypes num swedes subsequently used tests association
0.39201447.15277398.html.plaintext.txt	8	evaluate potential influence genetic variation ide insulin levels correlated quantitative traits haplotype tagging strategy used num swedish sample consisting num impaired glucose tolerance igt num nondiabetic control subjects table num study follows recent report num examined num polymorphic markers extending across ide relation alzheimer disease large swedish population used define regional linkage disequilibrium ld structure highlighted ld block spanning num kb around ide three single nucleotide polymorphism snp markers identified capable delineating common haplotypes num swedes subsequently used tests association
0.39201447.15277398.html.plaintext.txt	9	view table table num clinical characteristics igt nondiabetic control subjects
0.39201447.15277398.html.plaintext.txt	10	present study num snp markers extending locally across ide examined fig num including previously identified tag markers began genotyping entire male sample define ld structure identify common haplotypes num markers found hardy weinberg equilibrium pairwise marker correlations suggested strong ld region agreement earlier data num common haplotypes num frequency inferred haplotyper using num markers similar obtained based slightly modified marker set num ld estimates inferred haplotypes entire sample shown figs num num respectively definition patil et al num numnum used confirm studied region represent ld block also confirmed selection three tag markers equivalent previously used num would able delineate common haplotypes opted explore use alternative equally valid marker sets note variety different approaches exist defining optimal snp sets num explored use issues may relevance attempts replicating refuting present data ld structures differ markedly divergent populations kk kidd ajb personal communication
0.39201447.15277398.html.plaintext.txt	11	present study num snp markers extending locally across ide examined fig num including previously identified tag markers began genotyping entire male sample define ld structure identify common haplotypes num markers found hardy weinberg equilibrium pairwise marker correlations suggested strong ld region agreement earlier data num common haplotypes num frequency inferred haplotyper using num markers similar obtained based slightly modified marker set num ld estimates inferred haplotypes entire sample shown figs num num respectively definition patil et al num numnum used confirm studied region represent ld block also confirmed selection three tag markers equivalent previously used num would able delineate common haplotypes opted explore use alternative equally valid marker sets note variety different approaches exist defining optimal snp sets num explored use issues may relevance attempts replicating refuting present data ld structures differ markedly divergent populations kk kidd ajb personal communication
0.39201447.15277398.html.plaintext.txt	12	view larger version numk fig num details examined snps ide
0.39201447.15277398.html.plaintext.txt	13	view larger version numk fig num pairwise ld num snp markers extending across ide
0.39201447.15277398.html.plaintext.txt	14	view larger version numk fig num common haplotypes extending across ide
0.39201447.15277398.html.plaintext.txt	15	initial analyses intention reduce number exploratory tests examining critical set phenotypes limited number haplotypic genotypes also referable diplotypes brevity opted use latter term throughout report principal criterion diplotype construction inferred high probability thus reflect fidelity combinations common haplotypes individual presence limited allelic heterogeneity advantageous single marker tests fail detect effects due insufficient complex patterns ld pathogenic variants addition testing many single markers requires substantial degree multiple testing selection quantitative phenotypes analyses included six traits typically examined relation diabetes num num listed table num note studies numnum investigated ide relation diabetes report efforts relate genotypes either insulin levels obesity trait distributions highly skewed partially skewed six studied phenotypes thus log transformed data modeled correlations traits extremely high expected data shown
0.39201447.15277398.html.plaintext.txt	16	initial analyses intention reduce number exploratory tests examining critical set phenotypes limited number haplotypic genotypes also referable diplotypes brevity opted use latter term throughout report principal criterion diplotype construction inferred high probability thus reflect fidelity combinations common haplotypes individual presence limited allelic heterogeneity advantageous single marker tests fail detect effects due insufficient complex patterns ld pathogenic variants addition testing many single markers requires substantial degree multiple testing selection quantitative phenotypes analyses included six traits typically examined relation diabetes num num listed table num note studies numnum investigated ide relation diabetes report efforts relate genotypes either insulin levels obesity trait distributions highly skewed partially skewed six studied phenotypes thus log transformed data modeled correlations traits extremely high expected data shown
0.39201447.15277398.html.plaintext.txt	17	diplotypes inferred using three selected haplotype tagging markers fig num tested six traits highlighted table num men women separately six eight possible haplotypes predicted using markers sequences symb tcg symb tca symb cca symb tta symb ttg symb ccg posterior probability estimates excess numnum phase calls represent various combinations haplotypes threshold set retaining individuals analyses significant consistent effects upon traits evident notable exception fasting glucose num h glucose levels importantly effects evident exclusively men agreement results obtained karamohamed et al num results analyses shown fig num data male sample presented analyses combined igt individuals nondiabetic control subjects adjusted uniform phenotypic differences including group identity factor anova models diplotype group interaction terms second order factorial anova models significant analyses based probabilistically inferred data considered important also explore models entail use phase known data accomplished excluding individuals heterozygous two sites individuals one heterozygote site definition phase known demonstrate additional analysis performed men four associated traits shown fig num insulin num h insulin homeostasis model assessment insulin resistance homa ir bmi results revealed association four significance highest bmi symbnum numnum p numnum data comparisons shown reference fig num groups excluded analysis symbsymb symbsymb symbsymb symbsymb
0.39201447.15277398.html.plaintext.txt	18	diplotypes inferred using three selected haplotype tagging markers fig num tested six traits highlighted table num men women separately six eight possible haplotypes predicted using markers sequences symb tcg symb tca symb cca symb tta symb ttg symb ccg posterior probability estimates excess numnum phase calls represent various combinations haplotypes threshold set retaining individuals analyses significant consistent effects upon traits evident notable exception fasting glucose num h glucose levels importantly effects evident exclusively men agreement results obtained karamohamed et al num results analyses shown fig num data male sample presented analyses combined igt individuals nondiabetic control subjects adjusted uniform phenotypic differences including group identity factor anova models diplotype group interaction terms second order factorial anova models significant analyses based probabilistically inferred data considered important also explore models entail use phase known data accomplished excluding individuals heterozygous two sites individuals one heterozygote site definition phase known demonstrate additional analysis performed men four associated traits shown fig num insulin num h insulin homeostasis model assessment insulin resistance homa ir bmi results revealed association four significance highest bmi symbnum numnum p numnum data comparisons shown reference fig num groups excluded analysis symbsymb symbsymb symbsymb symbsymb
0.39201447.15277398.html.plaintext.txt	19	view larger version numk fig num diplotype association quantitative traits men mean values plus minus se fasting glucose num h glucose b fasting insulin c num h insulin d homa e bmi f men according diplotype groups estimated using haplotyper untransformed data shown categories less six observations excluded f ratios anova omnibus tests performed log transformed data traits associated p values shown upper right corner diagram number individuals category shown base column
0.39201447.15277398.html.plaintext.txt	20	attempt refine possible position pathogenic variants region single marker tests conducted phenotypes provided evidence association diplotype models considering multiple testing issues noted strongest individual finding homa ir p numnum affords num individual tests strict multiple testing correction renders finding insignificant given numnum tests using num markers performed male sample diplotype analyses gave us priori reason suspect latent associations single markers would present female set results shown fig num consistent effects symb symb seen upon traits common allele symb rare allele symb associated lower trait levels marker symb symb tested fasting glucose levels latter specifically reported karamohamed et al num two markers extremely high ld symb numnum fig num neither marker showed evidence association acknowledge present study less power aforementioned one result symb upon multiple phenotypes nonetheless supports likely presence primary trait modifying sequence num region ide speculated num effect symb num h insulin levels significant however albeit considerably attenuated comparison symb explore effects symb final model fitted rare allele homozygotes heterozygotes combined compared common allele homozygotes results follows symbnum numnum p numnum symbnum numnum p numnum symbnum numnum p numnum symbnum numnum p numnum fasting insulin num h insulin homa ir bmi respectively although throughout study tests conducted combined igt normal samples correction applied possible differences considered important confirm effect exists populations least one analysis using model focusing symb marker num h insulin trait significant effects observed igt symbnum numnum p numnum normal symbnum numnum p numnum groups cases common allele homozygote group lowest trait levels
0.39201447.15277398.html.plaintext.txt	21	attempt refine possible position pathogenic variants region single marker tests conducted phenotypes provided evidence association diplotype models considering multiple testing issues noted strongest individual finding homa ir p numnum affords num individual tests strict multiple testing correction renders finding insignificant given numnum tests using num markers performed male sample diplotype analyses gave us priori reason suspect latent associations single markers would present female set results shown fig num consistent effects symb symb seen upon traits common allele symb rare allele symb associated lower trait levels marker symb symb tested fasting glucose levels latter specifically reported karamohamed et al num two markers extremely high ld symb numnum fig num neither marker showed evidence association acknowledge present study less power aforementioned one result symb upon multiple phenotypes nonetheless supports likely presence primary trait modifying sequence num region ide speculated num effect symb num h insulin levels significant however albeit considerably attenuated comparison symb explore effects symb final model fitted rare allele homozygotes heterozygotes combined compared common allele homozygotes results follows symbnum numnum p numnum symbnum numnum p numnum symbnum numnum p numnum symbnum numnum p numnum fasting insulin num h insulin homa ir bmi respectively although throughout study tests conducted combined igt normal samples correction applied possible differences considered important confirm effect exists populations least one analysis using model focusing symb marker num h insulin trait significant effects observed igt symbnum numnum p numnum normal symbnum numnum p numnum groups cases common allele homozygote group lowest trait levels
0.39201447.15277398.html.plaintext.txt	22	view larger version numk fig num single marker quantitative trait tests men
0.39201447.15277398.html.plaintext.txt	23	summary provide strong evidence sequence variation within near ide contributes variability measures insulin metabolism several compelling features results first study study karamohamed et al num suggest primary functional variant occurs num region ide addition marker previously exhibited maximum evidence association symb num strong ld marker symb greatest effect present study true pathogenic variant likely high ld indeed could one markers second studies suggest effects either exclusively predominantly male subjects numerous studies detected genetic effects exclusively men numnum sex specificity may major confounding factor genetic analyses num third marker strongest association quantitative traits related alzheimer disease recent study num symb among num markers importantly however present analyses suggest may one functionally relevant polymorphic site near ide evident diplotype models single haplotype appears responsible either elevating reducing trait levels number possible interactions also apparent evidence allelic heterogeneity interaction general make fine mapping responsible variants daunting task num need considered future studies investigating ide region
0.39201447.15277398.html.plaintext.txt	24	summary provide strong evidence sequence variation within near ide contributes variability measures insulin metabolism several compelling features results first study study karamohamed et al num suggest primary functional variant occurs num region ide addition marker previously exhibited maximum evidence association symb num strong ld marker symb greatest effect present study true pathogenic variant likely high ld indeed could one markers second studies suggest effects either exclusively predominantly male subjects numerous studies detected genetic effects exclusively men numnum sex specificity may major confounding factor genetic analyses num third marker strongest association quantitative traits related alzheimer disease recent study num symb among num markers importantly however present analyses suggest may one functionally relevant polymorphic site near ide evident diplotype models single haplotype appears responsible either elevating reducing trait levels number possible interactions also apparent evidence allelic heterogeneity interaction general make fine mapping responsible variants daunting task num need considered future studies investigating ide region
0.39201447.15277398.html.plaintext.txt	25	directly addressed question whether variation ide influences risk type num diabetes two studies tested relationship produced either modest evidence association despite examining large clinical samples study provides evidence association fasting glucose levels primary phenotype used distinguish diabetic patients rather present data likely capture fundamental influence ide upon circulating insulin levels whereby genetically determined deficit enzyme activity may lead hyperinsulinemia could manifest modulator role type num diabetes might relevant phenotypes coronary heart disease num primary hypertension num believe continued replication efforts normal morbid populations well functional studies highly merited needed elucidate molecular basis clinical relevance observed phenotypic effects
0.39201447.15277398.html.plaintext.txt	26	directly addressed question whether variation ide influences risk type num diabetes two studies tested relationship produced either modest evidence association despite examining large clinical samples study provides evidence association fasting glucose levels primary phenotype used distinguish diabetic patients rather present data likely capture fundamental influence ide upon circulating insulin levels whereby genetically determined deficit enzyme activity may lead hyperinsulinemia could manifest modulator role type num diabetes might relevant phenotypes coronary heart disease num primary hypertension num believe continued replication efforts normal morbid populations well functional studies highly merited needed elucidate molecular basis clinical relevance observed phenotypic effects
0.39201447.15277398.html.plaintext.txt	27	research design methods top abstract research design methods references clinical characteristics subjects igt nondiabetic healthy individuals provided table num total num igt subjects num nondiabetic control subjects selected stockholm diabetes prevention program num num subjects igt previously diagnosed according world health organization num criteria medical treatment nondiabetic healthy subjects normal birth body weight bmi num kgsymb relatives first second degree diabetes participants study swedish ancestry selected districts stockholm informed consent received subjects study approved local ethics committee karolinska institute genomic dna extracted peripheral blood using puregene dna purification kit gentra minneapolis mn
0.39201447.15277398.html.plaintext.txt	28	research design methods top abstract research design methods references clinical characteristics subjects igt nondiabetic healthy individuals provided table num total num igt subjects num nondiabetic control subjects selected stockholm diabetes prevention program num num subjects igt previously diagnosed according world health organization num criteria medical treatment nondiabetic healthy subjects normal birth body weight bmi num kgsymb relatives first second degree diabetes participants study swedish ancestry selected districts stockholm informed consent received subjects study approved local ethics committee karolinska institute genomic dna extracted peripheral blood using puregene dna purification kit gentra minneapolis mn
0.39201447.15277398.html.plaintext.txt	29	quantitative trait measurements insulin resistance assessed homa num homa ir calculated present study using formula fasting plasma glucose millimoles per liter x fasting plasma insulin milliunits per milliliternumnum
0.39201447.15277398.html.plaintext.txt	30	quantitative trait measurements insulin resistance assessed homa num homa ir calculated present study using formula fasting plasma glucose millimoles per liter x fasting plasma insulin milliunits per milliliternumnum
0.39201447.15277398.html.plaintext.txt	31	snp selection verification num snps examined study listed table num details may found dbsnp database httpwwwncbinlmnihgovsnp respective ids surrounding num bp sequences direction examined repeats duplicated sequences using repeatmasker httpwwwrepeatmaskerorg blast httpwwwncbinlmnihgovblast verify snps polymorphic study populations snp tested set num swedish control samples assays num samples monomorphic excluded analysis convenience nomenclature used throughout report refer snps used recent report num
0.39201447.15277398.html.plaintext.txt	32	genotyping genotyping snps performed using induced fluorescence resonance energy transfer modification dynamic allele specific hybridization numnum pcrs run num num microl volumes numnum mmoll symb using num num ng genomic dna oligonucleotide sequences dynamic allele specific hybridization pcr assays snps presented previously num
0.39201447.15277398.html.plaintext.txt	33	statistical analysis deviation hardy weinberg equilibrium genotypes individual loci assessed using num statistic deviation normality trait distributions assessed using kolgomorov smirnov test correlations traits established using spearman statistic tests association genotypes quantitative traits performed using anova log transformed data included age group igt normal covariates analyses statistical analyses performed using statview version numnum abacus concepts piscataway nj haplotype frequencies estimated using haplotyper program num ld marker pairs estimated using symb metric num
0.39201447.15277398.html.plaintext.txt	34	acknowledgments study supported novo nordisk consortium swedish research council loo hans osterman foundation vetenskapligt arbete inom diabetologi foundation swedish diabetes association
0.39201447.15277398.html.plaintext.txt	35	thank subjects participating present study dr bo ding ylva behr valuable discussion camilla lagerberg yvonne stromberg excellent assistance
0.39201447.15277398.html.plaintext.txt	36	thank subjects participating present study dr bo ding ylva behr valuable discussion camilla lagerberg yvonne stromberg excellent assistance
0.39201447.15277398.html.plaintext.txt	37	footnotes homa ir homeostasis model assessment insulin resistance ide insulin degrading enzyme igt impaired glucose tolerance ld linkage disequilibrium snp single nucleotide polymorphism
0.39201447.15277398.html.plaintext.txt	38	address correspondence reprint requests suad efendic rolf luft center diabetes research department molecular medicine symbsymb karolinska hospital se num num stockholm sweden e mail suadefendicatmolmedkise
0.39201447.15277398.html.plaintext.txt	39	received publication february num num accepted revised form april num num
0.39201447.15277398.html.plaintext.txt	40	references top abstract research design methods references meigs jb panhuysen ci myers rh wilson pw cupples la genome wide scan loci linked plasma levels glucose symb community based sample caucasian pedigrees framingham offspring study symb num numnumabstractfree full text wiltshire hattersley hitman ga walker m levy jc sampson m o rahilly frayling tm bell ji lathrop gm bennett dhillon r fletcher c groves cj jones e prestwich p simecek n rao pv wishart m bottazzo gf foxon r howell smedley d cardon lr menzel mccarthy mi genomewide scan loci predisposing type num diabetes u k population diabetes uk warren num repository analysis num pedigrees provides independent replication susceptibility locus chromosome numq j hum symb num numnummedline ghosh watanabe rm valle tt hauser er magnuson vl langefeld cd ally ds mohlke kl silander k kohtamaki k chines p balow j jr birznieks g chang j eldridge w erdos mr karanjawala ze knapp ji kudelko k martin c morales mena musick musick pfahl c porter r rayman jb finland united states investigation non insulin dependent diabetes mellitus genetics fusion study autosomal genome scan genes predispose type num diabetes j hum symb num numnummedline duggirala r blangero j almasy l dyer td williams kl leach rj o connell p stern mp linkage type num diabetes mellitus age onset genetic location chromosome numq mexican americans j hum symb num numnummedline duckworth wc bennett rg hamel fg insulin degradation progress potential endocr symb num numnumabstractfree full text affholter ja cascieri ma bayne ml brange j casaretto m roth ra identification residues insulin molecule important binding insulin degrading enzyme symb num numnummedline affholter ja hsieh cl francke u roth ra insulin degrading enzyme stable expression human complementary dna characterization protein product chromosomal mapping human mouse genes mol symb num numnumabstract farris w mansourian chang y lindsley l eckman ea frosch mp eckman cb tanzi re selkoe dj guenette insulin degrading enzyme regulates levels insulin amyloid beta protein beta amyloid precursor protein intracellular domain vivo proc natl acad sci u symb num numnumabstractfree full text fakhrai rad h nikoshkov kamel fernstrom m zierath jr norgren luthman h galli j insulin degrading enzyme identified candidate diabetes susceptibility gene gk rats hum mol symb num numnumabstractfree full text karamohamed demissie volcjak j liu c heard costa n liu j shoemaker cm panhuysen ci meigs jb wilson p atwood ld cupples la herbert polymorphisms insulin degrading enzyme gene associated type num diabetes men nhlbi framingham heart study symb num numnumabstractfree full text groves cj wiltshire smedley d owen kr frayling tm walker m hitman ga levy jc o rahilly menzel hattersley mccarthy mi association haplotype analysis insulin degrading enzyme ide gene strong positional biological candidate type num diabetes susceptibility symb num numnumabstractfree full text johnson gc esposito l barratt bj smith heward j di genova g ueda h cordell hj eaves ia dudbridge f twells rc payne f hughes w nutland stevens h carr p tuomilehto wolf e tuomilehto j gough sc clayton dg todd ja haplotype tagging identification common disease genes nat symb num numnummedline prince ja feuk l gu hf gatz m blennow k brookes aj genetic variation haplotype block spanning ide symb hhex influences alzheimer disease hum symb num numnummedline patil n berno aj hinds da barrett wa doshi jm hacker cr kautzer cr lee dh marjoribanks c mcdonough dp nguyen bt norris mc sheehan jb shen n stern d stokowski rp thomas dj trulson mo vyas kr frazer ka blocks limited haplotype diversity revealed high resolution scanning human chromosome num symb num numnumabstractfree full text horne bd camp nj principal component analysis selection optimal snp sets capture intragenic variation genet symb num numnummedline carlsson persson p g grill v alvarsson m efendic norman svanstrom l ostenson c g weight history glucose tolerance insulin levels middle aged swedish men j symb num numnumabstract grill v persson g carlsson norman alvarsson m ostensson c g svanstrom l efendic family history diabetes middle aged swedish men gender unrelated factor associated insulinopenia newly diagnosed diabetic subjects symb num numnum agardh ee ahlbom andersson efendic grill v hallqvist j norman ostenson cg work stress low sense coherence associated type num diabetes middle aged swedish women diabetes symb num numnumabstractfree full text zondervan kt cardon lr complex interplay among factors influence allelic association nat rev symb num numnummedline o donnell cj lindpaintner k larson mg rao vs ordovas jm schaefer ej myers rh levy d evidence association genetic linkage angiotensin converting enzyme locus hypertension blood pressure men women framingham heart study symb num numnumabstractfree full text wittrup hh tybjaerg hansen steffensen r deeb ss brunzell jd jensen g nordestgaard bg mutations lipoprotein lipase gene associated ischemic heart disease men copenhagen city heart study arterioscler thromb vasc symb num numnumabstractfree full text mccarthy jj meyer j moliterno dj newby lk rogers wj topol ej evidence substantial effect modification gender large scale genetic association study metabolic syndrome among coronary heart disease patients hum symb num numnummedline cox r bouzekri n martin southam l hugill golamaully m cooper r adeyemo soubrier f ward r angiotensin num converting enzyme ace plasma concentration influenced multiple ace linked quantitative trait nucleotides hum mol symb num numnumabstractfree full text despres jp lamarche b mauriege p cantin b lupien pj dagenais gr risk factors ischaemic heart disease time measure insulin editorial eur heart symb num numnummedline andersen ub olsen mh dige petersen h ibsen h exercise blood pressure related insulin resistance subjects two hypertensive parents blood symb num numnummedline matthews dr rudenski naylor ba treacher df turner rc homeostasis model assessment insulin resistance beta cell function fasting plasma glucose insulin concentrations man symb num numnummedline jobs m howell wm stromqvist l mayr brookes aj dash num flexible low cost high throughput snp genotyping dynamic allele specific hybridization membrane arrays genome symb num numnumabstractfree full text prince ja feuk l howell wm jobs m emahazion blennow k brookes aj robust accurate single nucleotide polymorphism genotyping dynamic allele specific hybridization dash design criteria assay validation genome symb num numnumabstractfree full text niu qin zs xu x liu js bayesian haplotype inference multiple linked single nucleotide polymorphisms j hum symb num numnummedline hill wg estimation linkage disequilibrium randomly mating populations symb num numnummedline
0.39201447.15277398.html.plaintext.txt	41	references top abstract research design methods references meigs jb panhuysen ci myers rh wilson pw cupples la genome wide scan loci linked plasma levels glucose symb community based sample caucasian pedigrees framingham offspring study symb num numnumabstractfree full text wiltshire hattersley hitman ga walker m levy jc sampson m o rahilly frayling tm bell ji lathrop gm bennett dhillon r fletcher c groves cj jones e prestwich p simecek n rao pv wishart m bottazzo gf foxon r howell smedley d cardon lr menzel mccarthy mi genomewide scan loci predisposing type num diabetes u k population diabetes uk warren num repository analysis num pedigrees provides independent replication susceptibility locus chromosome numq j hum symb num numnummedline ghosh watanabe rm valle tt hauser er magnuson vl langefeld cd ally ds mohlke kl silander k kohtamaki k chines p balow j jr birznieks g chang j eldridge w erdos mr karanjawala ze knapp ji kudelko k martin c morales mena musick musick pfahl c porter r rayman jb finland united states investigation non insulin dependent diabetes mellitus genetics fusion study autosomal genome scan genes predispose type num diabetes j hum symb num numnummedline duggirala r blangero j almasy l dyer td williams kl leach rj o connell p stern mp linkage type num diabetes mellitus age onset genetic location chromosome numq mexican americans j hum symb num numnummedline duckworth wc bennett rg hamel fg insulin degradation progress potential endocr symb num numnumabstractfree full text affholter ja cascieri ma bayne ml brange j casaretto m roth ra identification residues insulin molecule important binding insulin degrading enzyme symb num numnummedline affholter ja hsieh cl francke u roth ra insulin degrading enzyme stable expression human complementary dna characterization protein product chromosomal mapping human mouse genes mol symb num numnumabstract farris w mansourian chang y lindsley l eckman ea frosch mp eckman cb tanzi re selkoe dj guenette insulin degrading enzyme regulates levels insulin amyloid beta protein beta amyloid precursor protein intracellular domain vivo proc natl acad sci u symb num numnumabstractfree full text fakhrai rad h nikoshkov kamel fernstrom m zierath jr norgren luthman h galli j insulin degrading enzyme identified candidate diabetes susceptibility gene gk rats hum mol symb num numnumabstractfree full text karamohamed demissie volcjak j liu c heard costa n liu j shoemaker cm panhuysen ci meigs jb wilson p atwood ld cupples la herbert polymorphisms insulin degrading enzyme gene associated type num diabetes men nhlbi framingham heart study symb num numnumabstractfree full text groves cj wiltshire smedley d owen kr frayling tm walker m hitman ga levy jc o rahilly menzel hattersley mccarthy mi association haplotype analysis insulin degrading enzyme ide gene strong positional biological candidate type num diabetes susceptibility symb num numnumabstractfree full text johnson gc esposito l barratt bj smith heward j di genova g ueda h cordell hj eaves ia dudbridge f twells rc payne f hughes w nutland stevens h carr p tuomilehto wolf e tuomilehto j gough sc clayton dg todd ja haplotype tagging identification common disease genes nat symb num numnummedline prince ja feuk l gu hf gatz m blennow k brookes aj genetic variation haplotype block spanning ide symb hhex influences alzheimer disease hum symb num numnummedline patil n berno aj hinds da barrett wa doshi jm hacker cr kautzer cr lee dh marjoribanks c mcdonough dp nguyen bt norris mc sheehan jb shen n stern d stokowski rp thomas dj trulson mo vyas kr frazer ka blocks limited haplotype diversity revealed high resolution scanning human chromosome num symb num numnumabstractfree full text horne bd camp nj principal component analysis selection optimal snp sets capture intragenic variation genet symb num numnummedline carlsson persson p g grill v alvarsson m efendic norman svanstrom l ostenson c g weight history glucose tolerance insulin levels middle aged swedish men j symb num numnumabstract grill v persson g carlsson norman alvarsson m ostensson c g svanstrom l efendic family history diabetes middle aged swedish men gender unrelated factor associated insulinopenia newly diagnosed diabetic subjects symb num numnum agardh ee ahlbom andersson efendic grill v hallqvist j norman ostenson cg work stress low sense coherence associated type num diabetes middle aged swedish women diabetes symb num numnumabstractfree full text zondervan kt cardon lr complex interplay among factors influence allelic association nat rev symb num numnummedline o donnell cj lindpaintner k larson mg rao vs ordovas jm schaefer ej myers rh levy d evidence association genetic linkage angiotensin converting enzyme locus hypertension blood pressure men women framingham heart study symb num numnumabstractfree full text wittrup hh tybjaerg hansen steffensen r deeb ss brunzell jd jensen g nordestgaard bg mutations lipoprotein lipase gene associated ischemic heart disease men copenhagen city heart study arterioscler thromb vasc symb num numnumabstractfree full text mccarthy jj meyer j moliterno dj newby lk rogers wj topol ej evidence substantial effect modification gender large scale genetic association study metabolic syndrome among coronary heart disease patients hum symb num numnummedline cox r bouzekri n martin southam l hugill golamaully m cooper r adeyemo soubrier f ward r angiotensin num converting enzyme ace plasma concentration influenced multiple ace linked quantitative trait nucleotides hum mol symb num numnumabstractfree full text despres jp lamarche b mauriege p cantin b lupien pj dagenais gr risk factors ischaemic heart disease time measure insulin editorial eur heart symb num numnummedline andersen ub olsen mh dige petersen h ibsen h exercise blood pressure related insulin resistance subjects two hypertensive parents blood symb num numnummedline matthews dr rudenski naylor ba treacher df turner rc homeostasis model assessment insulin resistance beta cell function fasting plasma glucose insulin concentrations man symb num numnummedline jobs m howell wm stromqvist l mayr brookes aj dash num flexible low cost high throughput snp genotyping dynamic allele specific hybridization membrane arrays genome symb num numnumabstractfree full text prince ja feuk l howell wm jobs m emahazion blennow k brookes aj robust accurate single nucleotide polymorphism genotyping dynamic allele specific hybridization dash design criteria assay validation genome symb num numnumabstractfree full text niu qin zs xu x liu js bayesian haplotype inference multiple linked single nucleotide polymorphisms j hum symb num numnummedline hill wg estimation linkage disequilibrium randomly mating populations symb num numnummedline
0.40214586.14747300.html.plaintext.txt	0	increased risk type num diabetes alzheimer disease juliette symbnum thomas symb joseph e symb peter o symb ronald c symb peter c symb
0.40214586.14747300.html.plaintext.txt	1	increased risk type num diabetes alzheimer disease juliette symbnum thomas symb joseph e symb peter o symb ronald c symb peter c symb
0.40214586.14747300.html.plaintext.txt	2	num endocrine research unit mayo clinic rochester minnesota num department pathology mayo clinic rochester minnesota num department biostatistics mayo clinic rochester minnesota num department neurology health sciences research mayo clinic rochester minnesota num division endocrinology diabetes keck school medicine university southern california los angeles california
0.40214586.14747300.html.plaintext.txt	3	abstract top abstract research design methods results discussion references alzheimer disease type num diabetes characterized increased prevalence aging genetic predisposition comparable pathological features islet brain amyloid derived amyloid ss protein brain alzheimer disease islet amyloid derived islet amyloid polypeptide pancreas type num diabetes evidence growing link precursors amyloid deposition brain pancreas pathogenesis alzheimer disease type num diabetes respectively given similarities questioned whether may common underlying mechanism predisposing islet cerebral amyloid address first examined prevalence type num diabetes community based controlled study mayo clinic alzheimer disease patient registry adpr follows patients alzheimer disease versus control subjects without alzheimer disease addition clinical study performed pathological study autopsy cases community determine whether increased prevalence islet amyloid patients alzheimer disease increased prevalence cerebral amyloid patients type num diabetes patients enrolled adpr alzheimer disease n num non alzheimer disease control subjects n num classified according fasting glucose concentration fpg nondiabetic fpg num mgdl impaired fasting glucose ifg fpg num num mgdl type num diabetes fpg num mgdl mean slope fpg num years case also compared alzheimer disease non alzheimer disease control subjects pancreas brain examined autopsy specimens obtained num humans first num cases alzheimer disease disease vs num non alzheimer disease control subjects second num subjects type num diabetes vs num non type num diabetes control subjects presence islet brain amyloid type num diabetes num vs num p numnum ifg num vs num p numnum prevalent alzheimer disease versus non alzheimer disease control subjects num cases alzheimer disease either type num diabetes ifg slope increase fpg age num years also greater alzheimer disease non alzheimer disease control subjects p numnum islet amyloid frequent p numnum extensive p numnum patients alzheimer disease non alzheimer disease control subjects however diffuse neuritic plaques common type num diabetes control subjects cases type num diabetes present duration type num diabetes correlated density diffuse p numnum neuritic plaques p numnum community cohort southeast minnesota type num diabetes ifg common patients alzheimer disease control subjects pathological hallmark type num diabetes islet amyloid however increase brain plaque formation cases type num diabetes although present correlated extent duration diabetes data support hypothesis patients alzheimer disease vulnerable type num diabetes possibility linkage processes responsible loss brain cells ss cells diseases
0.40214586.14747300.html.plaintext.txt	4	abstract top abstract research design methods results discussion references alzheimer disease type num diabetes characterized increased prevalence aging genetic predisposition comparable pathological features islet brain amyloid derived amyloid ss protein brain alzheimer disease islet amyloid derived islet amyloid polypeptide pancreas type num diabetes evidence growing link precursors amyloid deposition brain pancreas pathogenesis alzheimer disease type num diabetes respectively given similarities questioned whether may common underlying mechanism predisposing islet cerebral amyloid address first examined prevalence type num diabetes community based controlled study mayo clinic alzheimer disease patient registry adpr follows patients alzheimer disease versus control subjects without alzheimer disease addition clinical study performed pathological study autopsy cases community determine whether increased prevalence islet amyloid patients alzheimer disease increased prevalence cerebral amyloid patients type num diabetes patients enrolled adpr alzheimer disease n num non alzheimer disease control subjects n num classified according fasting glucose concentration fpg nondiabetic fpg num mgdl impaired fasting glucose ifg fpg num num mgdl type num diabetes fpg num mgdl mean slope fpg num years case also compared alzheimer disease non alzheimer disease control subjects pancreas brain examined autopsy specimens obtained num humans first num cases alzheimer disease disease vs num non alzheimer disease control subjects second num subjects type num diabetes vs num non type num diabetes control subjects presence islet brain amyloid type num diabetes num vs num p numnum ifg num vs num p numnum prevalent alzheimer disease versus non alzheimer disease control subjects num cases alzheimer disease either type num diabetes ifg slope increase fpg age num years also greater alzheimer disease non alzheimer disease control subjects p numnum islet amyloid frequent p numnum extensive p numnum patients alzheimer disease non alzheimer disease control subjects however diffuse neuritic plaques common type num diabetes control subjects cases type num diabetes present duration type num diabetes correlated density diffuse p numnum neuritic plaques p numnum community cohort southeast minnesota type num diabetes ifg common patients alzheimer disease control subjects pathological hallmark type num diabetes islet amyloid however increase brain plaque formation cases type num diabetes although present correlated extent duration diabetes data support hypothesis patients alzheimer disease vulnerable type num diabetes possibility linkage processes responsible loss brain cells ss cells diseases
0.40214586.14747300.html.plaintext.txt	5	islet langerhans type num diabetes characterized ss cell loss numnum islet amyloid derived islet amyloid polypeptide iapp num num protein coexpressed secreted insulin ss cells brain dysfunction alzheimer disease characterized loss neocortical neurons num focal amyloid deposits consist locally expressed amyloid ss protein assp num num prevalence alzheimer disease type num diabetes increases age genetic components num num
0.40214586.14747300.html.plaintext.txt	6	islet langerhans type num diabetes characterized ss cell loss numnum islet amyloid derived islet amyloid polypeptide iapp num num protein coexpressed secreted insulin ss cells brain dysfunction alzheimer disease characterized loss neocortical neurons num focal amyloid deposits consist locally expressed amyloid ss protein assp num num prevalence alzheimer disease type num diabetes increases age genetic components num num
0.40214586.14747300.html.plaintext.txt	7	assp iapp spontaneously form amyloid aggregates aqueous environment numnumnumnum role aggregates iapp assp ss cell cortical neuronal death type num diabetes alzheimer disease controversial small amyloid aggregates either proteins cytotoxic num num mechanism cytotoxicity mediated small protein aggregates hypothesized induction membrane damage num num case iapp evidence exists suggest abnormal aggregation occurs initially intracellularly cell death iapp derived fibrils accumulate extracellularly numnumnum similar mechanisms also possible alzheimer disease vivo even though iapp assp present aqueous environment health neither protein forms fibrils suggesting mechanisms exist prevent otherwise spontaneous process mechanisms likely include chaperone protein pathway system protein trafficking via intracellular binding proteins chaperone proteins bind nascent proteins facilitate transport within cell num
0.40214586.14747300.html.plaintext.txt	8	assp iapp spontaneously form amyloid aggregates aqueous environment numnumnumnum role aggregates iapp assp ss cell cortical neuronal death type num diabetes alzheimer disease controversial small amyloid aggregates either proteins cytotoxic num num mechanism cytotoxicity mediated small protein aggregates hypothesized induction membrane damage num num case iapp evidence exists suggest abnormal aggregation occurs initially intracellularly cell death iapp derived fibrils accumulate extracellularly numnumnum similar mechanisms also possible alzheimer disease vivo even though iapp assp present aqueous environment health neither protein forms fibrils suggesting mechanisms exist prevent otherwise spontaneous process mechanisms likely include chaperone protein pathway system protein trafficking via intracellular binding proteins chaperone proteins bind nascent proteins facilitate transport within cell num
0.40214586.14747300.html.plaintext.txt	9	previously hypothesized iapp amyloid formation type num diabetes may occur circumstances genetic variance results relative decreased affinity chaperone protein pathway trafficking iapp num plausible low affinity binding one chaperone proteins iapp may shared similar low affinity binding assp support hypothesis schwartz num suggested might relationship amyloid deposits brain pancreatic islets
0.40214586.14747300.html.plaintext.txt	10	previously hypothesized iapp amyloid formation type num diabetes may occur circumstances genetic variance results relative decreased affinity chaperone protein pathway trafficking iapp num plausible low affinity binding one chaperone proteins iapp may shared similar low affinity binding assp support hypothesis schwartz num suggested might relationship amyloid deposits brain pancreatic islets
0.40214586.14747300.html.plaintext.txt	11	used clinical studies living patients community based control subjects pathological studies examine existence shared risk alzheimer disease type num diabetes clinical studies took advantage unique community based olmsted county mn cohort well characterized patients alzheimer disease control subjects without alzheimer disease num address question type num diabetes common alzheimer disease pathology studies studied brain pancreas autopsy cases community address hypotheses num islet amyloid frequent patients alzheimer disease control subjects without alzheimer disease num amyloid deposits common brain patients type num diabetes nondiabetic humans
0.40214586.14747300.html.plaintext.txt	12	used clinical studies living patients community based control subjects pathological studies examine existence shared risk alzheimer disease type num diabetes clinical studies took advantage unique community based olmsted county mn cohort well characterized patients alzheimer disease control subjects without alzheimer disease num address question type num diabetes common alzheimer disease pathology studies studied brain pancreas autopsy cases community address hypotheses num islet amyloid frequent patients alzheimer disease control subjects without alzheimer disease num amyloid deposits common brain patients type num diabetes nondiabetic humans
0.40214586.14747300.html.plaintext.txt	13	research design methods top abstract research design methods results discussion references clinical studies primary objective mayo clinic alzheimer disease patient registry adpr acquire cohort patients alzheimer disease matched non alzheimer disease control subjects assessment progression alzheimer disease clinically respect imaging neurological studies patients southeastern minnesota dementia identified time routine general medical examination department community internal medicine mayo clinic studies approved mayo clinic institutional review board suspicion alzheimer disease routine periodic medical examination neurological evaluation included mini mental state exam geriatric depression scale hachinski ischemic scale short test mental status record independent living extensive neuropsychological testing performed num age sex matched control subjects randomly identified community clinics enrolled cases detailed evaluation confirm rule control subjects alzheimer disease patient enrolled adpr case alzheimer disease control followed annually clinical studies included fasting blood glucose measurement recruitment adpr haphazard ie deliberately biased respect presence absence diabetes blood glucose concentration exclusion criteria num chronic treatment glucocorticoids num history pancreatitis num type num diabetes distinction type num type num diabetes made conventional clinical criteria features favoring type num diabetes included lean bmi weight loss young age onset insulin requirement onset documented ketoacidosis presence autoimmune diseases family history autoimmune disease features favoring type num diabetes included strong family history prolonged insulin independent treatment obesity absence autoimmune diseases later age onset acknowledged distinction type num type num diabetes without error view large number cases present studies high prevalence type num versus type num diabetes unlikely conclusions present studies influenced erroneous inclusion cases type num diabetes table num
0.40214586.14747300.html.plaintext.txt	14	research design methods top abstract research design methods results discussion references clinical studies primary objective mayo clinic alzheimer disease patient registry adpr acquire cohort patients alzheimer disease matched non alzheimer disease control subjects assessment progression alzheimer disease clinically respect imaging neurological studies patients southeastern minnesota dementia identified time routine general medical examination department community internal medicine mayo clinic studies approved mayo clinic institutional review board suspicion alzheimer disease routine periodic medical examination neurological evaluation included mini mental state exam geriatric depression scale hachinski ischemic scale short test mental status record independent living extensive neuropsychological testing performed num age sex matched control subjects randomly identified community clinics enrolled cases detailed evaluation confirm rule control subjects alzheimer disease patient enrolled adpr case alzheimer disease control followed annually clinical studies included fasting blood glucose measurement recruitment adpr haphazard ie deliberately biased respect presence absence diabetes blood glucose concentration exclusion criteria num chronic treatment glucocorticoids num history pancreatitis num type num diabetes distinction type num type num diabetes made conventional clinical criteria features favoring type num diabetes included lean bmi weight loss young age onset insulin requirement onset documented ketoacidosis presence autoimmune diseases family history autoimmune disease features favoring type num diabetes included strong family history prolonged insulin independent treatment obesity absence autoimmune diseases later age onset acknowledged distinction type num type num diabetes without error view large number cases present studies high prevalence type num versus type num diabetes unlikely conclusions present studies influenced erroneous inclusion cases type num diabetes table num
0.40214586.14747300.html.plaintext.txt	15	view table table num study cases clinical studies
0.40214586.14747300.html.plaintext.txt	16	protocol num type num diabetes common alzheimer disease recruitment criteria provided total num patients alzheimer disease num non alzheimer disease control subjects protocol num cases control subjects classified according criteria american diabetes association one three groups nondiabetic num mgdl impaired fasting glucose ifg num num mgdl type num diabetes num mgdl based recent glucose concentration measurements individuals taking blood glucose lowering treatment diabetes classified type num diabetes regardless recent fasting glucose concentration
0.40214586.14747300.html.plaintext.txt	17	protocol num type num diabetes common alzheimer disease recruitment criteria provided total num patients alzheimer disease num non alzheimer disease control subjects protocol num cases control subjects classified according criteria american diabetes association one three groups nondiabetic num mgdl impaired fasting glucose ifg num num mgdl type num diabetes num mgdl based recent glucose concentration measurements individuals taking blood glucose lowering treatment diabetes classified type num diabetes regardless recent fasting glucose concentration
0.40214586.14747300.html.plaintext.txt	18	protocol num increase fasting plasma glucose age greater alzheimer disease also examined changes fasting plasma glucose fpg aging cohort patients subject regressed annual median fpg value age used obtain predicted fpg value subject decade also compare slopes regression lines groups alzheimer disease versus control subjects using two sided rank sum test included analysis patients required fpg values recorded spanned least num consecutive years age num greater least one value available calendar year ages bordernumnum years considered criteria resulted study population num patients alzheimer disease num non alzheimer disease control subjects
0.40214586.14747300.html.plaintext.txt	19	protocol num increase fasting plasma glucose age greater alzheimer disease also examined changes fasting plasma glucose fpg aging cohort patients subject regressed annual median fpg value age used obtain predicted fpg value subject decade also compare slopes regression lines groups alzheimer disease versus control subjects using two sided rank sum test included analysis patients required fpg values recorded spanned least num consecutive years age num greater least one value available calendar year ages bordernumnum years considered criteria resulted study population num patients alzheimer disease num non alzheimer disease control subjects
0.40214586.14747300.html.plaintext.txt	20	pathology studies case recruitment alzheimer disease patients group num control subjects non alzheimer disease group num enrolled mayo clinic adpr study life num death non alzheimer disease alzheimer disease cases autopsy examination brain diagnosis alzheimer disease absence confirmed using cerad consortium establish registry alzheimer disease criteria num pathology study include num cases clinically pathologically confirmed alzheimer disease non alzheimer disease num cases autopsy including brain pancreas num cases fpg documented mayo clinic within num years alzheimer disease num non alzheimer disease num cases num year non alzheimer disease num alzheimer disease num complete autopsies death mean fpg value subject mean least two independent measurements alzheimer disease patients sex age matched control subjects life per mayo clinic adpr study still matched age death num plus minus num vs num plus minus num years alzheimer disease vs non alzheimer disease p numnum alzheimer disease diagnosed numnum plus minus numnum range numnum numnum years death
0.40214586.14747300.html.plaintext.txt	21	pathology studies case recruitment alzheimer disease patients group num control subjects non alzheimer disease group num enrolled mayo clinic adpr study life num death non alzheimer disease alzheimer disease cases autopsy examination brain diagnosis alzheimer disease absence confirmed using cerad consortium establish registry alzheimer disease criteria num pathology study include num cases clinically pathologically confirmed alzheimer disease non alzheimer disease num cases autopsy including brain pancreas num cases fpg documented mayo clinic within num years alzheimer disease num non alzheimer disease num cases num year non alzheimer disease num alzheimer disease num complete autopsies death mean fpg value subject mean least two independent measurements alzheimer disease patients sex age matched control subjects life per mayo clinic adpr study still matched age death num plus minus num vs num plus minus num years alzheimer disease vs non alzheimer disease p numnum alzheimer disease diagnosed numnum plus minus numnum range numnum numnum years death
0.40214586.14747300.html.plaintext.txt	22	type num diabetes cases group num fpg num mgdl identified via mayo clinic autopsy records inclusion num died num years preceding study num also olmsted county num autopsy including brain pancreas num general medical examination performed including fpg mayo clinic year death exclusion criteria included inadequate preservation pancreatic tissue anatomic study type num diabetes secondary causes diabetes diagnosis diabetes cohort num plus minus num years death selection criteria yielded num cases mean age death younger type num diabetes alzheimer disease cases num plus minus num vs num plus minus num years p numnum therefore identified mayo clinic autopsy records additional control group consisting num cases group num age bmi sex matched type num diabetic patients normal fpg documented within num year death also meeting criteria num num group num groups num num included haphazardly ie consciously biased respect presence absence alzheimer disease characteristics four study groups summarized table num
0.40214586.14747300.html.plaintext.txt	23	type num diabetes cases group num fpg num mgdl identified via mayo clinic autopsy records inclusion num died num years preceding study num also olmsted county num autopsy including brain pancreas num general medical examination performed including fpg mayo clinic year death exclusion criteria included inadequate preservation pancreatic tissue anatomic study type num diabetes secondary causes diabetes diagnosis diabetes cohort num plus minus num years death selection criteria yielded num cases mean age death younger type num diabetes alzheimer disease cases num plus minus num vs num plus minus num years p numnum therefore identified mayo clinic autopsy records additional control group consisting num cases group num age bmi sex matched type num diabetic patients normal fpg documented within num year death also meeting criteria num num group num groups num num included haphazardly ie consciously biased respect presence absence alzheimer disease characteristics four study groups summarized table num
0.40214586.14747300.html.plaintext.txt	24	view table table num study cases pathology
0.40214586.14747300.html.plaintext.txt	25	protocol num islet amyloid increased patients alzheimer disease address question studied pancreas samples obtained autopsy num cases alzheimer disease num without alzheimer disease groups num num table num addition num cases type num diabetes num without type num diabetes studied point reference protocol num included total num cases
0.40214586.14747300.html.plaintext.txt	26	protocol num islet amyloid increased patients alzheimer disease address question studied pancreas samples obtained autopsy num cases alzheimer disease num without alzheimer disease groups num num table num addition num cases type num diabetes num without type num diabetes studied point reference protocol num included total num cases
0.40214586.14747300.html.plaintext.txt	27	protocol num brain amyloid common patients type num diabetes address question studied brain samples num cases num without type num diabetes groups num num table num reference num cases alzheimer disease num without alzheimer disease studied paraffin blocks superiormidfrontal gyrus available resulting num cases entering protocol num
0.40214586.14747300.html.plaintext.txt	28	protocol num brain amyloid common patients type num diabetes address question studied brain samples num cases num without type num diabetes groups num num table num reference num cases alzheimer disease num without alzheimer disease studied paraffin blocks superiormidfrontal gyrus available resulting num cases entering protocol num
0.40214586.14747300.html.plaintext.txt	29	light microscopy pancreas brain samples obtained autopsy four groups described slides examined blinded identity case light microscopy
0.40214586.14747300.html.plaintext.txt	30	pancreas sequential sections obtained paraffin embedded pancreas tail samples stained hematoxylineosin congo red immunostaining insulin num nature pink amyloid deposits congo red stained slides confirmed greenorange birefringence polarized light least num islets per specimen scored presence extent islet amyloid extent amyloid deposition classified per islet scale num num num deposits num one deposit num small deposits num major deposition num endocrine cells left confluent deposits
0.40214586.14747300.html.plaintext.txt	31	brain samples superiormidfrontal gyrus collected density neuritic diffuse plaques neurofibrillary tangle nft determined visualizing neurofilaments paraffin sections superiormidfrontal gyrus stained modified bielschowsky technique per sample number neuritic plaques diffuse plagues nft determined five microscope fields num symb
0.40214586.14747300.html.plaintext.txt	32	statistical analysis protocols num num rank sum test used compare age num tests used compare number groups according classification sex diabetic nondiabetic ifg status two sided rank sum test used compare slope fasting glucose versus age
0.40214586.14747300.html.plaintext.txt	33	statistical analysis protocols num num rank sum test used compare age num tests used compare number groups according classification sex diabetic nondiabetic ifg status two sided rank sum test used compare slope fasting glucose versus age
0.40214586.14747300.html.plaintext.txt	34	protocols num num unpaired two tailed student test used compare age bmi groups nonparametric mann whitney test used compare frequency extent islet amyloid fpg density neuritic plaques diffuse plagues nft among groups num test used compare number alzheimer disease non alzheimer disease subjects type num diabetes spearman rank correlations used examine relationships among diffuse plagues neuritic plaques nft density versus duration diabetes death age death type num diabetes
0.40214586.14747300.html.plaintext.txt	35	results top abstract research design methods results discussion references clinical studies prevalence type num diabetes ifg living cohort alzheimer disease versus non alzheimer disease control subjects trend fpg aging protocol num difference age sex distribution alzheimer disease non alzheimer disease control group table num bmi slightly significantly higher control subjects versus alzheimer disease prevalence type num diabetes numnum vs numnum p numnum ifg numnum vs numnum p numnum greater alzheimer disease versus non alzheimer disease control group fig num num alzheimer disease cases therefore either type num diabetes ifg
0.40214586.14747300.html.plaintext.txt	36	results top abstract research design methods results discussion references clinical studies prevalence type num diabetes ifg living cohort alzheimer disease versus non alzheimer disease control subjects trend fpg aging protocol num difference age sex distribution alzheimer disease non alzheimer disease control group table num bmi slightly significantly higher control subjects versus alzheimer disease prevalence type num diabetes numnum vs numnum p numnum ifg numnum vs numnum p numnum greater alzheimer disease versus non alzheimer disease control group fig num num alzheimer disease cases therefore either type num diabetes ifg
0.40214586.14747300.html.plaintext.txt	37	view larger version numk fig num protocol num prevalence diabetes ifg olmsted county community based cohort cases alzheimer disease ad control subjects non alzheimer disease non ad top protocol num slope fpg concentration versus age cohort bottom ttdm type num diabetes
0.40214586.14747300.html.plaintext.txt	38	protocol num trend fpg aging examined gradual increase aging groups p numnum vs change however alzheimer disease group greater increase per year compared non alzheimer disease control subjects numnum vs numnum mg dl num y num p numnum fig num greater rate increase blood glucose preserved alzheimer disease cases diabetes excluded analysis
0.40214586.14747300.html.plaintext.txt	39	pathology studies islet amyloid alzheimer disease protocol num brain amyloid type num diabetes protocol num protocol num islet amyloid alzheimer disease frequency extent islet amyloid higher alzheimer disease group versus non alzheimer disease group p numnum fig num despite trend toward lower bmi alzheimer disease numnum plus minus numnum vs numnum plus minus numnum kgsymb alzheimer disease vs non alzheimer disease p numnum expected frequency extent islet amyloid greater type num diabetes group num versus non type num diabetes group num p numnum fig num
0.40214586.14747300.html.plaintext.txt	40	pathology studies islet amyloid alzheimer disease protocol num brain amyloid type num diabetes protocol num protocol num islet amyloid alzheimer disease frequency extent islet amyloid higher alzheimer disease group versus non alzheimer disease group p numnum fig num despite trend toward lower bmi alzheimer disease numnum plus minus numnum vs numnum plus minus numnum kgsymb alzheimer disease vs non alzheimer disease p numnum expected frequency extent islet amyloid greater type num diabetes group num versus non type num diabetes group num p numnum fig num
0.40214586.14747300.html.plaintext.txt	41	view larger version numk fig num protocol num frequency islet amyloid top extent islet amyloid bottom patients alzheimer disease ad control subjects non alzheimer disease non ad patients type num diabetes ttdm control group non ttdm individual values medians line
0.40214586.14747300.html.plaintext.txt	42	inclusion cases autopsy protocol blinded respect presence absence diabetes requirement fpg documented subsequent analysis fpg concentrations revealed prevalence type num diabetes fpg num mgdl alzheimer disease group num non alzheimer disease cases num p numnum mean fpg alzheimer disease higher control subjects num plus minus num vs num plus minus num mgdl p numnum
0.40214586.14747300.html.plaintext.txt	43	inclusion cases autopsy protocol blinded respect presence absence diabetes requirement fpg documented subsequent analysis fpg concentrations revealed prevalence type num diabetes fpg num mgdl alzheimer disease group num non alzheimer disease cases num p numnum mean fpg alzheimer disease higher control subjects num plus minus num vs num plus minus num mgdl p numnum
0.40214586.14747300.html.plaintext.txt	44	protocol num brain amyloid type num diabetes density diffuse neuritic plaques nft different patients type num diabetes versus nondiabetic control subjects p numnum p numnum p numnum respectively table num expected density neuritic plaques diffuse plaques nft greater p numnum alzheimer disease cases group num versus non alzheimer disease group num
0.40214586.14747300.html.plaintext.txt	45	protocol num brain amyloid type num diabetes density diffuse neuritic plaques nft different patients type num diabetes versus nondiabetic control subjects p numnum p numnum p numnum respectively table num expected density neuritic plaques diffuse plaques nft greater p numnum alzheimer disease cases group num versus non alzheimer disease group num
0.40214586.14747300.html.plaintext.txt	46	view table table num brain pathology
0.40214586.14747300.html.plaintext.txt	47	num num type num diabetes cases year diagnosis diabetes documented diffuse plaques detected num neuritic plaques num num cases type num diabetes documented age onset diabetes positive relationship duration known diabetes extent diffuse plaques rs numnum p numnum neuritic plaques rs numnum p numnum cases fig num contrast neither type num diabetes non type num diabetes correlation density either plaques age death
0.40214586.14747300.html.plaintext.txt	48	num num type num diabetes cases year diagnosis diabetes documented diffuse plaques detected num neuritic plaques num num cases type num diabetes documented age onset diabetes positive relationship duration known diabetes extent diffuse plaques rs numnum p numnum neuritic plaques rs numnum p numnum cases fig num contrast neither type num diabetes non type num diabetes correlation density either plaques age death
0.40214586.14747300.html.plaintext.txt	49	view larger version numk fig num protocol num relationship density diffuse plaques rs numnum p numnum top neuritic plaques rs numnum p numnum bottom versus duration diabetes patients type num diabetes cases included duration diabetes documented respective plaque type detected y equal zero
0.40214586.14747300.html.plaintext.txt	50	discussion top abstract research design methods results discussion references report prevalence type num diabetes ifg increased well characterized community cohort patients alzheimer disease southeast minnesota related pathology studies also report increased frequency islet amyloid patients alzheimer disease however brain amyloid increased patients type num diabetes versus non type num diabetes density diffuse neuritic plaques present associated duration diabetes
0.40214586.14747300.html.plaintext.txt	51	discussion top abstract research design methods results discussion references report prevalence type num diabetes ifg increased well characterized community cohort patients alzheimer disease southeast minnesota related pathology studies also report increased frequency islet amyloid patients alzheimer disease however brain amyloid increased patients type num diabetes versus non type num diabetes density diffuse neuritic plaques present associated duration diabetes
0.40214586.14747300.html.plaintext.txt	52	studies initially undertaken test hypothesis may shared predisposition development islet amyloid brain amyloid patients alzheimer disease type num diabetes respectively postulate arose close resemblance pathology brain alzheimer disease islets type num diabetes diseases locally expressed protein assp alzheimer disease iapp type num diabetes deposited amyloid deposits gradual decline number cells respective proteins amyloid deposits assp iapp likely oligomeric precursors cytotoxic numnumnum num mechanism may relate membrane disruption num num however yet still clear explanation amyloidogenic proteins form amyloid fibrils develop type num diabetes alzheimer disease proteins spontaneously form amyloid fibrils vitro aqueous environment present cell mechanisms must exist health prevent aggregation presumably include chaperone protein pathway num newly synthesized proteins bound chaperone protein function preventing insoluble proteins eg iapp assp aggregating cells trafficking protein appropriate subcellular location chaperon proteins described promiscuous chaperone protein binds traffics numerous different proteins structurally similar properties num individual chaperone proteins traffic structurally similar peptides possible iapp assp share one chaperone proteins fig num amino acid sequence structural properties amino acid symb num symb num shown aligned reveal major overlap num structural properties symb num symb num areas hydrophobic therefore likely target binding chaperone proteins furthermore region iapp well established amyloidogenic sequence num symb num neurotoxic num recently suggested toxic intermediate form iapp assp oligomers recognized antibody suggesting strong structural relationship num
0.40214586.14747300.html.plaintext.txt	53	studies initially undertaken test hypothesis may shared predisposition development islet amyloid brain amyloid patients alzheimer disease type num diabetes respectively postulate arose close resemblance pathology brain alzheimer disease islets type num diabetes diseases locally expressed protein assp alzheimer disease iapp type num diabetes deposited amyloid deposits gradual decline number cells respective proteins amyloid deposits assp iapp likely oligomeric precursors cytotoxic numnumnum num mechanism may relate membrane disruption num num however yet still clear explanation amyloidogenic proteins form amyloid fibrils develop type num diabetes alzheimer disease proteins spontaneously form amyloid fibrils vitro aqueous environment present cell mechanisms must exist health prevent aggregation presumably include chaperone protein pathway num newly synthesized proteins bound chaperone protein function preventing insoluble proteins eg iapp assp aggregating cells trafficking protein appropriate subcellular location chaperon proteins described promiscuous chaperone protein binds traffics numerous different proteins structurally similar properties num individual chaperone proteins traffic structurally similar peptides possible iapp assp share one chaperone proteins fig num amino acid sequence structural properties amino acid symb num symb num shown aligned reveal major overlap num structural properties symb num symb num areas hydrophobic therefore likely target binding chaperone proteins furthermore region iapp well established amyloidogenic sequence num symb num neurotoxic num recently suggested toxic intermediate form iapp assp oligomers recognized antibody suggesting strong structural relationship num
0.40214586.14747300.html.plaintext.txt	54	view larger version numk fig num structural overlap iapp assp major overlap num structural properties symb num symb num amino acids classified acidic basic b nonpolar np polar uncharged pu gray boxed hatched areas identical amino acids gray boxed areas amino acids similar structural properties
0.40214586.14747300.html.plaintext.txt	55	chaperone protein pathway trafficking assp iapp shared decreased capacity trafficking either might also shared circumstances aggregation either proteins might occur resulting development relevant phenotype alzheimer disease andor type num diabetes addition type num diabetes alzheimer disease increase prevalence aging cell chaperone protein capacity declines aging num would expected reveal partial deficiency chaperone capacity aging therefore one potential explanation reported shared risk alzheimer disease type num diabetes similar pathology iapp assp share one chaperone proteins functional defect shared pathway decreased chaperone protein binding decreased chaperone protein availability results shared vulnerability assp aggregate ss pleated sheets cortical cells iapp aggregate ss cells
0.40214586.14747300.html.plaintext.txt	56	chaperone protein pathway trafficking assp iapp shared decreased capacity trafficking either might also shared circumstances aggregation either proteins might occur resulting development relevant phenotype alzheimer disease andor type num diabetes addition type num diabetes alzheimer disease increase prevalence aging cell chaperone protein capacity declines aging num would expected reveal partial deficiency chaperone capacity aging therefore one potential explanation reported shared risk alzheimer disease type num diabetes similar pathology iapp assp share one chaperone proteins functional defect shared pathway decreased chaperone protein binding decreased chaperone protein availability results shared vulnerability assp aggregate ss pleated sheets cortical cells iapp aggregate ss cells
0.40214586.14747300.html.plaintext.txt	57	alternative hypothesis account reported overlap islet amyloid brain amyloid subtle hyperglycemia causes alzheimer disease possibility reviewed finch cohen num finch cohen proposed progressive increase plasma glucose concentration occurs aging general population may important pathogenesis alzheimer disease proposed may mediated induction oxidative stress glycosylation key regulatory proteins numnum current study least partly supportive interesting hypothesis present density diffuse neuritic plaques brain increased duration diabetes age prolonged exposure hyperglycemia thus might trigger brain plaque formation risk however hypothesis overall increase pathological features alzheimer disease cases type num diabetes compared control subjects consistent previous pathological report num
0.40214586.14747300.html.plaintext.txt	58	alternative hypothesis account reported overlap islet amyloid brain amyloid subtle hyperglycemia causes alzheimer disease possibility reviewed finch cohen num finch cohen proposed progressive increase plasma glucose concentration occurs aging general population may important pathogenesis alzheimer disease proposed may mediated induction oxidative stress glycosylation key regulatory proteins numnum current study least partly supportive interesting hypothesis present density diffuse neuritic plaques brain increased duration diabetes age prolonged exposure hyperglycemia thus might trigger brain plaque formation risk however hypothesis overall increase pathological features alzheimer disease cases type num diabetes compared control subjects consistent previous pathological report num
0.40214586.14747300.html.plaintext.txt	59	high risk underlying vascular disease diabetes reported increase rates vascular dementia diabetes numnum furthermore hypertension hyperlipidemia strongly associated diabetes num risk factors vascular dementia num num another potential mechanism decreased cognitive function long standing diabetes recurrent hypoglycemia num num however present studies included cases type num diabetes recurrent hypoglycemia rare comparison type num diabetes
0.40214586.14747300.html.plaintext.txt	60	high risk underlying vascular disease diabetes reported increase rates vascular dementia diabetes numnum furthermore hypertension hyperlipidemia strongly associated diabetes num risk factors vascular dementia num num another potential mechanism decreased cognitive function long standing diabetes recurrent hypoglycemia num num however present studies included cases type num diabetes recurrent hypoglycemia rare comparison type num diabetes
0.40214586.14747300.html.plaintext.txt	61	multiple factors might influence relationship dementia type num diabetes well differences populations inclusion criteria likely contribute conflicting epidemiological data field studies suggest prevalence alzheimer disease increased type num diabetes num num whereas others reported decreased num num comparable numnumnum num confounding factor studies including current one alzheimer disease often accompanied decreased bmi presumed result decreased food intake potent risk factor development type num diabetes increased bmi possible association conditions obscured relative protective effect decreased bmi alzheimer disease alternatively possible people alzheimer disease exercise less therefore decreased insulin sensitivity increased risk type num diabetes type num diabetes tends develop younger age alzheimer disease associated decreased life expectancy early death complications diabetes might obscure subsequent development alzheimer disease current pathology studies unique inasmuch alzheimer disease non alzheimer disease groups fully characterized life autopsy although numbers small provocative distinct increase risk islet amyloid patients alzheimer disease despite lower bmi clinical data protocols num num also community based cases defined extensively respect presence absence dementia followed relatively long term num interest population based study region showed association type num diabetes alzheimer disease num whereas former study examined records known cases type num diabetes rochester area time study diagnosis dementia alzheimer disease numnum cases present study focused much smaller cohort patients alzheimer disease num cases control subjects num cases enrolled adpr num wherein diagnosis alzheimer disease rigorously established patients followed annually study thereafter deceased included autopsy studies one factor might caused discrepancies reported studies changing definition diabetes present study uses criteria adopted fpg concentrations num expert committee convened american diabetes association num consequence report plasma glucose concentration required establish diagnosis diabetes decreased num mgdl num mgdl furthermore high risk group established subsequent development diabetes fpg concentration num num mgdl studies used higher values diagnosis diabetes would report lower prevalence rates alzheimer disease control subjects possibly observe differences groups might evident criteria used
0.40214586.14747300.html.plaintext.txt	62	multiple factors might influence relationship dementia type num diabetes well differences populations inclusion criteria likely contribute conflicting epidemiological data field studies suggest prevalence alzheimer disease increased type num diabetes num num whereas others reported decreased num num comparable numnumnum num confounding factor studies including current one alzheimer disease often accompanied decreased bmi presumed result decreased food intake potent risk factor development type num diabetes increased bmi possible association conditions obscured relative protective effect decreased bmi alzheimer disease alternatively possible people alzheimer disease exercise less therefore decreased insulin sensitivity increased risk type num diabetes type num diabetes tends develop younger age alzheimer disease associated decreased life expectancy early death complications diabetes might obscure subsequent development alzheimer disease current pathology studies unique inasmuch alzheimer disease non alzheimer disease groups fully characterized life autopsy although numbers small provocative distinct increase risk islet amyloid patients alzheimer disease despite lower bmi clinical data protocols num num also community based cases defined extensively respect presence absence dementia followed relatively long term num interest population based study region showed association type num diabetes alzheimer disease num whereas former study examined records known cases type num diabetes rochester area time study diagnosis dementia alzheimer disease numnum cases present study focused much smaller cohort patients alzheimer disease num cases control subjects num cases enrolled adpr num wherein diagnosis alzheimer disease rigorously established patients followed annually study thereafter deceased included autopsy studies one factor might caused discrepancies reported studies changing definition diabetes present study uses criteria adopted fpg concentrations num expert committee convened american diabetes association num consequence report plasma glucose concentration required establish diagnosis diabetes decreased num mgdl num mgdl furthermore high risk group established subsequent development diabetes fpg concentration num num mgdl studies used higher values diagnosis diabetes would report lower prevalence rates alzheimer disease control subjects possibly observe differences groups might evident criteria used
0.40214586.14747300.html.plaintext.txt	63	another potential confounding factor previous well present studies recruitment bias studies performed major tertiary referral centers mayo clinic subject bias efforts made minimize present clinical studies recruitment patients local community community clinics mayo medical center patients therefore attending mayo clinic community clinics primary care recruited either alzheimer disease control groups clinical studies nonetheless recruitment bias may introduced study failure affected patients seek medical care therefore unavailable consideration present study greater proportion women men clinical studies might part reflection recruitment bias also potentially due shorter life span men women alzheimer disease diagnosed autopsy studies alzheimer disease cases control subjects islet amyloid would subject ascertainment bias adpr since cases adpr death autopsy studies type num diabetes cases versus control subjects brain amyloid sought minimize deliberate bias including recent autopsies reverse sequence cases appropriate inclusion criteria people autopsy course subgroup general population bias considered notwithstanding limitations opportunity presenting autopsy data cases well characterized life compared autopsy studies
0.40214586.14747300.html.plaintext.txt	64	another potential confounding factor previous well present studies recruitment bias studies performed major tertiary referral centers mayo clinic subject bias efforts made minimize present clinical studies recruitment patients local community community clinics mayo medical center patients therefore attending mayo clinic community clinics primary care recruited either alzheimer disease control groups clinical studies nonetheless recruitment bias may introduced study failure affected patients seek medical care therefore unavailable consideration present study greater proportion women men clinical studies might part reflection recruitment bias also potentially due shorter life span men women alzheimer disease diagnosed autopsy studies alzheimer disease cases control subjects islet amyloid would subject ascertainment bias adpr since cases adpr death autopsy studies type num diabetes cases versus control subjects brain amyloid sought minimize deliberate bias including recent autopsies reverse sequence cases appropriate inclusion criteria people autopsy course subgroup general population bias considered notwithstanding limitations opportunity presenting autopsy data cases well characterized life compared autopsy studies
0.40214586.14747300.html.plaintext.txt	65	conclusion report increased prevalence type num diabetes ifg community cohort patients alzheimer disease followed olmsted county rochester minnesota also report increased islet amyloid patients alzheimer disease compared control subjects however observe increased frequency brain amyloid cases type num diabetes although cases type num diabetes brain amyloid extent amyloid increased longer duration diabetes correlate extend age patients type num diabetes taken together clinical pathological studies support possible link neurodegenerative processes lead loss cortical brain cells alzheimer disease loss ss cells type num diabetes
0.40214586.14747300.html.plaintext.txt	66	conclusion report increased prevalence type num diabetes ifg community cohort patients alzheimer disease followed olmsted county rochester minnesota also report increased islet amyloid patients alzheimer disease compared control subjects however observe increased frequency brain amyloid cases type num diabetes although cases type num diabetes brain amyloid extent amyloid increased longer duration diabetes correlate extend age patients type num diabetes taken together clinical pathological studies support possible link neurodegenerative processes lead loss cortical brain cells alzheimer disease loss ss cells type num diabetes
0.40214586.14747300.html.plaintext.txt	67	acknowledgments study funded grants national institute aging mayo adpr ag num mayo alzheimer disease research center ag num jep rcp symb pcb larry hillblom foundation pcb
0.40214586.14747300.html.plaintext.txt	68	acknowledge excellent technical assistance jane kahl karen laakso staff mayo alzheimer disease research center excellent editorial assistance kim denkers thank robert rizza suggestions support
0.40214586.14747300.html.plaintext.txt	69	acknowledge excellent technical assistance jane kahl karen laakso staff mayo alzheimer disease research center excellent editorial assistance kim denkers thank robert rizza suggestions support
0.40214586.14747300.html.plaintext.txt	70	address correspondence reprint requests dr peter c butler division endocrinology diabetes keck school medicine university southern california num san pablo street bmt symb los angeles ca num e mail pbutleratuscedu
0.40214586.14747300.html.plaintext.txt	71	received publication august num num accepted revised form october num num
0.40214586.14747300.html.plaintext.txt	72	assp amyloid ss protein adpr alzheimer disease patient registry fpg fasting plasma glucose iapp islet amyloid polypeptide ifg impaired fasting glucose nft neurofibrillary tangle
0.40214586.14747300.html.plaintext.txt	73	references top abstract research design methods results discussion references westermark p wilander e influence amyloid deposits islet volume maturity onset diabetes mellitus symb num numnummedline clark wells ca buley id cruickshank jk vanhegan ri matthews dr cooper gj holman rr turner rc islet amyloid increased cells reduced b cells exocrine fibrosis quantitative changes pancreas type num diabetes diabetes symb num numnummedline cooper gj willis ac clark turner rc sim rb reid kb purification characterization peptide amyloid rich pancreases type num diabetic patients proc natl acad sci u symb num numnumabstract westermark p wernstedt c wilander e hayden dw o brien td johnson kh amyloid fibrils human insulinoma islets langerhans diabetic cat derived neuropeptide like protein also present normal islet cells proc natl acad sci u symb num numnumabstract johnson kh o brien td hayden dw jordan k ghobrial hk mahoney wc westermark p immunolocalization islet amyloid polypeptide iapp pancreatic beta cells means peroxidase antiperoxidase pap protein gold techniques j symb num numnumabstract braak h braak e human entorhinal cortex normal morphology lamina specific pathology various diseases neurosci symb num numnummedline glenner gg wong cw alzheimer disease initial report purification characterization novel cerebrovascular amyloid protein biochem biophys res symb num numnummedline masters cl simms g weinman na multhaup g mcdonald bl beyreuther k amyloid plaque core protein alzheimer disease syndrome proc natl acad sci u symb num numnumabstract masters cl multhaup g simms g pottgiesser j martins rn beyreuther k neuronal origin cerebral amyloid neurofibrillary tangles alzheimer disease contain protein amyloid plaque cores blood vessels embo symb num numnumabstract bahmanyar higgins ga goldgaber d lewis da morrison jh wilson mc shankar sk gajdusek dc localization amyloid beta protein messenger rna brains patients alzheimer disease symb num numnummedline goedert m neuronal localization amyloid beta protein precursor mrna normal human brain alzheimer disease embo symb num numnumabstract card jp meade rp davis lg immunocytochemical localization precursor protein beta amyloid rat central nervous system symb num numnummedline shivers bd hilbich c multhaup g salbaum m beyreuther k seeburg ph alzheimer disease amyloidogenic glycoprotein expression pattern rat brain suggests role cell contact embo symb num numnumabstract van broeckhoven c genthe vandenberghe horsthemke b backhovens h raeymaekers p van hul w wehnert gheuens j cras p et al failure familial alzheimer disease segregate symb amyloid gene several european families symb num numnummedline tanzi re st george hyslop ph haines jl polinsky rj nee l foncin jf neve rl mcclatchey ai conneally pm gusella jf genetic defect familial alzheimer disease tightly linked amyloid beta protein gene symb num numnummedline st george hyslop ph haines jl farrer la polinsky r van broeckhoven c goate mclachlan dr orr h bruni ac sorbi et al genetic linkage studies suggest alzheimer disease single homogeneous disorder fad collaborative study group symb num numnummedline wilson pw anderson km kannel wb epidemiology diabetes mellitus elderly framingham study j symbnuma num numnum barnett ah eff c leslie rd pyke da diabetes identical twins study num pairs symb num numnummedline newman b selby jv king mc slemenda c fabsitz r friedman gd concordance type num non insulin dependent diabetes mellitus male twins symb num numnummedline hilbich c kisters woike b reed j masters cl beyreuther k aggregation secondary structure synthetic amyloid beta symb peptides alzheimer disease j mol symb num numnummedline glenner gg eanes ed wiley ca amyloid fibrils formed segment pancreatic islet amyloid protein biochem biophys res symb num numnummedline lorenzo razzaboni b weir gc yankner ba pancreatic islet cell toxicity amylin associated type num diabetes mellitus symb num numnummedline schubert d behl c lesley r brack dargusch r sagara y kimura h amyloid peptides toxic via common oxidative mechanism proc natl acad sci u symb num numnumabstract o brien td butler pc kreutter dk kane la eberhardt nl human islet amyloid polypeptide expression cos num cells model intracellular amyloidogenesis j symb num numnumabstract janson j ashley rh harrison d mcintyre butler pc mechanism islet amyloid polypeptide toxicity membrane disruption intermediate sized toxic amyloid particles symb num numnumabstract mirzabekov ta lin mc kagan bl pore formation cytotoxic islet amyloid peptide amylin j biol symb num numnumabstractfree full text lashuel ha hartley d petre bm waltz lansbury pt neurodegenerative disease amyloid pores pathogenic mutations symb num num couce m kane la o brien td charlesworth j soeller w mcneish j kreutter d roche p butler pc treatment growth hormone dexamethasone mice transgenic human islet amyloid polypeptide causes islet amyloidosis ss cell dysfunction symb num numnumabstract o brien td butler ae roche pc johnson kh butler pc islet amyloid polypeptide human insulinomas evidence intracellular amyloidogenesis symb num numnumabstract craig ea weissman js horwich al heat shock proteins molecular chaperones mediators protein conformation turnover cell symb num numnummedline butler pc eberhardt nl o brien td islet amyloid polypeptide iapp insulin secretion molecular biology diabetes draznin b leroith d eds totowa nj humana pressnum pnum num schwartz p senile cerebral pancreatic insular cardiac amyloidosis trans n y acad symb num numnummedline petersen rc kokmen e tangalos e ivnik rj kurland lt mayo clinic alzheimer disease patient registry symb num numnummedline gearing m mirra ss hedreen jc sumi sm hansen la heyman consortium establish registry alzheimer disease cerad part x neuropathology confirmation clinical diagnosis alzheimer disease symb num numnumabstract betsholtz c christmansson l engstrom u rorsman f svensson v johnson kh westermark p sequence divergence specific region islet amyloid polypeptide iapp explains differences islet amyloid formation species febs symb num numnummedline westermark p engstrom u johnson kh westermark gt betsholtz c islet amyloid polypeptide pinpointing amino acid residues linked amyloid fibril formation proc natl acad sci u symb num numnumabstract zhang liu j saafi el cooper gj induction apoptosis human amylin symb islet beta cells associated enhanced expression symb symbnumsymb febs symb num numnummedline zhang liu j macgibbon g dragunow m cooper gj increased expression activation c jun contributes human amylin induced apoptosis pancreatic islet beta cells j mol symb num numnummedline bai jz saafi el shang cooper gj role symb apoptosis evoked human amylin pancreatic islet beta cells biochem symb num numnummedline tucker hm rydel re wright estus human amylin induces apoptotic pattern gene expression concomitant cortical neuronal apoptosis j symb num numnummedline laczko holly konya z soos k varga j hollosi m penke b conformational mapping amyloid peptides putative neurotoxic num num region biochem biophys res symb num numnummedline kayed r head e thompson jl mcintire tm milton sc glabe cg common structure soluble amyloid oligomers implies common mechanism pathogenesis symb num numnumabstractfree full text blake mj edelsman r feulner gj nortone dd holbrook nj stress induced heat shock protein num expression adrenal cortex adrenocorticotropic hormone sensitive age dependent response proc natl acad sci u symb num numnumabstract finch ce cohen dm aging metabolism alzheimer disease review hypothesis exp symb num numnummedline yan sd stern d schmidt rage receptor advanced glycation end products rage dark side glucose eur j clin symb num numnummedline sasaki n toki chowei h saito nakao n hayashi y takeuchi m makita z immunohistochemical distribution receptor advanced glycation end products neurons astrocytes alzheimer disease brain symb num numnummedline heitner j dickson d diabetics increased alzheimer type pathology age matched control subjects retrospective postmortem immunocytochemical histofluorescent study symb num numnumabstract curb jd rodriguez bl abbott rd petrovitch h ross gw masaki kh foley d blanchette pl harris chen r white lr longitudinal association vascular alzheimer dementias diabetes glucose tolerance symb num numnumabstractfree full text mackight c rockwood k awalt e mcdowell diabetes mellitus risk dementia alzheimer disease vascular cognitive impairment canadian study health aging dement geriatr cogn symb num numnummedline isomaa b almgren p tuomi forsen b lahti k nissen m taskinen m r groop l cardiovascular morbidity mortality associated metabolic syndrome diabetes symb num numnumabstractfree full text sasaki n fukatsu r tsuzuki k hayashi y yoshida fujii n koike wakayama yanagihara r garruto r amano n makita z advanced glycation end products alzheimer disease neurodegenerative diseases j symb num numnumabstractfree full text mast h thompson jl lee sh mohr jp sacco rl hypertension diabetes mellitus determinants multiple lacunar infarcts symb num numnumabstractfree full text tatemichi tk desmond dw paik m figueroa m gropen ti stern y sano m remien r williams jb mohr jp et al clinical determinants dementia related stroke ann symb num numnummedline desmond dw tatemichi tk paik m stern y risk factors cerebrovascular disease correlates cognitive function stroke free cohort arch symb num numnumabstract mccall al impact diabetes ncs symb num numnumabstract biessels gj kappelle ac bravenboer b erkelens dw gibsen wh cerebral function diabetes mellitus symb num numnummedline langen sj deary ij hepburn da frier bm cumulative cognitive impairment following recurrent severe hypoglycaemia adult patients insulin treated diabetes mellitus symb num numnummedline ott stolk rp van harskamp f pols h hofman breteler m diabetes mellitus risk dementia rotterdam study symb num numnumabstractfree full text leibson cl rocca wa hanson va cha r kokmen e o brien pc palumbo pj risk dementia among persons diabetes mellitus population based cohort study j symb num numnumabstract luchsinger ja tang m x yaakov shea mayeux r diabetes mellitus risk alzheimer disease dementia stroke multiethnic cohort j symb num numnumabstractfree full text bucht g adolfsson r lithner f winblad b changes blood glucose insulin secretion patients senile dementia alzheimer type acta med symb num numnummedline wolf klein gp silversone fa brod ms levy foley cj termotto v breuer j alzheimer patients healthier j geriatr symb num numnummedline ferini strambi l smirne garanchini p pinto p franceschi m clinical epidemiological aspects alzheimer disease presenile onset case control study symb num numnummedline landin k blennow k wallin gottfries c g low blood pressure blood glucose levels alzheimer disease evidence hypometabolic disorder j intern symb num numnummedline mortel kf wood pavol ma meyer js rexer jl analysis familial individual risk factors among patients ischemic vascular dementia alzheimer disease symb num numnummedline neilson ka nolan jh berchtold nc sandman ca mulnard ra cotman cw apolipoprotein e genotyping diabetic dementia patients diabetes rare alzheimer disease j geriatr symb num numnummedline heyman wilkinson stafford ja helms mj sigmon ah weinberg alzheimer disease study epidemiological aspects ann symb num numnummedline broe ga henderson creasey h mccusker e korten ae jorm af longley w anthony jc case controlled study alzheimer disease australia symb num numnumabstract kokmen e beard cm chandra v offord kp schoenberg bs ballard dj clinical risk factors alzheimer disease population based case control study symb num numnumabstract thorpe j widman lp wallin beiswanger j blumenthal ht comorbidity chronic age dependent diseases dementia aging clin exp symb num numnum curb jd roderiquez bl petrovich h masaki kh burchfiel cm ross w chen r harris white lr relationship diabetes glucose tolerance alzheimer disease vascular dementia abstract num neurobiol symb suppl symb num expert committee diagnosis classification diabetes mellitus diabetes symb num numnummedline
0.40214586.14747300.html.plaintext.txt	74	references top abstract research design methods results discussion references westermark p wilander e influence amyloid deposits islet volume maturity onset diabetes mellitus symb num numnummedline clark wells ca buley id cruickshank jk vanhegan ri matthews dr cooper gj holman rr turner rc islet amyloid increased cells reduced b cells exocrine fibrosis quantitative changes pancreas type num diabetes diabetes symb num numnummedline cooper gj willis ac clark turner rc sim rb reid kb purification characterization peptide amyloid rich pancreases type num diabetic patients proc natl acad sci u symb num numnumabstract westermark p wernstedt c wilander e hayden dw o brien td johnson kh amyloid fibrils human insulinoma islets langerhans diabetic cat derived neuropeptide like protein also present normal islet cells proc natl acad sci u symb num numnumabstract johnson kh o brien td hayden dw jordan k ghobrial hk mahoney wc westermark p immunolocalization islet amyloid polypeptide iapp pancreatic beta cells means peroxidase antiperoxidase pap protein gold techniques j symb num numnumabstract braak h braak e human entorhinal cortex normal morphology lamina specific pathology various diseases neurosci symb num numnummedline glenner gg wong cw alzheimer disease initial report purification characterization novel cerebrovascular amyloid protein biochem biophys res symb num numnummedline masters cl simms g weinman na multhaup g mcdonald bl beyreuther k amyloid plaque core protein alzheimer disease syndrome proc natl acad sci u symb num numnumabstract masters cl multhaup g simms g pottgiesser j martins rn beyreuther k neuronal origin cerebral amyloid neurofibrillary tangles alzheimer disease contain protein amyloid plaque cores blood vessels embo symb num numnumabstract bahmanyar higgins ga goldgaber d lewis da morrison jh wilson mc shankar sk gajdusek dc localization amyloid beta protein messenger rna brains patients alzheimer disease symb num numnummedline goedert m neuronal localization amyloid beta protein precursor mrna normal human brain alzheimer disease embo symb num numnumabstract card jp meade rp davis lg immunocytochemical localization precursor protein beta amyloid rat central nervous system symb num numnummedline shivers bd hilbich c multhaup g salbaum m beyreuther k seeburg ph alzheimer disease amyloidogenic glycoprotein expression pattern rat brain suggests role cell contact embo symb num numnumabstract van broeckhoven c genthe vandenberghe horsthemke b backhovens h raeymaekers p van hul w wehnert gheuens j cras p et al failure familial alzheimer disease segregate symb amyloid gene several european families symb num numnummedline tanzi re st george hyslop ph haines jl polinsky rj nee l foncin jf neve rl mcclatchey ai conneally pm gusella jf genetic defect familial alzheimer disease tightly linked amyloid beta protein gene symb num numnummedline st george hyslop ph haines jl farrer la polinsky r van broeckhoven c goate mclachlan dr orr h bruni ac sorbi et al genetic linkage studies suggest alzheimer disease single homogeneous disorder fad collaborative study group symb num numnummedline wilson pw anderson km kannel wb epidemiology diabetes mellitus elderly framingham study j symbnuma num numnum barnett ah eff c leslie rd pyke da diabetes identical twins study num pairs symb num numnummedline newman b selby jv king mc slemenda c fabsitz r friedman gd concordance type num non insulin dependent diabetes mellitus male twins symb num numnummedline hilbich c kisters woike b reed j masters cl beyreuther k aggregation secondary structure synthetic amyloid beta symb peptides alzheimer disease j mol symb num numnummedline glenner gg eanes ed wiley ca amyloid fibrils formed segment pancreatic islet amyloid protein biochem biophys res symb num numnummedline lorenzo razzaboni b weir gc yankner ba pancreatic islet cell toxicity amylin associated type num diabetes mellitus symb num numnummedline schubert d behl c lesley r brack dargusch r sagara y kimura h amyloid peptides toxic via common oxidative mechanism proc natl acad sci u symb num numnumabstract o brien td butler pc kreutter dk kane la eberhardt nl human islet amyloid polypeptide expression cos num cells model intracellular amyloidogenesis j symb num numnumabstract janson j ashley rh harrison d mcintyre butler pc mechanism islet amyloid polypeptide toxicity membrane disruption intermediate sized toxic amyloid particles symb num numnumabstract mirzabekov ta lin mc kagan bl pore formation cytotoxic islet amyloid peptide amylin j biol symb num numnumabstractfree full text lashuel ha hartley d petre bm waltz lansbury pt neurodegenerative disease amyloid pores pathogenic mutations symb num num couce m kane la o brien td charlesworth j soeller w mcneish j kreutter d roche p butler pc treatment growth hormone dexamethasone mice transgenic human islet amyloid polypeptide causes islet amyloidosis ss cell dysfunction symb num numnumabstract o brien td butler ae roche pc johnson kh butler pc islet amyloid polypeptide human insulinomas evidence intracellular amyloidogenesis symb num numnumabstract craig ea weissman js horwich al heat shock proteins molecular chaperones mediators protein conformation turnover cell symb num numnummedline butler pc eberhardt nl o brien td islet amyloid polypeptide iapp insulin secretion molecular biology diabetes draznin b leroith d eds totowa nj humana pressnum pnum num schwartz p senile cerebral pancreatic insular cardiac amyloidosis trans n y acad symb num numnummedline petersen rc kokmen e tangalos e ivnik rj kurland lt mayo clinic alzheimer disease patient registry symb num numnummedline gearing m mirra ss hedreen jc sumi sm hansen la heyman consortium establish registry alzheimer disease cerad part x neuropathology confirmation clinical diagnosis alzheimer disease symb num numnumabstract betsholtz c christmansson l engstrom u rorsman f svensson v johnson kh westermark p sequence divergence specific region islet amyloid polypeptide iapp explains differences islet amyloid formation species febs symb num numnummedline westermark p engstrom u johnson kh westermark gt betsholtz c islet amyloid polypeptide pinpointing amino acid residues linked amyloid fibril formation proc natl acad sci u symb num numnumabstract zhang liu j saafi el cooper gj induction apoptosis human amylin symb islet beta cells associated enhanced expression symb symbnumsymb febs symb num numnummedline zhang liu j macgibbon g dragunow m cooper gj increased expression activation c jun contributes human amylin induced apoptosis pancreatic islet beta cells j mol symb num numnummedline bai jz saafi el shang cooper gj role symb apoptosis evoked human amylin pancreatic islet beta cells biochem symb num numnummedline tucker hm rydel re wright estus human amylin induces apoptotic pattern gene expression concomitant cortical neuronal apoptosis j symb num numnummedline laczko holly konya z soos k varga j hollosi m penke b conformational mapping amyloid peptides putative neurotoxic num num region biochem biophys res symb num numnummedline kayed r head e thompson jl mcintire tm milton sc glabe cg common structure soluble amyloid oligomers implies common mechanism pathogenesis symb num numnumabstractfree full text blake mj edelsman r feulner gj nortone dd holbrook nj stress induced heat shock protein num expression adrenal cortex adrenocorticotropic hormone sensitive age dependent response proc natl acad sci u symb num numnumabstract finch ce cohen dm aging metabolism alzheimer disease review hypothesis exp symb num numnummedline yan sd stern d schmidt rage receptor advanced glycation end products rage dark side glucose eur j clin symb num numnummedline sasaki n toki chowei h saito nakao n hayashi y takeuchi m makita z immunohistochemical distribution receptor advanced glycation end products neurons astrocytes alzheimer disease brain symb num numnummedline heitner j dickson d diabetics increased alzheimer type pathology age matched control subjects retrospective postmortem immunocytochemical histofluorescent study symb num numnumabstract curb jd rodriguez bl abbott rd petrovitch h ross gw masaki kh foley d blanchette pl harris chen r white lr longitudinal association vascular alzheimer dementias diabetes glucose tolerance symb num numnumabstractfree full text mackight c rockwood k awalt e mcdowell diabetes mellitus risk dementia alzheimer disease vascular cognitive impairment canadian study health aging dement geriatr cogn symb num numnummedline isomaa b almgren p tuomi forsen b lahti k nissen m taskinen m r groop l cardiovascular morbidity mortality associated metabolic syndrome diabetes symb num numnumabstractfree full text sasaki n fukatsu r tsuzuki k hayashi y yoshida fujii n koike wakayama yanagihara r garruto r amano n makita z advanced glycation end products alzheimer disease neurodegenerative diseases j symb num numnumabstractfree full text mast h thompson jl lee sh mohr jp sacco rl hypertension diabetes mellitus determinants multiple lacunar infarcts symb num numnumabstractfree full text tatemichi tk desmond dw paik m figueroa m gropen ti stern y sano m remien r williams jb mohr jp et al clinical determinants dementia related stroke ann symb num numnummedline desmond dw tatemichi tk paik m stern y risk factors cerebrovascular disease correlates cognitive function stroke free cohort arch symb num numnumabstract mccall al impact diabetes ncs symb num numnumabstract biessels gj kappelle ac bravenboer b erkelens dw gibsen wh cerebral function diabetes mellitus symb num numnummedline langen sj deary ij hepburn da frier bm cumulative cognitive impairment following recurrent severe hypoglycaemia adult patients insulin treated diabetes mellitus symb num numnummedline ott stolk rp van harskamp f pols h hofman breteler m diabetes mellitus risk dementia rotterdam study symb num numnumabstractfree full text leibson cl rocca wa hanson va cha r kokmen e o brien pc palumbo pj risk dementia among persons diabetes mellitus population based cohort study j symb num numnumabstract luchsinger ja tang m x yaakov shea mayeux r diabetes mellitus risk alzheimer disease dementia stroke multiethnic cohort j symb num numnumabstractfree full text bucht g adolfsson r lithner f winblad b changes blood glucose insulin secretion patients senile dementia alzheimer type acta med symb num numnummedline wolf klein gp silversone fa brod ms levy foley cj termotto v breuer j alzheimer patients healthier j geriatr symb num numnummedline ferini strambi l smirne garanchini p pinto p franceschi m clinical epidemiological aspects alzheimer disease presenile onset case control study symb num numnummedline landin k blennow k wallin gottfries c g low blood pressure blood glucose levels alzheimer disease evidence hypometabolic disorder j intern symb num numnummedline mortel kf wood pavol ma meyer js rexer jl analysis familial individual risk factors among patients ischemic vascular dementia alzheimer disease symb num numnummedline neilson ka nolan jh berchtold nc sandman ca mulnard ra cotman cw apolipoprotein e genotyping diabetic dementia patients diabetes rare alzheimer disease j geriatr symb num numnummedline heyman wilkinson stafford ja helms mj sigmon ah weinberg alzheimer disease study epidemiological aspects ann symb num numnummedline broe ga henderson creasey h mccusker e korten ae jorm af longley w anthony jc case controlled study alzheimer disease australia symb num numnumabstract kokmen e beard cm chandra v offord kp schoenberg bs ballard dj clinical risk factors alzheimer disease population based case control study symb num numnumabstract thorpe j widman lp wallin beiswanger j blumenthal ht comorbidity chronic age dependent diseases dementia aging clin exp symb num numnum curb jd roderiquez bl petrovich h masaki kh burchfiel cm ross w chen r harris white lr relationship diabetes glucose tolerance alzheimer disease vascular dementia abstract num neurobiol symb suppl symb num expert committee diagnosis classification diabetes mellitus diabetes symb num numnummedline
0.40480462.14976159.html.plaintext.txt	0	law mass action applied neurodegenerative disease hypothesis concerning etiology pathogenesis complex diseases andrew singleton amanda myers john hardy
0.40480462.14976159.html.plaintext.txt	1	laboratory neurogenetics national institute aging national institutes health building num room numsymb symb bethesda md num usa
0.40480462.14976159.html.plaintext.txt	2	received january num num revised february num num accepted february num num
0.40480462.14976159.html.plaintext.txt	3	abstract top abstract introduction diseases methodological considerations conclusions predictions references loci underlying autosomal dominant forms neurodegenerative disease identified prion mutations cause gerstmann straussler syndrome hereditary creuzfeldt jakob disease tau mutations cause autosomal dominant frontal temporal dementia synuclein mutations cause autosomal dominant parkinsons disease cases pathogenic mutation protein deposited diseased tissue cases whole protein deposited alzheimers disease mutations app presenilin num num cause autosomal dominant disease substrate proteases respectively responsible production deposited peptide ass thus cases mutations lead disease mechanism involves deposition process briefly review remarkably predictable biology also point seems sporadic forms diseases predisposed genetic variability loci strongly suggesting quantity normal protein produced influences risk sporadic forms disease evidence assertion strongest parkinsons disease pd genetic variability synuclein expression affects risk developing disease although oldest evidence notion increased expression normal sequence protein lead disease comes observation alzheimers disease trisomy num cases observations make predictions concerning etiology pathogenesis neurodegenerative diseases general
0.40480462.14976159.html.plaintext.txt	4	abstract top abstract introduction diseases methodological considerations conclusions predictions references loci underlying autosomal dominant forms neurodegenerative disease identified prion mutations cause gerstmann straussler syndrome hereditary creuzfeldt jakob disease tau mutations cause autosomal dominant frontal temporal dementia synuclein mutations cause autosomal dominant parkinsons disease cases pathogenic mutation protein deposited diseased tissue cases whole protein deposited alzheimers disease mutations app presenilin num num cause autosomal dominant disease substrate proteases respectively responsible production deposited peptide ass thus cases mutations lead disease mechanism involves deposition process briefly review remarkably predictable biology also point seems sporadic forms diseases predisposed genetic variability loci strongly suggesting quantity normal protein produced influences risk sporadic forms disease evidence assertion strongest parkinsons disease pd genetic variability synuclein expression affects risk developing disease although oldest evidence notion increased expression normal sequence protein lead disease comes observation alzheimers disease trisomy num cases observations make predictions concerning etiology pathogenesis neurodegenerative diseases general
0.40480462.14976159.html.plaintext.txt	5	introduction top abstract introduction diseases methodological considerations conclusions predictions references last num years remarkable progress understanding etiology autosomal dominant neurodegenerative diseases loci underlying autosomal dominant forms creuzfeldt jakob disease num frontal temporal dementia num parkinsons disease identified num case underlying locus encoded protein often deposited disease creuzfeldt jakob disease prion protein frontal temporal dementia tau parkinsons disease synuclein alzheimers disease situation little complex deposited peptide ass derived fragment app protein metabolized secretase complex key component complex presenilins mutations either app presenilin num num lead disease num num
0.40480462.14976159.html.plaintext.txt	6	introduction top abstract introduction diseases methodological considerations conclusions predictions references last num years remarkable progress understanding etiology autosomal dominant neurodegenerative diseases loci underlying autosomal dominant forms creuzfeldt jakob disease num frontal temporal dementia num parkinsons disease identified num case underlying locus encoded protein often deposited disease creuzfeldt jakob disease prion protein frontal temporal dementia tau parkinsons disease synuclein alzheimers disease situation little complex deposited peptide ass derived fragment app protein metabolized secretase complex key component complex presenilins mutations either app presenilin num num lead disease num num
0.40480462.14976159.html.plaintext.txt	7	findings well established driven therapeutics research especially allowed development animal models diseases well defined therapeutic targets num examples precise pathologic species protein obscure one debated whether deposits intermediate species oligomer responsible extensively investigated balance recent data favoring smaller intermediate species toxic entities num however generality fact mutated protein example deposited suggests process pathogenicity related although perhaps separable process deposition
0.40480462.14976159.html.plaintext.txt	8	findings well established driven therapeutics research especially allowed development animal models diseases well defined therapeutic targets num examples precise pathologic species protein obscure one debated whether deposits intermediate species oligomer responsible extensively investigated balance recent data favoring smaller intermediate species toxic entities num however generality fact mutated protein example deposited suggests process pathogenicity related although perhaps separable process deposition
0.40480462.14976159.html.plaintext.txt	9	studying autosomal dominant forms diseases researchers hope gain insight common sporadic forms mechanistic perspective certainly case however perhaps surprisingly last num years become clear case many diseases least haplotype mendelian pathogenic locus influences disease risk sporadic disease
0.40480462.14976159.html.plaintext.txt	10	studying autosomal dominant forms diseases researchers hope gain insight common sporadic forms mechanistic perspective certainly case however perhaps surprisingly last num years become clear case many diseases least haplotype mendelian pathogenic locus influences disease risk sporadic disease
0.40480462.14976159.html.plaintext.txt	11	review briefly summarise data make predictions concerning etiology pathogenesis neurodegenerative diseases first though worth noting haplotypic association means mechanistic perspective absence coding changes haplotypic association implies genetic variability either amount expression protein alternate splicing protein contributes disease risk
0.40480462.14976159.html.plaintext.txt	12	review briefly summarise data make predictions concerning etiology pathogenesis neurodegenerative diseases first though worth noting haplotypic association means mechanistic perspective absence coding changes haplotypic association implies genetic variability either amount expression protein alternate splicing protein contributes disease risk
0.40480462.14976159.html.plaintext.txt	13	diseases top abstract introduction diseases methodological considerations conclusions predictions references prion diseases prion gene two common coding variants caucasian populations one prion symb prion symb numnum long recognized homozygosity codon num predisposes sporadic disease presumably necessity prion prion interactions symmetry considerations numnum however addition well established risk recent genetic data shown prion haplotype confers additional risk idiopathic disease num clearly suggesting genetic variability prion expression contributes disease risk genetic data establish whether high expressors low expressors susceptible since prion knockout mice completely resistant disease num parsimonious expect express high levels prion protein homozygotes codon num susceptible disease
0.40480462.14976159.html.plaintext.txt	14	diseases top abstract introduction diseases methodological considerations conclusions predictions references prion diseases prion gene two common coding variants caucasian populations one prion symb prion symb numnum long recognized homozygosity codon num predisposes sporadic disease presumably necessity prion prion interactions symmetry considerations numnum however addition well established risk recent genetic data shown prion haplotype confers additional risk idiopathic disease num clearly suggesting genetic variability prion expression contributes disease risk genetic data establish whether high expressors low expressors susceptible since prion knockout mice completely resistant disease num parsimonious expect express high levels prion protein homozygotes codon num susceptible disease
0.40480462.14976159.html.plaintext.txt	15	alzheimers disease extensive sequencing app gene late onset alzheimers disease failed identify mutations num however analysis data sibpairs affected late onset alzheimers disease consistently suggested app locus form disease numnum suggests genetic variability app locus contributes disease risk although precise variability identified finding consistent longstanding observation individuals trisomy num inevitably develop alzheimer pathology fifth decade num however cases syndrome caused triplication chromosome num distal app gene develop alzheimers disease num thus three copies app gene leads alzheimer pathology fifth decade yet unidentified genetic variability app locus appears contribute disease risk
0.40480462.14976159.html.plaintext.txt	16	alzheimers disease extensive sequencing app gene late onset alzheimers disease failed identify mutations num however analysis data sibpairs affected late onset alzheimers disease consistently suggested app locus form disease numnum suggests genetic variability app locus contributes disease risk although precise variability identified finding consistent longstanding observation individuals trisomy num inevitably develop alzheimer pathology fifth decade num however cases syndrome caused triplication chromosome num distal app gene develop alzheimers disease num thus three copies app gene leads alzheimer pathology fifth decade yet unidentified genetic variability app locus appears contribute disease risk
0.40480462.14976159.html.plaintext.txt	17	frontal temporal dementia tangle diseases mutations tau gene cause many cases autosomal dominant frontal temporal dementia tau pathology many sporadic diseases tau pathology occurs usually tangles also pick bodies argyrophilic grains num two genetic haplotype clades caucasian populations designated symb symb differ intron sizes promoter sequence wobble bases num symb haplotype frequency num caucasians thus symb homozygotes constitute num populations however individuals one three sporadic tau diseases progressive supranuclear palsy num corticobasal degeneration num argyrophilic grain disease num although picks disease num guam disease num show robust association symb homozygosity frequency symb homozygotes num data show clearly variability either tau expression tau splicing variability contribute disease risk case difficult determine whether control splicing control expression key variable indeed clear many mutations lead mendelian disease altering alternate splicing numnum
0.40480462.14976159.html.plaintext.txt	18	frontal temporal dementia tangle diseases mutations tau gene cause many cases autosomal dominant frontal temporal dementia tau pathology many sporadic diseases tau pathology occurs usually tangles also pick bodies argyrophilic grains num two genetic haplotype clades caucasian populations designated symb symb differ intron sizes promoter sequence wobble bases num symb haplotype frequency num caucasians thus symb homozygotes constitute num populations however individuals one three sporadic tau diseases progressive supranuclear palsy num corticobasal degeneration num argyrophilic grain disease num although picks disease num guam disease num show robust association symb homozygosity frequency symb homozygotes num data show clearly variability either tau expression tau splicing variability contribute disease risk case difficult determine whether control splicing control expression key variable indeed clear many mutations lead mendelian disease altering alternate splicing numnum
0.40480462.14976159.html.plaintext.txt	19	parkinsons diseaselewy body dementia mutations synuclein gene cause autosomal dominant parkinsons disease synuclein primary component lewy bodies pathognomic feature parkinsons disease num genetic variability synuclein promoter contributes risk sporadic parkinsons disease numnum associated promoter allele stronger promoter num perhaps convincingly triplication whole synuclein locus causes autosomal dominant parkinsons diseaselewy body dementia onset age fourth decade num duplication locus leads disease fifth decade num thus parkinsons disease clear dose relationship synuclein expression disease occurrence normal genetic variability promoter contributing risk typical idiopathic disease multiplications locus causing mendelian disease onset age determined precise dose protein studies cell lines affected individuals kindreds reveal amount synuclein produced correlates disease singleton et al unpublished data num
0.40480462.14976159.html.plaintext.txt	20	parkinsons diseaselewy body dementia mutations synuclein gene cause autosomal dominant parkinsons disease synuclein primary component lewy bodies pathognomic feature parkinsons disease num genetic variability synuclein promoter contributes risk sporadic parkinsons disease numnum associated promoter allele stronger promoter num perhaps convincingly triplication whole synuclein locus causes autosomal dominant parkinsons diseaselewy body dementia onset age fourth decade num duplication locus leads disease fifth decade num thus parkinsons disease clear dose relationship synuclein expression disease occurrence normal genetic variability promoter contributing risk typical idiopathic disease multiplications locus causing mendelian disease onset age determined precise dose protein studies cell lines affected individuals kindreds reveal amount synuclein produced correlates disease singleton et al unpublished data num
0.40480462.14976159.html.plaintext.txt	21	methodological considerations top abstract introduction diseases methodological considerations conclusions predictions references problems assessment haplotypic expression rigorous assessment impact haplotypic variation quantitative gene expression splicing surprisingly difficult problem num usual method test variability control expression tie artificial arbitrary reporter construct bacterially derived reporter gene measure transient effect expression tumor derived cell line clearly experiments unlikely yield data direct relevance subtle effects variation gene expression development allele specific gene expression methods numnum offers hope subtle effects studied although methods arduous require access large numbers well maintained human brain specimens num
0.40480462.14976159.html.plaintext.txt	22	methodological considerations top abstract introduction diseases methodological considerations conclusions predictions references problems assessment haplotypic expression rigorous assessment impact haplotypic variation quantitative gene expression splicing surprisingly difficult problem num usual method test variability control expression tie artificial arbitrary reporter construct bacterially derived reporter gene measure transient effect expression tumor derived cell line clearly experiments unlikely yield data direct relevance subtle effects variation gene expression development allele specific gene expression methods numnum offers hope subtle effects studied although methods arduous require access large numbers well maintained human brain specimens num
0.40480462.14976159.html.plaintext.txt	23	conclusions predictions top abstract introduction diseases methodological considerations conclusions predictions references diseases referred thus strong evidence frank mutations pathologic locus cause autosomal dominant disease protein deposition genetic variability expression normal protein contributes risk idiopathic disease alzheimers disease deposited protein peptide fragment primary locus mutations cleaving enzyme also lead disease simple observations lead predictions mutant wild type proteins quantitatively different qualitatively different properties cases diseases protein deposition part process polyglutamine diseases als genetic variability promoter gene considered factor influencing applicable risk sporadic disease age onset familial disease see num suggestions might also case huntingtons disease polyglutamine diseases deposited fragment cleaved precursor molecule genetic variability cleaving proteases interactors influence stability assessed risk factor loci loci impact risk diseases general may merely cause effect altering levels primary proteins either transcription factors responsible protein breakdown
0.40480462.14976159.html.plaintext.txt	24	conclusions predictions top abstract introduction diseases methodological considerations conclusions predictions references diseases referred thus strong evidence frank mutations pathologic locus cause autosomal dominant disease protein deposition genetic variability expression normal protein contributes risk idiopathic disease alzheimers disease deposited protein peptide fragment primary locus mutations cleaving enzyme also lead disease simple observations lead predictions mutant wild type proteins quantitatively different qualitatively different properties cases diseases protein deposition part process polyglutamine diseases als genetic variability promoter gene considered factor influencing applicable risk sporadic disease age onset familial disease see num suggestions might also case huntingtons disease polyglutamine diseases deposited fragment cleaved precursor molecule genetic variability cleaving proteases interactors influence stability assessed risk factor loci loci impact risk diseases general may merely cause effect altering levels primary proteins either transcription factors responsible protein breakdown
0.40480462.14976159.html.plaintext.txt	25	findings unexpected perhaps chemists know power law mass action perhaps surprised us may profound implications determining risks neurodegenerative disease num course one therapeutic approach cases therefore would aim reduce concentrations toxic proteins relevant tissue compartment either decreased production increased breakdown
0.40480462.14976159.html.plaintext.txt	26	findings unexpected perhaps chemists know power law mass action perhaps surprised us may profound implications determining risks neurodegenerative disease num course one therapeutic approach cases therefore would aim reduce concentrations toxic proteins relevant tissue compartment either decreased production increased breakdown
0.40480462.14976159.html.plaintext.txt	27	acknowledgements work supported nianih intramural programme
0.40480462.14976159.html.plaintext.txt	28	footnotes correspondence addressed tel num num fax num num email hardyjatmailnihgov
0.40480462.14976159.html.plaintext.txt	29	footnotes correspondence addressed tel num num fax num num email hardyjatmailnihgov
0.40480462.14976159.html.plaintext.txt	30	references top abstract introduction diseases methodological considerations conclusions predictions references owen f poulter m lofthouse r collinge j crow tj risby d baker hf ridley rm hsiao k prusiner sb num insertion prion protein gene familial creutzfeldt jakob disease lancet num num numcrossref
0.40480462.14976159.html.plaintext.txt	31	rogaeva e num solved unsolved mysteries genetics early onset alzheimers disease neuromol med num num numcrossref
0.40480462.14976159.html.plaintext.txt	32	hutton m num missing tau mutation identified ann neurol num num numnumnumconum numlinktypedoi crossrefmedline
0.43645546.14764623.html.plaintext.txt	0	alzheimers disease one disorder many genes lars bertram rudolph e tanzi
0.43645546.14764623.html.plaintext.txt	1	genetics aging research unit department neurology massgeneral institute neurodegenerative diseases massachusetts general hospital harvard medical school charlestown ma usa
0.43645546.14764623.html.plaintext.txt	2	received january num num accepted january num num
0.43645546.14764623.html.plaintext.txt	3	abstract top abstract introduction num good vintage conclusion references research alzheimers disease ad genetics extremely prolific past decade currently num genes reported show either positive negative evidence disease association per month review num studies num reporting total num association findings candidate genes ad positive results largely contradictory identified three loci chromosomes numsymb numsymb numsymb yielded positive results three independent studies addition well established ad association gene encoding apolipoprotein e apoe based data suggest may prudent investigators pay closer attention issues power replicability haplotype structure prior initial publication serve greatly decrease likelihood false positive false negative findings reported future years
0.43645546.14764623.html.plaintext.txt	4	introduction top abstract introduction num good vintage conclusion references several characteristics make search novel alzheimers disease ad genes particularly promising first importantly heritability ad high demonstrated various studies examining familial segregation disease past decades num num accordingly probability actually finding relevant disease causing predisposing genes relatively high well possibly even genetically complex neuropsychiatric disorders like parkinsons disease schizophrenia affective disorders num thus far ad achieved four genes app symb symb apoe variation latter also plays significant role common late onset form disorder see fully penetrant mutations app symb symb hand lead rare early onset familial forms ad via increased generation symb ss amyloid deposition major neuropathological hallmark disease secondly direct evidence based simulation well empirical data presence additional ad risk genes besides apoe instance recent simulation study predicted existence four seven additional ad genes searching age onset modifiers simulating variety different disease inheritance models num number corresponds well empirical data obtained full genome searches overlap num chromosomes six show significant results least one study table num finally progressive neurodegeneration gradually leading cognitive decline dementia ad patients exhibits distinct well established histopathological features upon post mortem examination allowing verification clinical ad num currently accuracy clinical ad diagnosis near beyond num academic centers num num allows significant reduction number phenocopies study populations using published research criteria thereby increases power subsequent genetic epidemiological analyses
0.43645546.14764623.html.plaintext.txt	5	view table table num overview concordant linkageassociation regions observed full genome screens published num disease specific characteristics together advent relatively inexpensive powerful high throughput genotyping technologies near completion human genome sequence led steep increase number laboratories studying genetics ad worldwide date less num full genome screens using linkage association based methodologies published ad using overlapping identical samples employing different sets genetic markers andor analytic strategies num num table num hand number locus specific candidate gene based ad association studies become nearly intractable course num num genes reported show either positive negative evidence association different ad phenotypes per month peer reviewed journals listed ncbis pubmed despite vast efforts single gene yet emerged attain nearly degree replication consistency observed literally hundreds laboratories studying association apoe num ad review present discuss findings genetic ad association studies published num excluding explicitly searching causes early onset familial ad cases ie private mutations using data example attempt pinpoint methodological difficulties likely underlie remarkable failure replicate genetic findings using current approaches
0.43645546.14764623.html.plaintext.txt	6	num good vintage ad genetics top abstract introduction num good vintage conclusion references genome screens outlined year num almost unprecedented terms number studies attempting unravel causes ad genetics three full genome screens numnumnum using association genetic linkage methods added nine studies already reported literature late onset ad study study comparison using p value numnum cut reveals total num regions num chromosomes yield positive signals across least two studies markers num mb apart table num interestingly chromosomes strongest consistent signals ie num num num num num num already implicated least num years earlier received support num based criteria new ad region emerge num chromosome numsymb num position num num mb interestingly region implicated studies using association methods fairly isolated homogeneous populations ie finns wadi ara numnum note inclusion exclusion criteria applied arbitrary may overestimate total number positive signals however allow comparison across multitude methodologically divergent approaches facilitate interpretation analyses based actual candidate genes
0.43645546.14764623.html.plaintext.txt	7	candidate gene studies searching pubmed wwwncbinlmnihgovpubmed keywords alzheimer association associated papers published january num december num num retrieved total num studies december num num num directly deal genetic association candidate polymorphisms ad seen table num studies examined total num genetic loci locus set markers within num mb genomic interval num different chromosomes total num analyzed genes within loci found positive judged authors num tested negative interestingly even num years discovery largest number nnum reports focusing single gene dealt association apoe ad using new polymorphisms new samplesethnic groups new phenotypes studies considered total num positive num negative papers remained
0.43645546.14764623.html.plaintext.txt	8	view table table num overview chromosomal loci tested genetic association ad num num represents one prolific vintages late onset ad genetic studies next pressing question large quantity studies also dilute quality product perhaps even making unpalatable quaff answer opinion yes least majority cases growing consensus success rate reliability genetic association studies complex diseases depend fulfillment several criteria numnum three discussed detail addition classic requirements least plausible biological andor positional candidacy investigated locus well direct proof pathophysiological consequences positive disease association former criterion fulfilled vast majority ad candidate genes investigated thus far latter condition elusive due several factors generally bedevil study genetic association complex diseases linkage disequilibrium actual functionally relevant disease modifying variant small effect sizes impede detection significant effects using basic molecular biochemical assays possibly involvement yet unknown pathophysiological mechanisms situation apoe num ad serves good example genetic association per se extremely well established past decade still consensus association translates pathophysiologically numnum
0.43645546.14764623.html.plaintext.txt	9	thus attempting uncover functional consequences putative new disease association propose emphasis must placed criteria allow better distinction false positive well false negative findings prior initial publication
0.43645546.14764623.html.plaintext.txt	10	power sample size structure enable investigators detect effect sizes moderate small extent obvious concern reports negative outcome power study also governs rate false positive findings ie probability observed significant association indeed genuine observed chance num num factors influencing ability detect meaningful effects include attributable risk polymorphism overall genetic variance degree linkage disequilibrium ld associated allele actual disease predisposing variant mode inheritance lesser extent disease prevalence variables course difficult estimate true disease gene unknown power given sample size fairly easily calculated variety possible plausible scenarios practice however still remains exception recent study estimated minimal number cases controls sufficient achieve num power numnum usually far greater num actual disease allele tested directly even favorable circumstances num interesting regardless estimates num studies published num still used smaller sample sizes thus probably suitable use reaching reliable conclusion
0.43645546.14764623.html.plaintext.txt	11	replicability result validatedreplicated independent sample sufficient size reports significant associations putative candidate genes ad every chromosome human genome past num years num none findings exception apoe num yet replicated consistently many seemingly positive result could validated independent dataset prior first publication several authors long suggesting guidelines proper quality control genetic association findings numnumnumnumnum current inflation probable false positive reports may avoided independent replication sought earlier independent sample found house establishment least temporary consortia collaborative laboratories test others positive signals prior publication would represent easy effective means restore credibility upon review num ad genetics literature less num studies either referred findings two independent samples published tandem independent reports investigating candidate genes andor genetic variants
0.43645546.14764623.html.plaintext.txt	12	replicability result validatedreplicated independent sample sufficient size reports significant associations putative candidate genes ad every chromosome human genome past num years num none findings exception apoe num yet replicated consistently many seemingly positive result could validated independent dataset prior first publication several authors long suggesting guidelines proper quality control genetic association findings numnumnumnumnum current inflation probable false positive reports may avoided independent replication sought earlier independent sample found house establishment least temporary consortia collaborative laboratories test others positive signals prior publication would represent easy effective means restore credibility upon review num ad genetics literature less num studies either referred findings two independent samples published tandem independent reports investigating candidate genes andor genetic variants
0.43645546.14764623.html.plaintext.txt	13	haplotype structure authors made attempts elucidate structure underlying haplotype architecture current systematic assessment haplotype structures various regions throughout genome past num num years emphasized importance performing haplotype systematic ld analyses searching novel complex disease genes numnum especially effect sizes expected lower conferred apoe num addition increasing power analyses approach also reduces number statistical tests need performed lead decrease false positive findings several recently published complex disease associations would impossible observe without thorough assessment underlying haplotype architecture num num along lines recent studies apoe shown locus would easily identified means haplotype analysis alone even without prior knowledge num polymorphism numnum yet num one third studies investigated one polymorphism per locus half carried less thorough assessment haplotype structure ie four polymorphisms per gene
0.43645546.14764623.html.plaintext.txt	14	haplotype structure authors made attempts elucidate structure underlying haplotype architecture current systematic assessment haplotype structures various regions throughout genome past num num years emphasized importance performing haplotype systematic ld analyses searching novel complex disease genes numnum especially effect sizes expected lower conferred apoe num addition increasing power analyses approach also reduces number statistical tests need performed lead decrease false positive findings several recently published complex disease associations would impossible observe without thorough assessment underlying haplotype architecture num num along lines recent studies apoe shown locus would easily identified means haplotype analysis alone even without prior knowledge num polymorphism numnum yet num one third studies investigated one polymorphism per locus half carried less thorough assessment haplotype structure ie four polymorphisms per gene
0.43645546.14764623.html.plaintext.txt	15	num papers published num topic genetic association candidate genes different ad phenotypes num num fulfilled least two criteria likely many observed discrepancies across studies could explained lack methodological thoroughness nonetheless three loci addition apoe tested positive across least three studies chromosomes numsymb numsymb numsymb table num loci covered remainder review
0.43645546.14764623.html.plaintext.txt	16	num papers published num topic genetic association candidate genes different ad phenotypes num num fulfilled least two criteria likely many observed discrepancies across studies could explained lack methodological thoroughness nonetheless three loci addition apoe tested positive across least three studies chromosomes numsymb numsymb numsymb table num loci covered remainder review
0.43645546.14764623.html.plaintext.txt	17	chromosome numsymb chromosomal region implicated harboring putative ad gene early num based association finding variants highly polymorphic major histocompatibility complex region hla num mb ad small case control study num two potential ad candidates map within num mb interval genes encoding hereditary haemochromatosis protein hfe num mb tumor necrosis factor alpha tnfa num mb num two studies reported significant evidence association latter two genes numnum two studies confirm findings numnum another candidate gene located region symb found associated certain neuropsychological variables num disease risk num finally one study investigated variation onset age function hla symb allele small sample ad patients find significant effects num literature search association studies genes including years num yielded least num positive studies num reports found evidence genetic involvement factors evidence direct involvement tnfa ass production toxicity num direct proof pathogenetic relevance genesproteins remains seen furthermore full genome screens ad genes consistently yielded signals numsymb residing num num mb whereas associated genes map num mb proximal thus increasing evidence supporting existence putative ad locus numsymb general possibility actual disease gene yet identified excluded despite overlapping positive results year past studies
0.43645546.14764623.html.plaintext.txt	18	chromosome numsymb chromosomal region implicated harboring putative ad gene early num based association finding variants highly polymorphic major histocompatibility complex region hla num mb ad small case control study num two potential ad candidates map within num mb interval genes encoding hereditary haemochromatosis protein hfe num mb tumor necrosis factor alpha tnfa num mb num two studies reported significant evidence association latter two genes numnum two studies confirm findings numnum another candidate gene located region symb found associated certain neuropsychological variables num disease risk num finally one study investigated variation onset age function hla symb allele small sample ad patients find significant effects num literature search association studies genes including years num yielded least num positive studies num reports found evidence genetic involvement factors evidence direct involvement tnfa ass production toxicity num direct proof pathogenetic relevance genesproteins remains seen furthermore full genome screens ad genes consistently yielded signals numsymb residing num num mb whereas associated genes map num mb proximal thus increasing evidence supporting existence putative ad locus numsymb general possibility actual disease gene yet identified excluded despite overlapping positive results year past studies
0.43645546.14764623.html.plaintext.txt	19	chromosome numsymb six candidate loci analyzed region numsymb numsymb num three reported associated ad phenotypes across multiple samples ie symbsymb symbide symbnum locus found associated one group investigators located num num mb encompasses genes symb num mb idesymbhhex num num probably best candidate biological grounds ide encoding insulin degrading enzyme protein ide metalloprotease shown degrade monomeric ass aggregate oligomeric forms ultimately ss amyloid plaques num several issues proposed mode action still remain controversial eg precise cellular location ass cleavage relevance ide functiondysfunction development ad number animal models available showing predicted effects vivo num num num two papers published showing allelic association microsatellite markers region numnum two reports find association ide variants nearby markers ad numnum note data one negative studies num actually largely overlaps positive paper edland et al num important exception authors first paper account potential interactions ide apoe num status may crucial since latter study found significant effect ide ad risk individuals lacking apoe num allele clearly studies independent samples sufficient size necessary elucidate potential role ide variants development ad general population
0.43645546.14764623.html.plaintext.txt	20	addition ide locus total four genes long arm chromosome num found associated ad two symb symb map num mb proximal ide two symbnum symb map num num mb distal none associations yet confirmed independent ad samples noteworthy two genes also found associated neurodegenerative illnesses frontotemporal dementia symb num parkinsons disease symbnum num potentially suggesting common pathway leading neuronal cell death across syndromes symb encodes cell division cycle num protein involved phosphorylation tau app found neurons bearing neurofibrillary tangles symb num encode glutathione transferase omega num num involved physiological response oxidative stress may particular responsible regulating expression inflammatory cytokines like symb ss thus plausible ad candidate genes positional well biologicalbiochemical grounds studies still necessary elucidate proposed roles influencing risk andor age onset ad general population
0.43645546.14764623.html.plaintext.txt	21	addition ide locus total four genes long arm chromosome num found associated ad two symb symb map num mb proximal ide two symbnum symb map num num mb distal none associations yet confirmed independent ad samples noteworthy two genes also found associated neurodegenerative illnesses frontotemporal dementia symb num parkinsons disease symbnum num potentially suggesting common pathway leading neuronal cell death across syndromes symb encodes cell division cycle num protein involved phosphorylation tau app found neurons bearing neurofibrillary tangles symb num encode glutathione transferase omega num num involved physiological response oxidative stress may particular responsible regulating expression inflammatory cytokines like symb ss thus plausible ad candidate genes positional well biologicalbiochemical grounds studies still necessary elucidate proposed roles influencing risk andor age onset ad general population
0.43645546.14764623.html.plaintext.txt	22	chromosome numsymb region near tip long arm chromosome num implicated one full genome screens published date num therefore appear table num yet total three studies showing significant association ad candidate gene num bace encoding ss site app cleaving enzyme ss secretase num num protein excellent ad candidate biochemical grounds ss secretase cleavage app ass liberated precursor via secretase cleavage interestingly contrast putative ad associations discussed appears high degree consistency respect site allelic nature underlying findings positive studies including initial report nowotny colleagues published num num observe representations g allele synonymous snp located codon num exon num ad cases compared healthy controls furthermore studies observed effect pronounced carriers apoe num allele yielding significantly elevated odds ratios ranging num num
0.43645546.14764623.html.plaintext.txt	23	chromosome numsymb region near tip long arm chromosome num implicated one full genome screens published date num therefore appear table num yet total three studies showing significant association ad candidate gene num bace encoding ss site app cleaving enzyme ss secretase num num protein excellent ad candidate biochemical grounds ss secretase cleavage app ass liberated precursor via secretase cleavage interestingly contrast putative ad associations discussed appears high degree consistency respect site allelic nature underlying findings positive studies including initial report nowotny colleagues published num num observe representations g allele synonymous snp located codon num exon num ad cases compared healthy controls furthermore studies observed effect pronounced carriers apoe num allele yielding significantly elevated odds ratios ranging num num
0.43645546.14764623.html.plaintext.txt	24	contrast four positive associations equal number studies literature showing apparent effects bace polymorphism ad however must pointed one studied early onset familial ad cases num remaining studies account potential interaction apoe num allele num num unless done similar situation encountered variants tested ide see firm conclusions reached whether exon num polymorphism bace genetic risk factor ad samples thus three known app cleaving enzymes associated proteins symbnum num ss bace symb secretase symb symb ncstn symb already tested genetic association ad phenotypes bace currently shows promise genuine relevant risk factor late onset ad case putative ad genes studies using sufficiently sized samples appropriate analytic strategies need performed general conclusions reached note first study examining putative genetic role bace late onset ad num also reports significant effect exon num polymorphism case control sample chinese origin num
0.43645546.14764623.html.plaintext.txt	25	contrast four positive associations equal number studies literature showing apparent effects bace polymorphism ad however must pointed one studied early onset familial ad cases num remaining studies account potential interaction apoe num allele num num unless done similar situation encountered variants tested ide see firm conclusions reached whether exon num polymorphism bace genetic risk factor ad samples thus three known app cleaving enzymes associated proteins symbnum num ss bace symb secretase symb symb ncstn symb already tested genetic association ad phenotypes bace currently shows promise genuine relevant risk factor late onset ad case putative ad genes studies using sufficiently sized samples appropriate analytic strategies need performed general conclusions reached note first study examining putative genetic role bace late onset ad num also reports significant effect exon num polymorphism case control sample chinese origin num
0.43645546.14764623.html.plaintext.txt	26	conclusion top abstract introduction num good vintage conclusion references year num extremely productive terms studies examining potential associations candidate genes ad phenotypes vast majority results previous years remains controversial cases could due factors disease specific eg larger anticipated genetic heterogeneity andor small effect sizes individual risk alleles good proportion controversies probably caused methodological issues based recent empirical simulation data regarding genetic make complex diseases power association studies general propose attention paid providing power estimates based structure analyzed sample variety effect sizes allele frequencies ii replicating positive signal least one independent population sufficient size power prior initial publication iii thoroughly assessing haplotype structure investigated locus especially reaching negative conclusions together statistical techniques take account potential interactions genetic non genetic factors allow adequate correction multiple comparisons adherence criteria ensure successful distinction clinically relevant irrelevantfalse positive findings eventually good vintage wine strategy elevate quality ad genetics research par quantity
0.43645546.14764623.html.plaintext.txt	27	acknowledgements work sponsored grants nimh nia adrc alzheimer association lb fellow harvard center neurodegeneration repair hcnr fellow deutsche forschungsgemeinschaft dfg
0.43645546.14764623.html.plaintext.txt	28	footnotes correspondence addressed genetics aging research unit department neurology massachusetts general hospital num numth street charlestown ma num usa tel num num fax num num email tanziathelixmghharvardedu
0.43645546.14764623.html.plaintext.txt	29	footnotes correspondence addressed genetics aging research unit department neurology massachusetts general hospital num numth street charlestown ma num usa tel num num fax num num email tanziathelixmghharvardedu
0.43645546.14764623.html.plaintext.txt	30	references top abstract introduction num good vintage conclusion references rao vs cupples van duijn cm kurz green rc chui h duara r auerbach sa volicer l wells j et al num evidence major gene inheritance alzheimer disease families patients without apolipoprotein e epsilon num j hum genet num num numisimedline
0.43645546.14764623.html.plaintext.txt	31	poirier j num apolipoprotein e alzheimers disease role amyloid catabolism ann ny acad sci num num numabstractfree full text
0.43713617.11809755.html.plaintext.txt	0	insulin degrading enzyme rapidly removes amyloid precursor protein intracellular domain aicd dieter edbauer michael willem sven lammich harald steiner christian haass
0.43713617.11809755.html.plaintext.txt	1	department biochemistry laboratory alzheimers parkinsons disease research adolf butenandt institute ludwig maximilians university schillerstrasse num num munich germany
0.43713617.11809755.html.plaintext.txt	2	received publication december num num revised form january num num
0.43713617.11809755.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.43713617.11809755.html.plaintext.txt	4	intramembranous secretase cleavage amyloid precursor protein app dependent biologically active presenilins ps notch also undergoes similar ps dependent secretase like cleavage resulting liberation notch intracellular domain nicd critically required developmental signal transduction secretase processing app results production similar fragment called aicd app intracellular domain may function nuclear signaling well aicd like nicd rapidly removed using battery protease inhibitors demonstrate aicd contrast nicd degraded cytoplasmic metalloprotease vitro degradation aicd reconstituted cytoplasmic fractions obtained neuronal non neuronal cells taking account inhibition profile cytoplasmic localization identified three candidate enzymes neurolysin thimet oligopeptidase insulin degrading enzyme ide also known insulysin involved degradation bioactive peptides brain insulin well characterized substrate ide added vitro degradation assay removal aicd efficiently blocked moreover overexpression ide resulted enhanced degradation aicd whereas overexpression inactive ide symb mutant affect aicd degradation finally immunodepletion ide significantly reduced aicd degrading activity therefore data demonstrate ide one proteases implicated removal extracellular also removes cytoplasmic product secretase cleaved app introduction top abstract introduction experimental procedures results discussion references
0.43713617.11809755.html.plaintext.txt	5	intramembranous secretase cleavage amyloid precursor protein app dependent biologically active presenilins ps notch also undergoes similar ps dependent secretase like cleavage resulting liberation notch intracellular domain nicd critically required developmental signal transduction secretase processing app results production similar fragment called aicd app intracellular domain may function nuclear signaling well aicd like nicd rapidly removed using battery protease inhibitors demonstrate aicd contrast nicd degraded cytoplasmic metalloprotease vitro degradation aicd reconstituted cytoplasmic fractions obtained neuronal non neuronal cells taking account inhibition profile cytoplasmic localization identified three candidate enzymes neurolysin thimet oligopeptidase insulin degrading enzyme ide also known insulysin involved degradation bioactive peptides brain insulin well characterized substrate ide added vitro degradation assay removal aicd efficiently blocked moreover overexpression ide resulted enhanced degradation aicd whereas overexpression inactive ide symb mutant affect aicd degradation finally immunodepletion ide significantly reduced aicd degrading activity therefore data demonstrate ide one proteases implicated removal extracellular also removes cytoplasmic product secretase cleaved app introduction top abstract introduction experimental procedures results discussion references
0.43713617.11809755.html.plaintext.txt	6	current evidence strongly implicates aggregation deposition amyloid peptide anum brains alzheimers disease patients invariant pathological feature num generated amyloid precursor protein app endoproteolytic processing two sequential cleavages first secretase followed secretase required liberate review see refs num num intramembranous secretase cleavage dependent biologically active presenilins ps may unusual aspartyl proteases num num probably constitute active site secretase review see refs num num pss involved proteolytic processing app also similar intramembraneous cut notch num notch like app type transmembrane protein undergoes similar endoproteolytic processing pathways review see refs num num ectodomain shedding notch cleaved within close transmembrane domain secretase like symb protease activity symb cut finally liberates notch intracellular domain nicd key molecule developmental signal transduction num cleavage notch symb ps dependent blocked secretase inhibitors num consistent role pss notch signaling symbsymb double knockout mice phenotype similar symb mice num notch cleavage completely inhibited ps deficient cells num num requirement pss nicd formation secretase cleavage app provided basis hypothesis secretase generated cytoplasmic domain app may also carry important function nuclear signaling recently several reports num num described secretase generated cytoplasmic fragment app termed aicd app intracellular domain num analogy nicd aicd generated ps dependent mechanism since symb gene knockout well dominant negative symb mutation symb inhibited aicd generation num moreover secretase inhibitors including ones known bind pss also blocked aicd generation vivo vitro num num num interestingly n terminus aicd predominantly generated cut amino acids num num amyloid domain expected secretase cut amino acids num num num num cleavage releases vivo num amino acid long aicd fragment cytoplasm predicted num num amino acid fragment sequence comparison revealed cleavage occurs similar position symb cleavage notch num num taken together analogies app notch processing may favor idea aicd like nicd physiological function nuclear signal transduction indeed recent findings highly sensitive reporter gene assays supported hypothesis aicd may involved gene transcription num however aicd alone sufficient allow detection significant transcriptional activity reporter gene assays upon co transfection symb nuclear adaptor protein shown bind app cytoplasmic tail num num significant transcriptional activity observed num may related observation recombinant num amino acid aicd like molecules stabilized co expression symb num although latter confirmed others num
0.43713617.11809755.html.plaintext.txt	7	current evidence strongly implicates aggregation deposition amyloid peptide anum brains alzheimers disease patients invariant pathological feature num generated amyloid precursor protein app endoproteolytic processing two sequential cleavages first secretase followed secretase required liberate review see refs num num intramembranous secretase cleavage dependent biologically active presenilins ps may unusual aspartyl proteases num num probably constitute active site secretase review see refs num num pss involved proteolytic processing app also similar intramembraneous cut notch num notch like app type transmembrane protein undergoes similar endoproteolytic processing pathways review see refs num num ectodomain shedding notch cleaved within close transmembrane domain secretase like symb protease activity symb cut finally liberates notch intracellular domain nicd key molecule developmental signal transduction num cleavage notch symb ps dependent blocked secretase inhibitors num consistent role pss notch signaling symbsymb double knockout mice phenotype similar symb mice num notch cleavage completely inhibited ps deficient cells num num requirement pss nicd formation secretase cleavage app provided basis hypothesis secretase generated cytoplasmic domain app may also carry important function nuclear signaling recently several reports num num described secretase generated cytoplasmic fragment app termed aicd app intracellular domain num analogy nicd aicd generated ps dependent mechanism since symb gene knockout well dominant negative symb mutation symb inhibited aicd generation num moreover secretase inhibitors including ones known bind pss also blocked aicd generation vivo vitro num num num interestingly n terminus aicd predominantly generated cut amino acids num num amyloid domain expected secretase cut amino acids num num num num cleavage releases vivo num amino acid long aicd fragment cytoplasm predicted num num amino acid fragment sequence comparison revealed cleavage occurs similar position symb cleavage notch num num taken together analogies app notch processing may favor idea aicd like nicd physiological function nuclear signal transduction indeed recent findings highly sensitive reporter gene assays supported hypothesis aicd may involved gene transcription num however aicd alone sufficient allow detection significant transcriptional activity reporter gene assays upon co transfection symb nuclear adaptor protein shown bind app cytoplasmic tail num num significant transcriptional activity observed num may related observation recombinant num amino acid aicd like molecules stabilized co expression symb num although latter confirmed others num
0.43713617.11809755.html.plaintext.txt	8	aicd plays role signal transduction activity may regulated case nicd ubiquitin dependent proteasomal degradation pathway prevents nicd accumulation constitutive signaling num num num aicd also rapidly degraded apparently protease activity different proteasome num num therefore searched protease activity involved aicd degradation surprisingly found aicd efficiently degraded insulin degrading enzyme ide thiol dependent metalloprotease known degrade insulin glucagon peptide hormones num interestingly ide also implicated clearance extracellular review see ref num data therefore suggest therapeutic stimulation ide activity remove also affect aicd metabolism potential function nuclear signal transduction experimental procedures top abstract introduction experimental procedures results discussion references
0.43713617.11809755.html.plaintext.txt	9	aicd plays role signal transduction activity may regulated case nicd ubiquitin dependent proteasomal degradation pathway prevents nicd accumulation constitutive signaling num num num aicd also rapidly degraded apparently protease activity different proteasome num num therefore searched protease activity involved aicd degradation surprisingly found aicd efficiently degraded insulin degrading enzyme ide thiol dependent metalloprotease known degrade insulin glucagon peptide hormones num interestingly ide also implicated clearance extracellular review see ref num data therefore suggest therapeutic stimulation ide activity remove also affect aicd metabolism potential function nuclear signal transduction experimental procedures top abstract introduction experimental procedures results discussion references
0.43713617.11809755.html.plaintext.txt	10	cell lines cell culture human embryonic kidney num cells symb cultured dulbeccos modified eagles medium supplemented num fetal bovine serum num penicillinstreptomycin num microgml symb select app expression num microgml zeocin select ide expression symb cells stably expressing rat ide variants generated transfection symb cells stably expressing symb containing swedish mutation swapp num mouse neuroblastoma symb cells stably expressing swapp cultured described previously num
0.43713617.11809755.html.plaintext.txt	11	cell lines cell culture human embryonic kidney num cells symb cultured dulbeccos modified eagles medium supplemented num fetal bovine serum num penicillinstreptomycin num microgml symb select app expression num microgml zeocin select ide expression symb cells stably expressing rat ide variants generated transfection symb cells stably expressing symb containing swedish mutation swapp num mouse neuroblastoma symb cells stably expressing swapp cultured described previously num
0.43713617.11809755.html.plaintext.txt	12	protease inhibitors protease inhibitors used following final concentrations vitro assays aicd degradation protease inhibitor mix without edta num x complete roche molecular biochemicals dapt num microm gift boehringer ingelheim kg edta num mm sigma numnum o phenanthroline pnt num mm sigma phosphoramidon num microm calbiochem bestatin num microm calbiochem clasto lactacystin lactone num microm sigma symb num microm calbiochem n ethylmaleimide nem numnum num mm sigma dynorphin num num numnum mm bachem pro ile num mm bachem cfp aay pab cfp num microm gift ian smith insulin num num microgml sigma zincov num microm calbiochem symb num microm roche molecular biochemicals phenylmethylsulfonyl fluoride num mm sigma leupeptin num microgml roche molecular biochemicals aprotinin num microgml roche molecular biochemicals antipain num microgml roche molecular biochemicals pepstatin num microgml calbiochem
0.43713617.11809755.html.plaintext.txt	13	protease inhibitors protease inhibitors used following final concentrations vitro assays aicd degradation protease inhibitor mix without edta num x complete roche molecular biochemicals dapt num microm gift boehringer ingelheim kg edta num mm sigma numnum o phenanthroline pnt num mm sigma phosphoramidon num microm calbiochem bestatin num microm calbiochem clasto lactacystin lactone num microm sigma symb num microm calbiochem n ethylmaleimide nem numnum num mm sigma dynorphin num num numnum mm bachem pro ile num mm bachem cfp aay pab cfp num microm gift ian smith insulin num num microgml sigma zincov num microm calbiochem symb num microm roche molecular biochemicals phenylmethylsulfonyl fluoride num mm sigma leupeptin num microgml roche molecular biochemicals aprotinin num microgml roche molecular biochemicals antipain num microgml roche molecular biochemicals pepstatin num microgml calbiochem
0.43713617.11809755.html.plaintext.txt	14	cdna constructs rat ide cdna gift r roth cloned symbnumzeo invitrogen nonfunctional ide symb mutant generated pcr mediated mutagenesis using appropriate primers
0.43713617.11809755.html.plaintext.txt	15	antibodies polyclonal antibody num num c terminal amino acids app num monoclonal antibody numsymb human ide num described antibody numsymb also recognizes rat ide
0.43713617.11809755.html.plaintext.txt	16	antibodies polyclonal antibody num num c terminal amino acids app num monoclonal antibody numsymb human ide num described antibody numsymb also recognizes rat ide
0.43713617.11809755.html.plaintext.txt	17	aicd generationdegradation vitro characterize protease activity involved aicd degradation used previously established vitro assay num symb cells resuspended numnum mlnum cm dish ice cold hypotonic homogenization buffer num mm mops ph numnum num mm kcl without protease inhibitors incubated ice num min following homogenization ice tight fitting homogenizer num strokes post nuclear supernatant prepared centrifugation num x g num min num degrees c crude membranes isolated post nuclear supernatant centrifugation numnum x g num min num degrees c membranes resuspended num microlnum cm dish assay buffer num mm sodium citrate ph numnum supplemented indicated protease inhibitors aicd generated incubation samples num degrees c num h volume num microlassay termination assay reactions ice samples separated pellet symb supernatant symb fractions ultracentrifugation num h numnum x g num degrees c symb fraction separated sds page num num tris tricine gels invitrogen numnum tris tricine gels num analyzed immunoblotting antibody num detection using enhanced chemiluminescence ecl amersham biosciences
0.43713617.11809755.html.plaintext.txt	18	aicd generationdegradation vitro characterize protease activity involved aicd degradation used previously established vitro assay num symb cells resuspended numnum mlnum cm dish ice cold hypotonic homogenization buffer num mm mops ph numnum num mm kcl without protease inhibitors incubated ice num min following homogenization ice tight fitting homogenizer num strokes post nuclear supernatant prepared centrifugation num x g num min num degrees c crude membranes isolated post nuclear supernatant centrifugation numnum x g num min num degrees c membranes resuspended num microlnum cm dish assay buffer num mm sodium citrate ph numnum supplemented indicated protease inhibitors aicd generated incubation samples num degrees c num h volume num microlassay termination assay reactions ice samples separated pellet symb supernatant symb fractions ultracentrifugation num h numnum x g num degrees c symb fraction separated sds page num num tris tricine gels invitrogen numnum tris tricine gels num analyzed immunoblotting antibody num detection using enhanced chemiluminescence ecl amersham biosciences
0.43713617.11809755.html.plaintext.txt	19	alkaline extraction membranes crude membranes prepared resuspended numnum mlnum cm dish num mm symbnum ph numnum num incubated ice num min ultracentrifugation num h numnum x g num degrees c two consecutive washes assay buffer carbonate extracted membranes resuspended num microlnum cm dish assay buffer analyzed aicd degradation
0.43713617.11809755.html.plaintext.txt	20	alkaline extraction membranes crude membranes prepared resuspended numnum mlnum cm dish num mm symbnum ph numnum num incubated ice num min ultracentrifugation num h numnum x g num degrees c two consecutive washes assay buffer carbonate extracted membranes resuspended num microlnum cm dish assay buffer analyzed aicd degradation
0.43713617.11809755.html.plaintext.txt	21	preparation cytosol cytosol prepared indicated cell lines ultracentrifugation post nuclear supernatant fraction numnum x g num h num degrees c soluble symb fraction used cytosol
0.43713617.11809755.html.plaintext.txt	22	preparation cytosol cytosol prepared indicated cell lines ultracentrifugation post nuclear supernatant fraction numnum x g num h num degrees c soluble symb fraction used cytosol
0.43713617.11809755.html.plaintext.txt	23	reconstitution aicd degradation vitro cytosol free membranes generated three consecutive washes membranes assay buffer centrifugation numnum x g num min num degrees c cytosol free membranes resuspended assay buffer num microlassay mixed aliquots num microl cytosol fractions containing indicated protein amounts aicd generated described assays insulin aicd first generated cytosol free membranes described ultracentrifugation membrane free symb fractions containing preformed aicd mixed cytosol preparations supplemented indicated amounts insulin assayed aicd degradation described
0.43713617.11809755.html.plaintext.txt	24	reconstitution aicd degradation vitro cytosol free membranes generated three consecutive washes membranes assay buffer centrifugation numnum x g num min num degrees c cytosol free membranes resuspended assay buffer num microlassay mixed aliquots num microl cytosol fractions containing indicated protein amounts aicd generated described assays insulin aicd first generated cytosol free membranes described ultracentrifugation membrane free symb fractions containing preformed aicd mixed cytosol preparations supplemented indicated amounts insulin assayed aicd degradation described
0.43713617.11809755.html.plaintext.txt	25	immunodepletion ide ide depleted cytosol preparations generated immunoprecipitation num h num degrees c using excess amounts antibody numsymb prebound rabbit anti mouse antibody sigma protein sepharose control mock immunoprecipitation lacking antibody numsymb carried rabbit anti mouse antibody prebound protein sepharose results top abstract introduction experimental procedures results discussion references
0.43713617.11809755.html.plaintext.txt	26	immunodepletion ide ide depleted cytosol preparations generated immunoprecipitation num h num degrees c using excess amounts antibody numsymb prebound rabbit anti mouse antibody sigma protein sepharose control mock immunoprecipitation lacking antibody numsymb carried rabbit anti mouse antibody prebound protein sepharose results top abstract introduction experimental procedures results discussion references
0.43713617.11809755.html.plaintext.txt	27	aicd rapidly degraded metalloprotease activity others previously demonstrated aicd efficiently generated vitro secretase ps dependent manner crude membrane fractions prepared centrifugation numnum numnum x g num num however vitro generated aicd extremely rapidly degraded addition protease inhibitor mix containing edta necessary stabilize aicd num num identify protease involved extremely rapid degradation pathway vitro assay carried presence variety protease inhibitors fig num absence inhibitor aicd could detected demonstrating num degrees c aicd degradation even faster de novo synthesis consistent previous results general protease inhibitor mix including edta inhibited aicd degradation additional presence secretase inhibitor dapt inhibited aicd generation expected num interestingly protease inhibitor mix without edta block aicd degradation suggesting involvement divalent metal ion dependent proteolytic activity aicd generation indeed metal chelators edta pnt allowed robust accumulation aicd used either alone combination however specific metalloprotease inhibitors phosphoramidon bestatin inhibitor aminopeptidases inhibit degradation aicd aicd degradation affected inhibitors cysteine proteases symb leupeptin serine proteases phenylmethylsulfonyl fluoride aspartyl proteases pepstatin data shown interestingly potent proteasome inhibitors clasto lactacystin lactone symb also block aicd degradation fig num contrast nicd shown rapidly degraded ubiquitin dependent proteasomal degradation pathway num num num thus although aicd nicd generated ps dependent protease degraded different proteolytic activities taken together conclude likely metalloprotease involved aicd degradation
0.43713617.11809755.html.plaintext.txt	28	aicd rapidly degraded metalloprotease activity others previously demonstrated aicd efficiently generated vitro secretase ps dependent manner crude membrane fractions prepared centrifugation numnum numnum x g num num however vitro generated aicd extremely rapidly degraded addition protease inhibitor mix containing edta necessary stabilize aicd num num identify protease involved extremely rapid degradation pathway vitro assay carried presence variety protease inhibitors fig num absence inhibitor aicd could detected demonstrating num degrees c aicd degradation even faster de novo synthesis consistent previous results general protease inhibitor mix including edta inhibited aicd degradation additional presence secretase inhibitor dapt inhibited aicd generation expected num interestingly protease inhibitor mix without edta block aicd degradation suggesting involvement divalent metal ion dependent proteolytic activity aicd generation indeed metal chelators edta pnt allowed robust accumulation aicd used either alone combination however specific metalloprotease inhibitors phosphoramidon bestatin inhibitor aminopeptidases inhibit degradation aicd aicd degradation affected inhibitors cysteine proteases symb leupeptin serine proteases phenylmethylsulfonyl fluoride aspartyl proteases pepstatin data shown interestingly potent proteasome inhibitors clasto lactacystin lactone symb also block aicd degradation fig num contrast nicd shown rapidly degraded ubiquitin dependent proteasomal degradation pathway num num num thus although aicd nicd generated ps dependent protease degraded different proteolytic activities taken together conclude likely metalloprotease involved aicd degradation
0.43713617.11809755.html.plaintext.txt	29	view larger version numk fig num chelators divalent metal ions block aicd degradation membrane preparations incubated num degrees c num h presence absence indicated protease inhibitors membranes pelleted ultracentrifugation aicd analyzed soluble fraction immunoblotting antibody num note aicd degradation blocked protease inhibitor mix pi mix well metal chelators edta pnt inhibitors proteasome clasto lactacystin lactone symb
0.43713617.11809755.html.plaintext.txt	30	aicd degraded cytoplasmic protease next investigated whether metalloprotease activity involved aicd degradation cytosolic membrane bound first assayed crude membranes aicd degradation alkaline extraction symbnum separates peripheral integral membrane proteins num shown fig numa aicd could recovered absence pntedta symbnum extracted membranes suggesting aicd degrading activity either peripherally attached membrane soluble addition data confirm previous findings secretase integrally membrane bound num next separated crude membranes residual cytosol additional centrifugation shown crude membranes used vitro assay aicd could recovered absence pntedta fig numb due rapid degradation contrast crude membranes used additional re centrifugation numnum x g robust accumulation aicd observed absence pntedta fig numb thus data suggest aicd degrading activity soluble protease primarily located within cytoplasm prove cytoplasmic localization aicd degrading activity vitro degradation assay performed washed cytosol free membranes allowed robust accumulation aicd absence pntedta degrading activity could reconstituted addition increasing amounts cytosol symb mouse neuroblastoma symb cells fig numc results conclude cytoplasmic metalloprotease present peripheral well neuronal cells involved aicd degradation
0.43713617.11809755.html.plaintext.txt	31	aicd degraded cytoplasmic protease next investigated whether metalloprotease activity involved aicd degradation cytosolic membrane bound first assayed crude membranes aicd degradation alkaline extraction symbnum separates peripheral integral membrane proteins num shown fig numa aicd could recovered absence pntedta symbnum extracted membranes suggesting aicd degrading activity either peripherally attached membrane soluble addition data confirm previous findings secretase integrally membrane bound num next separated crude membranes residual cytosol additional centrifugation shown crude membranes used vitro assay aicd could recovered absence pntedta fig numb due rapid degradation contrast crude membranes used additional re centrifugation numnum x g robust accumulation aicd observed absence pntedta fig numb thus data suggest aicd degrading activity soluble protease primarily located within cytoplasm prove cytoplasmic localization aicd degrading activity vitro degradation assay performed washed cytosol free membranes allowed robust accumulation aicd absence pntedta degrading activity could reconstituted addition increasing amounts cytosol symb mouse neuroblastoma symb cells fig numc results conclude cytoplasmic metalloprotease present peripheral well neuronal cells involved aicd degradation
0.43713617.11809755.html.plaintext.txt	32	view larger version numk fig num aicd degraded cytosolic metalloprotease alkaline extraction separates aicd degrading activity aicd generating activity crude membrane preparations subjected alkaline extraction symbnum following centrifugation numnum x g two subsequent washes membranes incubated num degrees c num h presence absence pntedta aicd analyzed fig num note aicd recovered absence pntedta upon removal degrading activity alkaline extraction symbnum without affecting aicd generating secretase activity b aicd degrading activity removed ultracentrifugation crude membrane preparations incubated directly preparation symb fractions additional centrifugation numnum x g symb fractions num degrees c num h presence absence pntedta aicd analyzed described legend fig num note aicd recovered even absence pntedta additional ultracentrifugation symb fractions c aicd degrading activity present cytosol cytosol free membrane preparations incubated num degrees c num h presence absence pntedta together indicated amounts cytosol fractions symb mouse symb cells aicd analyzed described legend fig num note dose dependent degradation aicd presence cytosol derived kidney neuronal cells
0.43713617.11809755.html.plaintext.txt	33	identification candidate enzymes responsible aicd degradation based inhibition profile cytoplasmic localization aicd degrading activity searched merops protease data base wwwmeropscouk candidate aicd degrading enzymes search revealed three cytoplasmic candidate proteases two metalloprotease families symb symb families could responsible degradation aicd thimet oligopeptidase top symb family neurolysin symb family ide insulysin symb family consistent candidate proteases thiol group dependent num num sh alkylating agents nem strongly inhibited aicd degradation fig numa next discriminate proteases could involved aicd degradation vitro assay carried presence absence dynorphin num num known inhibitor top neurolysin num potentially also ide dipeptide pro ile highly specific neurolysin inhibitor num cfp aay pab cfp potent top less potent neurolysin inhibitor num insulin well characterized substrate ide functions competitive inhibitor investigated well num shown fig numb weak inhibition aicd degradation dynorphin num num suggests either top neurolysin candidate protease without excluding ide however pro ile block aicd degradation ruling neurolysin candidate protease fig numb since cfp also block aicd degradation fig numb ide remained candidate aicd degradation indeed insulin competed aicd degrading activity present cytosol derived symb cells dose dependent manner fig numc bovine serum albumin used control unspecific inhibition degradation effect fig numc similar results obtained cytosol symb cells data shown thus data indicate ide may one aicd degrading enzymes symb symb cells
0.43713617.11809755.html.plaintext.txt	34	view larger version numk fig num identification candidate metalloproteases involved aicd degradation sh alkylating agent nem inhibits aicd degradation crude membrane preparations incubated num degrees c num h presence absence indicated concentrations nem aicd analyzed described legend fig num b aicd degradation reduced dynorphin num num specific neurolysin inhibitor pro ile specific top inhibitor cfp crude membrane preparations assayed aicd degradation fig num c dose dependent inhibition aicd degradation insulin aicd generated incubation cytosol free membranes num h num degrees c subsequently separated membranes ultracentrifugation symb fractions containing preformed aicd mixed cytosol num microg derived symb cells indicated amounts insulin bovine serum albumin assayed aicd degradation incubation num h num degrees c described legend fig num note dose dependent inhibition aicd degradation insulin bovine serum albumin
0.43713617.11809755.html.plaintext.txt	35	ide degrades aicd prove whether ide aicd degrading enzyme generated symb cell lines stably overexpressing rat ide inactive ide mutant ide symb glutamate hxxeh active site motif changed glutamine num num shown fig numa immunoblotting cytosol fractions confirmed overexpression wt mutant ide proteins cytosol fractions derived cells overexpressing wt ide contained significantly higher aicd degrading activity cytosol fractions ide symb overexpressing cells fig numb finally cytosol symb cells immunodepleted endogenous ide immunoprecipitation excess amounts anti ide antibody fig numc aicd generation assayed cytosol free membranes presence fractions shown fig numd dose dependent aicd degradation observed non depleted control fractions contrast markedly reduced aicd degrading activity ide depleted cytosol fractions thus data strongly suggest ide major aicd degrading enzyme
0.43713617.11809755.html.plaintext.txt	36	view larger version numk fig num ide aicd degrading enzyme cytosol fractions symb cells stably co expressing swedish mutant app rat wt ide inactive rat ide symb mutant analyzed ide expression immunoblotting antibody numsymb note increased levels ide variants cytosol fraction upon overexpression b overexpressed rat ide inactive ide symb efficiently degrades aicd cytosol free membrane preparations incubated num degrees c num h described legend fig numc presence absence pntedta indicated amounts cytosol fractions symb cells stably overexpressing ide inactive ide symb mutant note overexpressed wt ide strongly enhances aicd degradation compared inactive ide c immunodepletion ide cytosol fractions symb cells immunodepleted endogenous ide immunoprecipitation antibody numsymb control mock immunoprecipitation lacking antibody numsymb carried note significant depletion ide antibody numsymb d cytosol fractions immunodepleted ide assayed aicd degradation described legend fig numc note immunodepletion ide blocks degradation aicd discussion top abstract introduction experimental procedures results discussion references
0.43713617.11809755.html.plaintext.txt	37	pss may function facilitating nuclear signaling function well proven role ps nicd generation recently corresponding cytoplasmic fragment app aicd identified num num aicd generated remarkably similar molecular mechanism like nicd fig num aicd functions nuclear signaling proposed cao sudhof num one may expect rapid clearance fragment since constitutive uncontrolled signaling must avoided indeed case nicd rapidly removed ubiquitin dependent proteasomal degradation pathway num num num show aicd degraded proteasome completely different protease namely ide fig num biochemical properties ide make ideal candidate aicd degradation highly expressed cellular compartment aicd common enzyme brain tissue abundant app expression observed preferentially degrades small cytoplasmic peptides num num amino acids length review see ref num
0.43713617.11809755.html.plaintext.txt	38	pss may function facilitating nuclear signaling function well proven role ps nicd generation recently corresponding cytoplasmic fragment app aicd identified num num aicd generated remarkably similar molecular mechanism like nicd fig num aicd functions nuclear signaling proposed cao sudhof num one may expect rapid clearance fragment since constitutive uncontrolled signaling must avoided indeed case nicd rapidly removed ubiquitin dependent proteasomal degradation pathway num num num show aicd degraded proteasome completely different protease namely ide fig num biochemical properties ide make ideal candidate aicd degradation highly expressed cellular compartment aicd common enzyme brain tissue abundant app expression observed preferentially degrades small cytoplasmic peptides num num amino acids length review see ref num
0.43713617.11809755.html.plaintext.txt	39	view larger version numk fig num distinct pathways involved degradation aicd nicd aicd nicd generated ps dependent secretase symb protease cleavages similar sites within membrane following liberation membrane nicd probably also aicd translocate nucleus nucleus nicd activates transcription notch target genes proteasomal degradation nicd prevents accumulation constitutive signaling contrast nicd aicd degraded ide like neprilysin also involved extracellular degradation secreted
0.43713617.11809755.html.plaintext.txt	40	found extremely rapid turnover aicd even exceeds kinetics de novo production vitro consistent high levels ide cytoplasm many cells tissues although identified ide major aicd degrading enzyme non neuronal neuronal cell lysates exclude possibility enzymes may degrade aicd cells ide activity expression low num
0.43713617.11809755.html.plaintext.txt	41	found extremely rapid turnover aicd even exceeds kinetics de novo production vitro consistent high levels ide cytoplasm many cells tissues although identified ide major aicd degrading enzyme non neuronal neuronal cell lysates exclude possibility enzymes may degrade aicd cells ide activity expression low num
0.43713617.11809755.html.plaintext.txt	42	interestingly overexpressed artificial num amino acid aicd variants localized nucleus extent num num however contrast endogenous aicd correct n terminus far detected within nucleus due rather rapid turnover endogenous aicd apparent lack nuclear localization one may question function small peptide nuclear signaling however one needs point nicd could detected nucleus long time sensitive techniques lacking indeed using hypersensitive reporter gene assays cao sudhof num could provide indirect evidence cytoplasmic fragment app identical vivo existing aicd complexed symb histone acetyltransferase symb could mediate gene transcription however nuclear transport authentic aicd formation nuclear symb symb aicd complex remains shown identification ide aicd degrading enzyme may facilitate research putative role aicd nuclear signaling since function could strongly enhanced inhibition aicd degradation
0.43713617.11809755.html.plaintext.txt	43	interestingly overexpressed artificial num amino acid aicd variants localized nucleus extent num num however contrast endogenous aicd correct n terminus far detected within nucleus due rather rapid turnover endogenous aicd apparent lack nuclear localization one may question function small peptide nuclear signaling however one needs point nicd could detected nucleus long time sensitive techniques lacking indeed using hypersensitive reporter gene assays cao sudhof num could provide indirect evidence cytoplasmic fragment app identical vivo existing aicd complexed symb histone acetyltransferase symb could mediate gene transcription however nuclear transport authentic aicd formation nuclear symb symb aicd complex remains shown identification ide aicd degrading enzyme may facilitate research putative role aicd nuclear signaling since function could strongly enhanced inhibition aicd degradation
0.43713617.11809755.html.plaintext.txt	44	interestingly ide degrades aicd also involved clearance secreted brain num num although major degrading activity appears neprilysin num num surprisingly degrading ide appears released living cells num num small amounts far unknown cellular mechanisms contrast secreted aicd released cytoplasm rapidly degraded ide since ide one clearing enzymes tempting increase activity lower amyloid burden alzheimers disease patients indeed major goal behind identification degrading enzymes finding ide involved degradation also removal aicd may important implications therapeutic strategies involving manipulation ide activity one assumes aicd required nuclear signaling enhanced removal interfere aicd mediated functions moreover therapeutic strategies inhibition secretase activity also interfere aicd production case major reduction acid mediated signaling may occur could also detrimental implications careful analysis aicd function metabolism therefore required understand biological function app nuclear signaling also safety ongoing therapeutic trials acknowledgements
0.43713617.11809755.html.plaintext.txt	45	interestingly ide degrades aicd also involved clearance secreted brain num num although major degrading activity appears neprilysin num num surprisingly degrading ide appears released living cells num num small amounts far unknown cellular mechanisms contrast secreted aicd released cytoplasm rapidly degraded ide since ide one clearing enzymes tempting increase activity lower amyloid burden alzheimers disease patients indeed major goal behind identification degrading enzymes finding ide involved degradation also removal aicd may important implications therapeutic strategies involving manipulation ide activity one assumes aicd required nuclear signaling enhanced removal interfere aicd mediated functions moreover therapeutic strategies inhibition secretase activity also interfere aicd production case major reduction acid mediated signaling may occur could also detrimental implications careful analysis aicd function metabolism therefore required understand biological function app nuclear signaling also safety ongoing therapeutic trials acknowledgements
0.43713617.11809755.html.plaintext.txt	46	thank ian smith top inhibitors richard roth rat ide cdna antibody numsymb human ide klaus fuchs dapt gopal thinakaran mouse symb cells stably expressing swapp magdalena sastre discussion
0.43713617.11809755.html.plaintext.txt	47	work supported boehringer ingelheim pharma kg stipend l deutsche forschungsgemeinschaft dfgthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.43713617.11809755.html.plaintext.txt	48	senior authors correspondence may addressed tel num num num numnum fax num num num num e mail chaasspbmmeduni muenchende c h tel num num num num fax num num num num e mail hsteinerpbmmeduni muenchende h
0.43713617.11809755.html.plaintext.txt	49	published jbc papers press january num num doi numnumjbcsymb
0.43713617.11809755.html.plaintext.txt	50	abbreviations used amyloid peptide app amyloid precursor protein aicd app intracellular domain ide insulin degrading enzyme nicd notch intracellular domain ps presenilin hek human embryonic kidney dapt n n numnum difluorophenacetyl l alanyl phenylglycine butyl ester pnt numnum o phenanthroline nem n ethylmaleimide mops num morpholinepropanesulfonic acid tricine n num hydroxy numnum bishydroxymethylethylglycine top thimet oligopeptidase wt wild type
0.43713617.11809755.html.plaintext.txt	51	references top abstract introduction experimental procedures results discussion references num selkoe d j num nature num symb symbcrossrefmedline order article via infotrieve num esler w p wolfe m num science num num numabstractfree full text num walter j kaether c steiner h haass c num curr opin neurobiol num num numcrossrefmedline order article via infotrieve num wolfe m xia w ostaszewski b l diehl kimberly w selkoe d j num nature num num numcrossrefmedline order article via infotrieve num steiner h kostka m romig h basset g pesold b hardy j capell meyn l grim m g baumeister r fechteler k haass c num nat cell biol num num numcrossrefmedline order article via infotrieve num de strooper b annaert w cupers p saftig p craessaerts k mumm j schroeter e h schrijvers v wolfe m ray w j goate kopan r num nature num num numcrossrefmedline order article via infotrieve num mumm j kopan r num dev biol num num numcrossrefmedline order article via infotrieve num donoviel d b hadjantonakis k ikeda m zheng h hyslop p bernstein num genes dev num num numabstractfree full text num herreman serneels l annaert w collen d schoonjans l de strooper b num nat cell biol num num numcrossrefmedline order article via infotrieve num zhang z nadeau p song w donoviel d yuan m bernstein yankner b num nat cell biol num num numcrossrefmedline order article via infotrieve num mclendon c xin ziani cherif c murphy m p findlay k lewis p pinnix sambamurti k wang r fauq golde e num faseb j num num numabstractfree full text num pinnix musunuru u tun h sridharan golde eckman c ziani cherif c onstead l sambamurti k num j biol chem num num numabstractfree full text num sastre m steiner h fuchs k capell multhaup g condron m m teplow d b haass c num embo rep num num numabstractfree full text num gu y misonou h sato dohmae n takio k ihara y num j biol chem num num numabstractfree full text num yu c kim h ikeuchi xu h gasparini l wang r sisodia num j biol chem num num numabstractfree full text num cao x sudhof c num science num num numabstractfree full text num borg j p ooi j levy e margolis b num mol cell biol num num numabstract num fiore f zambrano n minopoli g donini v duilio russo num j biol chem num num numabstractfree full text num mcloughlin d m miller c c num febs lett num num numcrossrefmedline order article via infotrieve num kimberly w zheng j b guenette selkoe d j num j biol chem num num numabstractfree full text num cupers p orlans craessaerts k annaert w de strooper b num j neurochem num num numcrossrefmedline order article via infotrieve num oberg c li j pauley wolf e gurney m lendahl u num j biol chem num num numabstractfree full text num gupta rossi n le bail o gonen h brou c logeat f six e ciechanover israel num j biol chem num num numabstractfree full text num authier f posner b bergeron j j num clin invest med num num nummedline order article via infotrieve num selkoe d j num neuron num num nummedline order article via infotrieve num citron m oltersdorf haass c mcconlogue l hung y seubert p vigo pelfrey c lieberburg selkoe d j num nature num num numcrossrefmedline order article via infotrieve num thinakaran g teplow d b siman r greenberg b sisodia num j biol chem num num numabstractfree full text num shii k roth r num proc natl acad sci u num num numabstract num schagger h von jagow g num anal biochem num num nummedline order article via infotrieve num fujiki y hubbard l fowler lazarow p b num j cell biol num num numabstract num barrett j brown m dando p m knight c g mckie n rawlings n d serizawa num methods enzymol num num nummedline order article via infotrieve num becker b roth r num methods enzymol num num nummedline order article via infotrieve num shrimpton c n abbenante g lew r smith num biochem j num num numcrossrefmedline order article via infotrieve num becker b roth r num proc natl acad sci u num num numabstract num perlman r k gehm b d kuo w l rosner m r num j biol chem num num numabstractfree full text num vekrellis k ye z qiu w q walsh d hartley d chesneau v rosner m r selkoe d j num j neurosci num num numabstractfree full text num qiu w q walsh d m ye z vekrellis k zhang j podlisny m b rosner m r safavi hersh l b selkoe d j num j biol chem num num numabstractfree full text num mukherjee song e kihiko ehmann m goodman j p jr pyrek j estus hersh l b num j neurosci num num numabstractfree full text num mcdermott j r gibson m num neurochem res num num nummedline order article via infotrieve num kurochkin v goto num febs lett num num numcrossrefmedline order article via infotrieve num iwata n tsubuki takaki y watanabe k sekiguchi m hosoki e kawashima morishima m lee h j hama e sekine aizawa y saido c num nat med num num numcrossrefmedline order article via infotrieve num iwata n tsubuki takaki y shirotani k lu b gerard n p gerard c hama e lee h j saido c num science num num numabstractfree full text num shirotani k tsubuki iwata n takaki y harigaya w maruyama k kiryu seo kiyama h iwata h tomita iwatsubo saido c num j biol chem num num numabstractfree full text
0.43713617.11809755.html.plaintext.txt	52	copyright num american society biochemistry molecular biology inc
0.5010976.15944156.html.plaintext.txt	0	yeast tractable genetic system functional studies insulin degrading enzyme seonil kim andrea n lapham christopher g k freedman tiffany l reed walter k schmidt
0.5010976.15944156.html.plaintext.txt	1	departments cellular biology biochemistry molecular biology university georgia athens georgia num
0.5010976.15944156.html.plaintext.txt	2	received publication december num num revised form june num num
0.5010976.15944156.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references developed yeast expression genetic system functional studies insulin degrading enzyme ide cleaves inactivates certain small peptide molecules including insulin neurotoxic peptide show heterologously expressed rat ide enzymatically active judged ability ide containing yeast extracts cleave insulin vitro also show ide promote vivo production yeast factor mating pheromone function normally attributed yeast enzymes symb symb however ide substitute function symb promoting haploid axial budding repressing haploid invasive growth activities require uncharacterized activity symb particulate fractions enriched symb symb incapable cleaving insulin suggesting functional conservation enzymes may bidirectionally conserved made practical use genetic system confirm residues composing extended zinc metalloprotease motif symb family enzymes required enzymatic activity ide symb symb determined ide symb require intact c terminus optimal activity expect tractable genetic system developed useful investigating enzymatic structurefunction properties ide possibly identification novel ide alleles altered substrate specificity
0.5010976.15944156.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references developed yeast expression genetic system functional studies insulin degrading enzyme ide cleaves inactivates certain small peptide molecules including insulin neurotoxic peptide show heterologously expressed rat ide enzymatically active judged ability ide containing yeast extracts cleave insulin vitro also show ide promote vivo production yeast factor mating pheromone function normally attributed yeast enzymes symb symb however ide substitute function symb promoting haploid axial budding repressing haploid invasive growth activities require uncharacterized activity symb particulate fractions enriched symb symb incapable cleaving insulin suggesting functional conservation enzymes may bidirectionally conserved made practical use genetic system confirm residues composing extended zinc metalloprotease motif symb family enzymes required enzymatic activity ide symb symb determined ide symb require intact c terminus optimal activity expect tractable genetic system developed useful investigating enzymatic structurefunction properties ide possibly identification novel ide alleles altered substrate specificity
0.5010976.15944156.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references insulin degrading enzyme symb ec numnumnumnum ec broad substrate specificity able cleave inactivate number small molecules including peptides insulin num num animal models ide deficiency correlates increased levels insulin increased risks type num diabetes alzheimer disease num num despite findings biological role ide importance clearance insulin remains fully clarified num
0.5010976.15944156.html.plaintext.txt	6	symb symb proteins saccharomyces cerevisiae significant sequence homology ide num num identity respectively num genetic mutational studies indicate symb symb required proteolytic maturation yeast factor mating pheromone lipid modified peptide produced multistep process num num pheromone produced mata haploid cells required yeast mating fusion mata mat haploid cells form diploid cell although symb symb independently promote factor maturation enzymes fully redundant symb significantly less efficient symb producing biologically active pheromone num
0.5010976.15944156.html.plaintext.txt	7	symb symb proteins saccharomyces cerevisiae significant sequence homology ide num num identity respectively num genetic mutational studies indicate symb symb required proteolytic maturation yeast factor mating pheromone lipid modified peptide produced multistep process num num pheromone produced mata haploid cells required yeast mating fusion mata mat haploid cells form diploid cell although symb symb independently promote factor maturation enzymes fully redundant symb significantly less efficient symb producing biologically active pheromone num
0.5010976.15944156.html.plaintext.txt	8	symb several cellular roles addition role pheromone production symb required efficient post conjugation fusion haploid mating partners num role may indirectly related ability symb produce factor limiting levels pheromone similarly lead fusion defects num symb also required maintenance axial budding pattern characteristic haploid yeast num num absence symb haploid yeasts exhibit bipolar budding pattern typical diploid cells function symb process require proteolytic activity suggesting symb bi functional enzyme num symb also represses invasive growth haploid yeast num num whether proteolytic bud site selection another activity symb required process reported contrast symb reported cellular role symb factor production additional functions enzyme likely symb expressed mat diploid cell types produce factornum
0.5010976.15944156.html.plaintext.txt	9	symb several cellular roles addition role pheromone production symb required efficient post conjugation fusion haploid mating partners num role may indirectly related ability symb produce factor limiting levels pheromone similarly lead fusion defects num symb also required maintenance axial budding pattern characteristic haploid yeast num num absence symb haploid yeasts exhibit bipolar budding pattern typical diploid cells function symb process require proteolytic activity suggesting symb bi functional enzyme num symb also represses invasive growth haploid yeast num num whether proteolytic bud site selection another activity symb required process reported contrast symb reported cellular role symb factor production additional functions enzyme likely symb expressed mat diploid cell types produce factornum
0.5010976.15944156.html.plaintext.txt	10	ide symb symb members symb protease subfamily symb proteases characterized core inverted zinc metalloprotease motif typically located within first num residues enzymes pair glutamic acid residues num num amino acids distal core motif ie symbnume spacing core motif distal glutamates invariant num symb enzymes identified far except case symb spacing num residues histidine residues distal glutamate residue putative zinc ligands mutational alteration residues inactivates ide symb num num num members symb subfamily including ide sensitive thiol modifiers suggesting cysteine residues critical proper structure active site overall tertiary quaternary structure proteins num num sequence alignment ide yeast orthologs reveals two conserved cysteine residues one within core metalloprotease motif residue reportedly altered without affecting enzymatic activity num conserved cysteine exactly num amino acids distal extended motif symbnumsymb distal cysteine conserved escherichia coli protease iii bacterial symb enzyme insensitive thiol modifiers num
0.5010976.15944156.html.plaintext.txt	11	ide symb symb members symb protease subfamily symb proteases characterized core inverted zinc metalloprotease motif typically located within first num residues enzymes pair glutamic acid residues num num amino acids distal core motif ie symbnume spacing core motif distal glutamates invariant num symb enzymes identified far except case symb spacing num residues histidine residues distal glutamate residue putative zinc ligands mutational alteration residues inactivates ide symb num num num members symb subfamily including ide sensitive thiol modifiers suggesting cysteine residues critical proper structure active site overall tertiary quaternary structure proteins num num sequence alignment ide yeast orthologs reveals two conserved cysteine residues one within core metalloprotease motif residue reportedly altered without affecting enzymatic activity num conserved cysteine exactly num amino acids distal extended motif symbnumsymb distal cysteine conserved escherichia coli protease iii bacterial symb enzyme insensitive thiol modifiers num
0.5010976.15944156.html.plaintext.txt	12	sequence similarity ide symb symb prompted us investigate hypothesis proteins conserved enzymatic properties substrate specificity end present evidence indicating rat ide substitute symb symb factor production known functions symb importantly findings establish yeast genetically tractable system future studies ide function made practical use system create characterize novel mutations alter enzymatic properties ide
0.5010976.15944156.html.plaintext.txt	13	sequence similarity ide symb symb prompted us investigate hypothesis proteins conserved enzymatic properties substrate specificity end present evidence indicating rat ide substitute symb symb factor production known functions symb importantly findings establish yeast genetically tractable system future studies ide function made practical use system create characterize novel mutations alter enzymatic properties ide
0.5010976.15944156.html.plaintext.txt	14	experimental procedures top abstract introduction experimental procedures results discussion references strains media yeast strains used study listed table plasmid bearing versions strains generated transformation indicated plasmids according published methods num strains routinely grown num degrees c synthetic complete dropout sc media described previously num
0.5010976.15944156.html.plaintext.txt	15	experimental procedures top abstract introduction experimental procedures results discussion references strains media yeast strains used study listed table plasmid bearing versions strains generated transformation indicated plasmids according published methods num strains routinely grown num degrees c synthetic complete dropout sc media described previously num
0.5010976.15944156.html.plaintext.txt	16	view table table strains used study
0.5010976.15944156.html.plaintext.txt	17	plasmids plasmids used study indicated table ii plasmids symb cen symb symb symb cen symb symb described previously kindly provided dr c boone university toronto num plasmids used study created pcr directed recombination mediated plasmid construction andor standard molecular methods num
0.5010976.15944156.html.plaintext.txt	18	plasmids plasmids used study indicated table ii plasmids symb cen symb symb symb cen symb symb described previously kindly provided dr c boone university toronto num plasmids used study created pcr directed recombination mediated plasmid construction andor standard molecular methods num
0.5010976.15944156.html.plaintext.txt	19	view table table ii plasmids used study
0.5010976.15944156.html.plaintext.txt	20	general strategy epitope tagging symb symb ide encoding plasmids involved creation novel restriction site end respective open reading frame subcloning triply iterated ha tag symb cen symb symb numha created modifying symb follows ncoi site inserted immediately prior stop codon symb dna fragment encoding triply iterated ha tag inserted actuality two tandem copies tag inserted plasmid modified delete portion num untranslated region corresponding xhoi fragment order reduce overall size plasmid numnum numnum kb deletion effect protein expression symb cen symb symb numha created modifying symb similar manner described symb instance bamhi site introduced immediately prior stop codon symb triply iterated ha tag inserted symb two tandem copies tag actually inserted symb num micro symb ppgk ide ha created pcr amplification ide psr rat ide pcr product ends homologous parent yeast vector symb bglii restriction site immediately stop codon ide num bglii site used insertion triply iterated ha epitope tag symb identical symb except contains two copies triply iterated ha tag restriction digest analysis dna sequencing used confirm presence tag plasmids described
0.5010976.15944156.html.plaintext.txt	21	general strategy epitope tagging symb symb ide encoding plasmids involved creation novel restriction site end respective open reading frame subcloning triply iterated ha tag symb cen symb symb numha created modifying symb follows ncoi site inserted immediately prior stop codon symb dna fragment encoding triply iterated ha tag inserted actuality two tandem copies tag inserted plasmid modified delete portion num untranslated region corresponding xhoi fragment order reduce overall size plasmid numnum numnum kb deletion effect protein expression symb cen symb symb numha created modifying symb similar manner described symb instance bamhi site introduced immediately prior stop codon symb triply iterated ha tag inserted symb two tandem copies tag actually inserted symb num micro symb ppgk ide ha created pcr amplification ide psr rat ide pcr product ends homologous parent yeast vector symb bglii restriction site immediately stop codon ide num bglii site used insertion triply iterated ha epitope tag symb identical symb except contains two copies triply iterated ha tag restriction digest analysis dna sequencing used confirm presence tag plasmids described
0.5010976.15944156.html.plaintext.txt	22	general strategy creation site directed mutations plasmids also involved pcr directed recombination mediated plasmid construction brief dna fragment encoding appropriate segment target open reading frame amplified pcr one oligonucleotides contained mutation interest typically silent restriction site dna fragments co transformed target plasmid linearized gapped restriction enzymes near intended site mutation recombinant plasmids recovered yeast amplified e coli screened restriction analysis andor sequencing verify presence mutation mutant alleles confirmed immunoblot encode full length protein
0.5010976.15944156.html.plaintext.txt	23	general strategy creation site directed mutations plasmids also involved pcr directed recombination mediated plasmid construction brief dna fragment encoding appropriate segment target open reading frame amplified pcr one oligonucleotides contained mutation interest typically silent restriction site dna fragments co transformed target plasmid linearized gapped restriction enzymes near intended site mutation recombinant plasmids recovered yeast amplified e coli screened restriction analysis andor sequencing verify presence mutation mutant alleles confirmed immunoblot encode full length protein
0.5010976.15944156.html.plaintext.txt	24	epitope tagging symb straightforward dna sequencing intermediate plasmid construction symb revealed extra nucleotide near num end open reading frame present public sequence symb presence extra nucleotide confirmed symb sequence derived three different sources symb pcr products derived chromosomal amplification symb gene two distinct strain backgrounds symb symb independent group num proposed recently identical sequence annotation part effort identify mistakes published genome sequences extra nucleotide alters extends translation symb open reading frame amino acids num num code num distinct amino acids additional num amino acids gained extension original proposed translation
0.5010976.15944156.html.plaintext.txt	25	epitope tagging symb straightforward dna sequencing intermediate plasmid construction symb revealed extra nucleotide near num end open reading frame present public sequence symb presence extra nucleotide confirmed symb sequence derived three different sources symb pcr products derived chromosomal amplification symb gene two distinct strain backgrounds symb symb independent group num proposed recently identical sequence annotation part effort identify mistakes published genome sequences extra nucleotide alters extends translation symb open reading frame amino acids num num code num distinct amino acids additional num amino acids gained extension original proposed translation
0.5010976.15944156.html.plaintext.txt	26	protein extract preparations whole cell protein extracts western analysis prepared naohtrichloroacetic acid method num brief mid log cells amount equivalent num ml numnum symb culture harvested centrifugation washed cold water resuspended num ml cold water treated solution num n naoh num m mercaptoethanol proteins released precipitated trichloroacetic acid numnum final recovered centrifugation resuspended urea sample buffer usb num mm tris ph numnum num m urea num sds numnum bromphenol blue heated cleared insoluble material analysis sds page immunoblotting ha tagged proteins detected chemiluminescence ecl kit roche applied science immunodecorating proteins mouse anti ha horseradish peroxidase conjugated rabbit anti mouse antibodies
0.5010976.15944156.html.plaintext.txt	27	protein extract preparations whole cell protein extracts western analysis prepared naohtrichloroacetic acid method num brief mid log cells amount equivalent num ml numnum symb culture harvested centrifugation washed cold water resuspended num ml cold water treated solution num n naoh num m mercaptoethanol proteins released precipitated trichloroacetic acid numnum final recovered centrifugation resuspended urea sample buffer usb num mm tris ph numnum num m urea num sds numnum bromphenol blue heated cleared insoluble material analysis sds page immunoblotting ha tagged proteins detected chemiluminescence ecl kit roche applied science immunodecorating proteins mouse anti ha horseradish peroxidase conjugated rabbit anti mouse antibodies
0.5010976.15944156.html.plaintext.txt	28	particulate fractions used vitro assays prepared mechanical breakage yeast cells expressing either ide symb symb num num brief mid log cells harvested washed cold num mm symb treated trisdithiothreitol num mm tris ph numnum num mm dithiothreitol num min ice cells resuspended oxalyticase buffer num mm kpi ph numnum numnum m sorbitol num mm symb containing oxalyticase num microgsymb enzogenetics corvallis incubated num min num degrees c gentle mixing spheroplasts harvested centrifugation resuspended cold lysis buffer num mm tris ph numnum numnum m sorbitol num mm edta containing protease inhibitors num microgml leupeptin chymostatin pepstatin aprotinin num mm phenylmethylsulfonyl fluoride lysed using glass dounce homogenizer primary lysate cleared twice cell debris centrifugation num x g num min fractionated supernatant particulate fractions centrifugation numnum x g num min fractions adjusted num mgml lysis buffer stored num degrees c aliquots
0.5010976.15944156.html.plaintext.txt	29	particulate fractions used vitro assays prepared mechanical breakage yeast cells expressing either ide symb symb num num brief mid log cells harvested washed cold num mm symb treated trisdithiothreitol num mm tris ph numnum num mm dithiothreitol num min ice cells resuspended oxalyticase buffer num mm kpi ph numnum numnum m sorbitol num mm symb containing oxalyticase num microgsymb enzogenetics corvallis incubated num min num degrees c gentle mixing spheroplasts harvested centrifugation resuspended cold lysis buffer num mm tris ph numnum numnum m sorbitol num mm edta containing protease inhibitors num microgml leupeptin chymostatin pepstatin aprotinin num mm phenylmethylsulfonyl fluoride lysed using glass dounce homogenizer primary lysate cleared twice cell debris centrifugation num x g num min fractionated supernatant particulate fractions centrifugation numnum x g num min fractions adjusted num mgml lysis buffer stored num degrees c aliquots
0.5010976.15944156.html.plaintext.txt	30	assess effect chaotropic agents association ide symb symb yeast particulate fraction freshly prepared samples particulate fraction exposed either num m nacl numnum m symbnum ph numnum num sds buffer alone num min ice samples subjected centrifugation numnum x g num min equivalent portions supernatant particulate fraction analyzed sds page immunoblot described
0.5010976.15944156.html.plaintext.txt	31	insulin degradation assay insulin degradation assays carried essentially described previously using yeast derived lysates source enzyme activity num brief reactions assembled contain numnum mgml yeast lysate num pm numnum cpm numi insulin linco research st charles mo num microl reaction buffer num mm tris numnum m sorbitol ph numnum num mm edta samples incubated num degrees c times indicated appropriate figure legend final sample preparation involved addition bovine serum albumin num final trichloroacetic acid precipitation num final num min ice centrifugation numnum x g num min num degrees c supernatant containing insulin fragments transferred new tube radioactivity associated supernatant particulate fractions determined using wallac counter perkinelmer life sciences
0.5010976.15944156.html.plaintext.txt	32	insulin degradation assay insulin degradation assays carried essentially described previously using yeast derived lysates source enzyme activity num brief reactions assembled contain numnum mgml yeast lysate num pm numnum cpm numi insulin linco research st charles mo num microl reaction buffer num mm tris numnum m sorbitol ph numnum num mm edta samples incubated num degrees c times indicated appropriate figure legend final sample preparation involved addition bovine serum albumin num final trichloroacetic acid precipitation num final num min ice centrifugation numnum x g num min num degrees c supernatant containing insulin fragments transferred new tube radioactivity associated supernatant particulate fractions determined using wallac counter perkinelmer life sciences
0.5010976.15944156.html.plaintext.txt	33	yeast mating assay evaluate ability plasmid transformed mata symb symb strains promote factor production patch mating tests performed using symb mat symb established methods num test provides indirect assessment symb enzyme function factor production mata cells entirely dependent plasmid encoded copy symb enzyme brief master plates prepared patching mata yeast strains expressing symb symb ide onto yepd agar plates num num days growth patches replica printed onto lawns mat cells symb spread minimal media agar plates replica printed plates incubated num days num degrees c mat cell suspensions prepared approximately cell density solutions num num num yepd prepared mixtures yepd appropriate amount sterile symb trace amount yepd added minimal media allows limited survival auxotrophic haploid cells necessary mating process decreasing yepd amount shortens survival window haploid cells thus results decreased mating efficiency diploid cells result mating events prototrophic thus growth diploids test indicative mating functional symb enzyme
0.5010976.15944156.html.plaintext.txt	34	yeast mating assay evaluate ability plasmid transformed mata symb symb strains promote factor production patch mating tests performed using symb mat symb established methods num test provides indirect assessment symb enzyme function factor production mata cells entirely dependent plasmid encoded copy symb enzyme brief master plates prepared patching mata yeast strains expressing symb symb ide onto yepd agar plates num num days growth patches replica printed onto lawns mat cells symb spread minimal media agar plates replica printed plates incubated num days num degrees c mat cell suspensions prepared approximately cell density solutions num num num yepd prepared mixtures yepd appropriate amount sterile symb trace amount yepd added minimal media allows limited survival auxotrophic haploid cells necessary mating process decreasing yepd amount shortens survival window haploid cells thus results decreased mating efficiency diploid cells result mating events prototrophic thus growth diploids test indicative mating functional symb enzyme
0.5010976.15944156.html.plaintext.txt	35	mass spectroscopy factor mating pheromone produced yeast expressing ide symb symb purified according published methods analyzed mass spectroscopy num brief yeast cultured polypropylene culture tubes factor secreted yeast cultures recovered washing polypropylene culture tubes methanol secreted factor adsorbs polypropylene removed organic solvents enriched factor samples concentrated speed vac desalted using zip tip symb beads millipore washed three times numnum trifluoroacetic acid eluted num acetonitrile subjected maldi toftof mass spectroscopy using cyano num hydroxycinnamic acid matrix num proteomics analyzer spectrometer applied biosystems foster city ca factor halo assay total secreted factor produced saturated cultures indicated strains recovered described enriched samples dried speed vac resuspended num microl meoh num fold serial dilutions samples prepared yepd spotted onto lawn symb mat symb num symb symb symb symb symb mata symb num symb symb symb symb rme symb num symb cells latter served control unlikely possibility toxic product produced ide expressing strain num formation spot lawn indicative presence pheromone sample relative potency pheromone determined serial dilutions sample highest dilution biological activity referred end point equivalent concentration num pg microl factor num
0.5010976.15944156.html.plaintext.txt	36	mass spectroscopy factor mating pheromone produced yeast expressing ide symb symb purified according published methods analyzed mass spectroscopy num brief yeast cultured polypropylene culture tubes factor secreted yeast cultures recovered washing polypropylene culture tubes methanol secreted factor adsorbs polypropylene removed organic solvents enriched factor samples concentrated speed vac desalted using zip tip symb beads millipore washed three times numnum trifluoroacetic acid eluted num acetonitrile subjected maldi toftof mass spectroscopy using cyano num hydroxycinnamic acid matrix num proteomics analyzer spectrometer applied biosystems foster city ca factor halo assay total secreted factor produced saturated cultures indicated strains recovered described enriched samples dried speed vac resuspended num microl meoh num fold serial dilutions samples prepared yepd spotted onto lawn symb mat symb num symb symb symb symb symb mata symb num symb symb symb symb rme symb num symb cells latter served control unlikely possibility toxic product produced ide expressing strain num formation spot lawn indicative presence pheromone sample relative potency pheromone determined serial dilutions sample highest dilution biological activity referred end point equivalent concentration num pg microl factor num
0.5010976.15944156.html.plaintext.txt	37	invasive growth assay ability haploid yeast cells invade yeast agar determined using plate washing assay num brief cell suspensions spotted onto sc ura plates cells grown num days num degrees c plates washed running symb gently rubbing surface agar plate gloved finger agar plates scanned prior immediately washing
0.5010976.15944156.html.plaintext.txt	38	invasive growth assay ability haploid yeast cells invade yeast agar determined using plate washing assay num brief cell suspensions spotted onto sc ura plates cells grown num days num degrees c plates washed running symb gently rubbing surface agar plate gloved finger agar plates scanned prior immediately washing
0.5010976.15944156.html.plaintext.txt	39	view larger version numk fig num yeast expressed ide expected size associated particulate fraction protein extracts prepared yeast containing empty vector vectors encoding ha tagged symb symb ide equivalent amounts sample lanes num num num num fold serial dilutions symb lanes num num ide lanes num num samples analyzed sds page immunoblot using anti ha antibody b total yeast lysate containing ha tagged ide subjected differential centrifugation numnum x g corresponding particulate p supernatant fractions recovered equivalent amounts protein num microg analyzed sds page immunoblotting ha monoclonal antibody c samples yeast particulate fractions containing epitope tagged symb symb ide treated either lysis buffer num m nacl numnum m symbnum ph numnum num sds separated supernatant particulate p fractions centrifugation equivalent percentage sample evaluated sds page immunoblot using anti ha antibody strains used symb transformed symb vector symb symb numha symb ide numha either symb cen symb numha symb num micro symb numha b c
0.5010976.15944156.html.plaintext.txt	40	budding assay mid log cells grown selective liquid media harvested concentrate cell suspension num times cells treated num microgml calcofluor sigma num min cells washed twice symb absorbed onto polylysine coated glass slides viewed symb zeiss axioplan microscope equipped fluorescence optics fluorescent images captured using digital camera optronics dei num bud scars num cells evaluated categorized three patterns axial bipolar random axial pattern defined bud scars located solely one pole cell bipolar pattern scars poles random pattern displayed least one bud scar region poles num num
0.5010976.15944156.html.plaintext.txt	41	budding assay mid log cells grown selective liquid media harvested concentrate cell suspension num times cells treated num microgml calcofluor sigma num min cells washed twice symb absorbed onto polylysine coated glass slides viewed symb zeiss axioplan microscope equipped fluorescence optics fluorescent images captured using digital camera optronics dei num bud scars num cells evaluated categorized three patterns axial bipolar random axial pattern defined bud scars located solely one pole cell bipolar pattern scars poles random pattern displayed least one bud scar region poles num num
0.5010976.15944156.html.plaintext.txt	42	results top abstract introduction experimental procedures results discussion references ide heterologously expressed yeast many yeast enzymes required factor production functionally replaced orthologs eukaryotic species num num thus hypothesized ide could rescue mating defect strain lacking symb symb prior evaluating ability ide substitute functions yeast symb enzymes first determined whether yeast could used heterologous expression ide created plasmids encoding epitope tagged versions genes encoding ide yeast orthologs proteases dna fragment encoding ha epitope tag placed num end gene addition tag alter activities enzymes see fig numb
0.5010976.15944156.html.plaintext.txt	43	results top abstract introduction experimental procedures results discussion references ide heterologously expressed yeast many yeast enzymes required factor production functionally replaced orthologs eukaryotic species num num thus hypothesized ide could rescue mating defect strain lacking symb symb prior evaluating ability ide substitute functions yeast symb enzymes first determined whether yeast could used heterologous expression ide created plasmids encoding epitope tagged versions genes encoding ide yeast orthologs proteases dna fragment encoding ha epitope tag placed num end gene addition tag alter activities enzymes see fig numb
0.5010976.15944156.html.plaintext.txt	44	evaluation protein extracts strains expressing tagged proteases revealed tagged protein could detected protein expected size immunoblot fig numa also observed ide symb expressed num times higher levels symb determined comparison immunoblot signals constitutive phosphoglycerate kinase pgk promoter used drive ide expression abundant expression ide unexpected native promoters used drive symb symb expression relative abundance symb symb somewhat unexpected especially symb promote factor production efficiently symb thus reason decreased ability symb promote mating simply attributed reduced protein expression comparison symb
0.5010976.15944156.html.plaintext.txt	45	ide associated particulate yeast fraction subcellular distribution ide mammalian systems reported primarily cytosolic extracellular peroxisomal localizations also described num num ascertain effect heterologous expression subcellular distribution ide subjected total yeast lysate differential fractionation comparison equal amounts loaded protein immunoblot observed ide yeast symb enzymes highly enriched particulate fraction associated numnum x g centrifugation lysate symb although significant amount symb found supernatant fraction fig numb particular experiment symb encoded multicopy plasmid facilitate detection hence stronger signal relative observed total extracts see fig numa
0.5010976.15944156.html.plaintext.txt	46	ide associated particulate yeast fraction subcellular distribution ide mammalian systems reported primarily cytosolic extracellular peroxisomal localizations also described num num ascertain effect heterologous expression subcellular distribution ide subjected total yeast lysate differential fractionation comparison equal amounts loaded protein immunoblot observed ide yeast symb enzymes highly enriched particulate fraction associated numnum x g centrifugation lysate symb although significant amount symb found supernatant fraction fig numb particular experiment symb encoded multicopy plasmid facilitate detection hence stronger signal relative observed total extracts see fig numa
0.5010976.15944156.html.plaintext.txt	47	although localization symb reported previously symb known transiently associate components form sub plasma membrane complex required establishing bud sites whether ide symb assemble complex unknown better understand nature association ide symb symb symb yeast fraction performed extractions particulate fraction various chaotropic agents fig numc analysis revealed high ph detergent treatments significantly disrupted association proteins symb fraction whereas salt buffer alone minor impact profile consistent ide symb symb peripheral membrane proteins andor components large macromolecular complex sediments experimental conditions
0.5010976.15944156.html.plaintext.txt	48	although localization symb reported previously symb known transiently associate components form sub plasma membrane complex required establishing bud sites whether ide symb assemble complex unknown better understand nature association ide symb symb symb yeast fraction performed extractions particulate fraction various chaotropic agents fig numc analysis revealed high ph detergent treatments significantly disrupted association proteins symb fraction whereas salt buffer alone minor impact profile consistent ide symb symb peripheral membrane proteins andor components large macromolecular complex sediments experimental conditions
0.5010976.15944156.html.plaintext.txt	49	yeast expressed ide retains proteolytic activity next determined whether yeast expressed ide could cleave insulin well characterized substrate ide using previously described insulin degradation assay yeast derived particulate fractions num num high degree enrichment symb enzymes yeast particulate fractions samples used exclusively source activity vitro assays analysis enzymatic activity indicated ide containing samples insulin cleaving activity whereas samples containing symb symb activity sample prepared yeast lacking enzymes fig numa source residual activity preparations unknown likely due nonspecific enzymatic activity rather additional ide homolog numnum phenanthroline well documented ide inhibitor inhibit residual activity fig numb whether symb symb proteases preparations incapable cleaving insulin altered substrate specificity sub optimal reaction conditions reasons yet determined
0.5010976.15944156.html.plaintext.txt	50	yeast expressed ide retains proteolytic activity next determined whether yeast expressed ide could cleave insulin well characterized substrate ide using previously described insulin degradation assay yeast derived particulate fractions num num high degree enrichment symb enzymes yeast particulate fractions samples used exclusively source activity vitro assays analysis enzymatic activity indicated ide containing samples insulin cleaving activity whereas samples containing symb symb activity sample prepared yeast lacking enzymes fig numa source residual activity preparations unknown likely due nonspecific enzymatic activity rather additional ide homolog numnum phenanthroline well documented ide inhibitor inhibit residual activity fig numb whether symb symb proteases preparations incapable cleaving insulin altered substrate specificity sub optimal reaction conditions reasons yet determined
0.5010976.15944156.html.plaintext.txt	51	ide described thiol zinc dependent metalloprotease num determined ide heterologously expressed functional form next wanted confirm observed insulin degrading activity detected hallmarks ide mediated insulin degradation examined effect alkylating ie iodoacetamide n ethylmaleimide metal ion chelating agents ie numnum phenanthroline edta ide activity fig numb alkylating agents inhibited ide dependent insulin degrading activity inhibitory effect also observed numnum phenanthroline nonchelating agent numnum phenanthroline structurally similar edta measurably inhibit enzymatic activity extensive pretreatment edta reportedly required inhibition ide num inhibitor profile observed insulin degrading activity yeast identical reported ide establishes yeast synthesize ide possessing enzymatic properties described ide found metazoans num
0.5010976.15944156.html.plaintext.txt	52	ide described thiol zinc dependent metalloprotease num determined ide heterologously expressed functional form next wanted confirm observed insulin degrading activity detected hallmarks ide mediated insulin degradation examined effect alkylating ie iodoacetamide n ethylmaleimide metal ion chelating agents ie numnum phenanthroline edta ide activity fig numb alkylating agents inhibited ide dependent insulin degrading activity inhibitory effect also observed numnum phenanthroline nonchelating agent numnum phenanthroline structurally similar edta measurably inhibit enzymatic activity extensive pretreatment edta reportedly required inhibition ide num inhibitor profile observed insulin degrading activity yeast identical reported ide establishes yeast synthesize ide possessing enzymatic properties described ide found metazoans num
0.5010976.15944156.html.plaintext.txt	53	view larger version numk fig num ide functionally expressed yeast particulate fractions isolated yeast expressing ide symb symb equivalent amount fraction num microg assayed insulin degradation activity time course according established methods see experimental procedures degradation insulin indicated presence recovered insulin fragments precipitated trichloroacetic acid b effect various agents activity yeast expressed ide evaluated activities determined num min num min time points abbreviations used follows nem num mm n ethylmaleimide iaa num mm iodoacetamide numnum num mm numnum phenanthroline numnum num mm numnum phenanthroline edta num mm edta
0.5010976.15944156.html.plaintext.txt	54	ide promote yeast mating many yeast enzymes required factor production functionally replaced orthologous enzymes species num num similar fashion determined ide expression rescue mating defect yeast strain lacking symb symb mata symb symb fig numa top row mating defect strain due inability produce yeast factor whether symb symb extension ide participate directly indirectly pheromone production rigorously established num nevertheless result establishes ide yeast enzymes symb symb similarly promote yeast factor production thus evolutionarily conserved activity simplest explanation findings enzymes directly participate pheromone production enzymes shared substrate specificity respect cleavage factor precursor
0.5010976.15944156.html.plaintext.txt	55	ide promote yeast mating many yeast enzymes required factor production functionally replaced orthologous enzymes species num num similar fashion determined ide expression rescue mating defect yeast strain lacking symb symb mata symb symb fig numa top row mating defect strain due inability produce yeast factor whether symb symb extension ide participate directly indirectly pheromone production rigorously established num nevertheless result establishes ide yeast enzymes symb symb similarly promote yeast factor production thus evolutionarily conserved activity simplest explanation findings enzymes directly participate pheromone production enzymes shared substrate specificity respect cleavage factor precursor
0.5010976.15944156.html.plaintext.txt	56	yeast mating sensitive number variables including available nutrients depleted nutrient conditions mating less efficient taken advantage property yeast mating evaluate effectiveness ide rescuing mating defect yeast lacking symb symb expected observed decreasing nutrient conditions correlated decreased mating strains symb ide expressing strains showed significant reductions mating relative symb expressing strain fig numa epitope tagged versions enzymes similar activity profile assay fig numb relatively poor ability symb promote mating respect symb consistent previous reports properties enzyme may attributable number factors including altered substrate specificity andor altered subcellular localization pattern prevents interaction substrates num likewise reduced mating observed ide may attributable similar factors reduced mating observed ide symb expressing cells simply due low expression enzymes expressed significantly higher levels symb see fig num
0.5010976.15944156.html.plaintext.txt	57	yeast mating sensitive number variables including available nutrients depleted nutrient conditions mating less efficient taken advantage property yeast mating evaluate effectiveness ide rescuing mating defect yeast lacking symb symb expected observed decreasing nutrient conditions correlated decreased mating strains symb ide expressing strains showed significant reductions mating relative symb expressing strain fig numa epitope tagged versions enzymes similar activity profile assay fig numb relatively poor ability symb promote mating respect symb consistent previous reports properties enzyme may attributable number factors including altered substrate specificity andor altered subcellular localization pattern prevents interaction substrates num likewise reduced mating observed ide may attributable similar factors reduced mating observed ide symb expressing cells simply due low expression enzymes expressed significantly higher levels symb see fig num
0.5010976.15944156.html.plaintext.txt	58	view larger version numk fig num yeast expressed ide promotes yeast mating factor pheromone production mating competence mata symb symb cells transformed indicated symb enzyme encoded plasmid evaluated using patch mating test selective growth diploid cells minimal media indicative mating patch mating tests conducted using mat symb lawns containing various amounts nutrients num num num yepd top bottom lowering amount yepd lawn increases stringency mating test allows discrimination differences mating efficiency otherwise observable permissive mating conditions num yepd b patch mating tests conducted using mata strains expressing ha epitope tagged symb proteases mildly stringent mating conditions num yepd c factor produced strains described b recovered walls culture tubes using organic solvent concentrated samples analyzed spot halo test strain grown saturation volume media formation spot lawn mat symb cells indicative presence pheromone sample relative pheromone potency determined serial dilution sample highest dilution activity referred end point equivalent concentration num pg microl factor num d num fold serial dilutions ide sample prepared yepd spotted onto lawn symb mata symb num symb symb symb symb rme symb num symb serving control possibility toxic product produced ide expressing strain num strains used symb transformed symb wild type wt symb transformed symb vector symb symb symb symb symb ide symb symb numha symb symb numha symb ide numha
0.5010976.15944156.html.plaintext.txt	59	straightforward explanation reduced mating observed symb ide expressing strains strains reduced factor production comparison symb expressing strains thus compared relative amounts factor produced strains lifetime culture used bioassay relies natural growth arrest response mat cells factor pheromone detect quantifiably measure factor activity samples analysis revealed ide symb expressing strains produce significantly less factor symb expressing strain despite fact ide symb significantly overexpressed relative symb fig numc ide derived sample also bioassayed using mata cells cells fail undergo growth arrest response factor pheromone thus served control unlikely scenario ide expressing strains producing toxic secreted product growth inhibition mata cells observed ide derived sample fig numd
0.5010976.15944156.html.plaintext.txt	60	straightforward explanation reduced mating observed symb ide expressing strains strains reduced factor production comparison symb expressing strains thus compared relative amounts factor produced strains lifetime culture used bioassay relies natural growth arrest response mat cells factor pheromone detect quantifiably measure factor activity samples analysis revealed ide symb expressing strains produce significantly less factor symb expressing strain despite fact ide symb significantly overexpressed relative symb fig numc ide derived sample also bioassayed using mata cells cells fail undergo growth arrest response factor pheromone thus served control unlikely scenario ide expressing strains producing toxic secreted product growth inhibition mata cells observed ide derived sample fig numd
0.5010976.15944156.html.plaintext.txt	61	factor mating pheromone isoprenylated carboxymethylated dodecapeptide yiikgvfwdpacfarnesylmethyl alterations chemical form factor eg lipid removal primary sequence alterations impact function pheromone num example factor lacking tyrosine residue num biological activity full length pheromone judged yeast mating tests num thus reduced production factor pheromone ide symb expressing yeast could attributable cleavage factor precursor site asn tyr cleavage site recognized symb determine whether pheromone products produced ide symb symb identical determined mass factor species generated enzymes using maldi toftof mass spectroscopy several major species detected samples including num da peak corresponds exactly mass bona fide factor fig num c ide symb symb samples respectively species negative control fig numd num da species still observed samples data de isotoped fig num e g remained absent negative control fig numh based observations reasoned num da species indeed factor implies ide symb symb similar cleavage specificities
0.5010976.15944156.html.plaintext.txt	62	factor mating pheromone isoprenylated carboxymethylated dodecapeptide yiikgvfwdpacfarnesylmethyl alterations chemical form factor eg lipid removal primary sequence alterations impact function pheromone num example factor lacking tyrosine residue num biological activity full length pheromone judged yeast mating tests num thus reduced production factor pheromone ide symb expressing yeast could attributable cleavage factor precursor site asn tyr cleavage site recognized symb determine whether pheromone products produced ide symb symb identical determined mass factor species generated enzymes using maldi toftof mass spectroscopy several major species detected samples including num da peak corresponds exactly mass bona fide factor fig num c ide symb symb samples respectively species negative control fig numd num da species still observed samples data de isotoped fig num e g remained absent negative control fig numh based observations reasoned num da species indeed factor implies ide symb symb similar cleavage specificities
0.5010976.15944156.html.plaintext.txt	63	although species apparent de isotoped data ide symb derived samples indicated mass range additional species evident samples symb derived sample three additional species observed num num num da fig numg one distinct species observed negative control num da additional species reproducibly detected experimentsnum mass range shown panels inclusive masses theoretical symb derived factor species either lacking n terminal tyrosine num da extended n terminal asparagine num da none four unidentified species matched alternative factor cleavage products nature species therefore unknown
0.5010976.15944156.html.plaintext.txt	64	although species apparent de isotoped data ide symb derived samples indicated mass range additional species evident samples symb derived sample three additional species observed num num num da fig numg one distinct species observed negative control num da additional species reproducibly detected experimentsnum mass range shown panels inclusive masses theoretical symb derived factor species either lacking n terminal tyrosine num da extended n terminal asparagine num da none four unidentified species matched alternative factor cleavage products nature species therefore unknown
0.5010976.15944156.html.plaintext.txt	65	genetic evaluation ide mutants ability yeast expressed ide promote factor production suggests yeast mating used phenotype evaluate function ide mutant alleles test hypothesis created site directed deletion mutations ide tested ability mutants promote mating using genetic system confirmed residues comprising core metalloprotease motif hxxeh ide essential promoting mating fig numa residues required activity symb symb well fig num b c respectively distal glutamate extended motif symbnume also determined essential activity three enzymes whereas penultimate glutamate dispensable symb activity penultimate glutamate required activity mitochondrial processing peptidase symb protease proposed aid metal coordination enzyme num
0.5010976.15944156.html.plaintext.txt	66	genetic evaluation ide mutants ability yeast expressed ide promote factor production suggests yeast mating used phenotype evaluate function ide mutant alleles test hypothesis created site directed deletion mutations ide tested ability mutants promote mating using genetic system confirmed residues comprising core metalloprotease motif hxxeh ide essential promoting mating fig numa residues required activity symb symb well fig num b c respectively distal glutamate extended motif symbnume also determined essential activity three enzymes whereas penultimate glutamate dispensable symb activity penultimate glutamate required activity mitochondrial processing peptidase symb protease proposed aid metal coordination enzyme num
0.5010976.15944156.html.plaintext.txt	67	addition addressing importance established active site residues investigated functional importance cysteine residues function ide initially investigated role two cysteine residues invariably conserved ide symb symb symbnumsymb suspecting one residues likely target sulfhydryl modifying agents inactivate certain symb enzymes independent mutations residues alter abilities ide symb symb promote mating fig num mutation proximal cysteine ide symb reportedly alter thiol sensitivity profile ide num similarly found mutation distal cysteine ide symb effect thiol sensitivity idenum also determined combining mutations one molecule symbsymb alter mating function fig numa moreover sensitivity ide thiol modifiers unaffectednum similar results observed cysteine residues conserved ide symb symb symb symb respectively mutated fig numa
0.5010976.15944156.html.plaintext.txt	68	addition addressing importance established active site residues investigated functional importance cysteine residues function ide initially investigated role two cysteine residues invariably conserved ide symb symb symbnumsymb suspecting one residues likely target sulfhydryl modifying agents inactivate certain symb enzymes independent mutations residues alter abilities ide symb symb promote mating fig num mutation proximal cysteine ide symb reportedly alter thiol sensitivity profile ide num similarly found mutation distal cysteine ide symb effect thiol sensitivity idenum also determined combining mutations one molecule symbsymb alter mating function fig numa moreover sensitivity ide thiol modifiers unaffectednum similar results observed cysteine residues conserved ide symb symb symb symb respectively mutated fig numa
0.5010976.15944156.html.plaintext.txt	69	symb enzymes large proteins typically molecular mass excess numnum da metalloprotease motif symb enzymes localized near n terminal end enzymes absence structural data enzymes sought determine whether catalytic domain ide self contained within n terminal portion enzyme c terminally truncated forms ide created evaluated ability promote pheromone production truncations created fusions gfp alter ability ide function fig numa ide num num systematic deletions c terminus ide revealed relatively short truncations inactivated ide judged yeast mating tests deletion analysis symb revealed similar requirement intact c terminus although deletion required symb inactivation considerably larger fig numa symb num num site directed mutation residue conserved ide symb functionalnonfunctional truncation boundary symb ie ser num ide ser num symb reveal essential requirement residue either enzyme fig num
0.5010976.15944156.html.plaintext.txt	70	symb enzymes large proteins typically molecular mass excess numnum da metalloprotease motif symb enzymes localized near n terminal end enzymes absence structural data enzymes sought determine whether catalytic domain ide self contained within n terminal portion enzyme c terminally truncated forms ide created evaluated ability promote pheromone production truncations created fusions gfp alter ability ide function fig numa ide num num systematic deletions c terminus ide revealed relatively short truncations inactivated ide judged yeast mating tests deletion analysis symb revealed similar requirement intact c terminus although deletion required symb inactivation considerably larger fig numa symb num num site directed mutation residue conserved ide symb functionalnonfunctional truncation boundary symb ie ser num ide ser num symb reveal essential requirement residue either enzyme fig num
0.5010976.15944156.html.plaintext.txt	71	site directed truncation mutants created study evaluated protein expression using immunoblots site directed mutants judged expressed well relevant wild type control except symb symb expressed level approximately one quarter wild typenum exception mutant results rule trivial possibility inactive ide symb symb mutants nonfunctional poor expression exclude possibility mutants nonfunctional malfolding unknown reasons evaluation symb truncation mutants revealed expressed levels similar full length symb gfp fusion protein contrast ide truncation mutants similarly expressed fig numb observed decreased expression certain truncations suggesting c terminus ide reasons unknown required normal steady state expression decreased expression alone account loss activity ide one nonfunctional truncation ide num num expressed comparably full length ide gfp fusion importantly expression levels observed nonfunctional truncations symb ide encoded multicopy plasmids significantly respective full length fusion encoded low copy plasmid judged immunoblot analysis suggesting lowered expression alone account absence function mutants
0.5010976.15944156.html.plaintext.txt	72	site directed truncation mutants created study evaluated protein expression using immunoblots site directed mutants judged expressed well relevant wild type control except symb symb expressed level approximately one quarter wild typenum exception mutant results rule trivial possibility inactive ide symb symb mutants nonfunctional poor expression exclude possibility mutants nonfunctional malfolding unknown reasons evaluation symb truncation mutants revealed expressed levels similar full length symb gfp fusion protein contrast ide truncation mutants similarly expressed fig numb observed decreased expression certain truncations suggesting c terminus ide reasons unknown required normal steady state expression decreased expression alone account loss activity ide one nonfunctional truncation ide num num expressed comparably full length ide gfp fusion importantly expression levels observed nonfunctional truncations symb ide encoded multicopy plasmids significantly respective full length fusion encoded low copy plasmid judged immunoblot analysis suggesting lowered expression alone account absence function mutants
0.5010976.15944156.html.plaintext.txt	73	view larger version numk fig num mass spectroscopic analysis factor produced ide symb symb expressing yeast strains factor species secreted indicated mata strains enriched conditioned media described fig numc samples subjected maldi toftof mass spectroscopy using cyano num hydroxycinnamic acid matrix strains used symb transformed symb ide numha symb symb numha symb symb numha symb vector d respectively de isotoping data shown d resulted data presented e h respectively strains also contained symb num micro symb symb
0.5010976.15944156.html.plaintext.txt	74	yeast expressed ide substitute known functions symb symb involved regulating several cellular processes besides pheromone production example symb required repressing haploid invasive growth num haploid invasion occurs readily upon deletion symb phenotype fully reversed introduction plasmid borne copy symb order address ability ide substitute function symb invasive phenotype symb deficient strain symb expressed ide examined also investigated ability protease active site mutant symb suppress invasive growth found ide expression could repress invasive growth whereas symb active site mutant suppressed invasive growth fig num
0.5010976.15944156.html.plaintext.txt	75	yeast expressed ide substitute known functions symb symb involved regulating several cellular processes besides pheromone production example symb required repressing haploid invasive growth num haploid invasion occurs readily upon deletion symb phenotype fully reversed introduction plasmid borne copy symb order address ability ide substitute function symb invasive phenotype symb deficient strain symb expressed ide examined also investigated ability protease active site mutant symb suppress invasive growth found ide expression could repress invasive growth whereas symb active site mutant suppressed invasive growth fig num
0.5010976.15944156.html.plaintext.txt	76	symb also well described role maintenance axial budding pattern haploid yeast num symb reportedly role process determine whether ide could substitute function symb axial bud site selection expressed ide haploid strain defective axial budding evaluated budding pattern calcofluor staining bud scars consistent previous findings observed bipolar budding phenotype absence symb expression table iii vector axial budding phenotype observed upon introduction plasmid encoding symb symb strain symb whereas bipolar budding predominant pattern either symb ide introduced
0.5010976.15944156.html.plaintext.txt	77	symb also well described role maintenance axial budding pattern haploid yeast num symb reportedly role process determine whether ide could substitute function symb axial bud site selection expressed ide haploid strain defective axial budding evaluated budding pattern calcofluor staining bud scars consistent previous findings observed bipolar budding phenotype absence symb expression table iii vector axial budding phenotype observed upon introduction plasmid encoding symb symb strain symb whereas bipolar budding predominant pattern either symb ide introduced
0.5010976.15944156.html.plaintext.txt	78	view table table iii budding patterns observed symb symb ide expressing strains
0.5010976.15944156.html.plaintext.txt	79	view larger version numk fig num evaluation ide symb symb mutants c alanine substitution point mutations created ide symb b symb c functions mutant enzymes evaluated patch mating tests described fig numa permissive conditions num yepd mutations created sites invariably conserved ide symb symb include residues compose extended metalloprotease motif enzymes symbnume mutants exhibiting robust mating active unmodified parent enzyme judged mating tests stringent conditions strain used symb transformed ide encoding plasmids symb ide ha symb ide ha symb symb ide ha symb symb ide ha symb symb ide ha symb symb ide ha symb symb ide ha symb symb ide ha symb symb ide ha symb symb ide ha symb pws num ide symb symb ide ha symb symb symb encoding plasmids symb symb numha symb symb numha symb symb symb numsymb symb symb numha symb symb symb numha symb symb symb numha symb symb symb numha symb symb symb numsymb symb encoding plasmids symb symb numha symb symb numha symb symb symb numha symb symb symb numha symb symb symb numha symb symb symb numha symb symb symb numha symb symb symb numha ca symb symb numha symb
0.5010976.15944156.html.plaintext.txt	80	view larger version numk fig num evaluation gfp labeled ide symb truncation mutants full length c terminally truncated versions ide symb created fusions gfp activities fusions evaluated patch mating tests permissive conditions num yepd truncations exhibiting robust mating active full length fusion judged mating tests stringent conditions except symb num num reduced mating phenotype amino acids gfp fused indicated arrows shaded gray residues within c terminal regions ide symb conserved shown protein alignment mating tests arrowheads residue region targeted site directed mutational analysis see fig num indicated filled arrowhead b protein extracts prepared yeast containing vectors encoding gfp tagged ide equivalent amounts sample analyzed sds page immunoblot using anti gfp antibody strain used symb transformed ide encoding plasmids symb ide num num gfp symb ide num num gfp symb ide num num gfp symb ide num num gfp symb ide num num gfp symb encoding plasmids symb symb num num gfp symb symb num num gfp symb symb num num gfp symb symb num num gfp symb symb num num gfp
0.5010976.15944156.html.plaintext.txt	81	discussion top abstract introduction experimental procedures results discussion references majority studies ide relied vitro biochemical assays num recently knock overexpression mouse models described ide num num vitro vivo model systems led better understanding biochemical physiological properties ide proposed roles type num diabetes alzheimer disease num num num
0.5010976.15944156.html.plaintext.txt	82	discussion top abstract introduction experimental procedures results discussion references majority studies ide relied vitro biochemical assays num recently knock overexpression mouse models described ide num num vitro vivo model systems led better understanding biochemical physiological properties ide proposed roles type num diabetes alzheimer disease num num num
0.5010976.15944156.html.plaintext.txt	83	view larger version numk fig num ide repress haploid invasive growth plasmids encoding ha tagged symb symb symb ide transformed symb haploid strain equal cell density suspensions strains spotted onto sc ura allowed grow num days plates washed running water remove surface lying cells b presence cells washing step indicative invasive growth strains used symb transformed symb wild type wt symb symbsymb transformed symb vector symb symb numha symb symb numha symb symb ide numha
0.5010976.15944156.html.plaintext.txt	84	study developed yeast tractable genetic model system studying functional properties ide determined yeast used express functional form ide importantly ide promote factor production activity normally associated yeast enzymes symb symb homology ide results imply members symb metalloprotease family enzymes belong may shared substrate specificity fact three enzymes promote factor production supports hypothesis however inability demonstrate insulin cleavage yeast enzymes implies substrate specificity symb symb may restricted whether yeast enzymes cleave established ide substrates currently investigation also investigating ability symb enzymes cleave factor studies enzymes may benefit development tractable genetic system
0.5010976.15944156.html.plaintext.txt	85	study developed yeast tractable genetic model system studying functional properties ide determined yeast used express functional form ide importantly ide promote factor production activity normally associated yeast enzymes symb symb homology ide results imply members symb metalloprotease family enzymes belong may shared substrate specificity fact three enzymes promote factor production supports hypothesis however inability demonstrate insulin cleavage yeast enzymes implies substrate specificity symb symb may restricted whether yeast enzymes cleave established ide substrates currently investigation also investigating ability symb enzymes cleave factor studies enzymes may benefit development tractable genetic system
0.5010976.15944156.html.plaintext.txt	86	additional finding study ide enriched exclusively partition yeast particulate fraction suspect heterologously expressed ide either incorporated membranes loosely associated peripheral membrane protein assembling macromolecular complex partially sediments conditions used isolation particulate fraction although ide reportedly associates peroxisomes localization unlikely experimental conditions impose induction required formation yeast peroxisomes num moreover putative c terminal peroxisomal targeting signal found ide although potentially functional yeast blocked epitope tag yeast expressed enzyme alternatively ide may associating undefined membrane sites symb reported associate transiently components form sub plasma membrane complex required budding num thus also conceivable ide assembling complex nonfunctional component ultimately defining subcellular localization symb may provide insight subcellular targeting ide two enzymes appear conserved sequence enzymatic properties ide symb
0.5010976.15944156.html.plaintext.txt	87	additional finding study ide enriched exclusively partition yeast particulate fraction suspect heterologously expressed ide either incorporated membranes loosely associated peripheral membrane protein assembling macromolecular complex partially sediments conditions used isolation particulate fraction although ide reportedly associates peroxisomes localization unlikely experimental conditions impose induction required formation yeast peroxisomes num moreover putative c terminal peroxisomal targeting signal found ide although potentially functional yeast blocked epitope tag yeast expressed enzyme alternatively ide may associating undefined membrane sites symb reported associate transiently components form sub plasma membrane complex required budding num thus also conceivable ide assembling complex nonfunctional component ultimately defining subcellular localization symb may provide insight subcellular targeting ide two enzymes appear conserved sequence enzymatic properties ide symb
0.5010976.15944156.html.plaintext.txt	88	view larger version numk fig num schematic symb enzyme sequences sequences ide symb e coli protease iii symb represented schematic format top bottom respectively schematic drawn scale representation divided several domains borders domains vi operationally defined sites insertions num residues found symb sequence determined multiple sequence alignment clustalw four proteins domains ends molecules dark gray represent sequences variable length conserved enzymes n terminal sequences range num num residues c terminal sequences range num num residues relative position shortest c terminal truncation yielding nonfunctional mutant shown filled arrowhead values schematic represent percent identity indicated ide domain corresponding domains either symb e coli protease iii symb determined using dna strider numnum default settings b d several conserved motifs identified within domains b ii c v d purposes figure conserved motif defined block amino acids num num identical highly conserved residues ie st kr aiv second motif listed domain found within symb sequence extended metalloprotease motif whereas third found within symb sequence residues boldface mutated study neither cys num found near end domain cys num found beginning domain iv within conserved motifs
0.5010976.15944156.html.plaintext.txt	89	genetic model system developed far reaching utility characterization mutant ide alleles provided practical example utility detailing functional importance residues compose extended metalloprotease motif symbnume addition mutational study allows us make certain conclusions cysteine residues imparts sensitivity ide thiol modifiers provided single cysteine residue target thiol modification ide study excludes targets two cysteine residues invariably conserved three enzymes cys num cys num ide two cysteines semi conserved ide yeast symb enzymes cys num cys num ide double symbsymb mutant also remains sensitive thiol modifiers currently developing vitro assay monitoring activities symb symb expect determination whether enzymes sensitive thiol modifiers aid final identification cysteine residues targeted thiol modifiers enzyme family second practical example utility genetic system demonstrate first time c terminal region required activity ide absence structural information ide suspect c terminal region may required stabilizing overall tertiary possibly quaternary structure ide active site
0.5010976.15944156.html.plaintext.txt	90	genetic model system developed far reaching utility characterization mutant ide alleles provided practical example utility detailing functional importance residues compose extended metalloprotease motif symbnume addition mutational study allows us make certain conclusions cysteine residues imparts sensitivity ide thiol modifiers provided single cysteine residue target thiol modification ide study excludes targets two cysteine residues invariably conserved three enzymes cys num cys num ide two cysteines semi conserved ide yeast symb enzymes cys num cys num ide double symbsymb mutant also remains sensitive thiol modifiers currently developing vitro assay monitoring activities symb symb expect determination whether enzymes sensitive thiol modifiers aid final identification cysteine residues targeted thiol modifiers enzyme family second practical example utility genetic system demonstrate first time c terminal region required activity ide absence structural information ide suspect c terminal region may required stabilizing overall tertiary possibly quaternary structure ide active site
0.5010976.15944156.html.plaintext.txt	91	genetic system also useful investigating role residues function ide example several conserved sequence motifs identified multiple sequence alignment symb enzymes fig num future studies aimed determining whether motifs important function symb enzymes addition investigate whether e coli protease iii support factor production yeast system could conceivably used investigate structurefunction relationships enigmatic protease also lacks defined cellular role num
0.5010976.15944156.html.plaintext.txt	92	genetic system also useful investigating role residues function ide example several conserved sequence motifs identified multiple sequence alignment symb enzymes fig num future studies aimed determining whether motifs important function symb enzymes addition investigate whether e coli protease iii support factor production yeast system could conceivably used investigate structurefunction relationships enigmatic protease also lacks defined cellular role num
0.5010976.15944156.html.plaintext.txt	93	another potential utility genetic model system theoretical ability rapidly identify ide mutants altered substrate specificity already demonstrated system amenable screening specific mutant ide alleles ability promote mating approach could used identify ide mutants altered specificity toward factor envision positive genetic selection takes advantage observations ide dependent mating essentially nonexistent reduced nutrient levels fig numa highly stringent mating conditions yeast harboring ide mutants could screened expectation enhanced factor production would mating competent ide mutants would represent candidates improved factor recognition ie altered substrate specificity conceivably mutants might also altered specificity insulin andor ide mutants enhanced activity toward substrates could potentially used therapeutic agents diabetes alzheimer disease
0.5010976.15944156.html.plaintext.txt	94	another potential utility genetic model system theoretical ability rapidly identify ide mutants altered substrate specificity already demonstrated system amenable screening specific mutant ide alleles ability promote mating approach could used identify ide mutants altered specificity toward factor envision positive genetic selection takes advantage observations ide dependent mating essentially nonexistent reduced nutrient levels fig numa highly stringent mating conditions yeast harboring ide mutants could screened expectation enhanced factor production would mating competent ide mutants would represent candidates improved factor recognition ie altered substrate specificity conceivably mutants might also altered specificity insulin andor ide mutants enhanced activity toward substrates could potentially used therapeutic agents diabetes alzheimer disease
0.5010976.15944156.html.plaintext.txt	95	data clearly demonstrate symbsymb dependent step factor production supported ide result surprising given high degree similarity enzymes greater curiosity observation yeast enzymes required factor production functionally replaced mammalian counterparts first three steps associated factor production ie isoprenylation caax proteolysis carboxymethylation part biosynthetic pathway isoprenylated proteins ras rhob subsequent two proteolytic steps associated factor production analogous counterparts mammals thus ability mammalian enzymes promote latter steps entirely serendipitous reflects existence orphan biosynthetic pathway integrates steps associated factor biosynthesis latter analogy suspect molecule produced pathway would serve secreted signaling molecule possibly functioning regulate cell cell fusion events occur development certain tissues curiously morphological biochemical differentiation symb myoblasts myotubes reported involve ide num num thus analogy factor production hypothesize role ide cells might produce signaling molecule derived precursor aliphatic amino acid motif n terminal extension readily cleaved ide whether molecule exists mammalian systems remains determined
0.5010976.15944156.html.plaintext.txt	96	data clearly demonstrate symbsymb dependent step factor production supported ide result surprising given high degree similarity enzymes greater curiosity observation yeast enzymes required factor production functionally replaced mammalian counterparts first three steps associated factor production ie isoprenylation caax proteolysis carboxymethylation part biosynthetic pathway isoprenylated proteins ras rhob subsequent two proteolytic steps associated factor production analogous counterparts mammals thus ability mammalian enzymes promote latter steps entirely serendipitous reflects existence orphan biosynthetic pathway integrates steps associated factor biosynthesis latter analogy suspect molecule produced pathway would serve secreted signaling molecule possibly functioning regulate cell cell fusion events occur development certain tissues curiously morphological biochemical differentiation symb myoblasts myotubes reported involve ide num num thus analogy factor production hypothesize role ide cells might produce signaling molecule derived precursor aliphatic amino acid motif n terminal extension readily cleaved ide whether molecule exists mammalian systems remains determined
0.5010976.15944156.html.plaintext.txt	97	footnotes work supported part funds university georgia costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.5010976.15944156.html.plaintext.txt	98	footnotes work supported part funds university georgia costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.5010976.15944156.html.plaintext.txt	99	supported university georgia graduate school assistantship
0.5010976.15944156.html.plaintext.txt	100	correspondence addressed dept biochemistry molecular biology num green st athens ga num tel num num num fax num num num e mail wschmidtatbmbugaedu u d
0.5010976.15944156.html.plaintext.txt	101	correspondence addressed dept biochemistry molecular biology num green st athens ga num tel num num num fax num num num e mail wschmidtatbmbugaedu u d
0.5010976.15944156.html.plaintext.txt	102	num abbreviations used ide insulin degrading enzyme ha hemagglutinin maldi tof matrix assisted laser desorption ionization time flight gfp green fluorescent protein
0.5010976.15944156.html.plaintext.txt	103	acknowledgments grateful drs claiborne glover michelle momany ron orlando lance wells members respective laboratories technical advice access equipment critical discussions also thank pamela freshley chandra moore help plasmid constructions
0.5010976.15944156.html.plaintext.txt	104	acknowledgments grateful drs claiborne glover michelle momany ron orlando lance wells members respective laboratories technical advice access equipment critical discussions also thank pamela freshley chandra moore help plasmid constructions
0.5010976.15944156.html.plaintext.txt	105	references top abstract introduction experimental procedures results discussion references becker b roth r num methods enzymol num num nummedline order article via infotrieve qiu w q walsh d m ye z vekrellis k zhang j podlisny m b rosner m r safavi hersh l b selkoe d j num j biol chem num num numabstractfree full text edbauer d willem m lammich steiner h haass c num j biol chem num num numabstractfree full text farris w mansourian chang y lindsley l eckman e frosch m p eckman c b tanzi r e selkoe d j guenette num proc natl acad sci u num num numabstractfree full text leissring m farris w chang y walsh d m wu x sun x frosch m p selkoe d j num neuron num num numcrossrefmedline order article via infotrieve miller b c eckman e sambamurti k dobbs n chow k m eckman c b hersh l b thiele d l num proc natl acad sci u num num numabstractfree full text tanzi r e moir r d wagner l num neuron num num numcrossrefmedline order article via infotrieve fujita oka c arikawa y katagai tonouchi kuhara misumi y num nature num num nummedline order article via infotrieve adames n blundell k ashby m n boone c num science num num numabstract chen p sapperstein choi j d michaelis num j cell biol num num numabstractfree full text elia l marsh l num j cell biol num num numabstractfree full text brizzio v gammie e nijbroek g l michaelis rose m num j cell biol num num numabstract palecek p parikh kron j num genetics num num numabstractfree full text cullen p j sprague g f jr num mol biol cell num num numabstractfree full text perlman r k gehm b d kuo w l rosner m r num j biol chem num num numabstractfree full text perlman r k rosner m r num j biol chem num num numabstractfree full text ding l becker b suzuki roth r num j biol chem num num numabstractfree full text elble r num biotechniques num num nummedline order article via infotrieve michaelis herskowitz num mol cell biol num num nummedline order article via infotrieve oldenburg k r vo k michaelis paddon c num nucleic acids res num num numabstractfree full text seta k roth r num biochem biophys res commun num num numcrossrefmedline order article via infotrieve brachat dietrich f voegeli zhang z stuart l lerch gates k gaffney philippsen p num genome biol num symbcrossrefmedline order article via infotrieve fujimura kamada k nouvet f j michaelis num j cell biol num num numabstractfree full text schmidt w k tam fujimura kamada k michaelis num proc natl acad sci u num num numabstractfree full text schmidt w k tam michaelis num j biol chem num num numabstractfree full text nijbroek g l michaelis num methods enzymol num num nummedline order article via infotrieve chan r k otte c num mol cell biol num num nummedline order article via infotrieve marcus caldwell g miller d xue c b naider f becker j m num mol cell biol num num nummedline order article via infotrieve yalovsky trueblood c e callan k l narita j o jenkins m rine j gruissem w num mol cell biol num num numabstract dai q choy e chiu v romano j slivka r steitz michaelis philips m r num j biol chem num num numabstractfree full text tam nouvet f fujimura kamada k slunt h sisodia michaelis num j cell biol num num numabstractfree full text bracha k lavy m yalovsky num j biol chem num num numabstractfree full text cadinanos j schmidt w k fueyo varela lopez otin c freije j m num biochem j num num numcrossrefmedline order article via infotrieve cadinanos j varela mandel d schmidt w k diaz perales lopezotin c freije j m p num j biol chem num num numabstractfree full text duckworth w c bennett r g hamel f g num endocr rev num num numabstractfree full text morita m kurochkin v motojima k goto takano okamura sato r yokota imanaka num cell struct funct num num numcrossrefmedline order article via infotrieve caldwell g wang h xue c b jiang y lu h f naider f becker j m num j biol chem num num numabstractfree full text striebel h m rysavy p adamec j spizek j kalousek f num arch biochem biophys num num numcrossrefmedline order article via infotrieve fakhrai rad h nikoshkov kamel fernstrom m zierath j r norgren luthman h galli j num hum mol genet num num numabstractfree full text karamohamed demissie volcjak j liu c heard costa n liu j shoemaker c m panhuysen c meigs j b wilson p atwood l d cupples l herbert num diabetes num num numabstractfree full text farris w mansourian leissring m eckman e bertram l eckman c b tanzi r e selkoe d j num j pathol num num numabstractfree full text lazarow p b num curr opin cell biol num num numcrossrefmedline order article via infotrieve lord m inose f hiroko hata fujita chant j num curr biol num num numcrossrefmedline order article via infotrieve roth r num handbook proteolytic enzymes barrett j rawlings n d woessner j f eds numnd ed pp num num elsevier academic press london kayalar c wong w num j biol chem num num numabstractfree full text kayalar c wong w hendrickson l num j cell biochem num num numcrossrefmedline order article via infotrieve sikorski r hieter p num genetics num num numabstractfree full text article abstract full text pdf versions article numnumnum recent symbnum purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager copyright permissions google scholar articles kim articles schmidt w k articles citing article pubmed pubmed citation articles kim articles schmidt w k
0.5010976.15944156.html.plaintext.txt	106	home help feedback subscriptions archive search table contents asbmb journals molecular cellular proteomics journal lipid research biochemistry molecular biology education copyright num american society biochemistry molecular biology
0.5654884.15749695.html.plaintext.txt	0	mutation active site residues insulin degrading enzyme alters allosteric interactions eun suk song abigail daily michael g fried maria aparecida juliano luiz juliano louis b hersh
0.5654884.15749695.html.plaintext.txt	1	mutation active site residues insulin degrading enzyme alters allosteric interactions eun suk song abigail daily michael g fried maria aparecida juliano luiz juliano louis b hersh
0.5654884.15749695.html.plaintext.txt	2	department molecular cellular biochemistry university kentucky lexington kentucky num department biophysics escola paulista de medicina sao paulo num num brazil
0.5654884.15749695.html.plaintext.txt	3	received publication february num num
0.5654884.15749695.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references active site glutamate symb active site histidine symb insulin degrading enzyme ide mutated mutant enzymes exhibit addition large decrease catalytic activity change substrate velocity response sigmoidal one seen native enzyme hill coefficient num hyperbolic response num aminobenzoyl ggflrkhgq n numnum dinitrophenylethylenediamine substrate atp triphosphate increase reaction rate wild type enzyme num num fold effect dampened glutamate mutants effect less num fold increase activity changed inhibition histidine mutants sedimentation equilibrium shows ide mutants exhibit similar oligomeric distribution wild type enzyme predominantly monomeric triphosphate little effect oligomeric state triphosphate induce aggregation many ide mutants thus oligomeric state ide correlate kinetic properties symb mutants shown bind zinc lower affinity wild type enzyme glutamate mutants displayed altered cleavage profile peptide endorphin wild type ide cleaved endorphin symb symb symb symb whereas glutamate mutants cleaved sites addition symb symb symb symb thus active site mutations ide suggested reduce catalytic activity also cause local conformational changes affect allosteric properties enzyme
0.5654884.15749695.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references active site glutamate symb active site histidine symb insulin degrading enzyme ide mutated mutant enzymes exhibit addition large decrease catalytic activity change substrate velocity response sigmoidal one seen native enzyme hill coefficient num hyperbolic response num aminobenzoyl ggflrkhgq n numnum dinitrophenylethylenediamine substrate atp triphosphate increase reaction rate wild type enzyme num num fold effect dampened glutamate mutants effect less num fold increase activity changed inhibition histidine mutants sedimentation equilibrium shows ide mutants exhibit similar oligomeric distribution wild type enzyme predominantly monomeric triphosphate little effect oligomeric state triphosphate induce aggregation many ide mutants thus oligomeric state ide correlate kinetic properties symb mutants shown bind zinc lower affinity wild type enzyme glutamate mutants displayed altered cleavage profile peptide endorphin wild type ide cleaved endorphin symb symb symb symb whereas glutamate mutants cleaved sites addition symb symb symb symb thus active site mutations ide suggested reduce catalytic activity also cause local conformational changes affect allosteric properties enzyme
0.5654884.15749695.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references generally accepted accumulation amyloid peptides anum particularly amyloid peptide num num plays central role pathogenesis alzheimer disease ad mechanisms leading accumulation late onset ad currently unknown could result either overproduction peptide decreased clearance case autosomal dominant ad clear early onset disease linked increased production results mutations one several genes app symb presenilin num symb presenilin num num num however scattering evidence late onset ad attributable overproduction num recent reports num num secretase involved amyloid peptide synthesis increased sporadic ad patients whether increase cause consequence ad whether increase activity seen larger patient populations remains established
0.5654884.15749695.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references generally accepted accumulation amyloid peptides anum particularly amyloid peptide num num plays central role pathogenesis alzheimer disease ad mechanisms leading accumulation late onset ad currently unknown could result either overproduction peptide decreased clearance case autosomal dominant ad clear early onset disease linked increased production results mutations one several genes app symb presenilin num symb presenilin num num num however scattering evidence late onset ad attributable overproduction num recent reports num num secretase involved amyloid peptide synthesis increased sporadic ad patients whether increase cause consequence ad whether increase activity seen larger patient populations remains established
0.5654884.15749695.html.plaintext.txt	8	clearance currently receiving considerable attention key regulatory mechanism brain levels appear two paths clearance brain one pathway involves equilibration central nervous system plasma mediated cerebral spinal fluid num num pathway involves clearance proteolysis num num number peptidases implicated clearance received attention supported vivo studies peptidase deficient mice include neprilysin num num insulysin ide num num endothelin converting enzyme num num genetic studies suggested linkage late onset ad ide linkage region chromosome numq late onset alzheimer disease reported several groups num num region chromosome within num kilobases ide gene however date analysis refined point linkage ide unequivocally established
0.5654884.15749695.html.plaintext.txt	9	clearance currently receiving considerable attention key regulatory mechanism brain levels appear two paths clearance brain one pathway involves equilibration central nervous system plasma mediated cerebral spinal fluid num num pathway involves clearance proteolysis num num number peptidases implicated clearance received attention supported vivo studies peptidase deficient mice include neprilysin num num insulysin ide num num endothelin converting enzyme num num genetic studies suggested linkage late onset ad ide linkage region chromosome numq late onset alzheimer disease reported several groups num num region chromosome within num kilobases ide gene however date analysis refined point linkage ide unequivocally established
0.5654884.15749695.html.plaintext.txt	10	specificity ide complex enzyme cleaves variety peptides primarily exclusively basic bulky hydrophobic residues num num kurochkin num suggested ide cleaves peptides propensity form pleated sheet structures cleavage ide results loss neurotoxic effects peptide prevents deposition onto synthetic amyloid deposit num recently shown ide exhibits allosteric properties activated peptide substrates interestingly peptides activated ide toward peptide cleavage toward insulin cleavage num established ide exists mixture monomers dimers tetramers course studies allosteric properties ide generated number active site mutants control enzymes noted although activity mutants significantly reduced residual catalytic properties altered report results studies
0.5654884.15749695.html.plaintext.txt	11	specificity ide complex enzyme cleaves variety peptides primarily exclusively basic bulky hydrophobic residues num num kurochkin num suggested ide cleaves peptides propensity form pleated sheet structures cleavage ide results loss neurotoxic effects peptide prevents deposition onto synthetic amyloid deposit num recently shown ide exhibits allosteric properties activated peptide substrates interestingly peptides activated ide toward peptide cleavage toward insulin cleavage num established ide exists mixture monomers dimers tetramers course studies allosteric properties ide generated number active site mutants control enzymes noted although activity mutants significantly reduced residual catalytic properties altered report results studies
0.5654884.15749695.html.plaintext.txt	12	materials methods top abstract introduction materials methods results discussion references synthesis fluorogenic peptide substrate abz ggflrkhgqeddnp previously described num dynorphin num dynorphin num dynorphin num dynorphin b num insulin obtained bachem amyloid peptide num num product california research peptide inc endorphin obtained multiple peptide systems national institute drug abuse research tools program reagents obtained best grade available commercially
0.5654884.15749695.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references synthesis fluorogenic peptide substrate abz ggflrkhgqeddnp previously described num dynorphin num dynorphin num dynorphin num dynorphin b num insulin obtained bachem amyloid peptide num num product california research peptide inc endorphin obtained multiple peptide systems national institute drug abuse research tools program reagents obtained best grade available commercially
0.5654884.15749695.html.plaintext.txt	14	activity assays ide activity routinely measured fluorogenic peptide abz ggflrkhgq eddnp increase fluorescence occurred upon cleavage peptide residues r k num followed spectramax gemini xs fluorescence plate reader using excitation wavelength num nm emission wavelength num nm
0.5654884.15749695.html.plaintext.txt	15	activity assays ide activity routinely measured fluorogenic peptide abz ggflrkhgq eddnp increase fluorescence occurred upon cleavage peptide residues r k num followed spectramax gemini xs fluorescence plate reader using excitation wavelength num nm emission wavelength num nm
0.5654884.15749695.html.plaintext.txt	16	ide dependent hydrolysis insulin endorphin amyloid peptide num num dynorphin peptides followed reverse phase hplc using symb column linear gradient numnum trifluoroacetic acid num water num acetonitrile numnum trifluoroacetic acid num water num acetonitrile peptides followed absorbance num nm quantified peak area
0.5654884.15749695.html.plaintext.txt	17	ide dependent hydrolysis insulin endorphin amyloid peptide num num dynorphin peptides followed reverse phase hplc using symb column linear gradient numnum trifluoroacetic acid num water num acetonitrile numnum trifluoroacetic acid num water num acetonitrile peptides followed absorbance num nm quantified peak area
0.5654884.15749695.html.plaintext.txt	18	preparation purification ide mutants various symb symb rat ide mutants prepared pfast bac htb using site directed mutagenesis kit stratagene noted methionine located num residues downstream methionine num ide cdna appears represent major translational start site num thus symb would actually symb symb would symb however retained original numbering system avoid confusion earlier publications oligonucleotides used mutagenesis base changes wild type sequence underlined listed table
0.5654884.15749695.html.plaintext.txt	19	preparation purification ide mutants various symb symb rat ide mutants prepared pfast bac htb using site directed mutagenesis kit stratagene noted methionine located num residues downstream methionine num ide cdna appears represent major translational start site num thus symb would actually symb symb would symb however retained original numbering system avoid confusion earlier publications oligonucleotides used mutagenesis base changes wild type sequence underlined listed table
0.5654884.15749695.html.plaintext.txt	20	view table table oligonucleotides used
0.5654884.15749695.html.plaintext.txt	21	based secondary structure predicting programs phd num phdsec num ide predicted helical region residues num num encompasses mutated residues none mutations predicted affect ability region form helix
0.5654884.15749695.html.plaintext.txt	22	based secondary structure predicting programs phd num phdsec num ide predicted helical region residues num num encompasses mutated residues none mutations predicted affect ability region form helix
0.5654884.15749695.html.plaintext.txt	23	recombinant ide various mutants expressed sf num cells fusion protein containing n terminal hexahistidine affinity tag followed linker containing tobacco etch virus protease cleavage site num wild type ide mutants purified select hc nickel affinity gel column sigma experiments enzyme used symb ide however verify lack effect n terminal hexahistidine linker tobacco etch virus protease used remove region previously described num
0.5654884.15749695.html.plaintext.txt	24	recombinant ide various mutants expressed sf num cells fusion protein containing n terminal hexahistidine affinity tag followed linker containing tobacco etch virus protease cleavage site num wild type ide mutants purified select hc nickel affinity gel column sigma experiments enzyme used symb ide however verify lack effect n terminal hexahistidine linker tobacco etch virus protease used remove region previously described num
0.5654884.15749695.html.plaintext.txt	25	sedimentation equilibrium analysis analytical ultracentrifugation performed numnum plus minus numnum degrees c beckman xl centrifuge using num ti rotor scans obtained num nm step size numnum cm approach equilibrium considered complete scans made num h apart indistinguishable typically equilibration times equal greater num h met criterion five scans averaged sample rotor speed previous results num indicated ide self associates monomer dimer tetramer pattern sedimentation equilibrium data therefore analyzed according equation num
0.5654884.15749695.html.plaintext.txt	26	eq num ar absorbance radial position r mnum dnum tnum absorbances monomer dimer tetramer respectively reference radius ro parameter m reduced molecular weight monomer m mmnum numnumrt mm monomer molecular weight partial specific volume solvent density rotor angular velocity r gas constant absolute temperature base line offset solvent density measured using mettler density meter partial specific volume ide calculated amino acid composition using method cohn edsall num data sets obtained samples run three different rotor speeds fit simultaneously equation num using global fitting method first described johnson co workers num
0.5654884.15749695.html.plaintext.txt	27	results top abstract introduction materials methods results discussion references ide zinc metallopeptidase inverzincin family containing signature active site sequence symb two histidines conjunction downstream glutamate symb believed act ligands active site zinc num num zincins glutamate num believed directly involved catalysis probably acting general base facilitate removal proton water molecule attacks scissile bond effect mutating active site glutamate histidine reported produce inactive enzyme num num since noted varying extents inactivation mutating similar residues related zinc metallopeptidase puromycin sensitive aminopeptidase num quantitated effect mutating symb symb ide
0.5654884.15749695.html.plaintext.txt	28	results top abstract introduction materials methods results discussion references ide zinc metallopeptidase inverzincin family containing signature active site sequence symb two histidines conjunction downstream glutamate symb believed act ligands active site zinc num num zincins glutamate num believed directly involved catalysis probably acting general base facilitate removal proton water molecule attacks scissile bond effect mutating active site glutamate histidine reported produce inactive enzyme num num since noted varying extents inactivation mutating similar residues related zinc metallopeptidase puromycin sensitive aminopeptidase num quantitated effect mutating symb symb ide
0.5654884.15749695.html.plaintext.txt	29	two mutants symb symb symb generated well four mutants symb symb symb symb symb initially compared kinetics various symb symb mutants using fluorogenic substrate abz ggflrkhgq eddnp although native ide clearly displayed sigmoidal substrate binding curve fig num symb mutants four symb mutants displayed classical hyperbolic substrate binding curves illustrated symb mutant fig num table ii summarizes kinetic parameters mutants symb mutants exhibited num num fold increase km kcat decreased close numnum fold symb mutant less num fold symb mutant mutation active site glutamate valine leucine alanine phenylalanine produced enzyme forms effects km variable essentially change symb symb mutants greater num fold increase symb mutant range kcat values symb mutants varied decrease numnum fold symb decrease numnum fold symb
0.5654884.15749695.html.plaintext.txt	30	two mutants symb symb symb generated well four mutants symb symb symb symb symb initially compared kinetics various symb symb mutants using fluorogenic substrate abz ggflrkhgq eddnp although native ide clearly displayed sigmoidal substrate binding curve fig num symb mutants four symb mutants displayed classical hyperbolic substrate binding curves illustrated symb mutant fig num table ii summarizes kinetic parameters mutants symb mutants exhibited num num fold increase km kcat decreased close numnum fold symb mutant less num fold symb mutant mutation active site glutamate valine leucine alanine phenylalanine produced enzyme forms effects km variable essentially change symb symb mutants greater num fold increase symb mutant range kcat values symb mutants varied decrease numnum fold symb decrease numnum fold symb
0.5654884.15749695.html.plaintext.txt	31	view larger version numk fig num comparison kinetics wild type ide kinetics symb mutant reactions conducted num mm tris hcl ph numnum wild type ide num ng enzyme top symb mutant num microg enzyme bottom using abz ggflrkhgqeddnp variable substrate
0.5654884.15749695.html.plaintext.txt	32	view table table ii kinetic properties ide mutants abz ggflrkhgq eddnp substrate
0.5654884.15749695.html.plaintext.txt	33	activity determined num mm potassium phosphate buffer ph numnum
0.5654884.15749695.html.plaintext.txt	34	also examined effect symb symb mutations hydrolysis three physiological peptide substrates ide insulin endorphin amyloid peptide num num shown table iii saturating substrate conditions endorphin amyloid peptide num num hydrolysis decreased num fold symb mutants num fold symb mutants insulin substrate hydrolysis could detected symb mutants conditions decrease num fold could detected whereas symb mutants insulin hydrolysis decreased num x num fold symb num fold symb
0.5654884.15749695.html.plaintext.txt	35	also examined effect symb symb mutations hydrolysis three physiological peptide substrates ide insulin endorphin amyloid peptide num num shown table iii saturating substrate conditions endorphin amyloid peptide num num hydrolysis decreased num fold symb mutants num fold symb mutants insulin substrate hydrolysis could detected symb mutants conditions decrease num fold could detected whereas symb mutants insulin hydrolysis decreased num x num fold symb num fold symb
0.5654884.15749695.html.plaintext.txt	36	view table table iii rates hydrolysis physiological peptides ide mutants
0.5654884.15749695.html.plaintext.txt	37	activity determined num mm tris hcl buffer ph numnum num microm peptide rates hydrolysis determined following substrate disappearance hplc
0.5654884.15749695.html.plaintext.txt	38	ide found contain cationic regulatory site distinct active site binds nucleotide triphosphates primarily triphosphate moiety num binding polyanion site increases rate small peptides substrates larger physiological substrates insulin amyloid peptide since active site histidine glutamate mutations caused loss allosteric interactions tested whether mutant enzymes could still activated atp triphosphate shown table iv using abz ggflrkhgq eddnp dynorphin b num substrate symb mutants activated atp much lesser extent compared wild type enzyme similar effect observed triphosphate activator
0.5654884.15749695.html.plaintext.txt	39	ide found contain cationic regulatory site distinct active site binds nucleotide triphosphates primarily triphosphate moiety num binding polyanion site increases rate small peptides substrates larger physiological substrates insulin amyloid peptide since active site histidine glutamate mutations caused loss allosteric interactions tested whether mutant enzymes could still activated atp triphosphate shown table iv using abz ggflrkhgq eddnp dynorphin b num substrate symb mutants activated atp much lesser extent compared wild type enzyme similar effect observed triphosphate activator
0.5654884.15749695.html.plaintext.txt	40	view table table iv effect atp pppi mutant ide activity
0.5654884.15749695.html.plaintext.txt	41	activity determined num microm abz ggflrkhgq eddnp num microm dynorphin b num num mm tris hcl buffer ph numnum presence num mm atp num mm pppi compared absence addition specific activities absence added atp pppi abz ggflrkhgq eddnp substrate follows wild type ide numnum nmolminmg symb numnum nmolminmg symb numnum nmolminmg symb numnum nmolminmg symb numnum nmolminmg symb numnum nmolminmg symb num nmolminmg
0.5654884.15749695.html.plaintext.txt	42	activity determined num microm abz ggflrkhgq eddnp num microm dynorphin b num num mm tris hcl buffer ph numnum presence num mm atp num mm pppi compared absence addition specific activities absence added atp pppi abz ggflrkhgq eddnp substrate follows wild type ide numnum nmolminmg symb numnum nmolminmg symb numnum nmolminmg symb numnum nmolminmg symb numnum nmolminmg symb numnum nmolminmg symb num nmolminmg
0.5654884.15749695.html.plaintext.txt	43	symb mutants affected differently atp triphosphate acted inhibitors rather activators symb mutant triphosphate effective inhibitor abz ggflrkhgq eddnp hydrolysis micromolar concentrations microm microm whereas activation wild type enzyme required millimolar concentrations mm mm illustrated fig num
0.5654884.15749695.html.plaintext.txt	44	symb mutants affected differently atp triphosphate acted inhibitors rather activators symb mutant triphosphate effective inhibitor abz ggflrkhgq eddnp hydrolysis micromolar concentrations microm microm whereas activation wild type enzyme required millimolar concentrations mm mm illustrated fig num
0.5654884.15749695.html.plaintext.txt	45	view larger version numk fig num comparison effect triphosphate hydrolysis abz ggflrkhgq eddnp wild type ide top ide symb mutant bottom activity determined num mm tris hcl buffer ph numnum num microm abz ggflrkhgq eddnp substrate indicated concentration pppi reactions wild type enzyme contained num ng protein whereas symb mutant contained num microg protein wild type enzyme activity absence added pppi numnum nmolmin although shown effect pppi activity wild type enzyme concentration range used symb mutant
0.5654884.15749695.html.plaintext.txt	46	used sedimentation equilibrium determine effect active site mutations ide oligomerization fig num previously reported tris buffer wild type enzyme appeared predominantly mixture monomers dimers num monomer predominant species addition num mm triphosphate maintained monomer dominant species eliminated small amount dimers num study found symb mutant appeared monomeric trace higher aggregate possibly tetramer present addition pppi decreased solubility significantly change distribution oligomeric species contrast symb mutant appeared less soluble showed predominantly tetramers addition pppi decreased solubility clearly showed presence primarily monomers higher aggregates present symb symb symb appeared monomers trace tetramer present symb exhibited poor solubility could analyzed addition pppi symb symb effect distribution species induced aggregation symb complete aggregation symb thus clear correlation oligomeric state enzyme activity
0.5654884.15749695.html.plaintext.txt	47	view larger version numk fig num sedimentation equilibrium analysis wild type symb mutant ide proteins samples dissolved num mm tris hcl buffer ph numnum brought sedimentation equilibrium numnum rpm num degrees c open circles wild type ide filled circles symb mutant ide smooth curves represent global fits equation num data sets obtained numnum numnum numnum rpm small symmetric residuals demonstrate compatibility equation data data wild type mutant ide consistent mixtures monomeric enzyme predominates relatively small mol fractions higher oligomers
0.5654884.15749695.html.plaintext.txt	48	perlman et al num showed symb zinc coordinating residue provided evidence active site zinc lost symb mutant reexamined issue symb symb mutants accomplish looked ability edta o phenanthroline inhibit residual activity mutants shown table v inclusion numnum mm edta numnum mm o phenanthroline assay little effect activity wild type ide similarly numnum mm edta numnum mm o phenanthroline effect rate insulin hydrolysis glutamate mutants data shown contrast metal chelating agents completely inhibited activity histidine mutants shown table v although shown significant inhibition wild type enzyme glutamate mutants observed higher concentrations edta num mm o phenanthroline num mm thus symb mutants appear retain active site zinc zinc bound weakly thus looked ability zinc increase reaction rate mutants shown fig num addition zinc concentration range numnum num microm caused maximal numnum fold increase activity symb mutant numnum fold increase activity symb mutant followed inhibition higher zinc concentrations contrast zinc concentrations tested slightly inhibitory wild type activity
0.5654884.15749695.html.plaintext.txt	49	view table table v effect metal chelators mutant ide activity
0.5654884.15749695.html.plaintext.txt	50	activity determined num mm tris hcl ph numnum either num microm abz ggflrkhgq eddnp substrate num microm insulin values parenthesis substrate numnum mm edta numnum mm o phenanthroline added indicated
0.5654884.15749695.html.plaintext.txt	51	activity determined num mm tris hcl ph numnum either num microm abz ggflrkhgq eddnp substrate num microm insulin values parenthesis substrate numnum mm edta numnum mm o phenanthroline added indicated
0.5654884.15749695.html.plaintext.txt	52	view larger version numk fig num effect zinc activity wild type ide symb mutants activity determined num mm tris hcl buffer ph numnum num microm abz ggflrkhgq eddnp substrate indicated concentration symb
0.5654884.15749695.html.plaintext.txt	53	order determine whether mutations introduced ide affected enzyme specificity looked cleavage pattern three physiological peptides endorphin insulin amyloid peptide num num using mutants listed table ii insulin amyloid peptide num num substrate observed initial cleavage products various mutants wild type enzyme illustrated insulin cleavage symb mutant fig num previously noted num native ide cleaved endorphin symb symb symb symb bonds two histidine mutants produced cleavage pattern however glutamate num mutants produced addition cleavage symb symb symb symb cleavage symb symb symb symb illustrated fig num symb mutant based result also compared cleavage small dynorphin related peptides native ide symb mutant found dynorphin num dynorphin num dynorphin num dynorphin b num change cleavage site
0.5654884.15749695.html.plaintext.txt	54	order determine whether mutations introduced ide affected enzyme specificity looked cleavage pattern three physiological peptides endorphin insulin amyloid peptide num num using mutants listed table ii insulin amyloid peptide num num substrate observed initial cleavage products various mutants wild type enzyme illustrated insulin cleavage symb mutant fig num previously noted num native ide cleaved endorphin symb symb symb symb bonds two histidine mutants produced cleavage pattern however glutamate num mutants produced addition cleavage symb symb symb symb cleavage symb symb symb symb illustrated fig num symb mutant based result also compared cleavage small dynorphin related peptides native ide symb mutant found dynorphin num dynorphin num dynorphin num dynorphin b num change cleavage site
0.5654884.15749695.html.plaintext.txt	55	view larger version numk fig num hplc chromatograms showing cleavage endorphin insulin ide symb mutant top reaction mixtures containing num microm insulin num mm tris hcl ph numnum reacted wild type ide numnum microg num min b symb num microg num h c reaction products separated gradient hplc vydac symb reverse phase column described materials methods product peaks collected identified mass spectrometry peak num insulin symb num peak num insulin symb num peak num insulin symb num peak num insulin symb num peak insulin chain peak b insulin b chain bottom reaction mixtures containing num microm endorphin reacted wild type ide numnum microg num min b symb num microg num h c peak num endorphin num num peak num endorphin num num peak num endorphin num num peak num endorphin num num peak num endorphin num num peak num endorphin num num peak num endorphin num num
0.5654884.15749695.html.plaintext.txt	56	discussion top abstract introduction materials methods results discussion references mutation residues within active site motif hexxhor hxxeh zinc metallopeptidases reported lead loss catalytic activity however cases presence residual activity quantified generally lack availability large amounts mutant protein cases active site glutamate mutated num num although mutant enzyme reported catalytically inactive determined inactive enzyme retains ability bind substrate num num num num
0.5654884.15749695.html.plaintext.txt	57	discussion top abstract introduction materials methods results discussion references mutation residues within active site motif hexxhor hxxeh zinc metallopeptidases reported lead loss catalytic activity however cases presence residual activity quantified generally lack availability large amounts mutant protein cases active site glutamate mutated num num although mutant enzyme reported catalytically inactive determined inactive enzyme retains ability bind substrate num num num num
0.5654884.15749695.html.plaintext.txt	58	active site glutamate symb active site histidine symb ide previously mutated num num symb mutant transiently expressed cos cells appeared inactive measured crude extracts insulin substrate however mutant retained ability bind insulin determined cross linking studies num noted insulin cross linking actually increased mutant relative wild type enzyme attributed relaxation rigid conformation stabilized zinc evidence increased flexibility active site came demonstration treatment native enzyme o phenanthroline increased extent cross linking however o phenanthroline increase cross linking symb mutant
0.5654884.15749695.html.plaintext.txt	59	active site glutamate symb active site histidine symb ide previously mutated num num symb mutant transiently expressed cos cells appeared inactive measured crude extracts insulin substrate however mutant retained ability bind insulin determined cross linking studies num noted insulin cross linking actually increased mutant relative wild type enzyme attributed relaxation rigid conformation stabilized zinc evidence increased flexibility active site came demonstration treatment native enzyme o phenanthroline increased extent cross linking however o phenanthroline increase cross linking symb mutant
0.5654884.15749695.html.plaintext.txt	60	using radioactive zinc concluded symb mutant bind zinc finding residual activity two symb mutants symb mutants reduced treatment metal chelators indicates mutants contain zinc zinc bound considerably weakly native protein thus results symb symb mutants support extend general conclusions perlman rosner num mutation active site histidine causes change conformation active site ide results presented suggest due loss zinc binding probably due local conformational changes occur within active site
0.5654884.15749695.html.plaintext.txt	61	using radioactive zinc concluded symb mutant bind zinc finding residual activity two symb mutants symb mutants reduced treatment metal chelators indicates mutants contain zinc zinc bound considerably weakly native protein thus results symb symb mutants support extend general conclusions perlman rosner num mutation active site histidine causes change conformation active site ide results presented suggest due loss zinc binding probably due local conformational changes occur within active site
0.5654884.15749695.html.plaintext.txt	62	rather surprising finding mutation either catalytic glutamate zinc coordinating histidine converts substrate velocity curves sigmoidal hyperbolic thus homotropic allosteric activation previously reported us num absent mutants since established ide exist oligomeric state num num num num one possible explanation active site ide interface two subunits mutation active site residues produces local conformational change affects subunit interaction appear case since num perlman et al num shown formation oligomers containing active inactive subunits abrogate activity however mixed oligomer eliminate allosteric activation num thus data probably explained proposal active site mutations produce local conformational change transmitted adjacent subunit although end result appears differences local conformational changes produced mutating catalytic glutamate mutating zinc coordinating histidine evident observation cleavage profile endorphin altered glutamate mutants histidine mutants
0.5654884.15749695.html.plaintext.txt	63	rather surprising finding mutation either catalytic glutamate zinc coordinating histidine converts substrate velocity curves sigmoidal hyperbolic thus homotropic allosteric activation previously reported us num absent mutants since established ide exist oligomeric state num num num num one possible explanation active site ide interface two subunits mutation active site residues produces local conformational change affects subunit interaction appear case since num perlman et al num shown formation oligomers containing active inactive subunits abrogate activity however mixed oligomer eliminate allosteric activation num thus data probably explained proposal active site mutations produce local conformational change transmitted adjacent subunit although end result appears differences local conformational changes produced mutating catalytic glutamate mutating zinc coordinating histidine evident observation cleavage profile endorphin altered glutamate mutants histidine mutants
0.5654884.15749695.html.plaintext.txt	64	addition active site mutations affecting kinetics substrate binding mutations also desensitized enzyme activation triphosphates form atp triphosphate large increase activity seen native enzyme significantly reduced either effect less num fold increase activity glutamate mutants even amazing effect seen active site histidine mutants particularly symb case triphosphate changed activator rather potent inhibitor clearly indicates active site mutants conformationally different wild type enzyme modulated additional conformational changes produced binding triphosphate moiety
0.5654884.15749695.html.plaintext.txt	65	addition active site mutations affecting kinetics substrate binding mutations also desensitized enzyme activation triphosphates form atp triphosphate large increase activity seen native enzyme significantly reduced either effect less num fold increase activity glutamate mutants even amazing effect seen active site histidine mutants particularly symb case triphosphate changed activator rather potent inhibitor clearly indicates active site mutants conformationally different wild type enzyme modulated additional conformational changes produced binding triphosphate moiety
0.5654884.15749695.html.plaintext.txt	66	sedimentation equilibrium data show exception symb mutant native enzyme mutants predominantly monomeric triphosphate affect qualitative oligomerization mechanism soluble enzyme increased tendency form insoluble aggregates case symb symb mutants aggregation may reflect conformational change due triphosphate binding thus obvious correlation oligomeric state activity finding monomeric native enzyme consistent allosteric properties hand gel filtration shows native enzyme existing dimers tetramers higher protein concentrations dynamic light scattering shows exclusively tetramers thus clear ide exist number different oligomerization states would suggest allosteric kinetics observed result substrate induced oligomerization case mutant ide perhaps altered local conformational change active site transmitted protein prevents formation oligomers
0.5654884.15749695.html.plaintext.txt	67	sedimentation equilibrium data show exception symb mutant native enzyme mutants predominantly monomeric triphosphate affect qualitative oligomerization mechanism soluble enzyme increased tendency form insoluble aggregates case symb symb mutants aggregation may reflect conformational change due triphosphate binding thus obvious correlation oligomeric state activity finding monomeric native enzyme consistent allosteric properties hand gel filtration shows native enzyme existing dimers tetramers higher protein concentrations dynamic light scattering shows exclusively tetramers thus clear ide exist number different oligomerization states would suggest allosteric kinetics observed result substrate induced oligomerization case mutant ide perhaps altered local conformational change active site transmitted protein prevents formation oligomers
0.5654884.15749695.html.plaintext.txt	68	footnotes work supported part national institute health grants symb l b h symb l b h symb m g f grants alzheimers association l b h fundacao de amparo pesquisa estado de sao paulo fapesp l j conselho nacional de desenvolvimento cientifico e tecnologico cnpq l j human frontiers science progress grant rg numnum m l j costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance num usc section num solely indicate fact
0.5654884.15749695.html.plaintext.txt	69	correspondence sent dept molecular cellular biochemistry college medicine university kentucky num rose st lexington ky num num tel num num num fax num num num e mail lhershatukyedu u d
0.5654884.15749695.html.plaintext.txt	70	correspondence sent dept molecular cellular biochemistry college medicine university kentucky num rose st lexington ky num num tel num num num fax num num num e mail lhershatukyedu u d
0.5654884.15749695.html.plaintext.txt	71	num abbreviations used amyloid peptides pppi tripolyphosphate ad alzheimer disease ide insulin degrading enzyme hplc high pressure liquid chromatography abz num aminobenzoyl eddnp n numnum dinitrophenylethylenediamine
0.5654884.15749695.html.plaintext.txt	72	acknowledgments mass spectral data obtained university kentucky mass spectrometry facility mass spectrometry facility university kentucky center structural biology thank drs dr jack p goodman haining zhu xiaoning lu assisting mass spectral analysis
0.5654884.15749695.html.plaintext.txt	73	references top abstract introduction materials methods results discussion references st george hyslop p h num molecular genetics alzheimers disease raven press new york sherrington r rogaev e liang y rogaeva e levesque g ikeda m chi h lin c li g holman k tsuda mar l foncin j f bruni c montesi m p num nature num num numcrossrefmedline order article via infotrieve levy lahad e wasco w poorkaj p romano d m oshima j pettingell w h yu c jondro p d schmidt d wang k crowley c fu y h guenette y galas d nemens e num science num num nummedline order article via infotrieve rogaev e sherrington r rogaeva e levesque g ikeda m liang y chi h lin c holman k tsuda mar l sorbi nacmias b piacentini amaducci l num nature num num numcrossrefmedline order article via infotrieve leissring m lu condron m m teplow d b stein r l farris w selkoe dj num j biol chem num num numabstractfree full text fukumoto h cheung bs hyman b irizarry m c num arch neurol num num numabstractfree full text yang l b lindholm k yan r citron m xia w yang x l beach sue l wong p price d li r shen y num nat med num num numcrossrefmedline order article via infotrieve li r lindholm k yang l b yue x citron m yan r beach sue l sabbagh m cai h wong p price d shen y num proc natl acad sci u num num numabstractfree full text demattos r b bales k r cummins d j dodart j c paul m holtzman d m num proc natl acad sci u num num numabstractfree full text demattos r b bales k r cummins d j paul m holtzman d m num science num num numabstractfree full text zlokovic b v num j neurochem num num numcrossrefmedline order article via infotrieve qiu w q ye z kholodenko d seubert p selkoe d j num j biol chem num num numabstractfree full text mukherjee hersh l b num j alzheimers dis num num nummedline order article via infotrieve hersh l b num curr pharm des num num numcrossrefmedline order article via infotrieve carson j turner j num j neurochem num num numcrossrefmedline order article via infotrieve iwata n tsubuki takaki y watanabe k sekiguchi m hosoki e kawashima morishima m lee h j hama e sekine aizawa y saido c num nat med num num numcrossrefmedline order article via infotrieve marr r guan h rockenstein e kindy m gage f h verma masliah e hersh l b num j mol neurosci num num numcrossrefmedline order article via infotrieve miller b c eckman e sambamurti k dobbs n chow k m eckman c b hersh l b thiele d l num proc natl acad sci u num num numabstractfree full text farris w mansourian chang y lindsley l eckman ea frosch mp eckman c b tanzi r e selkoe d j guenette num proc natl acad sci u num num numabstractfree full text eckman e reed d k eckman c b num j biol chem num num numabstractfree full text eckman e watson m marlow l sambamurti k eckman c b num j biol chem num num numabstractfree full text bertram l blacker d mullin k keeney d jones j basu yhu mcinnis m g go r c vekrellis k selkoe d j saunders j tanzi r e num science num num numabstractfree full text ertekin taner n graff radford n younkin l h eckman c baker m adamson j ronald j blangero j hutton m younkin g num science num num numabstractfree full text ertekin taner n allen m fadale d scanlin l younkin l petersen r c graff radford n younkin g num hum mutat num num numcrossrefmedline order article via infotrieve myers holmans p marshall h kwon j meyer d ramic d shears booth j devrieze f w crook r hamshere m abraham r tunstall n rice f carty lillystone kehoe p rudrasingham v jones l lovestone perez tur j williams j owen m j hardy j goate m num science num num numabstractfree full text duckworth w c bennett r g hamel f g num endocr rev num num numabstractfree full text seta k roth r num biochem biophys res commun num num numcrossrefmedline order article via infotrieve vekrellis k ye z qiu w q walsh d hartley d chesneau v rosner m r selkoe d j num j neurosci num num numabstractfree full text qiu w q walsh d m ye z vekrellis k zhang j podlisny m b rosner m r safavi hersh l b selkoe d j num j biol chem num num numabstractfree full text farris w mansourian leissring m eckman e bertram l eckman c b tanzi r e selkoe d j num j pathol num num numabstractfree full text authier f posner b bergeron j j m num clin invest med num num nummedline order article via infotrieve safavi miller b c cottam l hersh l b num biochemistry num num numcrossrefmedline order article via infotrieve kurochkin v num trends biochem sci num num numcrossrefmedline order article via infotrieve mukherjee song e kihiko m goodman j p jr pyrek j estus hersh l b num j neurosci num num numabstractfree full text song e juliano m juliano l hersh l b num j biol chem num num numabstractfree full text csuhai e juliano m pyrek j harms c juliano l hersh l b num anal biochem num num numcrossrefmedline order article via infotrieve perlman r k rosner m r num j biol chem num num numabstractfree full text rost b num methods enzymol num num numcrossrefmedline order article via infotrieve rost b sander c num j mol biol num num numcrossrefmedline order article via infotrieve cohn e j edsall j num proteins amino acids peptides ions dipolar ions pp num num reinhold new york johnson m l correia j j yphantis d halvorson h r num biophys j num num numabstract perlman r k gehm b d kuo w l rosner m r num j biol chem num num numabstractfree full text thompson m w govindaswami m hersh l b num arch biochem biophys num num numcrossrefmedline order article via infotrieve song es juliano m juliano l fried m g wagner l hersh l b num j biol chem num num numabstractfree full text devault nault c zollinger m fournie zaluski m c roques b p crine p boileau g num j biol chem num num numabstractfree full text wetterholm medina j f radmark o shapiro r haeggstrom j z vallee b l samuelsson b num proc natl acad sci u num num numabstractfree full text vazeux g wang j corvol p llorens cortes c num j biol chem num num numabstractfree full text cha j auld d num biochemistry num num numcrossrefmedline order article via infotrieve kubo m mitsuda y takagi m imanaka num appl environ microbiol num num numabstract ding l becker b suzuki roth r num j biol chem num num numabstractfree full text shii k yokono k baba roth r num diabetes num num num article abstract full text pdf versions article numnumnum recent symbnum purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager copyright permissions google scholar articles song e articles hersh l b articles citing article pubmed pubmed citation articles song e articles hersh l b
0.5654884.15749695.html.plaintext.txt	74	home help feedback subscriptions archive search table contents asbmb journals molecular cellular proteomics journal lipid research biochemistry molecular biology education copyright num american society biochemistry molecular biology
0.5852807.12941771.html.plaintext.txt	0	insulin degrading enzyme inhibitor decreases amylin degradation increases amylin induced cytotoxicity increases amyloid formation insulinoma cell cultures robert g symbnum frederick g symbnum william c symbnumnum
0.5852807.12941771.html.plaintext.txt	1	num department internal medicine university nebraska medical center omaha nebraska num department medical research veterans affairs medical center omaha nebraska num endocrinology section carl hayden va medical center phoenix arizona num molecular cellular biology program arizona state university tempe arizona num department medicine university arizona tucson arizona
0.5852807.12941771.html.plaintext.txt	2	num department internal medicine university nebraska medical center omaha nebraska num department medical research veterans affairs medical center omaha nebraska num endocrinology section carl hayden va medical center phoenix arizona num molecular cellular biology program arizona state university tempe arizona num department medicine university arizona tucson arizona
0.5852807.12941771.html.plaintext.txt	3	abstract top abstract research design methods results discussion references amylin islet amyloid polypeptide chief component islet amyloid found type num diabetes amylin fibril precursors may cytotoxic pancreatic ss cells little known prevention amylin aggregation investigated role insulin degrading enzyme ide amylin degradation amyloid deposition cytotoxicity rin symb insulinoma cells human numi labeled amylin degradation inhibited num num addition num nmoll human amylin insulin respectively numi labeled insulin degradation inhibited num nmoll human amylin rat amylin insulin num num num respectively ide inhibitor bacitracin inhibited amylin degradation num insulin degradation num amyloid staining congo red fluorescence detectable num nmoll amylin pronounced numnum nmoll amylin treatment num h bacitracin treatment markedly increased staining amylin concentrations bacitracin amylin caused dramatic decrease cell viability compared amylin alone num num respectively num nmoll amylin summary rin symb cells degraded amylin insulin common proteolytic pathway ide inhibition bacitracin impaired amylin degradation increased amyloid formation increased amylin induced cytotoxicity suggesting role ide amylin clearance prevention amylin aggregation
0.5852807.12941771.html.plaintext.txt	4	abstract top abstract research design methods results discussion references amylin islet amyloid polypeptide chief component islet amyloid found type num diabetes amylin fibril precursors may cytotoxic pancreatic ss cells little known prevention amylin aggregation investigated role insulin degrading enzyme ide amylin degradation amyloid deposition cytotoxicity rin symb insulinoma cells human numi labeled amylin degradation inhibited num num addition num nmoll human amylin insulin respectively numi labeled insulin degradation inhibited num nmoll human amylin rat amylin insulin num num num respectively ide inhibitor bacitracin inhibited amylin degradation num insulin degradation num amyloid staining congo red fluorescence detectable num nmoll amylin pronounced numnum nmoll amylin treatment num h bacitracin treatment markedly increased staining amylin concentrations bacitracin amylin caused dramatic decrease cell viability compared amylin alone num num respectively num nmoll amylin summary rin symb cells degraded amylin insulin common proteolytic pathway ide inhibition bacitracin impaired amylin degradation increased amyloid formation increased amylin induced cytotoxicity suggesting role ide amylin clearance prevention amylin aggregation
0.5852807.12941771.html.plaintext.txt	5	type num diabetes characterized loss pancreatic ss cell mass accompanied presence islet amyloid deposits pancreas num major component islet amyloid amylin also known islet amyloid polypeptide polypeptide copackaged cosecreted insulin pancreatic ss cells num presently unclear whether islet amyloid merely consequence diabetes actually contributes progression disease however evidence intermediate precursors amylin fibrils cytotoxic ss cells whereas mature amyloid fibrils toxic suggesting ss cell toxicity may precede deposition islet amyloid numnum amylin continually produced individuals without type num diabetes mere presence amylin insufficient induce amylin induced ss cell toxicity islet amyloid transgenic animals producing human amyloidogenic amylin fail develop islet amyloid num num additional diabetic traits introduced islet amyloid detected num num therefore protective mechanism prevents amyloid deposition normal conditions impaired diabetic conditions proteolysis major pathway regulation protein levels degradation amylin may contribute prevention islet amyloid aggregation ss cell toxicity islet amyloid may therefore result imbalance amylin levels impaired degradation amylin present understanding proteolytic pathways contribute degradation amylin incomplete
0.5852807.12941771.html.plaintext.txt	6	type num diabetes characterized loss pancreatic ss cell mass accompanied presence islet amyloid deposits pancreas num major component islet amyloid amylin also known islet amyloid polypeptide polypeptide copackaged cosecreted insulin pancreatic ss cells num presently unclear whether islet amyloid merely consequence diabetes actually contributes progression disease however evidence intermediate precursors amylin fibrils cytotoxic ss cells whereas mature amyloid fibrils toxic suggesting ss cell toxicity may precede deposition islet amyloid numnum amylin continually produced individuals without type num diabetes mere presence amylin insufficient induce amylin induced ss cell toxicity islet amyloid transgenic animals producing human amyloidogenic amylin fail develop islet amyloid num num additional diabetic traits introduced islet amyloid detected num num therefore protective mechanism prevents amyloid deposition normal conditions impaired diabetic conditions proteolysis major pathway regulation protein levels degradation amylin may contribute prevention islet amyloid aggregation ss cell toxicity islet amyloid may therefore result imbalance amylin levels impaired degradation amylin present understanding proteolytic pathways contribute degradation amylin incomplete
0.5852807.12941771.html.plaintext.txt	7	enzyme responsible cellular proteolysis insulin insulin degrading enzyme ide num substrate specificity ide amyloidogenic polypeptides including atrial natriuretic peptide anp glucagon ss amyloid peptide found alzheimer disease therefore may act scavenger clears amyloidogenic peptides prevent amyloid deposition numnum recently showed amylin also ide substrate num therefore ide may involved controlling levels amylin degradation similar role regulating levels alzheimer related ss amyloid peptide num gk rat model type num diabetes ide identified diabetes susceptibility gene recently described ide null mice show impaired glucose metabolism models cellular insulin degrading activity found impaired therefore possible diabetes ide dysfunction also results impaired amylin degradation increased amylin aggregation eventually islet amyloid deposition present study performed address following questions num amylin insulin degraded ss cells common pathway num inhibition ide alter amylin degradation islet amyloid formation num ide inhibition affect cytotoxic properties amylin toward ss cells answer questions pancreatic ss cell derived cell line used characterize amylin degradation
0.5852807.12941771.html.plaintext.txt	8	enzyme responsible cellular proteolysis insulin insulin degrading enzyme ide num substrate specificity ide amyloidogenic polypeptides including atrial natriuretic peptide anp glucagon ss amyloid peptide found alzheimer disease therefore may act scavenger clears amyloidogenic peptides prevent amyloid deposition numnum recently showed amylin also ide substrate num therefore ide may involved controlling levels amylin degradation similar role regulating levels alzheimer related ss amyloid peptide num gk rat model type num diabetes ide identified diabetes susceptibility gene recently described ide null mice show impaired glucose metabolism models cellular insulin degrading activity found impaired therefore possible diabetes ide dysfunction also results impaired amylin degradation increased amylin aggregation eventually islet amyloid deposition present study performed address following questions num amylin insulin degraded ss cells common pathway num inhibition ide alter amylin degradation islet amyloid formation num ide inhibition affect cytotoxic properties amylin toward ss cells answer questions pancreatic ss cell derived cell line used characterize amylin degradation
0.5852807.12941771.html.plaintext.txt	9	research design methods top abstract research design methods results discussion references materials human rat amylin purchased bachem torrance ca human amylin radiolabeled numi cooh terminal purchased peninsula labs san carlos ca numi insulin mono iodinated num position chain biosynthetic human insulin provided lilly research laboratories bacitracin congo red obtained sigma ide specific monoclonal antibody numsymb num kindly provided dr richard roth stanford university stanford ca
0.5852807.12941771.html.plaintext.txt	10	research design methods top abstract research design methods results discussion references materials human rat amylin purchased bachem torrance ca human amylin radiolabeled numi cooh terminal purchased peninsula labs san carlos ca numi insulin mono iodinated num position chain biosynthetic human insulin provided lilly research laboratories bacitracin congo red obtained sigma ide specific monoclonal antibody numsymb num kindly provided dr richard roth stanford university stanford ca
0.5852807.12941771.html.plaintext.txt	11	preparation amylin solutions amylin solutions prepared immediately use num mgml stock solutions bsa coated test tubes prevent adhesion plastic minimize spontaneous amyloid fibril formation variable amounts contaminating low molecular weight fragments numi labeled albumin numi amylin purified adsorption symb sep pak waters milford ma eluted numnum trifluoroacetic acid acetonitrile eluent lyophilized resuspended original buffer numnum moll sodium phosphate ph numnum containing numnum moll nacl numnum symb numnum bsa frozen aliquots used
0.5852807.12941771.html.plaintext.txt	12	preparation amylin solutions amylin solutions prepared immediately use num mgml stock solutions bsa coated test tubes prevent adhesion plastic minimize spontaneous amyloid fibril formation variable amounts contaminating low molecular weight fragments numi labeled albumin numi amylin purified adsorption symb sep pak waters milford ma eluted numnum trifluoroacetic acid acetonitrile eluent lyophilized resuspended original buffer numnum moll sodium phosphate ph numnum containing numnum moll nacl numnum symb numnum bsa frozen aliquots used
0.5852807.12941771.html.plaintext.txt	13	cell culture rat insulinoma rin symb cells num purchased american type culture collection maintained rpmi num medium supplemented num fetal bovine serum numnum gl sodium bicarbonate numnum gl glucose num mmoll l glutamine num microgml gentamicin experiments cells subcultured num well plates numnum x num cellswell medium changed every num days used
0.5852807.12941771.html.plaintext.txt	14	cellular degradation amylin insulin degradation amylin insulin rin symb cells determined trichloroacetic acid tca solubility assay using variation method previously described num briefly rin symb cells num well plates changed serum free medium containing numnum bsa num h medium removed numi amylin numi labeled insulin serum free medium containing numnum bsa added numnum cpmml cells incubated num degrees c times indicated experiments bacitracin included num mgml medium removed brought numnum bsa num tca chilled num min ice centrifuged numnumg num min radioactivity supernatants pellets counted degrading activity expressed percent tca soluble counts addition conditioned medium cells removed aliquots tested degrading activity tca solubility described
0.5852807.12941771.html.plaintext.txt	15	cellular degradation amylin insulin degradation amylin insulin rin symb cells determined trichloroacetic acid tca solubility assay using variation method previously described num briefly rin symb cells num well plates changed serum free medium containing numnum bsa num h medium removed numi amylin numi labeled insulin serum free medium containing numnum bsa added numnum cpmml cells incubated num degrees c times indicated experiments bacitracin included num mgml medium removed brought numnum bsa num tca chilled num min ice centrifuged numnumg num min radioactivity supernatants pellets counted degrading activity expressed percent tca soluble counts addition conditioned medium cells removed aliquots tested degrading activity tca solubility described
0.5852807.12941771.html.plaintext.txt	16	immunodetection ide lysates prepared rin symb cells lysis buffer num mmoll tris ph numnum containing numnum moll nacl num triton x num numnum mmoll phenylmethylsulfonyl fluoride aliquots num microg total protein resolved numnum sds page transferred polyvinylidine fluoride membranes immunodetection membranes probed numsymb monoclonal antibody directed ide numnumnum dilution num h room temperature probed peroxidase conjugated goat anti mouse igg jackson immunochemicals temecula ca numnumnum dilution num h immunoreactive proteins detected chemiluminescence
0.5852807.12941771.html.plaintext.txt	17	amyloid formation rin symb cultures rin symb cells seeded onto poly l lysine coated eight well glass chamber slides num cellssymb medium changed serum free rpmi num containing numnum bsa treatment cells treated human amylin numnum numnum micromoll num h experiments bacitracin included num mgml determine involvement ide like proteolytic activity islet amyloid formation cells also treated ide inhibitor bacitracin num mgml time amylin addition treatment cells washed pbs fixed num min num buffered formalin stained amyloid using modified congo red staining procedure num briefly samples counterstained weigert iron hematoxylin num rinsed placed numnum hcl num ethanol num washed samples stained congo red num min samples immediately dehydrated xylene mounted degree amyloid formation determined fluorescence microscopy using tetramethyl rhodamine isothiocyanate filter set
0.5852807.12941771.html.plaintext.txt	18	amyloid formation rin symb cultures rin symb cells seeded onto poly l lysine coated eight well glass chamber slides num cellssymb medium changed serum free rpmi num containing numnum bsa treatment cells treated human amylin numnum numnum micromoll num h experiments bacitracin included num mgml determine involvement ide like proteolytic activity islet amyloid formation cells also treated ide inhibitor bacitracin num mgml time amylin addition treatment cells washed pbs fixed num min num buffered formalin stained amyloid using modified congo red staining procedure num briefly samples counterstained weigert iron hematoxylin num rinsed placed numnum hcl num ethanol num washed samples stained congo red num min samples immediately dehydrated xylene mounted degree amyloid formation determined fluorescence microscopy using tetramethyl rhodamine isothiocyanate filter set
0.5852807.12941771.html.plaintext.txt	19	cell toxicity assessment cell toxicity studies rin symb cells cultured num well plates treated human rat amylin without bacitracin described num h cell viability measured reduction methylthiazolyldiphenyl tetrazolium bromide mtt previously described num
0.5852807.12941771.html.plaintext.txt	20	statistics data expressed means plus minus se degradation assays comparisons differences groups made one way anova dunnett posttest degradation assays two way anova bonferroni posttest viability assay p numnum interpreted significant analyses made using graphpad symb software package
0.5852807.12941771.html.plaintext.txt	21	results top abstract research design methods results discussion references amylin insulin degradation rin symb cells examined time amount degradation limited num remain within linear range assay degradation numi amylin reached num num min fig num contrast numi insulin degraded much slowly required num min incubation reach num degradation fig num addition either unlabeled amylin insulin reaction decreased degradation substrates indicating common degradative pathway addition ide inhibitor bacitracin essentially eliminated degradation amylin insulin cells detectable amylin insulin degrading activity conditioned medium data shown suggesting degradation caused uptake intracellular degradation presence ide readily detected cells immunoreactive band num kda fig num therefore rin symb cells possess mechanisms internalize degrade insulin amylin express ide
0.5852807.12941771.html.plaintext.txt	22	results top abstract research design methods results discussion references amylin insulin degradation rin symb cells examined time amount degradation limited num remain within linear range assay degradation numi amylin reached num num min fig num contrast numi insulin degraded much slowly required num min incubation reach num degradation fig num addition either unlabeled amylin insulin reaction decreased degradation substrates indicating common degradative pathway addition ide inhibitor bacitracin essentially eliminated degradation amylin insulin cells detectable amylin insulin degrading activity conditioned medium data shown suggesting degradation caused uptake intracellular degradation presence ide readily detected cells immunoreactive band num kda fig num therefore rin symb cells possess mechanisms internalize degrade insulin amylin express ide
0.5852807.12941771.html.plaintext.txt	23	view larger version numk fig num amylin degradation rin symb cells time degradation amylin rin symb cells time measured production acid soluble products numi amylin cell culture media cells also treated numnum micromoll unlabeled amylin insulin ide inhibitor bacitracin num mgml data expressed percent acid soluble products produced n num treatment amylin insulin bacitracin
0.5852807.12941771.html.plaintext.txt	24	view larger version numk fig num insulin degradation rin symb cells time degradation insulin rin symb cells time measured production acid soluble products numi insulin cell culture media cells also treated numnum micromoll unlabeled amylin insulin ide inhibitor bacitracin num mgml data expressed percent acid soluble products produced n num treatment amylin insulin bacitracin b lysates rin symb probed ide specific monoclonal antibody numsymb immunoreactive proteins detected chemiluminescence single band num kda detected consistent presence ide
0.5852807.12941771.html.plaintext.txt	25	characterize amylin insulin degradation rin symb cells degradation measured increasing dosages unlabeled competitor degradation numi amylin decreased dosage dependent manner either unlabeled insulin amylin fig num concentrations unlabeled insulin effective inhibitor amylin similarly degradation numi insulin inhibited amylin insulin fig num insulin generally effective inhibitor observations consistent previously determined enzymatic properties ide insulin three sixfold higher affinity purified ide amylin num two possible complications cell culture system potential direct interaction human amylin insulin num membrane perturbations may impede receptor mediated uptake substrates num rat amylin also ide substrate num interact insulin cause membrane disruption rat amylin num nmoll inhibited insulin degradation numnum plus minus numnum baseline insulin degradation result similar found human amylin indicating reciprocal inhibition amylin insulin degradation attributable common pathway proteolysis
0.5852807.12941771.html.plaintext.txt	26	characterize amylin insulin degradation rin symb cells degradation measured increasing dosages unlabeled competitor degradation numi amylin decreased dosage dependent manner either unlabeled insulin amylin fig num concentrations unlabeled insulin effective inhibitor amylin similarly degradation numi insulin inhibited amylin insulin fig num insulin generally effective inhibitor observations consistent previously determined enzymatic properties ide insulin three sixfold higher affinity purified ide amylin num two possible complications cell culture system potential direct interaction human amylin insulin num membrane perturbations may impede receptor mediated uptake substrates num rat amylin also ide substrate num interact insulin cause membrane disruption rat amylin num nmoll inhibited insulin degradation numnum plus minus numnum baseline insulin degradation result similar found human amylin indicating reciprocal inhibition amylin insulin degradation attributable common pathway proteolysis
0.5852807.12941771.html.plaintext.txt	27	view larger version numk fig num amylin degradation rin symb cells degradation amylin rin symb cells measured production acid soluble products numi amylin cell culture media cells also treated indicated concentrations nmoll unlabeled amylin unlabeled insulin data expressed percent acid soluble products produced n num p numnum p numnum
0.5852807.12941771.html.plaintext.txt	28	view larger version numk fig num insulin degradation rin symb cells degradation insulin rin symb cells measured production acid soluble products numi amylin cell culture media cells also treated indicated concentrations nmoll unlabeled amylin unlabeled insulin data expressed percent acid soluble products produced n num p numnum
0.5852807.12941771.html.plaintext.txt	29	amylin produced healthy individuals without formation islet amyloid mechanism must place prevent amylin aggregation normal conditions examine whether cellular degradation ide may contribute protective process cell culture system study islet amyloid formation developed rin symb cells cultured poly l lysine coated glass chamber slides num days culture treated human amylin num numnum nmoll num h amyloid detected modified congo red fluorescence staining method num includes acidic iron hematoxylin counterstain minimizes intense autofluorescence seen using original method num human amylin induced dosage dependent increase staining detectable num nmoll pronounced num micromoll fig num finding demonstrated exogenous human amylin form amyloid deposits rin symb cell cultures cells treated ide inhibitor bacitracin amyloid staining markedly increased intensity amylin concentrations compared cells without bacitracin including lowest amylin concentration num nmoll findings suggest impairment cells ability clear amylin protease characteristics consistent ide
0.5852807.12941771.html.plaintext.txt	30	amylin produced healthy individuals without formation islet amyloid mechanism must place prevent amylin aggregation normal conditions examine whether cellular degradation ide may contribute protective process cell culture system study islet amyloid formation developed rin symb cells cultured poly l lysine coated glass chamber slides num days culture treated human amylin num numnum nmoll num h amyloid detected modified congo red fluorescence staining method num includes acidic iron hematoxylin counterstain minimizes intense autofluorescence seen using original method num human amylin induced dosage dependent increase staining detectable num nmoll pronounced num micromoll fig num finding demonstrated exogenous human amylin form amyloid deposits rin symb cell cultures cells treated ide inhibitor bacitracin amyloid staining markedly increased intensity amylin concentrations compared cells without bacitracin including lowest amylin concentration num nmoll findings suggest impairment cells ability clear amylin protease characteristics consistent ide
0.5852807.12941771.html.plaintext.txt	31	view larger version numk fig num bacitracin increases amyloid deposition rin symb cells rin symb cells treated num num num numnum nmoll human amylin indicated cells cultured absence left presence right ide inhibitor bacitracin bac deposition islet amyloid detected congo red fluorescence brightfield exposures cells shown insets magnification symb
0.5852807.12941771.html.plaintext.txt	32	amylin implicated ss cell toxicity effect ide inhibition rin symb cell viability determined mtt reduction fig num treatment human amylin num h decreased cell viability dosage dependent manner peaking num numnum nmoll amylin presence bacitracin cell viability markedly lower amylin concentrations reaching maximum reduction num num nmoll amylin conversely rat amylin effect viability whether without bacitracin therefore ide inhibitor increased ability amylin reduce rin symb cell viability
0.5852807.12941771.html.plaintext.txt	33	view larger version numk fig num bacitracin increases amylin induced cytotoxicity rin symb cells treated num num num numnum nmoll human amylin numnum nmoll rat amylin indicated cells cultured absence presence ide inhibitor bacitracin cell toxicity assessed degree mtt reduction cells n num p numnum
0.5852807.12941771.html.plaintext.txt	34	discussion top abstract research design methods results discussion references pathologic feature type num diabetes presence islet amyloid deposits composed predominantly amylin num whether islet amyloid merely marker type num diabetes actually contributes disease matter discussion several lines evidence suggest association presence islet amyloid diabetes reduced ss cell mass monkeys formation islet amyloid correlates early reduced insulin secretion glucose intolerance time correlates greater deficiency insulin secretion glucose tolerance ultimately hyperglycemia num humans degree amyloid formation correlates severity diabetes evidenced requirement insulin replacement therapy numnum evidence suggests ss cell death caused intermediate sized fibrils precursors islet amyloid numnum case islet amyloid deposits reflect end stage effect amylin aggregation secondary ss cell death
0.5852807.12941771.html.plaintext.txt	35	discussion top abstract research design methods results discussion references pathologic feature type num diabetes presence islet amyloid deposits composed predominantly amylin num whether islet amyloid merely marker type num diabetes actually contributes disease matter discussion several lines evidence suggest association presence islet amyloid diabetes reduced ss cell mass monkeys formation islet amyloid correlates early reduced insulin secretion glucose intolerance time correlates greater deficiency insulin secretion glucose tolerance ultimately hyperglycemia num humans degree amyloid formation correlates severity diabetes evidenced requirement insulin replacement therapy numnum evidence suggests ss cell death caused intermediate sized fibrils precursors islet amyloid numnum case islet amyloid deposits reflect end stage effect amylin aggregation secondary ss cell death
0.5852807.12941771.html.plaintext.txt	36	factors prevent amylin fibril formation ss cell death islet amyloid deposition nondisease state understood amylin continually produced nondiabetic humans amyloid formation mere presence amylin insufficient cause fibril formation indeed transgenic animals overexpressing human amylin form amyloid deposits num numnum confirming elevated amylin levels alone insufficient amyloid formation however diabetic conditions introduced ob mutation growth hormonesteroid treatment high fat diet animals develop islet amyloid islet dysfunction reduced insulin secretion hyperglycemia num num therefore type num diabetes balance shifts amylin clearance deposition either increased amounts factor promotes amylin aggregation decreased amounts factor clears amylin although numerous studies regarding amylin synthesis secretion present studies amylin degradation
0.5852807.12941771.html.plaintext.txt	37	factors prevent amylin fibril formation ss cell death islet amyloid deposition nondisease state understood amylin continually produced nondiabetic humans amyloid formation mere presence amylin insufficient cause fibril formation indeed transgenic animals overexpressing human amylin form amyloid deposits num numnum confirming elevated amylin levels alone insufficient amyloid formation however diabetic conditions introduced ob mutation growth hormonesteroid treatment high fat diet animals develop islet amyloid islet dysfunction reduced insulin secretion hyperglycemia num num therefore type num diabetes balance shifts amylin clearance deposition either increased amounts factor promotes amylin aggregation decreased amounts factor clears amylin although numerous studies regarding amylin synthesis secretion present studies amylin degradation
0.5852807.12941771.html.plaintext.txt	38	enzyme responsible intracellular degradation insulin ide cytosolic metallothioprotease also known insulysin numnum primary function ide mammalian tissues traditionally thought degradation insulin number proteins identified ide substrates including proteins structurally related insulin proinsulin igf ii relaxin seemingly unrelated peptides anp glucagon num however insulin anp glucagon contain regions form ss pleated sheets potentially amyloid forming num proposed rather targeting primary sequence motif ide specific toward amyloidogenic peptides num concept supported findings ide also degrades amylin ss amyloid peptide numnumnum recent studies supported role ide type num diabetes alzheimer disease two conditions characterized amyloid possible genetic linkages type num diabetes alzheimer disease mapped chromosomal region ide gene num num gk rat model type num diabetes ide identified diabetes susceptibility gene mutations associated model result lower cellular insulin degradation hyperglycemia reduced lipogenesis fat cells reduced glucose uptake vivo num recently described ide null mouse model displays impaired insulin ss amyloid degradation well hyperinsulinemia glucose intolerance cerebral accumulation ss amyloid hallmarks type num diabetes alzheimer disease num thus evidence mounting ide plays major role diseases characterized amyloid formation
0.5852807.12941771.html.plaintext.txt	39	enzyme responsible intracellular degradation insulin ide cytosolic metallothioprotease also known insulysin numnum primary function ide mammalian tissues traditionally thought degradation insulin number proteins identified ide substrates including proteins structurally related insulin proinsulin igf ii relaxin seemingly unrelated peptides anp glucagon num however insulin anp glucagon contain regions form ss pleated sheets potentially amyloid forming num proposed rather targeting primary sequence motif ide specific toward amyloidogenic peptides num concept supported findings ide also degrades amylin ss amyloid peptide numnumnum recent studies supported role ide type num diabetes alzheimer disease two conditions characterized amyloid possible genetic linkages type num diabetes alzheimer disease mapped chromosomal region ide gene num num gk rat model type num diabetes ide identified diabetes susceptibility gene mutations associated model result lower cellular insulin degradation hyperglycemia reduced lipogenesis fat cells reduced glucose uptake vivo num recently described ide null mouse model displays impaired insulin ss amyloid degradation well hyperinsulinemia glucose intolerance cerebral accumulation ss amyloid hallmarks type num diabetes alzheimer disease num thus evidence mounting ide plays major role diseases characterized amyloid formation
0.5852807.12941771.html.plaintext.txt	40	previous study using cell free extracts num ide readily degraded amylin lower affinity insulin radiolabeled amylin covalently cross linked ide monoclonal antibody directed ide immunoprecipitated insulin amylin degrading activities confirming ide amylin degrading protease extended findings rat ss cell derived line amylin insulin degraded rin symb cells insulin degraded much slowly possible reasons observation include differences binding internalization different receptors differences receptor availability eg desensitization cell toxicity differences may also attributed nature assay unlike amylin multiple cleavages required produce tca soluble fragments insulin therefore assay tends underestimate level insulin degradation amylin degradation began quickly leveled time probable explanation observation based insulin secretion cells cells changed fresh media containing labeled substrates initially endogenously produced insulin media rin cells rapidly secreted insulin reaching num num nmoll num h would act competitive inhibitor amylin degradation amylin present tracer amounts sufficient insulin competitively inhibit amylin degradation may well produced within num min insulin amylin capable competitive inhibition either substrate insulin general better competitive inhibitor amylin discussed likely attributable greater affinity insulin ide possibly also different internalization properties insulin amylin efficiency unlabeled insulin inhibition insulin degradation consistent previous reports showing num inhibition num num nmoll insulin using rin symb cells num taken together data suggest insulin amylin share common pathway degradation
0.5852807.12941771.html.plaintext.txt	41	previous study using cell free extracts num ide readily degraded amylin lower affinity insulin radiolabeled amylin covalently cross linked ide monoclonal antibody directed ide immunoprecipitated insulin amylin degrading activities confirming ide amylin degrading protease extended findings rat ss cell derived line amylin insulin degraded rin symb cells insulin degraded much slowly possible reasons observation include differences binding internalization different receptors differences receptor availability eg desensitization cell toxicity differences may also attributed nature assay unlike amylin multiple cleavages required produce tca soluble fragments insulin therefore assay tends underestimate level insulin degradation amylin degradation began quickly leveled time probable explanation observation based insulin secretion cells cells changed fresh media containing labeled substrates initially endogenously produced insulin media rin cells rapidly secreted insulin reaching num num nmoll num h would act competitive inhibitor amylin degradation amylin present tracer amounts sufficient insulin competitively inhibit amylin degradation may well produced within num min insulin amylin capable competitive inhibition either substrate insulin general better competitive inhibitor amylin discussed likely attributable greater affinity insulin ide possibly also different internalization properties insulin amylin efficiency unlabeled insulin inhibition insulin degradation consistent previous reports showing num inhibition num num nmoll insulin using rin symb cells num taken together data suggest insulin amylin share common pathway degradation
0.5852807.12941771.html.plaintext.txt	42	specificity amylin insulin degrading activity investigated using ide inhibitor bacitracin although bacitracin specific inhibitor ide ide inhibitors eg n ethylmaleimide numnum phenanthroline highly toxic rin symb cells rgb unpublished observations whereas bacitracin well tolerated cells amylin insulin degradation rin symb cells markedly inhibited bacitracin bacitracin also accelerated islet amyloid formation amylin concentrations suggesting inhibition amylin degradation accelerates amylin aggregation amyloid deposition amylin implicated ss cell death cell viability examined conditions cytotoxicity induced human amylin markedly increased bacitracin treatment whereas rat amylin effect suggesting amylin degradation responsible reducing cell toxicity caused amylin amylin induced cytotoxicity ss cells shown caused intermediate amylin precursors rather mature amyloid num ide degrades amylin monomers formation intermediate precursors amyloid fibrils would prevented experiments performed num h treatment freshly prepared amylin determine amylin species caused toxicity rin cells however degree cell death seen bacitracin treatment increased maximum attained even lowest amylin concentration could mean toxicity preceded amyloid deposition although amylin concentration required detection amyloid cell toxicity num num nmoll high relative circulating levels local amylin concentration around ss cells unknown may well higher especially conditions stimulate insulin amylin secretion
0.5852807.12941771.html.plaintext.txt	43	specificity amylin insulin degrading activity investigated using ide inhibitor bacitracin although bacitracin specific inhibitor ide ide inhibitors eg n ethylmaleimide numnum phenanthroline highly toxic rin symb cells rgb unpublished observations whereas bacitracin well tolerated cells amylin insulin degradation rin symb cells markedly inhibited bacitracin bacitracin also accelerated islet amyloid formation amylin concentrations suggesting inhibition amylin degradation accelerates amylin aggregation amyloid deposition amylin implicated ss cell death cell viability examined conditions cytotoxicity induced human amylin markedly increased bacitracin treatment whereas rat amylin effect suggesting amylin degradation responsible reducing cell toxicity caused amylin amylin induced cytotoxicity ss cells shown caused intermediate amylin precursors rather mature amyloid num ide degrades amylin monomers formation intermediate precursors amyloid fibrils would prevented experiments performed num h treatment freshly prepared amylin determine amylin species caused toxicity rin cells however degree cell death seen bacitracin treatment increased maximum attained even lowest amylin concentration could mean toxicity preceded amyloid deposition although amylin concentration required detection amyloid cell toxicity num num nmoll high relative circulating levels local amylin concentration around ss cells unknown may well higher especially conditions stimulate insulin amylin secretion
0.5852807.12941771.html.plaintext.txt	44	summary rin symb cells clear amylin bacitracin sensitive mechanism properties consistent ide inhibition mechanism increased amyloid formation cell toxicity data consistent emerging concept role ide diseases characterized amyloid regard interesting note transgenic animals expressing human amylin general develop islet amyloid unless diabetic conditions introduced one conditions high fat diet num interestingly shown increased lipid levels result impaired insulin degradation num free fatty acids directly inhibit ide activity num combination increased expression amyloidogenic amylin impaired insulin degrading activity may result formation islet amyloid models therefore possible conditions leading impaired ide activity eg elevated free fatty acids contribute amylin accumulation aggregation ss cell toxicity islet amyloid formation progression type num diabetes
0.5852807.12941771.html.plaintext.txt	45	summary rin symb cells clear amylin bacitracin sensitive mechanism properties consistent ide inhibition mechanism increased amyloid formation cell toxicity data consistent emerging concept role ide diseases characterized amyloid regard interesting note transgenic animals expressing human amylin general develop islet amyloid unless diabetic conditions introduced one conditions high fat diet num interestingly shown increased lipid levels result impaired insulin degradation num free fatty acids directly inhibit ide activity num combination increased expression amyloidogenic amylin impaired insulin degrading activity may result formation islet amyloid models therefore possible conditions leading impaired ide activity eg elevated free fatty acids contribute amylin accumulation aggregation ss cell toxicity islet amyloid formation progression type num diabetes
0.5852807.12941771.html.plaintext.txt	46	acknowledgments work supported us department veterans affairs research service bly memorial research fund university nebraska medical center
0.5852807.12941771.html.plaintext.txt	47	address correspondence reprint requests robert g bennett phd research service num veterans affairs medical center num woolworth ave omaha ne num e mail rgbennetatunmcedu
0.5852807.12941771.html.plaintext.txt	48	address correspondence reprint requests robert g bennett phd research service num veterans affairs medical center num woolworth ave omaha ne num e mail rgbennetatunmcedu
0.5852807.12941771.html.plaintext.txt	49	received publication january num num accepted revised form june num num
0.5852807.12941771.html.plaintext.txt	50	anp atrial natriuretic peptide ide insulin degrading enzyme mtt methylthiazolyldiphenyl tetrazolium bromide tca trichloroacetic acid
0.5852807.12941771.html.plaintext.txt	51	references top abstract research design methods results discussion references kahn se andrikopoulos verchere cb islet amyloid long recognized underappreciated pathological feature type num diabetessymbnum numnumabstractfree full text kahn se d alessio da schwartz mw fujimoto wy ensinck jw taborsky gj jr porte d jr evidence cosecretion islet amyloid polypeptide insulin beta cellssymbnum numnumabstract janson j ashley rh harrison d mcintyre butler pc mechanism islet amyloid polypeptide toxicity membrane disruption intermediate sized toxic amyloid particlessymbnum numnumabstract janson j soeller wc roche pc nelson rt torchia aj kreutter dk butler pc spontaneous diabetes mellitus transgenic mice expressing human islet amyloid polypeptideproc natl acad sci u symbnum numnumabstractfree full text verchere cb d alessio da wang andrikopoulos kahn se transgenic overproduction islet amyloid polypeptide amylin sufficient islet amyloid formationhorm metab symbnum numnummedline hoppener jw verbeek js de koning ej oosterwijk c van hulst kl visser vernooy hj hofhuis fm van gaalen berends mj hackeng wh et al chronic overproduction islet amyloid polypeptideamylin transgenic mice lysosomal localization human islet amyloid polypeptide lack marked hyperglycaemia hyperinsulinaemiasymbnum numnummedline fox n schrementi j nishi m ohagi chan sj heisserman ja westermark gt leckstrom westermark p steiner df human islet amyloid polypeptide transgenic mice model non insulin dependent diabetes mellitus niddmfebs symbnum numnummedline couce m kane la o brien td charlesworth j soeller w mcneish j kreutter d roche p butler pc treatment growth hormone dexamethasone mice transgenic human islet amyloid polypeptide causes islet amyloidosis beta cell dysfunctionsymbnum numnumabstract verchere cb d alessio da palmiter rd weir gc bonner weir baskin dg kahn se islet amyloid formation associated hyperglycemia transgenic mice pancreatic beta cell expression human islet amyloid polypeptideproc natl acad sci u symbnum numnumabstractfree full text hoppener jw oosterwijk c nieuwenhuis mg posthuma g thijssen jh vroom tm ahren b lips cj extensive islet amyloid formation induced development type ii diabetes mellitus contributes progression pathogenesis diabetes mouse modelsymbnum numnummedline duckworth wc bennett rg hamel fg insulin degradation progress potentialendocr symbnum numnumabstractfree full text kurochkin iv insulin degrading enzyme embarking amyloid destructiontrends biochem symbnum numnummedline bennett rg duckworth wc hamel fg degradation amylin insulin degrading enzymej biol symbnum numnumabstractfree full text vekrellis k ye z qiu wq walsh d hartley d chesneau v rosner mr selkoe dj neurons regulate extracellular levels amyloid beta protein via proteolysis insulin degrading enzymej symbnum numnumabstractfree full text shii k roth ra inhibition insulin degradation hepatoma cells microinjection monoclonal antibodies specific cytosolic proteaseproc natl acad sci u symbnum numnumabstract bhathena sj oie hk gazdar af voyles nr wilkins sd recant l insulin glucagon somatostatin receptors cultured cells clones rat islet cell tumorsymbnum numnumabstract peavy de edmondson jw duckworth wc selective effects inhibitors hormone processing insulin action isolated hepatocytessymbnum numnumabstract churukian cj improved puchtler congo red method demonstrating amyloidj symbnum numnum hansen mb nielsen se berg k re examination development precise rapid dye method measuring cell growthcell killj immunol symbnum numnummedline westermark p li zc westermark gt leckstrom steiner df effects beta cell granule components human islet amyloid polypeptide fibril formationfebs symbnum numnummedline puchtler h sweat f levine m binding congo red amyloidj histochem symbnum numnum howard cf longitudinal studies development diabetes individual macaca nigrasymbnum numnummedline kahn se verchere cb andrikopoulos asberry pj leonetti dl wahl pw boyko ej schwartz rs newell morris l fujimoto wy reduced amylin release characteristic impaired glucose tolerance type num diabetes japanese americanssymbnum numnumabstract westermark p amyloid polypeptide hormones relationshipsymbnum numnum d alessio da verchere cb kahn se hoagland v baskin dg palmiter rd ensinck jw pancreatic expression secretion human islet amyloid polypeptide transgenic mousesymbnum numnumabstract becker ab roth ra insulysin pitrilysin insulin degrading enzymes mammals bacteriameth symbnum numnummedline sipe jd amyloidosisannu rev symbnum numnummedline kurochkin iv amyloidogenic determinant substrate recognition motif insulin degrading enzymefebs symbnum numnummedline goto kurochkin iv alzheimer ss amyloid peptide interacts degraded insulin degrading enzymefebs symbnum numnummedline qiu wq walsh dm ye z vekrellis k zhang j podlisny mb rosner mr safavi hersh lb selkoe dj insulin degrading enzyme regulates extracellular levels amyloid beta protein degradationj biol symbnum numnumabstractfree full text wiltshire hattersley hitman ga walker m levy jc sampson m o rahilly frayling tm bell ji lathrop gm bennett dhillon r fletcher c groves cj jones e prestwich p simecek n rao pv wishart m bottazzo gf foxon r howell smedley d cardon lr menzel mccarthy mi genomewide scan loci predisposing type num diabetes uk population diabetes uk warren num repository analysis num pedigrees provides independent replication susceptibility locus chromosome numqam j hum symbnum numnummedline bertram l blacker d mullin k keeney d jones j basu yhu mcinnis mg go rc vekrellis k selkoe dj saunders aj tanzi re evidence genetic linkage alzheimer disease chromosome numqsymbnum numnumabstractfree full text myers holmans p marshall h kwon j meyer d ramic d shears booth j devrieze fw crook r hamshere m abraham r tunstall n rice f carty lillystone kehoe p rudrasingham v jones l lovestone perez tur j williams j owen mj hardy j goate susceptibility locus alzheimer disease chromosome numsymbnum numnumabstractfree full text ertekin taner n graff radford n younkin lh eckman c baker m adamson j ronald j blangero j hutton m younkin sg linkage plasma symb quantitative locus chromosome num late onset alzheimer disease pedigreessymbnum numnumabstractfree full text fakhrai rad h nikoshkov kamel fernstrom m zierath jr norgren luthman h galli j insulin degrading enzyme identified candidate diabetes susceptibility gene gk ratshum mol symbnum numnumabstractfree full text farris w mansourian chang y lindsley l eckman ea frosch mp eckman cb tanzi re selkoe dj guenette insulin degrading enzyme regulates levels insulin amyloid beta protein beta amyloid precursor protein intracellular domain vivoproc natl acad sci u symbnum numnumabstractfree full text bhathena sj timmers ki oie hk voyles nr recant l cytosolic insulin degrading activity islet derived tumor cell lines normal rat isletssymbnum numnumabstract oehler g bleyl h matthes kj hyperinsulinemia hepatic steatosisint j obe relat metab symb suppl numnum numnum hamel fg upward jl bennett rg vitro inhibition insulin degrading enzyme long chain fatty acids coenzyme thioesterssymbnum numnumabstractfree full text
0.5852807.12941771.html.plaintext.txt	52	references top abstract research design methods results discussion references kahn se andrikopoulos verchere cb islet amyloid long recognized underappreciated pathological feature type num diabetessymbnum numnumabstractfree full text kahn se d alessio da schwartz mw fujimoto wy ensinck jw taborsky gj jr porte d jr evidence cosecretion islet amyloid polypeptide insulin beta cellssymbnum numnumabstract janson j ashley rh harrison d mcintyre butler pc mechanism islet amyloid polypeptide toxicity membrane disruption intermediate sized toxic amyloid particlessymbnum numnumabstract janson j soeller wc roche pc nelson rt torchia aj kreutter dk butler pc spontaneous diabetes mellitus transgenic mice expressing human islet amyloid polypeptideproc natl acad sci u symbnum numnumabstractfree full text verchere cb d alessio da wang andrikopoulos kahn se transgenic overproduction islet amyloid polypeptide amylin sufficient islet amyloid formationhorm metab symbnum numnummedline hoppener jw verbeek js de koning ej oosterwijk c van hulst kl visser vernooy hj hofhuis fm van gaalen berends mj hackeng wh et al chronic overproduction islet amyloid polypeptideamylin transgenic mice lysosomal localization human islet amyloid polypeptide lack marked hyperglycaemia hyperinsulinaemiasymbnum numnummedline fox n schrementi j nishi m ohagi chan sj heisserman ja westermark gt leckstrom westermark p steiner df human islet amyloid polypeptide transgenic mice model non insulin dependent diabetes mellitus niddmfebs symbnum numnummedline couce m kane la o brien td charlesworth j soeller w mcneish j kreutter d roche p butler pc treatment growth hormone dexamethasone mice transgenic human islet amyloid polypeptide causes islet amyloidosis beta cell dysfunctionsymbnum numnumabstract verchere cb d alessio da palmiter rd weir gc bonner weir baskin dg kahn se islet amyloid formation associated hyperglycemia transgenic mice pancreatic beta cell expression human islet amyloid polypeptideproc natl acad sci u symbnum numnumabstractfree full text hoppener jw oosterwijk c nieuwenhuis mg posthuma g thijssen jh vroom tm ahren b lips cj extensive islet amyloid formation induced development type ii diabetes mellitus contributes progression pathogenesis diabetes mouse modelsymbnum numnummedline duckworth wc bennett rg hamel fg insulin degradation progress potentialendocr symbnum numnumabstractfree full text kurochkin iv insulin degrading enzyme embarking amyloid destructiontrends biochem symbnum numnummedline bennett rg duckworth wc hamel fg degradation amylin insulin degrading enzymej biol symbnum numnumabstractfree full text vekrellis k ye z qiu wq walsh d hartley d chesneau v rosner mr selkoe dj neurons regulate extracellular levels amyloid beta protein via proteolysis insulin degrading enzymej symbnum numnumabstractfree full text shii k roth ra inhibition insulin degradation hepatoma cells microinjection monoclonal antibodies specific cytosolic proteaseproc natl acad sci u symbnum numnumabstract bhathena sj oie hk gazdar af voyles nr wilkins sd recant l insulin glucagon somatostatin receptors cultured cells clones rat islet cell tumorsymbnum numnumabstract peavy de edmondson jw duckworth wc selective effects inhibitors hormone processing insulin action isolated hepatocytessymbnum numnumabstract churukian cj improved puchtler congo red method demonstrating amyloidj symbnum numnum hansen mb nielsen se berg k re examination development precise rapid dye method measuring cell growthcell killj immunol symbnum numnummedline westermark p li zc westermark gt leckstrom steiner df effects beta cell granule components human islet amyloid polypeptide fibril formationfebs symbnum numnummedline puchtler h sweat f levine m binding congo red amyloidj histochem symbnum numnum howard cf longitudinal studies development diabetes individual macaca nigrasymbnum numnummedline kahn se verchere cb andrikopoulos asberry pj leonetti dl wahl pw boyko ej schwartz rs newell morris l fujimoto wy reduced amylin release characteristic impaired glucose tolerance type num diabetes japanese americanssymbnum numnumabstract westermark p amyloid polypeptide hormones relationshipsymbnum numnum d alessio da verchere cb kahn se hoagland v baskin dg palmiter rd ensinck jw pancreatic expression secretion human islet amyloid polypeptide transgenic mousesymbnum numnumabstract becker ab roth ra insulysin pitrilysin insulin degrading enzymes mammals bacteriameth symbnum numnummedline sipe jd amyloidosisannu rev symbnum numnummedline kurochkin iv amyloidogenic determinant substrate recognition motif insulin degrading enzymefebs symbnum numnummedline goto kurochkin iv alzheimer ss amyloid peptide interacts degraded insulin degrading enzymefebs symbnum numnummedline qiu wq walsh dm ye z vekrellis k zhang j podlisny mb rosner mr safavi hersh lb selkoe dj insulin degrading enzyme regulates extracellular levels amyloid beta protein degradationj biol symbnum numnumabstractfree full text wiltshire hattersley hitman ga walker m levy jc sampson m o rahilly frayling tm bell ji lathrop gm bennett dhillon r fletcher c groves cj jones e prestwich p simecek n rao pv wishart m bottazzo gf foxon r howell smedley d cardon lr menzel mccarthy mi genomewide scan loci predisposing type num diabetes uk population diabetes uk warren num repository analysis num pedigrees provides independent replication susceptibility locus chromosome numqam j hum symbnum numnummedline bertram l blacker d mullin k keeney d jones j basu yhu mcinnis mg go rc vekrellis k selkoe dj saunders aj tanzi re evidence genetic linkage alzheimer disease chromosome numqsymbnum numnumabstractfree full text myers holmans p marshall h kwon j meyer d ramic d shears booth j devrieze fw crook r hamshere m abraham r tunstall n rice f carty lillystone kehoe p rudrasingham v jones l lovestone perez tur j williams j owen mj hardy j goate susceptibility locus alzheimer disease chromosome numsymbnum numnumabstractfree full text ertekin taner n graff radford n younkin lh eckman c baker m adamson j ronald j blangero j hutton m younkin sg linkage plasma symb quantitative locus chromosome num late onset alzheimer disease pedigreessymbnum numnumabstractfree full text fakhrai rad h nikoshkov kamel fernstrom m zierath jr norgren luthman h galli j insulin degrading enzyme identified candidate diabetes susceptibility gene gk ratshum mol symbnum numnumabstractfree full text farris w mansourian chang y lindsley l eckman ea frosch mp eckman cb tanzi re selkoe dj guenette insulin degrading enzyme regulates levels insulin amyloid beta protein beta amyloid precursor protein intracellular domain vivoproc natl acad sci u symbnum numnumabstractfree full text bhathena sj timmers ki oie hk voyles nr recant l cytosolic insulin degrading activity islet derived tumor cell lines normal rat isletssymbnum numnumabstract oehler g bleyl h matthes kj hyperinsulinemia hepatic steatosisint j obe relat metab symb suppl numnum numnum hamel fg upward jl bennett rg vitro inhibition insulin degrading enzyme long chain fatty acids coenzyme thioesterssymbnum numnumabstractfree full text
